aldosterone has been researched along with Hyperaldosteronism in 3378 studies
Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with confirmed primary aldosteronism underwent both AVS and 11C-Metomidate PET-CT (post-dexamethasone)." | 9.51 | 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial. ( Chuah, MB; Foo, RSY; Gomez-Sanchez, CE; Kek, PC; Khoo, CM; Lee, DHM; Ng, KS; O'Doherty, J; Puar, TH; Reilhac, A; Robins, EG; Shi, L; Tan, AWK; Tan, CJ; Tan, MCS; Teo, AE; Tong, AKT; Wang, KW; Wong, KM; Yee, S; Zheng, CQ, 2022) |
| "A common pharmacologic test for the diagnosis of primary aldosteronism (PA) is the administration of captopril to determine whether an abnormal plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio(ARR) persists, although active renin concentration (ARC) may offer advantages with regard to processing and standardization." | 9.14 | Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity. ( Chang, CC; Chang, HW; Chueh, SC; Fang, CC; Ho, YL; Huang, KH; Kuo, CC; Lin, CY; Lin, LY; Lin, SL; Lin, YH; Liu, KL; Tsai, CT; Wang, SM; Wu, KD; Wu, VC; Yen, RF, 2010) |
| "The aim of this study was to investigate the effect of short-term treatment with losartan, a selective and competitive angiotensin II (AngII) receptor blocker, on vascular endothelial growth factor (VEGF), active renin and kallikrein activity (KA) in patients with essential hypertension and primary aldosteronism." | 9.09 | Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension. ( Atanassova, I; Natchev, E; Orbetzova, M; Tzingilev, D; Zacharieva, S, 2001) |
| "The usefulness of the captopril test as a simultaneous screening method for primary aldosteronism (PA) and renovascular hypertension (RVH) was evaluated in 111 patients with essential hypertension, and in 79 patients with secondary hypertension, which included 16 patients with PA and 18 with RVH." | 9.07 | The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension. ( Inoue, J; Iwaoka, T; Naomi, S; Sasaki, M; Sato, T; Umeda, T; Yamauchi, J, 1993) |
| "The purpose of the study was to evaluate the effects of a dihydropyridine calcium antagonist, nicardipine (N), on blood pressure (BP) and aldosterone secretion in hypertensive patients (pt) with primary aldosteronism." | 9.06 | [Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism]. ( Begasse, F; Chamontin, B; David, D; Salvador, M, 1989) |
| " Therefore, we have studied the acute and chronic effect of nifedipine in 7 patients with idiopathic hyperaldosteronism (IHA) and 8 with aldosterone producing adenoma (APA)." | 9.06 | Acute and chronic effect of nifedipine in primary aldosteronism. ( Carpenè, G; Mantero, F; Opocher, G; Rocco, S, 1989) |
| "This presentation is a summary of our recent clinical studies on the therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism." | 9.05 | The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. ( Griffing, GT; Melby, JC, 1983) |
| " Since ketanserin, a more specific 5-HT2-serotoninergic (5-HT2) antagonist, has been shown to affect aldosterone secretion in essential hypertension, we have further investigated this mechanism by injecting ketanserin (10 mg i." | 9.05 | Effect of ketanserin in primary aldosteronism. ( Armanini, D; Boscaro, M; D'Agostino, D; Mantero, F; Opocher, G; Rocco, S, 1985) |
| "Captopril challenge test (CCT) is a simple and safe confirmatory test for primary aldosteronism (PA)." | 8.02 | Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism. ( Baba, S; Miyoshi, A; Obara, S; Shibayama, Y; Sugawara, H; Takahashi, B; Terae, S; Usubuchi, H; Wada, N, 2021) |
| "The saline suppression test (SST) and captopril challenge test (CCT) are commonly used confirmatory tests for primary aldosteronism (PA)." | 8.02 | Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study. ( Cheng, Q; Du, Z; Feng, Z; He, W; Hu, J; Li, Q; Liu, B; Song, Y; Wang, Z; Xu, Z; Yang, J; Yang, S, 2021) |
| "We prospectively enrolled 121 patients with confirmed primary aldosteronism who started mineralocorticoid receptor antagonist (canrenone) treatment." | 8.02 | Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism. ( Avataneo, V; Bertello, C; Buffolo, F; Burrello, J; D'Avolio, A; Mengozzi, G; Monticone, S; Mulatero, P; Pecori, A; Rabbia, F; Rumbolo, F; Veglio, F, 2021) |
| "The result interpretation of the captopril challenge test (CCT) for the diagnosis of primary aldosteronism (PA) is not standardized." | 8.02 | The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism. ( Chen, T; Li, Q; Li, Y; Ren, Y; Tian, H; Xiang, Q; Yu, K, 2021) |
| "Recent reports described cases of severe hypertension and hypokalemia accompanied by low renin and aldosterone levels during antifungal therapy with posaconazole and itraconazole." | 7.96 | Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals. ( Beck, KR; Odermatt, A; Telisman, L; Thompson, GR; van Koppen, CJ, 2020) |
| "Vascular function, including reactive hyperemia index (RHI), flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID), arterial stiffness including brachial-ankle pulse wave velocity (baPWV) and brachial intima-media thickness (IMT) and ROCK activity in peripheral leukocytes were measured before and after 12 weeks of treatment with eplerenone in 50 patients with IHA." | 7.91 | Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. ( Aibara, Y; Chayama, K; Goto, C; Hashimoto, H; Higashi, Y; Kajikawa, M; Kihara, Y; Kishimoto, S; Liao, JK; Maruhashi, T; Matsui, S; Nakashima, A; Noma, K; Oki, K; Takaeko, Y; Yusoff, FM, 2019) |
| "We investigated the changes of serum PTH levels induced by oral captopril (50 mg) administration in patients with primary essential hypertension (EH) and with primary aldosteronism (PA) caused by bilateral adrenal hyperplasia (BAH) or aldosterone-producing adenoma (APA), the latter before and after adrenalectomy." | 7.91 | PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy. ( Iacobone, M; Lenzini, L; Lerco, S; Maiolino, G; Prisco, S; Rossi, GP; Seccia, TM; Torresan, F; Vanderriele, PE, 2019) |
| " We report our long-term single-practice experience in 5 patients with chronic hyperaldosteronism (HA, including 3 with glucocorticoid remediable aldosteronism, GRA) treated with low-dose amiloride (a specific epithelial sodium channel [ENaC] blocker) 5-10 (mean 7) mg daily for 14-28 (mean 20) years." | 7.91 | Long-term BP control and vascular health in patients with hyperaldosteronism treated with low-dose, amiloride-based therapy. ( Hong, M; Hussain, T; Izzo, JL; Osmond, PJ, 2019) |
| "The saline infusion test (SIT) and the captopril test (CT) are widely used as confirmatory tests for primary aldosteronism (PA)." | 7.91 | Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism. ( Chang, CC; Lin, PC; Lin, YH; Tsai, YC; Wang, SM; Wu, CH; Wu, V; Yang, SY; Yang, YW, 2019) |
| "The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA)." | 7.91 | The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population. ( Feng, WH; Li, HY; Li, P; Zhang, WJ; Zhang, Y; Zhu, DL; Zhu, KY, 2019) |
| " We report our long-term single-practice experience in an unusual group of five patients with chronic hyperaldosteronism (HA, including three with glucocorticoid-remediable aldosteronism, GRA) treated with low-dose amiloride (a specific epithelial sodium channel [ENaC] blocker) 5-10 (mean 7) mg daily for 14-28 (mean 20) years." | 7.91 | Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism. ( Hong, M; Hussain, T; Izzo, JL; Osmond, PJ, 2019) |
| "Among patients with essential hypertension, circulating endogenous ouabain and Aldo are typically coelevated and their BP is salt-sensitive." | 7.83 | Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension. ( Brioni, E; Casamassima, N; Hamlyn, JM; Lanzani, C; Manunta, P; Messaggio, E; Simonini, M; Tentori, S; Zagato, L, 2016) |
| "As metoclopramide stimulates aldosterone secretion, we tested its usefulness in the assessment of lateralization of primary aldosteronism by adrenal vein sampling (AVS)." | 7.83 | Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism. ( Barbiero, G; Battistel, M; Bisogni, V; Maiolino, G; Miotto, D; Rossi, GP; Rossitto, G; Sanga, V, 2016) |
| "The objective of this article is to measure serum dehydroepiandrosterone sulfate (DHEA-S) concentration in both genders with primary aldosteronism (PA)." | 7.81 | Serum dehydroepiandrosterone sulfate concentration is lower in women with primary aldosteronism. ( Chen, AH; Huang, TS; Li, HY; Lin, YH; Wu, VC, 2015) |
| " In this study, we attempted to determine whether peripheral plasma levels of 18-oxocortisol (18oxoF) and 18-hydroxycortisol could contribute to the clinical differentiation between aldosteronoma and bilateral hyperaldosteronism in 234 patients with primary aldosteronism, including computed tomography (CT)-detectable aldosteronoma (n=113) and bilateral hyperaldosteronism (n=121), all of whom underwent CT and adrenal venous sampling." | 7.81 | Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. ( Arai, Y; Gomez-Sanchez, CE; Honma, S; Ito, S; Iwakura, Y; Kudo, M; Morimoto, R; Nakamura, Y; Okuyama, M; Omata, K; Ono, Y; Rainey, WE; Sasamoto, H; Sasano, H; Satoh, F; Seiji, K; Takase, K; Yamashita, K, 2015) |
| " We report a case of 55-year-old man with primary aldosteronism (PA) whose hyperaldosteronism was suppressed with the PPAR γ agonist pioglitazone." | 7.79 | Suppression of primary aldosteronism and resistant hypertension by the peroxisome proliferator-activated receptor gamma agonist pioglitazone. ( Harada, E; Kashiwagi, Y; Mizuno, Y; Morita, S; Shono, M; Yano, M; Yasue, H; Yoshimura, M, 2013) |
| "The aim of this paper is to report a case of unilateral PA with spontaneous remission and reduction of cardiac hypertrophy after long-term spironolactone (SP) therapy." | 7.78 | Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. ( Demura, M; Karashima, S; Kometani, M; Takata, H; Takeda, Y; Yamagishi, M; Yoneda, T, 2012) |
| "To study on the difference of plasma renin activity (PRA), angiotensin II (Ang II), and aldosterone levels in patients with essential hypertension (EH) or primary aldosteronism (PA) or pheochromocytoma (PHEO), and to analyze the sensitivity and specificity on the diagnosis of PA among patients with hypertension with aldosterone/PRA ratio (ARR)." | 7.78 | [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension]. ( Chen, S; Fu, CL; Li, M; Lu, L; Song, AL; Sun, ML; Tong, AL; Wang, YH; Zeng, ZP, 2012) |
| " We are not aware of any published QOL assessment in patients with bilateral primary aldosteronism (BPA), before or after commencing medical treatment (MT) with spironolactone and/or amiloride." | 7.77 | Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. ( Ahmed, AH; Gordon, RD; Pimenta, E; Stowasser, M; Sukor, N, 2011) |
| " We characterized the pharmacokinetic/pharmacodynamic relationships of a prototypical ASI, (+)-(5R)-4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl]benzonitrile hydrochloride (CGS020286A, FAD286, FAD) and compared these profiles to those of the 11beta-hydroxylase inhibitor metyrapone (MET) in two rodent models of secondary hyperaldosteronism and corticosteronism." | 7.76 | Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone. ( Beil, M; Fu, F; Hu, CW; Jeng, AY; Liang, G; Rigel, DF, 2010) |
| "We, therefore compared, head-to-head, the aldosterone-renin ratio based on PRA with that based on DRA, at baseline and after captopril administration, for identifying aldosterone-producing adenoma (APA) in 251 patients of the Primary Aldosteronism Prevalence in hYpertension Study (PAPY)." | 7.76 | The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. ( Barisa, M; Belfiore, A; Desideri, G; Ferri, C; Letizia, C; Maccario, M; Mantero, F; Morganti, A; Palumbo, G; Patalano, A; Pessina, AC; Roman, E; Rossi, GP; Seccia, TM, 2010) |
| "We describe an instance of a false-positive laboratory diagnosis of primary aldosteronism (by both screening and confirmatory test) in a normotensive 34-year-old healthy woman taking Yasmin (drospirenone + ethinylestradiol) (Shering S." | 7.74 | Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy. ( Corrocher, R; Olivieri, O; Pavan, C; Pizzolo, F, 2007) |
| "This prospective study was designed to compare the captopril suppression test with the salt-loading approach to confirm the diagnosis of primary aldosteronism." | 7.71 | Captopril suppression versus salt loading in confirming primary aldosteronism. ( Agharazii, M; Douville, P; Grose, JH; Lebel, M, 2001) |
| "We evaluated the effects of prolonged spironolactone treatment on aldosterone secretion in patients with primary aldosteronism." | 7.69 | Aldosterone response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment. ( Ichikawa, S; Murata, K; Nakamura, T; Ono, Z; Sakamaki, T; Sakamoto, H; Sato, K; Yagi, A, 1994) |
| " We examined the possible association between restriction fragment length polymorphisms in the atrial natriuretic peptide (ANP) gene and responsiveness of aldosterone to angiotensin II in 59 patients with primary aldosteronism due to aldosterone-producing adenoma (APA)." | 7.69 | Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. ( Ballantine, DM; Gordon, RD; Jonsson, JR; Klemm, SA; Stowasser, M; Tunny, TJ, 1994) |
| " Study 1: A long-term (4 weeks) treatment with slow-release nifedipine (Nif), 40-60 mg/day, was performed in 9 in-patients with essential hypertension (EHT)." | 7.69 | [Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism]. ( Iimura, O; Shimamoto, K; Yokoyama, T, 1995) |
| "Approximately half of Caucasian patients with essential hypertension and with hyperaldosteronism exhibit elevated circulating levels of endogenous ouabain." | 7.69 | Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. ( De Toni, R; Hamlyn, JM; Manunta, P; Pavan, E; Pessina, AC; Rossi, G; Semplicini, A, 1995) |
| " Tsukuba hypertensive mice (THM) carry both human renin and angiotensinogen genes, and develop hypertension." | 7.69 | Development of polyuria in Tsukuba hypertensive mice carrying human renin and angiotensinogen genes. ( Fukamizu, A; Ikemoto, F; Mino, N; Murakami, K; Nishikibe, M; Tsuchida, M; Uehara, S, 1995) |
| "We compared the aldosterone-producing potency of the angiotensin II-sensitive wild-type aldosterone synthase genes and the ACTH-sensitive hybrid 11 beta-hydroxylase/aldosterone synthase gene by examining aldosterone, PRA, and cortisol day-curves (2-hourly levels over 24 h) in patients with familial hyperaldosteronism type I, before and during long-term (0." | 7.69 | In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes. ( Gartside, MG; Gordon, RD; Stowasser, M; Taylor, WL; Tunny, TJ, 1997) |
| " Nineteen out of 47 patients (40%) with confirmed unilateral aldosterone-producing adenoma (APA) were responsive to low-dose angiotensin II infusion (AII-R), as defined by an increase in plasma aldosterone concentration of > 50% over basal at 2 ng/kg per min for 60 min." | 7.68 | Angiotensin-responsive aldosterone-producing adenomas: postoperative disappearance of aldosterone response to angiotensin. ( Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ, 1993) |
| " In vitro short-term production of cortisol by dispersed tumour and non-tumourous adrenal cortical cells was measured with and without added angiotensin II (AII) or adrenocorticotrophin (ACTH) in adrenals removed from five patients with primary aldosteronism." | 7.68 | Cortisol production by aldosterone-producing adenomas in vitro. ( Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ, 1993) |
| "Patients with an aldosterone-producing adenoma (APA) characteristically fail to show an increase in plasma aldosterone (PA) concentration with maneuvers that increase angiotensin II (Ang II), yet they retain a brisk response of PA to adrenocorticotrophic hormone." | 7.68 | Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism. ( Cook, MD; Cook, VI; Kimura, B; Phillips, MI; Wilcox, CS, 1993) |
| "A case of primary aldosteronism treated with spironolactone therapy has been followed up for 24 years." | 7.68 | Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma. ( Hashimoto, T; Ito, Y; Koshida, H; Miyamori, I; Morimoto, S; Morise, T; Takeda, R; Yamazaki, T, 1992) |
| "This study was conducted to elucidate renal uric acid metabolism in patients with primary aldosteronism (PA;16 cases) as compared with normotensive subjects (NT;25 cases) and essential hypertensives (EHT;51 cases)." | 7.68 | [Study on uric acid metabolism in patients with primary aldosteronism]. ( Iimura, O; Kikuchi, K; Komura, H; Marusaki, S; Namba, M; Ohtomo, T; Satoh, N; Suzuki, S; Takada, T, 1992) |
| "Urinary excretion of 18-hydroxycortisol (18-OHF), 18-hydroxycorticosterone (18-OHB) and aldosterone 18-glucuronide (Aldo-18-glu) was measured in 10 patients with primary aldosteronism; 5 with aldosterone-producing adenoma (APA) and 5 with idiopathic hyperaldosteronism (IHA), 10 patients with essential hypertension (EHT) and 11 normotensive subjects." | 7.68 | Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism. ( Iki, K; Itoh, Y; Miyamori, I; Takasaki, H; Takeda, R; Takeda, Y, 1992) |
| "We aimed to re-evaluate the captopril test in the diagnosis of primary hyperaldosteronism." | 7.68 | Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. ( Bartlett, WA; Browning, MC; Gunn, A; Hambling, C; Jung, RT, 1992) |
| " 19-dihydroxycorticosterone (18, 19(OH)2-B), 18-hydroxy-19-norcorticosterone (18-OH-19-nor-B), 18-hydroxycorticosterone (18-OH-B), 18-hydroxycortisol (18-OH-F) and aldosterone were measured in 25 patients with primary aldosteronism, 16 with an aldosterone-producing adenoma and 9 with idiopathic hyperaldosteronism." | 7.68 | Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism. ( Iki, K; Miyamori, I; Takeda, R; Takeda, Y; Vecsei, P, 1992) |
| "Plasma concentrations of renin and aldosterone were measured before and 60 min after taking 25 mg captopril in 242 patients with arterial hypertension (124 men, 118 women, aged 51." | 7.68 | [Does the captopril test improve the diagnosis of primary hyperaldosteronism?]. ( Bönner, G; Degenhardt, S; Grimm, U; Krone, W; Stimpel, M; Wambach, G, 1992) |
| "To evaluate the importance of an endogenous sodium pump inhibitor in the pathogenesis of low renin human hypertension, the urinary excretion of a digoxin-like immunoreactive substance (DLIS) was measured in eight patients with primary aldosteronism (n = 5, with adenomas) during two sequential 1-week periods of low- (20 mmol/l NaCl) and high- (200 mmol/l NaCl) sodium intake." | 7.68 | Does a digoxin-like substance participate in vascular and pressure control during dietary sodium changes in patients with primary aldosteronism? ( Clerico, A; Del Chicca, MG; Graziadei, L; Panarace, G; Pedrinelli, R; Salvetti, A; Spessot, M; Taddei, S, 1991) |
| "This paper documents an unexpected rise in plasma aldosterone concentration (PAC) to the furosemide-upright test despite a decrease in adrenocorticotropin (ACTH) by dexamethasone, and an unresponsiveness in plasma renin activity to this stimulus in a patient with aldosterone producing adenoma." | 7.68 | An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma. ( Kouchi, T; Mashiba, H; Shigemasa, C; Yoshida, A, 1991) |
| "The effect of captopril on the aldosterone response to potassium was studied in 6 patients with idiopathic adrenal hyperplasia (IAH) and in 4 patients with an aldosterone-producing adenoma (APA), who all have suppressed activity of circulating renin-angiotensin system (RAS)." | 7.68 | Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism. ( Chouman, M; Fallo, F; Pagotto, U; Pistorello, M, 1991) |
| "Plasma levels of atrial natriuretic peptide (ANP) were measured in patients with normal renin essential hypertension (n = 12), low renin essential hypertension (n = 11) and primary aldosteronism due to aldosterone producing adenoma (APA, n = 8) and idiopathic hyperaldosteronism (IHA, n = 3) after overnight rest in the supine position and after 4 h upright posture and furosemide administration." | 7.68 | Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism. ( Fütö, L; Gláz, E; Gutkowska, J; Kiss, R; Rácz, K; Sergev, O; Varga, I, 1991) |
| "This case of Conn's syndrome demonstrates long-term (seven years) efficacy of triamterene-thiazide therapy in controlling both hypertension and hypokalemia." | 7.68 | Long-term medical management of aldosterone-producing adenoma. ( Bornemann, M, 1990) |
| "In order to elucidate whether pituitary peptides other than ACTH which are derived from the proopiomelanocortin (POMC) are involved for aldosterone secretion in primary aldosteronism, we administered ovine corticotropin releasing factor (CRF), beta-endorphin and naloxone to seven patients with aldosterone producing adenoma." | 7.68 | Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism. ( Koshida, H; Matsubara, T; Miyamori, I; Okamoto, S; Soma, R; Takasaki, H; Takeda, R, 1990) |
| "Time-related changes in plasma levels of aldosterone, deoxycorticosterone, corticosterone, and cortisol were studied during treatment with spironolactone in 8 patients with primary aldosteronism due to adenomas." | 7.68 | Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism. ( Ichikawa, S; Murata, K; Nakamura, T; Ono, Z; Sakamaki, T; Sakamoto, H; Takayama, Y, 1990) |
| "The plasma aldosterone (A) and desoxycorticosterone (DOCS) levels were measured in 10 patients with primary aldosteronism and in 2 subgroups with low-renin hypertensive disease (LRHD): (1) those with normal adrenal glands++ (n - 11) and (2) those with structural changes in the cortex (n - 11)." | 7.68 | [Plasma mineralocorticoids--aldosterone and desoxycorticosterone-- in patients with"low-renin"arterial hypertension]. ( Bulkina, OS; Gorbacheva, ON; Levitskaia, IuV; Obtrakht, NV; Sokolova, RI; Ustinova, SE, 1990) |
| "Aldosterone-producing adenomas in patients who have not been given spironolactone are more responsive to ACTH than to angiotensin II." | 7.67 | In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy. ( Wisgerhof, M, 1984) |
| "We evaluated a new method utilizing saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism." | 7.67 | Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism. ( Brown, RD; Hegstad, RL; Hogan, MJ; Kem, DC, 1984) |
| "Plasma concentrations of atrial natriuretic factor and some vasoactive substances were determined in 8 patients with aldosterone-producing adenoma, 10 with idiopathic adrenal hyperplasia, 10 normotensive subjects and 12 patients with essential hypertension." | 7.67 | The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism. ( Furuta, H; Katayama, T; Nakada, T; Shimazaki, J; Sumiya, H, 1989) |
| "Effects of a single administration of captopril on plasma and urinary vasopressin (AVP) were examined in 8 normotensive (NT) female volunteers, 17 patients with essential hypertension (EHT) and 2 patients with primary aldosteronism (PA)." | 7.67 | Effect of single-administration captopril on plasma and urinary vasopressin in normotensive subjects and patients with essential hypertension and primary aldosteronism. ( Fujishima, M; Kimura, Y; Muratani, H; Nakao, Y; Takishita, S; Tomita, Y; Tsuchihashi, T; Ueno, M, 1989) |
| "The effects of ovine corticotropin releasing factor (o-CRF) on plasma aldosterone, 18-OH-corticosterone (18-OHB), plasma adrenocorticotropin (ACTH) and cortisol were determined in eight patients with primary aldosteronism, six with aldosterone-producing adenoma (APA) and two with idiopathic hyperaldosteronism (IHA)." | 7.67 | Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism. ( Ikeda, M; Koshida, H; Matsubara, T; Miyamori, I; Morise, T; Okamoto, S; Takeda, R; Takeda, Y; Vecsei, P; Yasuhara, S, 1987) |
| " To investigate this issue, the opiate antagonist naloxone was administered to 8 normals and 14 patients with primary aldosteronism, 6 with an aldosterone-producing adenoma (APA) and 8 with IHA." | 7.67 | Effect of naloxone on the adrenal cortex in primary aldosteronism. ( Boscaro, M; Fallo, F; Mantero, F; Sonino, N, 1988) |
| " The present study evaluated plasma beta-endorphin, ACTH, cortisol, and aldosterone levels in patients with IHA (n = 10), aldosterone-producing adenomas (n = 4), essential hypertension (n = 11), and normal subjects (n = 10)." | 7.67 | Plasma beta-endorphin levels in primary aldosteronism. ( Berelowitz, B; Griffing, GT; Hudson, M; Manson, JA; McIntosh, T; Melby, JC; Salzman, R, 1985) |
| "Bromocriptine can prevent an increase in plasma aldosterone during the infusion of angiotensin II in normal subjects and during upright posture in some patients with idiopathic hyperaldosteronism." | 7.67 | Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism. ( Mellinger, RC; Wisgerhof, M, 1985) |
| "Three patients with idiopathic hyperaldosteronism were continuously treated with trilostane, a competitive inhibitor of adrenal 3 beta-hydroxysteroid dehydrogenase (3 beta-HSDH) (3 to 4 2/3 years)." | 7.67 | Long-term treatment of idiopathic hyperaldosteronism using trilostane. ( Demura, H; Horiba, N; Nomura, K; Shizume, K, 1986) |
| "Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were measured in 19 cases with primary aldosteronism (PA) and 72 with essential hypertension (EHT) to differentiate the two disorders in the following conditions: after overnight recumbency (basal state) and after oral administration of captopril." | 7.67 | Single oral administration of captopril may not bring an improvement in screening of primary aldosteronism. ( Abe, I; Fujishima, M; Kawasaki, T; Kawazoe, N; Muratani, H; Takishita, S; Tomita, Y; Tsuchihashi, T; Ueno, M, 1987) |
| "The purpose of study was to investigate the role of angiotensin II in idiopathic primary aldosteronism (IPA) and to evaluate the interest of angiotensin converting enzyme inhibitors (ACEI) in its management." | 7.67 | [Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism]. ( Chamontin, B; Rostaing, L; Salva, P; Salvador, M, 1987) |
| "The validity of the captopril test for primary aldosteronism (PA) was tested in patients with surgically verified PA (n = 12) or essential hypertension (EHT, n = 20) with different levels of sodium intakes." | 7.67 | Effects of sodium intake on the captopril test for primary aldosteronism. ( Iwaoka, T; Naomi, S; Sato, T; Umeda, T, 1987) |
| "In order to evaluate whether changes in the plasma concentration of aldosterone (PA) following the administration of captopril, an inhibitor of angiotensin-converting enzyme, will establish the diagnosis of primary aldosteronism we have used this test in 9 healthy subjects and in 22 patients with various forms of hypertension, including 5 patients with primary aldosteronism due to idiopathic adrenal hyperplasia (n = 4) or aldosterone-producing adenoma (n = 1)." | 7.67 | [Detection of primary aldosteronism using the captopril test]. ( Graninger, W; Nowotny, P; Pirich, K; Vierhapper, H; Waldhäusl, W, 1987) |
| " In order to evaluate the effect of a calcium channel blocking agent (Verapamil) in conditions of abnormal aldosterone secretion, we have studied 11 patients with primary aldosteronism, 5 with idiopathic hyperaldosteronism (IHA) and 6 with aldosterone producing adenoma (APA)." | 7.67 | Effect of verapamil on aldosterone secretion in primary aldosteronism. ( Mantero, F; Murgia, A; Opocher, G; Rocco, S, 1987) |
| "Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were measured in 19 cases with primary aldosteronism (PA) and in 72 with essential hypertension (EHT) to differentiate the two disorders during the following conditions on normal salt diet: after overnight recumbency (basal state) and 2 hours after oral administration of 25 mg of captopril." | 7.67 | Is single oral administration of captopril beneficial in screening for primary aldosteronism? ( Abe, I; Kawasaki, T; Kawazoe, N; Kimura, Y; Muratani, H; Takishita, S; Tomita, Y; Tsuchihashi, T; Ueno, M; Uezono, K, 1986) |
| "To examine the previous suggestion that the endogenous dopaminergic activity would be increased in patients with primary aldosteronism, dose-response curves of aldosterone and prolactin stimulation by the dopamine antagonist metoclopramide were established in a pilot study by injecting metoclopramide 1, 2." | 7.67 | Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism. ( Althoff, PH; Jungmann, E; Rosak, C; Schöffling, K; Schwedes, U, 1986) |
| "Plasma aldosterone, 18-hydroxycorticosterone (18-OH-B), 18-hydroxydeoxycorticosterone (18-OH-DOC), corticosterone, cortisol and prolactin levels were determined during an angiotensin II infusion at increasing rates both with and without a simultaneous infusion of dopamine in seven normotensive subjects, in ten patients with essential hypertension, and in ten patients with primary aldosteronism." | 7.67 | Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. ( Lorenz, R; von Werder, K; Weber, PC; Witzgall, H, 1985) |
| "In order to investigate the validity of angiotensin converting enzyme inhibition with captopril as a screening test for primary aldosteronism (PA), 50 mg of captopril were administered orally to 7 patients with PA, 17 with essential hypertension (EH), 5 with renovascular hypertension (RVH), 2 with renoparenchymal hypertension (RH) and 8 normal volunteers." | 7.67 | Clinical evaluation of the captopril screening test for primary aldosteronism. ( Fujii, Y; Hamasaki, S; Inoue, J; Iwaoka, T; Miura, F; Naomi, S; Sato, T; Umeda, T, 1985) |
| "Serum 18-hydroxycorticosterone, aldosterone, and potassium were measured under basal conditions in 34 patients with documented primary aldosteronism, 10 patients with essential hypertension, and 9 normal subjects." | 7.67 | The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. ( Brown, RD; Hanson, CS; Hollifield, JW; Kem, DC; Painton, R; Tang, K; Weinberger, MH, 1985) |
| "In earlier studies by our group it was shown that the urinary tetrahydroaldosterone excretion is a more reliable test for the diagnosis of primary aldosteronism than aldosterone-18-glucuronide ('urinary aldosterone')." | 7.67 | 21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism. ( Abdelhamid, S; Lewicka, S; Vecsei, P; Winter, J, 1985) |
| "Six patients with primary aldosteronism (PA), one with idiopathic hyperaldosteronism (IHA), one with glucocorticoid responsible hyperaldosteronism (GRHA) and eight with essential hypertension (EH) were treated with trilostane (MWD-1822) (4 alpha, 5-epoxy-17 beta-hydroxy-3-oxo-5 alpha-androstane-2 alpha-carbonitrile), an inhibitor of adrenal steroid biosynthesis, for 9-47 days with a daily dose of 30-960 mg." | 7.66 | [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)]. ( Fukuchi, S; Haruyama, K; Shigetomi, S; Yamazaki, M, 1982) |
| "Angiotensin II (angio II) receptors have been compared using tissues from aldosterone-producing adenomas (APAs), adjacent nontumorus tissue, and normal human adrenal glomerulosa." | 7.66 | Angiotensin II receptors and in vitro aldosterone responses of aldosterone-producing adenomas, adjacent nontumorous tissue, and normal human adrenal glomerulosa. ( Bravo, E; Brown, G; Douglas, J, 1980) |
| "The humoral and hemodynamic effects of converting enzyme inhibition captopril are presented in two patients with primary hyperaldosteronism (PHA)." | 7.66 | Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism. ( Demers, LM; Harrison, TS; Hayes, AH; Luderer, JR, 1982) |
| "To investigate possible dopaminergic effects on aldosterone production, we administered the dopamine antagonist metoclopramide to 11 normal subjects, 8 patients with primary aldosteronism due to adenoma or hyperplasia, and 5 other patients with the glucocorticoid-suppressible form of hyperaldosteronism (GSH)." | 7.66 | Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism. ( Fineberg, NS; Ganguly, A; Grim, CE; Pratt, JH; Weinberger, MH, 1983) |
| "Infusion of angiotensin II into a patient with dexamethasone-suppressible hyperaldosteronism caused a brisk increase in plasma aldosterone concentration." | 7.66 | 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism. ( Brown, JJ; Fraser, R; Lever, AF; Robertson, JI; Usherwood, T; Zoccali, C, 1983) |
| "To assess the interaction between dopamine and aldosterone secretion in primary aldosteronism, the dopamine antagonist, metoclopramide (methoxy-2-chloro-5-procainamide), was given as an i." | 7.66 | Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism. ( Fukuchi, S; Hashimoto, S; Ikeda, K; Mizuno, K; Yaginuma, K; Yamazaki, M, 1983) |
| "To study the secretion of adrenocortical steroids, the renin releasing test and the angiotensin II analog (1-Sar, 8-Ala-Angiotensin II) infusion test was performed on four subjects with primary aldosteronism." | 7.66 | [Corticoid secretion in primary aldosteronism. II. The renin releasing test and the angiotensin II analog infusion test (author's transl)]. ( Eba, H; Funyu, T; Furusawa, M; Hitomi, H; Kawamata, A; Kido, K; Kogawa, T; Morita, S; Nigawara, K; Sugawara, S; Tanaka, T; Terayama, Y; Tulachan, Y; Yagihashi, Y, 1980) |
| "To study the role of serotonin in regulating the release of aldosterone, we gave single, oral doses of cyproheptadine, an antiserotoninergic agent, to five normal volunteers with high aldosterone levels secondary to sodium deprivation and to 14 patients with aldosteronism (six with idiopathic aldosteronism due to bilateral adrenal hyperplasia and eight with adrenal adenoma)." | 7.66 | Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism. ( Gniadek, TC; Grekin, RJ; Gross, MD; Villareal, JZ, 1981) |
| "The effect of 5 to 9 days of metyrapone administration (400 mg/m2 every 4 h) on aldosterone, deoxycorticosterone, plasma renin activity, electrolyte balance, and blood pressure was investigated in 2 normotensive siblings (one of whom showed limited ACTH reserve), in 3 patients with hypertension and dexamethasone-suppressible hyperaldosteronism, and in a hypertensive patient with primary hyperaldosteronism due to bilateral adrenal hyperplasia." | 7.66 | Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism. ( Levine, LS; New, MI; Sonino, N, 1981) |
| "The behaviour of plasma renin, aldosterone, cortisol and prolactin after administration of a drug with antidopaminergic action, metoclopramide, was evaluated in 6 normal subjects, 8 patients affected by primary aldosteronism and in 5 patients affected by anterior hypopituitarism." | 7.66 | Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism. ( Armanini, D; Boscaro, M; Fallo, F; Mantero, F; Opocher, G; Valpione, E, 1981) |
| "For distinguishing primary aldosteronism from essential hypertension, we use simple direct radioimmunoassays for "aldosterone" (aldosterone and other materials that react with the antibody to aldosterone) and "18-hydroxycorticosterone" (similarly) in unprocessed urine." | 7.66 | Direct radioimmunoassays for "aldosterone" and "18-hydroxycorticosterone" in unprocessed urine, and their use in screening to distinguish primary aldosteronism from hypertension. ( Abdelhamid, S; Benraad, TJ; Haack, D; Hofman, J; Lichtwald, K; Vecsei, P, 1982) |
| "The most abundant substance in the urinary free steroid fraction of patients with primary aldosteronism has been identified as 18-hydroxycortisol." | 7.66 | Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. ( Chu, MD; Ulick, S, 1982) |
| "To determine if the adrenal sensitivity to angiotensin II in patients with an aldosterone-producing adenoma differs from that in patients with idiopathic hyperaldosteronism, we infused graded doses of angiotensin II into 17 patients with primary aldosteronism and measured their plasma aldosterone concentrations after each dose." | 7.66 | The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. ( Brown, RD; Carpenter, PC; Edis, AJ; Hogan, MJ; Wisgerhof, M, 1981) |
| "In 31 patients with primary aldosteronism routine clinical and laboratory data, the effect of orthostasis on plasma aldosterone (PA), plasma renin activity (PRA) and cortisol (PC), effect of fludrocortisone or high sodium intake on basal PA and night-day fluctuations of basal PA and PC with and without suppression of pituitary ACTH by dexamethasone were determined to differentiate patients with a unilateral aldosterone producing tumour (adenoma, APA, n=20; carcinoma, CA, n=1) from those with idiopathic bilateral adrenal hyperplasia (IAH, n=10)." | 7.66 | Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone. ( Furrer, J; Glänzer, K; Siebenschein, R; Siegenthaler, W; Studer, A; Vetter, H; Vetter, W; Witassek, F, 1978) |
| "Plasma aldosterone increases briskly during upright posture in patients with idiopathic hyperaldosteronism, despite only small increases in PRA and presumably small increases in angiotensin II." | 7.66 | Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism. ( Brown, RD; Carpenter, PC; Wisgerhof, M, 1978) |
| "This study describes the effects of [des-Aspartyl(1)]-angiotensin II ([des-Asp]-AII) on blood pressure and aldosterone production in patients with primary aldosteronism due to aldosterone-producing adrenal adenoma (APA) and idiopathic adrenal hyperplasia (IHA), and in normotensive control subjects." | 7.66 | Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism. ( Ayers, CR; Carey, RM; Herf, SM; Peach, MJ; Vaughan, ED, 1979) |
| "Plasma 18-hydroxycorticosterone (180HB) concentration was measured in 23 patients with primary aldosteronism." | 7.66 | The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. ( Biglieri, EG; Schambelan, M, 1979) |
| "The response to indomethacin of a patient with Bartter's syndrome and proximal tubular sodium wasting is described." | 7.66 | Analysis of factors influencing the renin-aldosterone system in a patient with Bartter's syndrome. ( Falls, WF; Stacy, WK; Sudan, M, 1979) |
| "3%) the normal, aldosterone-18-glucuronide concentration was clinically misleading, but increased free aldosterone and/or tetrahydroaldosterone values suggested the presence of hyperaldosteronism, which in many of these cases was confirmed by elevated excretion of the possible major aldosterone precursor 18-hydroxycorticosterone (18-OH-B)." | 7.66 | Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension. ( Abdelhamid, S; Fiegel, P; Gless, KH; Haack, D; Lichtwald, K; Vecsei, P; Walb, D, 1979) |
| "In primary aldosteronism due to an adrenal adenoma (n=2), treatment with a spirolactone (160 mg Canrenone/day for 7 days) decreased plasma aldosterone and urinary aldosterone-18-glucuronide." | 7.65 | Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism. ( Appenheimer, M; Glänzer, K; Herschbach, ML; Krück, F; Lucas, R; Vetter, H; Weiand, H; Witassek, F, 1977) |
| "In three patients with Bartter's syndrome, indomethacin administration resulted in the disappearance of the hypokalemic alkalosis and in a normalization of the elevated plasma renin activity." | 7.65 | Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism? ( Bakker, K; Brentjens, JR; de Jong, PE; Donker, AJ; Doorenbos, H; van Eps, LW, 1977) |
| "To investigate the role of the renin angiotensin system in the pathogenesis of hypertension in Cushing's syndrome two patients with hypercorticism were infused with 20 mg saralasin (1-sar-8-ala-angiotensin II) over a period of 30 minutes under constant blood pressue control." | 7.65 | The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome. ( Beckerhoff, R; Cottier, P; Redlich, B; Siegenthaler, W; Vetter, H; Vetter, W, 1976) |
| "The responses of blood pressure, plasma renin activity (PRA) and plasma aldosterone concentration (PAC) to infusion of either angiotensin II (10 ng/Kg/min) or norepinephrine (100 ng/Kg/min) were observed in 25 patients with essential hypertension." | 7.65 | Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension. ( Yamamoto, Y, 1975) |
| "The response of plasma aldosterone to fludrocortisone administration (400 mug 12-hourly for 3 days) was studied in twenty-two patients with primary hyperaldosteronism." | 7.65 | Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension. ( Allison, ME; Brown, JJ; Ferriss, JB; Fraser, R; Lever, AF; Luke, RG; Padfield, PL; Robertson, JI, 1975) |
| " have applied the diazoxide test for the screening of primary hiperaldosteronism to 22 nephropatic patients suffering from hypertension and with different degrees of renal function." | 7.65 | [Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function]. ( Albertini, A; Cecchettin, M; Ghielmi, S; Maiorca, R; Orlandini, A; Signorini, C, 1975) |
| "A 44-year old woman without history of hypertension in her 4 pregnancies was hospitalized for hemoptysia and found to have hypertension 230/120 to 250/150: she had been taking 2 tablets of Lyndiol (5 mg lynestrenol and ." | 7.65 | [A case of arterial hypertension imputable to an estroprogestational contraceptive. Implication of the renin-angiotensin-aldosterone system]. ( Béquart, P; Boulangé, M; Camelot, G; Fontenaille, C, 1969) |
| "The effect of prolonged preoperative treatment with spironolactone has been studied in a series of 67 patients with hypertension, aldosterone excess, and low plasma renin." | 7.65 | Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. ( Brown, JJ; Davies, DL; Ferriss, JB; Fraser, R; Haywood, E; Lever, AF; Robertson, JI, 1972) |
| "The content of aldosterone, corticosterone, and cortisol has been assayed in normal adrenal tissue obtained at autopsy and in adrenal adenomas from both normotensive and hypertensive patients obtained at autopsy and from patients with primary aldosteronism obtained at surgery." | 7.64 | The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism. ( Kaplan, NM, 1967) |
| "Primary aldosteronism (PA) is an endocrine related condition leading to arterial hypertension due to inappropriately high and unregulated aldosterone concentration." | 6.82 | Primary Aldosteronism, Aldosterone, and Extracellular Vesicles. ( Carvajal, CA; Fardella, CE; Pérez, JA; Tapia-Castillo, A, 2022) |
| "Primary aldosteronism (PA) affects millions of individuals worldwide." | 6.82 | High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It. ( Lieberman, L; Turcu, AF; Wannachalee, T, 2022) |
| "Primary aldosteronism (PA) is the most common and potentially curable form of secondary hypertension, affecting 5-10% of primary care patients with hypertension." | 6.82 | Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care. ( Ariens, J; Choy, KW; Horvath, AR; Yang, J, 2022) |
| "Primary aldosteronism (PA) is the leading cause of secondary hypertension, accounting for over 10% of patients with high blood pressure." | 6.82 | Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas. ( Faucz, FR; Hannah-Shmouni, F; Pitsava, G; Stratakis, CA, 2022) |
| "Primary aldosteronism (PA) is a common form of secondary hypertension and has significant cardiovascular consequences." | 6.80 | Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population. ( Chang, CC; Chu, TS; Huang, KH; Lin, LY; Lin, SL; Lin, YH; Peng, KY; Tsai, YC; Wang, SM; Wu, CH; Wu, KD; Wu, VC; Yang, SY, 2015) |
| "Primary aldosteronism (PA) is associated with inappropriate left ventricular hypertrophy (LVH) in relation to a given gender and body size." | 6.78 | Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism. ( Chang, YY; Changh, YS; Chen, MF; Chueh, SC; Ho, YL; Hu, YH; Hung, CS; Lee, JK; Lin, YH; Sui, MJ; Wu, KD; Wu, VC; Wu, XM; Yang, SY, 2013) |
| "For the diagnosis of primary aldosteronism (PA), confirmatory testing is mandatory and different function tests can be employed." | 6.77 | Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism. ( Blondin, D; Gao, X; Rump, LC; Saleh, A; Scherbaum, WA; Schott, M; Vonend, O; Willenberg, HS, 2012) |
| "Primary aldosteronism (PA) is one of the most frequent curable forms of secondary hypertension." | 6.72 | Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension. ( Azizan, EA; Pauzi, FA, 2021) |
| "The ARR threshold to screen for primary aldosteronism may be based on measurement of irR." | 6.71 | Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. ( Ferrari, P; Nicod, J; Nussberger, J; Saner, E; Shaw, SG, 2004) |
| "Primary aldosteronism is a specifically treatable and potentially curable form of secondary hypertension." | 6.70 | Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. ( Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F, 2002) |
| "Surgical hyperaldosteronism leads to sodium and water retention during surgery and often causes postoperative edema." | 6.69 | Suppression of surgical hyperaldosteronism by potassium canrenoate during gynecologic surgery under sevoflurane anesthesia. ( Ogawa, R; Watanabe, T, 2000) |
| "In primary hyperaldosteronism, discriminating bilateral adrenal hyperplasia (BAH) from an aldosterone-producing adenoma (APA) is important because adrenalectomy, which is usually curative in APA, is seldom effective in BAH." | 6.69 | Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. ( Berman, AA; Choyke, PL; Doppman, JL; Gill, JR; Linehan, WM; Pezzullo, JC; Phillips, JL; Rayford, W; Walther, MM, 2000) |
| "patients with primary hyperaldosteronism (PH) including both aldosterone-producing adenoma and idiopathic hyperaldosteronism." | 6.68 | Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism. ( Contesse, V; Delarue, C; Dhib, M; Godin, M; Kuhn, JM; Lefebvre, H; Rieu, M; Vaudry, H; Wolf, LM, 1997) |
| "Idiopathic hyper-aldosteronism was diagnosed on the basis of the results of dexamethasone-suppressed adrenal scintigraphy and/or selective adrenal vein sampling." | 6.67 | Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. ( Chiesura-Corona, M; Feltrin, GP; Pelizzo, MR; Perale, R; Pessina, AC; Rossi, GP; Soattin, S; Tregnaghi, A; Zanin, L, 1993) |
| "Nicardipine (80 mg/day) was given orally for 12 weeks and no dietary restrictions were imposed." | 6.67 | Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism. ( Bisbocci, D; Chiandussi, L; Pinna, G; Piras, D; Rabbia, F; Veglio, F, 1990) |
| "Primary hyperaldosteronism (PA) is a well-known cause of hypertension although its exact prevalence amongst patients with apparent essential hypertension has been a matter of debate." | 6.66 | Five Reasons for the Failure to Diagnose Aldosterone Excess in Hypertension. ( Chrousos, GP; Kaltsas, G; Markou, A; Piaditis, GP, 2020) |
| "Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary hypertension." | 6.61 | Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism. ( Bidlingmaier, M; Junnila, RK; Schilbach, K, 2019) |
| "Primary aldosteronism (PA) is the most prevalent cause of secondary hypertension (3%-32% of hypertensive patients)." | 6.61 | The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges. ( Denieffe, S; Fitzgibbon, MC; Griffin, TP; O'Shea, PM, 2019) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 6.58 | Overview of aldosterone-related genetic syndromes and recent advances. ( Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2018) |
| "Primary aldosteronism (PA) is caused by excessive production of aldosterone by the adrenal cortex and is determined by a benign aldosterone-producing adenoma (APA) in a significant proportion of cases." | 6.53 | Local Control of Aldosterone Production and Primary Aldosteronism. ( Barhanin, J; Lalli, E; Warth, R; Zennaro, MC, 2016) |
| "Obese subjects often exhibit hyperaldosteronism, with increased salt sensitivity of blood pressure (BP)." | 6.53 | The Role of Aldosterone in Obesity-Related Hypertension. ( Fujita, T; Kawarazaki, W, 2016) |
| "Primary aldosteronism is the most common form of secondary hypertension and has significant cardiovascular consequences." | 6.50 | Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy? ( Gomez-Sanchez, CE; Oki, K, 2014) |
| "A close association exists between hyperaldosteronism, RHTN, and obstructive sleep apnea (OSA) based upon recent studies which indicate that OSA is worsened by aldosterone-mediated fluid retention." | 6.48 | Resistant hypertension and aldosterone: an update. ( Ahmed, MI; Calhoun, DA; Clark, D, 2012) |
| " The observation of reduced nitric oxide bioavailability in hyperaldosteronism implied the generation of oxidative stress by aldosterone." | 6.48 | Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases. ( Queisser, N; Schupp, N, 2012) |
| "In the setting of primary aldosteronism, elevated aldosterone levels are associated with increased blood pressure." | 6.46 | Aldosterone and arterial hypertension. ( Obermayer-Pietsch, B; Pieber, TR; Pilz, S; Ritz, E; Tomaschitz, A, 2010) |
| "Aldosterone was in the past considered only as a prohypertensinogenic agent." | 6.46 | Aldosterone in uremia - beyond blood pressure. ( Koleganova, N; Ritz, E, 2010) |
| "Primary aldosteronism (PA) is defined as inappropriately high and (relatively or absolutely) autonomous aldosterone secretion, which is not adequately suppressible by sodium loading." | 6.46 | Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism? ( Pilz, S; Tomaschitz, A, 2010) |
| "Surgically correctable forms of primary aldosteronism are characterized by unilateral aldosterone hypersecretion and renin suppression, associated with varying degrees of hypertension and hypokalemia." | 6.46 | Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. ( Amar, L; Plouin, PF; Steichen, O, 2010) |
| "The syndrome of primary aldosteronism, however, encompasses a wide spectrum of disorders that will require better definition." | 6.44 | Aldosterone and refractory hypertension. ( Nyirenda, MJ; Padfield, PL, 2007) |
| "Aldosterone is a mineralocorticoid with protean actions in both epithelial and nonepithelial cells." | 6.42 | Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone. ( Weber, KT, 2003) |
| "The classical form of primary aldosteronism is a rare disease with prevalence rates of 0." | 6.42 | [The aldosterone to Renin ratio in secondary hypertension]. ( Reincke, M; Seiler, L, 2003) |
| "Among these, classic primary hyperaldosteronism and its glucocorticoid remediable variety, in which hypertension is secondary to aldosterone production, must be considered." | 6.40 | [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements]. ( Fardella, CE; Montero, J; Mosso, L, 1999) |
| "The diagnosis of primary aldosteronism was confirmed in all patients by biochemical and radiologic studies." | 6.36 | Surgical management of aldosterone-producing adrenal adenomas: a review of 16 patients. ( Crane, MG; Mackett, MC; Smith, LL, 1981) |
| "According to the primary aldosteronism surgical outcome (PASO) criteria, complete and partial clinical success was achieved in 21 (40." | 5.91 | Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma. ( He, H; Jiang, J; Li, Q; Li, Y; Liu, X; Sun, F; Yan, Z; Zhang, H; Zhao, Z; Zhou, X; Zhu, Z, 2023) |
| "Primary aldosteronism (PA) screening relies on an elevated aldosterone to renin ratio with a minimum aldosterone level, which varies from 10 to 15 ng/dL (277-415." | 5.91 | Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening. ( Almeida, MQ; Bortolotto, LA; Brito, LP; Carnevale, FC; Cavalcante, ACBS; Chambo, JL; Coelho, FMA; Consolim-Colombo, FM; Drager, LF; Fagundes, GFC; Fragoso, MCBV; Freitas, TC; Goldbaum, TS; Latronico, AC; Ledesma, FL; Maciel, AAW; Mendonca, BB; Pereira, MAA; Petenuci, J; Pilan, B; Pio-Abreu, A; Silveira, JV; Srougi, V; Tanno, FY; Vilela, LAP; Zerbini, MCN, 2023) |
| "After genetic analysis, a diagnosis of Liddle syndrome was made due to the presence of a p." | 5.91 | A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism. ( Jin, Y; Qiu, W; Yao, J, 2023) |
| "Primary aldosteronism (PA) was suspected because of the high plasma aldosterone concentration-to-plasma renin activity ratio." | 5.91 | Coexistence of Pheochromocytoma and Primary Aldosteronism due to Multiple Aldosterone-producing Micronodules in the Ipsilateral Adrenal Gland. ( Fujita, Y; Hino, M; Horikawa, O; Inoue, K; Kageyama, S; Kawauchi, A; Maegawa, H; Nakaizumi, N; Noujima, M; Sasano, H; Sato, D; Ugi, S; Wada, A; Yamazaki, Y; Yonishi, M, 2023) |
| "Primary aldosteronism is the most frequent secondary hypertensive disease and is characterized by an elevated risk for cardiovascular disease." | 5.91 | Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism. ( Fujiwara, A; Haruna, A; Haze, T; Hirawa, N; Kawano, R; Kobayashi, Y; Ohki, Y; Ozawa, M; Saka, S; Suzuki, S; Tamura, K, 2023) |
| " No major adverse safety events related to SAAE were reported during the intraoperative, postoperative, and follow-up periods." | 5.91 | Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study. ( Dong, YF; Hu, CK; Jiang, XJ; Lai, ZQ; Li, N; Li, YD; Liang, NP; Qiu, J; Xiong, HL; Yang, J; Zhang, HJ, 2023) |
| "19 unilateral primary aldosteronism (UPA) patients and 19 healthy people were divided into UPA group and Control group, and the serum of bilateral adrenal veins and inferior vena cava collected by adrenal blood sampling (AVS) in UPA patients and the serum from the healthy subjects were all used to detect multiple cytokines by Luminex immunoassays." | 5.91 | Diagnostic accuracy of using multiple cytokines to predict aldosterone-producing adenoma. ( Huang, J; Lai, X; Li, J; Pan, Y; Qin, F; Wen, H; Yang, T; Yu, J; Zhong, X, 2023) |
| "Primary aldosteronism is frequently caused by an adrenocortical aldosterone-producing adenoma (APA) carrying a somatic mutation that drives aldosterone overproduction." | 5.91 | Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas. ( Blum, H; Gong, S; Koupourtidou, C; Krebs, S; Masserdotti, G; Meyer, LS; Rainey, WE; Reincke, M; Sun, N; Tetti, M; Walch, A; Williams, TA, 2023) |
| "Primary aldosteronism (PA) is considered the number one aetiology for secondary hypertension." | 5.91 | Duplicated adrenal veins in primary aldosteronism misdiagnosed with ectopic aldosteronoma due to apparent bilateral aldosterone suppression. ( Chen, K; Fan, C; Fang, T; Liu, H; Quan, H; Wei, W; Yu, J; Zhang, Y, 2023) |
| "Patients with primary aldosteronism (PA) have a higher risk of cardiovascular disease (CVD) than essential hypertension due to underlying hyperaldosteronism." | 5.91 | High plasma aldosterone concentration is associated with worse 24-h ambulatory blood pressure profile in patients with primary aldosteronism. ( Azushima, K; Haze, T; Kanaoka, T; Kinguchi, S; Kobayashi, K; Kobayashi, R; Morita, R; Sunohara, S; Tamura, K; Toya, Y; Wakui, H, 2023) |
| "The aldosterone/renin ratio is an important tool for PA screening, and dynamic testing in serum or urine is used to confirm the diagnosis." | 5.91 | A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism. ( Beriault, DR; Delaney, SR; Yazdanpanah, M, 2023) |
| "Primary aldosteronism was diagnosed based on 4 h PAC, adrenal imaging and/or adrenal venous sampling (AVS)." | 5.91 | Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism. ( Chanthanuwat, S; Jannoo, S; Phonanuwong, R; Soonthornpun, S, 2023) |
| "Primary aldosteronism (PA) is a well-known cause of secondary hypertension." | 5.91 | Simple standing test without furosemide is useful in the diagnosis of primary aldosteronism. ( Fushimi, Y; Iwamoto, H; Iwamoto, Y; Kaku, K; Kaneto, H; Katakura, Y; Kimura, T; Kusano, T; Mune, T; Nakanishi, S; Ohnishi, M; Sanada, J; Shimoda, M; Takenouchi, H; Tatsumi, F, 2023) |
| "Primary aldosteronism (PA) is the most common form of endocrine hypertension and is characterized by inappropriately elevated aldosterone production via a renin-independent mechanism." | 5.91 | Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. ( Bandulik, S; Blinder, AR; Else, T; Giordano, TJ; Kosmann, C; Kumar-Sinha, C; Lerario, AM; Nanba, K; Plain, A; Rainey, WE; Rege, J; Reincke, M; Sasano, H; Satoh, F; Turcu, AF; Udager, AM; Vats, P; Warth, R; Williams, TA; Yamazaki, Y, 2023) |
| "Atypical Liddle syndrome can be easily misdiagnosed due to its clinical phenotypes resembling hyperaldosteronism." | 5.91 | Liddle syndrome presenting with normal aldosterone levels: A case report. ( Pan, R; Wang, R; Zhang, R; Zhang, Y; Zhao, Y, 2023) |
| "In 2017, the Primary Aldosteronism Surgical Outcome (PASO) investigators proposed consensus criteria for clinical and biochemical outcomes." | 5.72 | Prediction of long-term biochemical cure in patients with unilateral primary hyperaldosteronism treated surgically based on the early post-operative plasma aldosterone value. ( Ishihara, Y; Kaneko, H; Kusakabe, T; Nanba, K; Satoh-Asahara, N; Tagami, T; Tsuiki, M; Umakoshi, H; Yasoda, A, 2022) |
| " The results of restricted cubic splines showed the dose-response association between increasing PAC, ARR, decreasing serum potassium, and the risk of WMLs." | 5.72 | Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism. ( Heizhati, M; Li, N; Liu, Y; Luo, Q; Wang, M; Yao, X; Yuan, Y; Zhu, Q, 2022) |
| "We identified patients with aortic dissection and aneurysm with assessed PAC before disease onset from hospital-based electronic database and set as case group." | 5.72 | Higher Plasma Aldosterone Concentrations Are Associated With Elevated Risk of Aortic Dissection and Aneurysm: a Case-Control Study. ( Gan, L; Heizhati, M; Hong, J; Li, N; Lin, M; Luo, Q; Wang, M; Yao, X; Yue, N; Zhang, W; Zhu, Q, 2022) |
| "Diagnosis of primary hyperaldosteronism in pregnancy is complicated due to lack of reference ranges for aldosterone, renin and aldosterone-to-renin ratio." | 5.72 | Establishing Reference Ranges for Aldosterone, Renin and Aldosterone-to-Renin Ratio for Women in the Third-Trimester of Pregnancy. ( Grzesiak, M; Horzelski, W; Lewandowski, KC; Lewinski, A; Tadros-Zins, M, 2022) |
| "Primary aldosteronism (PA) is the most common type of secondary hypertension, and it is associated with a higher rate of cardiovascular complications." | 5.72 | KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma. ( Chang, CC; Chang, YY; Chen, ZW; Chiu, YW; Chou, CH; Huang, JZ; Hung, CS; Kang, VJ; Lee, BC; Liao, CW; Lin, YH; Lin, YL; Pan, CT; Tsai, CH; Wu, VC, 2022) |
| "Among 43 patients with primary aldosteronism (PA), thirteen APA patients were enrolled in this study." | 5.72 | Early Renin Recovery After Adrenalectomy in Aldosterone-Producing Adenomas: A Prospective Study. ( Antonini, SR; de Castro, M; Elias, J; Elias, PCL; Mermejo, LM; Molina, CAF; Moreira, AC; Muglia, VF; Tucci, S, 2022) |
| "Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism." | 5.72 | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression. ( Hirose, R; Hoshino, Y; Inoue, K; Kakuta, Y; Katsuragawa, S; Kubo, H; Matsui, S; Nishikawa, T; Omura, M; Saito, J; Sasano, H; Shibahara, Y; Sunouchi, T; Tannai, H; Tsurutani, Y; Watanabe, K; Yamazaki, Y, 2022) |
| "Among those Liddle syndrome patients confirmed by a genetic test, for Test kit A all ARR were screened positive while for test kit B negative." | 5.72 | Liddle syndrome misdiagnosed as primary aldosteronism is caused by inaccurate aldosterone-rennin detection while a novel ( Chen, L; Qu, D; Sun, Q; Wu, C; Xu, X; Yang, Y; Zhao, X, 2022) |
| "Ambulatory FST is safe and accurate and can be performed with significantly less healthcare costs compared to FSTin." | 5.72 | Ambulatory fludrocortisone suppression test in the diagnosis of primary aldosteronism: Safety, accuracy and cost-effectiveness. ( Avander, K; Calissendorff, J; Carasel, A; Falhammar, H; Shabo, I; Volpe, C, 2022) |
| "Primary aldosteronism (PA), including aldosterone and cortisol producing adenoma (A/CPA), is the most common trigger of secondary hypertension." | 5.72 | Two cases of aldosterone and cortisol producing adenoma with different histopathological features: A case report. ( Gao, H; Li, L; Tian, H, 2022) |
| "A total of 142 cases of primary aldosteronism diagnosed as unilateral by adrenal venous sampling at 2 referral centers between 2009 and 2019 were included." | 5.72 | Aldosterone-Producing Adenomas of Increased Size Are Associated With Higher Steroidogenic Activity. ( Iiri, T; Makita, N; Manaka, K; Nakai, K; Nangaku, M; Nishikawa, T; Saito, J; Sasano, H; Sato, J; Takeuchi, M; Tsurutani, Y; Yamazaki, Y, 2022) |
| "We confirmed primary aldosteronism if post-seated SLT PAC by LC-MS/MS exceeded 5." | 5.72 | Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism. ( Cho, SH; Kim, JH; Kwon, SY; Lee, SY; Lee, YB; Park, J; Park, SH, 2022) |
| "Aldosterone values were similar in the two groups, while renin was significantly lower and the aldosterone to renin ratio was significantly higher in patients with endometriosis than in controls." | 5.72 | Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report. ( Ambrosini, G; Andrisani, A; Armanini, D; Bordin, L; Marin, L; Ragazzi, E; Sabbadin, C; Saccardi, C; Vitagliano, A, 2022) |
| "Primary aldosteronism, eponymously known as Conn's syndrome, has recently gained recognition as the most common cause of endocrine hypertension." | 5.62 | The role of surgery in Conn's syndrome - a case of refractory hypertension secondary to an aldosterone secreting adenoma. ( Bombil, I; Carides, MD; Christofides, C; Sishuba, NT, 2021) |
| "Primary aldosteronism was diagnosed." | 5.62 | Hypertension with unilateral adrenal aldosterone and cortisol cosecreting adenoma: A case report. ( Chen, X; Chu, SL; Hu, Z; Luo, FX; Shao, Y; Wang, JG, 2021) |
| "Primary aldosteronism is the most common form of secondary hypertension, and aldosteronoma makes up a significant proportion of primary aldosteronism cases." | 5.62 | In Silico Analysis of the Gene Expression Patterns between Aldosterone-Producing Adenoma and Nonfunctional Adrenocortical Adenoma. ( Dai, Y; Li, J; Liu, J; Wen, H, 2021) |
| "In primary aldosteronism (PA), aldosterone secretion is relatively independent of the renin-angiotensin system, but can be regulated by several other stimuli." | 5.62 | Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism. ( Bourdeau, I; Lacroix, A; Martin, M; St-Jean, M, 2021) |
| "Primary aldosteronism is an underdiagnosed cause of hypertension." | 5.62 | Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection. ( Fudim, T; Hundemer, GL; Moussa, M; Sacks, B; Underhill, J; Vaidya, A; Yozamp, N, 2021) |
| "Primary aldosteronism (PA) is highly prevalent in hypertensive population." | 5.62 | Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas. ( He, H; Hong, Y; Liu, X; Sun, F; Yan, Z; Zhang, H; Zhao, Z; Zhu, Z, 2021) |
| "Primary aldosteronism (PA), as a cause of secondary hypertension, can cause more serious cardiovascular damage than essential hypertension." | 5.62 | A case of primary aldosteronism with a negative aldosterone-to-renin ratio. ( Ding, Y; Liu, F; Wang, L, 2021) |
| "Accurate subtyping of the primary aldosteronism into aldosterone-producing adenoma (APA) and idiopathic adrenal hyperplasia (IAH) is important to direct for specific treatment modalities." | 5.56 | A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia. ( Chan, KW; Fong, CHY; Lau, EYF; Leung, HT; Leung, JYY; Tan, KCB; Woo, YC, 2020) |
| "Primary aldosteronism is recognized as the most frequent cause of secondary hypertension, and its screening is expected to become a routine evaluation in most patients with hypertension." | 5.56 | Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism. ( Buffolo, F; Burrello, J; Domenig, O; Monticone, S; Mulatero, P; Pecori, A; Poglitsch, M; Tetti, M, 2020) |
| "Primary aldosteronism (PA) due to unilateral aldosterone-producing adenoma (APA) is preferentially treated by unilateral adrenalectomy (ADX), but little is known about the changes in lipid and glucose metabolism that may occur after ADX." | 5.56 | Lipoprotein insulin resistance score and branched-chain amino acids increase after adrenalectomy for unilateral aldosterone-producing adenoma: a preliminary study. ( Adolf, C; Berends, AMA; Connelly, MA; Dullaart, RPF; Reincke, M, 2020) |
| "After the treatment of primary aldosteronism, glucose intolerance was improved in 66." | 5.56 | Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism. ( Fukuda, I; Moriya, A; Nagao, M; Oikawa, S; Okazaki-Hada, M; Sugihara, H, 2020) |
| "Aldosterone was associated with various markers of inflammation and metabolic dysregulation, which partly differed from the associations observed for renin." | 5.56 | Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity. ( Danser, AHJ; de Graaf, J; Deinum, J; Joosten, LAB; Netea, MG; Riksen, NP; Rutten, J; Schraa, K; Ter Horst, R; van den Munckhof, ICL; van der Heijden, CDCC, 2020) |
| "Primary aldosteronism (PA) is a common form of secondary hypertension that has significant cardiovascular events and increased prevalence of metabolic syndrome and diabetics." | 5.56 | Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma. ( Chang, CC; Chueh, JS; Er, LK; Hsiao, JK; Lin, MC; Peng, KY; Tsai, YC; Wu, VC; Yang, CY, 2020) |
| "Primary aldosteronism (PA) is associated with a higher prevalence of abdominal aortic calcification (AAC)." | 5.56 | Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels. ( Li, N; Luo, Q; Tuersun, T; Wang, G; Wang, M; Wu, T; Yue, N; Zhang, D; Zhang, Z; Zhou, K, 2020) |
| "Patients with confirmed primary aldosteronism underwent both AVS and 11C-Metomidate PET-CT (post-dexamethasone)." | 5.51 | 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial. ( Chuah, MB; Foo, RSY; Gomez-Sanchez, CE; Kek, PC; Khoo, CM; Lee, DHM; Ng, KS; O'Doherty, J; Puar, TH; Reilhac, A; Robins, EG; Shi, L; Tan, AWK; Tan, CJ; Tan, MCS; Teo, AE; Tong, AKT; Wang, KW; Wong, KM; Yee, S; Zheng, CQ, 2022) |
| "Cosyntropin's effect on primary aldosteronism (PA) lateralization, however, is controversial." | 5.51 | Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin During Adrenal Vein Sampling. ( Auchus, RJ; Nanba, AT; Nanba, K; Rainey, WE; Shields, JJ; Turcu, AF; Wannachalee, T; Zhao, L, 2019) |
| "The performance of new ARR in aldosteronism detection is poorly evaluated." | 5.51 | High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism. ( Chen, D; Feng, P; Gan, W; Li, Y; Lin, W; Ouyang, J; Yao, Z, 2019) |
| "A majority of primary aldosteronism patients have markedly lower aldosterone levels during sedated AVS compared with those found during outpatient diagnosis." | 5.51 | Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism. ( Chin, A; Darras, P; Holmes, DT; Kline, GA; Leung, AA; So, B, 2019) |
| "Aldosterone has been linked with obesity, metabolic syndrome (MetS), pro-inflammatory, and prothrombotic states; however, most studies relate these indicators with primary aldosteronism (PA), excluding non-PA patients." | 5.51 | The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism. ( Allende, F; Barros, ER; Baudrand, R; Campino, C; Carvajal, C; Fardella, CE; Fuentes, CA; García, H; Kalergis, AM; Martínez-Aguayo, A; Olmos, R; Solari, S; Tapia-Castillo, A; Vecchiola, A, 2019) |
| "We included primary aldosteronism patients who had undergone adrenalectomy from the Taiwan Primary Aldosteronism Investigation database between 1995 and 2017." | 5.51 | Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy. ( Chan, CK; Chang, CC; Chueh, E; Huang, KH; Kim, JH; Lai, TS; Lin, YF; Lin, YH; Wu, VC, 2019) |
| "Primary aldosteronism (PA) causes a cardiomyopathy (CM) which substrate and evolution after aldosterone normalization are unreported." | 5.51 | Primary aldosteronism-associated cardiomyopathy: Clinical-pathologic impact of aldosterone normalization. ( Chimenti, C; Francone, M; Frustaci, A; Grande, C; Letizia, C; Russo, MA; Sansone, L; Verardo, R, 2019) |
| "In addition, primary aldosteronism (PA) is clinically associated with not only more frequent cardiovascular events but also secondary metabolic disorders including abnormal calcium metabolism, osteoporosis and others." | 5.51 | The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals. ( Gao, X; Morimoto, R; Nakamura, Y; Ogata, H; Omata, K; Onodera, Y; Sasano, H; Satoh, F; Tezuka, Y; Yamazaki, Y, 2019) |
| "In patients with KCNJ5-mutated APA, left ventricular hypertrophy was significantly decreased by surgical treatment in patients from either Cured or Improved groups, although those patients with wild-type KCNJ5 showed no change." | 5.48 | KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma. ( Kitamoto, T; Nishikawa, T; Omura, M; Saito, J; Suematsu, S, 2018) |
| "Aldosterone treatment enhanced mRNA expression of genes associated with inflammation and fibrosis and stimulated differentiation of 3T3-L1 and brown preadipocytes." | 5.48 | Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma. ( Fan, C; Guan, M; Tan, W; Wang, L; Wei, Q; Wu, C; Wu, P; Xie, C; Xu, L; Xue, Y; Zhang, H; Zhang, J, 2018) |
| "Primary aldosteronism (PA) is associated with objectively measured lower physical fitness and blunted response of the renin-angiotensin-aldosterone system to exercise." | 5.48 | The effect of adrenalectomy on exercise response of the renin-angiotensin-aldosterone system and exercise tolerance in primary aldosteronism. ( Holaj, R; Krátká, Z; Matoulek, M; Mikeš, O; Petrák, O; Rosa, J; Štrauch, B; Tuka, V; Widimský, J; Zelinka, T, 2018) |
| "Primary aldosteronism patients aged <35 years with hypokalaemia and elevation of aldosterone and unilateral disease on adrenal CT could be spared AVS." | 5.48 | Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism. ( Fujii, Y; Ichijo, T; Inagaki, N; Itoh, H; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Matsuda, Y; Miyauchi, S; Naruse, M; Ogasawara, T; Ogawa, Y; Ogo, A; Okamura, S; Otsuki, M; Shibata, H; Shibayama, Y; Sone, M; Suzuki, T; Takahashi, K; Takeda, Y; Tsuiki, M; Umakoshi, H; Wada, N; Watanabe, M; Yamamto, K; Yanase, T; Yoshimoto, T, 2018) |
| "Primary aldosteronism is affecting about 10% of hypertensive patients." | 5.48 | Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration. ( Amar, L; Azizi, M; Baffalie, L; Baron, S; Blanchard, A; Faucard, C; Faucon, AL; Houillier, P; Pagny, JY; Travers, S, 2018) |
| "Current threshold values for primary aldosteronism (PA) diagnostic testing are based on measuring aldosterone (PAC) using immunoassays." | 5.48 | Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism. ( Ahmed, AH; Gordon, RD; Guo, Z; McWhinney, BC; Poglitsch, M; Stowasser, M; Ungerer, JPJ; Wolley, M, 2018) |
| "Chronic inflammation is an age-independent and body mass index-independent contributor to the development of multi-morbidity." | 5.46 | Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry. ( Adolf, C; Grotevendt, A; Hannemann, A; Hoffmann, W; Nauck, M; Quinkler, M; Reincke, M; Rettig, R; Wallaschofski, H, 2017) |
| "Consecutive patients with diagnosed primary hyperaldosteronism from June 2006 to July 2012 in our center underwent adrenal surgeries without pre-operational adrenal venous sampling (AVS) if all the three criteria were met: (1) round- or oval-shaped occupational lesion of low density after contrast enhancement with diameter >1 cm on CT scan was located in one adrenal gland; (2) unequivocally normal contralateral adrenal gland; (3) serum potassium level lower than 3." | 5.46 | Favorable surgical outcomes of aldosterone-producing adenoma based on lateralization by CT imaging and hypokalemia: a non-AVS-based strategy. ( Cao, X; Feng, X; Li, H; Li, Y; Liu, J; Liu, L; Wei, G, 2017) |
| "We described the prevalence of primary aldosteronism in our population before the change and, using the assumption of disease prevalence stability, determined the corresponding ratio cutoffs after the introduction of the new assay." | 5.46 | Novel Approach to Establishing an Aldosterone: Renin Ratio Cutoff for Primary Aldosteronism. ( Chin, A; Kline, GA; Leung, AA; Orton, DJ; Sadrzadeh, H, 2017) |
| "All primary aldosteronism patients were diagnosed by autonomous aldosterone secretion using confirmatory tests, and then divided into nPA (n = 130) and primary aldosteronism patients with high PAC (hPA: n = 162) using a PAC cutoff level of less than 443 pmol/l (16 ng/dl), representing the normal upper limit of PAC." | 5.46 | Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. ( Hamasaki, T; Hashimoto, K; Hayashi, RD; Kajimoto, Y; Kitamura, T; Kouhara, H; Kurebayashi, S; Mukai, K; Murata, M; Nakao, M; Otsuki, M; Shimomura, I; Takeiri, S; Tamada, D; Yamamoto, T, 2017) |
| "The tumor was a benign adrenocortical adenoma composed predominantly of clear cells positive for 17α-hydroxylase, [hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerases], and aldosterone synthase." | 5.43 | Extraordinarily high aldosterone, 901.0 ng/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism. ( Aizawa, T; Komatsu, M; Matsushita, T; Nakasone, Y; Nishikawa, T; Oguchi, K; Okubo, Y; Sasano, H; Sato, Y; Shirotori, K; Yamauchi, K; Yamazaki, Y, 2016) |
| "Eplerenone treatment of patients with PA reduces blood pressure, increases serum potassium level, and improves vascular status." | 5.43 | Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism. ( Anzai, K; Kawate, H; Matsuda, Y; Matsuzaki, C; Nomura, M; Ohnaka, K; Sakamoto, R; Shibue, K; Takayanagi, R, 2016) |
| "Primary aldosteronism is one of the most common forms of secondary hypertension, but it is often under diagnosed, which leads to the development of cardiovascular damage, and excess costs for long-term drug treatment and management of complications." | 5.43 | The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism. ( Bisogni, V; Rossi, GP, 2016) |
| "Primary aldosteronism not only results in hypertension but also stiffer arteries." | 5.43 | Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients. ( Chang, YY; Ho, YL; Hung, CS; Liao, CW; Lin, LY; Lin, YH; Lin, YT; Satoh, F; Wang, SM; Wu, KD; Wu, VC, 2016) |
| "Treatment with spironolactone inhibited Akt/AS160 phosphorylation, reduced Rab-dependent Kv1." | 5.43 | Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice. ( Buschmeyer, B; Koehncke, C; Lisewski, U; Pieske, B; Roepke, TK; Wilck, N, 2016) |
| "Of the two of 20 primary aldosteronism patients missed by AARR, none resulted affected by APA." | 5.43 | Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. ( Buffolo, F; Burrello, J; Lucchiari, M; Mengozzi, G; Monticone, S; Mulatero, P; Rabbia, F; Tetti, M; Veglio, F; Williams, TA, 2016) |
| "Primary aldosteronism was confirmed by using the oral sodium-loading test." | 5.43 | Aldosterone-producing Adenoma in Primary Aldosteronism: CT-guided Radiofrequency Ablation-Long-term Results and Recurrence Rate. ( Chiu, PW; Chow, FC; Chu, CC; Kong, AP; Liu, SY; Ng, EK; Tsui, TK; Wong, SK, 2016) |
| "Hypertension was resolved less frequently after treatment with RFA compared with laparoscopic adrenalectomy (13 of 36 versus 19 of 27 patients; P = 0·007)." | 5.43 | Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma. ( Chiu, PW; Chow, FC; Chu, CM; Kong, AP; Liu, SY; Ng, EK; Wong, SK, 2016) |
| "Prospective studies indicate that hyperaldosteronism is found in 20% of patients with resistant hypertension." | 5.43 | Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension. ( Calhoun, DA; Dudenbostel, T; Ghazi, L; Li, P; Liu, M; Oparil, S, 2016) |
| "Primary aldosteronism (PA), the most common form of secondary hypertension, causes relevant morbidity." | 5.43 | The Clinical Value of Salivary Aldosterone in Diagnosis and Follow-Up of Primary Aldosteronism. ( Asbach, E; Bidlingmaier, M; Fourkiotis, V; Gerum, S; Lichtenauer, UD; Manolopoulou, J; Quinkler, M; Reincke, M, 2016) |
| "The diagnosis of primary aldosteronism (PA) among the older-aged population has posed a crucial challenge." | 5.42 | The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old. ( Balakrishnan, P; Chen, YM; Chueh, SC; Hsein, YC; Kuo, CC; Wang, MJ; Wu, KD; Wu, VC, 2015) |
| "The prevalence of primary aldosteronism was 15." | 5.40 | Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism. ( Danser, AH; de Bruijne, EL; Deinum, J; Frenkel, WJ; Jansen, PM; Kerstens, MN; Smulders, YM; van den Born, BJ; van den Meiracker, AH; Wijbenga, JA; Woittiez, AJ; Zietse, R, 2014) |
| "The molecular mechanisms of primary aldosteronism, a common cause of human hypertension, are unknown, but alterations of K(+) channels can play a key role." | 5.40 | Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism. ( Bader, M; Belloni, AS; Campos, AG; Caroccia, B; Fassina, A; Ferraro, S; Kuppusamy, M; Lenzini, L; Rainey, WE; Rossi, GP; Seccia, TM; Skander, G, 2014) |
| "Aldosterone may increase in luteotropic/progestogenic and in hypothyroid states; LH and, occasionally, TSH receptors have been detected in normal adrenal cortex and aldosterone-producing adenoma." | 5.40 | LH, progesterone, and TSH can stimulate aldosterone in vitro: a study on normal adrenal cortex and aldosterone producing adenoma. ( Balzan, S; Fommei, E; Iacconi, P; Morelli, L; Nicolini, G; Ripoli, A; Sabatino, L, 2014) |
| "In 10 patients with primary aldosteronism, median supine ARRP was 298 (range 48-1222) and ARRD 34 (range 2." | 5.40 | Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. ( Bassani, N; Biganzoli, E; Gritti, A; Lonati, C; Morganti, A, 2014) |
| "A correct diagnosis of primary aldosteronism (PA) requires adrenal venous sampling (AVS) for the classification of subtypes (bilateral hyperplasia, BAH, or adenoma, APA)." | 5.40 | Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma. ( Brazzarola, P; Castagna, A; Cecconi, D; Chiecchi, L; D'Alessandro, A; Guarini, P; Gunasekaran, M; Morandini, F; Mulatero, P; Olivieri, O; Pizzolo, F; Veglio, F; Zolla, L, 2014) |
| "When diagnosing primary aldosteronism, the measurement of urinary aldosterone after oral sodium loading is one of the currently recommended confirmatory tests." | 5.40 | The role of urinary aldosterone for the diagnosis of primary aldosteronism. ( Ballon, M; Ceral, J; Malirova, E; Solar, M, 2014) |
| "The impact of 4HCH on the hyperaldosteronism, inflammation, and kidney injury provides new insights for future development of therapeutic strategies in resistant hypertension." | 5.40 | 4-Hydroxychalcone attenuates hyperaldosteronism, inflammation, and renal injury in cryptochrome-null mice. ( Dai, B; Li, X; Liu, Y; Qu, Q; Yang, B; Zhang, F, 2014) |
| "The patient was diagnosed with primary aldosteronism (PA) based on typical clinical findings." | 5.40 | Deoxycorticosterone-producing adenoma concomitant with aldosterone-producing microadenoma: a challenging combination. ( Ando, T; Horie, I; Kawakami, A; Nozaki, A; Oyama, K; Shigematsu, K; Takehara, K, 2014) |
| "Aldosterone excess has a direct negative effect on β-cell function in patients with PA." | 5.39 | Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. ( Adolf, C; Beuschlein, F; Bidlingmaier, M; Fischer, E; Pallauf, A; Reincke, M; Seissler, J; Then, C, 2013) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary arterial hypertension." | 5.39 | Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry. ( Bidlingmaier, M; Fischer, E; Hahner, S; Quinkler, M; Reincke, M; Reuschl, S; Rump, LC, 2013) |
| "Aldosterone values were adjusted statistically for age, sex, and the urinary sodium/creatinine ratio." | 5.39 | Bimodal aldosterone distribution in low-renin hypertension. ( Adlin, EV; Braitman, LE; Vasan, RS, 2013) |
| "In primary aldosteronism, adrenal vein sampling (AVS) suggests unilateral aldosterone-producing adenoma (APA) when the aldosterone/cortisol (A/F) ratio is less than or equal to peripheral on one side and at least two times peripheral on the other." | 5.39 | Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma. ( Ahmed, AH; Daunt, N; Gordon, RD; Pimenta, E; Slater, GJ; Stowasser, M; Wolley, M, 2013) |
| "Aldosterone treatment induced an anhedonic state manifested by decreased sucrose preference." | 5.38 | Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. ( Babic, S; Flynn, ME; Hlavacova, N; Jezova, D; Murck, H; Ondrejcakova, M; Poundstone, PK; Wes, PD, 2012) |
| "Hyperaldosteronism is associated with an increased prevalence of atrial fibrillation (AF)." | 5.38 | Aldosterone promotes atrial fibrillation. ( Allessie, MA; Böhm, M; Drautz, F; Hohl, M; Kazakow, A; Lipp, P; Müller, P; Münz, BM; Neuberger, HR; Reil, GH; Reil, JC; Selejan, S; Steendijk, P, 2012) |
| "The patients in this study had primary hyperaldosteronism with unilateral APA." | 5.38 | Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. ( Azizan, EA; Brown, MJ; Clarke, J; Happerfield, L; Hoffman, GJ; Kuc, RE; Lam, BY; Marker, A; Newhouse, SJ; Zhou, J, 2012) |
| "Moreover, aldosterone-producing adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases." | 5.38 | Aldosterone-producing adrenocortical carcinoma without hypertension. ( Bae, SB; Kim, SJ; Kim, YJ; Seo, SW; Song, MS, 2012) |
| "Primary aldosteronism caused by an aldosterone producing adrenal tumor/aldosteronoma (APA), is a potentially curable form of hypertension, via unilateral adrenalectomy." | 5.38 | Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems. ( Carter, Y; Chen, H; Roy, M; Sippel, RS, 2012) |
| "Thus, in rats with aldosteronism, in which a reduction in effective refractory period was not evident, the mechanism for VA susceptibility is presumably linked to a decrease in conduction velocity and/or increased dispersion of refractoriness, probably caused by consequential myocardial fibrosis." | 5.37 | Spironolactone prevents the inducibility of ventricular tachyarrhythmia in rats with aldosteronism. ( Bellary, SR; de Jongh Curry, AL; Deshmukh, PA; Kamalov, G; Magotra, M; Schwender, FT; Sun, Y; Weber, KT, 2011) |
| "Primary aldosteronism (PA) is associated with a higher incidence of cardiovascular events, probably through mineralocorticoid receptor (MR)-dependent endothelial cell dysfunction, in comparison with essential hypertension (EH)." | 5.37 | Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis. ( Chen, JW; Chen, YL; Huang, PH; Kuo, CC; Kuo, YS; Lee, BC; Liang, CJ; Lin, SJ; Lin, SL; Lin, YH; Lo, SC; Sun, YY; Tsai, CT; Wu, EL; Wu, KD; Wu, VC, 2011) |
| "Resistant hypertension has evolved as an important global health care problem." | 5.37 | What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated? ( Sica, DA, 2011) |
| "Primary aldosteronism (PA) is a possible cause of endocrine hypertension." | 5.37 | [Aldosterone/renin ratio in the diagnosis of primary aldosteronism]. ( Catay, E; Honnorat, E; Izquierdo, A; Popescu, BM; Ríos, MC; Rodríguez Cuimbra, S; Sotelo, M, 2011) |
| "Heart failure is accompanied by electrolyte disturbance including reduced calcium and sodium in the extracellular milieu but increased calcium within cells, a phenomenon called "calcium paradox"." | 5.36 | Aldosterone improves contractile function of adult rat ventricular cardiomyocytes in a non-acute way: potential relationship to the calcium paradox of aldosteronism. ( Abdallah, Y; Schlüter, KD; Schreckenberg, R; Tastan, I; Wenzel, S, 2010) |
| "Primary aldosteronism (PA) is a frequent cause of secondary hypertension and is amenable to surgical intervention when it is caused by aldosterone-producing adenoma (APA)." | 5.36 | Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma. ( Kim, RM; Lee, J; Soh, EY, 2010) |
| "Hyperaldosteronism (PRA < 1 ng x mL(-1) x h(-1) and UAldo > or = 12 microg/24-h) prevalence was 28% and OSA prevalence was 77%." | 5.36 | Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. ( Ahmed, MI; Calhoun, DA; Cofield, SS; Gaddam, KK; Gonzaga, CC; Harding, SM; Oparil, S; Pimenta, E; Thomas, SJ, 2010) |
| "Primary aldosteronism (PA) may account for as much as 6-20% of cases of refractory hypertension referred to hypertension clinics." | 5.35 | The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine. ( Fukuchi, K; Horio, T; Iwanaga, Y; Kamide, K; Kawano, Y; Nakahama, H; Nakamura, S; Nakata, H; Niizuma, S; Yoshihara, F, 2008) |
| "Primary aldosteronism (PA) is the most common secondary cause of hypertension that has recently been implicated in alterations of the immune system and progression of cardiovascular disease." | 5.35 | Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha. ( Carvajal, CA; Castillo, CR; Contreras, FJ; Fardella, CE; Herrada, AA; Kalergis, AM; Mosso, LM; Stehr, CB, 2009) |
| "Normokalaemia does not exclude primary aldosteronism as the underlying cause of hypertension." | 5.35 | [Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009]. ( Guthoff, M; Horger, M; Kirchhoff, K; Kurth, R; Müssig, K; Schnauder, G, 2009) |
| "Primary aldosteronism (PA) is a common curable disease of secondary hypertension." | 5.35 | Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. ( Chang, HW; Chueh, SC; Hsieh, BS; Li, HY; Lin, WC; Lin, YH; Liu, KL; Wu, KD; Wu, VC, 2008) |
| "Hyperaldosteronism is associated with hypertension, cardiovascular fibrosis, and electrolyte disturbances, including hypomagnesemia." | 5.35 | Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. ( Montezano, AC; Paravicini, T; Sontia, B; Tabet, F; Touyz, RM, 2008) |
| "In patients with primary aldosteronism, as a whole group, the cut-off value of 69 corresponded to the best compromise value between sensitivity (96%) and specificity (85%), with and without PRA adjustment." | 5.35 | Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism. ( Bardini, M; Bernini, G; Bernini, M; Berti, P; Miccoli, P; Moretti, A; Orlandini, C; Salvetti, A; Taurino, C, 2008) |
| "Primary aldosteronism (PA) is characterized by the onset of both cardiac and gluco-metabolic alterations." | 5.34 | Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. ( Agostinelli, L; Boscaro, M; Giacchetti, G; Mantero, F; Rilli, S; Ronconi, V; Turchi, F, 2007) |
| "Primary aldosteronism (PA) has been considered a rare cause of hypertension." | 5.34 | Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. ( Fogari, E; Fogari, R; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A, 2007) |
| "Here we describe a 13-yr-old girl with primary hyperaldosteronism secondary to aldosterone-secreting adenoma." | 5.34 | An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia. ( Acikalin, MF; Dinleyici, EC; Dogruel, N; Ilhan, H; Oztelcan, B; Tokar, B, 2007) |
| "When using ARR for screening primary hyperaldosteronism, posture and time of sampling should be standardized both within and between centers to minimize variability in cutoff levels." | 5.33 | The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. ( Chan, FK; Choi, CH; Kong, AP; Ng, CM; Ng, YW; Shek, CC; Tiu, SC, 2005) |
| "Recent reports suggesting that primary aldosteronism (PA) is more common than historically thought have often relied on use of the plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio (ARR) to identify patients with PA." | 5.33 | Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. ( Calhoun, DA; Cofield, S; Nishizaka, MK; Pratt-Ubunama, M; Zaman, MA, 2005) |
| "Primary hyperaldosteronism is known to be frequently characterized by multiple adrenal lesions." | 5.33 | Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. ( Arai, Y; Chiba, Y; Ishidoya, S; Ito, A; Sakai, K; Sato, F; Satoh, M, 2005) |
| "However, tempol failed to suppress cardiac hypertrophy, the formation of inflammatory lesions, and upregulation of cardiac MCP-1 and osteopontin by aldosterone, while N-acetylcysteine could inhibit all of them." | 5.33 | Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. ( Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Ueda, M; Wake, R; Yoshida, K; Yoshiyama, M; Yukimura, T, 2005) |
| "Primary aldosteronism (PAL) is the most frequent cause of secondary arterial hypertension." | 5.33 | Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. ( Assié, G; Auzan, C; Balaton, A; Baviera, E; Clauser, E; Corvol, P; Elalouf, JM; Gasc, JM; Jeunemaitre, X; Plouin, PF, 2005) |
| "A total of 25 patients with primary aldosteronism caused by Conn's adenoma, 29 patients with renovascular hypertension, and 29 patients with essential hypertension (EHT) were included in the present study." | 5.33 | Role of aldosterone in left ventricular hypertrophy in hypertension. ( Fujii, K; Iida, M; Matsumura, K; Oka, M; Oniki, H, 2006) |
| "Resistant hypertension is common in clinical practice." | 5.33 | Aldosterone and refractory hypertension: a prospective cohort study. ( Calò, LA; Cattelan, F; Ciccariello, L; De Toni, R; Macchini, L; Mascagna, V; Pessina, AC; Realdi, A; Sartori, M; Semplicini, A, 2006) |
| "Primary aldosteronism has recently been recognized as the most frequent cause of secondary hypertension." | 5.33 | Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. ( Beuschlein, F; Maser-Gluth, C; Nickel, C; Reincke, M; Rüdiger, F; Schirpenbach, C; Seiler, L, 2006) |
| "The appearance of SHPT in aldosteronism, induced by fallen plasma [Ca]o, leads to PTH-mediated Ca overloading of PBMC and their increased production of H2O2." | 5.33 | Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements. ( Ahokas, RA; Bhattacharya, SK; Gerling, IC; Goodwin, KD; Sun, Y; Weber, KT, 2006) |
| "To screen primary aldosteronism cases with ARR (aldosterone/plasma renin activity, ARR) from patients with hypertension, and to evaluate the diagnosis value of ARR in primary aldosteronism cases and analysis the clinical characters of primary aldosteronism cases." | 5.33 | [Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism]. ( Liu, ZJ; Shao, JM; Wang, DW; Yan, JT; Zhang, HL, 2006) |
| "The severity of obstructive sleep apnea (OSA) correlates with the difficulty of controlling BP." | 5.32 | Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. ( Calhoun, DA; Harding, SM; Nishizaka, MK; Zaman, MA, 2004) |
| "We report a rare case of adrenocortical carcinoma." | 5.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
| "Primary hyperaldosteronism is a well-recognized cause of secondary hypertension." | 5.32 | Serum aldosterone and the incidence of hypertension in nonhypertensive persons. ( Benjamin, EJ; Evans, JC; Larson, MG; Levy, D; Meigs, JB; Rifai, N; Vasan, RS; Wilson, PW, 2004) |
| "In patients with primary aldosteronism treated with spironolactone (n = 8), renin escaped suppression and reached very high levels." | 5.31 | Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. ( Hahn, EG; Hensen, J; Schobel, H; Seifarth, C; Trenkel, S, 2002) |
| "The prevalence of primary aldosteronism (PA) was assessed in a specialized hypertension center." | 5.31 | High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. ( Davoli, S; Negro, A; Perazzoli, F; Regolisti, G; Rossi, E; Sani, C, 2002) |
| "It is known that hyperaldosteronism has been associated with magnesium deficiency, yet there are no data on the intracellular concentration of ionized magnesium ([Mg(2+)(i)]) in subjects with primary aldosteronism (PA)." | 5.31 | Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis. ( Brazzarola, P; Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C, 2000) |
| "Idiopathic hyperaldosteronism (IH) is a rare disorder characterized by hypertension, hypokalemia and bilateral adrenal hypersecretion of aldosterone." | 5.31 | Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism. ( Cartier, D; Contesse, V; Delarue, C; Duparc, C; Fischmeister, R; Kuhn, JM; Lefebvre, H; Lihrmann, I; Vaudry, H, 2000) |
| "The traditional workup for primary aldosteronism is cumbersome and requires discontinuing antihypertensive medications, which is inconvenient and potentially dangerous." | 5.31 | Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. ( Ahmad, S; Davidson, RC; Gallay, BJ; Toivola, B; Xu, L, 2001) |
| "The hypertension of Conn's syndrome is due to autonomous aldosterone production by a unilateral adrenocortical adenoma." | 5.31 | Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome). ( Connell, JM; Davies, E; Fraser, R; Friel, EC; Inglis, GC; Plouin, PF, 2001) |
| "We report a rare case of aldosteronism due to APA in which PAC and blood pressure were well controlled with small dose dexamethasone for over one year." | 5.31 | Aldosterone-producing adenoma with prolonged amelioration by dexamethasone. ( Ban, Y; Gomi, Y; Murai, M; Suzuki, S; Takahashi, R; Taniyama, M, 2001) |
| "Also, 17 patients with known primary aldosteronism were retrospectively examined." | 5.31 | Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. ( Hahn, EG; Hensen, J; Schobel, H; Seifarth, C; Trenkel, S, 2002) |
| "Primary aldosteronism is a disorder with hypertension, hypokalemia, increased plasma aldosterone, and suppressed renin activity." | 5.31 | Diagnostic value of the post-captopril test in primary aldosteronism. ( Castro, OL; Kem, DC; Yu, X, 2002) |
| "Hyperaldosteronism has been causally linked to myocardial interstitial fibrosis experimentally, but it remains unclear if this link also applies to humans." | 5.31 | Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. ( Bertini, A; Cesari, M; Di Bello, V; Ganzaroli, C; Giorgi, D; Mariani, M; Pessina, AC; Rossi, GP; Sacchetto, A; Scognamiglio, R, 2002) |
| "It is, therefore, possible that primary hyperaldosteronism caused by an aldosterone-producing adenoma (APA) may be the result of constitutive activation of the AT1 receptor." | 5.30 | Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. ( Bonnardeaux, A; Clauser, E; Corvol, P; Davies, E; Plouin, PF, 1997) |
| "Hyperplasia is managed medically whereas adenomas are treated surgically." | 5.30 | Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma. ( Melby, JC; Rao, A, 1997) |
| "A case of primary hyperaldosteronism and cardiomegaly due to a unilateral adrenal adenoma in a newborn is presented." | 5.30 | Hypertensive cardiomegaly caused by an aldosterone-secreting adenoma in a newborn. ( Armanini, D; Cecchetto, G; Fassina, A; Opocher, G; Pozzan, GB; Rigon, F; Zacchello, F, 1997) |
| "Unlike other forms of primary aldosteronism, recent prospective studies have paradoxically revealed that glucocorticoid-remediable aldosteronism (GRA) is usually characterized by normal potassium (K+) levels." | 5.30 | Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. ( Coolidge, C; Dluhy, RG; Fallo, F; Lifton, RP; Litchfield, WR; Silva, P; Williams, GH, 1997) |
| "Aldosterone levels during treatment [13." | 5.30 | Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I. ( Gartside, MG; Gordon, RD; Stowasser, M; Taylor, WL; Tunny, TJ, 1997) |
| "Primary aldosteronism, though an uncommon cause of hypertension, causes significant morbidity, making it important to diagnose and treat this condition." | 5.30 | Aldosterone to renin ratios in the evaluation of primary aldosteronism. ( Eng, PH; Fok, AC; Ho, SC; Khoo, DH; Koh, LK; Lim, HS; Lim, SC; Tai, ES; Tan, CE; Tan, KE, 1997) |
| "Myelolipomas have occasionally been found in patients with Cushing's syndrome, pheochromocytoma and hyperthyroidism." | 5.30 | Aldosterone-producing adenoma associated with foci of myelolipoma. ( Bober, J; Lazurova, I; Pajtasova, D; Sokol, L; Trejbal, D; Zachar, M, 1998) |
| "Familial hyperaldosteronism type II (FH-II) is characterized by autosomal dominant inheritance and hypersecretion of aldosterone due to adrenocortical hyperplasia or an aldosterone-producing adenoma; unlike FH type I (FH-I), hyperaldosteronism in FH-II is not suppressible by dexamethasone." | 5.30 | Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. ( Chrousos, GP; Gordon, RD; Huggard, PR; Lin, JP; Stowasser, M; Stratakis, CA; Taymans, SE; Torpy, DJ, 1998) |
| "Although primary aldosteronism is rare, especially during pregnancy, it should be always considered as one of etiologies of hypertension in pregnancy." | 5.30 | Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman. ( Fujiyama, S; Inada, M; Iwasaka, T; Maruyama, K; Masaki, H; Matsubara, H; Matsuda, T; Mori, Y; Nagata, T; Okada, S; Umeda, Y; Yonemoto, T, 1999) |
| "However, hyperkalemia is generally neither severe nor prolonged, in which replacement therapy with mineralocorticoid is seldom necessary." | 5.30 | A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. ( Inoue, D; Koshiyama, H; Muramatsu, Y; Sasano, H; Sato, Y; Sugawa, A; Tanaka, S; Taniguchi, R; Yamauchi, M, 1998) |
| "Normotensive primary hyperaldosteronism is exceedingly rare." | 5.30 | Aldosterone-producing adenoma without hypertension: a report of two cases. ( Ghulam, A; Jeunemaitre, X; Lefebvre, J; Provost, F; Ronci, N; Tabarin, A; Vantyghem, MC, 1999) |
| "In primary hyperaldosteronism, it is important to distinguish between unilateral and bilateral disease, as management strategies differ." | 5.30 | Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas. ( Atkinson, AB; Ferrett, CG; Harper, R; McIlrath, EM; McKnight, JA; Russell, CF; Sheridan, B, 1999) |
| "Patients with primary aldosteronism had significantly higher (P < 0." | 5.29 | Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism. ( Pincus, S; Siragy, HM; Veldhuis, JD; Vieweg, WV, 1995) |
| "In patients with primary aldosteronism and renovascular hypertension the plasma aldosterone level was shown to be an important factor upregulating AT1 receptor mRNA." | 5.29 | Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile. ( Murakami, M; Saruta, T; Sato, A; Shibata, H; Suzuki, H, 1994) |
| "Patients with glucocorticoid-remediable aldosteronism (GRA) possess a chimeric gene resulting from fusion of the genes encoding steroid aldosterone synthase and 11 beta-hydroxylase." | 5.29 | Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism. ( Boscaro, M; Fallo, F; Kuhnle, U; Sonino, N, 1994) |
| "A case of normotensive primary aldosteronism in association with non-functioning adenoma and aldosterone producing adenoma in ipsilateral adrenal gland is reported." | 5.29 | [A case of normotensive primary aldosteronism in association with non-functioning adenoma and aldosterone producing adenoma in ipsilateral adrenal gland]. ( Akiyama, M; Suyama, B, 1994) |
| "From these data it emerges that hyperaldosteronism, as observed in these patients with CRI, is a relatively reliable marker of the extent of CRI and may occur independently of the activation of the RAA system, given that other factors, such as orthostatic stimulation, alterations in the acid-base equilibrium, and the degree of aldosterone hepatic and urinary clearance, contribute to its pathogenesis." | 5.29 | [Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]. ( Buracchi, P; Carletti, F; Gennari, C; Lucani, B; Martinelli, M; Nami, R; Panza, F; Pavese, G; Saia, F, 1993) |
| "The hyperaldosteronism could not be suppressed by dexamethasone." | 5.29 | [Unilateral autonomous aldosterone production in hyperaldosteronism suppressible by dexamethasone]. ( Haack, D; Jakob, F; Ludwig, J; Rendl, J; Schröder, K; Seufert, J; Vecsei, P, 1993) |
| "Spironolactone, however, was able to prevent myocardial fibrosis in RHT and aldosterone models of acquired arterial hypertension irrespective of the development of LVH and the presence of hypertension." | 5.29 | Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. ( Brilla, CG; Matsubara, LS; Weber, KT, 1993) |
| "We report a case of primary hyperaldosteronism due to unilateral diffuse hyperplasia." | 5.29 | Unilateral diffuse adrenal hyperplasia masquerading as aldosterone-producing adenoma in primary hyperaldosteronism. ( Hashimoto, T; Ishigooka, M; Kato, T; Kubota, Y; Nakada, T; Sasagawa, I; Suzuki, H, 1993) |
| "In glucocorticoid-remediable aldosteronism (GRA) a chimeric gene has been described with the activity of aldosterone synthase, but the promoter of 11 beta-hydroxylase leading to ectopic expression of aldosterone synthase activity in the zona fasciculata." | 5.29 | Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications. ( Bradwin, G; Carroll, J; Dluhy, R; Fallo, F; Gomez-Sanchez, CE; Mortensen, R; Pistorello, M, 1996) |
| "A 41-year-old woman developed primary aldosteronism due to bilateral multiple aldosterone-producing adenomas (APA)." | 5.29 | Primary aldosteronism with bilateral multiple aldosterone-producing adrenal adenomas. ( Beniko, M; Ikota, A; Koizumi, S; Kunita, H; Mashio, Y; Matsuda, A; Matsuya, K; Mizumoto, H; Sasano, H; Watanabe, T; Yamazaki, M, 1996) |
| "Four patients with primary hyperaldosteronism were treated with nadroparin 4100 or 6150 antiXa IU daily for 4 days." | 5.28 | A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism. ( Cailleux, N; Courtois, H; Godin, M; Levesque, H; Moore, N, 1992) |
| "The relevance of these findings to primary hyperaldosteronism and to the nature of the transition is discussed." | 5.28 | The origin and significance of 18-hydroxycortisol: studies in hyperaldosteronism and in bovine adrenocortical cells in vitro. ( Budd, PS; Connell, JM; Corrie, JE; Fraser, R; Kenyon, CJ, 1991) |
| "Aldosterone was secreted from the adrenal cortex in all patients and was increased by ACTH in 75% of the tissue specimens." | 5.28 | Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro. ( Grimelius, L; Gröndal, S; Hamberger, B; Thorén, M, 1991) |
| "The data used to make the diagnosis of primary hyperaldosteronism and to assess the likelihood of the presence of an adenoma indicate that patients studied at 40 centres in the UK show results very similar to those of North American series where large numbers of patients have been described but all have been studied in the same centre." | 5.28 | Primary hyperaldosteronism in England and Wales: a review of the use of a Supraregional Assay Service laboratory for the measurement of aldosterone and plasma renin activity. ( James, VH; Short, F, 1991) |
| "We describe four cases of primary hyperaldosteronism whose initial presentation was a moderate to severe hypertension." | 5.28 | [Significance of the captopril test in the diagnosis of primary hyperaldosteronism --apropos of 4 clinical cases]. ( Alberto, MJ; Gonçalves, P; Machado, J; Maltez, F; Martins, G; Proença, R, 1990) |
| "Aldosterone secretion was stimulated by ACTH, angiotensin II and potassium with or without ANF 10 microM." | 5.28 | Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies. ( D'Agostino, D; Leone, L; Mantero, F; Opocher, G; Rocco, S, 1989) |
| "A 37-year-old woman presented with hyperaldosteronism, suppressed renin levels, and a left adrenal mass on CT scanning." | 5.28 | Possible association of aldosterone producing adenoma and non-functioning adrenal tumor. ( Kobayashi, T; Kon-i, I; Matsubara, T; Miyamori, I; Morise, T; Nakagawa, A; Soma, R; Takasaki, H; Takeda, R, 1989) |
| " First, we performed a post-hoc analysis of the effect of eplerenone on parathyroid hormone levels in primary hyperparathyroidism (EPATH) study, a randomized controlled trial (RCT) in 110 patients with primary hyperparathyroidism (pHPT)." | 5.27 | Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data. ( Aberer, F; Alesutan, I; Bachmann, A; Catena, C; Grübler, MR; März, W; Meinitzer, A; Obermayer-Pietsch, B; Pandis, M; Pilz, S; Schwetz, V; Sechi, LA; Tomaschitz, A; Trummer, C; Verheyen, N; Voelkl, J, 2018) |
| "In the patients with hyperaldosteronism, plasma aldosterone concentrations (mean +/- 1 S." | 5.27 | Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor. ( Bumpus, FM; Carey, RM; Dolan, LM; Malchoff, CD; Sen, S, 1984) |
| "Most diagnostic tests for primary aldosteronism use maneuvers to expand the extracellular fluid volume, thereby suppressing the renin-angiotensin system." | 5.27 | Single dose captopril as a diagnostic test for primary aldosteronism. ( Brown, RD; Carollo, ML; Hanson, CS; Kem, DC; Lyons, DF, 1983) |
| "The diagnosis of primary tumoral hyperaldosteronism is based on a series of hormonal parameters, measured under resting conditions and after stimulation." | 5.27 | [Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril]. ( Corvol, P; Ménard, J; Plouin, PF; Thibonnier, M, 1983) |
| "A 7-year-old girl had hyperaldosteronism due to an adrenal cortical adenoma, a rare, surgically remediable cause of hypertension." | 5.27 | Hypertension caused by an aldosterone-secreting adenoma. Occurrence in a 7-year-old child. ( Bryer-Ash, M; Luetscher, JA; Rosenfeld, RG; Shochat, SJ; Tune, BM; Wilson, DM, 1984) |
| "Primary aldosteronism is a potentially curable cause of hypertension; it occurs in about 1% of hypertensive patients." | 5.27 | 'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma. ( Almog, C; Burke, M; Papo, J; Stavorovsky, M, 1984) |
| "Hyperaldosteronism was associated with the most pronounced deviations in the relationship between stimulants and aldosterone." | 5.27 | [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism]. ( Chikhladze, NM; Pershakova, LP; Shkhvatsabaia, IK; Uchitel', IA; Ustinova, SE, 1985) |
| "Hyperaldosteronism in the patients with renal-parenchymatous and essential arterial hypertension was regarded as secondary in a stable and malignant course of arterial hypertension." | 5.27 | [Radioimmunologic determination of aldosterone and renin in the blood in the diagnosis of different forms of arterial hypertension]. ( Khalmuratova, RA; Khamidov, RI; Sattarova, FK, 1987) |
| "In patients with primary aldosteronism (n = 21) elevated as well as normal values of urinary 21-deoxyaldosterone were found, indicating that in some patients aldosterone may be formed not only from corticosterone but also from the 21-deoxy compound." | 5.27 | 21-Deoxyaldosterone excretion in patients with primary aldosteronism and 21-hydroxylase deficiency. ( Abdelhamid, S; Bige, K; Bokkenheuser, V; Heinrich, U; Lewicka, S; Vecsei, P; Winter, J, 1987) |
| "A 50-year old female with primary aldosteronism and masked hyperaldosteronemia is reported." | 5.27 | A case report of aldosterone producing adenoma with masked hyperaldosteronemia. ( Arimori, S; Hiramatsu, K; Takahashi, K, 1986) |
| "Malignant hypertension in Conn's syndrome is rare." | 5.27 | Malignant hypertension due to an aldosterone producing adrenal adenoma. ( Kincaid-Smith, P; Murphy, BF; Whitworth, JA, 1985) |
| "This was an unusual form of primary aldosteronism which showed normal levels of aldosterone in both blood and urine." | 5.27 | Primary aldosteronism with normal aldosterone levels in blood and urine. ( Demura, H; Han, DC; Jibiki, K; Nomura, K; Shizume, K; Tsushima, T, 1985) |
| "In patients with primary hyperaldosteronism, a poor response of plasma aldosterone to angiotensin II infused alone was altered to a response comparable with that in normal subjects by supplying ACTH during the infusion." | 5.26 | The acute effect of angiotensin II on adrenal and anterior pituitary function in normal subjects and subjects with primary hyperaldosteronism. ( Fraser, R; Mason, PA; Young, J, 1980) |
| "In untreated patients with primary aldosteronism caused either by adrenal adenoma or hyperplasia plasma aldosterone and cortisol concentrations fluctuated in unison and dexamethasone reduced both hormones markedly." | 5.26 | Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration. ( Ganguly, A; Luetscher, JA; Weinberger, MH, 1982) |
| "Screening tests for primary aldosteronism were compared in 22 patients with this disorder and 140 hypertensive controls." | 5.26 | Simplified screening procedures for primary aldosteronism. Studies on the mechanism of the hyper-responsiveness to furosemide and standing. ( Anderson, GH; Streeten, DH, 1982) |
| "Twenty-four patients with primary aldosteronism were studied." | 5.26 | Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism. ( Lund, JO; Nielsen, MD, 1980) |
| "In primary aldosteronism, high UA and PAC together with suppressed PRA represent an important diagnostic guideline for differentiation from other types of low-renin hypertensions." | 5.26 | Renin-angiotensin-aldosterone system in arterial hypertension. ( Gregorová, I; Horký, K, 1980) |
| "1." | 5.26 | Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. ( Armanini, D; Boscaro, M; Fallo, F; Mantero, F; Opocher, G; Scaroni, C, 1981) |
| "Two adrenocortical adenomata causing Conn's syndrome were examined by electron microscopy." | 5.26 | Ultrastructure of aldosterone secreting adrenal adenomata. ( Gottardo, G; Mazzocchi, G; Meneghelli, V; Nussdorfer, GG; Robba, C, 1982) |
| "Primary aldosteronism, when caused by an aldosterone-producing adenoma, is a surgically treatable condition." | 5.26 | An aldosterone-producing adrenal cortical adenoma. ( Hugo, JM; Shipton, EA, 1982) |
| " We conclude that aldosterone antagonists in the dosage used had no effect on the course of postoperative hyperaldosteronism." | 5.26 | Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists. ( Haschke, F; Parth, K; Wimmer, M, 1981) |
| "In most of the patients examined hyperaldosteronism was found, which was attended by an increased percentage of 14C-aldosterone binding with aldosterone binding globulin (ABG) and particularly with glucocorticoid binding globulin (GBG)." | 5.26 | [14C-aldosterone binding by plasma proteins in adolescents with primary arterial hypertension]. ( Bakova, VV; Golov, AG; Kucherenko, AG; Markov, KhM, 1981) |
| "Four patients with hyperaldosteronism due to adrenal adenomas served as controls." | 5.26 | The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism. ( Gomez-Sanchez, C; Higgins, JR; Kem, DC; Kramer, NJ; Weinberger, MH, 1976) |
| "In nine patients with primary aldosteronism (PA), plasma aldosterone was measured in order to evaluate a role of the renin-angiotensin system, ACTH and potassium in the secretion of aldosterone." | 5.26 | [Secretory regulation and episodic secretion of aldosterone in patients with primary aldosteronism (author's transl)]. ( Murakami, T; Ohbuchi, S, 1976) |
| "These data show that patients with hyperaldosteronism from an adrenal adenoma or hyperplasia have a consistent and exaggerated response to ACTH." | 5.26 | Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. ( Gomez-Sanchez, C; Higgins, JR; Holland, OB; Kem, DC; Kramer, NJ; Weinberger, MH, 1978) |
| "Hyperaldosteronism is dependent on the maintenance of prostaglandin synthesis." | 5.26 | Hyperaldosteronism in the sodium-depleted rat: mode of aldosterone-stimulating action of frusemide. ( Spät, A; Tarján, E; Tóth, G, 1979) |
| "Among the atypical pictures of primary aldosteronism, sometimes, normal blood and urine concentration of aldosterone have been observed in association with an adrenal aldosterone-producing adenoma." | 5.26 | [Physiopathological and functional semeiologic considerations in a case of primary normoaldosteronemic hyperaldosteronism]. ( Banchini, E; Biggi, A; Bruschi, G; Civardi, E; Coruzzi, P; Martinelli, M; Mutti, A; Novarini, A, 1977) |
| "Twenty patients suffering from primary hyperaldosteronism were studied." | 5.26 | [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism]. ( Benguigui, L; Corvol, P; Houde, M; Menard, J; Milliez, P; Tonnelier, M, 1977) |
| "Aldosterone was significantly elevated in the manic patients, and elevated in the schizoaffective patients." | 5.25 | Lithium-responsive hyperaldosteronism in manic patients. ( Hendler, N, 1975) |
| "The aldosterone secretion was normal and responded normally to sodium deprivation in all patients studied during suppression with carbohydrate-active steroids." | 5.25 | Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia. ( Bartter, FC; Bryan, GT; Henkin, RI, 1968) |
| "In six patients with primary aldosteronism, plasma aldosterone on a normal sodium diet was 39." | 5.25 | Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism. ( Horton, R, 1969) |
| "Five obvious cases of hyperaldosteronism were found among the 16 low-renin patients." | 5.25 | Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. ( Collins, RD; Dowdy, AJ; Gonzales, CM; Luetscher, JA; Nokes, GW; Weinberger, MH, 1970) |
| "Failure of aldosterone suppression by sodium loading during fludrocortisone suppression testing (FST) or saline suppression testing (SST) confirms primary aldosteronism (PA)." | 5.19 | Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study. ( Ahmed, AH; Cowley, D; Gordon, RD; Stowasser, M; Taylor, PJ; Wolley, M; Xu, S, 2014) |
| "A common pharmacologic test for the diagnosis of primary aldosteronism (PA) is the administration of captopril to determine whether an abnormal plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio(ARR) persists, although active renin concentration (ARC) may offer advantages with regard to processing and standardization." | 5.14 | Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity. ( Chang, CC; Chang, HW; Chueh, SC; Fang, CC; Ho, YL; Huang, KH; Kuo, CC; Lin, CY; Lin, LY; Lin, SL; Lin, YH; Liu, KL; Tsai, CT; Wang, SM; Wu, KD; Wu, VC; Yen, RF, 2010) |
| "Renin, aldosterone, and their interrelation are influenced by circadian rhythms, telmisartan, ramipril, and amlodipine in patients with essential hypertension." | 5.11 | Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. ( de Champlain, J; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L, 2005) |
| "The aim of this study was to investigate the effect of short-term treatment with losartan, a selective and competitive angiotensin II (AngII) receptor blocker, on vascular endothelial growth factor (VEGF), active renin and kallikrein activity (KA) in patients with essential hypertension and primary aldosteronism." | 5.09 | Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension. ( Atanassova, I; Natchev, E; Orbetzova, M; Tzingilev, D; Zacharieva, S, 2001) |
| "The usefulness of the captopril test as a simultaneous screening method for primary aldosteronism (PA) and renovascular hypertension (RVH) was evaluated in 111 patients with essential hypertension, and in 79 patients with secondary hypertension, which included 16 patients with PA and 18 with RVH." | 5.07 | The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension. ( Inoue, J; Iwaoka, T; Naomi, S; Sasaki, M; Sato, T; Umeda, T; Yamauchi, J, 1993) |
| "The purpose of the study was to evaluate the effects of a dihydropyridine calcium antagonist, nicardipine (N), on blood pressure (BP) and aldosterone secretion in hypertensive patients (pt) with primary aldosteronism." | 5.06 | [Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism]. ( Begasse, F; Chamontin, B; David, D; Salvador, M, 1989) |
| "The chronic effect of the calcium antagonist nitrendipine was investigated on blood pressure (BP), plasma aldosterone concentration (PAC), plasma renin activity (PRA), and serum potassium in six patients with primary aldosteronism, either due to an (unilateral) aldosterone-producing adenoma (APA; n = 3; age, 44 +/- 4 years; PAC, 312 +/- 96 pg/ml; PRA, less than 0." | 5.06 | Therapeutic value of calcium antagonists in autonomous hyperaldosteronism. ( Ivens, K; Kaufmann, W; Stimpel, M; Volkmann, HP; Wambach, G, 1989) |
| " Therefore, we have studied the acute and chronic effect of nifedipine in 7 patients with idiopathic hyperaldosteronism (IHA) and 8 with aldosterone producing adenoma (APA)." | 5.06 | Acute and chronic effect of nifedipine in primary aldosteronism. ( Carpenè, G; Mantero, F; Opocher, G; Rocco, S, 1989) |
| "This presentation is a summary of our recent clinical studies on the therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism." | 5.05 | The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. ( Griffing, GT; Melby, JC, 1983) |
| " Since ketanserin, a more specific 5-HT2-serotoninergic (5-HT2) antagonist, has been shown to affect aldosterone secretion in essential hypertension, we have further investigated this mechanism by injecting ketanserin (10 mg i." | 5.05 | Effect of ketanserin in primary aldosteronism. ( Armanini, D; Boscaro, M; D'Agostino, D; Mantero, F; Opocher, G; Rocco, S, 1985) |
| " Hyperaldosteronism due to klotho deficiency results in vascular calcification, which can be mitigated by spironolactone treatment." | 4.90 | Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. ( Fahrleitner-Pammer, A; Gaksch, M; Grübler, M; Kienreich, K; Kraigher-Krainer, E; März, W; Mrak, P; Pieske, B; Pilz, S; Ritz, E; Rus-Machan, J; Tomaschitz, A; Toplak, H; Verheyen, N, 2014) |
| " The 30% improvement in mortality (and 35% in morbidity) seen in the RALES trial with the addition of low-dose spironolactone to best practice therapy in moderate to severe heart failure, similarly points to an unrecognized role for aldosterone in the pathophysiology of heart failure." | 4.81 | Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. ( Funder, JW; Young, MJ, 2002) |
| "Until recently, spironolactone was considered only as an antagonist at the aldosterone receptors of the epithelial cells of the kidney and was used clinically in the treatment of hyperaldosteronism and, occasionally, as a K(+)-sparing diuretic." | 4.81 | The spironolactone renaissance. ( Brown, L; Doggrell, SA, 2001) |
| "Hydralazine, doxazosin, and verapamil are currently recommended by the Endocrine Society as acceptable bridging treatment in those in whom full cessation of antihypertensive medication is infeasible during screening for primary aldosteronism (PA)." | 4.31 | The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof. ( Alnazer, RM; de Leeuw, PW; Kroon, AA; Veldhuizen, GP, 2023) |
| "We examined if measurement of adrenal androgens adds to subtype diagnostics of primary aldosteronism (PA) under cosyntropin-stimulated adrenal venous sampling (AVS)." | 4.12 | Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling. ( Hinkka, T; Kokko, E; Leijon, H; Matikainen, N; Nevalainen, PI; Pörsti, I; Schalin-Jäntti, C; Soinio, M; Vesterinen, T; Viukari, M, 2022) |
| "Captopril challenge test (CCT) is a simple and safe confirmatory test for primary aldosteronism (PA)." | 4.02 | Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism. ( Baba, S; Miyoshi, A; Obara, S; Shibayama, Y; Sugawara, H; Takahashi, B; Terae, S; Usubuchi, H; Wada, N, 2021) |
| "The saline suppression test (SST) and captopril challenge test (CCT) are commonly used confirmatory tests for primary aldosteronism (PA)." | 4.02 | Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study. ( Cheng, Q; Du, Z; Feng, Z; He, W; Hu, J; Li, Q; Liu, B; Song, Y; Wang, Z; Xu, Z; Yang, J; Yang, S, 2021) |
| "We prospectively enrolled 121 patients with confirmed primary aldosteronism who started mineralocorticoid receptor antagonist (canrenone) treatment." | 4.02 | Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism. ( Avataneo, V; Bertello, C; Buffolo, F; Burrello, J; D'Avolio, A; Mengozzi, G; Monticone, S; Mulatero, P; Pecori, A; Rabbia, F; Rumbolo, F; Veglio, F, 2021) |
| "The result interpretation of the captopril challenge test (CCT) for the diagnosis of primary aldosteronism (PA) is not standardized." | 4.02 | The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism. ( Chen, T; Li, Q; Li, Y; Ren, Y; Tian, H; Xiang, Q; Yu, K, 2021) |
| "Recent reports described cases of severe hypertension and hypokalemia accompanied by low renin and aldosterone levels during antifungal therapy with posaconazole and itraconazole." | 3.96 | Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals. ( Beck, KR; Odermatt, A; Telisman, L; Thompson, GR; van Koppen, CJ, 2020) |
| "Spironolactone treatment might increase insulin resistance in patients with PA." | 3.96 | Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism. ( Chang, CH; Chung, SD; Hu, YH; Lin, YF; Peng, KY; Wu, VC, 2020) |
| "Vascular function, including reactive hyperemia index (RHI), flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID), arterial stiffness including brachial-ankle pulse wave velocity (baPWV) and brachial intima-media thickness (IMT) and ROCK activity in peripheral leukocytes were measured before and after 12 weeks of treatment with eplerenone in 50 patients with IHA." | 3.91 | Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. ( Aibara, Y; Chayama, K; Goto, C; Hashimoto, H; Higashi, Y; Kajikawa, M; Kihara, Y; Kishimoto, S; Liao, JK; Maruhashi, T; Matsui, S; Nakashima, A; Noma, K; Oki, K; Takaeko, Y; Yusoff, FM, 2019) |
| "We investigated the changes of serum PTH levels induced by oral captopril (50 mg) administration in patients with primary essential hypertension (EH) and with primary aldosteronism (PA) caused by bilateral adrenal hyperplasia (BAH) or aldosterone-producing adenoma (APA), the latter before and after adrenalectomy." | 3.91 | PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy. ( Iacobone, M; Lenzini, L; Lerco, S; Maiolino, G; Prisco, S; Rossi, GP; Seccia, TM; Torresan, F; Vanderriele, PE, 2019) |
| " We report our long-term single-practice experience in 5 patients with chronic hyperaldosteronism (HA, including 3 with glucocorticoid remediable aldosteronism, GRA) treated with low-dose amiloride (a specific epithelial sodium channel [ENaC] blocker) 5-10 (mean 7) mg daily for 14-28 (mean 20) years." | 3.91 | Long-term BP control and vascular health in patients with hyperaldosteronism treated with low-dose, amiloride-based therapy. ( Hong, M; Hussain, T; Izzo, JL; Osmond, PJ, 2019) |
| "The saline infusion test (SIT) and the captopril test (CT) are widely used as confirmatory tests for primary aldosteronism (PA)." | 3.91 | Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism. ( Chang, CC; Lin, PC; Lin, YH; Tsai, YC; Wang, SM; Wu, CH; Wu, V; Yang, SY; Yang, YW, 2019) |
| "The Captopril challenge test (CCT) is an easy-conduct confirmatory test for diagnosing primary aldosteronism (PA)." | 3.91 | The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population. ( Feng, WH; Li, HY; Li, P; Zhang, WJ; Zhang, Y; Zhu, DL; Zhu, KY, 2019) |
| " We report our long-term single-practice experience in an unusual group of five patients with chronic hyperaldosteronism (HA, including three with glucocorticoid-remediable aldosteronism, GRA) treated with low-dose amiloride (a specific epithelial sodium channel [ENaC] blocker) 5-10 (mean 7) mg daily for 14-28 (mean 20) years." | 3.91 | Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism. ( Hong, M; Hussain, T; Izzo, JL; Osmond, PJ, 2019) |
| "Failure of plasma aldosterone suppression during fludrocortisone suppression testing (FST) or saline suppression testing (SST) confirms primary aldosteronism (PA)." | 3.88 | Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism. ( Ahmed, AH; Cowley, D; Gordon, RD; Guo, Z; McWhinney, BC; Stowasser, M; Ungerer, JP; Wolley, M, 2018) |
| "Longstanding primary aldosteronism (PA) has deleterious effects on renal function, often masked until treatment (adrenalectomy or spironolactone) is initiated." | 3.85 | Effects of Treating Primary Aldosteronism on Renal Function. ( Deinum, J; Kramers, BJ; Kramers, C; Lenders, JW, 2017) |
| "Among patients with essential hypertension, circulating endogenous ouabain and Aldo are typically coelevated and their BP is salt-sensitive." | 3.83 | Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension. ( Brioni, E; Casamassima, N; Hamlyn, JM; Lanzani, C; Manunta, P; Messaggio, E; Simonini, M; Tentori, S; Zagato, L, 2016) |
| "As metoclopramide stimulates aldosterone secretion, we tested its usefulness in the assessment of lateralization of primary aldosteronism by adrenal vein sampling (AVS)." | 3.83 | Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism. ( Barbiero, G; Battistel, M; Bisogni, V; Maiolino, G; Miotto, D; Rossi, GP; Rossitto, G; Sanga, V, 2016) |
| "The objective of this article is to measure serum dehydroepiandrosterone sulfate (DHEA-S) concentration in both genders with primary aldosteronism (PA)." | 3.81 | Serum dehydroepiandrosterone sulfate concentration is lower in women with primary aldosteronism. ( Chen, AH; Huang, TS; Li, HY; Lin, YH; Wu, VC, 2015) |
| "Forty-two patients with confirmed primary aldosteronism (21 with aldosterone-producing adenoma treated by unilateral laparoscopic adrenalectomy, 21 treated with spironolactone) were investigated by carotid ultrasound at baseline and 1 and 6 years after the specific treatment." | 3.81 | Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness. ( Holaj, R; Indra, T; Michalský, D; Novák, K; Petrák, O; Rosa, J; Šomlóová, Z; Štrauch, B; Wichterle, D; Widimský, J; Zelinka, T, 2015) |
| " In this study, we attempted to determine whether peripheral plasma levels of 18-oxocortisol (18oxoF) and 18-hydroxycortisol could contribute to the clinical differentiation between aldosteronoma and bilateral hyperaldosteronism in 234 patients with primary aldosteronism, including computed tomography (CT)-detectable aldosteronoma (n=113) and bilateral hyperaldosteronism (n=121), all of whom underwent CT and adrenal venous sampling." | 3.81 | Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. ( Arai, Y; Gomez-Sanchez, CE; Honma, S; Ito, S; Iwakura, Y; Kudo, M; Morimoto, R; Nakamura, Y; Okuyama, M; Omata, K; Ono, Y; Rainey, WE; Sasamoto, H; Sasano, H; Satoh, F; Seiji, K; Takase, K; Yamashita, K, 2015) |
| "Urinary 18-hydroxycortisol has been investigated as a marker of aldosterone-producing adenoma (APA)." | 3.79 | Quantification of urinary 18-hydroxycortisol using LC-MS/MS. ( Chiba, H; Fuda, H; Fujikawa, M; Hui, SP; Ikegawa, S; Jin, S; Kurosawa, T; Sakurai, T; Takahashi, Y; Takeda, S; Wada, N; Yanagisawa, K, 2013) |
| " Patients with IIH should be evaluated for aldosteronism and considered for spironolactone therapy." | 3.79 | Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism. ( Khalid, H; Khan, MU; Salpietro, V; Weber, KT, 2013) |
| " We report a case of 55-year-old man with primary aldosteronism (PA) whose hyperaldosteronism was suppressed with the PPAR γ agonist pioglitazone." | 3.79 | Suppression of primary aldosteronism and resistant hypertension by the peroxisome proliferator-activated receptor gamma agonist pioglitazone. ( Harada, E; Kashiwagi, Y; Mizuno, Y; Morita, S; Shono, M; Yano, M; Yasue, H; Yoshimura, M, 2013) |
| "The aim of this paper is to report a case of unilateral PA with spontaneous remission and reduction of cardiac hypertrophy after long-term spironolactone (SP) therapy." | 3.78 | Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. ( Demura, M; Karashima, S; Kometani, M; Takata, H; Takeda, Y; Yamagishi, M; Yoneda, T, 2012) |
| "Idiopathic primary hyperaldosteronism (IHA) and low-renin essential hypertension (LREH) are common forms of hypertension, characterized by an elevated aldosterone-renin ratio and hypersensitivity to angiotensin II." | 3.78 | TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. ( Barrett, PQ; Bayliss, DA; Carey, RM; Guagliardo, NA; Hu, C; Schertz, EM; Tyson, DA; Yao, J, 2012) |
| "To study on the difference of plasma renin activity (PRA), angiotensin II (Ang II), and aldosterone levels in patients with essential hypertension (EH) or primary aldosteronism (PA) or pheochromocytoma (PHEO), and to analyze the sensitivity and specificity on the diagnosis of PA among patients with hypertension with aldosterone/PRA ratio (ARR)." | 3.78 | [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension]. ( Chen, S; Fu, CL; Li, M; Lu, L; Song, AL; Sun, ML; Tong, AL; Wang, YH; Zeng, ZP, 2012) |
| " We are not aware of any published QOL assessment in patients with bilateral primary aldosteronism (BPA), before or after commencing medical treatment (MT) with spironolactone and/or amiloride." | 3.77 | Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. ( Ahmed, AH; Gordon, RD; Pimenta, E; Stowasser, M; Sukor, N, 2011) |
| "We evaluated the circulating levels of resistin, leptin, and adiponectin, echocardiographic left ventricle (LV) parameters, and the prevalence of metabolic syndrome (SM) in subjects with PA." | 3.76 | Adipokines and cardiometabolic profile in primary hyperaldosteronism. ( Cianci, R; Cotesta, D; De Toma, G; Iacobellis, G; Letizia, C; Pergolini, M; Petramala, L; Sciomer, S; Zinnamosca, L, 2010) |
| " We characterized the pharmacokinetic/pharmacodynamic relationships of a prototypical ASI, (+)-(5R)-4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl]benzonitrile hydrochloride (CGS020286A, FAD286, FAD) and compared these profiles to those of the 11beta-hydroxylase inhibitor metyrapone (MET) in two rodent models of secondary hyperaldosteronism and corticosteronism." | 3.76 | Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone. ( Beil, M; Fu, F; Hu, CW; Jeng, AY; Liang, G; Rigel, DF, 2010) |
| "We, therefore compared, head-to-head, the aldosterone-renin ratio based on PRA with that based on DRA, at baseline and after captopril administration, for identifying aldosterone-producing adenoma (APA) in 251 patients of the Primary Aldosteronism Prevalence in hYpertension Study (PAPY)." | 3.76 | The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. ( Barisa, M; Belfiore, A; Desideri, G; Ferri, C; Letizia, C; Maccario, M; Mantero, F; Morganti, A; Palumbo, G; Patalano, A; Pessina, AC; Roman, E; Rossi, GP; Seccia, TM, 2010) |
| "We describe an instance of a false-positive laboratory diagnosis of primary aldosteronism (by both screening and confirmatory test) in a normotensive 34-year-old healthy woman taking Yasmin (drospirenone + ethinylestradiol) (Shering S." | 3.74 | Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy. ( Corrocher, R; Olivieri, O; Pavan, C; Pizzolo, F, 2007) |
| "When performed with careful regard to confounding factors, measurement of the aldosterone : renin ratio in all hypertensive individuals, followed by fludrocortisone suppression testing to confirm or exclude primary aldosteronism and adrenal venous sampling to determine the subtype, can result in the detection of significant numbers of patients with specifically treatable or potentially curable hypertension." | 3.72 | High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. ( Archibald, C; Cowley, DC; Gordon, RD; Gunasekera, TG; Smithers, BM; Stowasser, M; Ward, G, 2003) |
| "This prospective study was designed to compare the captopril suppression test with the salt-loading approach to confirm the diagnosis of primary aldosteronism." | 3.71 | Captopril suppression versus salt loading in confirming primary aldosteronism. ( Agharazii, M; Douville, P; Grose, JH; Lebel, M, 2001) |
| " Five of these patients with aldosterone producing adenoma were operated on and four patients with idiopathic hyperaldosteronism were treated with spironolactone." | 3.70 | Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. ( Haas, T; Hilgertová, J; Prázný, M; Sindelka, G; Skrha, J; Widimský, J, 2000) |
| "We evaluated the effects of prolonged spironolactone treatment on aldosterone secretion in patients with primary aldosteronism." | 3.69 | Aldosterone response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment. ( Ichikawa, S; Murata, K; Nakamura, T; Ono, Z; Sakamaki, T; Sakamoto, H; Sato, K; Yagi, A, 1994) |
| " We examined the possible association between restriction fragment length polymorphisms in the atrial natriuretic peptide (ANP) gene and responsiveness of aldosterone to angiotensin II in 59 patients with primary aldosteronism due to aldosterone-producing adenoma (APA)." | 3.69 | Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma. ( Ballantine, DM; Gordon, RD; Jonsson, JR; Klemm, SA; Stowasser, M; Tunny, TJ, 1994) |
| "To investigate the possible role of dopamine, a catecholamine with natriuretic properties, in modulating the escape from the sodium-retaining effects of mineralocorticoids, we submitted six aldosterone-producing adenoma (APA) patients and six low-renin essential hypertensive patients to acute volume expansion by head-out water immersion with or without dopaminergic blockade by metoclopramide." | 3.69 | Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine? ( Coruzzi, P, 1994) |
| " Study 1: A long-term (4 weeks) treatment with slow-release nifedipine (Nif), 40-60 mg/day, was performed in 9 in-patients with essential hypertension (EHT)." | 3.69 | [Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism]. ( Iimura, O; Shimamoto, K; Yokoyama, T, 1995) |
| "Approximately half of Caucasian patients with essential hypertension and with hyperaldosteronism exhibit elevated circulating levels of endogenous ouabain." | 3.69 | Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. ( De Toni, R; Hamlyn, JM; Manunta, P; Pavan, E; Pessina, AC; Rossi, G; Semplicini, A, 1995) |
| "The pathogenesis of pseudohyperaldosteronism from licorice has been evaluated in 6 male volunteers taking daily 7 g of a commercial preparation of licorice for 7 days, corresponding to an intake of 500 mg/day of glycyrrhizic acid." | 3.69 | Further studies on the mechanism of the mineralocorticoid action of licorice in humans. ( Armanini, D; Gottardo, C; Lewicka, S; Pratesi, C; Scali, M; Simoncini, M; Spigariol, A; Zampollo, V; Zennaro, MC; Zovato, S, 1996) |
| " Tsukuba hypertensive mice (THM) carry both human renin and angiotensinogen genes, and develop hypertension." | 3.69 | Development of polyuria in Tsukuba hypertensive mice carrying human renin and angiotensinogen genes. ( Fukamizu, A; Ikemoto, F; Mino, N; Murakami, K; Nishikibe, M; Tsuchida, M; Uehara, S, 1995) |
| "We compared the aldosterone-producing potency of the angiotensin II-sensitive wild-type aldosterone synthase genes and the ACTH-sensitive hybrid 11 beta-hydroxylase/aldosterone synthase gene by examining aldosterone, PRA, and cortisol day-curves (2-hourly levels over 24 h) in patients with familial hyperaldosteronism type I, before and during long-term (0." | 3.69 | In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes. ( Gartside, MG; Gordon, RD; Stowasser, M; Taylor, WL; Tunny, TJ, 1997) |
| " Failure to suppress aldosterone with fludrocortisone acetate administration and oral salt loading confirmed the presence of primary aldosteronism in all six patients." | 3.68 | Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. ( Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ; Ziesak, MD, 1993) |
| " Nineteen out of 47 patients (40%) with confirmed unilateral aldosterone-producing adenoma (APA) were responsive to low-dose angiotensin II infusion (AII-R), as defined by an increase in plasma aldosterone concentration of > 50% over basal at 2 ng/kg per min for 60 min." | 3.68 | Angiotensin-responsive aldosterone-producing adenomas: postoperative disappearance of aldosterone response to angiotensin. ( Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ, 1993) |
| " In vitro short-term production of cortisol by dispersed tumour and non-tumourous adrenal cortical cells was measured with and without added angiotensin II (AII) or adrenocorticotrophin (ACTH) in adrenals removed from five patients with primary aldosteronism." | 3.68 | Cortisol production by aldosterone-producing adenomas in vitro. ( Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ, 1993) |
| "Patients with an aldosterone-producing adenoma (APA) characteristically fail to show an increase in plasma aldosterone (PA) concentration with maneuvers that increase angiotensin II (Ang II), yet they retain a brisk response of PA to adrenocorticotrophic hormone." | 3.68 | Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism. ( Cook, MD; Cook, VI; Kimura, B; Phillips, MI; Wilcox, CS, 1993) |
| "A case of primary aldosteronism treated with spironolactone therapy has been followed up for 24 years." | 3.68 | Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma. ( Hashimoto, T; Ito, Y; Koshida, H; Miyamori, I; Morimoto, S; Morise, T; Takeda, R; Yamazaki, T, 1992) |
| "This study was conducted to elucidate renal uric acid metabolism in patients with primary aldosteronism (PA;16 cases) as compared with normotensive subjects (NT;25 cases) and essential hypertensives (EHT;51 cases)." | 3.68 | [Study on uric acid metabolism in patients with primary aldosteronism]. ( Iimura, O; Kikuchi, K; Komura, H; Marusaki, S; Namba, M; Ohtomo, T; Satoh, N; Suzuki, S; Takada, T, 1992) |
| "Urinary excretion of 18-hydroxycortisol (18-OHF), 18-hydroxycorticosterone (18-OHB) and aldosterone 18-glucuronide (Aldo-18-glu) was measured in 10 patients with primary aldosteronism; 5 with aldosterone-producing adenoma (APA) and 5 with idiopathic hyperaldosteronism (IHA), 10 patients with essential hypertension (EHT) and 11 normotensive subjects." | 3.68 | Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism. ( Iki, K; Itoh, Y; Miyamori, I; Takasaki, H; Takeda, R; Takeda, Y, 1992) |
| "We aimed to re-evaluate the captopril test in the diagnosis of primary hyperaldosteronism." | 3.68 | Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. ( Bartlett, WA; Browning, MC; Gunn, A; Hambling, C; Jung, RT, 1992) |
| " 19-dihydroxycorticosterone (18, 19(OH)2-B), 18-hydroxy-19-norcorticosterone (18-OH-19-nor-B), 18-hydroxycorticosterone (18-OH-B), 18-hydroxycortisol (18-OH-F) and aldosterone were measured in 25 patients with primary aldosteronism, 16 with an aldosterone-producing adenoma and 9 with idiopathic hyperaldosteronism." | 3.68 | Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism. ( Iki, K; Miyamori, I; Takeda, R; Takeda, Y; Vecsei, P, 1992) |
| "Plasma concentrations of renin and aldosterone were measured before and 60 min after taking 25 mg captopril in 242 patients with arterial hypertension (124 men, 118 women, aged 51." | 3.68 | [Does the captopril test improve the diagnosis of primary hyperaldosteronism?]. ( Bönner, G; Degenhardt, S; Grimm, U; Krone, W; Stimpel, M; Wambach, G, 1992) |
| "To evaluate the importance of an endogenous sodium pump inhibitor in the pathogenesis of low renin human hypertension, the urinary excretion of a digoxin-like immunoreactive substance (DLIS) was measured in eight patients with primary aldosteronism (n = 5, with adenomas) during two sequential 1-week periods of low- (20 mmol/l NaCl) and high- (200 mmol/l NaCl) sodium intake." | 3.68 | Does a digoxin-like substance participate in vascular and pressure control during dietary sodium changes in patients with primary aldosteronism? ( Clerico, A; Del Chicca, MG; Graziadei, L; Panarace, G; Pedrinelli, R; Salvetti, A; Spessot, M; Taddei, S, 1991) |
| "This paper documents an unexpected rise in plasma aldosterone concentration (PAC) to the furosemide-upright test despite a decrease in adrenocorticotropin (ACTH) by dexamethasone, and an unresponsiveness in plasma renin activity to this stimulus in a patient with aldosterone producing adenoma." | 3.68 | An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma. ( Kouchi, T; Mashiba, H; Shigemasa, C; Yoshida, A, 1991) |
| "The effect of captopril on the aldosterone response to potassium was studied in 6 patients with idiopathic adrenal hyperplasia (IAH) and in 4 patients with an aldosterone-producing adenoma (APA), who all have suppressed activity of circulating renin-angiotensin system (RAS)." | 3.68 | Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism. ( Chouman, M; Fallo, F; Pagotto, U; Pistorello, M, 1991) |
| "Plasma levels of atrial natriuretic peptide (ANP) were measured in patients with normal renin essential hypertension (n = 12), low renin essential hypertension (n = 11) and primary aldosteronism due to aldosterone producing adenoma (APA, n = 8) and idiopathic hyperaldosteronism (IHA, n = 3) after overnight rest in the supine position and after 4 h upright posture and furosemide administration." | 3.68 | Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism. ( Fütö, L; Gláz, E; Gutkowska, J; Kiss, R; Rácz, K; Sergev, O; Varga, I, 1991) |
| "This case of Conn's syndrome demonstrates long-term (seven years) efficacy of triamterene-thiazide therapy in controlling both hypertension and hypokalemia." | 3.68 | Long-term medical management of aldosterone-producing adenoma. ( Bornemann, M, 1990) |
| " The hyperprolactinemia, hypogonadotropic hypogonadism, hyperaldosteronism and hypokalemia subsided with the administration of bromocriptine 5 mg/day." | 3.68 | Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism. ( Tan, LG; Tan, SA, 1990) |
| "In order to elucidate whether pituitary peptides other than ACTH which are derived from the proopiomelanocortin (POMC) are involved for aldosterone secretion in primary aldosteronism, we administered ovine corticotropin releasing factor (CRF), beta-endorphin and naloxone to seven patients with aldosterone producing adenoma." | 3.68 | Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism. ( Koshida, H; Matsubara, T; Miyamori, I; Okamoto, S; Soma, R; Takasaki, H; Takeda, R, 1990) |
| "Time-related changes in plasma levels of aldosterone, deoxycorticosterone, corticosterone, and cortisol were studied during treatment with spironolactone in 8 patients with primary aldosteronism due to adenomas." | 3.68 | Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism. ( Ichikawa, S; Murata, K; Nakamura, T; Ono, Z; Sakamaki, T; Sakamoto, H; Takayama, Y, 1990) |
| "The plasma aldosterone (A) and desoxycorticosterone (DOCS) levels were measured in 10 patients with primary aldosteronism and in 2 subgroups with low-renin hypertensive disease (LRHD): (1) those with normal adrenal glands++ (n - 11) and (2) those with structural changes in the cortex (n - 11)." | 3.68 | [Plasma mineralocorticoids--aldosterone and desoxycorticosterone-- in patients with"low-renin"arterial hypertension]. ( Bulkina, OS; Gorbacheva, ON; Levitskaia, IuV; Obtrakht, NV; Sokolova, RI; Ustinova, SE, 1990) |
| "Aldosterone-producing adenomas in patients who have not been given spironolactone are more responsive to ACTH than to angiotensin II." | 3.67 | In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy. ( Wisgerhof, M, 1984) |
| " A 64-year-old woman with diffuse histiocytic lymphoma developed persistent hypokalemia following a course of Cytoxan (cyclophosphamide), Adriamycin (doxorubicin), vincristine, and prednisone (CHOP)-Bleo." | 3.67 | Potassium-wasting nephropathy secondary to chemotherapy simulating Bartter's syndrome. ( Floyd, M; Lieber, IH; McGuffin, WL; Stoneburner, SD, 1984) |
| "In vitro aldosterone, deoxycorticosterone, corticosterone and cortisol production of human adrenocortical cells derived from adenomas (Conn's syndrome, Cushing's syndrome), from hyperplastic adrenals (Cushing's syndrome) and from adrenals surrounding aldosteronoma are described." | 3.67 | ACTH sensitivity of isolated human pathological adrenocortical cells: variability of responses in aldosterone, corticosterone, deoxycorticosterone and cortisol production. ( Gláz, E; Kiss, R; Rácz, K; Varga, I, 1984) |
| "We evaluated a new method utilizing saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism." | 3.67 | Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism. ( Brown, RD; Hegstad, RL; Hogan, MJ; Kem, DC, 1984) |
| "Plasma concentrations of atrial natriuretic factor and some vasoactive substances were determined in 8 patients with aldosterone-producing adenoma, 10 with idiopathic adrenal hyperplasia, 10 normotensive subjects and 12 patients with essential hypertension." | 3.67 | The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism. ( Furuta, H; Katayama, T; Nakada, T; Shimazaki, J; Sumiya, H, 1989) |
| "Effects of a single administration of captopril on plasma and urinary vasopressin (AVP) were examined in 8 normotensive (NT) female volunteers, 17 patients with essential hypertension (EHT) and 2 patients with primary aldosteronism (PA)." | 3.67 | Effect of single-administration captopril on plasma and urinary vasopressin in normotensive subjects and patients with essential hypertension and primary aldosteronism. ( Fujishima, M; Kimura, Y; Muratani, H; Nakao, Y; Takishita, S; Tomita, Y; Tsuchihashi, T; Ueno, M, 1989) |
| "The effects of ovine corticotropin releasing factor (o-CRF) on plasma aldosterone, 18-OH-corticosterone (18-OHB), plasma adrenocorticotropin (ACTH) and cortisol were determined in eight patients with primary aldosteronism, six with aldosterone-producing adenoma (APA) and two with idiopathic hyperaldosteronism (IHA)." | 3.67 | Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism. ( Ikeda, M; Koshida, H; Matsubara, T; Miyamori, I; Morise, T; Okamoto, S; Takeda, R; Takeda, Y; Vecsei, P; Yasuhara, S, 1987) |
| " To investigate this issue, the opiate antagonist naloxone was administered to 8 normals and 14 patients with primary aldosteronism, 6 with an aldosterone-producing adenoma (APA) and 8 with IHA." | 3.67 | Effect of naloxone on the adrenal cortex in primary aldosteronism. ( Boscaro, M; Fallo, F; Mantero, F; Sonino, N, 1988) |
| "The withdrawal effect of spironolactone treatment on natriuresis was studied in relation to atrial natriuretic peptide (ANP) in five patients with primary aldosteronism due to adenoma." | 3.67 | Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism. ( Ichikawa, S; Kato, T; Kogure, M; Murata, K; Nakamura, T; Sakamaki, T; Sato, K; Tajima, Y, 1987) |
| "Low-dose angiotensin II (ANG II) infusion raised plasma atrial natriuretic peptide (ANP) levels only when endogenous renin-angiotensin levels were low, as in aldosterone-producing adenoma." | 3.67 | Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man. ( Gordon, RD; Klemm, SA; Tunny, TJ, 1987) |
| " The present study evaluated plasma beta-endorphin, ACTH, cortisol, and aldosterone levels in patients with IHA (n = 10), aldosterone-producing adenomas (n = 4), essential hypertension (n = 11), and normal subjects (n = 10)." | 3.67 | Plasma beta-endorphin levels in primary aldosteronism. ( Berelowitz, B; Griffing, GT; Hudson, M; Manson, JA; McIntosh, T; Melby, JC; Salzman, R, 1985) |
| "Three patients with idiopathic hyperaldosteronism were continuously treated with trilostane, a competitive inhibitor of adrenal 3 beta-hydroxysteroid dehydrogenase (3 beta-HSDH) (3 to 4 2/3 years)." | 3.67 | Long-term treatment of idiopathic hyperaldosteronism using trilostane. ( Demura, H; Horiba, N; Nomura, K; Shizume, K, 1986) |
| "Hyperresponsiveness of plasma aldosterone to metoclopramide (MCP) was found in the patients with secondary aldosteronism." | 3.67 | [Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide]. ( Iwasaki, Y, 1987) |
| "Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were measured in 19 cases with primary aldosteronism (PA) and 72 with essential hypertension (EHT) to differentiate the two disorders in the following conditions: after overnight recumbency (basal state) and after oral administration of captopril." | 3.67 | Single oral administration of captopril may not bring an improvement in screening of primary aldosteronism. ( Abe, I; Fujishima, M; Kawasaki, T; Kawazoe, N; Muratani, H; Takishita, S; Tomita, Y; Tsuchihashi, T; Ueno, M, 1987) |
| "The purpose of study was to investigate the role of angiotensin II in idiopathic primary aldosteronism (IPA) and to evaluate the interest of angiotensin converting enzyme inhibitors (ACEI) in its management." | 3.67 | [Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism]. ( Chamontin, B; Rostaing, L; Salva, P; Salvador, M, 1987) |
| "The validity of the captopril test for primary aldosteronism (PA) was tested in patients with surgically verified PA (n = 12) or essential hypertension (EHT, n = 20) with different levels of sodium intakes." | 3.67 | Effects of sodium intake on the captopril test for primary aldosteronism. ( Iwaoka, T; Naomi, S; Sato, T; Umeda, T, 1987) |
| "In order to evaluate whether changes in the plasma concentration of aldosterone (PA) following the administration of captopril, an inhibitor of angiotensin-converting enzyme, will establish the diagnosis of primary aldosteronism we have used this test in 9 healthy subjects and in 22 patients with various forms of hypertension, including 5 patients with primary aldosteronism due to idiopathic adrenal hyperplasia (n = 4) or aldosterone-producing adenoma (n = 1)." | 3.67 | [Detection of primary aldosteronism using the captopril test]. ( Graninger, W; Nowotny, P; Pirich, K; Vierhapper, H; Waldhäusl, W, 1987) |
| " In order to evaluate the effect of a calcium channel blocking agent (Verapamil) in conditions of abnormal aldosterone secretion, we have studied 11 patients with primary aldosteronism, 5 with idiopathic hyperaldosteronism (IHA) and 6 with aldosterone producing adenoma (APA)." | 3.67 | Effect of verapamil on aldosterone secretion in primary aldosteronism. ( Mantero, F; Murgia, A; Opocher, G; Rocco, S, 1987) |
| "Plasma renin activity (PRA) and plasma aldosterone concentration (PAC) were measured in 19 cases with primary aldosteronism (PA) and in 72 with essential hypertension (EHT) to differentiate the two disorders during the following conditions on normal salt diet: after overnight recumbency (basal state) and 2 hours after oral administration of 25 mg of captopril." | 3.67 | Is single oral administration of captopril beneficial in screening for primary aldosteronism? ( Abe, I; Kawasaki, T; Kawazoe, N; Kimura, Y; Muratani, H; Takishita, S; Tomita, Y; Tsuchihashi, T; Ueno, M; Uezono, K, 1986) |
| "To examine the previous suggestion that the endogenous dopaminergic activity would be increased in patients with primary aldosteronism, dose-response curves of aldosterone and prolactin stimulation by the dopamine antagonist metoclopramide were established in a pilot study by injecting metoclopramide 1, 2." | 3.67 | Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism. ( Althoff, PH; Jungmann, E; Rosak, C; Schöffling, K; Schwedes, U, 1986) |
| "Plasma aldosterone, 18-hydroxycorticosterone (18-OH-B), 18-hydroxydeoxycorticosterone (18-OH-DOC), corticosterone, cortisol and prolactin levels were determined during an angiotensin II infusion at increasing rates both with and without a simultaneous infusion of dopamine in seven normotensive subjects, in ten patients with essential hypertension, and in ten patients with primary aldosteronism." | 3.67 | Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. ( Lorenz, R; von Werder, K; Weber, PC; Witzgall, H, 1985) |
| "In order to investigate the validity of angiotensin converting enzyme inhibition with captopril as a screening test for primary aldosteronism (PA), 50 mg of captopril were administered orally to 7 patients with PA, 17 with essential hypertension (EH), 5 with renovascular hypertension (RVH), 2 with renoparenchymal hypertension (RH) and 8 normal volunteers." | 3.67 | Clinical evaluation of the captopril screening test for primary aldosteronism. ( Fujii, Y; Hamasaki, S; Inoue, J; Iwaoka, T; Miura, F; Naomi, S; Sato, T; Umeda, T, 1985) |
| "Serum 18-hydroxycorticosterone, aldosterone, and potassium were measured under basal conditions in 34 patients with documented primary aldosteronism, 10 patients with essential hypertension, and 9 normal subjects." | 3.67 | The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. ( Brown, RD; Hanson, CS; Hollifield, JW; Kem, DC; Painton, R; Tang, K; Weinberger, MH, 1985) |
| "To determine the potential therapeutic effect of calcium entry blockade in primary aldosteronism, 10 patients (5 adenoma and 5 hyperplasia) documented by endocrine testing and/or surgery were given nifedipine (20 mg, sublingually) in the afternoon." | 3.67 | Therapeutic effect of calcium channel blockade in primary aldosteronism. ( Horton, R; Hsueh, W; Nadler, JL, 1985) |
| "In earlier studies by our group it was shown that the urinary tetrahydroaldosterone excretion is a more reliable test for the diagnosis of primary aldosteronism than aldosterone-18-glucuronide ('urinary aldosterone')." | 3.67 | 21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism. ( Abdelhamid, S; Lewicka, S; Vecsei, P; Winter, J, 1985) |
| "Six patients with primary aldosteronism (PA), one with idiopathic hyperaldosteronism (IHA), one with glucocorticoid responsible hyperaldosteronism (GRHA) and eight with essential hypertension (EH) were treated with trilostane (MWD-1822) (4 alpha, 5-epoxy-17 beta-hydroxy-3-oxo-5 alpha-androstane-2 alpha-carbonitrile), an inhibitor of adrenal steroid biosynthesis, for 9-47 days with a daily dose of 30-960 mg." | 3.66 | [The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)]. ( Fukuchi, S; Haruyama, K; Shigetomi, S; Yamazaki, M, 1982) |
| "Angiotensin II (angio II) receptors have been compared using tissues from aldosterone-producing adenomas (APAs), adjacent nontumorus tissue, and normal human adrenal glomerulosa." | 3.66 | Angiotensin II receptors and in vitro aldosterone responses of aldosterone-producing adenomas, adjacent nontumorous tissue, and normal human adrenal glomerulosa. ( Bravo, E; Brown, G; Douglas, J, 1980) |
| " Blood pressure was normal during treatment with spironolactone and during pregnancy, when the action of aldosterone and other similar steroids was presumably blocked by an increased production of progesterone; this suggests that the hypertension is dependent upon sodium-retaining steroids such as aldosterone." | 3.66 | Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism. ( Bartter, FC; Gill, JR, 1981) |
| "The humoral and hemodynamic effects of converting enzyme inhibition captopril are presented in two patients with primary hyperaldosteronism (PHA)." | 3.66 | Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism. ( Demers, LM; Harrison, TS; Hayes, AH; Luderer, JR, 1982) |
| "Infusion of angiotensin II into a patient with dexamethasone-suppressible hyperaldosteronism caused a brisk increase in plasma aldosterone concentration." | 3.66 | 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism. ( Brown, JJ; Fraser, R; Lever, AF; Robertson, JI; Usherwood, T; Zoccali, C, 1983) |
| "To assess the interaction between dopamine and aldosterone secretion in primary aldosteronism, the dopamine antagonist, metoclopramide (methoxy-2-chloro-5-procainamide), was given as an i." | 3.66 | Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism. ( Fukuchi, S; Hashimoto, S; Ikeda, K; Mizuno, K; Yaginuma, K; Yamazaki, M, 1983) |
| "Plasma aldosterone levels were measured during two tests of inhibition in 31 hypertensive patients (13 essential hypertension, 6 bilateral adrenal hyperplasia and 12 documented Conn adenomas) on normal salt diets after withdrawal of all therapy: 1--before and after intravenous infusion of 2 I normal saline in two hours; 2--before and three hours after administration of 1 mg/kg of Captopril." | 3.66 | [A new diagnostic test for primary tumoral hyperaldosteronism]. ( Corvol, P; Dufloux, MA; Ménard, J; Plouin, PF; Sassano, P; Thibonnier, M, 1983) |
| "In order to clarify the role of the kallikrein-kinin system in the hypotensive mechanisms of converting-enzyme inhibition, captopril was administered in a single oral dose of 50 mg to 17 hypertensive patients, of whom 14 had essential hypertension, one had chronic renal failure, one had primary aldosteronism, and one had glucocorticoid responsive hyperaldosteronism." | 3.66 | [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system]. ( Fukuchi, S; Gotoh, M; Haruyama, K; Hashimoto, S; Matsui, J; Mizuno, K; Toki, T, 1983) |
| "To study the secretion of adrenocortical steroids, the renin releasing test and the angiotensin II analog (1-Sar, 8-Ala-Angiotensin II) infusion test was performed on four subjects with primary aldosteronism." | 3.66 | [Corticoid secretion in primary aldosteronism. II. The renin releasing test and the angiotensin II analog infusion test (author's transl)]. ( Eba, H; Funyu, T; Furusawa, M; Hitomi, H; Kawamata, A; Kido, K; Kogawa, T; Morita, S; Nigawara, K; Sugawara, S; Tanaka, T; Terayama, Y; Tulachan, Y; Yagihashi, Y, 1980) |
| "To study the role of serotonin in regulating the release of aldosterone, we gave single, oral doses of cyproheptadine, an antiserotoninergic agent, to five normal volunteers with high aldosterone levels secondary to sodium deprivation and to 14 patients with aldosteronism (six with idiopathic aldosteronism due to bilateral adrenal hyperplasia and eight with adrenal adenoma)." | 3.66 | Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism. ( Gniadek, TC; Grekin, RJ; Gross, MD; Villareal, JZ, 1981) |
| "The effect of 5 to 9 days of metyrapone administration (400 mg/m2 every 4 h) on aldosterone, deoxycorticosterone, plasma renin activity, electrolyte balance, and blood pressure was investigated in 2 normotensive siblings (one of whom showed limited ACTH reserve), in 3 patients with hypertension and dexamethasone-suppressible hyperaldosteronism, and in a hypertensive patient with primary hyperaldosteronism due to bilateral adrenal hyperplasia." | 3.66 | Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism. ( Levine, LS; New, MI; Sonino, N, 1981) |
| "The behaviour of plasma renin, aldosterone, cortisol and prolactin after administration of a drug with antidopaminergic action, metoclopramide, was evaluated in 6 normal subjects, 8 patients affected by primary aldosteronism and in 5 patients affected by anterior hypopituitarism." | 3.66 | Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism. ( Armanini, D; Boscaro, M; Fallo, F; Mantero, F; Opocher, G; Valpione, E, 1981) |
| "For distinguishing primary aldosteronism from essential hypertension, we use simple direct radioimmunoassays for "aldosterone" (aldosterone and other materials that react with the antibody to aldosterone) and "18-hydroxycorticosterone" (similarly) in unprocessed urine." | 3.66 | Direct radioimmunoassays for "aldosterone" and "18-hydroxycorticosterone" in unprocessed urine, and their use in screening to distinguish primary aldosteronism from hypertension. ( Abdelhamid, S; Benraad, TJ; Haack, D; Hofman, J; Lichtwald, K; Vecsei, P, 1982) |
| "Simultaneous measurement of the 0800-hr plasma concentrations of deoxycorticosterone (DOC), corticosterone (B), 18-hydroxycorticosterone (18-OHB), aldosterone, 18-hydroxydeoxycorticosterone (18-OHDOC) and cortisol (F) in four types of primary aldosteronism provides evidence for primary adrenal disease." | 3.66 | The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism. ( Biglieri, EG; Brust, N; Chang, B; Hirai, J; Kater, CE, 1982) |
| "The most abundant substance in the urinary free steroid fraction of patients with primary aldosteronism has been identified as 18-hydroxycortisol." | 3.66 | Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. ( Chu, MD; Ulick, S, 1982) |
| " Patients with edema, ascites, or both had significantly greater elevation of plasma aldosterone levels compared to nonedematous patients; these patients also demonstrated a substantial degree of hepatic dysfunction as evidenced by lower serum albumin levels and higher bilirubin and alkaline phosphatase levels." | 3.66 | Hyperaldosteronism associated with liver metastases. ( Citrin, DL; Crowley, J; Pandya, KJ; Whitehead, R, 1980) |
| "To determine if the adrenal sensitivity to angiotensin II in patients with an aldosterone-producing adenoma differs from that in patients with idiopathic hyperaldosteronism, we infused graded doses of angiotensin II into 17 patients with primary aldosteronism and measured their plasma aldosterone concentrations after each dose." | 3.66 | The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. ( Brown, RD; Carpenter, PC; Edis, AJ; Hogan, MJ; Wisgerhof, M, 1981) |
| "In 31 patients with primary aldosteronism routine clinical and laboratory data, the effect of orthostasis on plasma aldosterone (PA), plasma renin activity (PRA) and cortisol (PC), effect of fludrocortisone or high sodium intake on basal PA and night-day fluctuations of basal PA and PC with and without suppression of pituitary ACTH by dexamethasone were determined to differentiate patients with a unilateral aldosterone producing tumour (adenoma, APA, n=20; carcinoma, CA, n=1) from those with idiopathic bilateral adrenal hyperplasia (IAH, n=10)." | 3.66 | Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone. ( Furrer, J; Glänzer, K; Siebenschein, R; Siegenthaler, W; Studer, A; Vetter, H; Vetter, W; Witassek, F, 1978) |
| "Plasma aldosterone increases briskly during upright posture in patients with idiopathic hyperaldosteronism, despite only small increases in PRA and presumably small increases in angiotensin II." | 3.66 | Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism. ( Brown, RD; Carpenter, PC; Wisgerhof, M, 1978) |
| "This study describes the effects of [des-Aspartyl(1)]-angiotensin II ([des-Asp]-AII) on blood pressure and aldosterone production in patients with primary aldosteronism due to aldosterone-producing adrenal adenoma (APA) and idiopathic adrenal hyperplasia (IHA), and in normotensive control subjects." | 3.66 | Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism. ( Ayers, CR; Carey, RM; Herf, SM; Peach, MJ; Vaughan, ED, 1979) |
| "Plasma 18-hydroxycorticosterone (180HB) concentration was measured in 23 patients with primary aldosteronism." | 3.66 | The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. ( Biglieri, EG; Schambelan, M, 1979) |
| "The response to indomethacin of a patient with Bartter's syndrome and proximal tubular sodium wasting is described." | 3.66 | Analysis of factors influencing the renin-aldosterone system in a patient with Bartter's syndrome. ( Falls, WF; Stacy, WK; Sudan, M, 1979) |
| "3%) the normal, aldosterone-18-glucuronide concentration was clinically misleading, but increased free aldosterone and/or tetrahydroaldosterone values suggested the presence of hyperaldosteronism, which in many of these cases was confirmed by elevated excretion of the possible major aldosterone precursor 18-hydroxycorticosterone (18-OH-B)." | 3.66 | Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension. ( Abdelhamid, S; Fiegel, P; Gless, KH; Haack, D; Lichtwald, K; Vecsei, P; Walb, D, 1979) |
| "Since the relationship between steroidogenic activity and morphological differentiation is not necessarily clear in the human adrenal cortex, aldosterone (Al), cortisol (F) and corticosterone (b) from the adrenal tissues cut into four small pieces (capsule and glomerulosa, outer fascicular, inner fascicular, and reticular zones) on a cryostat immediately after their removal at surgery were estimated by radioimmunoassay in 15 patients with adrenal diseases (8 primary aldosteronism, 1 idiopathic aldosteronism, 4 Cushing's syndrome and 2 pheochromocytoma) and 8 control subjects with other diseases." | 3.66 | [Microdetermination of corticosteroids in adrenocortical zones in various adrenal diseases (author's transl)]. ( Fukuchi, S; Nakajima, K; Nakamura, K; Sasano, N, 1978) |
| " Our results show that both before and after a 9-months therapy with spironolactone episodic aldosterone release of an aldosterone producing adrenal adenoma was mediated through ACTH and that endogeneous angiotensin II had no or only little influence." | 3.65 | Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication. ( Vetter, H; Vetter, W, 1975) |
| "In primary aldosteronism due to an adrenal adenoma (n=2), treatment with a spirolactone (160 mg Canrenone/day for 7 days) decreased plasma aldosterone and urinary aldosterone-18-glucuronide." | 3.65 | Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism. ( Appenheimer, M; Glänzer, K; Herschbach, ML; Krück, F; Lucas, R; Vetter, H; Weiand, H; Witassek, F, 1977) |
| "In three patients with Bartter's syndrome, indomethacin administration resulted in the disappearance of the hypokalemic alkalosis and in a normalization of the elevated plasma renin activity." | 3.65 | Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism? ( Bakker, K; Brentjens, JR; de Jong, PE; Donker, AJ; Doorenbos, H; van Eps, LW, 1977) |
| "To investigate the role of the renin angiotensin system in the pathogenesis of hypertension in Cushing's syndrome two patients with hypercorticism were infused with 20 mg saralasin (1-sar-8-ala-angiotensin II) over a period of 30 minutes under constant blood pressue control." | 3.65 | The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome. ( Beckerhoff, R; Cottier, P; Redlich, B; Siegenthaler, W; Vetter, H; Vetter, W, 1976) |
| "The effect of saralasin in lowering blood pressure and plasma aldosterone concentration in normal subjects, both sodium-replete and sodium-deplete, and in patients with various forms of hypertension, is closely related to the basal plasma angiotensin II concentration." | 3.65 | The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration. ( Brown, JJ; Brown, WC; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Rosei, EA; Trust, PM, 1976) |
| "The responses of blood pressure, plasma renin activity (PRA) and plasma aldosterone concentration (PAC) to infusion of either angiotensin II (10 ng/Kg/min) or norepinephrine (100 ng/Kg/min) were observed in 25 patients with essential hypertension." | 3.65 | Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension. ( Yamamoto, Y, 1975) |
| "The response of plasma aldosterone to fludrocortisone administration (400 mug 12-hourly for 3 days) was studied in twenty-two patients with primary hyperaldosteronism." | 3.65 | Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension. ( Allison, ME; Brown, JJ; Ferriss, JB; Fraser, R; Lever, AF; Luke, RG; Padfield, PL; Robertson, JI, 1975) |
| " have applied the diazoxide test for the screening of primary hiperaldosteronism to 22 nephropatic patients suffering from hypertension and with different degrees of renal function." | 3.65 | [Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function]. ( Albertini, A; Cecchettin, M; Ghielmi, S; Maiorca, R; Orlandini, A; Signorini, C, 1975) |
| "A 44-year old woman without history of hypertension in her 4 pregnancies was hospitalized for hemoptysia and found to have hypertension 230/120 to 250/150: she had been taking 2 tablets of Lyndiol (5 mg lynestrenol and ." | 3.65 | [A case of arterial hypertension imputable to an estroprogestational contraceptive. Implication of the renin-angiotensin-aldosterone system]. ( Béquart, P; Boulangé, M; Camelot, G; Fontenaille, C, 1969) |
| "The effect of prolonged preoperative treatment with spironolactone has been studied in a series of 67 patients with hypertension, aldosterone excess, and low plasma renin." | 3.65 | Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. ( Brown, JJ; Davies, DL; Ferriss, JB; Fraser, R; Haywood, E; Lever, AF; Robertson, JI, 1972) |
| "The content of aldosterone, corticosterone, and cortisol has been assayed in normal adrenal tissue obtained at autopsy and in adrenal adenomas from both normotensive and hypertensive patients obtained at autopsy and from patients with primary aldosteronism obtained at surgery." | 3.64 | The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism. ( Kaplan, NM, 1967) |
| " Salt restriction, cortisol after dexamethasone suppression test and dosage of renin-angiotensin-aldosterone-system (RAAS) blockers were independently associated with BP reduction." | 3.30 | Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: The salt CONNtrol trial. ( Adolf, C; Bidlingmaier, M; Britz, V; Heinrich, DA; Kunz, S; Künzel, H; Lechner, A; Müller, LM; Nowotny, HF; Potzel, AL; Reincke, M; Sarkis, AL; Schneider, H; Seiter, TM; Sturm, L, 2023) |
| "A total of 97 patients with primary aldosteronism were randomly assigned to either the enhanced CT-guided group (n = 48) or the traditional X-ray-guided group (n = 49)." | 3.30 | Enhanced CT-guided adrenal venous sampling versus traditional X-ray-guided adrenal venous sampling in patients with primary aldosteronism. ( Chen, C; Chen, X; Han, J; Li, F, 2023) |
| "Primary aldosteronism (PA) and diabetes mellitus (DM) are clinical conditions that increase cardiovascular risk." | 3.01 | Secondary diabetes mellitus due to primary aldosteronism. ( Moustaki, M; Paschou, SA; Vakali, EC; Vryonidou, A, 2023) |
| "Primary aldosteronism (PA) is a highly prevalent yet underdiagnosed secondary cause of hypertension." | 3.01 | Personalized Treatment of Patients With Primary Aldosteronism. ( Chen Cardenas, SM; Khairi, S; Obeid, H; Turcu, AF, 2023) |
| "Hypertension is the definitive risk factor for cardiovascular disease." | 3.01 | CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity. ( Itoh, H; Kurihara, I; Shibata, H; Sone, M; Yokota, K, 2023) |
| "The diagnosis and treatment of primary aldosteronism is of paramount significance, since depending on its subtype, surgical or pharmaceutical intervention can lead to the full recovery of the patient." | 3.01 | [The genetic background of primary aldosteronism]. ( Igaz, P; Vékony, B, 2023) |
| "Primary aldosteronism can be regulated by the ectopic expression of G-protein coupled receptors in aldosteronomas or bilateral hyperplasias." | 3.01 | HCG-responsive aldosteronoma with transient secretion during pregnancy confirmed through HCG-stimulated adrenal venous sampling. ( Castinetti, F; Guerin, C; Lacroix, A; Louiset, E, 2023) |
| "Primary aldosteronism (PA) is the leading cause of curable endocrine hypertension, which is associated with a higher risk of cardiovascular and metabolic insults compared to essential hypertension." | 3.01 | Cardiovascular and metabolic characters of ( Chang, CC; Chang, YY; Chen, ZW; Chou, CH; Hung, CS; Lee, BC; Liao, CW; Lin, YH; Lu, CC; Pan, CT; Peng, KY; Tsai, CH; Wu, VC, 2023) |
| "Both factors apply to primary aldosteronism, which is woefully underdiagnosed as a cause of hypertension and end-organ damage." | 3.01 | Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection. ( Bhalla, V; Funes Hernandez, M, 2023) |
| "Primary aldosteronism is associated with an increased risk of cardiovascular disease and kidney dysfunction compared to essential hypertension." | 3.01 | The Effect of Aldosterone on Cardiorenal and Metabolic Systems. ( Abe, M; Kobayashi, H; Otsuka, H, 2023) |
| "Primary aldosteronism (PA) is characterized by dysregulated, renin-independent aldosterone excess." | 3.01 | Primary Aldosteronism Prevalence - An Unfolding Story. ( Charoensri, S; Turcu, AF, 2023) |
| "Primary aldosteronism (PA), once considered a rare disease, is being increasingly recognized as an important cause of hypertension." | 3.01 | Improving Detection Rates for Primary Aldosteronism. ( Fuller, PJ; Libianto, R; Russell, G; Stowasser, M; Yang, J, 2023) |
| "Aldosterone measurements have been changed to the CLEIA method." | 3.01 | Recent progress in the diagnosis and treatment of primary aldosteronism. ( Shibata, H; Yoshida, Y, 2023) |
| "Aldosterone is a steroid hormone produced in the zona glomerulosa (ZG) of the adrenal cortex." | 3.01 | Ca ( Dinh, HA; Scholl, UI; Stölting, G, 2023) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 3.01 | Advances in the molecular imaging of primary aldosteronism. ( Cheng, G; Ren, X; Wang, Z, 2023) |
| "Primary aldosteronism, or Conn syndrome, is the most common endocrine cause of hypertension." | 3.01 | Mineralocorticoid receptor signalling in primary aldosteronism. ( Cole, TJ; Fuller, PJ; Yang, J; Young, MJ, 2023) |
| "Primary aldosteronism is the most common single cause of hypertension and is potentially curable when only one adrenal gland is the culprit." | 3.01 | Primary aldosteronism: molecular medicine meets public health. ( Azizan, EAB; Brown, MJ; Drake, WM, 2023) |
| "Primary aldosteronism (PA) is a leading global cause of secondary hypertension." | 3.01 | Key to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis. ( Liu, S; Pang, H; Xu, L; Zuo, R, 2023) |
| "Primary aldosteronism (PA), characterized by inappropriately high concentrations of the adrenal-derived hormone aldosterone, is the most common endocrine cause of arterial hypertension." | 3.01 | Primary aldosteronism 2.0: an update for clinicians on diagnosis and treatment. ( Kocjan, T; Pilz, S; Theiler-Schwetz, V; Trummer, C, 2023) |
| "Primary aldosteronism (PA) is the primary cause of secondary hypertension." | 2.82 | Adrenal venous sampling in the diagnostic workup of primary aldosteronism. ( Betz, MJ; Zech, CJ, 2022) |
| "Primary aldosteronism (PA) can be sporadic or familial and classified into unilateral and bilateral forms." | 2.82 | Pathophysiology and histopathology of primary aldosteronism. ( Reincke, M; Williams, TA, 2022) |
| "After confirmation of Conn's syndrome a differentiation between a unilateral and bilateral adrenal disease is necessary for further treatment planning." | 2.82 | [Conn's syndrome-Frequent and still too rarely diagnosed to underdiagnosed]. ( Adolf, C; Fuss, CT; Hahner, S; Heinrich, DA, 2022) |
| "Primary aldosteronism (PA) is an endocrine related condition leading to arterial hypertension due to inappropriately high and unregulated aldosterone concentration." | 2.82 | Primary Aldosteronism, Aldosterone, and Extracellular Vesicles. ( Carvajal, CA; Fardella, CE; Pérez, JA; Tapia-Castillo, A, 2022) |
| "Primary aldosteronism (PA) is the most common cause of secondary arterial hypertension." | 2.82 | [Diagnosis of primary hyperaldosteronism]. ( Araujo-Castro, M; Parra-Ramírez, P, 2022) |
| "Primary aldosteronism, the most common secondary form of hypertension, is thought to be present in ≈5% to 10% of hypertensive adults." | 2.82 | Primary Aldosteronism: Where Are We Now? Where to From Here? ( Carey, RM; Funder, JW, 2022) |
| "Primary aldosteronism (PA) affects millions of individuals worldwide." | 2.82 | High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It. ( Lieberman, L; Turcu, AF; Wannachalee, T, 2022) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 2.82 | Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects. ( Bioletto, F; Bollati, M; Ghigo, E; Lopez, C; Maccario, M; Parasiliti-Caprino, M; Ponzetto, F, 2022) |
| "Hyperkalemia was one of the complications after primary aldosteronism surgery." | 2.82 | [Persistent and serious hyperkalemia after surgery of primary aldosteronism: A case report]. ( Cai, L; Gao, Y; Guo, XH; Wang, W; Zhang, JQ, 2022) |
| "Primary aldosteronism (PA) is a pathological condition characterized by an excessive aldosterone secretion; once thought to be rare, PA is now recognized as the most common cause of secondary hypertension." | 2.82 | Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight. ( Arata, S; Bioletto, F; Bollati, M; Ghigo, E; Lopez, C; Maccario, M; Parasiliti-Caprino, M; Ponzetto, F; Procopio, M, 2022) |
| "Primary aldosteronism (PA) is the most common and potentially curable form of secondary hypertension, affecting 5-10% of primary care patients with hypertension." | 2.82 | Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care. ( Ariens, J; Choy, KW; Horvath, AR; Yang, J, 2022) |
| "Primary aldosteronism (PA) in pregnancy (PAP) can be a serious condition and is challenging to diagnose." | 2.82 | Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review. ( Rossi, GP; Rossitto, G; Sanga, V; Seccia, TM, 2022) |
| "In patients with primary aldosteronism, adrenalectomy or treatment with mineralocorticoid receptor antagonists significantly mitigate adverse aldosterone effects, reducing the risk of cardiovascular events, mortality, and incident atrial fibrillation." | 2.82 | Aldosterone as a Mediator of Cardiovascular Damage. ( Buffolo, F; Monticone, S; Mulatero, P; Tetti, M, 2022) |
| "Primary aldosteronism (PA) is the most common form of secondary arterial hypertension, with a prevalence of approximately 20% in patients with resistant hypertension." | 2.82 | Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome. ( Almeida, MQ; Guimaraes, AG; Santana, LS, 2022) |
| "Primary aldosteronism (PA) is the leading cause of secondary hypertension, accounting for over 10% of patients with high blood pressure." | 2.82 | Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas. ( Faucz, FR; Hannah-Shmouni, F; Pitsava, G; Stratakis, CA, 2022) |
| "Primary aldosteronism (PA) is a condition that is still largely overlooked, resulting in a considerable burden of mortality and morbidity." | 2.82 | Approach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism. ( Bertello, C; Monticone, S; Mulatero, P; Veglio, F, 2022) |
| "Primary aldosteronism is the most common surgically curable form of hypertension." | 2.82 | Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation. ( Gong, S; Reincke, M; Tetti, M; Veglio, F; Williams, TA, 2022) |
| "Hypertension due to primary aldosteronism poses a risk of severe cardiovascular complications compared to essential hypertension." | 2.82 | Clinical Translationality of ( Kitamoto, T; Nishikawa, T, 2022) |
| "Primary aldosteronism is a common cause of hypertension and is a risk factor for cardiovascular and renal morbidity and mortality, via mechanisms mediated by both hypertension and direct insults to target organs." | 2.82 | Primary aldosteronism - a multidimensional syndrome. ( Turcu, AF; Vaidya, A; Yang, J, 2022) |
| "Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment resistance and increased cardiovascular risk." | 2.82 | Identification of risk loci for primary aldosteronism in genome-wide association studies. ( Abdellatif, AB; Amar, L; Baron, S; Beuschlein, F; Boulkroun, S; Chantalat, S; Cosentino, T; Cusi, D; De Sousa, K; Deleuze, JF; Deschasaux, M; Druesne-Pecollo, N; Empana, JP; Ferey, M; Fernandes-Rosa, FL; Frouin, A; Gieger, C; Giscos-Douriez, I; Jeunemaitre, X; Jouven, X; Larsen, CK; Le Floch, E; Lenzini, L; Meatchi, T; Meneton, P; Peters, A; Reincke, M; Rossi, GP; Saintpierre, B; Salvi, E; Touvier, M; Waldenberger, M; Zennaro, MC, 2022) |
| "Arterial hypertension is a major risk factor for cardiovascular disease." | 2.82 | Who should be screened for primary aldosteronism? A comprehensive review of current evidence. ( Chen, CH; Cheng, HM; Chia, YC; Huang, WC; Kario, K; Lin, YH; Siddique, S; Sogunuru, G; Tay, JC; Wu, VC, 2022) |
| "Both primary aldosteronism and obstructive sleep apnea are well-known causes of hypertension and contribute to increased cardiovascular morbidity and mortality independently." | 2.82 | Primary aldosteronism and obstructive sleep apnea: What do we know thus far? ( Loh, HH; Sukor, N, 2022) |
| "Primary aldosteronism is the most common form of secondary arterial hypertension, due to excessive aldosterone production from the adrenal gland." | 2.82 | Vascular and hormonal interactions in the adrenal gland. ( Abdellatif, AB; Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2022) |
| " In the current study, we sought to determine if blood sampling and a shorter dosing period would provide a possible means to test for primary hyperaldosteronism." | 2.80 | Serum aldosterone and cortisol concentrations before and after suppression with fludrocortisone in cats: a pilot study. ( Behrend, EN; Johnson, A; Kemppainen, R; Lee, H; Matsuda, M; Refsal, K, 2015) |
| "Primary aldosteronism (PA) is a common form of secondary hypertension and has significant cardiovascular consequences." | 2.80 | Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population. ( Chang, CC; Chu, TS; Huang, KH; Lin, LY; Lin, SL; Lin, YH; Peng, KY; Tsai, YC; Wang, SM; Wu, CH; Wu, KD; Wu, VC; Yang, SY, 2015) |
| "Observational studies in primary hyperaldosteronism suggest a positive relationship between aldosterone and parathyroid hormone (PTH); however, interventions to better characterize the physiological relationship between the renin-angiotensin-aldosterone system (RAAS) and PTH are needed." | 2.79 | Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. ( Adler, GK; Brown, JM; Garg, R; Garza, AE; Luther, JM; Pojoga, LH; Ruan, DT; Vaidya, A; Williams, GH; Williams, JS, 2014) |
| "Primary aldosteronism (PA) is an established cause of hypertension, whereas high-normal serum aldosterone levels have been linked to an increased risk for hypertension." | 2.78 | Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. ( Chrousos, GP; Gouli, A; Kaltsas, G; Markou, A; Mitsakis, K; Papanastasiou, L; Pappa, T; Piaditis, GP; Prevoli, A; Tsiavos, V; Tsounas, P; Zografos, G, 2013) |
| "Primary aldosteronism (PA) is associated with inappropriate left ventricular hypertrophy (LVH) in relation to a given gender and body size." | 2.78 | Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism. ( Chang, YY; Changh, YS; Chen, MF; Chueh, SC; Ho, YL; Hu, YH; Hung, CS; Lee, JK; Lin, YH; Sui, MJ; Wu, KD; Wu, VC; Wu, XM; Yang, SY, 2013) |
| "Primary aldosteronism is the most frequent cause of secondary hypertension and is associated with more prominent left ventricular hypertrophy and increased myocardial fibrosis." | 2.77 | Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism. ( Chang, HW; Chueh, SC; Ho, YL; Lee, HH; Lee, JK; Lin, CY; Lin, LC; Lin, YH; Liu, YC; Lo, MT; Wu, KD; Wu, VC; Wu, XM, 2012) |
| "For the diagnosis of primary aldosteronism (PA), confirmatory testing is mandatory and different function tests can be employed." | 2.77 | Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism. ( Blondin, D; Gao, X; Rump, LC; Saleh, A; Scherbaum, WA; Schott, M; Vonend, O; Willenberg, HS, 2012) |
| "In patients with primary aldosteronism, adrenal vein sampling (AVS) is considered the only reliable technique to distinguish between unilateral and bilateral autonomous production of aldosterone, but agreement is lacking on the best criteria indicating successful cannulation and lateralization." | 2.75 | Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. ( Bertello, C; Daunt, N; Gordon, R; Leggett, D; Mengozzi, G; Mulatero, P; Rossato, D; Stowasser, M; Sukor, N; Veglio, F, 2010) |
| "Aldosterone was positively related to PRA and progesterone." | 2.74 | The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women. ( Di Cecco, P; Fommei, E; Ghione, S; Iervasi, A; Maffei, S; Ripoli, A; Turchi, S, 2009) |
| "Patients with primary aldosteronism (PA) were shown to have suppressed muscle sympathetic nerve activity (MSNA) in our previous study." | 2.73 | Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism? ( Matsukawa, T; Miyamoto, T, 2008) |
| "Hyperaldosteronism is a relatively more common disorder than previously recognized." | 2.72 | Primary Hyperaldosteronism: Approach to Diagnosis and Management. ( Arafah, BM; El-Asmar, N; Rajpal, A, 2021) |
| "Primary aldosteronism is a common cause of secondary hypertension associated with excess cardiovascular morbidities." | 2.72 | Diagnosis and treatment of primary aldosteronism. ( Bancos, I; Mulatero, P; Reincke, M; Scholl, UI; Stowasser, M; Williams, TA, 2021) |
| "Primary aldosteronism (PA), the most common form of secondary hypertension, has been considered for decades as a "benign" form of hypertension, but evidences progressively built up to show that patients with PA had an excess rate of cardiovascular damage as compared to blood pressure-matched essential hypertensive patients." | 2.72 | The cardiovascular consequences of hyperaldosteronism. ( Cesari, M; Maiolino, G; Rossi, GP; Seccia, TM, 2021) |
| "Primary aldosteronism (PA) is a common cause of secondary hypertension and is associated with worse cardiovascular outcomes." | 2.72 | Left ventricular remodeling and dysfunction in primary aldosteronism. ( Chang, YY; Chen, ZW; Hung, CS; Lin, YH; Pan, CT; Tsai, CH; Wu, VC, 2021) |
| " Primary aldosteronism (PA) is the most common detectable cause of secondary hypertension." | 2.72 | Update: Selective adrenal venous sampling (AVS) - Indication, technique, and significance. ( Antoch, G; Dringenberg, T; Fürst, G; Haase, M; Loberg, C; Rump, LC; Schimmöller, L; Stegbauer, J; Steuwe, A, 2021) |
| "Metabolic syndrome is a cluster of conditions that increase the risk of cardiovascular diseases, and comprises obesity, hypertension, impaired glucose metabolism and dyslipidaemia." | 2.72 | The mineralocorticoid receptor-an emerging player in metabolic syndrome? ( Stowasser, M; Thuzar, M, 2021) |
| "Hyperaldosteronism can occur either as primary aldosteronism (renin-independent) or secondary aldosteronism (renin-dependent)." | 2.72 | [Hyperaldosteronism]. ( Scholl, UI, 2021) |
| "Primary aldosteronism, characterized by renin-independent aldosterone secretion from one or both adrenal glands, is the most common and modifiable form of secondary hypertension." | 2.72 | How common is primary aldosteronism? ( Hundemer, GL; Kline, GA; Leung, AA, 2021) |
| "Primary aldosteronism (PA) is one of the most frequent curable forms of secondary hypertension." | 2.72 | Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension. ( Azizan, EA; Pauzi, FA, 2021) |
| "Primary aldosteronism (PA), a condition characterized by autonomous aldosterone hypersecretion, constitutes the most common cause of secondary hypertension." | 2.72 | Unravelling the Genetic Basis of Primary Aldosteronism. ( Charmandari, E; Markou, A; Mourtzi, N; Piaditis, GP; Sertedaki, A, 2021) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension and is significantly under-diagnosed." | 2.72 | Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism. ( Fraker, DL; Wachtel, H, 2021) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 2.72 | Primary Aldosteronism: a Continuum from Normotension to Hypertension. ( Turcu, AF; Wannachalee, T, 2021) |
| "From a disease standpoint, primary aldosteronism (PA) is the most common of all adrenal disorders." | 2.72 | Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism. ( Nanba, K; Rainey, WE; Udager, AM, 2021) |
| "The ARR threshold to screen for primary aldosteronism may be based on measurement of irR." | 2.71 | Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. ( Ferrari, P; Nicod, J; Nussberger, J; Saner, E; Shaw, SG, 2004) |
| "Primary hyperaldosteronism was confirmed if plasma renin activity was <1." | 2.70 | Hyperaldosteronism among black and white subjects with resistant hypertension. ( Calhoun, DA; Nishizaka, MK; Thakkar, RB; Weissmann, P; Zaman, MA, 2002) |
| "Primary aldosteronism is a specifically treatable and potentially curable form of secondary hypertension." | 2.70 | Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. ( Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F, 2002) |
| "Surgical hyperaldosteronism leads to sodium and water retention during surgery and often causes postoperative edema." | 2.69 | Suppression of surgical hyperaldosteronism by potassium canrenoate during gynecologic surgery under sevoflurane anesthesia. ( Ogawa, R; Watanabe, T, 2000) |
| "In familial hyperaldosteronism type I, inheritance of a hybrid 11beta-hydroxylase/aldosterone synthase gene leads to ACTH-regulated overproduction of aldosterone (causing hypertension) and of "hybrid" steroids, 18-hydroxy- and 18-oxo-cortisol." | 2.69 | Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. ( Bachmann, AW; Gordon, RD; Huggard, PR; Rossetti, TR; Stowasser, M, 2000) |
| "In primary hyperaldosteronism, discriminating bilateral adrenal hyperplasia (BAH) from an aldosterone-producing adenoma (APA) is important because adrenalectomy, which is usually curative in APA, is seldom effective in BAH." | 2.69 | Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. ( Berman, AA; Choyke, PL; Doppman, JL; Gill, JR; Linehan, WM; Pezzullo, JC; Phillips, JL; Rayford, W; Walther, MM, 2000) |
| "patients with primary hyperaldosteronism (PH) including both aldosterone-producing adenoma and idiopathic hyperaldosteronism." | 2.68 | Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism. ( Contesse, V; Delarue, C; Dhib, M; Godin, M; Kuhn, JM; Lefebvre, H; Rieu, M; Vaudry, H; Wolf, LM, 1997) |
| "Idiopathic hyper-aldosteronism was diagnosed on the basis of the results of dexamethasone-suppressed adrenal scintigraphy and/or selective adrenal vein sampling." | 2.67 | Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. ( Chiesura-Corona, M; Feltrin, GP; Pelizzo, MR; Perale, R; Pessina, AC; Rossi, GP; Soattin, S; Tregnaghi, A; Zanin, L, 1993) |
| "Nicardipine (80 mg/day) was given orally for 12 weeks and no dietary restrictions were imposed." | 2.67 | Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism. ( Bisbocci, D; Chiandussi, L; Pinna, G; Piras, D; Rabbia, F; Veglio, F, 1990) |
| "Primary aldosteronism is currently considered to represent 5-13% of hypertension, yet fewer than 1% of patients with the disorder are ever diagnosed and treated." | 2.66 | Primary aldosteronism: Treatment of the disease, and new therapeutic approaches. ( Funder, J, 2020) |
| "Primary aldosteronism (PA), the most common cause of secondary hypertension, is a well-recognized condition that can lead to cardiovascular and renal complications." | 2.66 | Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far? ( Loh, HH; Sukor, N, 2020) |
| "Primary aldosteronism (PA) is the most common potentially curable form of hypertension." | 2.66 | Prevalence, diagnosis and outcomes of treatment for primary aldosteronism. ( Reincke, M; Williams, TA; Yang, Y, 2020) |
| "Primary aldosteronism (PA) is the most common form of secondary hypertension affecting 5%-10% of patients with arterial hypertension." | 2.66 | Old and new genes in primary aldosteronism. ( Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2020) |
| "Primary aldosteronism (PA) is the most common form of endocrine hypertension." | 2.66 | Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism. ( Gong, S; Meyer, LS; Reincke, M; Williams, TA, 2020) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 2.66 | The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease. ( Lim, JS; Rainey, WE, 2020) |
| "Conn, primary aldosteronism (PA) today is well established as a relevant cause of secondary hypertension and accounts for about 5-10 % of hypertensives." | 2.66 | Salt Appetite and its Effects on Cardiovascular Risk in Primary Aldosteronism. ( Adolf, C; Handgriff, L; Heinrich, DA; Reincke, M; Schneider, H, 2020) |
| "Hypokalemia is closely linked with the pathophysiology of primary aldosteronism (PA)." | 2.66 | Hypokalemia and the Prevalence of Primary Aldosteronism. ( Beuschlein, F; Gruber, S, 2020) |
| "Unilateral aldosteronism may also be due to multiple CYP11B2-expressing nodules of various sizes or a continuous band of hyperplastic ZG cells expressing CYP11B2." | 2.66 | Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism. ( Gomez-Sanchez, CE; Gomez-Sanchez, EP; Nishimoto, K, 2020) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 2.66 | [Update and Research Progress in the Diagnosis of Primary Aldosteronism]. ( Chen, T; Li, YM; Ren, Y; Tian, HM, 2020) |
| "Primary aldosteronism is associated with higher cardiovascular and renal morbidity and mortality than essential hypertension in age- and sex-matched patients with the same degree of blood pressure elevation." | 2.66 | Treatment of primary hyperaldosteronism. ( Araujo-Castro, M, 2020) |
| "The landscape of primary aldosteronism has evolved to recognize that it is a prevalent syndrome of renin-independent aldosterone production that contributes to the pathogenesis of hypertension and cardiovascular disease." | 2.66 | Evolution of the Primary Aldosteronism Syndrome: Updating the Approach. ( Carey, RM; Vaidya, A, 2020) |
| "Primary hyperaldosteronism (PA) is a well-known cause of hypertension although its exact prevalence amongst patients with apparent essential hypertension has been a matter of debate." | 2.66 | Five Reasons for the Failure to Diagnose Aldosterone Excess in Hypertension. ( Chrousos, GP; Kaltsas, G; Markou, A; Piaditis, GP, 2020) |
| "Primary aldosteronism is the most common form of secondary hypertension with a prevalence of 5-10% in hypertensive patients." | 2.66 | The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma. ( Gomez-Sanchez, CE; Oki, K, 2020) |
| "Primary aldosteronism is common and contributes to adverse cardiovascular, kidney, and metabolic outcomes." | 2.66 | MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism. ( Hundemer, GL; Vaidya, A, 2020) |
| "Aldosterone is a mineralocorticoid hormone that participates in the regulation of electrolyte balance, blood pressure, and tissue remodeling." | 2.61 | Endothelial Dysfunction in Primary Aldosteronism. ( Chen, ZW; Chou, CH; Hung, CS; Liao, CW; Lin, YH; Pan, CT; Tsai, CH; Wu, VC, 2019) |
| "Low-renin hypertension affects 30% of hypertensive patients." | 2.61 | Low-Renin Hypertension. ( Athimulam, S; Bancos, I; Lazik, N, 2019) |
| "Resistant hypertension is a common clinical entity, defined as suboptimal blood pressure response to multiple therapies after excluding medication nonadherence and secondary forms of hypertension." | 2.61 | Resistant Hypertension: A Clinical Perspective. ( Gubbi, S; Hannah-Shmouni, F; Koch, CA; Spence, JD; Stratakis, CA, 2019) |
| "Primary aldosteronism, the excessive production of the steroid hormone aldosterone, is the most common cause of secondary hypertension." | 2.61 | [Primary aldosteronism : Genetics and pathology]. ( Scholl, U, 2019) |
| "Primary aldosteronism (PA) is a common, but frequently overlooked, cause of arterial hypertension and excess cardiovascular events, particularly atrial fibrillation." | 2.61 | Primary Aldosteronism: JACC State-of-the-Art Review. ( Rossi, GP, 2019) |
| "Primary aldosteronism (PA) results from excess production of mineralocorticoid hormone aldosterone by the adrenal cortex." | 2.61 | Molecular Mechanisms of Primary Aldosteronism. ( Fox, SC; Ghayee, HK; Tevosian, SG, 2019) |
| "Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary hypertension." | 2.61 | Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism. ( Bidlingmaier, M; Junnila, RK; Schilbach, K, 2019) |
| "The strategy for diagnosis of primary aldosteronism (PA) in the hypertensive population includes firstly a screening step, based on the measurement of plasma aldosterone-to-renin ratio (ARR), a test which must have high sensitivity, and secondly a confirmatory step based on the demonstration of excessive aldosterone production independent of the renin-angiotensin-aldosterone system (RAAS) activity." | 2.61 | MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism. ( Morera, J; Reznik, Y, 2019) |
| "The term 'idiopathic hyperaldosteronism' may soon become obsolete." | 2.61 | Immunohistochemistry for aldosterone synthase CYP11B2 and matrix-assisted laser desorption ionization imaging mass spectrometry for in-situ aldosterone detection. ( Mukai, K; Mune, T; Nishimoto, K; Nishiyama, M; Sugiura, Y; Terada, Y; Zhang, Z, 2019) |
| "Refractory hypertension is defined as uncontrolled blood pressure despite use of ≥5 antihypertensive agents of different classes, including a long-acting thiazide-like diuretic and an MR (mineralocorticoid receptor) antagonist, at maximal or maximally tolerated doses." | 2.61 | Treatment of Resistant and Refractory Hypertension. ( Acelajado, MC; Calhoun, DA; Hughes, ZH; Oparil, S, 2019) |
| "Cases of primary aldosteronism associated with CLCN2 mutations appear to be bilateral and respond well to medical treatment." | 2.61 | Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels. ( Gordon, RD; Schewe, J; Scholl, UI; Stölting, G; Stowasser, M; Wolley, M; Wu, A, 2019) |
| "Primary aldosteronism (PA) is the most prevalent cause of secondary hypertension (3%-32% of hypertensive patients)." | 2.61 | The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges. ( Denieffe, S; Fitzgibbon, MC; Griffin, TP; O'Shea, PM, 2019) |
| " Third, as recommendations differ from other indications like heart failure, drug dosing is often inadequate." | 2.61 | THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism. ( Adolf, C; Beuschlein, F; Heinrich, D; Holler, F; Lechner, B; Lechner, K; Reincke, M; Schneider, H, 2019) |
| "Primary aldosteronism (PA), characterized by autonomous aldosterone overproduction by the adrenal glands, affects 6% of the general hypertensive population and can be either sporadic or familial." | 2.58 | GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism. ( Buffolo, F; Monticone, S; Mulatero, P; Pasini, B; Tetti, M; Veglio, F, 2018) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 2.58 | Overview of aldosterone-related genetic syndromes and recent advances. ( Boulkroun, S; Fernandes-Rosa, FL; Zennaro, MC, 2018) |
| "Aldosterone excess plays an important role in the association between resistant hypertension and obstructive sleep apnea." | 2.58 | Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome. ( Calhoun, DA; Valaiyapathi, B, 2018) |
| "Moreover, primary aldosteronism patients are exposed to an increased risk of cardio and cerebrovascular events and metabolic comorbidities compared with patients affected by essential hypertension." | 2.58 | Primary aldosteronism in the primary care setting. ( Buffolo, F; Monticone, S; Mulatero, P; Tetti, M, 2018) |
| "Primary aldosteronism is the most common form of endocrine hypertension with a prevalence of 6% in the general population with hypertension." | 2.58 | Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism. ( Aristizabal Prada, ET; Beuschlein, F; Castellano, I; Meyer, LS; Reincke, M; Sušnik, E; Tetti, M; Williams, TA; Yang, Y, 2018) |
| "All physicians who treat hypertension should routinely screen appropriate patients for PA." | 2.58 | Primary Aldosteronism: Practical Approach to Diagnosis and Management. ( Auchus, RJ; Byrd, JB; Turcu, AF, 2018) |
| "Primary aldosteronism (PA) is the most common form of secondary hypertension and is critical to identify because when caused by an aldosterone-producing adenoma (APA) or another unilateral form, it is potentially curable, and even when caused by bilateral disease, antihypertensives more specific to PA treatment can be employed (ie, aldosterone antagonists)." | 2.55 | Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice. ( Holmes, DT; Kline, G, 2017) |
| "The biological diagnosis of primary aldosteronism (PA) is a real challenge in clinical laboratories." | 2.55 | Biological diagnosis of primary aldosteronism: summary of new French and international guidelines. ( Denimal, D; Duvillard, L; Lemaire, S, 2017) |
| "The management of primary aldosteronism is widely varied within various published guidelines, with very little in the way of data supporting the choice of one variation over others." | 2.55 | Primary Aldosteronism: The Next Five Years. ( Funder, JW, 2017) |
| "Primary aldosteronism (PA) was first reported by Jerome W." | 2.55 | Is Primary Aldosteronism Still Largely Unrecognized? ( Buffolo, F; Burrello, J; Monticone, S; Mulatero, P; Tetti, M; Veglio, F; Williams, TA, 2017) |
| "Primary aldosteronism (PA) comprises two main subtypes: unilateral aldosteronism, mainly caused by aldosterone-producing adenoma; and bilateral adrenal hyperplasia." | 2.55 | Subtyping of Patients with Primary Aldosteronism: An Update. ( Eisenhofer, G; Lenders, JWM; Reincke, M, 2017) |
| "Untreated patients with primary aldosteronism showed an impaired physical and mental HRQoL as compared to the general population." | 2.55 | Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review. ( Burgers, VWG; de Nooijer, AH; Deinum, J; Hermus, ARMM; Husson, O; Lenders, JWM; Timmers, HJLM; Velema, MS, 2017) |
| "Primary aldosteronism (PA) significantly increases the risk of cardiovascular complications, and early diagnosis and targeted treatment based on its pathophysiology is warranted." | 2.55 | Aldosterone-Producing Cell Clusters in Normal and Pathological States. ( Omata, K; Rainey, WE; Tomlins, SA, 2017) |
| "Primary aldosteronism is the most common type of secondary hypertension affecting 6-10% of patients with primary hypertension." | 2.55 | Disordered CYP11B2 Expression in Primary Aldosteronism. ( Gomez-Sanchez, CE; Kuppusamy, M; Reincke, M; Williams, TA, 2017) |
| "Familial hyperaldosteronism has been with us for 50 years, and somatic mutations responsible for aldosterone producing adenomas for five." | 2.55 | Genetic disorders in primary aldosteronism-familial and somatic. ( Funder, JW, 2017) |
| "Accordingly, primary aldosteronism (PA) characterized by an inappropriately high aldosterone secretion is the most common form of secondary hypertension." | 2.55 | Of channels and pumps: different ways to boost the aldosterone? ( Bandulik, S, 2017) |
| "Hyperaldosteronism is the leading cause of secondary hypertension with up to 80% due to APA, statistically the most common functioning adrenal nodule." | 2.55 | Radiofrequency ablation treatment for aldosterone-producing adenomas. ( Faintuch, S; Sacks, AC; Sacks, BA, 2017) |
| "Primary aldosteronism (PA) is associated with a high rate of cardio- and cerebrovascular complications and metabolic alterations." | 2.53 | Issues in the Diagnosis and Treatment of Primary Aldosteronism. ( Buffolo, F; Burrello, J; Giraudo, G; Monticone, S; Mulatero, P; Schiavone, D; Tetti, M; Veglio, F, 2016) |
| "Primary aldosteronism (PA) is caused by excessive production of aldosterone by the adrenal cortex and is determined by a benign aldosterone-producing adenoma (APA) in a significant proportion of cases." | 2.53 | Local Control of Aldosterone Production and Primary Aldosteronism. ( Barhanin, J; Lalli, E; Warth, R; Zennaro, MC, 2016) |
| "Obese subjects often exhibit hyperaldosteronism, with increased salt sensitivity of blood pressure (BP)." | 2.53 | The Role of Aldosterone in Obesity-Related Hypertension. ( Fujita, T; Kawarazaki, W, 2016) |
| "Primary aldosteronism (PA) is the most common secondary cause of hypertension, accounting for 10 % of hypertensives and 20 % of those with drug-resistant hypertension." | 2.53 | Hyperaldosteronism: Screening and Diagnostic Tests. ( Fallo, F; Sabbadin, C, 2016) |
| "Most mutations causing primary aldosteronism are in genes encoding cation channels or pumps, leading to increased calcium influx." | 2.53 | Novel genetic determinants of adrenal aldosterone regulation. ( Azizan, EA; Brown, MJ, 2016) |
| "Primary aldosteronism (PA), characterized by the inappropriate and abnormal adrenal secretion of aldosterone, is the most common cause of secondary hypertension." | 2.53 | Hyperaldosteronism: How to Discriminate Among Different Disease Forms? ( Buffolo, F; Burrello, J; Crudo, V; Monticone, S; Mulatero, P; Tetti, M; Veglio, F, 2016) |
| "Pseudohyperaldosteronism is characterized by a clinical picture of hyperaldosteronism with suppression of renin and aldosterone." | 2.53 | Syndromes that Mimic an Excess of Mineralocorticoids. ( Armanini, D; Sabbadin, C, 2016) |
| "Primary aldosteronism is the most common form of secondary hypertension and affects 8-13% of patients with hypertension." | 2.53 | Genetics of primary hyperaldosteronism. ( Dutta, RK; Gimm, O; Söderkvist, P, 2016) |
| "Once thought to be rare, primary aldosteronism (PA, in which aldosterone secretion by the adrenal is excessive and autonomous of its principal regulator, angiotensin II) is now known to be the most common specifically treatable and potentially curable form of hypertension, with most patients lacking the clinical feature of hypokalemia, the presence of which was previously considered to be necessary to warrant further efforts towards confirming a diagnosis of PA." | 2.53 | Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney. ( Gordon, RD; Stowasser, M, 2016) |
| "Primary aldosteronism (PA) encompasses a broad, heterogeneous group of disorders including both sporadic and familial forms (familial hyperaldosteronism type I, II and III)." | 2.52 | Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. ( Else, T; Monticone, S; Mulatero, P; Rainey, WE; Williams, TA, 2015) |
| "Primary aldosteronism (PA) is a condition well worth detecting because it is a common cause of hypertension and is associated with excessive morbidity for the degree of hypertension and reduced quality of life, all of which can be abrogated with specific surgical or medical treatment." | 2.52 | Update in primary aldosteronism. ( Stowasser, M, 2015) |
| "Primary aldosteronism (PA) is the most common and curable form of secondary hypertension." | 2.52 | An update on novel mechanisms of primary aldosteronism. ( Boulkroun, S; Fernandes-Rosa, F; Zennaro, MC, 2015) |
| "A brief introduction to primary aldosteronism is provided." | 2.52 | Laboratory challenges in primary aldosteronism screening and diagnosis. ( Cavalier, E; Don-Wauchope, AC; Holmes, DT; Raizman, JE; Rehan, M, 2015) |
| "Hypertension is one of the most common cardiovascular diseases during pregnancy." | 2.52 | [Hypertension in the course of primary aldosteronism during pregnancy]. ( Chudek, J; Maruniak-Chudek, I; Olszanecka-Glinianowicz, M; Sikora, J; Wyskida, K; Wyskida, M, 2015) |
| "Primary aldosteronism is one of the commonly identified causes of hypertension and is treatable and/or potentially curable." | 2.52 | Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension. ( Ardhanari, S; Chaudhary, K; Kannuswamy, R; Lockette, W; Whaley-Connell, A, 2015) |
| "Primary aldosteronism, caused by autonomous secretion of aldosterone by the adrenals, is estimated to account for at least 5% of hypertension cases." | 2.52 | Pharmacological treatment of aldosterone excess. ( Deinum, J; Lenders, JW; Riksen, NP, 2015) |
| "Primary aldosteronism (PA) is characterized by autonomic aldosterone production, usually leading to severe hypertension and hypokalaemia." | 2.52 | [Primary aldosteronism: new insights into familial forms]. ( Claahsen van der Grinten, HL; Danser, AH; Deinum, J; van den Meiracker, AH; van der Linde, AA, 2015) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary arterial hypertension." | 2.52 | Parathyroid Gland Function in Primary Aldosteronism. ( Asbach, E; Bekeran, M; Reincke, M, 2015) |
| "Primary aldosteronism (PA) is detected with increasing frequency in hypertensive patients and is associated with excess cardiovascular, renal, and metabolic complications." | 2.52 | Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? ( Catena, C; Colussi, GL; Novello, M; Sechi, LA; Uzzau, A, 2015) |
| "Primary aldosteronism is the most common form of secondary hypertension and has significant cardiovascular consequences." | 2.50 | Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy? ( Gomez-Sanchez, CE; Oki, K, 2014) |
| "Studies in primary aldosteronism, congestive heart failure, and chronic kidney disease have identified associations between hyperaldosteronism, hyperparathyroidism, and bone loss, which appear to improve when inhibiting the RAAS." | 2.50 | Interactions between adrenal-regulatory and calcium-regulatory hormones in human health. ( Brown, JM; Vaidya, A, 2014) |
| "Hyperaldosteronism causes sodium and fluid retention in the kidney." | 2.50 | Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders. ( Magill, SB, 2014) |
| "Primary aldosteronism (PA) is the most common form of secondary hypertension with an estimated prevalence of around 10% in referral centers and 4% in a primary care setting." | 2.49 | Regulation of aldosterone secretion: from physiology to disease. ( Beuschlein, F, 2013) |
| "Aldosterone plays a major role in the regulation of sodium and potassium homeostasis and blood pressure." | 2.49 | Genetics of mineralocorticoid excess: an update for clinicians. ( Boulkroun, S; Rickard, AJ; Zennaro, MC, 2013) |
| "Aldosterone has been found to be associated with cardiovascular toxicity." | 2.49 | Diagnosis and management of primary aldosteronism: an updated review. ( Chang, CC; Chao, CT; Chueh, SJ; Kuo, CC; Lin, YH; Pimenta, E; Stowasser, M; Wu, KD; Wu, VC, 2013) |
| "Aldosterone is a downstream effector of angiotensin II in the renin-angiotensin-aldosterone system and binds to the mineralocorticoid receptor." | 2.49 | Aldosterone receptor antagonists: current perspectives and therapies. ( Ahmed, MI; Calhoun, DA; Clark, D; Guichard, JL, 2013) |
| "The identification of primary aldosteronism as a common cause of resistant hypertension is a significant advance in our ability to care for patients with hypertension." | 2.49 | Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. ( Weiner, ID, 2013) |
| "Primary aldosteronism (PA) is now recognized as the most frequent form of secondary arterial hypertension." | 2.49 | Diagnosis and treatment of unilateral forms of primary aldosteronism. ( Burrello, J; Crudo, V; Galmozzi, M; Loiacono, M; Monticone, S; Mulatero, P; Tizzani, D; Veglio, F; Versace, K; Viola, A, 2013) |
| "Primary aldosteronism is the commonest form of hormone-related hypertension, with an estimated prevalence of 6-13% in the generalpopulation of hypertensive patients." | 2.49 | Primary aldosteronism - recent progress and current concepts. ( Januszewicz, A; Januszewicz, W; Kołodziejczyk-Kruk, S; Pęczkowska, M; Prejbisz, A; Zgliczyński, W, 2013) |
| "Primary aldosteronism (PA) seems to be a pathogenetically heterogenous disease." | 2.49 | Primary aldosteronism: a new insight into pathogenesis, diagnosis, and treatment in hypertensive patients. ( Hyla-Klekot, L; Kokot, F, 2013) |
| "Primary aldosteronism is characterised by the dysregulation of aldosterone production and comprises both sporadic forms, caused by an aldosterone-producing adenoma or bilateral adrenal hyperplasia, and familial forms (familial hyperaldosteronism types I, II and III)." | 2.49 | Role of KCNJ5 in familial and sporadic primary aldosteronism. ( Monticone, S; Mulatero, P; Rainey, WE; Veglio, F; Williams, TA, 2013) |
| "Primary aldosteronism (PA) has a prevalence in the general hypertensive population from 5 to 10%, and is widely recognized as the most frequent form of secondary hypertension." | 2.48 | Primary aldosteronism: who should be screened? ( Burrello, J; Crudo, V; Galmozzi, M; Monticone, S; Mulatero, P; Tizzani, D; Veglio, F; Viola, A, 2012) |
| "Especially in patients with primary hyperaldosteronism (PHA) a significant higher risk of developing cardiovascular comorbidities and comortalities was reported." | 2.48 | Aldosterone and the kidney. ( Fourkiotis, VG; Hanslik, G; Hanusch, F; Lepenies, J; Quinkler, M, 2012) |
| "In the setting of primary aldosteronism, renal and faecal calcium loss triggers increased PTH secretion which in turn aggravates aldosterone secretion and CV damage." | 2.48 | Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. ( Drechsler, C; Fahrleitner-Pammer, A; Horina, JH; Kienreich, K; März, W; Ofner, M; Pieber, TR; Pieske, B; Pilz, S; Ritz, E; Tomaschitz, A, 2012) |
| "A close association exists between hyperaldosteronism, RHTN, and obstructive sleep apnea (OSA) based upon recent studies which indicate that OSA is worsened by aldosterone-mediated fluid retention." | 2.48 | Resistant hypertension and aldosterone: an update. ( Ahmed, MI; Calhoun, DA; Clark, D, 2012) |
| " The observation of reduced nitric oxide bioavailability in hyperaldosteronism implied the generation of oxidative stress by aldosterone." | 2.48 | Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases. ( Queisser, N; Schupp, N, 2012) |
| "In view of the fact that primary aldosteronism (PA) is a problem that is more prevalent than previously thought and its diagnosis is of greater clinical significance than previously believed, the Endocrine Society has recently published recommendations on the diagnosis and management of PA." | 2.48 | Primary aldosteronism: a common and important problem. A practical guide to the diagnosis and treatment. ( Górska, M; Myśliwiec, J, 2012) |
| "Endocrine hypertension is the most common cause of secondary hypertension affecting ~3 % of the population, with primary hyperaldosteronism and pheochromocytoma being the principal conditions." | 2.48 | [Update on endocrine hypertension]. ( Al-Salameh, A; Chanson, P; Cohen, R; Plouin, PF, 2012) |
| "Primary hyperaldosteronism (PHA) is characterized by an increased Aldosterone synthesis which is independent of the Renin-Angiotensin-Aldosterone-System (RAAS)." | 2.48 | [Primay hyperaldosteronism--diagnostic and treatment]. ( Beuschlein, F; Potthoff, SA; Vonend, O, 2012) |
| "The prevalence of hyperaldosteronism is increased among patients with obesity or resistant hypertension." | 2.47 | This is not Dr. Conn's aldosterone anymore. ( Brown, NJ, 2011) |
| "Primary aldosteronism is considered the most prevalent form of secondary hypertension with pathophysiological and clinical features different from those of essential hypertension." | 2.46 | Animal models of primary aldosteronism. ( Beuschlein, F, 2010) |
| "In the setting of primary aldosteronism, elevated aldosterone levels are associated with increased blood pressure." | 2.46 | Aldosterone and arterial hypertension. ( Obermayer-Pietsch, B; Pieber, TR; Pilz, S; Ritz, E; Tomaschitz, A, 2010) |
| "Primary Aldosteronism (PA) is a disorder of the adrenal zona glomerulosa (ZG) in which aldosterone secretion is increased and is relatively autonomous of normal regulatory mechanisms." | 2.46 | Progress in primary aldosteronism: present challenges and perspectives. ( Fallo, F; Gomez-Sanchez, CE; Mannelli, M; Rossi, GP, 2010) |
| "Aldosterone was in the past considered only as a prohypertensinogenic agent." | 2.46 | Aldosterone in uremia - beyond blood pressure. ( Koleganova, N; Ritz, E, 2010) |
| "Primary aldosteronism is the most common form of secondary hypertension and patients with hyperaldosteronism are more prone to premature cardiovascular complications compared to essential hypertensives." | 2.46 | Confirmatory tests in the diagnosis of primary aldosteronism. ( Bertello, C; Iannaccone, A; Mengozzi, G; Monticone, S; Mulatero, P; Tizzani, D; Veglio, F, 2010) |
| "Primary aldosteronism (PA) is defined as inappropriately high and (relatively or absolutely) autonomous aldosterone secretion, which is not adequately suppressible by sodium loading." | 2.46 | Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism? ( Pilz, S; Tomaschitz, A, 2010) |
| "Animal models for human idiopathic hyperaldosteronism have been reported for the first time." | 2.46 | Aldosterone and cardiovascular disease. ( Carey, RM, 2010) |
| "The evaluation of primary hyperaldosteronism presents a challenge to endocrinologists, radiologists, and urologic surgeons." | 2.46 | Diagnosis and surgical management for primary hyperaldosteronism. ( Munver, R; Yates, J, 2010) |
| "Surgically correctable forms of primary aldosteronism are characterized by unilateral aldosterone hypersecretion and renin suppression, associated with varying degrees of hypertension and hypokalemia." | 2.46 | Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. ( Amar, L; Plouin, PF; Steichen, O, 2010) |
| "Primary hyperaldosteronism has historically been underdiagnosed as a cause of hypertension, but recent reports highlight its ubiquitous nature with a prevalence of 5%-10% in screened hypertensive patients." | 2.46 | Adrenal vein sampling. ( Angle, JF; Kahn, SL, 2010) |
| "Primary aldosteronism (PA) is a common cause of arterial hypertension: in the PA Prevalence in Hypertensives (PAPY) Study, the prevalence of PA was 11." | 2.46 | Prevalence and diagnosis of primary aldosteronism. ( Rossi, GP, 2010) |
| "Primary aldosteronism (PA) is one of the common forms of curable hypertension." | 2.46 | Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. ( Catena, C; Colussi, G; Di Fabio, A; Sechi, LA, 2010) |
| "Aldosterone is an adrenal hormone that regulates sodium, fluid, and potassium balance." | 2.45 | Aldosterone and cardiovascular disease. ( Calhoun, DA; Gaddam, KK; Husain, S; Pimenta, E, 2009) |
| "Aldosterone is a key regulator of electrolyte and water homeostasis and plays a central role in blood pressure regulation." | 2.45 | Hyperaldosteronism in pregnancy. ( Escher, G, 2009) |
| "Primary hyperaldosteronism is a growing cause of apparently essential hypertension (until 15 % of patients with hypertension)." | 2.45 | [Primary hyperaldosteronisms: from diagnosis to treatment]. ( Carnaille, B; Douillard, C; Mounier-Vehier, C; Wémeau, JL, 2009) |
| "Aldosterone has been found to accelerate the increase in left ventricular mass in patients with hypertension." | 2.45 | Resistant hypertension: who and how to evaluate. ( Acelajado, MC; Calhoun, DA, 2009) |
| "Primary aldosteronism (PA) is the most frequent endocrine form of secondary hypertension." | 2.45 | Differential diagnosis of primary aldosteronism subtypes. ( Avenatti, E; Bertello, C; Giraudo, G; Limerutti, G; Mengozzi, G; Mulatero, P; Rossato, D; Tizzani, D; Veglio, F; Verhovez, A, 2009) |
| "Primary hyperaldosteronism is the most common curable cause of hypertension with a prevalence of up to 12% among patients with hypertension." | 2.45 | [Use of C-arm CT for improving the hit rate for selective blood sampling from adrenal veins]. ( Georgiades, C; Hong, K; Kharlip, J; Valdeig, S; Wacker, FK, 2009) |
| "Studies describing adults with primary aldosteronism who underwent CT/MRI and AVS were included." | 2.45 | Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. ( Deinum, J; Hermus, AR; Kempers, MJ; Lenders, JW; Schultze Kool, LJ; van der Wilt, GJ; van Outheusden, L, 2009) |
| "Primary aldosteronism (PA) and, in particular, its two commonest subtypes (i." | 2.44 | Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas. ( Athyros, VG; Harsoulis, F; Kakafika, AI; Karagiannis, A; Mikhailidis, DP; Tziomalos, K, 2008) |
| "Hyperaldosteronism is associated with endothelial dysfunction and impaired vascular reactivity in patients with hypertension or congestive heart failure." | 2.44 | Mineralocorticoid receptor antagonists and endothelial function. ( Leopold, JA; Maron, BA, 2008) |
| "Primary aldosteronism is the most common cause of mineralocorticoid-induced hypertension, and MR antagonism offers the best prospect for achieving therapeutic goals." | 2.44 | Mineralocorticoid antagonism and cardiac hypertrophy. ( Nagata, K, 2008) |
| "Primary aldosteronism (PA) is a known cause of hypertension." | 2.44 | [Primary aldosteronism]. ( Carvajal, CA; Fardella, CE; Mosso, LM, 2008) |
| "Primary hyperaldosteronism is the most common secondary form of hypertension." | 2.44 | [Diagnosis of primary hyperaldosteronism]. ( Bidlingmaier, M; Diederich, S; Quinkler, M; Reincke, M, 2007) |
| "Primary aldosteronism has been shown to represent 8-13% (rather than <1%) of unselected hypertensive patients, and patients with primary aldosteronism to have higher indices of cardiovascular damage than controls of the same age, sex, and BP status." | 2.44 | The role of aldosterone and mineralocorticoid receptors in cardiovascular disease. ( Funder, JW, 2007) |
| "Primary aldosteronism is a relatively common form of secondary hypertension -- affecting 5 to 10% of all patients with hypertension." | 2.44 | Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism. ( Young, WF, 2007) |
| "Individuals with primary aldosteronism make up a substantial proportion of those with hypertension." | 2.44 | Hyperaldosteronism: a commonly occurring underlying feature of essential hypertension and the metabolic syndrome? ( Chun, TY; Pratt, JH, 2007) |
| "The syndrome of primary aldosteronism, however, encompasses a wide spectrum of disorders that will require better definition." | 2.44 | Aldosterone and refractory hypertension. ( Nyirenda, MJ; Padfield, PL, 2007) |
| "The clinical syndrome congestive heart failure (CHF) has its origins rooted in a salt-avid state mediated largely by effector hormones of the renin-angiotensin-aldosterone system (RAAS)." | 2.44 | The importance of lost minerals in heart failure. ( Bhattacharya, SK; Goodwin, KD; Hatcher, EA; Neal, MT; Newman, KP; Roberts, M, 2007) |
| "Hyperaldosteronism is now recognized as the most common secondary cause and all patients with resistant hypertension should be screened with a plasma aldosterone-renin ratio even if the serum potassium level is normal." | 2.44 | Resistant hypertension and aldosteronism. ( Calhoun, DA; Pimenta, E, 2007) |
| "Hypertension is frequently found in endogenous Cushing's Syndrome (CS)." | 2.44 | Endocrine arterial hypertension: diagnostic approach in clinical practice. ( Armigliato, M; Cuppini, S; Mazza, A; Pessina, AC; Rempelou, P; Rubello, D; Zamboni, S; Zennaro, R, 2008) |
| "Aldosterone also has a major role in progression and outcome of ischemic heart disease." | 2.44 | A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. ( Connell, JM; Davies, E; Fraser, R; Freel, EM; MacKenzie, SM, 2008) |
| "1." | 2.44 | Selection of patients for surgery for primary aldosteronism. ( Amar, L; Plouin, PF; Rossignol, P, 2008) |
| "The use of ARAs for the treatment of myocardial failure and selected cases of hypertension, in combination with the current therapy, has been strongly supported by trials such as the Randomized Aldactone Evaluation Study (RALES) and the Eplerenone Neurohormonal Efficacy and Survival Study (EPHESUS)." | 2.43 | Aldosterone receptor antagonists: biology and novel therapeutic applications. ( Magni, P; Motta, M, 2005) |
| "Primary aldosteronism is a rare cause of hypertension." | 2.43 | [Hypertension due to primary aldosteronism]. ( Bovy, C; Delanaye, P; Hamoir, E; Krzesinski, JM; Maweja, S; Radermecker, RP, 2005) |
| "In primary and secondary aldosteronism, aldosterone synthesis continues despite volume expansion and causes hypertension." | 2.43 | Miscellaneous endocrine causes of hypertension. ( Auchus, RJ, 2005) |
| "Primary aldosteronism is a much more common cause of secondary hypertension than once suspected, accounting for approximately 10% of cases." | 2.43 | The pharmacological treatment of primary aldosteronism. ( Bouloux, PM; Janmohamed, S, 2006) |
| "Primary aldosteronism is caused by bilateral idiopathic hyperplasia in approximately two-thirds of cases and aldosterone-producing adenoma in one-third." | 2.43 | Primary aldosteronism: diagnostic and treatment strategies. ( Mattsson, C; Young, WF, 2006) |
| "Normokalaemic manifestation of primary aldosteronism is a frequent cause of secondary hypertension." | 2.43 | Screening for primary aldosteronism. ( Reincke, M; Schirpenbach, C, 2006) |
| "Surgically correctable forms of primary aldosteronism are generally held to be less common than forms requiring medical therapy." | 2.43 | Surgically correctable hypertension caused by primary aldosteronism. ( Rossi, GP, 2006) |
| "Primary aldosteronism (PA) is a form of surgically curable secondary hypertension." | 2.43 | [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism]. ( Nishikawa, T; Omura, M, 2006) |
| " Fibrosis of the right ventricle, the atria, and the pulmonary artery supports the concept that these effects are BP independent, corroborated by the finding that spironolactone in a dosage not sufficient to lower BP prevents myocardial fibrosis." | 2.42 | Aldosterone-induced cardiac damage: focus on blood pressure independent effects. ( Schmidt, BM; Schmieder, RE, 2003) |
| "Aldosterone has direct effects on the vasculature and has been associated with vascular smooth muscle cell hypertrophy, endothelial dysfunction, cardiac fibrosis, proteinuria, and renal vascular injury." | 2.42 | Aldosterone: a risk factor for vascular disease. ( Fritsch Neves, M; Schiffrin, EL, 2003) |
| "Patients with primary aldosteronism can have impaired pancreatic insulin release and reduction in insulin sensitivity." | 2.42 | The effect of aldosterone on glucose metabolism. ( Corry, DB; Tuck, ML, 2003) |
| "These forms of hypertension are rather rare in their complete expression, but they point to candidate genes whose mutations may predispose to hypertension." | 2.42 | [Monogenic hypertension]. ( Bähr, V; Diederich, S; Oelkers, W, 2003) |
| "Mineralocorticoid hypertension is the consequence of an overactivity of the epithelial sodium channel expressed at the apical membrane of renal cells in the distal nephron." | 2.42 | Forms of mineralocorticoid hypertension. ( Bonny, O; Ferrari, P, 2003) |
| "Heart failure is a major health problem of epidemic proportions." | 2.42 | Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets. ( Ahokas, RA; Gerling, IC; Guntaka, RV; Kiani, MF; Postlethwaite, AE; Sun, Y; Warrington, KJ; Weber, KT, 2003) |
| "Pseudohyperaldosteronism is characterized by a clinical picture of hyperaldosteronism with suppression of plasma renin activity and aldosterone." | 2.42 | Pseudohyperaldosteronism: pathogenetic mechanisms. ( Armanini, D; Calò, L; Semplicini, A, 2003) |
| "Primary hyperaldosteronism (PHA), autonomic secretion of aldosterone by the adrenal gland, is rare." | 2.42 | [Primary hyperaldosteronism]. ( Deinum, J; van den Meiracker, AH, 2003) |
| "Aldosterone is a mineralocorticoid with protean actions in both epithelial and nonepithelial cells." | 2.42 | Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone. ( Weber, KT, 2003) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 2.42 | Recent advances in diagnosis and treatment of primary aldosteronism. ( Leotta, G; Morello, F; Mulatero, P; Rabbia, F; Veglio, F, 2003) |
| "The classical form of primary aldosteronism is a rare disease with prevalence rates of 0." | 2.42 | [The aldosterone to Renin ratio in secondary hypertension]. ( Reincke, M; Seiler, L, 2003) |
| "Hypertension is an important determinant of heart failure." | 2.42 | A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism. ( Weber, KT, 2003) |
| "Pheochromocytomas are rare, but because they are a curable cause of hypertension and potentially fatal if not found, important to diagnose." | 2.42 | Hyperaldosteronism and pheochromocytoma: new tricks and tests. ( Capell, PT; Failor, RA, 2003) |
| "Aldosterone levels were not increased in any of the cases when measured." | 2.42 | Hypokalemia and alkalosis in adipsic hypernatremia are not associated with hyperaldosteronism. ( Chalew, SA; Deputy, S; Rambeau, F; Torchinsky, MY, 2004) |
| " An important phenomenon related to this issue is the aldosterone breakthrough which implies a reelevation of plasma aldosterone during chronic administration of ACE inhibitors and Angiotensin receptor antagonists." | 2.42 | [Aldosterone]. ( Naruse, M; Takagi, S; Takano, K; Tanabe, A; Tsuiki, M; Watanabe, D, 2004) |
| "Primary aldosteronism is a disorder characterized by hypertension and, in more severe form, hypokalemia, due to autonomous aldosterone secretion from the adrenocortical zona glomerulosa." | 2.41 | New genetic insights in familial hyperaldosteronism. ( Jackson, RV; Lafferty, A; Stratakis, C; Torpy, DJ, 2002) |
| "The two major subtypes of primary aldosteronism are unilateral aldosterone-producing adenoma (APA) and bilateral idiopathic hyperplasia (IHA)." | 2.41 | Primary aldosteronism: management issues. ( Young, WF, 2002) |
| "When primary aldosteronism is diagnosed, fewer than one-third of patients are suitable for surgery as initial treatment, but this still represents a significant percentage of hypertensive patients." | 2.41 | Primary aldosteronism: are we diagnosing and operating on too few patients? ( Gordon, RD; Rutherford, JC; Stowasser, M, 2001) |
| "Primary aldosteronism (PAL) may be as much as ten times more common than has been traditionally thought, with most patients normokalemic." | 2.41 | Familial hyperaldosteronism. ( Gordon, RD; Stowasser, M, 2001) |
| "Primary aldosterone excess or hyperaldosteronism is an important cause of hypertension which, when associated with an aldosterone secreting adenoma, is amenable to surgical cure." | 2.41 | Primary aldosteronism, a common entity? the myth persists. ( Padfield, PL, 2002) |
| "2." | 2.41 | Familial varieties of primary aldosteronism. ( Gordon, RD; Gunasekera, TG; Stowasser, M, 2001) |
| "Primary aldosteronism is a potentially curable form of hypertension." | 2.41 | Primary aldosteronism. ( Fardella, CE; Mosso, L, 2002) |
| "The syndrome is due to a deficiency of the renal enzyme 11-beta-hydroxysteroid dehydrogenase type II, which protects the mineralocorticoid receptor against cortisol that binds to the mineralocorticoid receptor like aldosterone." | 2.40 | [Mineralocorticoid-induced hypertension]. ( Hensen, J; Oelkers, W, 1997) |
| "A new form of familial aldosteronism has been described, familial hyperaldosteronism type II; linkage analysis and direct mutation screening has shown that this disorder is unrelated to mutations in the genes for aldosterone synthase or the angiotensin II receptor." | 2.40 | Hyper- and hypoaldosteronism. ( Chrousos, GP; Stratakis, CA; Torpy, DJ, 1999) |
| "Microscopically, a glucagonoma, measuring 2." | 2.40 | A rare combination consisting of primary hyperaldosteronism and glucagonoma. ( Abe, H; Kimura, W; Kubota, K; Makuuchi, M; Noie, T, 1999) |
| "Among these, classic primary hyperaldosteronism and its glucocorticoid remediable variety, in which hypertension is secondary to aldosterone production, must be considered." | 2.40 | [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements]. ( Fardella, CE; Montero, J; Mosso, L, 1999) |
| "Primary aldosteronism occurs much more commonly than generally appreciated." | 2.39 | Primary aldosteronism. ( Holland, OB, 1995) |
| "Primary aldosteronism is the commonest cause of potentially curable hypertension when diagnosed in both florid and less florid forms." | 2.39 | Primary aldosteronism--some genetic, morphological, and biochemical aspects of subtypes. ( Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ, 1995) |
| "We report a rare case of primary hyperaldosteronism due to a unilateral adrenal cortical adenoma in an 11-year-old female patient." | 2.39 | Aldosterone-secreting adrenal cortical adenoma in an 11-year-old child and collective review of the literature. ( Chi, CS; Li, JT; Shu, SG, 1994) |
| "Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant form of human hypertension." | 2.39 | Glucocorticoid-remediable aldosteronism. ( Dluhy, RG; Lifton, RP, 1994) |
| "Conditions of secondary aldosteronism are common in clinical medicine, occurring in normotensive and hypertensive settings." | 2.39 | Secondary aldosteronism. ( Corry, DB; Tuck, ML, 1995) |
| "Hyperaldosteronism owing to aldosterone-producing adenoma (Conn syndrome) is a rare but potentially curable form of pediatric hypertension." | 2.39 | Conn syndrome in a child, caused by adrenal adenoma. ( Abasiyanik, A; Calişkan, U; Erkul, I; Kaymakçi, A; Oran, B; Yaşar, C, 1996) |
| "Cushing's syndrome is rarely an admitting diagnosis to critical care but is a disorder that can seriously affect recovery from coexisting illnesses if not treated." | 2.38 | Endocrinopathies of hyperfunction: Cushing's syndrome and aldosteronism. ( Gumowski, J; Kessler, CA; Proch, M, 1992) |
| "Thus, primary aldosteronism represents one of a few potentially curable forms of hypertension." | 2.38 | Cellular origin of aldosteronomas. ( Ganguly, A, 1992) |
| "Hyperaldosteronism is associated with hypertension, potassium depletion, and suppressed plasma renin activity." | 2.38 | Diagnosis of hyperaldosteronism. ( Melby, JC, 1991) |
| "The diagnosis of primary aldosteronism has been made by the measurement of plasma renin and aldosterone, CT and 131I-cholesterol scintigraphy." | 2.38 | [Diagnosis of adrenal diseases focusing on morphological and endocrinological viewpoints]. ( Miyazaki, S; Yamakita, N; Yasuda, K, 1991) |
| "Among 154 cases of primary aldosteronism seen in the General Clinical Research Center at San Francisco General Hospital, twelve patients did not fulfill established characteristics of an aldosterone producing adenoma (APA) or idiopathic hyperaldosteronism (IHA)." | 2.38 | Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. ( Biglieri, EG; Irony, I; Kater, CE; Shackleton, CH, 1990) |
| " Suitable techniques for the investigation of secondary aldosteronism of unknown cause and for primary and secondary hypoaldosteronism are described, as well as the adjustment of dosage for replacement therapy where mineralocorticoid secretion is deficient." | 2.37 | Disorders of mineralocorticoid activity. ( Drury, PL, 1985) |
| "The diagnosis of primary aldosteronism was confirmed in all patients by biochemical and radiologic studies." | 2.36 | Surgical management of aldosterone-producing adrenal adenomas: a review of 16 patients. ( Crane, MG; Mackett, MC; Smith, LL, 1981) |
| "These results suggest that Bartter's syndrome results from beta adrenergic and prostaglandin-mediated proximal tubular rejection of sodium leading to increased distal sodium-potassium exchange." | 2.35 | Role of prostaglandins in the pathogenesis of Bartter's syndrome. ( Fichman, MP; Golub, M; Rude, R; Speckart, P; Telfer, N; Zia, P, 1976) |
| "Hypertension is common in patients with type 2 diabetes who carry increased cardiovascular risk; however, it is unknown how frequently they are tested for PA." | 1.91 | Screening for primary aldosteronism in the diabetic population: a cohort study. ( Libianto, R; Tan, SJ; Wong, J; Yang, J, 2023) |
| "Primary hyperaldosteronism (PHA) is an underdiagnosed cause of secondary hypertension, with an increased risk of cardiovascular and renal complications compared with those with essential hypertension alone." | 1.91 | Discordant imaging: adrenal vein sampling in almost half of patients with primary aldosteronism and a unilateral adrenal adenoma. ( Kaur, R; Young, S, 2023) |
| "Primary aldosteronism is the most common cause of secondary hypertension." | 1.91 | Intraprocedural cortisol testing improves adrenal vein cannulation success and diagnostic accuracy in assessment of primary aldosteronism, in a medium throughput centre. ( Bischoff, C; Hayes, A; Morgan, B; Stowasser, M; Torpy, DJ; Umapathysivam, MM; Wilks, M, 2023) |
| "Bilateral idiopathic hyperaldosteronism (IHA) is responsible for 60% of primary aldosteronism (PA) cases." | 1.91 | Unilateral Adrenalectomy for Primary Aldosteronism Due to Bilateral Adrenal Disease Can Result in Resolution of Hypokalemia and Amelioration of Hypertension. ( Bancos, I; Dy, BM; Foster, TR; Lyden, ML; McKenzie, TJ; Shariq, OA; Szabo Yamashita, T; Young, WF, 2023) |
| "According to the primary aldosteronism surgical outcome (PASO) criteria, complete and partial clinical success was achieved in 21 (40." | 1.91 | Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma. ( He, H; Jiang, J; Li, Q; Li, Y; Liu, X; Sun, F; Yan, Z; Zhang, H; Zhao, Z; Zhou, X; Zhu, Z, 2023) |
| "Adrenalectomy for primary aldosteronism (PA) has been associated with decreased kidney function after surgery." | 1.91 | Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism. ( Andreassen, M; Clausen, C; Feltoft, CL; Hornum, M; Jepsen, JV; Krogh, J; Mørup, S; Voss, N, 2023) |
| "Primary aldosteronism (PA) patients have a higher degree of arterial stiffness, which can be reversed after adrenalectomy." | 1.91 | Implication of MR Activity in Posttreatment Arterial Stiffness Reversal in Patients With Primary Aldosteronism. ( Chang, CC; Chang, YY; Chen, ZW; Chiu, YW; Chueh, JS; Huang, WC; Hung, CS; Lee, BC; Liao, CW; Lin, YH; Lu, CC; Pan, CT; Tsai, CH; Wang, SM; Wu, VC, 2023) |
| "Primary Aldosteronism (PA) is increasingly considered as a common disease affecting up to 10% of the hypertensive population." | 1.91 | Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy. ( Bouhanick, B; Boulestreau, R; Costa, N; Cremer, A; Delchier, MC; Gombault-Datzenko, E; Gosse, P; Lagarde, S; Lepage, B; Molinier, L; Mounie, M; Papadopoulos, P; Rousseau, H; Trillaud, H, 2023) |
| "Primary aldosteronism (PA) screening relies on an elevated aldosterone to renin ratio with a minimum aldosterone level, which varies from 10 to 15 ng/dL (277-415." | 1.91 | Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening. ( Almeida, MQ; Bortolotto, LA; Brito, LP; Carnevale, FC; Cavalcante, ACBS; Chambo, JL; Coelho, FMA; Consolim-Colombo, FM; Drager, LF; Fagundes, GFC; Fragoso, MCBV; Freitas, TC; Goldbaum, TS; Latronico, AC; Ledesma, FL; Maciel, AAW; Mendonca, BB; Pereira, MAA; Petenuci, J; Pilan, B; Pio-Abreu, A; Silveira, JV; Srougi, V; Tanno, FY; Vilela, LAP; Zerbini, MCN, 2023) |
| "In patients with primary aldosteronism (PA), multiple adrenocortical nodules may be present on the surgical side." | 1.91 | Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism. ( Kakuta, Y; Koike, Y; Kubo, H; Makita, K; Matsui, S; Nakai, K; Nishikawa, T; Saito, J; Sasano, H; Tannai, H; Tsurutani, Y; Yamazaki, Y, 2023) |
| "After genetic analysis, a diagnosis of Liddle syndrome was made due to the presence of a p." | 1.91 | A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism. ( Jin, Y; Qiu, W; Yao, J, 2023) |
| "Hypokalemia was cured in all patients in the normal PAC group after adrenalectomy compared with 98% of patients in the high PAC group (100% vs 98%, P = 1)." | 1.91 | Adrenal Vein Sampling Results and Surgical Outcomes in Patients with a Normal Plasma Aldosterone Concentration. ( Cohen, DL; Fraker, D; Hung, ML; Trerotola, SO; Wachtel, H, 2023) |
| "Primary hyperaldosteronism is a major cause of secondary hypertension and carries additional cardiovascular risks beyond that of the elevated blood pressure." | 1.91 | Fatty acids as a direct regulator of aldosterone hypersecretion. ( Albert, SG; Bruno, J; Dhindsa, S; Ling, G, 2023) |
| "Aldosterone concentration was significantly higher in OC users than nonusers at 17 years (median 486 pmol/L vs 347 pmol/L, P < 0." | 1.91 | Effect of Oral Contraception on Screening Tests for Primary Aldosteronism: A 10-Year Longitudinal Study. ( Beilin, LJ; Fuller, PJ; Gwini, SM; Mori, TA; Schlaich, M; Stowasser, M; Yang, J; Young, MJ, 2023) |
| "Primary aldosteronism (PA) is the most common form of secondary hypertension, with its main manifestations including hypertension and hypokalemia." | 1.91 | Advances in Medical Treatment of Primary Aldosteronism. ( Ji, ZG; Li, YJ; Wen, J, 2023) |
| "The elevated aldosterone in primary aldosteronism (PA) is associated with increased insulin resistance and prevalence of diabetes mellitus (DM)." | 1.91 | Diabetes mellitus is associated with more adverse non-hemodynamic left ventricular remodeling and less recovery in patients with primary aldosteronism. ( Chang, CC; Chang, YR; Chang, YY; Chen, UL; Chueh, JS; Huang, KH; Hung, CS; Lai, TS; Lee, BC; Liao, CW; Lin, YH; Lu, CC; Tsai, CH; Wang, SM; Wu, VC, 2023) |
| "Primary aldosteronism (PA) was suspected because of the high plasma aldosterone concentration-to-plasma renin activity ratio." | 1.91 | Coexistence of Pheochromocytoma and Primary Aldosteronism due to Multiple Aldosterone-producing Micronodules in the Ipsilateral Adrenal Gland. ( Fujita, Y; Hino, M; Horikawa, O; Inoue, K; Kageyama, S; Kawauchi, A; Maegawa, H; Nakaizumi, N; Noujima, M; Sasano, H; Sato, D; Ugi, S; Wada, A; Yamazaki, Y; Yonishi, M, 2023) |
| "Primary aldosteronism (PA) is one of the most frequent causes of secondary hypertension." | 1.91 | International multicenter survey on screening and confirmatory testing in primary aldosteronism. ( Azizan, EABA; Beuschlein, F; Ceccato, F; Dalmazi, GD; Deinum, J; Furnica, RM; Gallego, NV; Gruber, S; Grytaas, MA; Kalugina, V; Kastelan, D; Katabami, T; Kobayashi, H; Kocjan, T; Kraljevic, I; Kürzinger, L; Lacroix, A; Laycock, K; Maiolino, G; Markou, A; Murakami, M; Naruse, M; Nijhoff, MF; O'Toole, S; Parasiliti-Caprino, M; Piaditis, G; Puar, T; Quinkler, M; Ragnarsson, O; St-Jean, M; Sukor, N; Suzuki, T; Tanabe, A; Tong, CV; Torre, EM; Tsuiki, M; Wada, N, 2023) |
| "This work aimed to evaluate the diagnostic utility of the adrenal CT combined with PST in the classification diagnosis of PA." | 1.91 | Significance of computed tomography combined with postural stimulation test in predicting laterality of primary aldosteronism. ( Hu, C; Hu, H; Li, P; Peng, Q; Rao, J; Wu, Y; Wu, Z, 2023) |
| "Primary aldosteronism is the most frequent secondary hypertensive disease and is characterized by an elevated risk for cardiovascular disease." | 1.91 | Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism. ( Fujiwara, A; Haruna, A; Haze, T; Hirawa, N; Kawano, R; Kobayashi, Y; Ohki, Y; Ozawa, M; Saka, S; Suzuki, S; Tamura, K, 2023) |
| "Primary aldosteronism (PA) is a common cause of secondary hypertension, whereas pheochromocytoma is a rare cause of it." | 1.91 | Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report. ( Asayama, Y; Daa, T; Fujinami, H; Gotoh, K; Masaki, T; Miyamoto, S; Nishida, H; Okamoto, M; Ozeki, Y; Shibata, H; Shin, T; Yoshida, Y, 2023) |
| "Primary aldosteronism (PA), characterised by low-renin hypertension, confers a high cardiovascular risk and is the most common cause of secondary hypertension, with an increased prevalence in patients with treatment-resistant hypertension." | 1.91 | RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension. ( Beger, C; Haller, H; Hinrichs, JB; Karg, T; Limbourg, FP; Meyer, BC; Ringe, B, 2023) |
| "Hypertension plus obstructive sleep apnea (OSA) is recommended in some guidelines as an indication to screen for primary aldosteronism (PA), yet prior data has brought the validity of this recommendation into question." | 1.91 | Screening for Primary Aldosteronism Among Hypertensive Adults with Obstructive Sleep Apnea: A Retrospective Population-Based Study. ( Agharazii, M; Goupil, R; Hundemer, GL; Imsirovic, H; Kendzerska, T; Kline, GA; Knoll, G; Leung, AA; Madore, F; Sood, MM; Vaidya, A, 2023) |
| " No major adverse safety events related to SAAE were reported during the intraoperative, postoperative, and follow-up periods." | 1.91 | Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study. ( Dong, YF; Hu, CK; Jiang, XJ; Lai, ZQ; Li, N; Li, YD; Liang, NP; Qiu, J; Xiong, HL; Yang, J; Zhang, HJ, 2023) |
| "Aldosterone was eventually isolated and identified in the fraction and was soon shown to cause hypertension when in excess." | 1.91 | An Abbreviated History of Aldosterone Metabolism, Current and Future Challenges. ( Gomez-Sanchez, CE; Gomez-Sanchez, EP, 2023) |
| "Primary aldosteronism (PA) is a typical example of low renin hypertension, whereas renal artery stenosis (RAS) is a classic form of high renin hypertension." | 1.91 | Renal Artery Stenosis Complicated with Primary Aldosteronism. ( Bao, M; Li, J, 2023) |
| "19 unilateral primary aldosteronism (UPA) patients and 19 healthy people were divided into UPA group and Control group, and the serum of bilateral adrenal veins and inferior vena cava collected by adrenal blood sampling (AVS) in UPA patients and the serum from the healthy subjects were all used to detect multiple cytokines by Luminex immunoassays." | 1.91 | Diagnostic accuracy of using multiple cytokines to predict aldosterone-producing adenoma. ( Huang, J; Lai, X; Li, J; Pan, Y; Qin, F; Wen, H; Yang, T; Yu, J; Zhong, X, 2023) |
| "In aldosterone-treated rats compared with control rats, switching from a low-salt diet to a high-salt diet initiated significantly greater increases in mean arterial pressure and SVR and significantly greater decreases in heart rate and CO." | 1.91 | Hypertension in Primary Aldosteronism Is Initiated by Salt-Induced Increases in Vascular Resistance With Reductions in Cardiac Output. ( DiCarlo, SE; Kurtz, TW; Lujan, HL; Morris, RC; Pravenec, M, 2023) |
| "In this setting, primary aldosteronism (PA) is a frequent cause of RH and its prevalence in RH patients is likely higher than 20%." | 1.91 | Primary Aldosteronism and Drug Resistant Hypertension: A "Chicken-Egg" Story. ( Lenzini, L; Pintus, G; Rossi, GP; Rossitto, G; Seccia, TM, 2023) |
| "Primary hyperaldosteronism is the most common cause of secondary hypertension." | 1.91 | [Adrenalectomy for primary hyperaldosteronism : retrospective review of 57 patients in CHU of Liege]. ( Hamoir, E; Wilmont, E, 2023) |
| "Primary aldosteronism is frequently caused by an adrenocortical aldosterone-producing adenoma (APA) carrying a somatic mutation that drives aldosterone overproduction." | 1.91 | Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas. ( Blum, H; Gong, S; Koupourtidou, C; Krebs, S; Masserdotti, G; Meyer, LS; Rainey, WE; Reincke, M; Sun, N; Tetti, M; Walch, A; Williams, TA, 2023) |
| "Primary aldosteronism (PA) is considered the number one aetiology for secondary hypertension." | 1.91 | Duplicated adrenal veins in primary aldosteronism misdiagnosed with ectopic aldosteronoma due to apparent bilateral aldosterone suppression. ( Chen, K; Fan, C; Fang, T; Liu, H; Quan, H; Wei, W; Yu, J; Zhang, Y, 2023) |
| "Renin-independent aldosteronism (RIA) describes the spectrum of autonomous aldosterone secretion from mild to overt." | 1.91 | Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses. ( Chen, X; Cheng, Q; Gong, L; Hu, J; Li, Q; Luo, W; Luo, Y; Shu, X; Wang, Z; Yang, J; Yang, S; Zeng, Q, 2023) |
| "Patients with primary aldosteronism (PA) have a higher risk of cardiovascular disease (CVD) than essential hypertension due to underlying hyperaldosteronism." | 1.91 | High plasma aldosterone concentration is associated with worse 24-h ambulatory blood pressure profile in patients with primary aldosteronism. ( Azushima, K; Haze, T; Kanaoka, T; Kinguchi, S; Kobayashi, K; Kobayashi, R; Morita, R; Sunohara, S; Tamura, K; Toya, Y; Wakui, H, 2023) |
| "Primary aldosteronism (PA) is the most common cause of endocrine hypertension." | 1.91 | Biochemical Evaluation by Confirmatory Tests after Unilateral Adrenalectomy for Primary Aldosteronism. ( Asari, Y; Daimon, M; Kageyama, K; Kinoshita, N; Murasawa, S; Nakada, Y; Takayasu, S; Usutani, M; Watanuki, Y, 2023) |
| "The aldosterone/renin ratio is an important tool for PA screening, and dynamic testing in serum or urine is used to confirm the diagnosis." | 1.91 | A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism. ( Beriault, DR; Delaney, SR; Yazdanpanah, M, 2023) |
| "Data from the Taiwan Primary Aldosteronism Investigation Group database were analyzed, including patients with unilateral PA who had adrenalectomy between December 2015 and October 2018." | 1.91 | Association of urinary liver-type fatty acid-binding protein with outcomes after adrenalectomy for unilateral primary aldosteronism. ( Chen, CH; Chuang, YW; Lin, YH; Shiao, CC; Wu, CY; Wu, JT; Wu, MJ; Wu, VC; Yu, TM, 2023) |
| "Renal cysts were identified using contrast-enhanced computed tomography." | 1.91 | Non-suppression of renin by renal cysts in a subset of patients with primary aldosteronism-a prospective observational single center study. ( Hämäläinen, E; Hinkka, T; Huhtala, H; Matikainen, N; Nevalainen, PI; Nevalainen, R; Niemelä, O; Pörsti, I; Ylänen, A, 2023) |
| "Primary aldosteronism was diagnosed based on 4 h PAC, adrenal imaging and/or adrenal venous sampling (AVS)." | 1.91 | Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism. ( Chanthanuwat, S; Jannoo, S; Phonanuwong, R; Soonthornpun, S, 2023) |
| "However, obesity has an independent deleterious impact on improvement in blood pressure post-adrenalectomy for PA." | 1.91 | The Impact of Obesity on the Resolution of Hypertension Following Adrenalectomy for Primary Hyperaldosteronism. ( Chidambaram, S; Damji, S; Di Marco, AN; Meeran, K; Palazzo, F; Todd, J; Van Den Heede, K; Wernig, F, 2023) |
| "Screening test results for primary aldosteronism were positive for about one-quarter of urban Indigenous and non-Indigenous participants." | 1.91 | Aldosterone and renin concentrations and blood pressure in young Indigenous and non-Indigenous adults in the Northern Territory: a cross-sectional study. ( Fuller, PJ; Gwini, SM; Ng, E; Singh, GR; Stowasser, M; Yang, J; Young, MJ, 2023) |
| "Primary aldosteronism (PA) is a well-known cause of secondary hypertension." | 1.91 | Simple standing test without furosemide is useful in the diagnosis of primary aldosteronism. ( Fushimi, Y; Iwamoto, H; Iwamoto, Y; Kaku, K; Kaneto, H; Katakura, Y; Kimura, T; Kusano, T; Mune, T; Nakanishi, S; Ohnishi, M; Sanada, J; Shimoda, M; Takenouchi, H; Tatsumi, F, 2023) |
| ""Likely" primary aldosteronism was defined as ARR ≥ 70 pmol/mIU." | 1.91 | Associations Between Aldosterone-Renin-Ratio and Bone Parameters Derived from Peripheral Quantitative Computed Tomography and Impact Microindentation in Men. ( Anderson, KB; Diez-Perez, A; Gwini, SM; Henneberg, M; Holloway-Kew, KL; Hyde, NK; Kotowicz, MA; Liao, WH; Pasco, JA; Rufus-Membere, P; Sui, SX; Tembo, MC; Yang, J, 2023) |
| "Primary aldosteronism (PA) is the most common form of endocrine hypertension and is characterized by inappropriately elevated aldosterone production via a renin-independent mechanism." | 1.91 | Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. ( Bandulik, S; Blinder, AR; Else, T; Giordano, TJ; Kosmann, C; Kumar-Sinha, C; Lerario, AM; Nanba, K; Plain, A; Rainey, WE; Rege, J; Reincke, M; Sasano, H; Satoh, F; Turcu, AF; Udager, AM; Vats, P; Warth, R; Williams, TA; Yamazaki, Y, 2023) |
| "Primary aldosteronism is the underlying cause of hypertension in primary care settings in approximately 6% of cases, and it is even more common in patients with resistant hypertension." | 1.91 | Primary Aldosteronism. ( Quencer, KB; Rugge, JB; Senashova, O, 2023) |
| "Primary aldosteronism (PA) with unilateral adrenal disease can be cured or improved by adrenalectomy." | 1.91 | Surgery based on computed tomography images might be feasible for primary aldosteronism patients with visible unilateral adenoma. ( Dai, J; Fang, C; He, W; Huang, X; Sun, F; Xu, J; Zhao, J, 2023) |
| "Newly presenting hypertension is much the same-hold off on first-order antihypertensive(s) and prescribe spironolactone 25 mg/day for 4 weeks." | 1.91 | Who and How Should We Screen for Primary Aldosteronism? ( Funder, JW, 2023) |
| "Patients with bilateral primary aldosteronism (PA) generally are treated with antihypertensive drugs, but optimal treatment for patients with complications due to refractory hypertension has not been established." | 1.91 | Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication. ( Akaihata, H; Hata, J; Honda-Takinami, R; Hoshi, S; Kataoka, M; Kojima, Y; Matsuoka, K; Ogawa, S; Onagi, A; Sato, Y; Tanji, R, 2023) |
| "Atypical Liddle syndrome can be easily misdiagnosed due to its clinical phenotypes resembling hyperaldosteronism." | 1.91 | Liddle syndrome presenting with normal aldosterone levels: A case report. ( Pan, R; Wang, R; Zhang, R; Zhang, Y; Zhao, Y, 2023) |
| "The left adrenocortical adenoma was removed by robot-assisted laparoscopic resection." | 1.91 | Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report. ( Chen, F; Chen, T; Gao, H; Li, L; Ren, Y; Tian, H, 2023) |
| "Aldosterone was positively associated with PTH levels (r = 0." | 1.72 | Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors. ( Altieri, P; Balacchi, C; Borghi, C; Cosentino, ER; Di Cintio, I; Di Dalmazi, G; Golfieri, R; Malandra, J; Mosconi, C; Pagotto, U; Pelusi, C; Vicennati, V; Zavatta, G, 2022) |
| "In patients with primary aldosteronism, adrenal venous sampling (AVS) is performed to determine the presence of unilateral or bilateral adrenal disease." | 1.72 | Utility of Epinephrine Levels in Determining Adrenal Vein Cannulation During Adrenal Venous Sampling for Primary Aldosteronism. ( Doffek, K; Dream, S; Evans, DB; Findling, JW; Kidambi, S; Magill, SB; Park, S; Rein, L; Rilling, W; Wang, TS; Yen, TW, 2022) |
| "Primary aldosteronism is a common, yet highly underdiagnosed, cause of hypertension that leads to disproportionately high rates of cardiovascular disease." | 1.72 | Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study. ( Agharazii, M; Goupil, R; Hundemer, GL; Imsirovic, H; Knoll, G; Madore, F; Sood, MM; Vaidya, A; Yozamp, N, 2022) |
| "Primary aldosteronism (PA) shows histological heterogeneity and clinical variability, including the coexistence of hypercortisolemia." | 1.72 | Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism. ( Ahn, CH; Choi, JY; Jung, KC; Kim, JH; Kim, SJ; Kim, SW; Lee, KE; Na, HY; Park, SY; Yu, HW, 2022) |
| "In 2017, the Primary Aldosteronism Surgical Outcome (PASO) investigators proposed consensus criteria for clinical and biochemical outcomes." | 1.72 | Prediction of long-term biochemical cure in patients with unilateral primary hyperaldosteronism treated surgically based on the early post-operative plasma aldosterone value. ( Ishihara, Y; Kaneko, H; Kusakabe, T; Nanba, K; Satoh-Asahara, N; Tagami, T; Tsuiki, M; Umakoshi, H; Yasoda, A, 2022) |
| " The results of restricted cubic splines showed the dose-response association between increasing PAC, ARR, decreasing serum potassium, and the risk of WMLs." | 1.72 | Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism. ( Heizhati, M; Li, N; Liu, Y; Luo, Q; Wang, M; Yao, X; Yuan, Y; Zhu, Q, 2022) |
| "Only 795 (4." | 1.72 | Screening Rate for Primary Aldosteronism Among Patients With Apparent Treatment-Resistant Hypertension: Retrospective Analysis of Current Practice. ( Tessier, KM; Zekarias, K, 2022) |
| "Primary aldosteronism (PA) is the commonest cause of endocrine hypertension ranging from 4." | 1.72 | Enhanced performance of a modified diagnostic test of primary aldosteronism in patients with adrenal adenomas. ( Chrousos, GP; Gravvanis, C; Kaltsas, GA; Kanti, G; Markou, A; Papanastasiou, L; Piaditis, G; Voulgaris, N; Zografos, GN, 2022) |
| "Targeted treatment of primary aldosteronism (PA) is informed by adrenal vein sampling (AVS), which remains limited to specialized centers." | 1.72 | External Validation of Clinical Prediction Models in Unilateral Primary Aldosteronism. ( Caughlin, CE; Chin, A; Harvey, A; Hundemer, GL; Kline, GA; Leung, AA; Pasieka, JL; Przybojewski, SJ; Sam, D; So, B, 2022) |
| "Diagnosis of primary aldosteronism (PA) for many patients depends on positive results for the saline infusion test (SIT)." | 1.72 | The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy. ( Beuschlein, F; Bidlingmaier, M; Constantinescu, G; Eisenhofer, G; Fuss, CT; Gruber, S; Kaden, D; Kołodziejczyk-Kruk, S; Kunz, S; Kurlbaum, M; Lenders, JWM; Müller, LM; Peitzsch, M; Prejbisz, A; Reincke, M; Remde, H; Schulze, M; Williams, TA, 2022) |
| "Primary aldosteronism (PA) is a common form of secondary hypertension." | 1.72 | Mass spectrometry-based cortisol profiling during adrenal venous sampling reveals misdiagnosis for subtyping primary aldosteronism. ( Chen, F; Chen, H; Gao, X; Guo, W; Jiang, J; Li, X; Lu, Z; Ma, Y; Zhao, L; Zhou, B, 2022) |
| "We identified patients with aortic dissection and aneurysm with assessed PAC before disease onset from hospital-based electronic database and set as case group." | 1.72 | Higher Plasma Aldosterone Concentrations Are Associated With Elevated Risk of Aortic Dissection and Aneurysm: a Case-Control Study. ( Gan, L; Heizhati, M; Hong, J; Li, N; Lin, M; Luo, Q; Wang, M; Yao, X; Yue, N; Zhang, W; Zhu, Q, 2022) |
| "Primary aldosteronism (PA) is the most common cause of endocrine hypertension and adrenalectomy is the firstline treatment for unilateral PA." | 1.72 | Prognostic value of contralateral suppression for remission after surgery in patients with primary aldosteronism. ( Andreassen, M; Clausen, C; Feltoft, CL; Krogh, J; Mørup, S; Voss, N, 2022) |
| "Primary aldosteronism represents the most frequent cause of endocrine hypertension." | 1.72 | [Diagnosis and therapy of primary aldosteronism: new aspects]. ( Asbach, E; Reincke, M, 2022) |
| "Diagnosis of primary hyperaldosteronism in pregnancy is complicated due to lack of reference ranges for aldosterone, renin and aldosterone-to-renin ratio." | 1.72 | Establishing Reference Ranges for Aldosterone, Renin and Aldosterone-to-Renin Ratio for Women in the Third-Trimester of Pregnancy. ( Grzesiak, M; Horzelski, W; Lewandowski, KC; Lewinski, A; Tadros-Zins, M, 2022) |
| "Primary aldosteronism (PA) is the most common and potentially curable endocrine cause of secondary hypertension, and carries a worse prognosis than essential hypertension." | 1.72 | Screening for primary aldosteronism is underutilised in patients with chronic kidney disease. ( Chauhan, K; Fuller, PJ; Hutton, H; Kerr, PG; Libianto, R; Ryan, J; Schachna, E; Wilson, S; Yang, J, 2022) |
| "To assess the identification of primary aldosteronism (PA) in newly diagnosed, treatment-naïve patients with hypertension by screening in primary care." | 1.72 | Detecting primary aldosteronism in Australian primary care: a prospective study. ( Fuller, PJ; Gwini, SM; Libianto, R; Nuttall, P; Russell, GM; Shen, J; Stowasser, M; Yang, J; Young, MJ, 2022) |
| "Primary aldosteronism (PA) is the most common type of secondary hypertension, and it is associated with a higher rate of cardiovascular complications." | 1.72 | KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma. ( Chang, CC; Chang, YY; Chen, ZW; Chiu, YW; Chou, CH; Huang, JZ; Hung, CS; Kang, VJ; Lee, BC; Liao, CW; Lin, YH; Lin, YL; Pan, CT; Tsai, CH; Wu, VC, 2022) |
| "In primary aldosteronism (PA), renal impairment has been identified as an important comorbidity." | 1.72 | Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk. ( Ichijo, T; Inagaki, N; Izawa, S; Kakutani, M; Katabami, T; Kobayashi, H; Kurihara, I; Matsuba, R; Nakagawa, T; Naruse, M; Ogawa, Y; Sone, M; Takahashi, K; Tanabe, A; Tsuiki, M; Wada, N; Yamamoto, K; Yoshimoto, T, 2022) |
| "Unilateral subtype of primary aldosteronism (PA) is a common surgically curable form of endocrine hypertension." | 1.72 | Machine learning-based models for predicting clinical outcomes after surgery in unilateral primary aldosteronism. ( Fukumoto, T; Ichijo, T; Ishihara, Y; Iwahashi, N; Kaneko, H; Katsuhara, S; Matsuda, Y; Ogata, M; Ogawa, Y; Sakamoto, R; Sakamoto, S; Tagami, T; Terada, E; Umakoshi, H; Wada, N; Watanabe, T; Yokomoto-Umakoshi, M, 2022) |
| "In Japan, a new guideline for primary aldosteronism has been announced, with changes in the aldosterone measurement method." | 1.72 | Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion. ( Gotoh, K; Kambara, K; Kinoshita, M; Masaki, T; Miyamoto, S; Okamoto, M; Ozeki, Y; Shibata, H; Yoshida, Y, 2022) |
| "Among 43 patients with primary aldosteronism (PA), thirteen APA patients were enrolled in this study." | 1.72 | Early Renin Recovery After Adrenalectomy in Aldosterone-Producing Adenomas: A Prospective Study. ( Antonini, SR; de Castro, M; Elias, J; Elias, PCL; Mermejo, LM; Molina, CAF; Moreira, AC; Muglia, VF; Tucci, S, 2022) |
| "Optimal management of primary aldosteronism (PA) is crucial due to the increased risk of cardiovascular and cerebrovascular diseases." | 1.72 | Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism. ( Ahn, CH; Kim, JH; Kim, JW; Kim, SJ; Kim, SW; Koh, JM; Lee, KE; Lee, SH; Lee, YM; Shin, CS; Sung, TY; Yoon, HK, 2022) |
| "Primary aldosteronism (PA) is associated with higher cardiovascular morbidity and mortality rates than essential hypertension." | 1.72 | Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. ( Hasegawa, T; Hashimoto, S; Haze, T; Ichijo, T; Izawa, S; Katabami, T; Kobayashi, H; Kurihara, I; Naruse, M; Ogawa, Y; Ohno, Y; Oki, Y; Omura, M; Otsuki, M; Rakugi, H; Saiki, A; Sakamoto, R; Satoh, F; Shibata, H; Sone, M; Takahashi, K; Takeda, Y; Tamura, K; Tanabe, A; Tanaka, T; Tsuiki, M; Wada, N; Yamamoto, K; Yoneda, T; Yoshimoto, T, 2022) |
| "Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism." | 1.72 | Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression. ( Hirose, R; Hoshino, Y; Inoue, K; Kakuta, Y; Katsuragawa, S; Kubo, H; Matsui, S; Nishikawa, T; Omura, M; Saito, J; Sasano, H; Shibahara, Y; Sunouchi, T; Tannai, H; Tsurutani, Y; Watanabe, K; Yamazaki, Y, 2022) |
| "Primary hyperaldosteronism (PHA) is the most common form of endocrine hypertension." | 1.72 | [Immunogenetics of primary hyperaldosteronism: fundamental studies and their clinical prospects]. ( Eristavi, SK; Platonova, NM; Troshina, EA, 2022) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension, and patients are at an increased risk of atrial fibrillation (AF) and stroke." | 1.72 | Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation. ( Aw, TC; Chai, SC; Fones, S; Foo, RSY; Lai, J; Mamauag, MJB; Nguyen, V; Ong, L; Puar, TH; Saffari, SE; Tu, TM; Zhang, M, 2022) |
| "Primary aldosteronism (PA) is a common disease." | 1.72 | Machine learning approach to predict subtypes of primary aldosteronism is helpful to estimate indication of adrenal vein sampling. ( Abe, H; Inoue, S; Ishii, K; Ito, R; Iwasaki, H; Miwa, T; Odawara, M; Saito, K; Sasaki, J; Sasaki, T; Shikuma, J; Suwanai, H; Suzuki, R; Takamiya, T; Tamaru, S, 2022) |
| "Evidence of primary aldosteronism physiology was prevalent (11." | 1.72 | Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study. ( Ballantyne, CM; Boerwinkle, E; Brown, JM; Claggett, BL; Coresh, J; Grams, ME; Shah, AM; Solomon, SD; Vaidya, A; Wang, Z; Wijkman, MO; Yu, B, 2022) |
| " Patients underwent adrenalectomies and received medical management dosed based on surgical outcomes." | 1.72 | Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in primary aldosteronism. ( Arjani, S; Bostonian, TJ; Chokshi, RJ; Prasath, V; Quinn, PL, 2022) |
| "Primary aldosteronism (PA) and nonclassic apparent mineralocorticoid excess (NCAME) have been recognized as endocrine-related conditions having a broad clinical-biochemical spectrum, spanning from normotension to severe arterial hypertension (AHT)." | 1.72 | Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess. ( Carvajal, CA; Fardella, CE; Pérez, JA; Tapia-Castillo, A, 2022) |
| "Patients were screened for primary aldosteronism with the aldosterone-renin ratio and underwent a saline infusion test for diagnostic confirmation." | 1.72 | Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea. ( Ha, J; Hong, N; Ku, CR; Lee, CJ; Park, S; Rhee, Y; Yoon, M, 2022) |
| "Among those Liddle syndrome patients confirmed by a genetic test, for Test kit A all ARR were screened positive while for test kit B negative." | 1.72 | Liddle syndrome misdiagnosed as primary aldosteronism is caused by inaccurate aldosterone-rennin detection while a novel ( Chen, L; Qu, D; Sun, Q; Wu, C; Xu, X; Yang, Y; Zhao, X, 2022) |
| "Ambulatory FST is safe and accurate and can be performed with significantly less healthcare costs compared to FSTin." | 1.72 | Ambulatory fludrocortisone suppression test in the diagnosis of primary aldosteronism: Safety, accuracy and cost-effectiveness. ( Avander, K; Calissendorff, J; Carasel, A; Falhammar, H; Shabo, I; Volpe, C, 2022) |
| "Background Primary aldosteronism can cause cardiac dysfunction, including left ventricular hypertrophy, left ventricular diastolic dysfunction, and left atrial enlargement." | 1.72 | Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients With Primary Aldosteronism. ( Hoshino, Y; Inoue, K; Nakai, K; Nishikawa, T; Ono, M; Osada, J; Saito, J; Tsurutani, Y; Ueda, T; Yumoto, K, 2022) |
| "The aldosterone/renin ratio was proposed to increase the detection rate of PA, which has the shortcoming of a high underdiagnosis rate when relying only on clinical manifestations." | 1.72 | Reliability Analysis of a Functional Diagnostic Test for Primary Hyperaldosteronism Based on Data Analysis. ( Cai, J; Wang, Y, 2022) |
| "Primary aldosteronism is mainly caused by APAs or idiopathic hyperaldosteronism (IHA)." | 1.72 | Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution. ( Gomez-Sanchez, CE; Horiuchi, Y; Iwahashi, N; Kosaka, T; Mukai, K; Nishimoto, K; Ogawa, Y; Oya, M; Seki, M; Seki, T; Suematsu, M; Suzuki, Y; Umakoshi, H; Umezawa, Y, 2022) |
| "Background Primary aldosteronism (PA) is a common but under-recognized cause of secondary hypertension." | 1.72 | Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities. ( Grigoryan, S; Holevinski, L; Liu, H; Nhan, W; Turcu, AF; Urban, C; Zhang, L; Zhao, L, 2022) |
| "primary aldosteronism patients with a definite subtyping diagnosis based on AVS and/or surgery." | 1.72 | Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism. ( Du, Z; Feng, Z; Fuller, PJ; He, W; Hu, J; Li, Q; Luo, T; Ma, L; Ng, E; Shen, H; Song, Y; Wang, Y; Wu, FF; Yang, J; Yang, S; Yang, Y, 2022) |
| "Aldosterone level was an independent risk factor for DM not for CCVD." | 1.72 | Newly diagnosed diabetes mellitus is a risk factor for cardiocerebrovascular events in primary aldosteronism. ( Jiang, L; Jiang, Y; Su, T; Wang, W; Wu, L; Zhang, C; Zhong, X; Zhou, W, 2022) |
| "原发性醛固酮增多症（primary aldosteronism，PA）根据肾上腺病变部位不同分为单侧和双侧PA，前者可手术治疗，后者应药物控制。单侧PA影像学上常表现为肾上腺低密度结节或增粗。肾上腺CT显像“无异常”的单侧PA既往国内未见报道。本文通过对1例肾上腺CT显像“无异常”的单侧PA患者的临床特点及诊治过程进行分析，总结诊治要点并结合文献复习进行讨论，以期为影像学阴性的单侧PA的临床诊治提供一些借鉴和思路。." | 1.72 | [Unilateral primary aldosteronism with "negative" adrenal CT imaging: a case report]. ( Fei, J; Feng, ZP; He, WW; Hu, JB; Li, QF; Song, Y; Wang, Y; Yang, SM; Yang, Y, 2022) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 1.72 | Clinical and biochemical predictors and predictive model of primary aldosteronism. ( Atthakomol, P; Manosroi, W; Tacharearnmuang, N, 2022) |
| "Primary aldosteronism (PA), including aldosterone and cortisol producing adenoma (A/CPA), is the most common trigger of secondary hypertension." | 1.72 | Two cases of aldosterone and cortisol producing adenoma with different histopathological features: A case report. ( Gao, H; Li, L; Tian, H, 2022) |
| "Primary aldosteronism (PA) represents the most frequent cause of endocrine arterial hypertension." | 1.72 | Prevalence of Primary Aldosteronism in Newly Diagnosed Hypertensive Patients in Primary Care. ( Asbach, E; Bekeran, M; Bidlingmaier, M; Kellnar, A; Reincke, M; Schelling, J, 2022) |
| "A total of 142 cases of primary aldosteronism diagnosed as unilateral by adrenal venous sampling at 2 referral centers between 2009 and 2019 were included." | 1.72 | Aldosterone-Producing Adenomas of Increased Size Are Associated With Higher Steroidogenic Activity. ( Iiri, T; Makita, N; Manaka, K; Nakai, K; Nangaku, M; Nishikawa, T; Saito, J; Sasano, H; Sato, J; Takeuchi, M; Tsurutani, Y; Yamazaki, Y, 2022) |
| "It showed that cardiac hypertrophy was associated with obesity while microalbuminuria was related to plasma aldosterone concentration (PAC) in PA patients." | 1.72 | Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome. ( Bu, X; He, H; Li, Y; Liu, X; Sun, F; Yan, Z; Zhang, H; Zhao, Z; Zhu, Z, 2022) |
| "Primary aldosteronism is the most common surgically curable cause of endocrine hypertension." | 1.72 | Impact of dedicated multidisciplinary service on patient selection and outcomes for surgical treatment of primary aldosteronism. ( Fuller, PJ; Grodski, S; Lee, JC; Libianto, R; Shen, J; Yang, J; Zhang, J, 2022) |
| "However, adrenocortical carcinomas (ACC) and primary aldosteronism (PA) are rare in MEN1." | 1.72 | Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma. ( Bourdeau, I; Corbeil, G; Duranceau, C; El-Haffaf, Z; Karakiewicz, PI; Lacroix, A; Latour, M; Parisien-La Salle, S, 2022) |
| "Primary aldosteronism is now recognized as the most common cause of secondary hypertension." | 1.72 | Primary aldosteronism presenting as embolic myocardial infarction. ( Jin, HY; Kim, YJ; Lee, HW; Lee, KA, 2022) |
| "The pathology report confirmed left adrenal cortical adenoma and left para-aortic PGL." | 1.72 | Left adrenal aldosteronism coexisting with left paraaortic paraganglioma presenting as bilateral adrenal and left paraaortic tumors- comprehensive adrenal evaluation aiding perfect management: a case report. ( Chen, CY; Hsu, YC; Hung, CJ; Lee, CH, 2022) |
| "We confirmed primary aldosteronism if post-seated SLT PAC by LC-MS/MS exceeded 5." | 1.72 | Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism. ( Cho, SH; Kim, JH; Kwon, SY; Lee, SY; Lee, YB; Park, J; Park, SH, 2022) |
| "Unilateral primary aldosteronism (UPA) and bilateral primary aldosteronism (BPA) are the two subtypes of PA." | 1.72 | A new machine learning-based prediction model for subtype diagnosis in primary aldosteronism. ( Gao, L; Li, L; Li, Q; Ren, Y; Shi, S; Tian, Y; Wang, J; Xu, S; Yu, M, 2022) |
| "Forty-five patients with primary aldosteronism undergoing AVS were enrolled in our retrospective study and divided into three groups." | 1.72 | Pre-interventional assessment of right renal to right adrenal vein distance: Impact on procedure time and radiation dose in adrenal vein sampling. ( Adam, G; Avanesov, M; Bannas, P; Henes, FO; Lenz, A; Salamon, J; Schoennagel, BP; Spink, C; Well, L, 2022) |
| "Aldosterone values were similar in the two groups, while renin was significantly lower and the aldosterone to renin ratio was significantly higher in patients with endometriosis than in controls." | 1.72 | Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report. ( Ambrosini, G; Andrisani, A; Armanini, D; Bordin, L; Marin, L; Ragazzi, E; Sabbadin, C; Saccardi, C; Vitagliano, A, 2022) |
| "Similarly, patients with primary aldosteronism had a lower plasma leukocyte mtDNA copy number." | 1.72 | Aldosterone suppresses cardiac mitochondria. ( Chang, YY; Chen, ZW; Chou, CH; Hung, CS; Lee, BC; Liao, CW; Lin, YH; Pan, CT; Peng, SY; Tsai, CH; Wan, CH; Wu, VC; Wu, XM; Young, MJ, 2022) |
| "Primary hyperaldosteronism caused by adrenal neoplasia has been well described in cats." | 1.62 | Retrospective study of aldosterone and progesterone secreting adrenal tumors in 10 cats. ( Alston, SM; Cousins, WM; Folger, W; Gross, C; Harro, CC; Langlois, DK; Mazaki-Tovi, M; Monahan, CF; Refsal, KR; Shaw, N, 2021) |
| "Primary aldosteronism (PA) patients diagnosed with aldosterone-producing adenoma and unilateral adrenal hyperplasia are preferred for surgical treatment." | 1.62 | [Controversy and strategy of partial versus total adrenalectomy in the treatment of primary aldosteronism]. ( Liu, G; Luo, GH, 2021) |
| "Primary aldosteronism, eponymously known as Conn's syndrome, has recently gained recognition as the most common cause of endocrine hypertension." | 1.62 | The role of surgery in Conn's syndrome - a case of refractory hypertension secondary to an aldosterone secreting adenoma. ( Bombil, I; Carides, MD; Christofides, C; Sishuba, NT, 2021) |
| "Aldosterone levels before treatment were positively correlated with serum PTH levels." | 1.62 | Hyperparathyroidism in patients with overt and mild primary aldosteronism. ( Glycofridi, S; Gravvanis, C; Markou, Α; Papanastasiou, L; Piaditis, G; Theodora, K; Tyfoxylou, E; Voulgaris, N, 2021) |
| "Primary aldosteronism was diagnosed." | 1.62 | Hypertension with unilateral adrenal aldosterone and cortisol cosecreting adenoma: A case report. ( Chen, X; Chu, SL; Hu, Z; Luo, FX; Shao, Y; Wang, JG, 2021) |
| "Primary aldosteronism is the most common form of secondary hypertension, and aldosteronoma makes up a significant proportion of primary aldosteronism cases." | 1.62 | In Silico Analysis of the Gene Expression Patterns between Aldosterone-Producing Adenoma and Nonfunctional Adrenocortical Adenoma. ( Dai, Y; Li, J; Liu, J; Wen, H, 2021) |
| "Primary aldosteronism (PA) is caused by autonomous overproduction of aldosterone, which induces organ damage directly via activation of the mineralocorticoid receptor (MR); however, no specific or sensitive biomarkers are able to reflect MR activity." | 1.62 | γENaC/CD9 in urinary extracellular vesicles as a potential biomarker of MR activity. ( Fukuhara, A; Hayakawa, T; Otsuki, M; Saiki, A; Shimomura, I, 2021) |
| "Patients with primary aldosteronism (PA) without apparent adrenal nodularity have not been well characterised in the literature." | 1.62 | Unilateral Disease Is Common in Patients With Primary Aldosteronism Without Adrenal Nodules. ( Kline, GA; Leung, AA; Przybojewski, SJ; Sam, D; So, B, 2021) |
| "The Taiwan Society of Aldosteronism (TSA) Task Force reviewed the latest literature and reached a consensus after group meetings." | 1.62 | Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis. ( Chang, CC; Chen, CK; Chen, YY; Er, LK; Lai, TS; Lu, CC; Tu, KH; Wu, VC; Zeng, YH, 2021) |
| "In primary aldosteronism (PA), aldosterone secretion is relatively independent of the renin-angiotensin system, but can be regulated by several other stimuli." | 1.62 | Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism. ( Bourdeau, I; Lacroix, A; Martin, M; St-Jean, M, 2021) |
| "Primary aldosteronism is an underdiagnosed cause of hypertension." | 1.62 | Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection. ( Fudim, T; Hundemer, GL; Moussa, M; Sacks, B; Underhill, J; Vaidya, A; Yozamp, N, 2021) |
| "Primary aldosteronism was screened by measuring plasma aldosterone concentration (PAC) and direct renin concentration (DRC) and calculating aldosterone-to-renin ratio (ARR), followed by confirmatory saline infusion test (SIT) according to Endocrine Society Guideline." | 1.62 | High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension. ( Alam, S; Goyal, A; Kandasamy, D; Karthikeyan, G; Khadgawat, R; Singh, S; Vishnubhatla, S, 2021) |
| " In patients who have bilateral aldosterone hypersecretion, the optimal management is a low sodium diet and lifelong treatment with a mineralocorticoid receptor antagonist administered at a dosage to maintain a high-normal serum potassium concentration without the aid of oral potassium supplements." | 1.62 | [Primary aldosteronism: from diagnosis to therapy in clinical practice]. ( Cassaniti, L; Francese, GM; Gulizia, MM; Vetri, M, 2021) |
| "In 15 primary aldosteronism patients, we performed intraoperative endoscopic ultrasound, ex vivo magnetic resonance imaging and histopathological examination." | 1.62 | Partial Adrenalectomy Carries a Considerable Risk of Incomplete Cure in Primary Aldosteronism. ( Aalders, TW; Deinum, J; Küsters, B; Langenhuijsen, JF; Mann, R; Mukai, K; van de Wiel, ECJ; Veltien, A; Verhaegh, GW, 2021) |
| "Objective Primary aldosteronism (PA) is a major cause of secondary hypertension." | 1.62 | Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study. ( Aono, D; Fujimoto, A; Gondoh-Noda, Y; Higashitani, T; Karashima, S; Kometani, M; Matsuoka, T; Sawada, K; Takeda, Y; Usukura, M; Yoneda, T; Yoshikura, S, 2021) |
| "BACKGROUND Primary aldosteronism, also known as Conn's syndrome, is a clinical condition caused by excessive production of aldosterone." | 1.62 | Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases. ( Chen, CT; Lin, CM; Wang, YC, 2021) |
| "Her high blood pressure was initially attributed to emotional stress, however, she was later referred for additional evaluation for secondary causes of hypertension." | 1.62 | [HYPERTENSION IN A YOUNG WOMAN WITH ANXIETY DISORDER: THE CHICKEN OR THE EGG?] ( Angel Korman, A; Hausmann, M; Katzir, Z; Rapoport, V; Raz, O, 2021) |
| "Patients with primary aldosteronism (PA) have cardiac remodeling due to hemodynamic and non-hemodynamic causes." | 1.62 | Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism. ( Chang, CC; Chang, YR; Chang, YY; Chen, YL; Chen, ZW; Hung, CS; Lee, BC; Liao, CW; Lin, LC; Lin, YH; Pan, CT; Tsai, CH; Wu, XM, 2021) |
| "Aldosterone plays pivotal roles in renin-angiotensin-aldosterone system in order to maintain the equilibrium of liquid volume and electrolyte metabolism." | 1.62 | Pathology of Aldosterone Biosynthesis and its Action. ( Gao, X; Morimoto, R; Nakamura, Y; Omata, K; Ono, Y; Sasano, H; Satoh, F; Suzuki, T; Tezuka, Y; Yamazaki, Y, 2021) |
| "Primary aldosteronism (PA) is highly prevalent in hypertensive population." | 1.62 | Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas. ( He, H; Hong, Y; Liu, X; Sun, F; Yan, Z; Zhang, H; Zhao, Z; Zhu, Z, 2021) |
| "Normal pregnancy is associated with a rise in aldosterone and renin levels early in pregnancy making the aldosterone:renin ratio which is normally used to screen for primary aldosteronism, difficult to interpret." | 1.62 | Screening for primary aldosteronism in pregnancy. ( Kumar, S; Morton, A; Vidyasagar, S, 2021) |
| "Primary aldosteronism has two main clinically and biologically distinct subtypes: unilateral aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (BAH)." | 1.62 | Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period. ( Fujii, Y; Ichijo, T; Inagaki, N; Itoh, H; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Naruse, M; Ogawa, Y; Oki, K; Saito, K; Sone, M; Suzuki, T; Tamura, K; Tanabe, A; Tsuiki, M; Wada, N; Yamada, M; Yamada, T; Yamamoto, K; Yasoda, A; Yoneda, T, 2021) |
| "Primary aldosteronism (PA) is the most common endocrine cause of arterial hypertension." | 1.62 | Prevalence of Primary Aldosteronism Across the Stages of Hypertension Based on a New Combined Overnight Test. ( Chrousos, G; Gravvanis, C; Gryparis, A; Kaltsas, G; Kapsali, C; Kassi, E; Kyriazi, E; Markou, A; Papanastasiou, L; Piaditis, G; Tyfoxylou, E; Vlachou, S; Voulgaris, N, 2021) |
| "Primary aldosteronism (PA), as a cause of secondary hypertension, can cause more serious cardiovascular damage than essential hypertension." | 1.62 | A case of primary aldosteronism with a negative aldosterone-to-renin ratio. ( Ding, Y; Liu, F; Wang, L, 2021) |
| "Patients with primary aldosteronism have a higher risk of chronic kidney disease." | 1.62 | Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism. ( Fujiwara, A; Hatakeyama, M; Haze, T; Hirawa, N; Kawano, R; Kobayashi, Y; Komiya, S; Ohki, Y; Saka, S; Suzuki, S; Tamura, K, 2021) |
| "Primary aldosteronism (PA) is a common curable cause of hypertension." | 1.56 | Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan. ( Fujii, Y; Fujita, M; Ichijo, T; Inagaki, N; Itoh, H; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Matsuda, Y; Miyauchi, S; Naruse, M; Ogasawara, T; Ogawa, Y; Ogo, A; Okamura, S; Otsuki, M; Shibata, H; Shibayama, Y; Sone, M; Suzuki, T; Takahashi, K; Takeda, Y; Tsuiki, M; Umakoshi, H; Wada, N; Watanabe, M; Yamamto, K; Yanase, T; Yoshimoto, T, 2020) |
| "Primary aldosteronism (PA) is mainly treated by mineralocorticoid receptor antagonists or laparoscopic adrenalectomy (LA), but the effectiveness of surgical versus medical treatment in patients with adrenal venous sampling (AVS)-proven unilateral PA is unclear." | 1.56 | Long-term blood pressure outcomes of patients with adrenal venous sampling-proven unilateral primary aldosteronism. ( Cai, J; Fan, P; Jiang, XJ; Lou, Y; Lu, PP; Ma, WJ; Meng, X; Song, L; Wu, HY; Zhang, HM; Zhang, Y; Zhou, XL, 2020) |
| "Accurate subtyping of the primary aldosteronism into aldosterone-producing adenoma (APA) and idiopathic adrenal hyperplasia (IAH) is important to direct for specific treatment modalities." | 1.56 | A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia. ( Chan, KW; Fong, CHY; Lau, EYF; Leung, HT; Leung, JYY; Tan, KCB; Woo, YC, 2020) |
| "Primary aldosteronism is a common cause of secondary hypertension." | 1.56 | Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system. ( Beninato, T; Fahey, TJ; Sivarajah, M, 2020) |
| "In AVS-left primary aldosteronism patients, the cutoff value of the L/Rv with the highest Youden index was 1." | 1.56 | Left-versus-right-adrenal-volume ratio as a screening index before adrenal venous sampling to identify unilateral primary aldosteronism patients. ( Chen, T; Li, S; Ma, L; Qing, B; Ren, Y; Sun, H; Sun, J; Tian, H; Xie, W; Zhao, L; Zhu, Y, 2020) |
| "Primary aldosteronism, which is usually caused by an aldosterone-producing tumour, affects glucose metabolism." | 1.56 | Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma. ( Fukuoka, H; Hirota, Y; Iguchi, G; Komada, H; Nakamura, T; Ogawa, W; Okuno, Y; Sakaguchi, K; So, A; Takahashi, Y, 2020) |
| "In primary aldosteronism (PA), excessive, autonomous secretion of aldosterone is not suppressed by salt loading or fludrocortisone." | 1.56 | Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS. ( Ahmed, AH; Gordon, RD; Guo, Z; McWhinney, BC; Stowasser, M; Thuzar, M; Ungerer, JP; Ward, G; Wolley, M; Young, K, 2020) |
| "Primary aldosteronism is recognized as the most frequent cause of secondary hypertension, and its screening is expected to become a routine evaluation in most patients with hypertension." | 1.56 | Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism. ( Buffolo, F; Burrello, J; Domenig, O; Monticone, S; Mulatero, P; Pecori, A; Poglitsch, M; Tetti, M, 2020) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary hypertension." | 1.56 | Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism. ( Kietsiriroje, N; Murray, RD; Suntornlohanakul, O; Wonghirundecha, R, 2020) |
| "Primary aldosteronism (PA) is known to increase vertebral fracture (VF), although the detailed mechanism remains to be elucidated." | 1.56 | Unilateral primary aldosteronism as an independent risk factor for vertebral fracture. ( Fukumoto, T; Matsuda, Y; Nagata, H; Ogata, M; Ogawa, Y; Sakamoto, R; Umakoshi, H; Yokomoto-Umakoshi, M, 2020) |
| "Primary aldosteronism (PA) contributed to the cardiovascular disease and metabolic alterations independent of the blood pressure level." | 1.56 | The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism. ( Azhar Shah, S; Ismail, NA; Kamaruddin, NA; Sukor, N, 2020) |
| "Primary aldosteronism (PA) due to unilateral aldosterone-producing adenoma (APA) is preferentially treated by unilateral adrenalectomy (ADX), but little is known about the changes in lipid and glucose metabolism that may occur after ADX." | 1.56 | Lipoprotein insulin resistance score and branched-chain amino acids increase after adrenalectomy for unilateral aldosterone-producing adenoma: a preliminary study. ( Adolf, C; Berends, AMA; Connelly, MA; Dullaart, RPF; Reincke, M, 2020) |
| "Hyperaldosteronism has been reported to be associated with a higher prevalence of non-alcoholic fatty liver disease (NAFLD)." | 1.56 | The risk factors for hepatic steatosis in patients with primary aldosteronism. ( Atsumi, T; Baba, S; Nakamura, A; Obara, S; Sakai, H; Shibayama, Y; Terae, S; Usubuchi, H; Wada, N, 2020) |
| "Primary aldosteronism (PA) is notably an independent risk factor for cerebral vascular disease but currently with limited knowledge among young adults." | 1.56 | Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics. ( Chen, H; Cheng, Q; Du, Z; He, W; Hu, J; Li, Q; Luo, T; Ma, L; Mei, M; Song, Y; Tang, Z; Wang, Z; Yang, S, 2020) |
| "Diagnosis of primary aldosteronism (PA) involves a multistep process reliant on the accuracy of aldosterone measurements at each step." | 1.56 | Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interference. ( Bidlingmaier, M; Bornstein, SR; Constantinescu, G; Deinum, J; Eisenhofer, G; Gruber, M; Hofmockel, T; Kunath, C; Langton, K; Lenders, JWM; Peitzsch, M; Poitz, DM; Reincke, M; van Herwaarden, AE, 2020) |
| "Primary aldosteronism is a nonsuppressible renin-independent aldosterone production that causes hypertension and cardiovascular disease." | 1.56 | The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study. ( Brown, JM; Calhoun, DA; Carey, RM; Hopkins, PN; Siddiqui, M; Vaidya, A; Williams, GH, 2020) |
| "After the treatment of primary aldosteronism, glucose intolerance was improved in 66." | 1.56 | Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism. ( Fukuda, I; Moriya, A; Nagao, M; Oikawa, S; Okazaki-Hada, M; Sugihara, H, 2020) |
| "Aldosterone was associated with various markers of inflammation and metabolic dysregulation, which partly differed from the associations observed for renin." | 1.56 | Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity. ( Danser, AHJ; de Graaf, J; Deinum, J; Joosten, LAB; Netea, MG; Riksen, NP; Rutten, J; Schraa, K; Ter Horst, R; van den Munckhof, ICL; van der Heijden, CDCC, 2020) |
| "Hypertension was the most common chief complaint, in contrast, the proportion of fatigue and/or numbness as the symptoms of hypokalemia was declining." | 1.56 | [Diagnosis and Treatment of Primary Aldosteronism in West China Hospital of Sichuan University from 2009 to 2018]. ( Chen, T; Li, QR; Li, YM; Liu, HD; Ren, Y; Tian, HM; Wang, W; Zhu, YC, 2020) |
| "Primary aldosteronism (PA) comprises unilateral (lateralized [LPA]) and bilateral disease (BPA)." | 1.56 | Development and Validation of Prediction Models for Subtype Diagnosis of Patients With Primary Aldosteronism. ( Adolf, C; Burrello, A; Burrello, J; Forestiero, V; Monticone, S; Mulatero, P; Pieroni, J; Rabbia, P; Reincke, M; Sconfienza, E; Veglio, F; Williams, TA, 2020) |
| "Conn's syndrome is a curable condition if identified properly." | 1.56 | Seizure and coma secondary to Conn's syndrome: a case report. ( Alseddeeqi, E; Altinoz, A; Ghashir, NB, 2020) |
| "Primary aldosteronism (PA) is a common form of secondary hypertension that has significant cardiovascular events and increased prevalence of metabolic syndrome and diabetics." | 1.56 | Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma. ( Chang, CC; Chueh, JS; Er, LK; Hsiao, JK; Lin, MC; Peng, KY; Tsai, YC; Wu, VC; Yang, CY, 2020) |
| "Correct subtyping of primary aldosteronism (PA) is critical for guiding clinical management." | 1.56 | The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation. ( Caoili, E; Nanba, A; Nanba, K; Rainey, WE; Shields, JJ; Turcu, AF; Wannachalee, T, 2020) |
| "Primary aldosteronism (PA) is associated with a higher prevalence of abdominal aortic calcification (AAC)." | 1.56 | Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels. ( Li, N; Luo, Q; Tuersun, T; Wang, G; Wang, M; Wu, T; Yue, N; Zhang, D; Zhang, Z; Zhou, K, 2020) |
| "In primary aldosteronism, cosecretion of cortisol may alter cortisol-derived adrenal venous sampling indices." | 1.56 | Low-grade Cortisol Cosecretion Has Limited Impact on ACTH-stimulated AVS Parameters in Primary Aldosteronism. ( Akker, SA; Chung, TT; Dawnay, A; Drake, WM; Druce, MR; Matson, M; O'Toole, SM; Parvanta, L; Pitkin, S; Sahdev, A; Sze, WC; Waterhouse, M, 2020) |
| "Primary aldosteronism (PA) occurs in 10%-20% of patients with resistant hypertension." | 1.56 | Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism. ( Bloomgarden, N; Friedmann, P; In, H; Laird, AM; Libutti, SK; McAuliffe, JC; Yeung, A, 2020) |
| " Catheter-based adrenal ablation appears to produce substantial and sustained blood pressure reduction and biochemical improvement, with only minor adverse events in PA patients without apparent aldosteronoma." | 1.56 | Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial. ( Bu, X; He, H; Hong, Y; Li, Q; Li, Y; Liu, X; Shen, R; Sun, F; Yan, Z; Yang, G; Zhang, H; Zhao, Z; Zheng, H; Zhou, X; Zhu, Z, 2020) |
| "The diagnostic algorithm for primary aldosteronism is sequentially based on hormonal tests (screening and confirmation tests), followed by lateralization studies (adrenal CT scanning and adrenal venous sampling) to distinguish between unilateral and bilateral disease." | 1.56 | Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. ( Amar, L; Beuschlein, F; Deinum, J; Fallo, F; Lin, YH; Monticone, S; Morganti, A; Mulatero, P; Nishikawa, T; Prejbisz, A; Rossi, GP; Seccia, TM; Widimsky, J; Zennaro, MC, 2020) |
| " In patients with bilateral aldosterone hypersecretion, the optimal is a low-sodium diet and lifelong treatment with a mineralocorticoid receptor antagonist administered at a dosage to reach a high-normal serum potassium concentration." | 1.56 | [Primary aldosteronism: The Mayo Clinic approach]. ( Balutina, OV; Beltsevich, DG; Ladygina, DO; Young, W, 2020) |
| "Aldosterone-renin ratio was significantly higher in the MRA group (median, 375." | 1.56 | Adrenal Vein Sampling Without Discontinuation of Mineralocorticoid Receptor Antagonist Therapy. ( Abadin, SS; Fogelfeld, L; Ganesh, M, 2020) |
| "Primary aldosteronism is a common cause of secondary hypertension." | 1.56 | Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: An important tool for improved patient follow-up. ( Hamberger, B; Juhlin, CC; Volpe, C; Zedenius, J, 2020) |
| "Four out of 25 patients with primary hyperaldosteronism failed dexamethasone suppression tests." | 1.51 | The relevance of cortisol co-secretion from aldosterone-producing adenomas. ( Bhatt, PS; Meeran, KM; Salem, V; Sam, AH, 2019) |
| "Cosyntropin's effect on primary aldosteronism (PA) lateralization, however, is controversial." | 1.51 | Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin During Adrenal Vein Sampling. ( Auchus, RJ; Nanba, AT; Nanba, K; Rainey, WE; Shields, JJ; Turcu, AF; Wannachalee, T; Zhao, L, 2019) |
| "Primary aldosteronism is characterized by inappropriate overproduction of aldosterone by adrenal lesions and leads to hypertension." | 1.51 | Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism. ( Ichihara, A; Morimoto, S; Seki, Y; Watanabe, D; Yamashita, K, 2019) |
| "Primary hyperaldosteronism (PA) - is the clinical syndrome, results from autonomous of the major regulators of secretion, aldosterone overproduction by a tumorous or hyperplastic tissue in adrenal cortex." | 1.51 | [Primary hyperaldosteronism: difficulties in diagnosis]. ( Belcevich, DG; Kolesnikova, GS; Kovalevich, LD; Molashenko, NV; Platonova, NM; Romanova, NY; Shifman, BM; Sitkin, II; Troshina, EA, 2019) |
| "The performance of new ARR in aldosteronism detection is poorly evaluated." | 1.51 | High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism. ( Chen, D; Feng, P; Gan, W; Li, Y; Lin, W; Ouyang, J; Yao, Z, 2019) |
| "Objective The association of primary aldosteronism (PA) with thyroid disease has already been suggested." | 1.51 | Association of Papillary Thyroid Carcinoma with Primary Aldosteronism. ( Ishimori, M; Nakamura, S; Yamakita, N, 2019) |
| "Unilateral primary aldosteronism is surgically curable." | 1.51 | Primary aldosteronism with nonlocalizing imaging. ( Bhandari, S; Cohen, DL; Fraker, DL; Roses, RE; Trerotola, SO; Wachtel, H, 2019) |
| "Primary aldosteronism (PA) may cause myocardial injury." | 1.51 | Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism. ( Chen, X; Chen, Y; Li, Y; Shao, S; Wang, D; Wang, JG; Xu, JZ; Xu, TY; Zhang, W; Zhu, LM, 2019) |
| "Aldosterone/renin ratio was available in 1473 patients, and abnormal in 374 (25." | 1.51 | Rates of abnormal aldosterone/renin ratio in African-origin compared to European-origin patients: A retrospective study. ( Abadi, S; Ahmed, KS; Behan, LA; Bogdanet, D; Boran, G; Dineen, R; Gibney, J; Sherlock, M; Woods, CP, 2019) |
| "Subtyping of primary aldosteronism (PA) using imaging and adrenal vein sampling (AVS) may yield discordant results, causing confusion in management." | 1.51 | Discordance Between Imaging and Adrenal Vein Sampling in Primary Aldosteronism Irrespective of Interpretation Criteria. ( Kline, GA; Leung, AA; Sam, D; So, B, 2019) |
| "To determine the frequency of primary hyperaldosteronism in young hypertensives in hospital settings of Rawalpindi." | 1.51 | Frequency of Primary Hyperaldosteronism in Young Hypertensives in a Tertiary Care Setting of Rawalpindi. ( Akram, A; Asif, N; Gilani, M; Nawaz, A, 2019) |
| "APA cause primary aldosteronism (PA), which affect 3-10% of the hypertensive population." | 1.51 | Aldosterone-Producing Adenomas. ( Åkerström, T; Björklund, P; Hellman, P, 2019) |
| "A majority of primary aldosteronism patients have markedly lower aldosterone levels during sedated AVS compared with those found during outpatient diagnosis." | 1.51 | Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism. ( Chin, A; Darras, P; Holmes, DT; Kline, GA; Leung, AA; So, B, 2019) |
| "Primary aldosteronism (PA) is a frequent cause of resistant hypertension." | 1.51 | [Two case reports on resistant hypertension]. ( Beger, C; Haller, H; Limbourg, FP, 2019) |
| "Aldosterone has been linked with obesity, metabolic syndrome (MetS), pro-inflammatory, and prothrombotic states; however, most studies relate these indicators with primary aldosteronism (PA), excluding non-PA patients." | 1.51 | The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism. ( Allende, F; Barros, ER; Baudrand, R; Campino, C; Carvajal, C; Fardella, CE; Fuentes, CA; García, H; Kalergis, AM; Martínez-Aguayo, A; Olmos, R; Solari, S; Tapia-Castillo, A; Vecchiola, A, 2019) |
| "Risk factors for idiopathic hyperaldosteronism (IHA) differentiating from aldosterone-producing adenoma (APA) were identified using logistic regression analysis." | 1.51 | A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism. ( Jiang, L; Jiang, Y; Ning, G; Su, T; Wang, W; Xiao, L; Zhang, C; Zhou, W, 2019) |
| "The diagnostic workup for primary aldosteronism includes a screening step using the aldosterone-to-renin ratio (ARR) and a confirmatory step based on dynamic testing of aldosterone secretion autonomy." | 1.51 | Evaluation of Biochemical Conditions Allowing Bypass of Confirmatory Testing in The Workup of Primary Aldosteronism: A Retrospective Study in a French Hypertensive Population. ( Deberles, E; Guenet, D; Haddouche, A; Morello, R; Reznik, Y; Vivien, M, 2019) |
| "Patients with primary aldosteronism undergo imaging of the adrenal glands after confirmation of the disease." | 1.51 | Influence of Adrenal Venous Sampling on Management in Patients with Primary Aldosteronism Independent of Lateralization on Cross-Sectional Imaging. ( Campbell, RA; Lairmore, TC; McDonald, DK; Milan, SA; Shaver, CN; Snyder, SK; Young, DS, 2019) |
| "Using a large database of primary aldosteronism patients in Japan, we analyzed 2122 patients with successful ACTH-AVS." | 1.51 | Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling. ( Akasaka, H; Fujii, Y; Fujita, M; Ichijo, T; Inagaki, N; Itoh, H; Kamemura, K; Katabami, T; Kawamura, T; Kawashima, J; Kobayashi, H; Kurihara, I; Matsuda, Y; Miyauchi, S; Nagasawa, M; Naruse, M; Ogawa, Y; Ogo, A; Okamura, S; Otsuki, M; Rakugi, H; Shibata, H; Shibayama, Y; Sone, M; Suzuki, T; Takahashi, K; Takeda, M; Takeda, Y; Tsuiki, M; Umakoshi, H; Wada, N; Watanabe, M; Yamamoto, K; Yanase, T; Yoshimoto, T, 2019) |
| "According to the Primary Aldosteronism Surgical Outcomes criteria, patients were classified as complete, partial, or absent clinical success." | 1.51 | Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients. ( Borel Rinkes, IHM; Postma, EL; Spiering, W; Valk, GD; van Beek, DJ; Vorselaars, WMCM; Vriens, MR, 2019) |
| "Some primary aldosteronism (PA) patients with ATs are diagnosed with bilateral PA based on adrenal venous sampling (AVS), and their ATs are apparently nonfunctioning." | 1.51 | Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism. ( Chiba, Y; Fukuoka, T; Hashimoto, S; Ichijo, T; Inagaki, N; Izawa, S; Kai, T; Katabami, T; Kurihara, I; Naruse, M; Ogawa, Y; Ohno, Y; Okamura, S; Sone, M; Takeda, Y; Tsuiki, M; Wada, N; Yamada, M; Yoshikawa, Y, 2019) |
| "Current clinical guidelines of primary aldosteronism recommend adrenalectomy (AdX) for unilateral primary aldosteronism based on the studies showing the potential superiority of AdX over the medical treatment." | 1.51 | Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism. ( Fujii, Y; Fujita, M; Fukuda, H; Ichijo, T; Inagaki, N; Ito, H; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Matsuda, Y; Naruse, M; Ogawa, Y; Ogo, A; Otsuki, M; Shibata, H; Shibayama, Y; Sone, M; Suzuki, T; Takahashi, K; Takeda, Y; Tanaka, Y; Tsuiki, M; Tsukiyama, H; Wada, N; Watanabe, M; Yamamoto, K; Yanase, T; Yoshimoto, T, 2019) |
| "Our study included 107 primary aldosteronism patients [52 aldosterone-producing adenoma (APA) and 55 idiopathic hyperaldosteronism (IHA)] and 50 primary hypertensive patients." | 1.51 | Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography. ( Chen, X; Li, Y; Wang, D; Wang, JG; Xu, JZ; Xu, TY; Zhang, W, 2019) |
| "Patients with primary aldosteronism induced hypertension are more likely to experience cardiovascular events compared to patients with essential hypertension." | 1.51 | Hypertension with primary aldosteronism is associated with increased carotid intima-media thickness and endothelial dysfunction. ( Demirkiran, A; Dreijerink, KM; Elitok, A; Everaars, H; Ozcan, M; Smulders, YM; Tanakol, R; van de Ven, PM, 2019) |
| "We included primary aldosteronism patients who had undergone adrenalectomy from the Taiwan Primary Aldosteronism Investigation database between 1995 and 2017." | 1.51 | Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy. ( Chan, CK; Chang, CC; Chueh, E; Huang, KH; Kim, JH; Lai, TS; Lin, YF; Lin, YH; Wu, VC, 2019) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary hypertension." | 1.51 | Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism. ( Akasaka, H; Chiba, Y; Fujita, M; Ichijo, T; Izawa, S; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Matsuda, Y; Miyauchi, S; Nagasawa, M; Nakamaru, R; Naruse, M; Ogawa, Y; Okamura, S; Rakugi, H; Sone, M; Takeda, Y; Tamura, K; Tanabe, A; Tsuiki, M; Wada, N; Watanabe, M; Yamamoto, K; Yoshimoto, T, 2019) |
| "Primary aldosteronism (PA) causes a cardiomyopathy (CM) which substrate and evolution after aldosterone normalization are unreported." | 1.51 | Primary aldosteronism-associated cardiomyopathy: Clinical-pathologic impact of aldosterone normalization. ( Chimenti, C; Francone, M; Frustaci, A; Grande, C; Letizia, C; Russo, MA; Sansone, L; Verardo, R, 2019) |
| "Primary aldosteronism (PA) is the most common form of secondary arterial hypertension." | 1.51 | [Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review)]. ( Kolesnikova, GS; Molashenko, NV; Platonova, NM; Romanova, NY; Shifman, BM; Troshina, EA, 2019) |
| "The diagnosis of primary hyperaldosteronism (PHPA) has progressively increased over the last years and some authors consider it as the main cause of secondary hypertension." | 1.51 | [Primary hyperaldosteronism in a population of hypertensive patients]. ( Artiles Vizcaíno, J; Lorenzo Villalba, N; Marrero Medina, I; Rivera Martínez, E; Sablón González, N; Suárez Ortega, S, 2019) |
| "In addition, primary aldosteronism (PA) is clinically associated with not only more frequent cardiovascular events but also secondary metabolic disorders including abnormal calcium metabolism, osteoporosis and others." | 1.51 | The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals. ( Gao, X; Morimoto, R; Nakamura, Y; Ogata, H; Omata, K; Onodera, Y; Sasano, H; Satoh, F; Tezuka, Y; Yamazaki, Y, 2019) |
| "Primary aldosteronism (PA) is hemodynamically independently associated with arterial wall stiffness as assessed by pulse wave velocity (PWV) compared with essential hypertension." | 1.51 | Aldosterone Induces Vascular Damage. ( Chang, CC; Chen, CH; Chen, ZW; Cheng, HM; Hung, CS; Liao, CW; Lin, YH; Pan, CT; Sung, SH; Wu, VC, 2019) |
| "The diagnostic criteria of primary aldosteronism were plasma aldosterone concentration-to-plasma renin activity ratio [ARR, (ng/dl)/(ng/ml per h)] at least 20 and at least one positive result in four types of challenge tests." | 1.48 | Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K. ( Ando, T; Endo, T; Fukuhara, S; Fukuma, S; Hasegawa, T; Koyama, M; Mita, T; Miura, T; Moniwa, N; Ohno, K; Ohnuma, Y; Shimizu, S; Takada, A; Tobisawa, T; Togashi, N; Tsuchida, A; Yamashita, T; Yoshida, H, 2018) |
| "Primary aldosteronism is associated with a higher incidence of left ventricular (LV) hypertrophy and diastolic dysfunction than essential hypertension." | 1.48 | Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study. ( Chang, YY; Chen, CW; Chen, ZW; Huang, KC; Hung, CS; Lee, JK; Liao, CW; Lin, LC; Lin, YH; Wu, VC, 2018) |
| "In patients with KCNJ5-mutated APA, left ventricular hypertrophy was significantly decreased by surgical treatment in patients from either Cured or Improved groups, although those patients with wild-type KCNJ5 showed no change." | 1.48 | KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma. ( Kitamoto, T; Nishikawa, T; Omura, M; Saito, J; Suematsu, S, 2018) |
| "Aldosterone treatment enhanced mRNA expression of genes associated with inflammation and fibrosis and stimulated differentiation of 3T3-L1 and brown preadipocytes." | 1.48 | Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma. ( Fan, C; Guan, M; Tan, W; Wang, L; Wei, Q; Wu, C; Wu, P; Xie, C; Xu, L; Xue, Y; Zhang, H; Zhang, J, 2018) |
| "In patients with primary aldosteronism (PA), adrenal venous sampling (AVS) is recommended to differentiate between unilateral (UNI) or bilateral (BIL) adrenal disease." | 1.48 | A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved. ( Evans, DB; Findling, JW; Kline, G; Liu, Y; Pasieka, JL; Rilling, W; So, B; Wang, TS; Yen, TW; Yin, Z, 2018) |
| "The Primary Aldosteronism Surgical Outcomes (PASO) group recently established new consensus definitions for biochemical and clinical cure of PA." | 1.48 | Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System. ( Auchus, RJ; Cohen, MS; Gauger, PG; Hughes, DT; Miller, BS; Nanba, AT; Turcu, AF, 2018) |
| "The diagnosis of primary aldosteronism typically requires at least one confirmatory test." | 1.48 | Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study. ( Bruemmer, D; Cheng, Q; He, W; Hu, J; Li, Q; Luo, T; Ma, L; Mei, M; Peng, B; Qing, H; Song, Y; Wang, Y; Wang, Z; Yang, S; Zhang, S; Zhen, Q, 2018) |
| "Primary aldosteronism causes hypertension and hypokalemia and is often surgically treatable." | 1.48 | Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism. ( Berber, E; Jin, J; Kahramangil, B; Krishnamurthy, V; Monteiro, R; Shin, J; Siperstein, A; Swearingen, AJ, 2018) |
| "Primary aldosteronism (PA) is associated with objectively measured lower physical fitness and blunted response of the renin-angiotensin-aldosterone system to exercise." | 1.48 | The effect of adrenalectomy on exercise response of the renin-angiotensin-aldosterone system and exercise tolerance in primary aldosteronism. ( Holaj, R; Krátká, Z; Matoulek, M; Mikeš, O; Petrák, O; Rosa, J; Štrauch, B; Tuka, V; Widimský, J; Zelinka, T, 2018) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary hypertension." | 1.48 | Prevalence of primary aldosteronism in primary care: a cross-sectional study. ( Biermans, MC; Bor, HJ; de Grauw, WJ; Deinum, J; Käyser, SC; Lenders, JW; Schalk, BW; Schermer, TR, 2018) |
| "The first discovery of primary hyperaldosteronism secondary to an aldosterone-secreting adrenal adenoma has been credited solely to Dr." | 1.48 | Who was Dr. William C. Baum? ( Ladd, MR; Zeiger, MA, 2018) |
| "Primary aldosteronism patients aged <35 years with hypokalaemia and elevation of aldosterone and unilateral disease on adrenal CT could be spared AVS." | 1.48 | Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism. ( Fujii, Y; Ichijo, T; Inagaki, N; Itoh, H; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Matsuda, Y; Miyauchi, S; Naruse, M; Ogasawara, T; Ogawa, Y; Ogo, A; Okamura, S; Otsuki, M; Shibata, H; Shibayama, Y; Sone, M; Suzuki, T; Takahashi, K; Takeda, Y; Tsuiki, M; Umakoshi, H; Wada, N; Watanabe, M; Yamamto, K; Yanase, T; Yoshimoto, T, 2018) |
| "Primary aldosteronism (PA) is the most common endocrine form of arterial hypertension." | 1.48 | Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms. ( Adolf, C; Beuschlein, F; Hahner, S; Heinrich, DA; Januszewicz, A; Nirschl, N; Quack, I; Quinkler, M; Reincke, M; Rump, LC; Seufert, J; Sturm, L; Willenberg, HS, 2018) |
| "Primary aldosteronism is affecting about 10% of hypertensive patients." | 1.48 | Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration. ( Amar, L; Azizi, M; Baffalie, L; Baron, S; Blanchard, A; Faucard, C; Faucon, AL; Houillier, P; Pagny, JY; Travers, S, 2018) |
| "Primary aldosteronism (PA) is a common form of secondary hypertension." | 1.48 | Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone? ( Athyros, VG; Doumas, M; Finitsis, S; Georgopoulou, V; Imprialos, KP; Kamparoudis, A; Karagiannis, A; Katsiki, N; Papadopoulos, C; Petidis, K; Petras, P; Stavropoulos, K, 2018) |
| "Primary aldosteronism (PA) is an increasingly identified cause of secondary hypertension." | 1.48 | Psychological Symptoms and Well-Being After Treatment for Primary Aldosteronism. ( de Nooijer, AH; Deinum, J; Jacobs, N; Nijkamp, MD; Terlouw, JM; Velema, MS, 2018) |
| "Unilateral primary aldosteronism is the most common surgically correctable form of endocrine hypertension and is usually differentiated from bilateral forms by adrenal venous sampling (AVS) or computed tomography (CT)." | 1.48 | Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism. ( Adolf, C; Baudrand, R; Bernardi, S; Beuschlein, F; Burrello, J; Catena, C; Douma, S; Doumas, M; Fallo, F; Fardella, CE; Giacchetti, G; Hahner, S; Heinrich, DA; Jansen, PM; Januszewicz, A; Kocjan, T; Matrozova, J; Mulatero, P; Nishikawa, T; Quinkler, M; Reincke, M; Saint-Hilary, G; Satoh, F; Sechi, LA; Stowasser, M; Umakoshi, H; Widimský, J; Williams, TA, 2018) |
| "Unilateral primary aldosteronism (PA) is the most common surgically curable form of hypertension that must be accurately differentiated from bilateral PA for therapeutic management (surgical versus medical)." | 1.48 | Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism. ( Beuschlein, F; Burrello, A; Burrello, J; Castellano, I; Eisenhofer, G; Fallo, F; Gomez-Sanchez, CE; Hahner, S; Kline, GA; Knösel, T; Kocjan, T; Lenders, JWM; Meyer, LS; Mulatero, P; Naruse, M; Nishikawa, T; Peitzsch, M; Reincke, M; Rump, LC; Sušnik, E; Wang, X; Williams, TA, 2018) |
| "A subtype prediction score for primary aldosteronism has not yet been developed and validated using a large dataset." | 1.48 | Development and validation of subtype prediction scores for the workup of primary aldosteronism. ( Abe, M; Fujii, Y; Ichijo, T; Inagaki, N; Itoh, H; Kamemura, K; Katabami, T; Kawashima, J; Kobayashi, H; Kurihara, I; Matsuda, Y; Nanba, K; Naruse, M; Ogawa, Y; Ogo, A; Otsuki, M; Shibata, H; Soma, M; Sone, M; Suzuki, T; Takahashi, K; Takeda, Y; Tanabe, A; Tsuiki, M; Umakoshi, H; Wada, N; Watanabe, M; Yamamoto, K; Yanase, T; Yoshimoto, T, 2018) |
| "Primary hyperaldosteronism as compared to other renin angiotensin aldosterone system disorders was found to be the leading cause of hypertension in young population." | 1.48 | Spectrum of renin angiotensin aldosterone system disorders in young hypertensives. ( Akram, A; Asif, N; Gilani, M; Ijaz, A; Malik, SS, 2018) |
| "Primary aldosteronism (PA) represents the most frequent form of endocrine hypertension." | 1.48 | Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy. ( Adolf, C; Arlt, W; Beuschlein, F; Bidlingmaier, M; Franke, A; Heinrich, DA; Köhler, A; Ladurner, R; Lang, K; Löw, A; Reincke, M; Riester, A; Treitl, M, 2018) |
| "Current threshold values for primary aldosteronism (PA) diagnostic testing are based on measuring aldosterone (PAC) using immunoassays." | 1.48 | Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism. ( Ahmed, AH; Gordon, RD; Guo, Z; McWhinney, BC; Poglitsch, M; Stowasser, M; Ungerer, JPJ; Wolley, M, 2018) |
| "Excess aldosterone causes cardiac hypertrophy, fibrosis, inflammation, and hypertension." | 1.48 | MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction. ( Ball, JP; Hall, ME; Mathis, KW; Romero, DG; Rothenberg, ME; Ryan, MJ; Syed, M; Yanes Cardozo, LL, 2018) |
| "Vascular function, including reactive hyperemia index (RIH), flow-mediated vasodilation (FMD), and nitroglycerine-induced vasodilation (NID) were evaluated in 52 patients with IHA, 53 patients with aldosterone-producing adenoma (APA), and 52 age-, sex-, and blood pressure-matched patients with essential hypertension (EHT)." | 1.48 | Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism. ( Hashimoto, H; Higashi, Y; Kajikawa, M; Kihara, Y; Kishimoto, S; Maruhashi, T; Matsui, S; Matsumoto, T; Oki, K; Yusoff, FM, 2018) |
| "Primary aldosteronism affects ≈5% to 10% of hypertensive patients and has unilateral and bilateral forms." | 1.48 | Cellular and Genetic Causes of Idiopathic Hyperaldosteronism. ( Anand, SK; Guo, Z; Ito, S; Morimoto, R; Nakamura, Y; Omata, K; Rainey, WE; Sasano, H; Satoh, F; Stowasser, M; Tomlins, SA; Yamazaki, Y, 2018) |
| "Cases of PA with malignant arrhythmia as the first symptom have been reported." | 1.48 | Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: A case report. ( Cai, Q; Li, H; Shao, D; Wang, S; Zhang, R; Zhang, Z; Zheng, Y; Zhou, S, 2018) |
| "Primary aldosteronism is a secondary hypertensive disease caused by autonomous aldosterone production that often caused by an aldosterone-producing adenoma (APA)." | 1.48 | Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions. ( Higashi, T; Kosaka, T; Mizuno, Y; Nishikawa, T; Nishimoto, K; Omura, M; Oya, M; Seki, T; Shimma, S; Suematsu, M; Sugiura, Y; Takeo, E; Yokota, M, 2018) |
| "Family hyperaldosteronism type I (glucocorticoids-remediable hyperaldosteronism) is a rare form of symptomatic arterial hypertension (AH), which often leads to the development of cerebrovascular complications." | 1.48 | Family hyperaldosteronism type I: a clinical case and review of literature. ( Chazova, IE; Chikladze, NM; Favorova, OO, 2018) |
| "Exploration showed primary hyperaldosteronism (aldosterone = 2645 pmol/l, aldosterone/renin ratio = 327 pmol/MUI), with hypersecretion of glucocorticoids." | 1.48 | [Corticosurrenaloma: an exceptional cause of primary hyperaldosteronism]. ( Alaya, W; Ammari, FL; Arfa, S; Berriche, O; Boubaker, F; Charrada, I; Elati, Z; Sfar, MH; Zantour, B, 2018) |
| "Primary aldosteronism is characterized by excess aldosterone (ALDO) secretion independent of the renin-angiotensin system and accounts for approximately 10% of hypertension cases." | 1.46 | Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats. ( Ball, JP; Hall, ME; Kc, R; Marañon, RO; Reckelhoff, JF; Romero, DG; Syed, M; Yanes Cardozo, LL, 2017) |
| "Bartter syndrome is a severe inherited tubulopathy characterized at birth by salt wasting, severe polyuria, dehydration, growth retardation and secondary hyperaldosteronism." | 1.46 | Prenatal diagnosis of Bartter syndrome: amniotic fluid aldosterone. ( Chevenne, D; Czerkiewicz, I; Deschênes, G; Dreux, S; Muller, F; Oury, JF; Pean de Ponfilly, G; Rachid, M; Vargas-Poussou, R, 2017) |
| "For evaluation of primary aldosteronism, international guidelines recommend a 4-6 week withdrawal of spironolactone, eplerenone, and amiloride prior to adrenal vein sampling (AVS)." | 1.46 | Adrenal Vein Sampling for Primary Aldosteronism: A 2-Week Protocol for Withdrawal of Renin-Stimulating Antihypertensives. ( Ching, KC; Cohen, DL; Fraker, DL; Trerotola, SO, 2017) |
| "Primary aldosteronism is a common cause of hypertension, which becomes refractory if undiagnosed, but potentially curable when caused by an aldosterone-producing adenoma (APA)." | 1.46 | Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin). ( Brown, MJ; Garg, S; Gomez-Sanchez, CE; Gurnell, M; Johnson, TI; Teo, AE; Zhao, W; Zhou, J, 2017) |
| "Aldosterone is a uniquely terrestrial hormone, first appearing in lungfish, which have both gills and lungs." | 1.46 | Aldosterone and Mineralocorticoid Receptors-Physiology and Pathophysiology. ( Funder, JW, 2017) |
| "were enrolled individuals with type 2 diabetes between February 2008 and December 2013." | 1.46 | Prevalence of primary aldosteronism among patients with type 2 diabetes. ( Dahlqvist, S; Eggertsen, R; Eliasson, B; Imberg, H; Johannsson, G; Lind, M; Lindblad, U; Tancredi, M, 2017) |
| "Primary hyperaldosteronism is a common cause of hypertension in the adult population." | 1.46 | A case of confirmed primary hyperaldosteronism diagnosed despite normal screening investigations. ( Carroll, R; Feltham, J; Gould, A; Harper, S, 2017) |
| "Functional hypoaldosteronism had appreciated in 18/29 (62%) patients, whereas 11 patients (38%) had normal postoperative aldosterone." | 1.46 | Considering Postoperative Functional Hypoaldosteronism after Unilateral Adrenalectomy. ( Christakis, I; Graham, P; Grubbs, EG; Julien, JS; Lee, JE; Perrier, ND; Schwarz, K; Starker, LF, 2017) |
| "Chronic inflammation is an age-independent and body mass index-independent contributor to the development of multi-morbidity." | 1.46 | Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry. ( Adolf, C; Grotevendt, A; Hannemann, A; Hoffmann, W; Nauck, M; Quinkler, M; Reincke, M; Rettig, R; Wallaschofski, H, 2017) |
| "The Taiwan Society of Aldosteronism (TSA) Task Force acknowledges the above-mentioned issues and reached this Taiwan PA consensus at its inaugural meeting, in order to provide updated information of internationally acceptable standards, and also to incorporate our local disease characteristics into the management of PA." | 1.46 | Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism. ( Chang, CC; Chang, CH; Chang, YL; Er, LK; Hu, YH; Jeff Chueh, SC; Lin, JH; Lin, YH; Lu, CC; Tseng, FY; Tu, ST; Wang, CY; Wang, TD; Wu, KD; Wu, VC; Yen, RF, 2017) |
| "Consecutive patients with diagnosed primary hyperaldosteronism from June 2006 to July 2012 in our center underwent adrenal surgeries without pre-operational adrenal venous sampling (AVS) if all the three criteria were met: (1) round- or oval-shaped occupational lesion of low density after contrast enhancement with diameter >1 cm on CT scan was located in one adrenal gland; (2) unequivocally normal contralateral adrenal gland; (3) serum potassium level lower than 3." | 1.46 | Favorable surgical outcomes of aldosterone-producing adenoma based on lateralization by CT imaging and hypokalemia: a non-AVS-based strategy. ( Cao, X; Feng, X; Li, H; Li, Y; Liu, J; Liu, L; Wei, G, 2017) |
| "Primary aldosteronism is recognized as a severe form of renin-independent aldosteronism that results in excessive mineralocorticoid receptor (MR) activation." | 1.46 | The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study. ( Allison, MA; Baudrand, R; Brown, JM; de Boer, IH; Ix, JH; Kestenbaum, B; Luque-Fernandez, MA; Robinson-Cohen, C; Vaidya, A, 2017) |
| "Primary hyperaldosteronism is an adrenal abnormality in which there is some degree of autonomy of aldosterone secretion." | 1.46 | Primary Hyperaldosteronism Due to Adrenocortical Adenoma: a Case Report. ( Amarwati, S; Naibaho, R; Pemayun, TGD; Santosa, A; Wiyati, MW, 2017) |
| "Aldosterone plays vital physiological roles through the mineralocorticoid receptor (MR) but in certain cell types, it can also activate the glucocorticoid (GC) receptor (GR)." | 1.46 | Primary aldosteronism patients show skin alterations and abnormal activation of glucocorticoid receptor in keratinocytes. ( Bigas, J; Boix, J; Caroccia, B; Citton, M; Iacobone, M; Pérez, P; Rossi, GP; Sevilla, LM; Torresan, F, 2017) |
| "Subclinical hypercortisolism (SH) occurs in 5% to 30% of adrenal incidentalomas (AIs)." | 1.46 | Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas. ( Annamalai, AK; Dennedy, MC; Freeman, N; Graggaber, J; Gurnell, M; Halsall, DJ; Koulouri, O; Powlson, AS; Prankerd-Smith, O; Shaw, A; Vengopal, K, 2017) |
| "A total of 62 primary aldosteronism and 56 essential hypertension patients were enrolled." | 1.46 | Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism. ( Castagna, A; Chiariello, C; Chiecchi, L; Morandini, F; Olivieri, O; Pattini, P; Pizzolo, F; Salvagno, G; Zaltron, C; Zorzi, F, 2017) |
| "Aldosterone values were significantly higher in animals carrying mutations in four different genes (Sspo, Dguok, Hoxaas2 and Clstn3) and associated statistically significant adrenal Cyp11b2 overexpression as well as increased ARR was present only in mice with Sspo mutation." | 1.46 | Genetic characterization of a mouse line with primary aldosteronism. ( Beuschlein, F; Hantel, C; Hrabě de Angelis, M; Perez-Rivas, LG; Rathkolb, B; Reincke, M; Rhayem, Y; Sabrautzki, S; Spyroglou, A, 2017) |
| "We described the prevalence of primary aldosteronism in our population before the change and, using the assumption of disease prevalence stability, determined the corresponding ratio cutoffs after the introduction of the new assay." | 1.46 | Novel Approach to Establishing an Aldosterone: Renin Ratio Cutoff for Primary Aldosteronism. ( Chin, A; Kline, GA; Leung, AA; Orton, DJ; Sadrzadeh, H, 2017) |
| "All primary aldosteronism patients were diagnosed by autonomous aldosterone secretion using confirmatory tests, and then divided into nPA (n = 130) and primary aldosteronism patients with high PAC (hPA: n = 162) using a PAC cutoff level of less than 443 pmol/l (16 ng/dl), representing the normal upper limit of PAC." | 1.46 | Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism. ( Hamasaki, T; Hashimoto, K; Hayashi, RD; Kajimoto, Y; Kitamura, T; Kouhara, H; Kurebayashi, S; Mukai, K; Murata, M; Nakao, M; Otsuki, M; Shimomura, I; Takeiri, S; Tamada, D; Yamamoto, T, 2017) |
| "Primary hyperaldosteronism (PA), known as Mb Conn, is one of the most common forms of secondary hypertension in middle-aged adults." | 1.43 | Primary hyperaldosteronism diagnosed with adrenal vein sampling. Characteristics and follow-up after adrenalectomy in a Danish study. ( Ankjærgaard, KL; Jensen, LT; Karlsen, MA; Pedersen, M, 2016) |
| "The tumor was a benign adrenocortical adenoma composed predominantly of clear cells positive for 17α-hydroxylase, [hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerases], and aldosterone synthase." | 1.43 | Extraordinarily high aldosterone, 901.0 ng/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism. ( Aizawa, T; Komatsu, M; Matsushita, T; Nakasone, Y; Nishikawa, T; Oguchi, K; Okubo, Y; Sasano, H; Sato, Y; Shirotori, K; Yamauchi, K; Yamazaki, Y, 2016) |
| "Primary hyperaldosteronism (PHA) is one of the most common endocrine forms of secondary hypertension." | 1.43 | Sodium interference in the determination of urinary aldosterone. ( Aldea, ML; Barallat, J; Granada, ML; Martín, MA; Pastor, MC; Rosas, I, 2016) |
| "Eplerenone treatment of patients with PA reduces blood pressure, increases serum potassium level, and improves vascular status." | 1.43 | Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism. ( Anzai, K; Kawate, H; Matsuda, Y; Matsuzaki, C; Nomura, M; Ohnaka, K; Sakamoto, R; Shibue, K; Takayanagi, R, 2016) |
| "Of the six adrenocortical adenomas with CYP11B2 heterogeneity, three had aldosterone-regulating mutations (CACNA1D p." | 1.43 | Molecular Heterogeneity in Aldosterone-Producing Adenomas. ( Chen, AX; Else, T; Giordano, TJ; Hammer, GD; Nanba, K; Omata, K; Rainey, WE; Tomlins, SA; Vinco, M, 2016) |
| "Aldosterone excess can cause DNA damage in vitro and in vivo." | 1.43 | Prevalence of Malignancies in Patients With Primary Aldosteronism. ( Allolio, B; Dietz, AS; Friedrichs, N; Fuss, CT; Hahner, S; Hannemann, A; Heinze, B; Lang, K; Quack, I; Quinkler, M; Reincke, M; Rump, LC; Wallaschofski, H; Weber, K; Willenberg, HS, 2016) |
| " The aim of this study was to investigate whether or not the effect of β-blocker therapy on the ARR could be predicted from the dosing regimen." | 1.43 | A cross-sectional study of the effects of β-blocker therapy on the interpretation of the aldosterone/renin ratio: can dosing regimen predict effect? ( Browne, GA; Dennedy, MC; Griffin, TP; OʼShea, PM; Wall, D, 2016) |
| "Primary aldosteronism is one of the most common forms of secondary hypertension, but it is often under diagnosed, which leads to the development of cardiovascular damage, and excess costs for long-term drug treatment and management of complications." | 1.43 | The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism. ( Bisogni, V; Rossi, GP, 2016) |
| "Primary aldosteronism not only results in hypertension but also stiffer arteries." | 1.43 | Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients. ( Chang, YY; Ho, YL; Hung, CS; Liao, CW; Lin, LY; Lin, YH; Lin, YT; Satoh, F; Wang, SM; Wu, KD; Wu, VC, 2016) |
| "KCNMB2(-/-) mice displayed hyperaldosteronism, normal plasma K(+) concentration, and produced dilute urine with decreased K(+) concentration." | 1.43 | Hyperaldosteronism after decreased renal K+ excretion in KCNMB2 knockout mice. ( Bleich, M; de Bruijn, PI; Jensen, IS; Larsen, CK; Leipziger, J; Praetorius, HA; Sorensen, MV, 2016) |
| "Primary aldosteronism (PA) is associated with increased cardiovascular risk and left ventricle (LV) changes." | 1.43 | Epicardial Fat Thickness and Primary Aldosteronism. ( Calvieri, C; Concistrè, A; De Toma, G; Iacobellis, G; Iannucci, G; Letizia, C; Marinelli, C; Petramala, L; Zinnamosca, L, 2016) |
| "Treatment with spironolactone inhibited Akt/AS160 phosphorylation, reduced Rab-dependent Kv1." | 1.43 | Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice. ( Buschmeyer, B; Koehncke, C; Lisewski, U; Pieske, B; Roepke, TK; Wilck, N, 2016) |
| "Normotensive hyperaldosteronism is a rare disorder." | 1.43 | A Woman with Normotensive Primary Hyperaldosteronism. ( Amirbaigloo, A; Moradi, S; Shafiepour, M, 2016) |
| "Of the two of 20 primary aldosteronism patients missed by AARR, none resulted affected by APA." | 1.43 | Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. ( Buffolo, F; Burrello, J; Lucchiari, M; Mengozzi, G; Monticone, S; Mulatero, P; Rabbia, F; Tetti, M; Veglio, F; Williams, TA, 2016) |
| "To establish the cause of primary aldosteronism (PA), it is essential to distinguish unilateral from bilateral adrenal aldosterone secretion, as adrenalectomy improves aldosterone secretion and controls hypertension and hypokalemia only in the former." | 1.43 | SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis. ( Bardet, S; Chamontin, B; Douillard, C; Hernigou, A; Joffre, F; Pagny, JY; Plouin, PF; Steichen, O, 2016) |
| "Primary aldosteronism (PA) is the most common cause of endocrine hypertension that is diagnosed following a two-step process: an initial screening test, based on the serum aldosterone-to-renin ratio (ARR), followed by a relatively laborious and time-consuming confirmatory test to document autonomous aldosterone (ALD) secretion." | 1.43 | A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism. ( Androulakis, II; Chrousos, GP; Kaltsas, G; Kassi, E; Kounadi, T; Markou, A; Papanastasiou, L; Piaditis, GP; Tsiavos, V; Voulgaris, N; Zachaki, A, 2016) |
| "Primary aldosteronism (PA) is one of the most frequent forms of secondary hypertension, associated with atherosclerosis and higher risk of cardiovascular events." | 1.43 | Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism. ( Carnevale, R; Ciardi, A; Concistrè, A; De Toma, G; Galassi, M; Iacobellis, G; Iannucci, G; Letizia, C; Lucia, P; Marinelli, C; Petramala, L; Pignatelli, P; Violi, F; Zinnamosca, L, 2016) |
| "In patients with primary aldosteronism, plasma TIMP-1 was correlated with 24-hour urinary aldosterone, left ventricular mass, and impairment of left ventricular diastolic function." | 1.43 | Aldosterone Induces Tissue Inhibitor of Metalloproteinases-1 Expression and Further Contributes to Collagen Accumulation: From Clinical to Bench Studies. ( Chang, YY; Chen, MF; Chen, YH; Chou, CH; Ho, YL; Hung, CS; Liao, CW; Lin, YH; Lin, YT; Su, MJ; Wu, KD; Wu, VC; Wu, XM, 2016) |
| "In patients with suspected primary aldosteronism (PA), the first diagnostic step, screening, must have high sensitivity and negative predictive value." | 1.43 | SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps. ( Douillard, C; Girerd, X; Houillier, P; Nussberger, J, 2016) |
| "Aldosterone/renin ratio was elevated in 99 patients of whom 31 exhibited elevated supine aldosterone, as well." | 1.43 | [Renin and aldosterone determinations in hypertensive patients]. ( Bajnok, L; Bódis, B; Hussein, T; Mezősi, E; Nemes, O; Rucz, K, 2016) |
| "In older patients, primary aldosteronism, obstructive sleep apnoea and renal artery stenosis are more prevalent than previously thought." | 1.43 | Secondary hypertension in adults. ( Debajyoti, R; How, CH; Khoo, J; Mok, Y; Ng, AK; Puar, TH, 2016) |
| "Primary aldosteronism was confirmed by using the oral sodium-loading test." | 1.43 | Aldosterone-producing Adenoma in Primary Aldosteronism: CT-guided Radiofrequency Ablation-Long-term Results and Recurrence Rate. ( Chiu, PW; Chow, FC; Chu, CC; Kong, AP; Liu, SY; Ng, EK; Tsui, TK; Wong, SK, 2016) |
| "To investigate the diagnostic value of plasma aldosterone-to-active-renin ratio(ARR)in combination with plasma aldosterone concentration(PAC)in the predication of aldosteronoma(APA)." | 1.43 | [An evaluation of plasma aldosterone-to-active-renin ratio in different postures in combination with aldosterone concentration in the diagnosis of aldosteronoma]. ( Ba, JM; Dou, JT; Gu, WJ; Guo, QH; Jin, N; Lyu, ZH; Mu, YM; Wang, XL; Yang, GQ; Yang, LJ; Zang, L; Zhu, J, 2016) |
| "Primary aldosteronism (PA) causes excess left ventricular (LV) hypertrophy and diastolic dysfunction; whether this occurs also in secondary aldosteronism (SA) without hypertension is unknown." | 1.43 | Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study. ( Angeli, P; Cesari, M; Letizia, C; Rosi, S; Rossi, GP; Sciomer, S, 2016) |
| "Aldosterone, which plays a key role in maintaining water and electrolyte balance, is produced by zona glomerulosa cells of the adrenal cortex." | 1.43 | Small-Conductance Ca2+-Activated Potassium Channels Negatively Regulate Aldosterone Secretion in Human Adrenocortical Cells. ( Barrett, PQ; Hu, C; Liang, Q; Mei, YA; Shi, Y; Yang, T; Zhang, HL, 2016) |
| "In the diagnosis for primary aldosteronism, the measurement of urinary aldosterone is part of the confirmation test but diagnostic accuracy may be blunted due to poor immunoassay performance for urinary aldosterone." | 1.43 | Determination of urinary aldosterone using a plasma aldosterone 2D ID LC-MS/MS method. ( Ackermans, MT; Bekkach, Y; Endert, E; Heijboer, AC, 2016) |
| "Hypertension was resolved less frequently after treatment with RFA compared with laparoscopic adrenalectomy (13 of 36 versus 19 of 27 patients; P = 0·007)." | 1.43 | Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma. ( Chiu, PW; Chow, FC; Chu, CM; Kong, AP; Liu, SY; Ng, EK; Wong, SK, 2016) |
| "Prospective studies indicate that hyperaldosteronism is found in 20% of patients with resistant hypertension." | 1.43 | Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension. ( Calhoun, DA; Dudenbostel, T; Ghazi, L; Li, P; Liu, M; Oparil, S, 2016) |
| "Primary aldosteronism (PA), the most common form of secondary hypertension, causes relevant morbidity." | 1.43 | The Clinical Value of Salivary Aldosterone in Diagnosis and Follow-Up of Primary Aldosteronism. ( Asbach, E; Bidlingmaier, M; Fourkiotis, V; Gerum, S; Lichtenauer, UD; Manolopoulou, J; Quinkler, M; Reincke, M, 2016) |
| "Patients with hypertension and hyperaldosteronism show an increased risk of stroke compared with patients with essential hypertension." | 1.43 | Hyperaldosteronism induces left atrial systolic and diastolic dysfunction. ( Böhm, M; Hohl, M; Kaestner, L; Linz, D; Lipp, P; Neuberger, HR; Oberhofer, M; Reil, GH; Reil, JC; Steendijk, P; Tauchnitz, M; Thiele, H; Tian, Q, 2016) |
| "Hypertension is the prime risk factor for stroke, and primary aldosteronism (PA) is the most common cause of secondary hypertension." | 1.43 | Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization. ( Joki, H; Kamide, T; Kawabata, Y; Kitamura, Y; Minami, T; Miyaji, Y; Mori, K; Nakaguchi, H; Nomura, M; Sasaki, M; Seki, S; Shima, H; Tamase, A; Tanaka, F; Tsunoda, T; Yamada, M, 2016) |
| "In our series of patients with primary aldosteronism, we compared diagnostic concordance and clinical outcomes after adrenalectomy between adrenal venous sampling (AVS) and computed tomography (CT) imaging." | 1.43 | Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy. ( Chu, S; Gao, P; Lu, X; Shen, Z; Tang, X; Tao, B; Wang, JG; Xu, J; Zhang, H; Zhang, J; Zhang, Y; Zheng, F; Zhou, W; Zhu, D; Zhu, L, 2016) |
| "Primary aldosteronism is present in ≈10% of hypertensives." | 1.43 | Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues. ( Azizan, EA; Brown, MJ; Lam, B; Neogi, SG; Yeo, GS; Zhou, J, 2016) |
| "To determine the prevalence of primary aldosteronism (PA) in hypertensive patients presenting to the primary care clinic at The Mount Sinai Hospital, regardless of the degree of hypertension and to identify clinical criteria that should prompt screening for PA." | 1.43 | PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION. ( Amer, C; Bagiella, E; Boyajian, MK; Cheesman, KC; Galati, SJ; Hopkins, SM; Inabnet, WB; Krakoff, L; Levine, AC; Springer-Miller, R; Ying, TK; Zhuk, RA, 2016) |
| "The diagnosis of primary aldosteronism (PA) among the older-aged population has posed a crucial challenge." | 1.42 | The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old. ( Balakrishnan, P; Chen, YM; Chueh, SC; Hsein, YC; Kuo, CC; Wang, MJ; Wu, KD; Wu, VC, 2015) |
| "Primary aldosteronism (PA) is estimated to occur in 5-12% of patients with hypertension." | 1.42 | The ratios of aldosterone / plasma renin activity (ARR) versus aldosterone / direct renin concentration (ADRR). ( Bednarek-Papierska, L; Gietka-Czernel, M; Glinicki, P; Jeske, W; Kasperlik-Załuska, A; Kruszyńska, A; Rosłonowska, E; Słowińska-Srzednicka, J; Zgliczyński, W, 2015) |
| "Primary aldosteronism could exert a negative feedback on prorenin secretion, of possibly different magnitude, whether it is related to an aldosterone-producing adenoma (APA) or an idiopathic hyperaldosteronism (IHA)." | 1.42 | Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications. ( Berge, C; Bricca, G; Courand, PY; Fauvel, JP; Harbaoui, B; Khettab, F; Lantelme, P; Paget, V, 2015) |
| "Hypertension was improved in 97% and normalized in 38%." | 1.42 | Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy. ( Calissendorff, J; Hamberger, B; Höög, A; Mukai, K; Thorén, M; Volpe, C; Wahrenberg, H; Zedenius, J, 2015) |
| "Unilateral primary aldosteronism (PA) should have a contralaterally normal and therefore suppressed adrenal zona glomerulosa." | 1.42 | Defining contralateral adrenal suppression in primary aldosteronism: implications for diagnosis and outcome. ( Chin, A; Harvey, A; Kline, GA; Pasieka, JL; So, B, 2015) |
| "Aldosterone levels were compared to those in age-matched males undergoing FST." | 1.42 | Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study. ( Ahmed, AH; Gordon, RD; Kogovsek, C; Stowasser, M; Ward, G; Wolley, M, 2015) |
| "In primary aldosteronism (PA), adrenal vein sampling (AVS) distinguishes unilateral and bilateral disease by comparison of aldosterone/cortisol (A/F) ratios." | 1.42 | Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. ( Ahmed, AH; Gordon, RD; Stowasser, M; Wolley, MJ, 2015) |
| "If detected in patients with primary aldosteronism could implicate prorenin in the development of primary aldosteronism." | 1.42 | Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism. ( Belloni, AS; Caroccia, B; Ceolotto, G; Gonzales-Campos, A; Lenzini, L; Nussberger, J; Petrelli, L; Rainey, WE; Recarti, C; Rossi, GP; Seccia, TM, 2015) |
| "Primary aldosteronism is the most frequent endocrine cause of secondary hypertension." | 1.42 | Primary aldosteronism and its various clinical scenarios. ( Abad-Cardiel, M; Alvarez-Alvarez, B; García-Donaire, JA; Martell-Claros, N; Pérez, CF, 2015) |
| "Resistant hypertension is common, mainly idiopathic, but sometimes related to primary aldosteronism." | 1.42 | Reliability of a Bayesian network to predict an elevated aldosterone-to-renin ratio. ( Baguet, JP; Ducher, M; Fauvel, JP; Lantelme, P; Mounier-Véhier, C; Vaisse, B, 2015) |
| "Primary aldosteronism (PA) is present in up to 20% of patients with treatment-resistant hypertension (TRH)." | 1.42 | Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension. ( Arbique, D; Brinker, S; Chung, O; Das, SR; Lotan, Y; Pandey, A; Price, A; Raza, F; Velasco, A; Vongpatanasin, W, 2015) |
| "Although primary aldosteronism is associated with more prominent cardiac remodeling and diastolic dysfunction, the reversibility of diastolic function is unclear." | 1.42 | Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction. ( Chang, YS; Chang, YY; Chen, MF; Chen, YH; Chou, CH; Ho, YL; Hung, CS; Lin, YH; Su, MJ; Tsai, YC; Wu, KD; Wu, VC; Wu, XM, 2015) |
| "Primary hyperaldosteronism is a common cause of hypertension, with significant cardiovascular, renal, and metabolic sequelae." | 1.42 | Incidental and Intentional Medicine Achieve Similar Results in Primary Hyperaldosteronism. ( Fraker, DL; Kelz, RR; Kuo, LE; Roses, RE; Wachtel, H, 2015) |
| "Primary aldosteronism (PA) is characterized by the autonomous overproduction of aldosterone." | 1.42 | Screening for primary aldosteronism in an argentinian population: a multicenter prospective study. ( Belli, SH; Chervin, RA; Contreras, LN; Cornaló, D; Costa, L; Damilano, SA; Fenili, CA; Gómez, RM; Leal Reyna, M; Lupi, SN; Martínez, MS; Nofal, MT; Pardes, EM; Rossi, MA; Ruibal, GF, 2015) |
| "Primary aldosteronism (PA) represents the most common cause of secondary hypertension, but little is known regarding its adrenal cellular origins." | 1.42 | Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. ( Cani, AK; Edwards, MA; Giordano, TJ; Gomez-Sanchez, CE; Hovelson, DH; Kuick, R; Liu, CJ; Nanba, K; Nishimoto, K; Rainey, WE; Sanjanwala, AR; Tomlins, SA, 2015) |
| "Primary aldosteronism affects 6% of hypertensive patients." | 1.42 | [Primary aldosteronism]. ( Amar, L, 2015) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 1.42 | Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma. ( Amar, L; Boulkroun, S; Fernandes-Rosa, FL; Giscos-Douriez, I; Gomez-Sanchez, CE; Meatchi, T; Zennaro, MC, 2015) |
| "Aldosterone suppression was assessed in 73 essential hypertensive and 46 primary aldosteronism patients." | 1.42 | Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. ( Bidlingmaier, M; Diederich, S; Dietz, A; Fischer, E; Grimminger, P; Holmes, D; Junnila, R; Manolopoulou, J; Morganti, A; Reincke, M, 2015) |
| "Aldosterone is a mineralocorticoid steroid hormone, the measurement of which in the clinical laboratory is principally performed for the investigation of primary hyperaldosteronism." | 1.42 | Measurement of serum aldosterone in picomolar level by LC-MS/MS using charge-tagged technique. ( Fong, BM; Siu, TS; Tam, S, 2015) |
| "Here we describe three women with hyperaldosteronism, two who presented in pregnancy and one who presented after menopause." | 1.42 | Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations. ( Azizan, EA; Bienz, M; Brown, MJ; Garg, S; Gurnell, M; Happerfield, L; Karet Frankl, FE; Marker, A; Shaikh, LH; Teo, AE; Zhou, J, 2015) |
| "Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well-known manifestation of hypokalemia." | 1.42 | Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism. ( Concistrè, A; Fiacco, F; Letizia, C; Marinelli, C; Mitterhofer, AP; Petramala, L; Tinti, F; Umbro, I; Zavatto, A; Zingaretti, V, 2015) |
| "Primary aldosteronism is the cause of hypertension in 5-10% of the hypertensive population." | 1.42 | [The importance of adrenal vein sampling in primary aldosteronism. Necessary examination for many patients as computed tomography can lead to errors]. ( Johannsson, G; Muth, A; Ragnarsson, O; Sakinis, A; Wängberg, B, 2015) |
| "Primary aldosteronism (PA) is the most frequent form of secondary hypertension, but diagnostic tools for this disease still lack optimal accuracy." | 1.40 | NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. ( Aprili, I; Castagna, A; Chiecchi, L; Consoli, L; Guarini, P; Olivieri, O; Pavan, C; Pizzolo, F; Salvagno, GL; Zorzi, F, 2014) |
| "The prevalence of primary aldosteronism was 15." | 1.40 | Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism. ( Danser, AH; de Bruijne, EL; Deinum, J; Frenkel, WJ; Jansen, PM; Kerstens, MN; Smulders, YM; van den Born, BJ; van den Meiracker, AH; Wijbenga, JA; Woittiez, AJ; Zietse, R, 2014) |
| "Primary aldosteronism (PA, also Conn syndrome) is a benign disease in majority of cases." | 1.40 | Predictors of malignancy in primary aldosteronism. ( Agha, A; Haneya, A; Hornung, M; Iesalnieks, I; Jung, EM; Schlitt, HJ; Schreyer, A, 2014) |
| "Primary aldosteronism (PA) is the main cause of secondary hypertension, resulting from adrenal aldosterone-producing adenomas (APA) or bilateral hyperplasia." | 1.40 | WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. ( Amar, L; Assié, G; Batisse-Lignier, M; Bertherat, J; Berthon, A; Boulkroun, S; Drelon, C; Lefèbvre, H; Lefrançois-Martinez, AM; Martinez, A; Plateroti, M; Plouin, PF; Ragazzon, B; Sahut-Barnola, I; Samson-Couterie, B; Skah, S; Tissier, F; Val, P; Zennaro, MC, 2014) |
| "sPRR in patients with primary aldosteronism (low renin-low prorenin) and Gitelman syndrome (high renin-high prorenin) were similar and ≈10% higher than in healthy subjects." | 1.40 | Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity. ( Azizi, M; Baron, S; Bergerot, D; Blanchard, A; Caumont-Prim, A; Chambon, Y; Curis, E; Frank, M; Hirose, T; Nguyen, G; Tabard, SB; Totsune, K, 2014) |
| "In patients with primary aldosteronism (PA), adrenalectomy is potentially curative for those correctly identified as having unilateral excessive aldosterone production." | 1.40 | Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling. ( Akker, SA; Berney, D; Carpenter, R; Chew, SL; Drake, WM; Druce, MR; Grossman, AB; Lau, JH; Matson, M; Monson, JP; Reznek, R; Riddoch, F; Sahdev, A; Soh, LM; Sze, WC; Waterhouse, M, 2014) |
| "The molecular mechanisms of primary aldosteronism, a common cause of human hypertension, are unknown, but alterations of K(+) channels can play a key role." | 1.40 | Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism. ( Bader, M; Belloni, AS; Campos, AG; Caroccia, B; Fassina, A; Ferraro, S; Kuppusamy, M; Lenzini, L; Rainey, WE; Rossi, GP; Seccia, TM; Skander, G, 2014) |
| "Aldosterone may increase in luteotropic/progestogenic and in hypothyroid states; LH and, occasionally, TSH receptors have been detected in normal adrenal cortex and aldosterone-producing adenoma." | 1.40 | LH, progesterone, and TSH can stimulate aldosterone in vitro: a study on normal adrenal cortex and aldosterone producing adenoma. ( Balzan, S; Fommei, E; Iacconi, P; Morelli, L; Nicolini, G; Ripoli, A; Sabatino, L, 2014) |
| "Primary aldosteronism (autonomous aldosterone production with suppressed renin) plays an important pathophysiological role in what has been previously labeled as essential hypertension." | 1.40 | Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism. ( Gordon, RD; Massimo, G; Murthy, M; O'Shaughnessy, KM; Stowasser, M; Wolley, M; Xu, S, 2014) |
| "In 10 patients with primary aldosteronism, median supine ARRP was 298 (range 48-1222) and ARRD 34 (range 2." | 1.40 | Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension. ( Bassani, N; Biganzoli, E; Gritti, A; Lonati, C; Morganti, A, 2014) |
| "Hypertension was cured in 24 cases (38 %), and 28 patients (45 %) showed improvement with a reduction in AM." | 1.40 | Is adrenal venous sampling mandatory before surgical decision in case of primary hyperaldosteronism? ( Baguet, JP; Chabre, O; Chaffanjon, P; Naem, N; Pirvu, A; Thony, F, 2014) |
| "A correct diagnosis of primary aldosteronism (PA) requires adrenal venous sampling (AVS) for the classification of subtypes (bilateral hyperplasia, BAH, or adenoma, APA)." | 1.40 | Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma. ( Brazzarola, P; Castagna, A; Cecconi, D; Chiecchi, L; D'Alessandro, A; Guarini, P; Gunasekaran, M; Morandini, F; Mulatero, P; Olivieri, O; Pizzolo, F; Veglio, F; Zolla, L, 2014) |
| "Primary aldosteronism (PA), the most frequent form of secondary hypertension, is characterized by a higher rate of cardiovascular (CV) events than essential hypertension (EH)." | 1.40 | Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. ( Boscaro, M; Ceccoli, L; di Tizio, V; Giacchetti, G; Ronconi, V; Turchi, F, 2014) |
| "Primary aldosteronism (PA) is the most common cause of endocrine hypertension." | 1.40 | A subtype prediction score for primary aldosteronism. ( Hirokawa, Y; Nakao, K; Nanba, A; Nanba, K; Naruse, M; Okuno, H; Shimatsu, A; Shimbo, T; Suzuki, T; Tagami, T; Tsuiki, M; Usui, T, 2014) |
| "From 257 consecutive primary aldosteronism patients, we identified 176 who had both a diagnosis of APA by the 'four corners' criteria and high-quality echocardiographic data." | 1.40 | KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. ( Cesari, M; Cicala, MV; Iacobone, M; Kuppusamy, M; Letizia, C; Mantero, F; Mareso, S; Pessina, AC; Rossi, GP; Sciomer, S; Seccia, TM; Zinnamosca, L, 2014) |
| "When diagnosing primary aldosteronism, the measurement of urinary aldosterone after oral sodium loading is one of the currently recommended confirmatory tests." | 1.40 | The role of urinary aldosterone for the diagnosis of primary aldosteronism. ( Ballon, M; Ceral, J; Malirova, E; Solar, M, 2014) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 1.40 | Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. ( Allolio, B; Amar, L; Bernini, G; Beuschlein, F; Boulkroun, S; Cicala, MV; Fallo, F; Fernandes-Rosa, FL; Giacchetti, G; Jeunemaitre, X; Maccario, M; Mantero, F; Meatchi, T; Monticone, S; Mulatero, P; Quinkler, M; Reincke, M; Riester, A; Steichen, O; Strom, TM; Williams, TA; Zennaro, MC, 2014) |
| "The prevalence of primary aldosteronism (PA) in hypertensive patients varies according to diagnostic testing and ascertained normal cut-offs." | 1.40 | Primary aldosteronism in hypertensive patients: clinical implications and target therapy. ( Chrousos, G; Dasou, A; Fountoulakis, S; Gouli, A; Gryparis, A; Kaltsas, G; Kounadi, T; Markou, A; Papanastasiou, L; Pappa, T; Piaditis, G; Samara, C; Tsiama, V; Tsounas, P; Zografos, G, 2014) |
| "Primary aldosteronism, an important form of secondary hypertension, is associated with significant increase of cardiovascular risk (ischaemic heart, cerebrovascular events, arrhythmias) (relative risk 4." | 1.40 | Oxidative stress in patients affected by primary aldosteronism. ( Carnevale, R; Concistrè, A; De Toma, G; Letizia, C; Marinelli, C; Petramala, L; Pignatelli, P; Settevendemmie, A; Tonnarini, G; Violi, F; Zinnamosca, L, 2014) |
| "The impact of 4HCH on the hyperaldosteronism, inflammation, and kidney injury provides new insights for future development of therapeutic strategies in resistant hypertension." | 1.40 | 4-Hydroxychalcone attenuates hyperaldosteronism, inflammation, and renal injury in cryptochrome-null mice. ( Dai, B; Li, X; Liu, Y; Qu, Q; Yang, B; Zhang, F, 2014) |
| "The patient was diagnosed with primary aldosteronism (PA) based on typical clinical findings." | 1.40 | Deoxycorticosterone-producing adenoma concomitant with aldosterone-producing microadenoma: a challenging combination. ( Ando, T; Horie, I; Kawakami, A; Nozaki, A; Oyama, K; Shigematsu, K; Takehara, K, 2014) |
| "Primary aldosteronism (PA) is common in young or middle-aged hypertensive patients, but PA among the elderly has recently become more common." | 1.40 | The influence of aging on the diagnosis of primary aldosteronism. ( Hongyo, K; Ito, N; Kamide, K; Kawai, T; Nakama, C; Onishi, M; Rakugi, H; Sugimoto, K; Takeya, Y; Yamamoto, K, 2014) |
| "Patients with primary aldosteronism are associated with increased myocardial fibrosis." | 1.40 | Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans. ( Chang, YY; Chen, YH; Chou, CH; Ho, YL; Hsieh, FJ; Hung, CS; Lin, YH; Tzeng, YL; Wu, KD; Wu, VC; Wu, XM, 2014) |
| "Sensitivity and specificity were calculated for clinical prediction score of ≥5 points." | 1.40 | A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable. ( Dias, VC; Harvey, A; Kline, GA; Pasieka, JL; So, B; Venos, ES, 2014) |
| "Although primary aldosteronism (PA) is the most common cause of endocrine hypertension, histopathological methods to reveal the presence and sites of aldosterone overproduction remain to be established." | 1.39 | Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. ( Katabami, T; Kawa, G; Mukai, K; Nanba, K; Naruse, M; Nishimoto, K; Okumura, A; Okuno, H; Sawai, K; Shimatsu, A; Tagami, T; Tanabe, A; Tsuiki, M; Usui, T; Yamamoto, T, 2013) |
| "In primary aldosteronism (PA), lateralized aldosterone excess can be treated with aldosterone antagonists or surgery, which raises the question as to whether surgery or medications should be the preferred management." | 1.39 | Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes. ( Dias, VC; Harvey, A; Kline, GA; Pasieka, JL; So, B, 2013) |
| "Aldosterone excess has a direct negative effect on β-cell function in patients with PA." | 1.39 | Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. ( Adolf, C; Beuschlein, F; Bidlingmaier, M; Fischer, E; Pallauf, A; Reincke, M; Seissler, J; Then, C, 2013) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary arterial hypertension." | 1.39 | Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry. ( Bidlingmaier, M; Fischer, E; Hahner, S; Quinkler, M; Reincke, M; Reuschl, S; Rump, LC, 2013) |
| "Hypertension is a frequent complication of type 2 diabetes mellitus (DM) because of the close etiological relationship between these two diseases." | 1.39 | Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension. ( Akehi, Y; Murase, K; Nagaishi, R; Nomiyama, T; Takenoshita, H; Yanase, T, 2013) |
| "Aldosterone values were adjusted statistically for age, sex, and the urinary sodium/creatinine ratio." | 1.39 | Bimodal aldosterone distribution in low-renin hypertension. ( Adlin, EV; Braitman, LE; Vasan, RS, 2013) |
| "Primary aldosteronism (PA) is the most common etiology of endocrine hypertension (HTN), and recent prevalence studies suggest that it may be under-diagnosed." | 1.39 | Primary aldosteronism: emerging trends. ( Cheesman, KC; Galati, SJ; Hopkins, SM; Levine, AC; Zhuk, RA, 2013) |
| "Insulin sensitivity was determined by hyperinsulinemic-euglycemic clamps and two-dimensional echocardiograms were used to evaluate cardiac function." | 1.39 | Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet. ( Aroor, AR; DeMarco, VG; Garro, M; Habibi, J; Hayden, MR; Manrique, C; Mugerfeld, I; Sowers, JR, 2013) |
| "Familial hyperaldosteronism type I (FH-I) is caused by the unequal recombination between the 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes, resulting in the generation of a CYP11B1/B2 chimeric gene and abnormal adrenal aldosterone production." | 1.39 | Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro. ( Allende, F; Campino, C; Carvajal, CA; Fardella, CE; Fuentes, CA; Lagos, CF; Mukai, K; Ogishima, T; Owen, G; Solari, S; Tapia-Castillo, A; Valdivia, C; Vecchiola, A, 2013) |
| "In primary aldosteronism, adrenal vein sampling (AVS) suggests unilateral aldosterone-producing adenoma (APA) when the aldosterone/cortisol (A/F) ratio is less than or equal to peripheral on one side and at least two times peripheral on the other." | 1.39 | Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma. ( Ahmed, AH; Daunt, N; Gordon, RD; Pimenta, E; Slater, GJ; Stowasser, M; Wolley, M, 2013) |
| "In assumption about presence of primary hyperaldosteronism the blood from the adrenal veins ostium were taken selectively." | 1.39 | [Diagnosis and treatment of patients with benign formations of the adrenal cortex]. ( Podluzhnyĭ, AA, 2013) |
| "Primary aldosteronism (PA) is the most common endocrine form of hypertension and may carry an increased risk of atrial flutter or fibrillation (AFF)." | 1.39 | Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design. ( Belfiore, A; Bernini, G; Caielli, P; Cipollone, F; Cottone, S; Ferri, C; Gallina, V; Giacchetti, G; Grassi, G; Leoni, L; Letizia, C; Maccario, M; Mantero, F; Morganti, A; Muiesan, ML; Olivieri, O; Palumbo, G; Pengo, M; Pessina, AC; Ragazzo, F; Rizzoni, D; Rossi, E; Rossi, GP; Seccia, TM; Sechi, L; Volpe, M, 2013) |
| "Primary hyperaldosteronism is most commonly due to a solitary cortical adenoma." | 1.39 | Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism. ( Abraham, SB; Barak, S; Kebebew, E; Mathur, A; Nilubol, N; Quezado, M; Stratakis, CA; Webb, RC; Weisbrod, AB, 2013) |
| "Hyperaldosteronism has emerged as a promoter of pulmonary vascular disease in experimental animal models of PAH; however, the extent to which hyperaldosteronism is associated with PAH in patients is unknown." | 1.39 | Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. ( Landzberg, MJ; Leopold, JA; Loscalzo, J; Maron, BA; Opotowsky, AR; Waxman, AB, 2013) |
| "Primary aldosteronism (PA) is a common cause of secondary hypertension but the reported prevalence varies." | 1.39 | Screening for primary aldosteronism in a primary care unit. ( Hamberger, B; Thorén, M; Volpe, C; Wahrenberg, H, 2013) |
| "Primary hyperaldosteronism is the most common cause of secondary hypertension." | 1.39 | Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk. ( Abad-Cardiel, M; Alvarez-Álvarez, B; Fernández, C; Fernández-Cruz, A; Luque-Fernandez, L; Martell-Claros, N, 2013) |
| "Aldosterone is a mineralocorticoid steroid hormone whose measurement in the clinical laboratory is principally performed for the investigation of primary hyperaldosteronism." | 1.39 | Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry. ( Carter, S; Hinchliffe, E; Keevil, BG; Owen, LJ, 2013) |
| "Hyperaldosteronism was defined as a plasma renin activity of < 1 ng/mL/h and urinary aldosterone level of ≥ 12 μg/24 h." | 1.39 | Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. ( Batlouni, M; Calhoun, DA; Gordon, RD; Harding, SM; Oparil, S; Pimenta, E; Stowasser, M; Zhang, B, 2013) |
| "In most cases of primary aldosteronism (PA), An adrenal aldosterone-secreting tumor cannot be reasonably proven, so these patients undergo medical treatment." | 1.39 | Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion. ( Benso, A; Capello, E; Caprino, MP; Ghigo, E; Lucatello, B; Maccario, M; Marafetti, L; Oleandri, SE; Rossato, D; Tabaro, I, 2013) |
| "Primary aldosteronism was the most common form of endocrine hypertension resulting in hypertension, metabolic alkalosis, and hypokalemia." | 1.38 | Torsade de pointes--a rare presentation of primary hyperaldosteronism. ( Chen, KS; Huang, CN; Kornelius, E; Yang, YS, 2012) |
| "Aldosterone treatment induced an anhedonic state manifested by decreased sucrose preference." | 1.38 | Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. ( Babic, S; Flynn, ME; Hlavacova, N; Jezova, D; Murck, H; Ondrejcakova, M; Poundstone, PK; Wes, PD, 2012) |
| "We conclude that primary aldosteronism may exacerbate the clinical course of autoimmune thyroiditis and probably also of other autoimmune disorders." | 1.38 | Coexistence of primary aldosteronism and Hashimoto's thyroiditis. ( Krysiak, R; Okopien, B, 2012) |
| "Hyperaldosteronism is associated with an increased prevalence of atrial fibrillation (AF)." | 1.38 | Aldosterone promotes atrial fibrillation. ( Allessie, MA; Böhm, M; Drautz, F; Hohl, M; Kazakow, A; Lipp, P; Müller, P; Münz, BM; Neuberger, HR; Reil, GH; Reil, JC; Selejan, S; Steendijk, P, 2012) |
| "In primary aldosteronism (PA), discriminating unilateral from bilateral disease is crucial because adrenalectomy is frequently curative in the former case but rarely helps in the latter." | 1.38 | A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism. ( Akker, SA; Berney, DM; Carpenter, R; Chew, SL; Drake, WM; Grossman, AB; Lau, JH; Matson, M; Monson, JP; Reznek, RH; Sahdev, A; Sze, WC, 2012) |
| "She was diagnosed with combined primary hyperaldosteronism and Cushing's syndrome." | 1.38 | Combined aldosterone and cortisol secretion by adrenal incidentaloma. ( di Dalmazi, G; Giampalma, E; Golfieri, R; Marrano, N; Minni, F; Pasquali, R; Repaci, A; Rinaldi, E; Santini, D; Vicennati, V, 2012) |
| "Familial hyperaldosteronism type I is caused by an unequal crossover of 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes, giving rise to a chimeric CYP11B1/CYP11B2 gene (CG)." | 1.38 | A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern. ( Aglony, M; Bancalari, R; Baudrand, R; Campino, C; Carvajal, CA; Fardella, CE; Garcia, H; Lagos, CF; Martinez-Aguayo, A; Mellado, C; Tichauer, JE; Trejo, P; Valdivia, C, 2012) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary hypertension, and is associated with more prominent vascular stiffness and atherosclerosis." | 1.38 | Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. ( Chen, A; Chueh, SC; Ho, YL; Lee, JK; Lin, LY; Lin, WC; Lin, YH; Lo, MT; Su, TC; Wang, PC; Wu, KD; Wu, VC; Wu, XM, 2012) |
| "Primary hyperaldosteronism, one cause of which is aldosterone-producing adenomas (APAs), may account for ≤5% to 10% of cases of essential hypertension." | 1.38 | Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. ( Azizan, EA; Brown, MJ; Gordon, R; Kowalski, B; Murthy, M; O'Shaughnessy, KM; Stowasser, M; Xu, S, 2012) |
| "Primary aldosteronism (PA) is the most frequent cause of secondary arterial hypertension." | 1.38 | The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience. ( Beuschlein, F; Fischer, E; Hofbauer, L; Holinski-Feder, E; Morak, M; Pallauf, A; Reincke, M; Schirpenbach, C; Zwermann, O, 2012) |
| "Primary aldosteronism is the most common form of secondary hypertension." | 1.38 | Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. ( Allolio, B; Amar, L; Benecke, A; Beuschlein, F; Boulkroun, S; Ceolotto, G; Cicala, MV; Fallo, F; Fischer, E; Golib-Dzib, JF; Hahner, S; Jeunemaitre, X; Lang, K; Lefebvre, H; Lenzini, L; Letizia, C; Maniero, C; Mantero, F; Monticone, S; Mulatero, P; Perrocheau, M; Pilon, C; Plouin, PF; Quinkler, M; Rayes, N; Reincke, M; Rossi, GP; Samson-Couterie, B; Seccia, TM; Veglio, F; Williams, TA; Zennaro, MC; Zinnamosca, L, 2012) |
| "Currently, if hypertension is present in 20% of the population, PA will account for 2%; of these PA patients only 1% are ever screened, let alone diagnosed and treated, and the remaining 99% suboptimally treated, if at all." | 1.38 | Primary aldosteronism: are we missing the wood for the trees? ( Funder, JW, 2012) |
| "In 36 primary aldosteronism patients, AVS was performed both under basal conditions and after continuous ACTH infusion, and in 40 primary aldosteronism patients, AVS was performed both under basal conditions and after ACTH IV bolus." | 1.38 | Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. ( Boscaro, M; Giacchetti, G; Ito, S; Iwakura, Y; Kudo, M; Monticone, S; Morimoto, R; Mulatero, P; Ono, Y; Paci, E; Rainey, W; Satoh, F; Turchi, F; Veglio, F; Viola, A, 2012) |
| "Aldosterone has been linked to the deleterious cardiovascular effects of obesity in humans." | 1.38 | The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity. ( Dorrance, AM; Fink, GD; Garver, H; Haywood, JR; Laimon-Thomson, EL; McClain, JL; Northcott, CA; Pires, PW; Rainey, WE; Rigsby, CS, 2012) |
| "Primary aldosteronism (PA) patients display an increased incidence of insulin resistance." | 1.38 | Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients. ( Bertello, C; Fallo, F; Giraudo, G; Monticone, S; Mulatero, P; Urbanet, R; Veglio, F; Vettor, R; Williams, TA, 2012) |
| "Myelolipomas are adrenal tumors composed of both adipose and hematopoietic tissues which are rarely associated with primary aldosteronism (PA)." | 1.38 | A case of myelolipoma with bilateral adrenal hyperaldosteronism cured after unilateral adrenalectomy. ( Arai, H; Fujii, T; Fukuda, Y; Honda, K; Inuzuka, M; Kanamoto, N; Kojima, K; Kondo, E; Mikami, Y; Miura, M; Nakao, K; Sasano, H; Sone, M; Sonoyama, T; Tamura, N; Taura, D; Ueda, Y; Yamada, G; Yamashita, Y; Yasoda, A, 2012) |
| "The patients in this study had primary hyperaldosteronism with unilateral APA." | 1.38 | Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors. ( Azizan, EA; Brown, MJ; Clarke, J; Happerfield, L; Hoffman, GJ; Kuc, RE; Lam, BY; Marker, A; Newhouse, SJ; Zhou, J, 2012) |
| "The prevalence of primary aldosteronism in unselected hypertensive patients is currently unknown." | 1.38 | Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. ( Beuschlein, F; Bidlingmaier, M; Biffar, R; Döring, A; Felix, SB; Friedrich, N; Hannemann, A; Manolopoulou, J; Meisinger, C; Nauck, M; Peters, A; Reincke, M; Rettig, R; Seissler, J; Spyroglou, A; Völzke, H; Wallaschofski, H; Wichmann, HE, 2012) |
| "Hyperaldosteronism combined with hypertension favored the macrophage infiltration (CD68(+) cells) in heart, and enhanced the mRNA level of monocyte chemoattractant protein 1, osteopontin, and galectin 3." | 1.38 | Aldosterone inhibits antifibrotic factors in mouse hypertensive heart. ( Azibani, F; Benard, L; Carrier, L; Chatziantoniou, C; Delcayre, C; Fazal, L; Launay, JM; Merval, R; Polidano, E; Samuel, JL; Schlossarek, S; Tournoux, F, 2012) |
| "Arterial hypertension (AH) induces cardiac hypertrophy and reactivation of "fetal" gene expression." | 1.38 | Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice. ( Azibani, F; Carrier, L; Chatziantoniou, C; Coutance, G; Delcayre, C; Devaux, Y; Fazal, L; Launay, JM; Merval, R; Polidano, E; Samuel, JL; Schlossarek, S; Solal, AC, 2012) |
| "Primary aldosteronism (PA) is the most common cause of endocrine hypertension with a high frequency of cardiovascular complications." | 1.38 | Have main types of primary aldosteronism different phenotype? ( Holaj, R; Indra, T; Petrák, O; Rosa, J; Somlóová, Z; Strauch, B; Widimský, J; Zelinka, T, 2012) |
| "Moreover, aldosterone-producing adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases." | 1.38 | Aldosterone-producing adrenocortical carcinoma without hypertension. ( Bae, SB; Kim, SJ; Kim, YJ; Seo, SW; Song, MS, 2012) |
| "Primary hyperaldosteronism or Conn syndrome is the syndrome formed from the triad of hypertension, hypokalemia, and metabolic alkalosis." | 1.38 | Sixteen years experience in six cases of Conn syndrome in Jakarta. ( Siregar, P, 2012) |
| "We tested this in 2 animal models of aldosteronism (aldosterone infusion or low-sodium diet) and in patients with primary aldosteronism." | 1.38 | The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism. ( Danser, AH; Fenton, RA; Hoorn, EJ; Jansen, PM; Salih, M; van den Meiracker, AH; van der Lubbe, N; Zietse, R, 2012) |
| "Primary aldosteronism (PA, autonomous aldosterone production from the adrenal cortex) causes the most common form of secondary arterial hypertension (HT), which is also the most common curable form of HT." | 1.38 | Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex. ( Bandulik, S; Barhanin, J; Bendahhou, S; El Wakil, A; Guy, N; Lalli, E; Mari, B; Niehrs, C; Warth, R; Zennaro, MC, 2012) |
| "Primary aldosteronism caused by an aldosterone producing adrenal tumor/aldosteronoma (APA), is a potentially curable form of hypertension, via unilateral adrenalectomy." | 1.38 | Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems. ( Carter, Y; Chen, H; Roy, M; Sippel, RS, 2012) |
| "Hyperaldosteronism is associated with vascular injury and increased cardiovascular events." | 1.37 | Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans. ( Bauersachs, J; Dietrich, B; Ertl, G; Fleissner, F; Hahner, S; Jazbutyte, V; Schmitter, K; Thum, T; Widder, JD; Wiebking, V, 2011) |
| "Because primary aldosteronism is not uncommon, specifically treatable and in some cases curable, and carries higher risks for cardiovascular morbidity and mortality than essential hypertension, screening hypertensive patients for its presence by measuring aldosterone to renin ratio (ARR) is increasingly common." | 1.37 | Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? ( Ahmed, AH; Gordon, RD; Pimenta, E; Stowasser, M; Taylor, PJ; Ward, G, 2011) |
| "Primary aldosteronism (PA) is associated a worse cardiovascular outcome than essential hypertension." | 1.37 | The association of serum potassium level with left ventricular mass in patients with primary aldosteronism. ( Chen, MF; Chien, KL; Chueh, SC; Ho, YL; Huang, KH; Kuo, CC; Lee, JK; Lin, LY; Lin, YH; Liu, KL; Wang, SM; Wang, WJ; Wu, KD; Wu, VC; Yen, RF, 2011) |
| "To evaluate the prevalence of primary aldosteronism (PA) in newly diagnosed and untreated hypertensive patients in primary care using the aldosterone/renin ratio (ARR), and to assess clinical and biochemical characteristics in patients with high and normal ARR." | 1.37 | Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area. ( Bergenfelz, A; Isaksson, A; Nerbrand, C; Valdemarsson, S; Westerdahl, C, 2011) |
| "The aldosterone level was normalized in all but 2 patients (98." | 1.37 | Single-center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling. ( Arai, Y; Ishibashi, T; Ishidoya, S; Ito, A; Ito, S; Kaiho, Y; Morimoto, R; Nakamura, Y; Sasano, H; Satoh, F, 2011) |
| "Current data on primary aldosteronism (PA) from Asian populations are scarce." | 1.37 | Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). ( Chang, CC; Chang, HW; Chu, TS; Chueh, SC; Huang, KH; Kao, TW; Kuo, CC; Lai, CF; Lee, TY; Lin, CY; Lin, WC; Lin, YH; Lu, CC; Tsai, CW; Wang, SM; Wang, WJ; Wu, KD; Wu, MS; Wu, VC; Yang, WS, 2011) |
| "Primary hyperaldosteronism (PHA) is characterized by a raised plasma aldosterone concentration (PAC) with suppressed plasma renin activity (PRA)." | 1.37 | The clinical utility of two renin mass methods to detect primary hyperaldosteronism compared with renin activity. ( Barnes, SC; Scanlon, MJ; Wedatilake, YN, 2011) |
| "Familial hyperaldosteronism type 1 is an autosomal dominant disorder attributed to a chimeric CYP11B1/CYP11B2 gene (CG)." | 1.37 | Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation. ( Aglony, M; Avalos, C; Avila, A; Bancalari, R; Bolte, L; Brinkmann, K; Campino, C; Carvajal, CA; Fardella, CE; García, H; Giadrosich, V; Inostroza, A; Loureiro, C; Martínez-Aguayo, A; Mericq, V; Perez, V; Rocha, A; Trejo, P, 2011) |
| "Primary aldosteronism (PA) is sometimes associated with the autonomous secretion of cortisol." | 1.37 | Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. ( Hashimoto, K; Monden, T; Mori, M; Nakajima, Y; Okada, S; Ozawa, A; Satoh, T; Shibusawa, N; Taguchi, R; Yamada, M, 2011) |
| "Glucocorticoid-remediable aldosteronism (GRA) is caused by the presence of a chimeric gene originating from an unequal cross-over between the CYP11B1 and CYP11B2 genes." | 1.37 | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. ( Haag, C; Kamrath, C; Maser-Gluth, C; Schulze, E, 2011) |
| "Thus, in rats with aldosteronism, in which a reduction in effective refractory period was not evident, the mechanism for VA susceptibility is presumably linked to a decrease in conduction velocity and/or increased dispersion of refractoriness, probably caused by consequential myocardial fibrosis." | 1.37 | Spironolactone prevents the inducibility of ventricular tachyarrhythmia in rats with aldosteronism. ( Bellary, SR; de Jongh Curry, AL; Deshmukh, PA; Kamalov, G; Magotra, M; Schwender, FT; Sun, Y; Weber, KT, 2011) |
| "Hyperaldosteronism was classified as an aldosterone/renin ratio (ARR) ≥ 30." | 1.37 | Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database. ( Garcia, EA; Lopez, JR; Meier, JL; Siegel, D; Swislocki, AL, 2011) |
| "Primary aldosteronism (PA) is associated with a higher incidence of cardiovascular events, probably through mineralocorticoid receptor (MR)-dependent endothelial cell dysfunction, in comparison with essential hypertension (EH)." | 1.37 | Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis. ( Chen, JW; Chen, YL; Huang, PH; Kuo, CC; Kuo, YS; Lee, BC; Liang, CJ; Lin, SJ; Lin, SL; Lin, YH; Lo, SC; Sun, YY; Tsai, CT; Wu, EL; Wu, KD; Wu, VC, 2011) |
| "Spironolactone treatment reversed all the above effects." | 1.37 | A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. ( Cachofeiro, V; Díez, J; Fortuno, MA; Lahera, V; López-Andrés, N; Martin-Fernandez, B; Rossignol, P; Zannad, F, 2011) |
| "Resistant hypertension has evolved as an important global health care problem." | 1.37 | What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated? ( Sica, DA, 2011) |
| "Primary aldosteronism (PA) is a possible cause of endocrine hypertension." | 1.37 | [Aldosterone/renin ratio in the diagnosis of primary aldosteronism]. ( Catay, E; Honnorat, E; Izquierdo, A; Popescu, BM; Ríos, MC; Rodríguez Cuimbra, S; Sotelo, M, 2011) |
| "We postulate that hyperreninemic-hyperaldosteronism followed by fluid retention caused a sudden severe increase in ventricular afterload and subsequent congestive heart failure in this patient." | 1.37 | Congestive heart failure as an initial manifestation of reninoma. ( Cho, MJ; Lee, HD; Park, JA; Sung, EY, 2011) |
| "S-Aldosterone was normalized." | 1.36 | Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism. ( Andreasson, S; Botling, J; Hägg, A; Hellman, P; Hennings, J; Sundin, A, 2010) |
| "Metabolic syndrome was defined according to ATPIII criteria." | 1.36 | Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. ( Agostinelli, L; Boscaro, M; Di Mattia, D; Giacchetti, G; Rilli, S; Ronconi, V; Turchi, F, 2010) |
| "Heart failure is accompanied by electrolyte disturbance including reduced calcium and sodium in the extracellular milieu but increased calcium within cells, a phenomenon called "calcium paradox"." | 1.36 | Aldosterone improves contractile function of adult rat ventricular cardiomyocytes in a non-acute way: potential relationship to the calcium paradox of aldosteronism. ( Abdallah, Y; Schlüter, KD; Schreckenberg, R; Tastan, I; Wenzel, S, 2010) |
| "Insulin resistance is associated with nonalcoholic fatty liver disease (NAFLD) and may play a role in its pathophysiology." | 1.36 | Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. ( Bertello, C; Catena, C; Dalla Pozza, A; Ermani, M; Fabris, B; Fallo, F; Mulatero, P; Sabato, N; Sechi, LA; Sonino, N; Tecchio, M; Tona, F, 2010) |
| "After a positive screening, primary aldosteronism diagnosis needs confirmation by an inhibitory test such as intravenous saline load (ivSLT)." | 1.36 | Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. ( Chiecchi, L; Corrocher, R; Franchi, M; Guarini, P; Guidi, GC; Memmo, A; Olivieri, O; Pavan, C; Pizzolo, F; Raffaelli, R, 2010) |
| "Primary hyperaldosteronism (PHA) is potentially curable by laparoscopic unilateral adrenalectomy (LUA)." | 1.36 | Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology. ( Girerd, X; Godiris-Petit, G; Hoang, C; Menegaux, F; Salepçioglu, H; Trésallet, C, 2010) |
| "In 22 patients with unilateral primary aldosteronism (UPA), unilateral laparoscopic adrenalectomy (ADX) not only corrected hypokalemia and led to cure or improvement of hypertension, but also significantly improved quality of life (QOL)." | 1.36 | Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. ( Gordon, RD; Kogovsek, C; Robson, D; Stowasser, M; Sukor, N, 2010) |
| "Primary hyperaldosteronism (PHA) is being recognized more frequently in cats." | 1.36 | Feline primary hyperaldosteronism. ( Schulman, RL, 2010) |
| "Primary aldosteronism (PA), the most common secondary cause of hypertension, can be screened for using the aldosterone/renin ratio." | 1.36 | A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin. ( Alvarez-Madrazo, S; Connell, JM; Dorrian, CA; Kelly, A; Toole, BJ; Wallace, AM, 2010) |
| "This is the first report of a Conn's syndrome diagnosed after bowel cleansing with a sodium phosphate solution." | 1.36 | A case of Conn's syndrome revealed after oral sodium phosphate (Fleet) preparation for colonoscopy. ( Hershfield, NB; Lee, R; Storr, M, 2010) |
| "Insulin resistance in primary aldosteronism might occur in compartments other than fat and/or depend on concurrent environmental factors." | 1.36 | Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism. ( Calcagno, A; Fallo, F; Giacchetti, G; Giorgino, F; Gomez-Sanchez, C; Hubert, EL; Mulatero, P; Peschechera, A; Pilon, C; Sonino, N; Toffanin, M; Urbanet, R; Vettor, R; Zennaro, MC, 2010) |
| "Primary aldosteronism (PA) is a common form of secondary hypertension." | 1.36 | The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism. ( Dvoráková, J; Holaj, R; Masek, M; Petrák, O; Rosa, J; Somlóová, Z; Strauch, B; Vlková, J; Wichterle, D; Widimský, J; Zelinka, T, 2010) |
| "Primary aldosteronism (PA) is a frequent cause of secondary hypertension and is amenable to surgical intervention when it is caused by aldosterone-producing adenoma (APA)." | 1.36 | Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma. ( Kim, RM; Lee, J; Soh, EY, 2010) |
| "Aldosterone has been correlated with increased oxidative stress, endothelial inflammation, and fibrosis, particularly in patients with heart disease." | 1.36 | Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients. ( Becerra, E; Carvajal, CA; Fardella, CE; García, L; Jalil, J; Lavandero, S; Mellado, R; Mosso, L; Ocaranza, MP; Solis, M; Stehr, CB, 2010) |
| "Moreover, the hyperaldosteronism was partially reversed by Ca(2+)-deficient diet." | 1.36 | Hyperaldosteronism in Klotho-deficient mice. ( Ackermann, TF; Boini, KM; Fischer, SS; Föller, M; Hocher, B; Kempe, DS; Kuro-O, M; Lang, F; Leibrock, CB; Rexhepaj, R; Rosenblatt, KP; Siraskar, B, 2010) |
| "Hyperaldosteronism (PRA < 1 ng x mL(-1) x h(-1) and UAldo > or = 12 microg/24-h) prevalence was 28% and OSA prevalence was 77%." | 1.36 | Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. ( Ahmed, MI; Calhoun, DA; Cofield, SS; Gaddam, KK; Gonzaga, CC; Harding, SM; Oparil, S; Pimenta, E; Thomas, SJ, 2010) |
| "In patients with primary hyperaldosteronism, distinguishing between unilateral and bilateral adrenal hypersecretion is critical in assessing treatment options." | 1.36 | Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. ( Alexander, HR; Ayala, A; Baid, S; Chang, RE; Dutta, U; Hughes, M; Kebebew, E; Kemp, CD; Lange, E; Libutti, SK; Linehan, WM; Mathur, A; Papademetriou, V; Phan, GQ; Pingpank, JF; Pinto, PA; Steinberg, SM; Stratakis, CA, 2010) |
| "Glucocorticoid-remediable aldosteronism (GRA) is an autosomal-dominant inheritable form of hyperaldosteronism with early onset hypertension." | 1.36 | Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism. ( Jang, HW; Jo, YS; Kim, MK; Kim, SY; Lee, IS; Lee, JH; Lee, YH, 2010) |
| "Primary aldosteronism is the most common form of secondary hypertension with hypokalemia and suppressed renin-angiotensin system caused by autonomous aldosterone production." | 1.36 | Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism. ( Amar, L; Benecke, A; Boulkroun, S; Dzib, JF; Jeunemaitre, X; Lalli, E; Lefebvre, H; Louiset, E; Meatchi, T; Plouin, PF; Samson-Couterie, B; Zennaro, MC, 2010) |
| "Primary aldosteronism is more common than previously recognized but much less common than most experts in this arena have recently stated." | 1.36 | Current diagnosis and treatment of primary aldosteronism. ( Kaplan, NM, 2010) |
| "The diagnosis of primary hyperaldosteronism due to microadenoma or unilateral adrenal hyperplasia can be challenging, since hypokalaemic alkalosis, high plasma aldosterone and a definite adenoma on imaging may all be absent." | 1.35 | Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension. ( Appleton, DS; Brown, MJ; Coghill, S; Jamieson, N; Lomas, DJ; Myint, KS; Taylor, KP; Watts, M, 2008) |
| "Primary aldosteronism (PA) represents a clinical model useful in assessing the effect of aldosterone increase on LVM." | 1.35 | Inappropriate left ventricular mass in patients with primary aldosteronism. ( Agabiti-Rosei, C; Agabiti-Rosei, E; Aggiusti, C; Belotti, E; Castellano, M; Galbassini, G; Monteduro, C; Muiesan, ML; Paini, A; Rizzoni, D; Salvetti, M, 2008) |
| "We report six patients with primary aldosteronism who had serial adrenal venous sampling." | 1.35 | Change in the pattern of adrenal venous sampling over time in patients with primary aldosteronism. ( Cohen, DL; Fraker, DL; Han, D; Murashima, M; Townsend, RR; Trerotola, SO, 2009) |
| "Recent data suggest that primary aldosteronism is found in about 10% of hypertensive patients managed in primary care and diagnosed in about 20% of treated but uncontrolled hypertensive patients." | 1.35 | [Primary hyperaldosteronism in hypertension]. ( Girerd, X, 2008) |
| "Primary aldosteronism (PA) may account for as much as 6-20% of cases of refractory hypertension referred to hypertension clinics." | 1.35 | The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine. ( Fukuchi, K; Horio, T; Iwanaga, Y; Kamide, K; Kawano, Y; Nakahama, H; Nakamura, S; Nakata, H; Niizuma, S; Yoshihara, F, 2008) |
| "Fludrocortisone was administered 4 times daily over 4 days and sodium chloride was supplemented in 3 different doses." | 1.35 | Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone. ( Bergenfelz, A; Isaksson, A; Larsson, J; Nerbrand, C; Valdemarsson, S; Westerdahl, C; Wihl, A, 2009) |
| "Type I familial hyperaldosteronism is caused by the presence of a chimaeric gene CYPl 1B1/CYP11BZ which encodes an enzyme with aldosterone synthetase activity regulated by adrenocorticotrophic hormone (ACTH)." | 1.35 | [Subclinical endothelial inflammation markers in a family with type I familial hyperaldosteronism caused by a de novo mutation]. ( Alcaíno, H; Carvajal, CA; Cattani, A; Fardella, CE; Lacourt, P; Lavandera, S; Mellado, R; Mosso, LM; Stehr, CB, 2008) |
| "Surgical treatment of primary hyperaldosteronism (PHA) requires demonstration of unilateral adrenal hypersecretion." | 1.35 | The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. ( Cho, KJ; Doherty, GM; Gauger, PG; Hammer, GD; Miller, BS; Thompson, NW; White, ML, 2008) |
| "Hyperaldosteronism is associated with impaired endothelium-dependent vascular reactivity owing to increased reactive oxygen species and decreased bioavailable nitric oxide (NO(." | 1.35 | Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. ( Beuve, A; Handy, DE; Leopold, JA; Loscalzo, J; Maron, BA; Tang, SS; Zhang, YY, 2009) |
| "Findings suggested that primary hyperaldosteronism should be considered as a possible cause in ferrets with hypokalemia, hypertension, and an adrenal gland mass." | 1.35 | Primary hyperaldosteronism in a domestic ferret with an adrenocortical adenoma. ( Desmarchelier, M; Dunn, M; Lair, S; Langlois, I, 2008) |
| "Until recently, primary hyperaldosteronism was considered a rare cause of secondary hypertension." | 1.35 | Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league. ( Faria, Mdos S; Figueiredo Neto, JA; Lopes, Mde C; Memória, EV; Oliveira, TC; Ribeiro, MJ; Salgado Filho, N, 2009) |
| "Some diseases, such as Gitelman's syndrome, Bartter's syndrome, and primary hyperaldosteronism (Conn's syndrome), may bear some similar clinical and laboratory findings." | 1.35 | Hypokalemic paralysis due to primary hyperaldosteronism simulating Gitelman's syndrome. ( Akalin, A; Cansu, DU; Kasifoglu, T; Korkmaz, C, 2009) |
| "Primary aldosteronism is caused by autonomous secretion of aldosterone by the adrenal cortex which results in hypertension with clinically, biochemically and therapeutically distinct features." | 1.35 | Animal models of primary aldosteronism. ( Beuschlein, F, 2009) |
| "Primary aldosteronism (PA) is a secondary hypertension characterized by autonomous aldosterone hypersecretion from adrenocortical adenoma and/or hyperplasia." | 1.35 | Endothelial dysfunction is related to aldosterone excess and raised blood pressure. ( Hirata, Y; Tsuchiya, K; Yoshimoto, T, 2009) |
| "320 patients with primary hyperaldosteronism (Conn syndrome) were operated on." | 1.35 | [Anesthetic management and surgical technique in treatment of primary hyperaldosteronism]. ( Chernyshev, VN; Chernysheva, NI; Skladchikova, TIu, 2009) |
| "Adrenal masses in Gardner's syndrome are rare, and few have displayed clinical manifestations." | 1.35 | Hyperaldosteronism in an adolescent with Gardner's syndrome. ( Felner, EI; Gow, K; Taweevisit, M, 2009) |
| "Increased incidence of primary aldosteronism (PA) in approximately 10% of the hypertensive population has increased interest in the mineralocorticoid aldosterone." | 1.35 | Saliva as a medium for aldosterone measurement in repeated sampling studies. ( Bidlingmaier, M; Manolopoulou, J; Maser-Gluth, C; Mulatero, P; Petersenn, S; Plouin, PF; Reincke, M; Rossignol, P; Spyroglou, A; Vakrilova, Y; Zwermann, O, 2009) |
| "The hyperaldosteronism of apc(Min/+) mice was paralleled by significantly elevated plasma volume and blood pressure." | 1.35 | Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC. ( Bhandaru, M; Kempe, DS; Kuhl, D; Lang, F; Rexhepaj, R; Rotte, A, 2009) |
| "Primary aldosteronism (PA) is the most common secondary cause of hypertension that has recently been implicated in alterations of the immune system and progression of cardiovascular disease." | 1.35 | Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha. ( Carvajal, CA; Castillo, CR; Contreras, FJ; Fardella, CE; Herrada, AA; Kalergis, AM; Mosso, LM; Stehr, CB, 2009) |
| "Primary aldosteronism (PA) is caused by autonomous hypersecretion of aldosterone from the adrenal cortex, classically from an adenoma, resulting in sodium and water retention, hypokalaemia and raised blood pressure." | 1.35 | Atrial fibrillation in primary aldosteronism. ( Beevers, DG; Karthikeyan, VJ; Lip, GY; Watson, T, 2009) |
| "Normokalaemia does not exclude primary aldosteronism as the underlying cause of hypertension." | 1.35 | [Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009]. ( Guthoff, M; Horger, M; Kirchhoff, K; Kurth, R; Müssig, K; Schnauder, G, 2009) |
| "Endocrine hypertension is rare, but frequently refractory." | 1.35 | [Endocrine hypertension]. ( Ibsen, H; Poulsen, PL, 2009) |
| "CONFIRMATION OF DIAGNOSIS: Primary hyperaldosteronism was diagnosed based on an elevated plasma aldosterone concentration and normal plasma renin activity." | 1.35 | Hyperaldosteronism and hyperprogesteronism in a cat. ( Barrs, VR; Beatty, JA; Briscoe, K; Foster, DF, 2009) |
| "The prevalence of primary aldosteronism has increased since many patients who were previously considered as being affected by low renin essential hypertension are actually satisfying the new diagnostic criteria using plasma aldosterone/ plasma renin activity (PRA) ratio." | 1.35 | Some considerations about evolution of idiopathic primary aldosteronism. ( Armanini, D; Fiore, C, 2009) |
| "The aldosterone phenotype was caused by an adrenocortical zonation defect." | 1.35 | Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. ( Aller, MI; Bandulik, S; Barhanin, J; Bendahhou, S; Derand, R; El Wakil, A; Gomez-Sanchez, CE; Guy, N; Heitzmann, D; Jungbauer, S; Lalli, E; Lesage, F; Mengual, R; Reichold, M; Schweda, F; Sterner, C; Tegtmeier, I; Warth, R; Weber, A; Wisden, W, 2008) |
| "Laboratory data suggested primary aldosteronism (PA)." | 1.35 | Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling. ( Adachi, J; Araki, A; Chiba, Y; Horiuchi, T; Ito, H; Kasuya, Y; Mori, S; Murayama, T; Sasano, H; Sawabe, M; Takeda, K; Tamura, Y, 2008) |
| "Patients with primary aldosteronism were compared with patients with essential hypertension and were treated to reach a blood pressure of less than 140/90 mm Hg." | 1.35 | Cardiovascular outcomes in patients with primary aldosteronism after treatment. ( Baroselli, S; Catena, C; Chiuch, A; Colussi, G; Lapenna, R; Nadalini, E; Sechi, LA, 2008) |
| "Primary aldosteronism (PA) is a common curable disease of secondary hypertension." | 1.35 | Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. ( Chang, HW; Chueh, SC; Hsieh, BS; Li, HY; Lin, WC; Lin, YH; Liu, KL; Wu, KD; Wu, VC, 2008) |
| "Yet, the etiology of nontumorigenic primary hyperaldosteronism caused by bilateral idiopathic hyperaldosteronism remains unknown." | 1.35 | TASK channel deletion in mice causes primary hyperaldosteronism. ( Barrett, PQ; Bayliss, DA; Carey, RM; Chen, X; Davies, LA; Guagliardo, NA; Hu, C; Sen, N; Talley, EM, 2008) |
| "Hyperaldosteronism is associated with hypertension, cardiovascular fibrosis, and electrolyte disturbances, including hypomagnesemia." | 1.35 | Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. ( Montezano, AC; Paravicini, T; Sontia, B; Tabet, F; Touyz, RM, 2008) |
| "In patients with primary aldosteronism, as a whole group, the cut-off value of 69 corresponded to the best compromise value between sensitivity (96%) and specificity (85%), with and without PRA adjustment." | 1.35 | Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism. ( Bardini, M; Bernini, G; Bernini, M; Berti, P; Miccoli, P; Moretti, A; Orlandini, C; Salvetti, A; Taurino, C, 2008) |
| "Primary aldosteronism (PA) is characterized by the onset of both cardiac and gluco-metabolic alterations." | 1.34 | Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. ( Agostinelli, L; Boscaro, M; Giacchetti, G; Mantero, F; Rilli, S; Ronconi, V; Turchi, F, 2007) |
| "Primary aldosteronism accompanied by hypokalemia is a cause of secondary hypertension." | 1.34 | Hypertension associated with rhabdomyolysis. ( Aslanidis, S; Douma, S; Kartali, N; Papaefthimiou, P; Petidis, K; Zamboulis, C, 2007) |
| "The most common causes of hyperaldosteronism (HA) are bilateral idiopathic hyperaldosteronism (IHA), aldosterone-producing adenoma (APA), and unilateral primary adrenal hyperplasia (PAH)." | 1.34 | Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery? ( Bellantone, R; De Crea, C; Lombardi, CP; Raffaelli, M; Rufini, V; Treglia, G, 2007) |
| "Primary hyperaldosteronism is described in a 27-year-old Brazilian woman from an endemic area of schistosomiasis." | 1.34 | Clinics in diagnostic imaging (113). ( Costa, AF; dos Santos, VM; Resurreição, FM; Vieira, MT, 2007) |
| "The aldosterone/renin ratio is a valid screening and sodium loading a valid confirmation test in GRA." | 1.34 | A German family with glucocorticoid-remediable aldosteronism. ( Altenhenne, C; Büchner, NJ; Dekomien, G; Epplen, JT; Hofebauer, S; Maser-Gluth, C; Rump, LC; Sellin, L; Vonend, O; Weiner, SM, 2007) |
| "Primary aldosteronism (PA) has been considered a rare cause of hypertension." | 1.34 | Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. ( Fogari, E; Fogari, R; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A, 2007) |
| "Primary aldosteronism (PA) represents an important cause of secondary hypertension, potentially curable, and it has been receiving particular attention due to its increasing prevalence, after the beginning of the use of plasma aldosterone concentration to plasma renin activity ratio as a screening method." | 1.34 | [Primary aldosteronism caused by aldosteronoma: problems in the etiologic diagnosis]. ( Brandão Neto, RA; Danilovic, DL; Freire, DS; Lucon, AM; Paraíba, DB; Pereira, MA, 2007) |
| "Treatment of primary aldosteronism decreased blood pressure (BP) and restored normal potassium concentrations." | 1.34 | Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment. ( Baroselli, S; Bazzocchi, M; Catena, C; Chiuch, A; Colussi, GL; Lapenna, R; Nadalini, E; Novello, M; Sechi, LA, 2007) |
| "Forty patients with primary aldosteronism and 40 matched patients with low-renin essential hypertension (LREH) were studied." | 1.34 | Adiponectin and insulin sensitivity in primary aldosteronism. ( Bertello, C; Della Mea, P; Ermani, M; Fallo, F; Mulatero, P; Sonino, N; Veglio, F; Vettor, R, 2007) |
| "Primary hyperaldosteronism is not as uncommon as previously thought, but its prevalence depends on the selected population." | 1.34 | Resistant hypertension: a methodological approach to diagnosis and treatment. ( Tamimi, NA, 2007) |
| "At baseline, patients with primary aldosteronism had higher creatinine clearance and albuminuria than 323 patients with essential hypertension and 113 normotensive individuals." | 1.34 | Relationships of plasma renin levels with renal function in patients with primary aldosteronism. ( Baroselli, S; Catena, C; Chiuch, A; Colussi, G; Lapenna, R; Nadalini, E; Sechi, LA, 2007) |
| "Primary aldosteronism (PA) is the most common secondary cause of hypertension and recently has been implicated as a cause of impaired glucose tolerance." | 1.34 | A possible association between primary aldosteronism and a lower beta-cell function. ( Artigas, RA; Carvajal, CA; Castillo, CR; Fardella, CE; Maiz, A; Mosso, LM; Ortiz, EH, 2007) |
| "Aldosterone excess has been reported to be a common cause of resistant hypertension." | 1.34 | Aldosterone excess and resistance to 24-h blood pressure control. ( Calhoun, DA; Cofield, SS; Gaddam, KK; Nishizaka, MK; Oparil, S; Pimenta, E; Pratt-Ubunama, MN, 2007) |
| "Fifty-four patients with primary aldosteronism were enrolled in a prospective study and were followed for a mean of 6." | 1.34 | Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. ( Catena, C; Chiuch, A; Colussi, G; Gianfagna, P; Lapenna, R; Nadalini, E; Sechi, LA, 2007) |
| "There is a high prevalence for primary hyperaldosteronism (PHA) in hypertensive patients." | 1.34 | [Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism]. ( Adams, S; Hahn, K; Kokulinsky, P; Liermann, D; Rump, LC; Stegbauer, J; Vonend, O, 2007) |
| "Thus, a reliable screening test for primary hyperaldosteronism (PA) is essential to avoid unnecessary diagnostic procedures to this population." | 1.34 | The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses. ( Botoula, E; Effraimidis, G; Effremidis, G; Gavalas, N; Szabo, A; Thalassinos, NC; Tzanela, M; Valatsou, A; Vassiliadi, D, 2007) |
| "Primary hyperaldosteronism (PH), resulting in hypokalaemic hypertension, may be due to an aldosterone-producing adenoma (APA) or bilateral zona glomerulosa hyperplasia." | 1.34 | Prospective evaluation and characteristics of patients with suspected primary hyperaldosteronism. ( Boyne, MS; McKenzie, CA; Wright-Pascoe, R, 2007) |
| "Here we describe a 13-yr-old girl with primary hyperaldosteronism secondary to aldosterone-secreting adenoma." | 1.34 | An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia. ( Acikalin, MF; Dinleyici, EC; Dogruel, N; Ilhan, H; Oztelcan, B; Tokar, B, 2007) |
| "To examine the role of hyperaldosteronism, we also evaluated rats treated with a sodium-deficient diet or subcutaneous aldosterone infusion." | 1.33 | Induction of 11beta-hydroxysteroid dehydrogenase type 2 and hyperaldosteronism are essential for enhanced sodium absorption after total colectomy in rats. ( Fukushima, K; Funayama, Y; Krozowski, Z; Naito, H; Sasaki, I; Sasano, H; Sato, S; Shibata, C; Suzuki, T, 2005) |
| "Primary hyperaldosteronism was diagnosed on the basis of plasma concentrations of aldosterone (PAC) and plasma renin activity (PRA), and the calculation of the PAC:PRA ratio." | 1.33 | Primary hyperaldosteronism, a mediator of progressive renal disease in cats. ( Boer, WH; Djajadiningrat-Laanen, SC; Javadi, S; Kooistra, HS; Rijnberk, A; van den Ingh, TS; van Dongen, AM; van Sluijs, FJ; Voorhout, G, 2005) |
| "The aldosterone/renin ratio has been proposed as the most sensitive criterium." | 1.33 | [Biochemical detection of Conn's adenoma: definition of criteria and reference values]. ( Clementy, J; Gosse, P; Guiheneuf-Tobie, C; Lasserre, R; Lemetayer, P; Minifie, C, 2005) |
| "Aldosterone has long been known to control water and electrolyte balance by acting on mineralocorticoid receptors in kidney." | 1.33 | Aldosterone makes human endothelium stiff and vulnerable. ( Oberleithner, H, 2005) |
| "Recent reports suggesting that primary aldosteronism (PA) is more common than historically thought have often relied on use of the plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio (ARR) to identify patients with PA." | 1.33 | Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. ( Calhoun, DA; Cofield, S; Nishizaka, MK; Pratt-Ubunama, M; Zaman, MA, 2005) |
| "Primary hyperaldosteronism is known to be frequently characterized by multiple adrenal lesions." | 1.33 | Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. ( Arai, Y; Chiba, Y; Ishidoya, S; Ito, A; Sakai, K; Sato, F; Satoh, M, 2005) |
| "Familial hyperaldosteronism type II (FH-II) is characterized by the familial occurrence of primary aldosteronism; unlike FH-I, it is not glucocorticoid-remediable and not associated with the hybrid CYP11B1/CYP11B2 gene mutation." | 1.33 | Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. ( Duffy, DL; Gordon, RD; Jeske, YW; Lin-Su, K; New, MI; So, A; Stowasser, M, 2005) |
| "However, tempol failed to suppress cardiac hypertrophy, the formation of inflammatory lesions, and upregulation of cardiac MCP-1 and osteopontin by aldosterone, while N-acetylcysteine could inhibit all of them." | 1.33 | Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. ( Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Ueda, M; Wake, R; Yoshida, K; Yoshiyama, M; Yukimura, T, 2005) |
| "Primary aldosteronism (PAL) is the most frequent cause of secondary arterial hypertension." | 1.33 | Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. ( Assié, G; Auzan, C; Balaton, A; Baviera, E; Clauser, E; Corvol, P; Elalouf, JM; Gasc, JM; Jeunemaitre, X; Plouin, PF, 2005) |
| "Aldosterone and renin were measured in 52 renal artery disease patients (8 with fibrodysplastic and 44 with atherosclerotic lesions), in whom successful PTRA/PTRAS had been performed previously." | 1.33 | Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease. ( Corrocher, R; Girelli, D; Guarini, P; Olivieri, O; Pavan, C; Pizzolo, F; Trabetti, E, 2005) |
| "Screening for primary hyperaldosteronism (PHA) is often indicated in individuals with resistant hypertension or hypokalaemia." | 1.33 | Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. ( Brown, NJ; Conlin, PR; Hopkins, PN; Jeunemaitre, X; Raji, A; Williams, GH; Williams, JS, 2006) |
| "Primary aldosteronism is an important and one of the few potentially curable forms of secondary hypertension." | 1.33 | [Endosonography -- an additional diagnostic possibility in the differentiation between the two common types of primary hyperaldosteronism]. ( Kann, PH; Klein, HH; Roggenland, D; Schneider, S, 2006) |
| "A total of 25 patients with primary aldosteronism caused by Conn's adenoma, 29 patients with renovascular hypertension, and 29 patients with essential hypertension (EHT) were included in the present study." | 1.33 | Role of aldosterone in left ventricular hypertrophy in hypertension. ( Fujii, K; Iida, M; Matsumura, K; Oka, M; Oniki, H, 2006) |
| "Primary aldosteronism is the most common form of mineralocorticoid hypertension." | 1.33 | [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases]. ( Dabasi, G; Füto, L; Gláz, E; Horányi, J; Jakab, C; Járay, J; Kiss, R; Major, L; Molnár, F; Patócs, A; Perner, F; Rácz, K; Szücs, N; Tóth, M; Tulassay, Z; Varga, I, 2006) |
| "Primary aldosteronism is the most common endocrine form of secondary hypertension, but no single test or imaging method always identifies it." | 1.33 | The role of adrenal venous sampling in the surgical management of primary aldosteronism. ( Bernante, P; Pelizzo, MR; Rossi, GP; Toniato, A, 2006) |
| "Resistant hypertension is common in clinical practice." | 1.33 | Aldosterone and refractory hypertension: a prospective cohort study. ( Calò, LA; Cattelan, F; Ciccariello, L; De Toni, R; Macchini, L; Mascagna, V; Pessina, AC; Realdi, A; Sartori, M; Semplicini, A, 2006) |
| "Primary aldosteronism (PA) is the most frequent form of secondary hypertension, accounting for up to 5-10% of all hypertensive patients, and the diagnosis of PA can present an important challenge for the clinician." | 1.33 | Comparison of confirmatory tests for the diagnosis of primary aldosteronism. ( Fallo, F; Fardella, C; Maccario, M; Marafetti, L; Milan, A; Mosso, L; Mulatero, P; Pizzolo, F; Regolisti, G; Veglio, F, 2006) |
| "Primary aldosteronism has recently been recognized as the most frequent cause of secondary hypertension." | 1.33 | Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. ( Beuschlein, F; Maser-Gluth, C; Nickel, C; Reincke, M; Rüdiger, F; Schirpenbach, C; Seiler, L, 2006) |
| "There is growing awareness of primary hyperaldosteronism as a cause of secondary hypertension." | 1.33 | Primary hyperaldosteronism associated with hypertensive emergencies. ( Labinson, PT; Mansoor, GA; Tendler, BE; White, WB, 2006) |
| "Patients with primary aldosteronism were compared with 247 patients with essential hypertension with the same severity and duration of disease and 102 normotensive subjects." | 1.33 | Insulin sensitivity in patients with primary aldosteronism: a follow-up study. ( Baroselli, S; Catena, C; Cavarape, A; Colussi, G; Favret, G; Lapenna, R; Melis, A; Nadalini, E; Novello, M; Sechi, LA, 2006) |
| "The appearance of SHPT in aldosteronism, induced by fallen plasma [Ca]o, leads to PTH-mediated Ca overloading of PBMC and their increased production of H2O2." | 1.33 | Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements. ( Ahokas, RA; Bhattacharya, SK; Gerling, IC; Goodwin, KD; Sun, Y; Weber, KT, 2006) |
| "To search for primary hyperaldosteronism (PHA) among previously known hypertensive patients in primary care, using the aldosterone/renin ratio (ARR), and to evaluate clinical and biochemical characteristics in patients with high or normal ratio." | 1.33 | High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden. ( Bergenfelz, A; Isaksson, A; Nerbrand, C; Valdemarsson, S; Westerdahl, C; Wihl, A, 2006) |
| "Adenomatous primary aldosteronism (Conn's syndrome)." | 1.33 | Diagnosis of adenomatous primary aldosteronism in a patient with severe hypertension. ( Connell, JM; Freel, EM, 2005) |
| "To screen primary aldosteronism cases with ARR (aldosterone/plasma renin activity, ARR) from patients with hypertension, and to evaluate the diagnosis value of ARR in primary aldosteronism cases and analysis the clinical characters of primary aldosteronism cases." | 1.33 | [Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism]. ( Liu, ZJ; Shao, JM; Wang, DW; Yan, JT; Zhang, HL, 2006) |
| "The clinical data of 267 patients of primary hyperaldosteronism with adrenal adenoma confirmed by operation 1995 - 2005 were analyzed." | 1.33 | [Causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and strategy therefore]. ( Li, HZ; Pan, DL; Yan, QZ, 2006) |
| "The association of Conn's syndrome with Behcet's disease was thought to be coincidental." | 1.32 | Conn's syndrome associated with Behcet's disease. ( Kim, YA; Lee, SS, 2003) |
| "A 68-year-old male with primary aldosteronism who was scheduled for electroconvulsive therapy (ECT)." | 1.32 | [Anesthetic management for electroconvulsive therapy (ECT) in a patient with primary aldosteronism]. ( Hamaguchi, S; Kimura, Y; Kitajima, T; Nagao, M; Okuda, Y; Takanishi, T; Tezuka, M; Wake, K, 2003) |
| "Left ventricular hypertrophy was present in 60% of patients." | 1.32 | The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. ( Cybulska, I; Dobrucki, T; Janas, J; Janaszek-Sitkowska, H; Januszkiewicz, A; Kabat, M; Makowiecka-Cieśla, M; Peczkowska, M; Postuła, M; Prejbisz, A, 2003) |
| "Primary aldosteronism (PA) is defined as an autonomous over-production of aldosterone by the zona glomerulosa of the adrenal glands." | 1.32 | [Primary hyperaldosteronism. A study of 18 cases]. ( Ben Abdallah, N; Ben Maïz, H; Cherif, L; Essaies, O; Hadj, AI; Khiari, K; Ktari, S; Yahyaoui, R; Zidi, B, 2003) |
| "Thus, aldosteronism is associated with an activation of circulating immune cells induced by iterations in PBMC divalent cations and transduced by oxidative/nitrosative stress." | 1.32 | Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. ( Ahokas, RA; Bhattacharya, SK; Gerling, IC; Herring, PA; Lu, L; Postlethwaite, AE; Sun, Y; Warrington, KJ; Weber, KT; Wodi, LA, 2003) |
| "Aortic dissection is a rare but severe disease." | 1.32 | [Primary aldosteronism. A risk factor for aortic dissection?]. ( Blacher, J; Kesri, L; Mourad, JJ; Safar, M; Tartière, JM, 2003) |
| "In glucocorticoid-remediable aldosteronism (GRA), there is a large interfamily variation of phenotype." | 1.32 | Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. ( De Iasio, R; Fallo, F; Montanari, P; Morra Di Cella, S; Mulatero, P; Pilon, C; Sonino, N; Veglio, F; Williams, TA, 2004) |
| "The severity of obstructive sleep apnea (OSA) correlates with the difficulty of controlling BP." | 1.32 | Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. ( Calhoun, DA; Harding, SM; Nishizaka, MK; Zaman, MA, 2004) |
| "Primary aldosteronism (PA) is a common form of endocrine hypertension previously believed to account for less than 1% of hypertensive patients." | 1.32 | Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. ( Fardella, CE; Gomez-Sanchez, CE; Gordon, RD; Loh, KC; Mosso, L; Mulatero, P; Stowasser, M; Veglio, F; Young, WF, 2004) |
| "Once considered rare, primary aldosteronism (PAL) is now regarded as the commonest potentially curable and specifically treatable form of hypertension." | 1.32 | Primary aldosteronism--careful investigation is essential and rewarding. ( Gordon, RD; Stowasser, M, 2004) |
| "Hyperaldosteronism was diagnosed on the basis of a renin activity <1." | 1.32 | Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. ( Calhoun, DA; Green, SA; Nishizaka, MK; Renfroe, KY; Zaman, MA, 2004) |
| "Primary hyperaldosteronism was not detected among the normokalemic essential hypertensives at any age using aldosterone/plasma renin activity ratio as a primary screening method." | 1.32 | Age dependence of the levels of plasma norepinephrine, aldosterone, renin activity and urinary vanillylmandelic acid in normal and essential hypertensives. ( Abd-Allah, NM; Esmat, AY; Hammad, SA; Hassan, FH, 2004) |
| "We report a rare case of adrenocortical carcinoma." | 1.32 | Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma. ( Azizlerli, H; Kapran, Y; Kurtulmus, N; Yarman, S, 2004) |
| "Primary hyperaldosteronism is a well-recognized cause of secondary hypertension." | 1.32 | Serum aldosterone and the incidence of hypertension in nonhypertensive persons. ( Benjamin, EJ; Evans, JC; Larson, MG; Levy, D; Meigs, JB; Rifai, N; Vasan, RS; Wilson, PW, 2004) |
| "Primary aldosteronism is a clinical syndrome characterized by hypokalemia, suppressed activities of plasma renin and high urinary and plasma aldosterone levels in hypertensive patients." | 1.32 | [A brief history of diagnosis and treatment of primary aldosteronism.]. ( Kong, C; Li, Z; Wang, Y; Yang, C, 2004) |
| "Primary aldosteronism (PA) is characterized by hypertension and suppressed renin activity with or without hypokalemia and comprises the aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia or idiopatic hyperaldosteronism (IHA)." | 1.32 | The syndromes of low-renin hypertension: "separating the wheat from the chaff". ( Biglieri, EG; Kater, CE, 2004) |
| "Treatment with losartan reverses this aldosterone-induced decrease in pump function, and coadministration with MR antagonists produces an additive effect on pump function, consistent with a beneficial effect of MR blockade in patients with hypertension and congestive heart failure treated with angiotensin type 1 receptor antagonists." | 1.31 | Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia. ( Funder, JW; Mardini, M; Mihailidou, AS; Raison, M, 2002) |
| "In patients with primary aldosteronism treated with spironolactone (n = 8), renin escaped suppression and reached very high levels." | 1.31 | Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. ( Hahn, EG; Hensen, J; Schobel, H; Seifarth, C; Trenkel, S, 2002) |
| "The prevalence of primary aldosteronism (PA) was assessed in a specialized hypertension center." | 1.31 | High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. ( Davoli, S; Negro, A; Perazzoli, F; Regolisti, G; Rossi, E; Sani, C, 2002) |
| "Primary hyperaldosteronism represents less tha 1% of all causes of hypertension." | 1.31 | [Bilateral Conn's adenoma. Diagnostic discussions]. ( Ameur, A; Arharbi, M; Beddouch, A; el Younassi, B; Lezrek, M; Zarzur, J, 2002) |
| "It is known that hyperaldosteronism has been associated with magnesium deficiency, yet there are no data on the intracellular concentration of ionized magnesium ([Mg(2+)(i)]) in subjects with primary aldosteronism (PA)." | 1.31 | Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis. ( Brazzarola, P; Degan, M; Delva, P; Lechi, A; Montesi, G; Pastori, C, 2000) |
| "Hyperaldosteronism was induced by a low-salt diet and hypothyroidism by methimazole." | 1.31 | Permissive effect of thyroid hormones on induction of rat colonic Na+ transport by aldosterone is not localised at the level of Na+ channel transcription. ( Mrnka, L; Pácha, J, 2000) |
| "Hyperaldosteronism sustains much of the hypertension, but the stimuli to the increased aldosterone levels are uncertain." | 1.31 | Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model. ( Hostetter, TH; Ibrahim, HN, 2000) |
| "Primary aldosteronism (PA) was thought to be rare but recent evidence from Australia suggests that it may be more common." | 1.31 | High prevalence of primary aldosteronism in the Tayside hypertension clinic population. ( Brennan, G; Dow, E; Jung, RT; Lim, PO; MacDonald, TM, 2000) |
| "A Fludrocortisone test was done to confirm the diagnosis." | 1.31 | Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. ( Cortés, P; Fardella, CE; Foradori, A; Gómez, L; Gómez-Sánchez, C; Huete, A; Montero, J; Mosso, L; Oestreicher, E; Pinto, M; Soto, J, 2000) |
| "Patients with familial adenomatous polyposis (FAP) frequently have extracolonic manifestations of their disease." | 1.31 | Primary aldosteronism in a patient with familial adenomatous polyposis. ( Alexander, GL; Schwartz, DA; Thompson, GB, 2000) |
| "Aldosterone was unresponsive (rose by <50%) to AII in all subjects." | 1.31 | Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. ( Bachmann, AW; Gordon, RD; Huggard, PR; Rossetti, TR; Stowasser, M, 2000) |
| "Primary aldosteronism was confirmed with the determination of PAC after 2 L saline administered iv over 4 h." | 1.31 | Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. ( Emmanuel, SC; Khaw, MC; Koay, ES; Loh, KC; Young, WF, 2000) |
| "Primary hyperaldosteronism is characterized by high plasma and urinary aldosterone and suppressed PRA." | 1.31 | Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage. ( Bähr, V; Diederich, S; Oelkers, W, 2000) |
| "Idiopathic hyperaldosteronism (IH) is a rare disorder characterized by hypertension, hypokalemia and bilateral adrenal hypersecretion of aldosterone." | 1.31 | Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism. ( Cartier, D; Contesse, V; Delarue, C; Duparc, C; Fischmeister, R; Kuhn, JM; Lefebvre, H; Lihrmann, I; Vaudry, H, 2000) |
| "Thus, retroperitoneoscopic treatment of Conn's syndrome should not be carried out unless venous sampling is carried out first." | 1.31 | An assessment of diagnostic procedures preparatory to retroperitoneoscopic removal of adenoma in cases of primary hyperaldosteronism. ( Brockmann, J; Cromme, S; Glodny, B; Kühle, C; Winde, G, 2000) |
| "The most common types of primary aldosteronism are bilateral adrenal hyperplasia (BAH), aldosterone-producing adenomas (APA), and primary adrenal hyperplasia." | 1.31 | Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. ( Brickner, RC; Findling, JW; Kehoe, ME; Knechtges, TE; Magill, SB; Raff, H; Shaker, JL, 2001) |
| "We found that hyperaldosteronism was associated with significantly higher alveolar fluid clearance and that this increase was related to the amiloride-sensitive component." | 1.31 | Modulation of transalveolar fluid absorption by endogenous aldosterone in adult rats. ( Darnel, AD; Kondo, T; Krozowski, ZS; Sasano, H; Suzuki, S; Suzuki, T; Tsubochi, H, 2001) |
| "The traditional workup for primary aldosteronism is cumbersome and requires discontinuing antihypertensive medications, which is inconvenient and potentially dangerous." | 1.31 | Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. ( Ahmad, S; Davidson, RC; Gallay, BJ; Toivola, B; Xu, L, 2001) |
| "Specific treatment of primary aldosteronism (adrenalectomy, treatment with spironolactone) led to the normalization of the BP curve with a marked BP decline." | 1.31 | Twenty-Four hour blood pressure profile in subjects with different subtypes of primary aldosteronism. ( Widimský, J; Zelinka, T, 2001) |
| "Primary hyperaldosteronism is more frequent among subjects with essential hypertension than previously thought." | 1.31 | [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach]. ( Ahuad, J; Claverie, X; Cortés, P; Fardella, C; Foradori, A; Gac, H; Montero, J; Mosso, L; Oestreicher, E; Soto, J, 2000) |
| "Setback in insulin resistance has been described in patients with essential hypertension." | 1.31 | [Effect of insulin in hypertension with high and low levels of renin]. ( Kasalová, Z; Prázný, M; Sindelka, G; Skrha, J; Widimský, J, 2001) |
| "The hypertension of Conn's syndrome is due to autonomous aldosterone production by a unilateral adrenocortical adenoma." | 1.31 | Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome). ( Connell, JM; Davies, E; Fraser, R; Friel, EC; Inglis, GC; Plouin, PF, 2001) |
| "Hypertension was resolved at follow-up (blood pressure < 140/90 mm Hg) without use of antihypertensive agents in 31 of 93 patients (33%)." | 1.31 | Primary aldosteronism: factors associated with normalization of blood pressure after surgery. ( Farley, DR; Grant, CS; Leibson, C; Sawka, AM; Thompson, GB; van Heerden, JA; Young, WF, 2001) |
| "We report a rare case of aldosteronism due to APA in which PAC and blood pressure were well controlled with small dose dexamethasone for over one year." | 1.31 | Aldosterone-producing adenoma with prolonged amelioration by dexamethasone. ( Ban, Y; Gomi, Y; Murai, M; Suzuki, S; Takahashi, R; Taniyama, M, 2001) |
| "Primary aldosteronism is a common cause of non-renal secondary hypertension." | 1.31 | Normokalemic hyperaldosteronism in patients with resistant hypertension. ( Benchetrit, S; Bernheim, J; Podjarny, E, 2002) |
| "Aldosterone treatment of M-1 cells substantially increased prostasin expression and stimulated (22)Na uptake." | 1.31 | Regulation of prostasin by aldosterone in the kidney. ( Adachi, M; Chai, KX; Chao, J; Chen, LM; Iwashita, K; Kitamura, K; Miyoshi, T; Narikiyo, T; Nonoguchi, H; Shiraishi, N; Tomita, K, 2002) |
| "Primary aldosteronism rarely complicates pregnancy." | 1.31 | Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. ( Asano, K; Fujimori, K; Hashimoto, T; Okawa, T; Sato, A; Yanagida, K, 2002) |
| "Primary aldosteronism is classified as aldosterone-producing adenoma (APA), idiopathic hyperaldosteronism (IHA), unilateral adrenal hyperplasia (UAH), primary adrenal hyperplasia (PAH), adrenal cancer, and glucocorticoid-remediable aldosteronism." | 1.31 | Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. ( Fujiwara, T; Nishikawa, T; Omura, M; Sasano, H; Yamaguchi, K, 2002) |
| "1." | 1.31 | Is primary aldosteronism underdiagnosed in clinical practice? ( Bobrie, G; Fiquet-Kempf, B; Launay-Mignot, P; Plouin, PF, 2001) |
| "Since primary aldosteronism has been reported in asymptomatic incidental adrenal masses (adrenal incidentalomas, AI), the aim of our study was to detect primary aldosteronism in normokalemic patients with AI and to verify whether a raised plasma aldosterone (ALD)/plasma renin activity (PRA) ratio may be useful for diagnosis." | 1.31 | Primary aldosteronism in normokalemic patients with adrenal incidentalomas. ( Argenio, G; Bernini, G; Moretti, A; Salvetti, A, 2002) |
| "Also, 17 patients with known primary aldosteronism were retrospectively examined." | 1.31 | Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. ( Hahn, EG; Hensen, J; Schobel, H; Seifarth, C; Trenkel, S, 2002) |
| "Primary aldosteronism is a disorder with hypertension, hypokalemia, increased plasma aldosterone, and suppressed renin activity." | 1.31 | Diagnostic value of the post-captopril test in primary aldosteronism. ( Castro, OL; Kem, DC; Yu, X, 2002) |
| "Primary aldosteronism is a disorder that is commonly considered in patients referred to the hypertension clinic." | 1.31 | Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning. ( Arici, MH; Karimeddini, MK; Malchoff, CD; Mansoor, GA; Whalen, GF, 2002) |
| "Formerly, the incidence of primary aldosteronism (PA) among patients with hypertension was believed to be less than 1%." | 1.31 | New diagnostic procedure for primary aldosteronism: adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blocker--application to a case of bilateral multiple adrenal microadenomas. ( Fukunaga, Y; Itoh, H; Masatsugu, K; Nakao, K; Sakaguchi, S; Sasano, H; Sawada, N; Sone, M; Yamahara, K; Yamamoto, A; Yurugi, T, 2002) |
| "Hyperaldosteronism has been causally linked to myocardial interstitial fibrosis experimentally, but it remains unclear if this link also applies to humans." | 1.31 | Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. ( Bertini, A; Cesari, M; Di Bello, V; Ganzaroli, C; Giorgi, D; Mariani, M; Pessina, AC; Rossi, GP; Sacchetto, A; Scognamiglio, R, 2002) |
| "Glucocorticoid remediable hyperaldosteronism (GRA) is a monogenic form of inherited hypertension caused by a chimeric gene originating from an unequal cross-over between the 11 beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) genes." | 1.31 | Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. ( Chiandussi, L; di Cella, SM; Gomez-Sanchez, CE; Mengozzi, G; Milan, A; Mulatero, P; Veglio, F; Williams, TA, 2002) |
| "It is, therefore, possible that primary hyperaldosteronism caused by an aldosterone-producing adenoma (APA) may be the result of constitutive activation of the AT1 receptor." | 1.30 | Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. ( Bonnardeaux, A; Clauser, E; Corvol, P; Davies, E; Plouin, PF, 1997) |
| "In primary aldosteronism, protein kinase C and calmodulin seem to have synergistic stimulatory effects on red blood cell Na(+)-H+ exchange, and both increase the affinity of the exchanger to H+, while their effect on Na+ binding is opposite." | 1.30 | Increased Na(+)-H+ exchange in red blood cells of patients with primary aldosteronism. ( Koren, W; Postnov, IY; Postnov, YV, 1997) |
| "In contrast, left ventricular hypertrophy markedly progressed despite the mild extracardiac target-organ damage in primary aldosteronism." | 1.30 | Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. ( Hamada, M; Hara, Y; Hayashi, Y; Hiwada, K; Kodama, K; Kohara, K; Okayama, H; Shigematsu, Y, 1997) |
| "Hyperplasia is managed medically whereas adenomas are treated surgically." | 1.30 | Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma. ( Melby, JC; Rao, A, 1997) |
| "Since hyperaldosteronism has been experimentally related to myocardial interstitial fibrosis, we investigated the effects of hypertension and excess aldosterone due to aldosterone-producing adenomas (APAs) on the heart." | 1.30 | Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. ( Canali, C; Graniero, GR; Palatini, P; Pavan, E; Pessina, AC; Rossi, GP; Sacchetto, A, 1997) |
| "A case of primary hyperaldosteronism and cardiomegaly due to a unilateral adrenal adenoma in a newborn is presented." | 1.30 | Hypertensive cardiomegaly caused by an aldosterone-secreting adenoma in a newborn. ( Armanini, D; Cecchetto, G; Fassina, A; Opocher, G; Pozzan, GB; Rigon, F; Zacchello, F, 1997) |
| "Unlike other forms of primary aldosteronism, recent prospective studies have paradoxically revealed that glucocorticoid-remediable aldosteronism (GRA) is usually characterized by normal potassium (K+) levels." | 1.30 | Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. ( Coolidge, C; Dluhy, RG; Fallo, F; Lifton, RP; Litchfield, WR; Silva, P; Williams, GH, 1997) |
| "Primary aldosteronism is one of the differential diagnosis of secondary hypertension." | 1.30 | Primary aldosteronism due to unilateral adrenal hyperplasia: a case report. ( Chen, LG; Lee, TI; Lin, HD; Liu, WY; Tang, KT; Wang, HC, 1997) |
| "The results suggest that left ventricular hypertrophy is more pronounced in patients with primary aldosteronism than in patients with other forms of hypertension." | 1.30 | Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. ( Demura, H; Demura, R; Hase, M; Naruse, K; Naruse, M; Seki, T; Tanabe, A; Tanaka, M; Yoshimoto, T, 1997) |
| "Glucocorticoid-remediable aldosteronism (GRA) is a rare form of inherited hypertension caused by a characteristic gene duplication." | 1.30 | Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. ( Coolidge, C; Dluhy, RG; Lifton, RP; Litchfield, WR; New, MI, 1997) |
| "Primary aldosteronism very rarely develops to malignant hypertension, and even in that case ARC is suppressed." | 1.30 | Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration. ( Fujiwara, K; Hayashi, K; Nakazato, T; Oka, K; Saruta, T; Suzawa, T, 1997) |
| " A dose-response curve to acetylcholine was performed at cumulative concentrations from 10(-9) to 10(-5) mol/L." | 1.30 | Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. ( Agabiti-Rosei, E; Bernini, G; Bettoni, G; Castellano, M; Giulini, SM; Muiesan, ML; Porteri, E; Rizzoni, D; Rossi, G; Tiberio, G, 1998) |
| "Aldosterone levels during treatment [13." | 1.30 | Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I. ( Gartside, MG; Gordon, RD; Stowasser, M; Taylor, WL; Tunny, TJ, 1997) |
| "Primary aldosteronism, though an uncommon cause of hypertension, causes significant morbidity, making it important to diagnose and treat this condition." | 1.30 | Aldosterone to renin ratios in the evaluation of primary aldosteronism. ( Eng, PH; Fok, AC; Ho, SC; Khoo, DH; Koh, LK; Lim, HS; Lim, SC; Tai, ES; Tan, CE; Tan, KE, 1997) |
| "Primary aldosteronism consists of a mixture of subgroups." | 1.30 | Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients. ( Haapiainen, R; Huikuri, K; Sirén, J; Sivula, A; Välimäki, M; Voutilainen, P, 1998) |
| "Hypertension is a common multifactorial disorder associated with considerable morbidity and mortality." | 1.30 | The diagnosis of Liddle syndrome by identification of a mutation in the beta subunit of the epithelial sodium channel. ( Houtman, P; Jackson, SN; Trembath, RC; Williams, B, 1998) |
| "Myelolipomas have occasionally been found in patients with Cushing's syndrome, pheochromocytoma and hyperthyroidism." | 1.30 | Aldosterone-producing adenoma associated with foci of myelolipoma. ( Bober, J; Lazurova, I; Pajtasova, D; Sokol, L; Trejbal, D; Zachar, M, 1998) |
| "In conclusion, primary aldosteronism is characterized by decreased supine and standing BP variability, which is due in part to the preservation of baroreflex function." | 1.30 | Decreased blood pressure variability at rest in patients with primary aldosteronism. ( Abe, K; Aihara, A; Imai, Y; Munakata, M; Yoshinaga, K, 1998) |
| "Twenty-three patients with primary aldosteronism, 22 essential hypertensive patients and 16 normal controls were studied." | 1.30 | Impaired baroreflex function and arterial compliance in primary aldosteronism. ( Cat Genova, G; Chiandussi, L; Grosso, T; Martini, G; Melchio, R; Molino, P; Rabbia, F; Veglio, F, 1999) |
| "Although primary aldosteronism is rare, especially during pregnancy, it should be always considered as one of etiologies of hypertension in pregnancy." | 1.30 | Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman. ( Fujiyama, S; Inada, M; Iwasaka, T; Maruyama, K; Masaki, H; Matsubara, H; Matsuda, T; Mori, Y; Nagata, T; Okada, S; Umeda, Y; Yonemoto, T, 1999) |
| "Ventricular fibrillation has not previously been described as a presention of a biochemically and surgically proven aldosterone-producing adenoma." | 1.30 | Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism. ( Abdo, A; Bebb, RA; Wilkins, GE, 1999) |
| "However, hyperkalemia is generally neither severe nor prolonged, in which replacement therapy with mineralocorticoid is seldom necessary." | 1.30 | A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. ( Inoue, D; Koshiyama, H; Muramatsu, Y; Sasano, H; Sato, Y; Sugawa, A; Tanaka, S; Taniguchi, R; Yamauchi, M, 1998) |
| "Normotensive primary hyperaldosteronism is exceedingly rare." | 1.30 | Aldosterone-producing adenoma without hypertension: a report of two cases. ( Ghulam, A; Jeunemaitre, X; Lefebvre, J; Provost, F; Ronci, N; Tabarin, A; Vantyghem, MC, 1999) |
| "In the 12 patients with hyperaldosteronism, retrospective analysis of clinical (age, sex, blood pressure), biochemical (plasmatic and urinary potassium, plasmatic aldosterone, plasma renin activity, and plasmatic aldosterone/renin activity ratio), and morphological (computed tomography, magnetic resonance, and norcholesterol scintigraphy) data was performed." | 1.30 | [Primary hyperaldosteronism--12 clinical cases]. ( Almeida, G; Coucelo, J; da Silva, EP; Lutucuta, S; Machado, FS; Telles, EC; Vagueiro, C, 1999) |
| "In primary hyperaldosteronism, it is important to distinguish between unilateral and bilateral disease, as management strategies differ." | 1.30 | Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas. ( Atkinson, AB; Ferrett, CG; Harper, R; McIlrath, EM; McKnight, JA; Russell, CF; Sheridan, B, 1999) |
| "To study severity of left ventricular hypertrophy (LVH) and left ventricular function in patients with primary aldosteronism (PA) in comparison with hyperaldosteronemia and preoperative arterial hypertension, to follow the dynamics of these parameters early and late after surgical removal of aldosteroma." | 1.30 | [Left ventricular myocardial structure and function in patients with primary aldosteronism]. ( Arabidze, GG; Chikhladze, NM; Iarovaia, EB; Sergakova, LM, 1999) |
| "Primary hyperaldosteronism is more frequent than previously thought, it is overlooked when hypokalemia is used as the screening test and it can only be diagnosed measuring plasma aldosterone and renin activity." | 1.30 | [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]. ( Fardella, C; Foradori, A; Huete, A; Montero, J; Mosso, L; Rojas, A; Rojas, P; Rojas, V; Sánchez, O; Soto, J, 1999) |
| "Aldosterone-renin ratio was in PH patients 10-fold higher comparing with EH patients." | 1.30 | [Incidence of primary hyperaldosteronism in hospitalized patients with hypertension]. ( Bober, J; Lazurova, I; Schwartz, P; Sokol, L; Trejbal, D; Trejbalova, L; Valansky, L; Wagnerova, H; Zachar, M, 1999) |
| "Primary aldosteronism comprises two different conditions, the tumoral form usually caused by an adenoma and the idiopathic form due to nodular hyperplasia of the two adenals." | 1.29 | [Conceptual basis and diagnosis of primary hyperaldosteronism]. ( Amar, J; Begasse, F; Chamontin, B; Guittard, J; Salvador, M, 1995) |
| "Dexamethasone-sensitive hyperaldosteronism is associated with early onset hypertension and primary hyperaldosteronism." | 1.29 | [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. ( Aupetit-Faisant, B; Charru, A; Corvol, P; Guyene, TT; Jeunemaitre, X; Pascoe, L; Plouin, PF; Schambelan, M; Shackleton, CH, 1995) |
| "The degree of hyperaldosteronism in the subjects was mild compared with other conditions and, although an effect on left ventricular mass index could be detected, the present results indicate that other factors may be necessary for the development of left ventricular hypertrophy." | 1.29 | Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism. ( Connell, JM; Jamieson, A; Kennedy, JA; Murdoch, D, 1995) |
| "Patients with primary aldosteronism had significantly higher (P < 0." | 1.29 | Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism. ( Pincus, S; Siragy, HM; Veldhuis, JD; Vieweg, WV, 1995) |
| "In patients with primary aldosteronism and renovascular hypertension the plasma aldosterone level was shown to be an important factor upregulating AT1 receptor mRNA." | 1.29 | Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile. ( Murakami, M; Saruta, T; Sato, A; Shibata, H; Suzuki, H, 1994) |
| "Primary aldosteronism caused by an aldosterone-producing adrenal adenoma was documented in an 11-year-old girl who presented with persistent hypertension, headache, tinnitus and hypokalemia." | 1.29 | Adrenal adenoma with primary aldosteronism in a child: a case report. ( Chang, WT; Chen, HC; Lai, FC; Peng, HC; Wen, MC, 1994) |
| "In patients with primary aldosteronism due to aldosterone producing adenoma (APA) (n = 21) and Cushing's disease or syndrome (Cushing's disease n = 13; adrenocortical adenoma n = 10), plasma 18oxoF level early in the morning following an overnight fast was evaluated as well as plasma cortisol and aldosterone levels." | 1.29 | Plasma 18-oxocortisol levels in the patients with adrenocortical disorders. ( Gomez-Sanchez, CE; Miura, K; Morita, H; Mune, T; Yamakita, N; Yasuda, K, 1994) |
| "Spironolactone treatment (100 mg/daily) completely reversed the syndrome of mineralocorticoid excess." | 1.29 | Unilateral adrenal hypersecretion of both aldosterone and cortisol in two first cousins with a syndrome of mineralocorticoid excess but without signs of hypercortisolism. ( Balsano, F; Bonavita, MS; Carlomagno, A; Coassin, S; De Siati, L; Falaschi, P; Ferri, C; Gualdi, G, 1994) |
| "Patients with glucocorticoid-remediable aldosteronism (GRA) possess a chimeric gene resulting from fusion of the genes encoding steroid aldosterone synthase and 11 beta-hydroxylase." | 1.29 | Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism. ( Boscaro, M; Fallo, F; Kuhnle, U; Sonino, N, 1994) |
| "A case of normotensive primary aldosteronism in association with non-functioning adenoma and aldosterone producing adenoma in ipsilateral adrenal gland is reported." | 1.29 | [A case of normotensive primary aldosteronism in association with non-functioning adenoma and aldosterone producing adenoma in ipsilateral adrenal gland]. ( Akiyama, M; Suyama, B, 1994) |
| "A retrospective review of patients with primary hyperaldosteronism treated at the Duke University Medical Center was performed." | 1.29 | Surgical treatment of primary hyperaldosteronism. ( Gunnells, JC; Leight, GS; Weigel, RJ; Wells, SA, 1994) |
| "From these data it emerges that hyperaldosteronism, as observed in these patients with CRI, is a relatively reliable marker of the extent of CRI and may occur independently of the activation of the RAA system, given that other factors, such as orthostatic stimulation, alterations in the acid-base equilibrium, and the degree of aldosterone hepatic and urinary clearance, contribute to its pathogenesis." | 1.29 | [Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]. ( Buracchi, P; Carletti, F; Gennari, C; Lucani, B; Martinelli, M; Nami, R; Panza, F; Pavese, G; Saia, F, 1993) |
| "The hyperaldosteronism could not be suppressed by dexamethasone." | 1.29 | [Unilateral autonomous aldosterone production in hyperaldosteronism suppressible by dexamethasone]. ( Haack, D; Jakob, F; Ludwig, J; Rendl, J; Schröder, K; Seufert, J; Vecsei, P, 1993) |
| "In 30-40% of patients with primary aldosteronism owing to adenoma, hypertension is not relieved even though a hyper-functioning adenoma has been completely removed." | 1.29 | [The prediction of blood pressure after adrenalectomy in primary aldosteronism]. ( Ishibashi, K; Ishida, M; Ishida, T; Kanbe, M; Kido, K; Matsuura, H; Mitsuda, H; Oshima, T; Ozono, R; Watanabe, M, 1993) |
| "Because familial hyperaldosteronism type II (FH-II) includes tumor formation, we examined the karyotypes of benign adrenocortical aldosterone-producing adenomas (APAs), including those from patients with FH-II." | 1.29 | Karyotypic abnormalities in benign adrenocortical tumors producing aldosterone. ( Conic, S; Epping, A; Gordon, RD; Klemm, SA; Martin, N; Rutherford, JC; Stowasser, M; Tunny, TJ, 1993) |
| "In cells from primary aldosteronism, increasing concentrations of etomidate (10(-11)-10(-5) M) produced a dose-dependent decrease of basal and ACTH-stimulated cortisol, aldosterone, 18-hydroxycorticosterone, and corticosterone secretions (ED50: 10(-9)-10(-8) M for each of these corticosteroids)." | 1.29 | Direct inhibitory effect of etomidate on corticosteroid secretion in human pathologic adrenocortical cells. ( Fütö, L; Gláz, E; Kiss, R; Rácz, K; Sergev, O; Tóth, M; Varga, I, 1993) |
| "Effective management of primary aldosteronism is dependent upon correct localization of excessive aldosterone production." | 1.29 | Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. ( Bihrle, R; Donohue, JP; Dugan, J; Eller, D; Gleason, PE; Pratt, JH; Weinberger, MH, 1993) |
| "Spironolactone, however, was able to prevent myocardial fibrosis in RHT and aldosterone models of acquired arterial hypertension irrespective of the development of LVH and the presence of hypertension." | 1.29 | Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. ( Brilla, CG; Matsubara, LS; Weber, KT, 1993) |
| "The most common cause of primary aldosteronism is a small aldosterone-secreting adrenal adenoma." | 1.29 | CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients. ( Dunnick, NR; Kurylo, L; Leder, RA; Leight, GS; Paulson, E; Roubidoux, MA, 1993) |
| "Hypokalemia is an uncommon presentation of renovascular hypertension." | 1.29 | Unilateral renal artery stenosis seen initially as severe and symptomatic hypokalemia. Pathophysiologic assessment and effects of surgical revascularization. ( Burch, A; Ruby, ST; White, WB, 1993) |
| "The aldosterone content was significantly elevated, while the androstenedione content was significantly decreased in the tumour portion of the adenoma compared with that in the normal control adrenals." | 1.29 | Significance of steroidogenic enzymes in the pathogenesis of adrenal tumour. ( Ishimura, Y; Ogishima, T; Saruta, T; Shibata, H; Suzuki, H, 1993) |
| "We report a case of primary hyperaldosteronism due to unilateral diffuse hyperplasia." | 1.29 | Unilateral diffuse adrenal hyperplasia masquerading as aldosterone-producing adenoma in primary hyperaldosteronism. ( Hashimoto, T; Ishigooka, M; Kato, T; Kubota, Y; Nakada, T; Sasagawa, I; Suzuki, H, 1993) |
| "A small subgroup of primary aldosteronism due to aldosteronoma, named aldosterone-producing renin-responsive adenoma (AP-RA), has been reported to masquerade as idiopathic hyperaldosteronism (IHA) because of the responsiveness of the plasma aldosterone concentration (PAC) to upright posture (UP)." | 1.29 | Characteristics of aldosterone-producing adenoma responsive to upright posture. ( Aiba, M; Demura, H; Kikuchi, C; Kono, A; Nomura, K; Ogasawara, M; Toraya, S, 1995) |
| "Primary aldosteronism (PA) is caused by an adrenal aldosterone-producing tumor (A-APT) or adrenal hyperplasia." | 1.29 | Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients. ( Abdelhamid, S; Bönhof, JA; Müller-Lobeck, H; Pahl, S; Remberger, K; Röckel, A; Walb, D, 1996) |
| "Although primary hyperaldosteronism is an uncommon cause of hypertension, it is the most common form of renin-independent hypermineralocorticoidism." | 1.29 | [Adrenal adenoma or hyperplasia? Problems of differential diagnosis in an unusual case of primary hyperaldosteronism]. ( Bonifacio, V; Ciampani, T; Giannini, D; Mancini, G; Sanna, AL, 1996) |
| "Primary hyperaldosteronism is an uncommon disorder, and there are few reports of its occurrence and management in pregnancy." | 1.29 | Primary hyperaldosteronism in pregnancy. A case report. ( Moore, F; Seely, EW; Solomon, CG; Thiet, M, 1996) |
| "It has been recognised recently that primary hyperaldosteronism may be more common than previously thought, the frequency of diagnosis being improved by screening using a plasma aldosterone concentration to renin activity ratio." | 1.29 | Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'? ( Brown, MA; Cramp, HA; Whitworth, JA; Zammit, VC, 1996) |
| "Aldosterone was unresponsive (<50% rise) to 2 h of upright posture following overnight recumbency in 15 out of 15 (100%) patients studied, and to angiotensin II infusion (2 ng/kg per min for 1 h) in 14 out of 14 patients (100%)." | 1.29 | Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I. ( Bachmann, AW; Gordon, RD; Jonsson, JR; Klemm, SA; Stowasser, M; Tunny, TJ, 1995) |
| "The patients with primary aldosteronism had lower serum potassium and higher plasma aldosterone concentrations than those with essential hypertension." | 1.29 | Albuminuria in untreated patients with primary aldosteronism or essential hypertension. ( Halimi, JM; Mimran, A, 1995) |
| "Primary aldosteronism should be considered in patients presenting with neuromuscular weakness associated with hypokalemia, regardless of the degree of hypertension." | 1.29 | Paralytic myopathy--a leading clinical presentation for primary aldosteronism in Taiwan. ( Hsu, BR; Huang, YY; Tsai, JS, 1996) |
| "In glucocorticoid-remediable aldosteronism (GRA) a chimeric gene has been described with the activity of aldosterone synthase, but the promoter of 11 beta-hydroxylase leading to ectopic expression of aldosterone synthase activity in the zona fasciculata." | 1.29 | Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications. ( Bradwin, G; Carroll, J; Dluhy, R; Fallo, F; Gomez-Sanchez, CE; Mortensen, R; Pistorello, M, 1996) |
| "In primary aldosteronism, high-resolution adrenal computed tomography (CT) increasingly identifies subtle anatomic abnormalities." | 1.29 | Primary aldosteronism: adrenal venous sampling. ( Grant, CS; Stanson, AW; Thompson, GB; van Heerden, JA; Young, WF, 1996) |
| "In control subjects and patients with Conn's syndrome, the DOC:B ratio was not affected by ACTH." | 1.29 | Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism. ( Connell, JM; Davies, E; Fraser, R; Inglis, GC; Ingram, MC; Jamieson, A, 1996) |
| "In control subjects and patients with Conn's syndrome, the DOC:B ratio was not affected by ACTH." | 1.29 | 11 beta-Hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension? ( Connell, JM; Davies, E; Fraser, R; Ingram, M; Jamieson, AJ; Soro, A, 1996) |
| "A 41-year-old woman developed primary aldosteronism due to bilateral multiple aldosterone-producing adenomas (APA)." | 1.29 | Primary aldosteronism with bilateral multiple aldosterone-producing adrenal adenomas. ( Beniko, M; Ikota, A; Koizumi, S; Kunita, H; Mashio, Y; Matsuda, A; Matsuya, K; Mizumoto, H; Sasano, H; Watanabe, T; Yamazaki, M, 1996) |
| "Liddle's syndrome (or pseudoprimary aldosteronism) is a rare hereditary disease; only 18 cases have been reported since 1963." | 1.28 | [Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases]. ( Charpentier, B; Dommergues, JP; Fries, D; Garay, RP; Guillot, M; Jullien, M; Kleinknecht, D; Nazaret, C; Noblins, M, 1992) |
| "Twenty-eight patients with primary aldosteronism were treated from 1974 to 1990." | 1.28 | [Diagnosis and treatment of primary aldosteronism]. ( Wang, GY, 1992) |
| "This case shows that secondary hyperaldosteronism, possibly due to an impairment of sodium conservation in the distal tubule, may contribute to the loss of potassium from the distal tubule even after the correction of acidosis." | 1.28 | Renal potassium wasting in distal renal tubular acidosis: role of aldosterone. ( Asano, Y; Kano, S; Muto, S; Okazaki, H, 1992) |
| "Aldosterone-producing adenomas (Conn's syndrome) are also commonly composed of zona fasciculata-like cells, make "hybrid steroids" in excess and are very sensitive to ACTH but not to angiotensin II." | 1.28 | Primary aldosteronism: hypertension with a genetic basis. ( Gordon, RD; Klemm, SA; Stowasser, M; Tunny, TJ, 1992) |
| "In patients with primary aldosteronism, the mean supine ANP plasma level was significantly higher than in the age matched normal subject group; supine ANP was significantly higher in the APA than in the IHA group." | 1.28 | Usefulness of atrial natriuretic peptide assay in primary aldosteronism. ( Carpené, G; Cimolato, M; Mantero, F; Opocher, G; Rocco, S; Vettoretti, A, 1992) |
| "3." | 1.28 | Concurrence of primary aldosteronism and renal artery stenosis. ( Gordon, RD; Grunstein, H; Monaghan, JC; Roche, J; Stokes, GS, 1992) |
| "The relevance of these findings to primary hyperaldosteronism and to the nature of the transition is discussed." | 1.28 | The origin and significance of 18-hydroxycortisol: studies in hyperaldosteronism and in bovine adrenocortical cells in vitro. ( Budd, PS; Connell, JM; Corrie, JE; Fraser, R; Kenyon, CJ, 1991) |
| "Secondary hyperaldosteronism due to involvement of small and medium-sized renal arteries caused severe hypertension and left ventricular hypertrophy, and together with abdominal complaints, loss of weight, livedo reticularis and elevated titers of streptococcal antibodies formed the clinical pattern of the disease." | 1.28 | [Panarteritis nodosa with secondary hyperaldosteronism involving renal arterioles]. ( Bart, G; Neugebauer, H, 1991) |
| "Aldosterone was secreted from the adrenal cortex in all patients and was increased by ACTH in 75% of the tissue specimens." | 1.28 | Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro. ( Grimelius, L; Gröndal, S; Hamberger, B; Thorén, M, 1991) |
| "Twenty patients with primary hyperaldosteronism had endocrinologic and radiologic studies to distinguish aldosterone-producing adenoma from idiopathic hyperaldosteronism due to bilateral micro- or macronodular hyperplasia of the adrenal cortex." | 1.28 | Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies. ( Manoogian, C; Nadler, JL; Radin, DR, 1992) |
| "Treatment with spironolactone alone, or in combination with either intravenous dopamine or ibopamine orally, amiloride, enalapril, hydralazine or clonidine corrected serum potassium values but failed to normalize blood pressure and to correct plasma renin activity and plasma aldosterone." | 1.28 | A neonate with idiopathic hyperaldosteronism. ( Derkx, FH; Donckerwolcke, RA; Griffiven, AW; Schalekamp, MA; Vande Walle, JG; Veenhoven, RH; Wit, JM, 1991) |
| "The aldosterone content was significantly higher in adrenocortical adenomas than in normal adrenal glands, while F content in adenomas was similar to the level in normal adrenal glands." | 1.28 | Expression of cytochrome P-450 mRNAs in steroidogenesis of adrenocortical adenomas from patients with primary aldosteronism. ( Haji, M; Nawata, H; Ogo, A; Ohashi, M, 1991) |
| "We report 2 cases of primary aldosteronism associated with a unilateral hyperplastic macronodule resembling an aldosterone-producing adenoma on CT scan." | 1.28 | [Macronodule associated with bilateral adrenal hyperplasia. A rare misleading cause of primary aldosteronism (two cases)]. ( Barat, JL; Dallocchio, M; Dubourg, H; Ducassou, D; Latapie, JL; Leprat, F; Roger, P; Tabarin, A, 1991) |
| "The data used to make the diagnosis of primary hyperaldosteronism and to assess the likelihood of the presence of an adenoma indicate that patients studied at 40 centres in the UK show results very similar to those of North American series where large numbers of patients have been described but all have been studied in the same centre." | 1.28 | Primary hyperaldosteronism in England and Wales: a review of the use of a Supraregional Assay Service laboratory for the measurement of aldosterone and plasma renin activity. ( James, VH; Short, F, 1991) |
| "Volume expansion reverses the hyperaldosteronism." | 1.28 | Modulation of the renin-aldosterone system by iodotyrosines as tyrosine hydroxylase inhibitors. ( Berk, LS; Tan, LG; Tan, SA, 1990) |
| "Four cases of pseudohyperaldosteronism due to chronic ingestion of liquorice-containing laxatives are described." | 1.28 | Pseudohyperaldosteronism from liquorice-containing laxatives. ( Armanini, D; Pratesi, C; Scali, M; Zampollo, V; Zennaro, MC, 1990) |
| "The aldosterone responses were not stimulated by angiotensin II (10(-9) mol/L) in normal adrenal and adenoma tissues, but angiotensin II (5 x 10(-9) mol/L) can stimulate APA tissues." | 1.28 | [Effects of alpha-human ANF and angiotensin II on aldosterone secretion in vitro from cultured human adrenal tissues and APA tissues]. ( Sun, M, 1990) |
| "A peculiar form of hyperaldosteronism is the glucocorticoid-remediable subtype." | 1.28 | New aspects of mineralocorticoid hypertension. ( Armanini, D; Biason, A; Boscaro, M; Carpenè, G; Fallo, F; Mantero, F; Opocher, G; Rocco, S; Scaroni, C; Sonino, N, 1990) |
| "This report deals with three cases of Bartter's syndrome whose symptomatology was associated with indirect hyperbilirubinemia." | 1.28 | Bartter's syndrome associated with indirect hyperbilirubinemia: a possible clinical variety. ( Battisti, P; Cugini, P; Di Palma, L; Di Simone, S; Kawasaki, T; Sasaki, H; Uezono, K, 1990) |
| "We describe four cases of primary hyperaldosteronism whose initial presentation was a moderate to severe hypertension." | 1.28 | [Significance of the captopril test in the diagnosis of primary hyperaldosteronism --apropos of 4 clinical cases]. ( Alberto, MJ; Gonçalves, P; Machado, J; Maltez, F; Martins, G; Proença, R, 1990) |
| "We have reported a case of Conn's syndrome, with pain, tenderness, and swelling of the calf mimicking deep vein thrombophlebitis." | 1.28 | Conn's syndrome with rhabdomyolysis mimicking deep vein thrombophlebitis. ( Mahdyoon, H; Mermiges, DN; Wisgerhof, M, 1990) |
| "The case of a young woman with primary aldosteronism originating extraadrenally--ovarian tumor--is reported." | 1.28 | Autonomous aldosterone-secreting ovarian tumor. ( Chinoy, R; Kamat, MR; Kulkarni, JN; Lotlikar, RG; Mistry, RC, 1990) |
| "The association of hypokalemia, aldosteronism, and renal cysts was also supported by the finding of multiple medullary cysts in two patients with primary renal potassium wasting." | 1.28 | Association of hypokalemia, aldosteronism, and renal cysts. ( Hattery, RR; Offord, KP; Torres, VE; Young, WF, 1990) |
| "1." | 1.28 | Levels of atrial natriuretic peptide are not always consistent with atrial pressure: is there alternative regulation as evidenced in Gordon's and Bartter's syndromes? ( Finn, WL; Gordon, RD; Hamlet, SM; Hawkins, PG; Kewal, NK; Klemm, SA; Purton, KJ; Tunny, TJ, 1989) |
| "Aldosterone secretion was stimulated by ACTH, angiotensin II and potassium with or without ANF 10 microM." | 1.28 | Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies. ( D'Agostino, D; Leone, L; Mantero, F; Opocher, G; Rocco, S, 1989) |
| "Dexamethasone-suppressible hyperaldosteronism (DSH) is a rare familial variety of primary aldosteronism in which the biochemical features of mineralocorticoid excess are corrected by treatment with glucocorticoids." | 1.28 | Dexamethasone-suppressible hyperaldosteronism: a large new kindred. ( Burns, A; Murnaghan, DJ; O'Mahony, S, 1989) |
| "Postoperatively the signs of hyperaldosteronism (Conn's syndrome) regressed and the average blood pressure was 112/76 mm Hg." | 1.28 | [Primary hyperaldosteronism without arterial hypertension]. ( Andrassy, K; Buhr, H; Osterziel, KJ; Raue, F; Vecsei, P; Zeier, M; Ziegler, R, 1989) |
| "A 37-year-old woman presented with hyperaldosteronism, suppressed renin levels, and a left adrenal mass on CT scanning." | 1.28 | Possible association of aldosterone producing adenoma and non-functioning adrenal tumor. ( Kobayashi, T; Kon-i, I; Matsubara, T; Miyamori, I; Morise, T; Nakagawa, A; Soma, R; Takasaki, H; Takeda, R, 1989) |
| "Serum of patients with Bartter's syndrome incubated with healthy RBC distinctly increased their 86Rb influx." | 1.27 | The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome. ( Dvoráková, J; Horký, K; Schreiber, V, 1984) |
| "This suggests that in Bartter's syndrome the rate of entry of PGI2 into the circulation is normal." | 1.27 | Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome. ( Branch, RA; Brash, AR; Gill, JR; Oates, JA; Watson, ML, 1983) |
| "The aldosterone levels in patients with Conn's syndrome were significantly increased in plasma and also in saliva." | 1.27 | A simple solid phase enzyme immunoassay for aldosterone in plasma and saliva. ( Freymann, E; Garten, CD; Hofmann, F; Hubl, W; Meissner, D; Neef, B; Schmidt, PK; Taubert, H; Thiele, HJ, 1983) |
| "In the patients with hyperaldosteronism, plasma aldosterone concentrations (mean +/- 1 S." | 1.27 | Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor. ( Bumpus, FM; Carey, RM; Dolan, LM; Malchoff, CD; Sen, S, 1984) |
| "A male patient presenting with primary hyperaldosteronism after a three-year delay, was found to have an aldosterone producing adrenocortical carcinoma." | 1.27 | Carcinoma of the adrenal cortex causing primary hyperaldosteronism. A case report and review of the literature. ( Schaberg, A; Slee, PH; Van Brummelen, P, 1983) |
| "Although secondary hyperaldosteronism due to renal vein thrombosis may occur as a result of renal cell carcinoma or adrenal cortical carcinoma, primary hyperaldosteronism is rarely associated with the latter." | 1.27 | Adrenal cortical carcinoma: an unusual cause of hyperaldosteronism. ( Telner, AH, 1983) |
| "Most diagnostic tests for primary aldosteronism use maneuvers to expand the extracellular fluid volume, thereby suppressing the renin-angiotensin system." | 1.27 | Single dose captopril as a diagnostic test for primary aldosteronism. ( Brown, RD; Carollo, ML; Hanson, CS; Kem, DC; Lyons, DF, 1983) |
| "The diagnosis of primary tumoral hyperaldosteronism is based on a series of hormonal parameters, measured under resting conditions and after stimulation." | 1.27 | [Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril]. ( Corvol, P; Ménard, J; Plouin, PF; Thibonnier, M, 1983) |
| "These findings suggested Bartter's syndrome." | 1.27 | Cystic fibrosis mimicking Bartter's syndrome. ( Davison, AG; Snodgrass, GJ, 1983) |
| "A definite diagnosis of primary aldosteronism cannot be made during toxemia of pregnancy, and it is necessary to do serial determinations of plasma renin activity and plasma aldosterone concentration after delivery to confirm the diagnosis." | 1.27 | Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism. ( Akahoshi, M; Aoi, W; Doi, Y; Hashiba, K; Kuramochi, M; Shimizu, A; Suzuki, S; Utsunomiya, T, 1983) |
| "In two children with Bartter's syndrome, treatment with indomethacin halved the urinary excretion of prostaglandins E and F within 24 hours and subsequently maintained it within the normal range during follow-up for more than 5 years." | 1.27 | The role of prostaglandins in Bartter's syndrome. ( Hewitt, GJ; Mitchell, MD; Winterborn, MH, 1984) |
| "The hyperaldosteronism has been documented by hypopotassiemia , a raised level of plasma aldosterone as well as suppressed plasma renin activity even after adequate stimulus." | 1.27 | [Pseudohypoparathyroidism associated with hyperaldosteronism and polyglobulia]. ( Bambara, LM; Battaia, L; Corrocher, R; Pachor, ML; Pedrazzoli, M, 1984) |
| "A 7-year-old girl had hyperaldosteronism due to an adrenal cortical adenoma, a rare, surgically remediable cause of hypertension." | 1.27 | Hypertension caused by an aldosterone-secreting adenoma. Occurrence in a 7-year-old child. ( Bryer-Ash, M; Luetscher, JA; Rosenfeld, RG; Shochat, SJ; Tune, BM; Wilson, DM, 1984) |
| "Her condition was diagnosed as primary aldosteronism without hypertension, which is very rare, based on an increased level of plasma aldosterone concentration, low plasma renin activity, and a typical finding of aldosterone-producing adenoma by adrenal scintigraphy." | 1.27 | A case of normotensive primary aldosteronism--comparison with 13 previously experienced cases with hypertension. ( Iimura, O; Kikuchi, K; Nakamura, Y; Nishimiya, T; Oimatsu, H; Ota, S; Shimamoto, K, 1984) |
| "Treatment with indomethacin also improved the pressor responsiveness to angiotensin II and norepinephrine, but this occurred in association with a decrease in PRA, PAC and urinary excretion of PGE2 and PGF2 alpha." | 1.27 | Hypokalemia and prostaglandin overproduction in Bartter's syndrome. ( Amagasaki, Y; Kato, E; Konishi, K; Nakata, I; Ozawa, Y; Saruta, T; Senba, S, 1984) |
| "Fifteen patients with idiopathic hyperaldosteronism were examined." | 1.27 | [Clinical aspects, diagnosis and treatment of idiopathic hyperaldosteronism]. ( Babloian, GV; Kazanchian, PO; Litvinov, AP; Migalina, LA; Pokrovskiĭ, AV, 1984) |
| "Primary aldosteronism is a potentially curable cause of hypertension; it occurs in about 1% of hypertensive patients." | 1.27 | 'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma. ( Almog, C; Burke, M; Papo, J; Stavorovsky, M, 1984) |
| "Twenty-nine patients with primary hyperaldosteronism were evaluated with computed tomography (CT), adrenal venous sampling, and adrenal venography." | 1.27 | Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling. ( Borkowski, GP; Bravo, EL; Geisinger, MA; O'Donovan, PB; Risius, BF; Zelch, MG, 1983) |
| "Thirty-four patients with untreated Conn's syndrome were studied in a metabolic ward." | 1.27 | Relation of blood pressure with body and plasma electrolytes in Conn's syndrome. ( Beretta-Piccoli, C; Brown, JJ; Davies, DL; Ferriss, B; Fraser, R; Lasaridis, A; Lever, AF; Morton, JJ; Robertson, JI; Semple, PF, 1983) |
| "The most common causes of virilization are considered unlikely on the basis of clinical and laboratory data." | 1.27 | Aldosteronism in pregnancy: association with virilization of female offspring. ( Elterman, JJ; Hagen, GA, 1983) |
| "Aldosterone excretion was elevated in six patients and within the normal range in three patients." | 1.27 | Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone. ( Ganguly, A; Gill, JR; Gomez-Sanchez, CE; Gordon, RD, 1988) |
| "Patients with primary aldosteronism and unilateral renovascular hypertension of similar blood pressure levels, age and sex have almost identical degrees of left ventricular hypertrophy and anatomy." | 1.27 | Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism. ( Abe, H; Ashizawa, A; Iwata, S; Kuramochi, M; Nagata, S; Omae, T; Saitoh, F; Suzuki, T, 1988) |
| "Hyperaldosteronism was associated with the most pronounced deviations in the relationship between stimulants and aldosterone." | 1.27 | [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism]. ( Chikhladze, NM; Pershakova, LP; Shkhvatsabaia, IK; Uchitel', IA; Ustinova, SE, 1985) |
| "Four patients with Bartter's syndrome were given asn1-,val5-AII by iv infusion at rates of 10, 20, 50 and 100 pmol/kg X min, each for 7 min." | 1.27 | Responses of patients with Bartter's syndrome to angiotensin III and angiotensin II-(3-8)-hexapeptide. ( Ikeda, F; Imura, H; Khosla, MC; Kono, T; Oseko, F; Taniguchi, A; Yoshioka, M, 1985) |
| "Idiopathic hyperaldosteronism was diagnosed in an 8-year-old castrated male Yorkshire Terrier, based on increased concentration of plasma aldosterone, hypertension, hypernatremia, decreased natriuresis, hypokalemia, and hyperkaluria." | 1.27 | Idiopathic hyperaldosteronism in a dog. ( Anson, LW; Breitschwerdt, EB; Cook, CS; Fulghum, RE; Greenfield, CL; Meuten, DJ, 1985) |
| "Four patients with idiopathic aldosteronism all had an increase in plasma aldosterone levels after 5HTP administration, whereas the response in four patients with aldosterone-producing adenoma was variable." | 1.27 | Central serotonergic stimulation of aldosterone secretion. ( Grekin, RJ; Gross, MD; Shenker, Y, 1985) |
| "Out of 100 cases of tumoral primary aldosteronism studied from 1977 to 1987, we observed 4 ACC and 96 Conn's adenomas (CONN)." | 1.27 | [Malignant adrenal cortex carcinoma revealed by an isolated picture of primary hyperaldosteronism]. ( Chatellier, G; Corvol, P; Farge, D; Pagny, JY; Plouin, PF, 1988) |
| "Hyperaldosteronism in the patients with renal-parenchymatous and essential arterial hypertension was regarded as secondary in a stable and malignant course of arterial hypertension." | 1.27 | [Radioimmunologic determination of aldosterone and renin in the blood in the diagnosis of different forms of arterial hypertension]. ( Khalmuratova, RA; Khamidov, RI; Sattarova, FK, 1987) |
| "In patients with primary aldosteronism (n = 21) elevated as well as normal values of urinary 21-deoxyaldosterone were found, indicating that in some patients aldosterone may be formed not only from corticosterone but also from the 21-deoxy compound." | 1.27 | 21-Deoxyaldosterone excretion in patients with primary aldosteronism and 21-hydroxylase deficiency. ( Abdelhamid, S; Bige, K; Bokkenheuser, V; Heinrich, U; Lewicka, S; Vecsei, P; Winter, J, 1987) |
| "The case of a woman with autonomous aldosteronism, hypertension, and malignant ovarian tumour is reported." | 1.27 | Primary aldosteronism due to a malignant ovarian tumour. ( Jackson, B; Valentine, R; Wagner, G, 1986) |
| "A 50-year old female with primary aldosteronism and masked hyperaldosteronemia is reported." | 1.27 | A case report of aldosterone producing adenoma with masked hyperaldosteronemia. ( Arimori, S; Hiramatsu, K; Takahashi, K, 1986) |
| "A patient with primary aldosteronism had bilateral adrenal tumours on computed tomography." | 1.27 | False localization of an aldosteronoma by dexamethasone-suppressed adrenal scintigraphy. ( Davidson, JK; Fraser, R; Herd, GW; Hilditch, TE; Parker, D; Semple, PF, 1987) |
| "Malignant hypertension in Conn's syndrome is rare." | 1.27 | Malignant hypertension due to an aldosterone producing adrenal adenoma. ( Kincaid-Smith, P; Murphy, BF; Whitworth, JA, 1985) |
| "In 72 patients with primary aldosteronism who were classified on the basis of adrenal pathology after adrenalectomy, analysis of routine clinical and laboratory data, of supine and upright plasma aldosterone, and of plasma renin activity were of limited value in differentiating patients with aldosterone-producing adenoma(s) (APA, n = 59) from those with idiopathic adrenal hyperplasia (IAH, n = 13)." | 1.27 | Primary aldosteronism: diagnosis and noninvasive lateralization procedures. ( Baumgart, P; Fischer, M; Galanski, M; Stieber, U; Tenschert, W; Vetter, H; Vetter, W; Winterberg, B, 1985) |
| "Among 10 patients with primary aldosteronism and 3 patients with pseudoaldosteronism, 5 patients were admitted to our hospital because of muscular weakness." | 1.27 | Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizine-induced pseudoaldosteronism. ( Atsumi, T; Ishikawa, S; Kuzuya, T; Okada, K; Saito, T, 1985) |
| "This was an unusual form of primary aldosteronism which showed normal levels of aldosterone in both blood and urine." | 1.27 | Primary aldosteronism with normal aldosterone levels in blood and urine. ( Demura, H; Han, DC; Jibiki, K; Nomura, K; Shizume, K; Tsushima, T, 1985) |
| "In patients with primary hyperaldosteronism adrenal-vein plasma aldosterone/cortisol concentration ratios successfully lateralised all 21 adenomas." | 1.26 | The diagnosis of primary hyperaldosteronism. ( Jowett, TP; Lightman, SL; Ma, JT; Payne, NN; Slater, JD; Vaughan, NJ; Wiggins, RC, 1981) |
| "Aldosterone secretion was temporarily suppressed after dexamethasone administration and was stimulated by exogenous ACTH." | 1.26 | Primary aldosteronism due to unilateral adrenal hyperplasia. ( Ganguly, A; Luetscher, JA; Zager, PG, 1980) |
| "In patients with primary hyperaldosteronism, a poor response of plasma aldosterone to angiotensin II infused alone was altered to a response comparable with that in normal subjects by supplying ACTH during the infusion." | 1.26 | The acute effect of angiotensin II on adrenal and anterior pituitary function in normal subjects and subjects with primary hyperaldosteronism. ( Fraser, R; Mason, PA; Young, J, 1980) |
| "Patients with primary aldosteronism from adenomas had relatively higher concentrations (p less than 0." | 1.26 | Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism. ( Guthrie, GP, 1981) |
| "Aldosterone levels were unresponsive to variations in dietary salt intake and plasma renin activity was suppressed." | 1.26 | Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis. ( Lee, SM; Levine, L; Lightner, E; New, MI; Oberfield, S; Witte, M, 1982) |
| "Pseudohypoaldosteronism (PHA) is an uncommon cause of the renal salt loosing syndrome in infancy." | 1.26 | [Pseudohypoaldosteronism: familial forms. Eight case-reports, with a review of the literature (author's transl)]. ( Caille, B; Cruveiller, J; Debray, P; Harpey, JP; Renault, F; Roy, C, 1982) |
| "Plasma aldosterone in the primary aldosteronism group increased significantly at 0." | 1.26 | Effects of angiotensin III and ACTH on aldosterone secretion. ( Luetscher, JA; Zager, PG, 1982) |
| "In untreated patients with primary aldosteronism caused either by adrenal adenoma or hyperplasia plasma aldosterone and cortisol concentrations fluctuated in unison and dexamethasone reduced both hormones markedly." | 1.26 | Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration. ( Ganguly, A; Luetscher, JA; Weinberger, MH, 1982) |
| "Screening tests for primary aldosteronism were compared in 22 patients with this disorder and 140 hypertensive controls." | 1.26 | Simplified screening procedures for primary aldosteronism. Studies on the mechanism of the hyper-responsiveness to furosemide and standing. ( Anderson, GH; Streeten, DH, 1982) |
| "Pretreatment with indomethacin (75 mg/day) reversed the hypotensive effect of the analogue of angiotensin II and abolished the increase of plasma renin concentration." | 1.26 | Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome. ( Vierhapper, H; Waldhäusl, W, 1980) |
| "We report a case of primary hyperaldosteronism in a 37-year-old woman presenting early in pregnancy with hypertension and hypokalaemia." | 1.26 | Primary hyperaldosteronism in pregnancy. ( Buchanan, JD; Hammond, TG; Scoggins, BA; Thatcher, R; Whitworth, JA, 1982) |
| "Twenty-four patients with primary aldosteronism were studied." | 1.26 | Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism. ( Lund, JO; Nielsen, MD, 1980) |
| "Hyperaldosteronism is an important factor contributing to fluid and sodium retention in infants with heart failure." | 1.26 | The occurrence of hyperaldosteronism in infants with congestive heart failure. ( Baylen, BG; Johnson, G; Kaplan, S; Srivastava, L; Tsang, R, 1980) |
| "Three children with a Bartter's syndrome have been investigated: all of them had growth retardation, hypokalemia (less than 3 mmol/l), raised plasma renin activity and urinary prostaglandins (PGE2 and PGF2 alpha) and a decreased sensibility for angiotensin." | 1.26 | [Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)]. ( Bagros, P; Benatre, A; Dray, F; Drucker, J; Grenier, B; Lebranchu, Y; Nivet, H; Rolland, JC, 1980) |
| "In primary aldosteronism, high UA and PAC together with suppressed PRA represent an important diagnostic guideline for differentiation from other types of low-renin hypertensions." | 1.26 | Renin-angiotensin-aldosterone system in arterial hypertension. ( Gregorová, I; Horký, K, 1980) |
| "Indomethacin (150 mg/day) was administered for 5 days." | 1.26 | Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment. ( Shimoyama, R, 1980) |
| "The lack of hypertension in primary aldosteronism is a rare condition." | 1.26 | Normotensive primary aldosteronism. ( Ando, H; Ebitani, I; Hara, M; Kawamura, S; Numazawa, K; Sasaki, H; Shiroto, H, 1980) |
| " With the long-term use of diuretics and various kinds of antihypertensive drugs in the treatment of high blood pressure in patients with PA, normal basal level and responsiveness of PRA were observed." | 1.26 | [Clinical observation of 12 cases of primary aldosteronism, special reference to the diagnostic problem (author's transl)]. ( Hata, S; Ito, Y; Kadena, N; Kunita, H; Nakagawa, K; Nakagawa, S; Obara, T; Okamoto, M; Suzuki, H, 1980) |
| "In three children Bartter's syndrome was diagnosed on the basis of the typical laboratory findings and the characteristic histological changes of the kidney." | 1.26 | [Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)]. ( Ploier, R; Tulzer, W, 1981) |
| "Spironolactone was indicated preoperatively for all surgical candidates, for non-operated APA patients, and for all IHA patients." | 1.26 | Primary aldosteronism -- screening, diagnosis and therapy. ( Gregorová, I; Horký, K; Hradec, E; Silinková-Málková, E; Vancura, J, 1981) |
| "1." | 1.26 | Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. ( Armanini, D; Boscaro, M; Fallo, F; Mantero, F; Opocher, G; Scaroni, C, 1981) |
| "In 6 patients with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency, the renin activity was also elevated and normalized after corticoid treatment." | 1.26 | Enzyme immunoassay for plasma renin activity: II. Clinical application. ( Büchner, M; Dörner, G; Garten, CD; Hubl, W; Schmidt, PK, 1981) |
| "Thus screening for primary aldosteronism can be restricted to hypokalaemic patients." | 1.26 | Simple screening procedure for the diagnosis of primary aldosteronism. ( Giese, J; Lund, JO; Nielsen, MD, 1981) |
| "min into 2 patients with Bartter's syndrome for 60 min, it caused marked decrease in PRA and plasma aldosterone but no change in blood pressure." | 1.26 | Biological activity of des-asp1-des-arg2-angiotensin II in man. ( Bumpus, FM; Ikeda, F; Imura, H; Khosla, MC; Kono, T; Muranaka, H; Nakano, R; Ohmori, Y; Oseko, F; Taniguchi, A, 1982) |
| "These results were compatible with Bartter's syndrome." | 1.26 | A case report of pseudohypoparathyroidism (Drezner's type I) associated with probable Bartter's syndrome. ( Hojo, K; Iba, K; Kishimoto, T; Mitsuhashi, T; Morii, H; Okahara, T; Wada, M; Yasumoto, R, 1981) |
| "Diagnosis and therapy of pseudo-hypoaldosteronism are discussed as well as the problems of long-term oral sodium chloride substitution and long-term therapy with sodium-polystyrol-sulfonate, a cation-exchange resin." | 1.26 | [Diagnosis, treatment and follow-up of a patient with pseudohypoaldosteronism (author's transl)]. ( Herkner, K; Pollak, A; Popow, C; Schober, E; Waldhäusl, W, 1982) |
| "Recurrent pheochromocytomas were the most difficult to localize on CT due to the surgical changes in the region of the adrenals and the frequent extra-adrenal locations." | 1.26 | Localization of functional adrenal tumors by computed tomography and venous sampling. ( Brennan, MF; Doppman, JL; Dunnick, NR; Gill, JR; Keiser, HR; Strott, CA, 1982) |
| "These features are consistent with Bartter's syndrome occurring in 2 successive generations in 1 family." | 1.26 | Familial Bartter's syndrome and the effect of indomethacin in one family member. ( Branch, RA; Fukunaga, T; Nishioka, T; Ohno, N; Shizume, K; Takano, K; Tsunoda, S; Tsushima, T; Yumura, W, 1982) |
| "Two adrenocortical adenomata causing Conn's syndrome were examined by electron microscopy." | 1.26 | Ultrastructure of aldosterone secreting adrenal adenomata. ( Gottardo, G; Mazzocchi, G; Meneghelli, V; Nussdorfer, GG; Robba, C, 1982) |
| "Primary aldosteronism, when caused by an aldosterone-producing adenoma, is a surgically treatable condition." | 1.26 | An aldosterone-producing adrenal cortical adenoma. ( Hugo, JM; Shipton, EA, 1982) |
| "Adrenocortical adenomas causing hyperaldosteronism in two women heterozygous at the X chromosome-linked glucose-6-phosphate dehydrogenase (G-6-PD) locus exhibited only one G-6-PD isoenzyme." | 1.26 | Probable clonal origin of aldosteronomas versus multicellular origin of parathyroid "adenomas". ( Block, MA; Cerny, JC; Fialkow, PJ; Jackson, CE, 1982) |
| "Secondary aldosteronism in connection with decompensated cirrhosis of the liver arises mainly under therapy with diuretics." | 1.26 | [What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?]. ( Albert, JP; Hartmann, F, 1981) |
| " We conclude that aldosterone antagonists in the dosage used had no effect on the course of postoperative hyperaldosteronism." | 1.26 | Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists. ( Haschke, F; Parth, K; Wimmer, M, 1981) |
| "In most of the patients examined hyperaldosteronism was found, which was attended by an increased percentage of 14C-aldosterone binding with aldosterone binding globulin (ABG) and particularly with glucocorticoid binding globulin (GBG)." | 1.26 | [14C-aldosterone binding by plasma proteins in adolescents with primary arterial hypertension]. ( Bakova, VV; Golov, AG; Kucherenko, AG; Markov, KhM, 1981) |
| "The occurrence of Bartter's syndrome is described in a 74-year-old woman with a fractured hip." | 1.26 | Bartter's syndrome in a 74-year-old woman: response to anti-inflammatory agents. ( Gordon, M; Pollard, A, 1980) |
| "In 15% of patients with Conn's syndrome the tumor may be bilateral." | 1.26 | [Multiple, bilateral aldosteroma]. ( Ametov, AS; Gerasimenko, PP, 1980) |
| "In all of the 10 patients with primary aldosteronism, ACTH stimulated aldosterone secretion from the adenomas more significantly than did angiotensin II and III." | 1.26 | [Studies on the mechanism of secretion of adrenal steroid hormones from adenomas of primary aldosteronism and Cushing's syndrome (author's transl)]. ( Eguchi, T; Kondo, K; Matsuki, S; Murai, M; Nakamura, R; Oka, M; Okuno, T; Saito, I; Saruta, T; Yasui, T, 1980) |
| "Hyperparathyroidism and hyperaldosteronism coexisted in association with medullary sponge kidneys in a 27-year-old woman with severe hypertension." | 1.26 | Hyperaldosteronism, hyperparathyroidism, medullary sponge kidneys, and hypertension. ( Hellman, DE; Kartchner, M; Komar, N; Mayes, D; Pitt, M, 1980) |
| "Aldosterone-oxime was labelled with 125I by using the chloramine T method described by Hunter and Greenwood." | 1.26 | [A simple method for measuring aldosterone secretion rate using 125I-aldosterone (authors' transl)]. ( Fukuchi, S; Haruyama, K; Toki, T; Yamazaki, M, 1980) |
| "Two of nine patients with primary aldosteronism had normal Also-18-G excretion but elevated TH-Aldo excretion." | 1.26 | Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients. ( Gomez-Sanchez, CE; Holland, OB, 1981) |
| "We were able to separate Bartter's syndrome patients into two groups: Group 1 patients are seen at a young age, with hyponatremia and episodes of extracellular volume contraction." | 1.26 | Bartter's syndrome. Differentiation into two clinical groups. ( Arbus, GS; Balfe, JW; Robson, WL, 1979) |
| "A young patient with Bartter's syndrome was treated for three months with 100 mg/kg/day of aspirin to inhibit prostaglandin synthesis." | 1.26 | Prostaglandins and aspirin therapy in Bartter's syndrome. ( Flamenbaum, W; Lentz, R; Norby, L; Ramwell, P, 1976) |
| "Hyporeninaemic hypoaldosteronism may develop in subjects who are unable to increase chloriuretic hormone concentrations appropriately in response to progressive impairment of renal function." | 1.26 | Disorders of chloriuretic hormone secretion. ( Grekin, RJ; Nicholls, MG; Padfield, PL, 1979) |
| "Ten children with Bartter's syndrome are described." | 1.26 | Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy. ( Dillon, MJ; Mitchell, MD; Shah, V, 1979) |
| "Six children with Bartter's syndrome aged 6 years 4 months to 13 years 11 months were treated with indomethacin (1." | 1.26 | [Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)]. ( David, M; Floret, D; Hage, GN; Roux, A; Teyssier, G, 1979) |
| "A case of an adult with Bartter's syndrome (hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis) is described; the patient had the unusual manifestation of cardiomyopathy, probably secondary to severe hypokalemia." | 1.26 | Cardiomyopathy in an adult with Bartter's syndrome and hypokalemia. Hemodynamic, angiographic and metabolic studies. ( Dalakos, TG; Jones, D; Potts, JL; Streeten, DH, 1977) |
| "A 26-year-old female with Bartter's syndrome associated with Graves' disease is reported." | 1.26 | Bartter's syndrome--case report. ( Hiramatsu, M; Makino, H; Miyoshi, A; Ofuji, T; Ota, Z; Suzuki, S; Takahara, J; Takahashi, K; Takehisa, Y; Yamane, Y, 1979) |
| "Four patients with hyperaldosteronism due to adrenal adenomas served as controls." | 1.26 | The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism. ( Gomez-Sanchez, C; Higgins, JR; Kem, DC; Kramer, NJ; Weinberger, MH, 1976) |
| "The hypothesis that hyperaldosteronism is not the sole cause of hypertension in dexamethasone-suppressible hyperaldosteronsim was tested in an 18-year-old male." | 1.26 | Evidence for an unidentified ACTH-induced steroid hormone causing hypertension. ( Levine, LS; New, MI; Peterson, RE; Saenger, P, 1976) |
| "In nine patients with primary aldosteronism (PA), plasma aldosterone was measured in order to evaluate a role of the renin-angiotensin system, ACTH and potassium in the secretion of aldosterone." | 1.26 | [Secretory regulation and episodic secretion of aldosterone in patients with primary aldosteronism (author's transl)]. ( Murakami, T; Ohbuchi, S, 1976) |
| "Primary hyperaldosteronism usually causes moderate hypertension." | 1.26 | [Primary hyperaldosteronism with paroxysmal arterial hypertension. Apropos of 2 operated cases]. ( Griffe, J; Morin, PP; Tatibouet, L, 1978) |
| "These data show that patients with hyperaldosteronism from an adrenal adenoma or hyperplasia have a consistent and exaggerated response to ACTH." | 1.26 | Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. ( Gomez-Sanchez, C; Higgins, JR; Holland, OB; Kem, DC; Kramer, NJ; Weinberger, MH, 1978) |
| "Two patients, one with Bartter's syndrome and one with severe abuse of diuretics, were investigated before and after indomethacin treatment." | 1.26 | On the pathogenetic role of prostaglandins in Bartter's syndrome. ( Christensen, P; Hesse, B; Nielsen, I, 1979) |
| "Patients with proved aldosteronism are outside the normal ranges of plasma renin activity." | 1.26 | Evaluation of patients for secondary hypertension. ( Donohue, JP; Grim, CE; Weinberger, MH, 1979) |
| "Two adults with Bartter's syndrome were treated first with propranolol and a potassium-sparing diuretic and then with indomethacin for 22 months." | 1.26 | [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis]. ( Dray, F; Favre, L; Flory, ED; Glasson, P; Vallotton, MB, 1979) |
| "Fourteen patients with sickle cell anemia, ages 6 to 20 years, were studied while ingesting high- and low-sodium diets." | 1.26 | Hyperreninemia and hyperaldosteronism in sickle cell anemia. ( Carpentieri, U; Corn, C; Matustik, MC; Meyer, WJ, 1979) |
| "(4) Far above other mechanism hyperaldosteronism is most often induced by saluretic treatment of ascites and edema." | 1.26 | [Secondary hyperaldosteronism in patients with liver cirrhosis, frequently caused by therapy]. ( Spech, HJ, 1979) |
| "Hyperaldosteronism is dependent on the maintenance of prostaglandin synthesis." | 1.26 | Hyperaldosteronism in the sodium-depleted rat: mode of aldosterone-stimulating action of frusemide. ( Spät, A; Tarján, E; Tóth, G, 1979) |
| "The postop." | 1.26 | [The significance of sodium intake in postoperative aldosteronism]. ( Bachhuber, F; Schildberg, FW; Schreiber, M; Witte, J, 1977) |
| "Patients with primary aldosteronism had elevated levels of DOC and 18-OH-DOC as well as aldosterone." | 1.26 | Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man. ( Aida, M; Kambegawa, A; Ojima, M, 1978) |
| "In 6 patients with primary hyperaldosteronism (P." | 1.26 | Differentiation between subtypes of primary hyperaldosteronism by multiple steroid measurement after dexamethasone administration. ( Oelkers, W; Pellnitz, W; Schöneshöfer, M, 1978) |
| "Treatment with indomethacin, which decreased urinary prostaglandin E-like material by 69 per cent or more, did not affect blood pressure." | 1.26 | Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. ( Bartter, FC; Bowden, RE; Frölich, JC; Gill, JR; Keiser, HR; Oates, JA; Seyberth, HW; Taylor, AA, 1976) |
| "Of these, 13 had primary aldosteronism (ALDO), 19 high renin (HRH), 30 low renin (LRH), and 57 normal renin (NRH) essential hypertension." | 1.26 | Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis. ( Grim, CE; Higgins, JT; Luft, FC; Weinberger, MH; Willis, LR, 1977) |
| "Secondary hyperaldosteronism was almost exclusively observed in patients who had been taking diuretics during the last few days before the measurements were done." | 1.26 | [Catamnestic and endocrinological investigations in women with idiopathic edema (author's transl)]. ( Oelkers, W; Palicki, H; Rawer, C; Schöneshöfer, M; Wiederholt, M, 1977) |
| "Among the atypical pictures of primary aldosteronism, sometimes, normal blood and urine concentration of aldosterone have been observed in association with an adrenal aldosterone-producing adenoma." | 1.26 | [Physiopathological and functional semeiologic considerations in a case of primary normoaldosteronemic hyperaldosteronism]. ( Banchini, E; Biggi, A; Bruschi, G; Civardi, E; Coruzzi, P; Martinelli, M; Mutti, A; Novarini, A, 1977) |
| "Twenty patients suffering from primary hyperaldosteronism were studied." | 1.26 | [The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism]. ( Benguigui, L; Corvol, P; Houde, M; Menard, J; Milliez, P; Tonnelier, M, 1977) |
| "125I-aldosterone was used in the first method and 3H-aldosterone in the second." | 1.26 | [A simple method measuring plasma aldosterone by radioimmunoassay without extraction (author's transl)]. ( Fukuchi, S; Haruyama, K; Iinuma, K; Nakajima, K; Saito, M, 1977) |
| "In a 52-year-old patient with Bartter's syndrome, peripheral venous prostaglandin E2 (PGE2) and plasma renin activity (PRA) levels were markedly elevated and plasma aldosterone concentration (pa) was at the upper limit of normal, though inappropriately high relative to the decreased plasma and whole body potassium levels." | 1.26 | [Increased renal prostaglandin E2 secretion in Bartter's syndrome]. ( Flammer, J; Messerli, FH; Reubi, RC; Schwarz, HA; Weidmann, P; Zia, PK, 1977) |
| " In normotensives with normal plasma renin activity saralasine in the usual dosage (4." | 1.26 | [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)]. ( Dürr, H; Klaus, D; Lange, H; Witzgall, H; Zehner, J, 1976) |
| "The probe continues." | 1.26 | A perspective on aldosterone abnormalities. ( Biglieri, EG, 1976) |
| "Five patients with Bartter's syndrome were investigated." | 1.26 | Effect of sodium restriction and angiotensin II infusion in Bartter's syndrome. ( Bizollon, CA; David, M; Floret, D; Francois, R; Richard, P; Sann, L; Sassard, J, 1976) |
| " In normal subjects, Sar1-Ile-AII showed pressor (agonistic) activity, which was related to both dosage and sodium intake." | 1.26 | Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders. ( Doi, K; Hata, T; Ichihara, K; Kumahara, Y; Ogihara, T; Yamamoto, T, 1976) |
| "In two patients with primary hyperaldosteronism, the aldosterone excretion during the night was relatively more elevated than in the day." | 1.26 | [Diurnal variation in the urinary excretion of vanilmandelic acid and aldosterone in normal and hypertensive persons (author's transl)]. ( Deck, KA; Eberlein, L; Luedtke, A, 1976) |
| "Hypokalemic hypertension is the leading symptome of the disease." | 1.26 | [Primary aldosteronism]. ( Beckerhoff, R; Braun, KP; Furrer, J; Nussberger, J; Pouliadis, G; Siegenthaler, W; Sobbe, A; Vetter, H; Vetter, W; Witassek, F, 1976) |
| "Two patient with primary aldosteronism, one with a solitary adrenal adenoma and the other with bilateral nodular hyperplasia, are described." | 1.25 | Primary aldosteronism. A study in contrasts. ( Espiner, EA; Hughes, H; Nicholls, MG; Ross, J; Stewart, DT, 1975) |
| "Aldosterone was found by the double radioisotopic technique in the neoplastic tissue." | 1.25 | Primary aldosteronism due to a malignant ovarian tumor. ( Borsatti, A; Mantero, F; Terribile, V; Todesco, S, 1975) |
| "In thirteen patients with ketoacidosis, mean plasma renin activity (PRA) was 58 plus or minus 12 (S." | 1.25 | Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism. ( Assal, JP; Christlieb, AR; Katsilambros, N; Kozak, GP; Suzuki, T; Williams, GH, 1975) |
| "Aldosterone was significantly elevated in the manic patients, and elevated in the schizoaffective patients." | 1.25 | Lithium-responsive hyperaldosteronism in manic patients. ( Hendler, N, 1975) |
| "This hypercorticism is corrected by aminogluthetimide." | 1.25 | [Bartter's disease associated with hypercorticism, phosphate and magnesium deficiencies and familial renal tubular disease]. ( François, R; Longin, B; Moreau, P; Sann, L; Sassard, J, 1975) |
| "It is suggested that patients with Bartter's syndrome be treated simultaneously with large doses of spironolactone and a high sodium intake." | 1.25 | Bartter's syndrome. New insights into pathogenesis and treatment. ( Brown, RS; Solomon, RJ, 1975) |
| "Hyperaldosteronism due to aldosteronoma is a rare but potentially curable form of pediatric hypertension." | 1.25 | Aldosteronoma in a child with localization by adrenal vein aldosterone: collective review of the literature. ( DeQuattro, V; Kafrouni, G; Lurvey, AN; Oakes, MD, 1975) |
| "It is proposed that postoperative hyperaldosteronism is at least partly mediated through the renin-angiotensin-system." | 1.25 | [Plasma renin activity, plasma aldosterone and electrolyte balance in the postoperative period (author's transl)]. ( Hackl, JM; Skrabal, F, 1975) |
| "The aldosterone secretion was normal and responded normally to sodium deprivation in all patients studied during suppression with carbohydrate-active steroids." | 1.25 | Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia. ( Bartter, FC; Bryan, GT; Henkin, RI, 1968) |
| "In six patients with primary aldosteronism, plasma aldosterone on a normal sodium diet was 39." | 1.25 | Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism. ( Horton, R, 1969) |
| "Five obvious cases of hyperaldosteronism were found among the 16 low-renin patients." | 1.25 | Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. ( Collins, RD; Dowdy, AJ; Gonzales, CM; Luetscher, JA; Nokes, GW; Weinberger, MH, 1970) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1352 (40.02) | 18.7374 |
| 1990's | 283 (8.38) | 18.2507 |
| 2000's | 443 (13.11) | 29.6817 |
| 2010's | 773 (22.88) | 24.3611 |
| 2020's | 527 (15.60) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X | 7 |
| Jin, L | 1 |
| Zhang, H | 10 |
| Ma, W | 1 |
| Song, L | 3 |
| Zhou, X | 3 |
| Cai, J | 3 |
| Harro, CC | 2 |
| Refsal, KR | 2 |
| Shaw, N | 1 |
| Alston, SM | 1 |
| Folger, W | 1 |
| Gross, C | 1 |
| Cousins, WM | 1 |
| Monahan, CF | 1 |
| Mazaki-Tovi, M | 2 |
| Langlois, DK | 2 |
| Zavatta, G | 1 |
| Di Dalmazi, G | 2 |
| Altieri, P | 1 |
| Pelusi, C | 1 |
| Golfieri, R | 2 |
| Mosconi, C | 1 |
| Balacchi, C | 1 |
| Borghi, C | 1 |
| Cosentino, ER | 1 |
| Di Cintio, I | 1 |
| Malandra, J | 1 |
| Pagotto, U | 3 |
| Vicennati, V | 3 |
| Luo, GH | 2 |
| Liu, G | 2 |
| Chu, ZG | 1 |
| Xu, B | 3 |
| Yang, B | 3 |
| Lei, L | 1 |
| Zhang, Y | 11 |
| Li, YL | 1 |
| Gu, FJ | 1 |
| Carides, MD | 1 |
| Sishuba, NT | 1 |
| Bombil, I | 1 |
| Christofides, C | 1 |
| Veldhuizen, GP | 6 |
| Alnazer, RM | 6 |
| de Leeuw, PW | 6 |
| Kroon, AA | 6 |
| Gravvanis, C | 3 |
| Papanastasiou, L | 7 |
| Glycofridi, S | 1 |
| Voulgaris, N | 4 |
| Tyfoxylou, E | 2 |
| Theodora, K | 1 |
| Piaditis, G | 6 |
| Markou, Α | 1 |
| Sato, Y | 5 |
| Shirota, G | 1 |
| Makita, K | 8 |
| Itoh, D | 1 |
| Hayashi, TY | 1 |
| Akamatsu, N | 1 |
| Matsui, S | 11 |
| Saito, J | 24 |
| Omura, M | 26 |
| Nishikawa, T | 40 |
| Abe, O | 3 |
| De Sousa, K | 3 |
| Abdellatif, AB | 4 |
| Giscos-Douriez, I | 4 |
| Meatchi, T | 7 |
| Amar, L | 30 |
| Fernandes-Rosa, FL | 13 |
| Boulkroun, S | 23 |
| Zennaro, MC | 35 |
| Memon, SS | 1 |
| Lila, A | 1 |
| Barnabas, R | 1 |
| Goroshi, M | 1 |
| Sarathi, V | 1 |
| Shivane, V | 1 |
| Patil, V | 1 |
| Shah, N | 1 |
| Bandgar, T | 1 |
| Dream, S | 1 |
| Park, S | 2 |
| Yen, TW | 2 |
| Rilling, W | 2 |
| Rein, L | 1 |
| Doffek, K | 1 |
| Findling, JW | 3 |
| Magill, SB | 6 |
| Kidambi, S | 1 |
| Evans, DB | 2 |
| Wang, TS | 2 |
| Lin, W | 2 |
| Yao, Z | 2 |
| Li, Y | 14 |
| Liao, Z | 1 |
| Xiao, J | 1 |
| Chen, Y | 3 |
| Feng, P | 2 |
| Gan, W | 2 |
| Monticone, S | 32 |
| Veglio, F | 44 |
| Mulatero, P | 63 |
| Rossi, GP | 85 |
| Rossitto, G | 17 |
| Kmieć, P | 1 |
| Sworczak, K | 1 |
| Betz, MJ | 2 |
| Zech, CJ | 1 |
| Kong, L | 2 |
| Zhang, J | 11 |
| Dong, L | 2 |
| Xu, J | 7 |
| Gao, PJ | 5 |
| Wang, JG | 10 |
| Zhu, L | 6 |
| Lee, SH | 5 |
| Kim, JW | 3 |
| Yoon, HK | 3 |
| Kim, SW | 5 |
| Kim, SJ | 4 |
| Lee, KE | 3 |
| Lee, YM | 2 |
| Sung, TY | 2 |
| Hong, SJ | 1 |
| Shin, CS | 3 |
| Koh, JM | 5 |
| Kim, JH | 11 |
| Hu, Z | 2 |
| Chen, X | 9 |
| Shao, Y | 1 |
| Luo, FX | 1 |
| Chu, SL | 2 |
| Hundemer, GL | 14 |
| Imsirovic, H | 2 |
| Vaidya, A | 19 |
| Yozamp, N | 5 |
| Goupil, R | 2 |
| Madore, F | 2 |
| Agharazii, M | 4 |
| Knoll, G | 2 |
| Sood, MM | 2 |
| Naruse, M | 45 |
| Tanabe, A | 23 |
| Yamamoto, K | 16 |
| Rakugi, H | 7 |
| Kometani, M | 11 |
| Yoneda, T | 19 |
| Kobayashi, H | 28 |
| Abe, M | 11 |
| Ohno, Y | 7 |
| Inagaki, N | 20 |
| Izawa, S | 13 |
| Sone, M | 26 |
| El-Asmar, N | 1 |
| Rajpal, A | 1 |
| Arafah, BM | 1 |
| He, X | 1 |
| Peter, PR | 1 |
| Auchus, RJ | 9 |
| Dai, Y | 1 |
| Li, J | 10 |
| Wen, H | 2 |
| Liu, J | 3 |
| Singhania, P | 1 |
| Bhattacharjee, R | 1 |
| Gkaniatsa, E | 2 |
| Ekerstad, E | 1 |
| Gavric, M | 1 |
| Muth, A | 2 |
| Trimpou, P | 1 |
| Olsson, DS | 1 |
| Johannsson, G | 4 |
| Ragnarsson, O | 4 |
| Ahn, CH | 2 |
| Na, HY | 1 |
| Park, SY | 1 |
| Yu, HW | 1 |
| Choi, JY | 1 |
| Jung, KC | 1 |
| Williams, TA | 39 |
| Reincke, M | 89 |
| Ishihara, Y | 6 |
| Umakoshi, H | 23 |
| Kaneko, H | 7 |
| Nanba, K | 20 |
| Tsuiki, M | 27 |
| Kusakabe, T | 2 |
| Satoh-Asahara, N | 2 |
| Yasoda, A | 6 |
| Tagami, T | 9 |
| Hayakawa, T | 1 |
| Fukuhara, A | 1 |
| Saiki, A | 2 |
| Otsuki, M | 13 |
| Shimomura, I | 3 |
| Petramala, L | 8 |
| Concistrè, A | 5 |
| Circosta, F | 1 |
| Gigante, A | 1 |
| Sarlo, F | 1 |
| Schina, M | 1 |
| Soldini, M | 1 |
| Iannucci, G | 3 |
| Cianci, R | 2 |
| Letizia, C | 21 |
| Yuan, Y | 2 |
| Li, N | 9 |
| Liu, Y | 9 |
| Wang, M | 7 |
| Heizhati, M | 5 |
| Zhu, Q | 4 |
| Yao, X | 5 |
| Luo, Q | 9 |
| Tannai, H | 6 |
| Koike, Y | 5 |
| Tsurutani, Y | 15 |
| Bancos, I | 10 |
| Scholl, UI | 12 |
| Stowasser, M | 86 |
| Lin, JH | 2 |
| Peng, KY | 9 |
| Kuo, YP | 1 |
| Liu, H | 3 |
| Tan, CB | 1 |
| Lin, YF | 4 |
| Chiu, HW | 1 |
| Lin, YH | 46 |
| Chen, YM | 6 |
| Chueh, JS | 7 |
| Wu, VC | 55 |
| Zekarias, K | 1 |
| Tessier, KM | 1 |
| Fuss, CT | 5 |
| Hahner, S | 11 |
| Heinrich, DA | 11 |
| Adolf, C | 19 |
| Evans, J | 2 |
| Ward, J | 1 |
| Domenig, O | 2 |
| Mochel, JP | 1 |
| Creevy, K | 1 |
| Zhang, W | 5 |
| Zhang, D | 7 |
| Chang, G | 1 |
| Cao, M | 1 |
| Zhou, K | 4 |
| Wang, L | 3 |
| Hu, J | 14 |
| Maimaiti, N | 1 |
| Markou, A | 12 |
| Kaltsas, GA | 1 |
| Kanti, G | 1 |
| Zografos, GN | 1 |
| Chrousos, GP | 9 |
| Parksook, WW | 1 |
| Moussa, M | 4 |
| Underhill, J | 4 |
| Fudim, T | 4 |
| Sacks, B | 4 |
| Imiela, AM | 1 |
| Mikołajczyk, TP | 1 |
| Siedliński, M | 1 |
| Dobrowolski, P | 1 |
| Konior-Rozlachowska, A | 1 |
| Wróbel, A | 1 |
| Biernat-Kałuża, E | 1 |
| Januszewicz, M | 1 |
| Guzik, B | 1 |
| Guzik, TJ | 1 |
| Januszewicz, A | 5 |
| Prejbisz, A | 7 |
| Carvajal, CA | 11 |
| Tapia-Castillo, A | 4 |
| Pérez, JA | 2 |
| Fardella, CE | 18 |
| Araujo-Castro, M | 3 |
| Parra-Ramírez, P | 1 |
| Sam, D | 4 |
| Kline, GA | 22 |
| So, B | 19 |
| Pasieka, JL | 11 |
| Harvey, A | 11 |
| Chin, A | 8 |
| Przybojewski, SJ | 2 |
| Caughlin, CE | 1 |
| Leung, AA | 12 |
| Eisenhofer, G | 10 |
| Kurlbaum, M | 2 |
| Peitzsch, M | 7 |
| Constantinescu, G | 2 |
| Remde, H | 2 |
| Schulze, M | 1 |
| Kaden, D | 1 |
| Müller, LM | 2 |
| Kunz, S | 2 |
| Kołodziejczyk-Kruk, S | 3 |
| Gruber, S | 3 |
| Beuschlein, F | 49 |
| Lenders, JWM | 7 |
| Bidlingmaier, M | 27 |
| Schiavone, D | 3 |
| Iacobone, M | 7 |
| Ma, Y | 1 |
| Chen, H | 4 |
| Chen, F | 2 |
| Jiang, J | 2 |
| Guo, W | 1 |
| Li, X | 5 |
| Gao, X | 6 |
| Lu, Z | 1 |
| Zhou, B | 2 |
| Zhao, L | 7 |
| Tan, SJ | 1 |
| Libianto, R | 10 |
| Yang, J | 34 |
| Wong, J | 1 |
| Lin, M | 2 |
| Gan, L | 2 |
| Hong, J | 1 |
| Yue, N | 3 |
| Motomura, N | 2 |
| Yamazaki, Y | 21 |
| Tezuka, Y | 13 |
| Omata, K | 17 |
| Ono, Y | 12 |
| Morimoto, R | 18 |
| Satoh, F | 34 |
| Nakamura, Y | 21 |
| Shim, J | 1 |
| Choi, MH | 2 |
| Ito, A | 5 |
| Sasano, H | 44 |
| Mørup, S | 2 |
| Voss, N | 2 |
| Clausen, C | 2 |
| Feltoft, CL | 2 |
| Andreassen, M | 2 |
| Krogh, J | 2 |
| Yan, Y | 4 |
| Sun, HW | 1 |
| Qi, Y | 1 |
| Funder, JW | 31 |
| Carey, RM | 15 |
| Wang, Y | 8 |
| Li, CX | 1 |
| Lin, YN | 1 |
| Zhang, LY | 1 |
| Li, SQ | 1 |
| Zhang, L | 3 |
| Yan, YR | 1 |
| Lu, FY | 1 |
| Li, QY | 1 |
| Asbach, E | 5 |
| Lewandowski, KC | 1 |
| Tadros-Zins, M | 1 |
| Horzelski, W | 1 |
| Grzesiak, M | 1 |
| Lewinski, A | 1 |
| Rizzolo, K | 1 |
| Beck, NM | 1 |
| Ambruso, SL | 1 |
| Wannachalee, T | 6 |
| Lieberman, L | 1 |
| Turcu, AF | 18 |
| Viukari, M | 2 |
| Kokko, E | 2 |
| Pörsti, I | 3 |
| Leijon, H | 1 |
| Vesterinen, T | 1 |
| Hinkka, T | 2 |
| Soinio, M | 1 |
| Schalin-Jäntti, C | 1 |
| Matikainen, N | 3 |
| Nevalainen, PI | 3 |
| Chauhan, K | 1 |
| Schachna, E | 1 |
| Ryan, J | 1 |
| Hutton, H | 1 |
| Fuller, PJ | 24 |
| Wilson, S | 1 |
| Kerr, PG | 1 |
| Bollati, M | 5 |
| Lopez, C | 5 |
| Bioletto, F | 5 |
| Ponzetto, F | 4 |
| Ghigo, E | 9 |
| Maccario, M | 18 |
| Parasiliti-Caprino, M | 9 |
| Russell, GM | 1 |
| Gwini, SM | 9 |
| Nuttall, P | 1 |
| Shen, J | 7 |
| Young, MJ | 11 |
| Ceccato, F | 3 |
| Di Carlo, MC | 1 |
| Voltan, G | 2 |
| Rossato, D | 10 |
| Giraudo, G | 5 |
| Scaroni, C | 6 |
| Nanao, Y | 1 |
| Oki, K | 18 |
| Kobuke, K | 2 |
| Itcho, K | 2 |
| Baba, R | 1 |
| Kodama, T | 1 |
| Otagaki, Y | 1 |
| Okada, A | 1 |
| Yoshii, Y | 2 |
| Nagano, G | 1 |
| Ohno, H | 2 |
| Arihiro, K | 1 |
| Gomez-Sanchez, CE | 45 |
| Hattori, N | 1 |
| Yoneda, M | 2 |
| Liu, W | 3 |
| Yang, Y | 9 |
| Jin, Y | 3 |
| Li, Z | 2 |
| You, L | 1 |
| Luo, J | 1 |
| Su, X | 3 |
| Christou, F | 1 |
| Pivin, E | 1 |
| Denys, A | 1 |
| Abid, KA | 1 |
| Zingg, T | 1 |
| Matter, M | 1 |
| Pechère-Bertschi, A | 1 |
| Maillard, M | 1 |
| Grouzmann, E | 1 |
| Wuerzner, G | 1 |
| Lee, BC | 14 |
| Kang, VJ | 1 |
| Pan, CT | 9 |
| Huang, JZ | 1 |
| Lin, YL | 1 |
| Chang, YY | 17 |
| Tsai, CH | 9 |
| Chou, CH | 10 |
| Chen, ZW | 10 |
| Liao, CW | 13 |
| Chiu, YW | 2 |
| Hung, CS | 20 |
| Chang, CC | 28 |
| Kaur, R | 1 |
| Young, S | 1 |
| Choy, KW | 10 |
| Simpson, I | 1 |
| Lattanzio, MR | 1 |
| Weir, MR | 2 |
| Katabami, T | 24 |
| Matsuba, R | 1 |
| Nakagawa, T | 1 |
| Kurihara, I | 27 |
| Ichijo, T | 26 |
| Wada, N | 35 |
| Ogawa, Y | 29 |
| Yoshimoto, T | 19 |
| Takahashi, K | 15 |
| Kakutani, M | 2 |
| Delić, R | 1 |
| Pavalec, M | 1 |
| Koren, J | 1 |
| Ogata, M | 9 |
| Sakamoto, S | 5 |
| Watanabe, T | 7 |
| Iwahashi, N | 6 |
| Fukumoto, T | 8 |
| Terada, E | 1 |
| Katsuhara, S | 1 |
| Yokomoto-Umakoshi, M | 8 |
| Matsuda, Y | 22 |
| Sakamoto, R | 13 |
| Ozeki, Y | 4 |
| Kinoshita, M | 2 |
| Miyamoto, S | 3 |
| Yoshida, Y | 5 |
| Okamoto, M | 5 |
| Gotoh, K | 3 |
| Masaki, T | 3 |
| Kambara, K | 1 |
| Shibata, H | 30 |
| Chen, YJ | 1 |
| Liao, HW | 1 |
| Hsieh, TY | 1 |
| Wang, SM | 15 |
| Mermejo, LM | 1 |
| Elias, PCL | 1 |
| Molina, CAF | 1 |
| Tucci, S | 1 |
| Muglia, VF | 1 |
| Elias, J | 1 |
| Antonini, SR | 1 |
| de Castro, M | 1 |
| Moreira, AC | 1 |
| Oki, Y | 3 |
| Takeda, Y | 27 |
| Tanaka, T | 6 |
| Tamura, K | 13 |
| Hashimoto, S | 6 |
| Hasegawa, T | 7 |
| Haze, T | 5 |
| Wang, W | 13 |
| Cai, L | 1 |
| Gao, Y | 2 |
| Guo, XH | 1 |
| Zhang, JQ | 1 |
| Russell, G | 3 |
| Li, Q | 20 |
| Leenaerts, M | 1 |
| Tang, X | 5 |
| Kang, Y | 1 |
| Tong, J | 1 |
| Shen, W | 2 |
| Liu, Z | 6 |
| Deng, X | 2 |
| Luo, L | 1 |
| Li, S | 2 |
| Li, M | 4 |
| Deng, Q | 1 |
| Zhong, W | 1 |
| Kubo, H | 4 |
| Inoue, K | 7 |
| Watanabe, K | 1 |
| Sunouchi, T | 1 |
| Hoshino, Y | 2 |
| Hirose, R | 1 |
| Katsuragawa, S | 1 |
| Shibahara, Y | 1 |
| Kakuta, Y | 4 |
| Eristavi, SK | 1 |
| Platonova, NM | 3 |
| Troshina, EA | 3 |
| Nguyen, V | 1 |
| Tu, TM | 1 |
| Mamauag, MJB | 1 |
| Lai, J | 1 |
| Saffari, SE | 1 |
| Aw, TC | 1 |
| Ong, L | 1 |
| Foo, RSY | 3 |
| Chai, SC | 1 |
| Fones, S | 1 |
| Zhang, M | 2 |
| Puar, TH | 5 |
| Harashima, S | 1 |
| Suzuki, H | 9 |
| Kwon, GE | 1 |
| Wu, XM | 13 |
| Shun, CT | 2 |
| Wen, WF | 2 |
| Arata, S | 2 |
| Procopio, M | 2 |
| Tamaru, S | 1 |
| Suwanai, H | 1 |
| Abe, H | 5 |
| Sasaki, J | 1 |
| Ishii, K | 2 |
| Iwasaki, H | 1 |
| Shikuma, J | 1 |
| Ito, R | 2 |
| Miwa, T | 1 |
| Sasaki, T | 2 |
| Takamiya, T | 1 |
| Inoue, S | 1 |
| Saito, K | 3 |
| Odawara, M | 1 |
| Suzuki, R | 2 |
| Brown, JM | 6 |
| Wijkman, MO | 1 |
| Claggett, BL | 1 |
| Shah, AM | 1 |
| Ballantyne, CM | 1 |
| Coresh, J | 1 |
| Grams, ME | 2 |
| Wang, Z | 9 |
| Yu, B | 1 |
| Boerwinkle, E | 2 |
| Solomon, SD | 1 |
| Arjani, S | 1 |
| Bostonian, TJ | 1 |
| Prasath, V | 1 |
| Quinn, PL | 1 |
| Chokshi, RJ | 1 |
| Chen, PT | 4 |
| Chang, D | 1 |
| Liu, KL | 11 |
| Liao, WC | 1 |
| Rainey, WE | 31 |
| Ariens, J | 1 |
| Horvath, AR | 1 |
| Yoon, M | 1 |
| Hong, N | 1 |
| Ha, J | 2 |
| Lee, CJ | 1 |
| Ku, CR | 1 |
| Rhee, Y | 1 |
| Sanga, V | 2 |
| Seccia, TM | 38 |
| Nainani, AK | 1 |
| Peters, S | 1 |
| Khoo, CM | 1 |
| Tan, CJ | 1 |
| Tong, AKT | 1 |
| Tan, MCS | 1 |
| Teo, AE | 3 |
| Ng, KS | 2 |
| Wong, KM | 1 |
| Reilhac, A | 1 |
| O'Doherty, J | 1 |
| Kek, PC | 2 |
| Yee, S | 1 |
| Tan, AWK | 1 |
| Chuah, MB | 1 |
| Lee, DHM | 1 |
| Wang, KW | 2 |
| Zheng, CQ | 1 |
| Shi, L | 1 |
| Robins, EG | 1 |
| Nakai, K | 8 |
| Okudela, K | 1 |
| Wu, C | 2 |
| Qu, D | 1 |
| Xu, X | 3 |
| Chen, L | 1 |
| Sun, Q | 1 |
| Zhao, X | 1 |
| Paja Fano, M | 1 |
| González Boillos, M | 1 |
| Pla Peris, B | 1 |
| Pascual-Corrales, E | 1 |
| García Cano, AM | 1 |
| Parra Ramírez, P | 1 |
| Rojas-Marcos, PM | 1 |
| Ruiz-Sanchez, JG | 1 |
| Vicente Delgado, A | 1 |
| Gómez Hoyos, E | 1 |
| Ferreira, R | 1 |
| García Sanz, I | 1 |
| Recasens Sala, M | 1 |
| Barahona San Millan, R | 1 |
| Picón César, MJ | 1 |
| Díaz Guardiola, P | 1 |
| García González, JJ | 1 |
| Perdomo, CM | 1 |
| Manjón Miguélez, L | 1 |
| García Centeno, R | 1 |
| Percovich, JC | 1 |
| Rebollo Román, Á | 1 |
| Gracia Gimeno, P | 1 |
| Robles Lázaro, C | 1 |
| Morales-Ruiz, M | 1 |
| Hanzu, FA | 1 |
| Tseng, CS | 1 |
| Tsai, YC | 7 |
| Huang, KH | 12 |
| Lin, WC | 5 |
| Hu, YH | 6 |
| Carasel, A | 1 |
| Calissendorff, J | 2 |
| Avander, K | 1 |
| Shabo, I | 1 |
| Volpe, C | 4 |
| Falhammar, H | 1 |
| Nomura, M | 4 |
| Itoh, H | 14 |
| Yamada, T | 2 |
| Yabe, D | 1 |
| Takahashi, Y | 4 |
| Suzuki, T | 28 |
| Buffolo, F | 12 |
| Tetti, M | 16 |
| Ueda, T | 1 |
| Osada, J | 1 |
| Ono, M | 1 |
| Yumoto, K | 1 |
| Baker, JE | 1 |
| Blinder, AR | 3 |
| Bick, NR | 1 |
| Liu, CJ | 2 |
| Lim, JS | 2 |
| Wachtel, H | 10 |
| Cohen, DL | 13 |
| Lyden, ML | 4 |
| Young, WF | 22 |
| Else, T | 5 |
| Giordano, TJ | 5 |
| Udager, AM | 5 |
| Zibar Tomsic, K | 1 |
| Dusek, T | 1 |
| Alduk, A | 1 |
| Knezevic, N | 1 |
| Molnar, V | 1 |
| Kraljevic, I | 2 |
| Skoric Polovina, T | 1 |
| Balasko, A | 1 |
| Solak, M | 1 |
| Matas, N | 1 |
| Popovac, H | 1 |
| Kralik-Oguic, S | 1 |
| Kastelan, D | 2 |
| Seki, T | 7 |
| Mukai, K | 15 |
| Suematsu, M | 5 |
| Umezawa, Y | 1 |
| Oya, M | 5 |
| Kosaka, T | 5 |
| Seki, M | 1 |
| Suzuki, Y | 2 |
| Horiuchi, Y | 1 |
| Nishimoto, K | 12 |
| Santana, LS | 1 |
| Guimaraes, AG | 1 |
| Almeida, MQ | 4 |
| Morimoto, S | 7 |
| Ichihara, A | 3 |
| Pitsava, G | 1 |
| Faucz, FR | 2 |
| Stratakis, CA | 10 |
| Hannah-Shmouni, F | 3 |
| Nhan, W | 1 |
| Grigoryan, S | 1 |
| Urban, C | 1 |
| Holevinski, L | 1 |
| Song, Y | 10 |
| Shen, H | 2 |
| Ng, E | 3 |
| Feng, Z | 3 |
| Ma, L | 5 |
| Du, Z | 4 |
| Luo, T | 4 |
| He, W | 7 |
| Wu, FF | 1 |
| Yang, S | 11 |
| Spyroglou, A | 6 |
| Handgriff, L | 5 |
| Müller, L | 2 |
| Schwarzlmüller, P | 1 |
| Hirsch, A | 1 |
| O'Toole, SM | 2 |
| Thuzar, M | 6 |
| Deflorenne, E | 1 |
| Vrckovnik, R | 3 |
| Kocjan, T | 10 |
| Zhang, CD | 1 |
| Li, D | 1 |
| Singh, S | 2 |
| Murakami, M | 9 |
| Quinkler, M | 24 |
| Drake, WM | 8 |
| Fassnacht, M | 3 |
| Zhang, C | 5 |
| Jiang, Y | 5 |
| Su, T | 5 |
| Jiang, L | 5 |
| Zhou, W | 7 |
| Zhong, X | 3 |
| Wu, L | 2 |
| Fei, J | 1 |
| Yang, SM | 3 |
| Hu, JB | 2 |
| He, WW | 2 |
| Feng, ZP | 2 |
| Li, QF | 3 |
| Manosroi, W | 1 |
| Tacharearnmuang, N | 1 |
| Atthakomol, P | 1 |
| Gao, H | 2 |
| Li, L | 6 |
| Tian, H | 6 |
| Bertello, C | 11 |
| Moustaki, M | 1 |
| Paschou, SA | 1 |
| Vakali, EC | 1 |
| Vryonidou, A | 1 |
| Gong, S | 7 |
| Kitamoto, T | 7 |
| van de Wiel, E | 1 |
| Chaman Baz, AH | 1 |
| Küsters, B | 3 |
| van Bonzel, L | 1 |
| van Erp, M | 1 |
| Deinum, J | 28 |
| Langenhuijsen, J | 1 |
| Mourtzi, N | 2 |
| Sertedaki, A | 4 |
| Piaditis, GP | 7 |
| Katsanis, N | 1 |
| Traeger-Synodinos, J | 1 |
| Tsigos, C | 1 |
| Charmandari, E | 4 |
| van Rooyen, D | 1 |
| Baliga, R | 1 |
| Le Floch, E | 1 |
| Cosentino, T | 1 |
| Larsen, CK | 2 |
| Baron, S | 5 |
| Chantalat, S | 1 |
| Saintpierre, B | 1 |
| Lenzini, L | 11 |
| Frouin, A | 1 |
| Ferey, M | 1 |
| Empana, JP | 1 |
| Jouven, X | 1 |
| Gieger, C | 2 |
| Waldenberger, M | 1 |
| Peters, A | 2 |
| Cusi, D | 1 |
| Salvi, E | 1 |
| Meneton, P | 1 |
| Touvier, M | 1 |
| Deschasaux, M | 1 |
| Druesne-Pecollo, N | 1 |
| Deleuze, JF | 1 |
| Jeunemaitre, X | 14 |
| Schneider, H | 5 |
| Sturm, L | 6 |
| Künzel, H | 6 |
| Seidensticker, M | 2 |
| Deniz, S | 1 |
| Ladurner, R | 4 |
| Kellnar, A | 1 |
| Bekeran, M | 2 |
| Schelling, J | 1 |
| Manaka, K | 1 |
| Sato, J | 1 |
| Takeuchi, M | 1 |
| Iiri, T | 1 |
| Nangaku, M | 2 |
| Makita, N | 2 |
| Bu, X | 2 |
| Sun, F | 7 |
| Zhao, Z | 4 |
| He, H | 4 |
| Yan, Z | 4 |
| Zhu, Z | 5 |
| Grodski, S | 1 |
| Lee, JC | 1 |
| Chan, CK | 3 |
| Lai, TS | 4 |
| Lu, CC | 7 |
| Liu, YC | 2 |
| Gancayco, CA | 1 |
| Gerding, MR | 1 |
| Breault, DT | 1 |
| Beenhakker, MP | 1 |
| Barrett, PQ | 6 |
| Guagliardo, NA | 5 |
| Burrello, J | 17 |
| Sakaguchi, S | 2 |
| Okamoto, R | 3 |
| Inoue, C | 1 |
| Akao, M | 1 |
| Kamemura, K | 15 |
| Fujita, S | 1 |
| Yano, Y | 3 |
| Dohi, K | 1 |
| Lu, ZX | 1 |
| Doery, JCG | 5 |
| Parisien-La Salle, S | 1 |
| Corbeil, G | 2 |
| El-Haffaf, Z | 1 |
| Duranceau, C | 1 |
| Latour, M | 2 |
| Karakiewicz, PI | 1 |
| Lacroix, A | 13 |
| Bourdeau, I | 11 |
| Lee, HW | 1 |
| Kim, YJ | 2 |
| Jin, HY | 1 |
| Lee, KA | 1 |
| Umapathysivam, MM | 1 |
| Morgan, B | 1 |
| Bischoff, C | 1 |
| Hayes, A | 1 |
| Wilks, M | 1 |
| Torpy, DJ | 4 |
| Huang, WC | 2 |
| Chen, CH | 3 |
| Siddique, S | 1 |
| Chia, YC | 1 |
| Tay, JC | 1 |
| Sogunuru, G | 1 |
| Cheng, HM | 2 |
| Kario, K | 1 |
| Szabo Yamashita, T | 1 |
| Shariq, OA | 4 |
| Foster, TR | 1 |
| Dy, BM | 3 |
| McKenzie, TJ | 6 |
| Miao, XY | 1 |
| Chen, K | 4 |
| Zeng, ZP | 5 |
| Fujiki, R | 1 |
| Sada, K | 1 |
| Mori, Y | 4 |
| Matsuda, N | 1 |
| Noguchi, T | 2 |
| Nakama, H | 1 |
| Loh, HH | 2 |
| Sukor, N | 8 |
| Jepsen, JV | 1 |
| Hornum, M | 1 |
| Johnson, PC | 1 |
| Thompson, SM | 1 |
| Adamo, D | 1 |
| Fleming, CJ | 1 |
| Cheville, J | 1 |
| Andrews, JC | 2 |
| Obeid, H | 1 |
| Chen Cardenas, SM | 1 |
| Khairi, S | 1 |
| Wu, T | 3 |
| Jiang, W | 1 |
| Chikhladze, NM | 9 |
| Wang, J | 5 |
| Shao, M | 1 |
| Zhao, Y | 2 |
| Ji, H | 1 |
| Guo, F | 1 |
| Fan, X | 1 |
| Wei, F | 1 |
| Qin, G | 1 |
| Meng, Y | 1 |
| Xie, A | 1 |
| Huang, J | 3 |
| Chen, N | 1 |
| Zang, L | 2 |
| Liu, YS | 1 |
| Guo, QH | 3 |
| Lyu, ZH | 3 |
| Dou, YM | 1 |
| Mu, Y | 1 |
| Hsu, YC | 1 |
| Lee, CH | 1 |
| Chen, CY | 1 |
| Hung, CJ | 1 |
| Zhu, R | 4 |
| Shagjaa, T | 2 |
| Caroccia, B | 12 |
| Gregori, D | 1 |
| Costa, N | 3 |
| Mounie, M | 3 |
| Gombault-Datzenko, E | 3 |
| Boulestreau, R | 3 |
| Cremer, A | 3 |
| Delchier, MC | 3 |
| Gosse, P | 5 |
| Lagarde, S | 3 |
| Lepage, B | 3 |
| Molinier, L | 3 |
| Papadopoulos, P | 3 |
| Trillaud, H | 3 |
| Rousseau, H | 3 |
| Bouhanick, B | 5 |
| Sato, T | 9 |
| Matsutomo, N | 3 |
| Yamamoto, T | 9 |
| Fukami, M | 3 |
| Kono, T | 14 |
| Maciel, AAW | 3 |
| Freitas, TC | 3 |
| Fagundes, GFC | 3 |
| Petenuci, J | 3 |
| Vilela, LAP | 3 |
| Brito, LP | 3 |
| Goldbaum, TS | 3 |
| Zerbini, MCN | 3 |
| Ledesma, FL | 3 |
| Tanno, FY | 3 |
| Srougi, V | 3 |
| Chambo, JL | 3 |
| Pereira, MAA | 3 |
| Coelho, FMA | 3 |
| Cavalcante, ACBS | 3 |
| Carnevale, FC | 3 |
| Pilan, B | 3 |
| Pio-Abreu, A | 3 |
| Silveira, JV | 3 |
| Consolim-Colombo, FM | 3 |
| Bortolotto, LA | 3 |
| Latronico, AC | 3 |
| Fragoso, MCBV | 3 |
| Drager, LF | 3 |
| Mendonca, BB | 3 |
| Mai, X | 3 |
| Kemter, E | 3 |
| Wolf, E | 3 |
| Ishinoda, Y | 3 |
| Uto, A | 3 |
| Yamada, Y | 4 |
| Okazaki, M | 3 |
| Asada, H | 3 |
| Wakamatsu, S | 3 |
| Ishii, T | 4 |
| Kumagai, H | 3 |
| Kasuga, A | 3 |
| Kwon, SY | 2 |
| Park, J | 2 |
| Park, SH | 2 |
| Cho, SH | 2 |
| Lee, YB | 2 |
| Lee, SY | 3 |
| Qiu, W | 2 |
| Yao, J | 4 |
| Hung, ML | 2 |
| Fraker, D | 2 |
| Trerotola, SO | 11 |
| Shi, S | 2 |
| Tian, Y | 2 |
| Ren, Y | 12 |
| Yu, M | 3 |
| Gao, L | 2 |
| Xu, S | 6 |
| Yokota, K | 4 |
| Ling, G | 1 |
| Bruno, J | 1 |
| Albert, SG | 1 |
| Dhindsa, S | 1 |
| Well, L | 1 |
| Spink, C | 1 |
| Lenz, A | 1 |
| Avanesov, M | 1 |
| Salamon, J | 1 |
| Adam, G | 1 |
| Schoennagel, BP | 1 |
| Henes, FO | 1 |
| Bannas, P | 1 |
| Sabbadin, C | 9 |
| Saccardi, C | 1 |
| Andrisani, A | 5 |
| Vitagliano, A | 1 |
| Marin, L | 1 |
| Ragazzi, E | 1 |
| Bordin, L | 6 |
| Ambrosini, G | 5 |
| Armanini, D | 29 |
| Barbar, B | 1 |
| Truran, P | 1 |
| Ramsingh, J | 1 |
| Bliss, R | 1 |
| Boot, C | 1 |
| Ramzan, M | 1 |
| Quinton, R | 1 |
| Mamoojee, YH | 1 |
| Beilin, LJ | 1 |
| Schlaich, M | 1 |
| Mori, TA | 1 |
| Li, YJ | 2 |
| Ji, ZG | 1 |
| Wen, J | 1 |
| Chen, UL | 1 |
| Chang, YR | 2 |
| Hashimura, H | 2 |
| Chee, NYN | 6 |
| Chong, W | 4 |
| Harris, E | 1 |
| Bouchalli, WE | 1 |
| Mir, KE | 1 |
| Jabiry, SE | 1 |
| Berrimi, M | 1 |
| Azizi, M | 10 |
| Leopold, JA | 4 |
| Ingelfinger, JR | 1 |
| Murai, S | 1 |
| Kakeshita, K | 1 |
| Imamura, T | 1 |
| Koike, T | 2 |
| Fujioka, H | 1 |
| Yamazaki, H | 1 |
| Kinugawa, K | 1 |
| Ugi, S | 1 |
| Yonishi, M | 1 |
| Sato, D | 1 |
| Nakaizumi, N | 1 |
| Horikawa, O | 1 |
| Fujita, Y | 1 |
| Wada, A | 1 |
| Kageyama, S | 1 |
| Kawauchi, A | 1 |
| Hino, M | 1 |
| Noujima, M | 1 |
| Maegawa, H | 1 |
| St-Jean, M | 3 |
| O'Toole, S | 2 |
| Torre, EM | 1 |
| Puar, T | 1 |
| Laycock, K | 1 |
| Grytaas, MA | 1 |
| Tong, CV | 1 |
| Gallego, NV | 1 |
| Kürzinger, L | 1 |
| Azizan, EABA | 1 |
| Nijhoff, MF | 1 |
| Maiolino, G | 14 |
| Dalmazi, GD | 1 |
| Kalugina, V | 1 |
| Furnica, RM | 1 |
| Wu, Y | 2 |
| Wu, Z | 4 |
| Hu, H | 1 |
| Rao, J | 1 |
| Hu, C | 6 |
| Peng, Q | 1 |
| Li, P | 4 |
| Gomez-Sanchez, EP | 9 |
| Ozawa, M | 2 |
| Kawano, R | 2 |
| Haruna, A | 1 |
| Ohki, Y | 2 |
| Suzuki, S | 13 |
| Kobayashi, Y | 3 |
| Fujiwara, A | 2 |
| Saka, S | 2 |
| Hirawa, N | 4 |
| Chen, SY | 1 |
| Nishida, H | 1 |
| Fujinami, H | 1 |
| Shin, T | 1 |
| Daa, T | 1 |
| Asayama, Y | 1 |
| Beger, C | 2 |
| Karg, T | 1 |
| Hinrichs, JB | 1 |
| Ringe, B | 1 |
| Haller, H | 2 |
| Meyer, BC | 1 |
| Limbourg, FP | 2 |
| Karashima, S | 7 |
| Kawakami, M | 2 |
| Nambo, H | 2 |
| Fujita, M | 7 |
| Suwa, T | 1 |
| Yamada, M | 10 |
| Lu, YC | 1 |
| Chueh, SJ | 3 |
| Wu, KD | 29 |
| Su, YR | 1 |
| Du, ZP | 2 |
| He, Y | 1 |
| Cheng, Q | 7 |
| Kang, B | 2 |
| Tang, S | 1 |
| Zhang, A | 1 |
| Shu, X | 2 |
| Jing, Y | 1 |
| Kendzerska, T | 1 |
| Asakawa, M | 1 |
| Takagi, N | 1 |
| Hamada, D | 1 |
| Yamasaki, Y | 1 |
| Takaku, Y | 1 |
| Kawada, M | 1 |
| Murata, T | 1 |
| Katsuta, H | 1 |
| Qiu, J | 1 |
| Xiong, HL | 1 |
| Li, YD | 1 |
| Hu, CK | 1 |
| Lai, ZQ | 1 |
| Liang, NP | 1 |
| Zhang, HJ | 1 |
| Jiang, XJ | 2 |
| Dong, YF | 1 |
| Vékony, B | 1 |
| Igaz, P | 2 |
| Castinetti, F | 1 |
| Guerin, C | 1 |
| Louiset, E | 3 |
| Sarkis, AL | 1 |
| Britz, V | 1 |
| Lechner, A | 1 |
| Potzel, AL | 1 |
| Nowotny, HF | 1 |
| Seiter, TM | 1 |
| Shen, YY | 1 |
| Zhu, J | 2 |
| Shi, Y | 2 |
| Tan, L | 1 |
| Li, TM | 1 |
| Lei, F | 1 |
| Tang, XD | 1 |
| Wan, J | 1 |
| Yang, W | 1 |
| Liang, Q | 2 |
| Jin, P | 1 |
| Funes Hernandez, M | 1 |
| Bhalla, V | 2 |
| Pieroni, J | 4 |
| Forestiero, V | 3 |
| Fonio, P | 1 |
| Nonnato, A | 1 |
| Settanni, F | 1 |
| Mengozzi, G | 12 |
| Otsuka, H | 4 |
| Charoensri, S | 2 |
| Yin, Y | 1 |
| Ma, C | 1 |
| Yu, S | 1 |
| Ai, Q | 1 |
| Han, C | 1 |
| Zhong, J | 1 |
| Luo, W | 2 |
| Ma, X | 5 |
| Yu, J | 3 |
| Cui, J | 1 |
| Qiu, L | 1 |
| Bao, M | 1 |
| Mitchell, BD | 1 |
| Whitlatch, HB | 1 |
| Mansur, A | 1 |
| Turchin, A | 1 |
| Qin, F | 1 |
| Pan, Y | 1 |
| Lai, X | 1 |
| Yang, T | 3 |
| Marzano, L | 3 |
| Kazory, A | 2 |
| Husain-Syed, F | 1 |
| Ronco, C | 1 |
| Kurtz, TW | 1 |
| Morris, RC | 2 |
| Pravenec, M | 1 |
| Lujan, HL | 1 |
| DiCarlo, SE | 1 |
| Pintus, G | 1 |
| Hiremath, S | 2 |
| Wilmont, E | 1 |
| Hamoir, E | 2 |
| Dubrofsky, L | 1 |
| Mandal, C | 1 |
| Dutta, PK | 1 |
| Sun, N | 3 |
| Meyer, LS | 5 |
| Koupourtidou, C | 1 |
| Krebs, S | 1 |
| Masserdotti, G | 1 |
| Blum, H | 1 |
| Walch, A | 2 |
| Williams, DM | 1 |
| Shaikh, A | 1 |
| Williams, E | 1 |
| Maroof, A | 1 |
| Michael, T | 1 |
| Boregowda, K | 1 |
| Fan, C | 2 |
| Wei, W | 1 |
| Fang, T | 1 |
| Quan, H | 1 |
| Goto, Y | 1 |
| Tanaka, S | 8 |
| Maruo, M | 1 |
| Sugawara, S | 3 |
| Chiba, K | 1 |
| Miyazaki, K | 1 |
| Inoue, A | 1 |
| Ichikawa, T | 2 |
| Nagata, M | 1 |
| Lin, L | 3 |
| Shen, S | 2 |
| Xu, H | 2 |
| Huang, H | 3 |
| Chen, T | 11 |
| Zhou, L | 2 |
| Zhu, Y | 6 |
| Beccuti, G | 1 |
| Luo, Y | 1 |
| Zeng, Q | 1 |
| Gong, L | 1 |
| Morita, R | 3 |
| Azushima, K | 1 |
| Sunohara, S | 1 |
| Kobayashi, R | 1 |
| Kinguchi, S | 1 |
| Kanaoka, T | 1 |
| Kobayashi, K | 2 |
| Toya, Y | 1 |
| Wakui, H | 1 |
| Li, H | 7 |
| Pei, Y | 1 |
| Yang, GQ | 3 |
| Ni, Q | 1 |
| Chen, YL | 3 |
| Ba, JM | 3 |
| Mu, YM | 4 |
| Murasawa, S | 1 |
| Kageyama, K | 3 |
| Usutani, M | 1 |
| Asari, Y | 1 |
| Kinoshita, N | 1 |
| Nakada, Y | 1 |
| Watanuki, Y | 1 |
| Takayasu, S | 1 |
| Daimon, M | 1 |
| Yazdanpanah, M | 1 |
| Delaney, SR | 1 |
| Beriault, DR | 1 |
| Wu, X | 2 |
| Azizan, EAB | 3 |
| Goodchild, E | 2 |
| Garg, S | 5 |
| Hagiyama, M | 1 |
| Cabrera, CP | 2 |
| Kuan, JL | 2 |
| Tiang, Z | 2 |
| David, A | 1 |
| Mein, CA | 2 |
| Wozniak, E | 2 |
| Zhao, W | 7 |
| Marker, A | 4 |
| Buss, F | 1 |
| Saleeb, RS | 1 |
| Salsbury, J | 2 |
| King, PJ | 1 |
| Gurnell, M | 7 |
| Ceral, J | 4 |
| Ryska, A | 1 |
| Mustangin, M | 1 |
| Wong, YP | 1 |
| Tan, GC | 1 |
| Solar, M | 4 |
| Foo, RS | 2 |
| Takaoka, Y | 1 |
| Murray, SA | 1 |
| Brown, MJ | 16 |
| Dinh, HA | 2 |
| Stölting, G | 7 |
| Chang, YL | 3 |
| Chen, GY | 1 |
| Weng, TI | 1 |
| Bagordo, D | 1 |
| Riester, A | 12 |
| Degenhart, C | 8 |
| Widimský, J | 15 |
| Negro, A | 8 |
| Rossi, E | 12 |
| Kline, G | 8 |
| Rump, LC | 14 |
| Vonend, O | 10 |
| Willenberg, HS | 17 |
| Shafigullina, Z | 3 |
| Oliveras, A | 3 |
| Krátká, Z | 4 |
| Battistel, M | 7 |
| Jia, M | 1 |
| Yu, H | 1 |
| Song, X | 2 |
| An, X | 1 |
| Mo, D | 3 |
| Zhang, T | 2 |
| Wu, N | 1 |
| Ren, X | 1 |
| Cheng, G | 1 |
| Wu, CY | 1 |
| Wu, MJ | 1 |
| Yu, TM | 1 |
| Chuang, YW | 1 |
| Wu, JT | 1 |
| Shiao, CC | 1 |
| Kishi, T | 1 |
| Baba, S | 6 |
| Sugawara, H | 2 |
| Miyoshi, A | 4 |
| Obara, S | 4 |
| Ylänen, A | 1 |
| Nevalainen, R | 1 |
| Huhtala, H | 2 |
| Hämäläinen, E | 2 |
| Niemelä, O | 2 |
| Phonanuwong, R | 1 |
| Jannoo, S | 1 |
| Chanthanuwat, S | 1 |
| Soonthornpun, S | 2 |
| Chidambaram, S | 1 |
| Van Den Heede, K | 1 |
| Damji, S | 1 |
| Meeran, K | 2 |
| Todd, J | 1 |
| Wernig, F | 1 |
| Palazzo, F | 1 |
| Di Marco, AN | 1 |
| Shen, Z | 4 |
| Guan, S | 1 |
| Chen, B | 3 |
| Gao, Z | 2 |
| Liu, L | 3 |
| Casadaban, L | 1 |
| Jensen, A | 1 |
| Ho, B | 1 |
| Neves da Silva, H | 1 |
| Selph, C | 1 |
| Hughes, M | 2 |
| Trivedi, P | 1 |
| Kishimoto, S | 5 |
| Maruhashi, T | 6 |
| Kajikawa, M | 5 |
| Mizobuchi, A | 1 |
| Harada, T | 3 |
| Yamaji, T | 3 |
| Hashimoto, Y | 1 |
| Yoshimura, K | 2 |
| Nakano, Y | 3 |
| Goto, C | 4 |
| Yusoff, FM | 4 |
| Nakashima, A | 4 |
| Higashi, Y | 6 |
| Cole, TJ | 1 |
| Magaña-Ávila, GR | 1 |
| Castañeda-Bueno, M | 1 |
| Kamada, H | 2 |
| Seiji, K | 4 |
| Oguro, S | 2 |
| Ota, H | 4 |
| Yanagaki, S | 2 |
| Takase, K | 7 |
| Karadeniz, A | 1 |
| Babayiğit, E | 1 |
| Görenek, B | 1 |
| Younes, N | 1 |
| Larose, S | 1 |
| Therasse, E | 7 |
| Singh, GR | 1 |
| Iwamoto, Y | 2 |
| Kimura, T | 2 |
| Ohnishi, M | 1 |
| Kusano, T | 1 |
| Takenouchi, H | 1 |
| Iwamoto, H | 2 |
| Sanada, J | 1 |
| Fushimi, Y | 1 |
| Katakura, Y | 1 |
| Tatsumi, F | 1 |
| Shimoda, M | 1 |
| Nakanishi, S | 1 |
| Kaku, K | 2 |
| Mune, T | 6 |
| Kaneto, H | 2 |
| Jojima, K | 1 |
| Tanaka, A | 1 |
| Node, K | 1 |
| O'Malley, KJ | 1 |
| Alnablsi, MW | 1 |
| Xi, Y | 1 |
| Pathak, M | 1 |
| Khan, F | 1 |
| Pillai, AK | 1 |
| Kathuria, MK | 1 |
| Vongpatanasin, W | 3 |
| Holloway-Kew, KL | 1 |
| Anderson, KB | 1 |
| Rufus-Membere, P | 1 |
| Tembo, MC | 1 |
| Sui, SX | 1 |
| Hyde, NK | 1 |
| Kotowicz, MA | 1 |
| Diez-Perez, A | 1 |
| Henneberg, M | 1 |
| Liao, WH | 1 |
| Pasco, JA | 1 |
| Laffin, LJ | 1 |
| Rodman, D | 1 |
| Luther, JM | 3 |
| Rajicic, N | 1 |
| Slingsby, BT | 1 |
| Nissen, SE | 1 |
| Mansour, N | 1 |
| Mittermeier, A | 1 |
| Walter, R | 1 |
| Schachtner, B | 1 |
| Rudolph, J | 1 |
| Erber, B | 1 |
| Schmidt, VF | 1 |
| Heinrich, D | 4 |
| Bruedgam, D | 1 |
| Tschaidse, L | 1 |
| Nowotny, H | 1 |
| Kunz, SL | 1 |
| Ricke, J | 2 |
| Reisch, N | 1 |
| Wildgruber, M | 1 |
| Ingrisch, M | 1 |
| Volkert, M | 1 |
| Hellmig, N | 1 |
| Schewe, J | 3 |
| Hennicke, L | 1 |
| Seidel, E | 3 |
| Oberacher, H | 1 |
| Lifton, RP | 7 |
| Urban, I | 1 |
| Long, M | 1 |
| Rivalan, M | 1 |
| Nottoli, T | 1 |
| Rege, J | 1 |
| Bandulik, S | 7 |
| Kosmann, C | 1 |
| Plain, A | 1 |
| Vats, P | 1 |
| Kumar-Sinha, C | 1 |
| Lerario, AM | 1 |
| Warth, R | 9 |
| Quencer, KB | 1 |
| Rugge, JB | 1 |
| Senashova, O | 1 |
| Zuo, R | 1 |
| Liu, S | 2 |
| Xu, L | 4 |
| Pang, H | 1 |
| Fang, C | 2 |
| Dai, J | 1 |
| Zhao, J | 1 |
| Huang, X | 2 |
| Maier, P | 1 |
| Heinze, B | 2 |
| Gabor, S | 1 |
| Reese, S | 1 |
| Schirbel, A | 1 |
| Pilz, S | 11 |
| Theiler-Schwetz, V | 1 |
| Trummer, C | 2 |
| Chen, C | 1 |
| Li, F | 6 |
| Han, J | 1 |
| Hoshi, S | 1 |
| Onagi, A | 1 |
| Tanji, R | 1 |
| Honda-Takinami, R | 1 |
| Matsuoka, K | 1 |
| Hata, J | 1 |
| Akaihata, H | 1 |
| Kataoka, M | 1 |
| Ogawa, S | 1 |
| Kojima, Y | 2 |
| Park, W | 1 |
| Whitfield, P | 1 |
| Corley, B | 1 |
| Harper, S | 2 |
| Feltham, J | 2 |
| Carroll, R | 2 |
| Zhu, ZM | 1 |
| Wu, H | 2 |
| Kawabata, M | 1 |
| Toyama, H | 1 |
| Tanimoto, K | 2 |
| Konno, D | 1 |
| Yamauchi, M | 2 |
| Niwa, Y | 1 |
| Miyamoto, H | 1 |
| Mori, K | 2 |
| Ishihata, H | 1 |
| Wang, R | 2 |
| Pan, R | 1 |
| Zhang, R | 2 |
| Bhatt, PS | 1 |
| Sam, AH | 1 |
| Meeran, KM | 1 |
| Salem, V | 2 |
| Demura, M | 4 |
| Aono, D | 3 |
| Gondoh, Y | 1 |
| Yasuda, M | 2 |
| Horike, SI | 1 |
| Nanba, AT | 4 |
| Shields, JJ | 4 |
| Yamashita, K | 4 |
| Seki, Y | 2 |
| Watanabe, D | 3 |
| Anno, T | 1 |
| Takai, M | 1 |
| Hirukawa, H | 1 |
| Kawasaki, F | 1 |
| Okimoto, N | 1 |
| Fujii, Y | 14 |
| Shibayama, Y | 8 |
| Kawashima, J | 12 |
| Watanabe, M | 13 |
| Yamamto, K | 3 |
| Ogo, A | 11 |
| Yanase, T | 13 |
| Okamura, S | 9 |
| Miyauchi, S | 8 |
| Ogasawara, T | 2 |
| Tanemoto, M | 6 |
| Donlon, PT | 1 |
| Fallahi, H | 1 |
| Beard, WL | 1 |
| Shahzad, A | 1 |
| Heflin, L | 1 |
| Cox, W | 1 |
| Bloomberg, B | 1 |
| Lillich, JD | 1 |
| Ganta, CK | 1 |
| O'Sullivan, GJ | 1 |
| Ruvio, G | 1 |
| O'Shea, PM | 3 |
| O'Halloran, M | 1 |
| Prakash, P | 1 |
| Dennedy, MC | 3 |
| Schultze Kool, L | 3 |
| Christian Rump, L | 2 |
| Dun Wu, K | 1 |
| Barbiero, G | 5 |
| Vanderriele, PE | 4 |
| Pessina, AC | 28 |
| Piazza, M | 2 |
| Scarpa, R | 1 |
| Persichitti, P | 1 |
| Basso, D | 1 |
| Holler, F | 2 |
| Lechner, B | 2 |
| Rhayem, Y | 4 |
| Kunzke, T | 2 |
| Feuchtinger, A | 2 |
| Ludwig, P | 1 |
| Strom, TM | 3 |
| Gomez-Sanchez, C | 8 |
| Knösel, T | 3 |
| Kirchner, T | 1 |
| Walch, AK | 1 |
| Meng, X | 2 |
| Ma, WJ | 1 |
| Lu, PP | 1 |
| Fan, P | 1 |
| Zhang, HM | 1 |
| Wu, HY | 1 |
| Zhou, XL | 1 |
| Lou, Y | 1 |
| Vorselaars, WMCM | 4 |
| van Beek, DJ | 3 |
| Postma, EL | 2 |
| Spiering, W | 4 |
| Borel Rinkes, IHM | 3 |
| Valk, GD | 4 |
| Vriens, MR | 4 |
| Leung, HT | 1 |
| Woo, YC | 1 |
| Fong, CHY | 1 |
| Tan, KCB | 1 |
| Lau, EYF | 1 |
| Chan, KW | 1 |
| Leung, JYY | 1 |
| Maniero, C | 6 |
| Scudieri, P | 1 |
| Haris Shaikh, L | 1 |
| Galietta, LJV | 1 |
| Sivarajah, M | 1 |
| Beninato, T | 2 |
| Fahey, TJ | 3 |
| Sun, H | 1 |
| Xie, W | 1 |
| Sun, J | 1 |
| Qing, B | 1 |
| Sugawa, T | 1 |
| Nagano, H | 2 |
| Saiga, A | 2 |
| Kubota, Y | 4 |
| Fujimoto, M | 1 |
| Felizola, SJA | 1 |
| Ishiwata, K | 1 |
| Tamura, A | 1 |
| Higuchi, S | 1 |
| Sakuma, I | 1 |
| Hashimoto, N | 1 |
| Koide, H | 1 |
| Takeshita, N | 1 |
| Ban, T | 1 |
| Yokote, K | 1 |
| Uno, T | 2 |
| Athimulam, S | 2 |
| Lazik, N | 1 |
| Gubbi, S | 1 |
| Spence, JD | 4 |
| Koch, CA | 1 |
| Nagata, H | 4 |
| Gerards, J | 1 |
| Ziganshina, AP | 1 |
| Gosmanov, AR | 1 |
| Komada, H | 1 |
| Hirota, Y | 1 |
| So, A | 2 |
| Nakamura, T | 5 |
| Okuno, Y | 1 |
| Fukuoka, H | 1 |
| Iguchi, G | 1 |
| Sakaguchi, K | 1 |
| Ogawa, W | 1 |
| Young, K | 1 |
| Ahmed, AH | 15 |
| Ward, G | 6 |
| Wolley, M | 14 |
| Guo, Z | 8 |
| Gordon, RD | 74 |
| McWhinney, BC | 6 |
| Ungerer, JP | 3 |
| Scholl, U | 2 |
| He, M | 3 |
| Xu, Z | 2 |
| Guo, Y | 4 |
| Wang, K | 2 |
| Forslund, S | 1 |
| Marko, L | 1 |
| Peters, J | 3 |
| Muller, DN | 1 |
| Fahlke, C | 3 |
| Cesari, M | 10 |
| Pecori, A | 3 |
| Poglitsch, M | 4 |
| Silhol, F | 2 |
| Sarlon-Bartoli, G | 1 |
| Vaïsse, B | 3 |
| Lin, C | 2 |
| Jing, H | 1 |
| Wang, H | 2 |
| Tsodikov, A | 1 |
| Ren, J | 1 |
| O'Day, PJ | 1 |
| Giacherio, D | 1 |
| Wang, G | 4 |
| Zhu, B | 1 |
| Takahashi, B | 2 |
| Usubuchi, H | 3 |
| Terae, S | 3 |
| Funder, J | 4 |
| Kietsiriroje, N | 2 |
| Wonghirundecha, R | 1 |
| Suntornlohanakul, O | 2 |
| Murray, RD | 2 |
| Loh, WJ | 1 |
| Lim, DS | 1 |
| Loh, LM | 1 |
| Lee, L | 1 |
| Swee, DS | 1 |
| Khoo, J | 2 |
| Tay, D | 1 |
| Kam, JW | 2 |
| Dekkers, T | 5 |
| Velema, M | 1 |
| Tevosian, SG | 1 |
| Fox, SC | 1 |
| Ghayee, HK | 1 |
| Arora, A | 1 |
| Jha, C | 1 |
| Singh, P | 1 |
| Beck, KR | 1 |
| Telisman, L | 1 |
| van Koppen, CJ | 1 |
| Thompson, GR | 1 |
| Odermatt, A | 2 |
| Miller, BS | 5 |
| Suurd, DPD | 1 |
| Postma, E | 1 |
| Ceolotto, G | 4 |
| Ungerer, JPJ | 3 |
| Takamatsu, K | 1 |
| Takeda, T | 2 |
| Hattori, S | 1 |
| Tanaka, N | 1 |
| Morita, S | 5 |
| Matsumoto, K | 1 |
| Mizuno, R | 1 |
| Shinojima, T | 1 |
| Kikuchi, E | 1 |
| Asanuma, H | 1 |
| Ismail, NA | 1 |
| Kamaruddin, NA | 1 |
| Azhar Shah, S | 1 |
| Wack, M | 1 |
| Rocha, A | 2 |
| Travers, S | 2 |
| Berends, AMA | 1 |
| Connelly, MA | 1 |
| Dullaart, RPF | 1 |
| Losano, I | 1 |
| Cavaglià, G | 1 |
| Araki, E | 2 |
| Hu, Y | 2 |
| Tömböl, Z | 1 |
| Turai, PI | 1 |
| Decmann, Á | 1 |
| Sakai, H | 3 |
| Nakamura, A | 1 |
| Atsumi, T | 2 |
| Tang, Z | 1 |
| Mei, M | 3 |
| Solanki, P | 1 |
| Gruber, M | 1 |
| Poitz, DM | 1 |
| van Herwaarden, AE | 1 |
| Langton, K | 1 |
| Kunath, C | 1 |
| Hofmockel, T | 1 |
| Bornstein, SR | 3 |
| Srisintorn, W | 1 |
| Yatabe, M | 1 |
| Bokuda, K | 1 |
| Shimizu, S | 2 |
| Tu, W | 1 |
| Pratt, JH | 6 |
| Braun, L | 1 |
| Nirschl, N | 2 |
| Abdul-Wahab, A | 1 |
| Lau, KK | 1 |
| Lam, Q | 1 |
| MacIsaac, RJ | 2 |
| Chiang, C | 1 |
| Siddiqui, M | 1 |
| Calhoun, DA | 21 |
| Hopkins, PN | 2 |
| Williams, GH | 10 |
| Fries, CM | 1 |
| Bae, YJ | 1 |
| Rayes, N | 2 |
| Sandner, B | 1 |
| Isermann, B | 1 |
| Stumvoll, M | 1 |
| Fagotto, V | 1 |
| Mandy, V | 1 |
| Kratzsch, J | 1 |
| Fenske, WK | 1 |
| Okazaki-Hada, M | 1 |
| Moriya, A | 1 |
| Nagao, M | 2 |
| Oikawa, S | 1 |
| Fukuda, I | 1 |
| Sugihara, H | 2 |
| Udager, A | 1 |
| van der Heijden, CDCC | 2 |
| Ter Horst, R | 1 |
| van den Munckhof, ICL | 1 |
| Schraa, K | 1 |
| de Graaf, J | 1 |
| Joosten, LAB | 1 |
| Danser, AHJ | 1 |
| Netea, MG | 1 |
| Rutten, J | 1 |
| Riksen, NP | 3 |
| Kitamoto, KK | 1 |
| Takiguchi, T | 1 |
| Li, YM | 4 |
| Tian, HM | 4 |
| Li, QR | 2 |
| Zhang, TT | 1 |
| Zhou, FL | 1 |
| Du, J | 2 |
| Liu, HD | 1 |
| Zhu, YC | 2 |
| Burrello, A | 3 |
| Sconfienza, E | 2 |
| Rabbia, P | 1 |
| Shifman, BM | 2 |
| Molashenko, NV | 2 |
| Sitkin, II | 1 |
| Belcevich, DG | 1 |
| Kovalevich, LD | 1 |
| Romanova, NY | 2 |
| Kolesnikova, GS | 2 |
| Alseddeeqi, E | 1 |
| Altinoz, A | 1 |
| Ghashir, NB | 1 |
| Bouchard-Bellavance, R | 1 |
| Perrault, F | 1 |
| Soulez, G | 4 |
| Chagnon, M | 3 |
| Desrochers, MJ | 1 |
| El Ghorayeb, N | 2 |
| Huang, YC | 1 |
| Tsai, MH | 2 |
| Fang, YW | 2 |
| Tu, ML | 1 |
| Er, LK | 3 |
| Lin, MC | 1 |
| Hsiao, JK | 1 |
| Yang, CY | 1 |
| Caoili, E | 1 |
| Nanba, A | 2 |
| Lee, J | 3 |
| Kim, MH | 1 |
| Choi, B | 1 |
| Hong, TH | 1 |
| Kang, MI | 1 |
| Lim, DJ | 1 |
| Tuersun, T | 2 |
| Zhang, Z | 5 |
| Sze, WC | 4 |
| Chung, TT | 1 |
| Akker, SA | 4 |
| Druce, MR | 3 |
| Waterhouse, M | 3 |
| Pitkin, S | 1 |
| Dawnay, A | 1 |
| Sahdev, A | 4 |
| Matson, M | 4 |
| Parvanta, L | 3 |
| Gürtler, F | 1 |
| Jordan, K | 1 |
| Tegtmeier, I | 3 |
| Herold, J | 1 |
| Stindl, J | 3 |
| Murck, H | 3 |
| Schlageter, L | 2 |
| Schneider, A | 2 |
| Sun, L | 1 |
| Hashimoto, H | 3 |
| Takaeko, Y | 2 |
| Han, Y | 1 |
| Kihara, Y | 5 |
| Chayama, K | 3 |
| Yeung, A | 1 |
| Friedmann, P | 1 |
| In, H | 1 |
| Bloomgarden, N | 1 |
| McAuliffe, JC | 2 |
| Libutti, SK | 4 |
| Laird, AM | 2 |
| Hong, Y | 2 |
| Shen, R | 1 |
| Zheng, H | 1 |
| Yang, G | 1 |
| Miyazawa, T | 2 |
| Chen, YY | 1 |
| Zeng, YH | 1 |
| Chen, CK | 1 |
| Tu, KH | 1 |
| Ma, D | 1 |
| Zeng, L | 1 |
| Yuan, P | 1 |
| Xie, J | 3 |
| Yuan, G | 1 |
| Wang, S | 2 |
| Yu, X | 3 |
| Xu, A | 1 |
| Kaltsas, G | 8 |
| Jensterle, M | 1 |
| Vidmar, G | 2 |
| Berden, P | 1 |
| Stankovic, M | 2 |
| Morganti, A | 5 |
| Fallo, F | 35 |
| Pitt, B | 2 |
| Byrd, JB | 4 |
| Yokota, H | 1 |
| Sawada, K | 2 |
| Wada, T | 1 |
| Horikoshi, T | 1 |
| Edelman, ER | 1 |
| Butala, NM | 1 |
| Avery, LL | 1 |
| Lundquist, AL | 1 |
| Dighe, AS | 1 |
| Martin, M | 1 |
| Zhang, SL | 1 |
| Gao, JW | 1 |
| Feng, QL | 1 |
| Tang, JY | 1 |
| Yan, L | 3 |
| Wang, JF | 1 |
| Cheng, H | 3 |
| Liu, PM | 1 |
| Amongero, M | 1 |
| Brohm, K | 2 |
| Hannemann, A | 5 |
| Kendl, S | 1 |
| Deutschbein, T | 1 |
| Kroiss, M | 2 |
| Cheng, QF | 1 |
| Wang, KR | 1 |
| Xu, ZX | 1 |
| Thiesmeyer, JW | 1 |
| Ullmann, TM | 1 |
| Stamatiou, AT | 1 |
| Limberg, J | 1 |
| Stefanova, D | 1 |
| Finnerty, BM | 2 |
| Vignaud, T | 1 |
| Leclerc, J | 1 |
| Brunaud, L | 2 |
| Mirallie, E | 2 |
| Zarnegar, R | 3 |
| Motoya, M | 1 |
| Choudhary, MK | 1 |
| Koskela, J | 1 |
| Tikkakoski, A | 1 |
| Mustonen, J | 1 |
| Morita, M | 1 |
| Nakano, T | 1 |
| Sato, I | 1 |
| Yokoyama, A | 1 |
| Sugawara, A | 1 |
| Sawamura, T | 2 |
| Nagase, S | 1 |
| Shimizu, E | 1 |
| Higashitani, T | 2 |
| Ohbatake, A | 1 |
| Furukawa, K | 1 |
| Chang, CH | 4 |
| Chung, SD | 1 |
| Loberg, C | 1 |
| Antoch, G | 2 |
| Stegbauer, J | 2 |
| Dringenberg, T | 1 |
| Steuwe, A | 1 |
| Fürst, G | 1 |
| Haase, M | 1 |
| Schimmöller, L | 1 |
| Klapper-Goldstein, H | 1 |
| Verma, A | 1 |
| Elyagon, S | 1 |
| Gillis, R | 1 |
| Murninkas, M | 1 |
| Pittala, S | 1 |
| Paul, A | 1 |
| Shoshan-Barmatz, V | 1 |
| Etzion, Y | 1 |
| Young, W | 1 |
| Ladygina, DO | 1 |
| Balutina, OV | 1 |
| Beltsevich, DG | 1 |
| Auchus, R | 3 |
| Chen, J | 2 |
| Wu, J | 1 |
| Lu, L | 3 |
| Ma, XJ | 1 |
| Alam, S | 1 |
| Kandasamy, D | 1 |
| Goyal, A | 1 |
| Vishnubhatla, S | 1 |
| Karthikeyan, G | 1 |
| Khadgawat, R | 1 |
| Boscaro, M | 23 |
| Cheng, YB | 1 |
| Zhang, G | 2 |
| Tang, L | 1 |
| Yang, L | 1 |
| Ganesh, M | 1 |
| Abadin, SS | 1 |
| Fogelfeld, L | 2 |
| Smeets, EMM | 1 |
| Aarntzen, EHJG | 1 |
| Wesseling, M | 1 |
| de Jager, SCA | 1 |
| Hatanaka, Y | 5 |
| Fukuda, N | 6 |
| Romero-Velez, G | 1 |
| Barajas, ME | 1 |
| Sierra-Salazar, M | 1 |
| Herrera, MF | 1 |
| Parides, MK | 1 |
| Pereira, X | 1 |
| Cosma, C | 1 |
| Padoan, A | 1 |
| Plebani, M | 3 |
| Teruyama, K | 1 |
| Wei, DS | 1 |
| Ghoshal, K | 1 |
| Peng, D | 1 |
| Adler, GK | 2 |
| Nian, H | 1 |
| Yu, C | 1 |
| Solorzano, CC | 1 |
| Pozzi, A | 1 |
| Brown, NJ | 4 |
| Kalaria, T | 1 |
| Buch, H | 1 |
| Gama, R | 1 |
| Dong, H | 1 |
| Zou, Y | 1 |
| He, J | 1 |
| Deng, Y | 1 |
| Gao, R | 1 |
| Jiang, X | 1 |
| Görge, V | 1 |
| Hoster, E | 1 |
| Velema, MS | 3 |
| Canu, L | 1 |
| Hermus, ARMM | 2 |
| Timmers, HJLM | 2 |
| Schultze Kool, LJ | 3 |
| Groenewoud, HJMM | 1 |
| Jacobs, C | 1 |
| Jørgensen, AP | 1 |
| Fuke, Y | 1 |
| Hoenig, MP | 1 |
| Hoorn, EJ | 2 |
| Ritzel, K | 1 |
| Pauzi, FA | 1 |
| Azizan, EA | 7 |
| Liu, B | 1 |
| DePietro, DM | 1 |
| Fraker, DL | 11 |
| Vetri, M | 1 |
| Cassaniti, L | 1 |
| Francese, GM | 1 |
| Gulizia, MM | 1 |
| Jansen, PM | 4 |
| van de Wiel, ECJ | 1 |
| Mann, R | 1 |
| Veltien, A | 1 |
| Aalders, TW | 1 |
| Verhaegh, GW | 1 |
| Langenhuijsen, JF | 2 |
| Gondoh-Noda, Y | 1 |
| Matsuoka, T | 1 |
| Yoshikura, S | 1 |
| Fujimoto, A | 1 |
| Usukura, M | 2 |
| Vermue, FC | 1 |
| van den Berg, SAA | 1 |
| Kai, T | 6 |
| Chiba, Y | 5 |
| Chen, CT | 1 |
| Wang, YC | 1 |
| Lin, CM | 1 |
| Xu, F | 2 |
| Zhou, Z | 1 |
| Chee, MR | 1 |
| Hoo, J | 1 |
| Hamilton, G | 1 |
| Narayan, O | 1 |
| Angel Korman, A | 1 |
| Raz, O | 1 |
| Rapoport, V | 1 |
| Katzir, Z | 1 |
| Hausmann, M | 1 |
| Okamoto, K | 1 |
| Dominguez, DA | 1 |
| Chatani, P | 1 |
| Murphy, R | 1 |
| Copeland, AR | 1 |
| Chang, R | 1 |
| Sadowski, SM | 1 |
| Nilubol, N | 2 |
| Rumbolo, F | 1 |
| Avataneo, V | 1 |
| D'Avolio, A | 1 |
| Rabbia, F | 7 |
| Lin, LC | 3 |
| Segawa, H | 1 |
| Higashi, A | 1 |
| Masuda, I | 1 |
| Yoshii, K | 1 |
| Iwahori, T | 1 |
| Ueshima, H | 1 |
| Hung, A | 1 |
| Ahmed, S | 1 |
| Gupta, A | 1 |
| Davis, A | 1 |
| Ruzicka, M | 1 |
| Zhang, B | 2 |
| Yu, P | 1 |
| Zhou, H | 1 |
| Shan, L | 1 |
| Gu, Z | 1 |
| Zhong, S | 1 |
| Tao, Z | 1 |
| Gu, W | 1 |
| Yu, Y | 3 |
| He, Z | 1 |
| Uhrová, J | 1 |
| Benáková, H | 1 |
| Vaníčková, Z | 1 |
| Zima, T | 1 |
| Campbell, DJT | 1 |
| Venos, E | 1 |
| Pasieka, J | 2 |
| Vidyasagar, S | 1 |
| Kumar, S | 1 |
| Morton, A | 1 |
| Crimì, F | 1 |
| Cent Wu, V | 1 |
| Xiang, Q | 1 |
| Yu, K | 1 |
| Sykes, E | 1 |
| Dad, T | 1 |
| Tamura, N | 4 |
| Watanabe, E | 1 |
| Shirakawa, R | 1 |
| Nakatani, E | 1 |
| Yamada, K | 2 |
| Hatakeyama, H | 1 |
| Torii-Hanakita, M | 1 |
| Kyo, C | 1 |
| Kosugi, R | 1 |
| Ogawa, T | 1 |
| Kotani, M | 1 |
| Usui, T | 4 |
| Inoue, T | 2 |
| Vlachou, S | 1 |
| Kyriazi, E | 1 |
| Kapsali, C | 1 |
| Gryparis, A | 2 |
| Kassi, E | 2 |
| Chrousos, G | 2 |
| Liu, F | 1 |
| Ding, Y | 1 |
| Liang, S | 1 |
| Lai, Q | 1 |
| Zhou, Y | 1 |
| Yao, B | 1 |
| Xu, W | 1 |
| Yang, X | 1 |
| Chen, KM | 2 |
| Wu, TH | 3 |
| Hong, JS | 2 |
| Lin, KH | 1 |
| Hatakeyama, M | 1 |
| Komiya, S | 1 |
| Moon, SJ | 1 |
| Jang, HN | 1 |
| Moon, MK | 1 |
| Yang, YS | 2 |
| Yoo, JH | 1 |
| Lee, JH | 2 |
| Hong, AR | 1 |
| Lee, DH | 1 |
| Zhou, J | 6 |
| Argentesi, G | 1 |
| Cottrell, E | 1 |
| Senanayake, R | 1 |
| Åkerström, T | 4 |
| Backman, S | 3 |
| Jordan, S | 1 |
| Polubothu, S | 1 |
| Berney, DM | 3 |
| Gluck, A | 1 |
| Lines, KE | 1 |
| Thakker, RV | 1 |
| Tuthill, A | 1 |
| Joyce, C | 1 |
| Kaski, JP | 1 |
| Karet Frankl, FE | 2 |
| Metherell, LA | 1 |
| Teo, AED | 1 |
| Klinzing, D | 1 |
| Gomez Sanchez, CE | 1 |
| Hellman, P | 7 |
| Kinsler, VA | 1 |
| Björklund, P | 6 |
| Storr, HL | 1 |
| Ohara, N | 1 |
| Kobayashi, M | 1 |
| Yoneoka, Y | 1 |
| Hasegawa, G | 1 |
| Aoki, Y | 1 |
| Kazama, Y | 1 |
| Nishiyama, T | 1 |
| Peng, SY | 1 |
| Wan, CH | 2 |
| Khandelwal, P | 1 |
| Teresa Fuss, C | 1 |
| Baudrand, R | 5 |
| Curhan, G | 1 |
| Ball, JP | 2 |
| Syed, M | 2 |
| Marañon, RO | 1 |
| Hall, ME | 2 |
| Kc, R | 1 |
| Reckelhoff, JF | 1 |
| Yanes Cardozo, LL | 2 |
| Romero, DG | 2 |
| Rachid, M | 1 |
| Dreux, S | 1 |
| Pean de Ponfilly, G | 1 |
| Vargas-Poussou, R | 1 |
| Czerkiewicz, I | 1 |
| Chevenne, D | 1 |
| Oury, JF | 1 |
| Deschênes, G | 1 |
| Muller, F | 1 |
| Ching, KC | 1 |
| Calò, LA | 4 |
| Ise, K | 2 |
| Nozawa, Y | 2 |
| Tomlins, SA | 6 |
| Ito, S | 16 |
| Castellano, I | 6 |
| Pilon, C | 7 |
| Santini, D | 2 |
| Maffeis, V | 1 |
| Fassina, A | 6 |
| Johnson, TI | 2 |
| Sugisawa, C | 2 |
| Tancredi, M | 1 |
| Eliasson, B | 1 |
| Eggertsen, R | 1 |
| Lindblad, U | 1 |
| Dahlqvist, S | 1 |
| Imberg, H | 1 |
| Lind, M | 1 |
| Gould, A | 1 |
| Bisogni, V | 7 |
| Steichen, O | 9 |
| Prebtani, APH | 1 |
| Schiffrin, EL | 4 |
| McHedlishvili, D | 1 |
| McIntire, WE | 1 |
| Erisir, A | 1 |
| Coburn, CA | 1 |
| Santarelli, VP | 1 |
| Bayliss, DA | 4 |
| Starker, LF | 2 |
| Christakis, I | 1 |
| Julien, JS | 1 |
| Schwarz, K | 1 |
| Graham, P | 1 |
| Grubbs, EG | 1 |
| Lee, JE | 1 |
| Perrier, ND | 1 |
| Grotevendt, A | 1 |
| Wallaschofski, H | 4 |
| Nauck, M | 2 |
| Hoffmann, W | 1 |
| Rettig, R | 3 |
| Kudo, M | 9 |
| Yamamoto, S | 1 |
| Arai, T | 1 |
| Griffin, TP | 3 |
| Wall, D | 2 |
| Browne, GA | 2 |
| Dennehy, MC | 1 |
| Niu, W | 2 |
| Zheng, F | 2 |
| Stavropoulos, K | 3 |
| Imprialos, KP | 3 |
| Doumas, M | 5 |
| Tsujiguchi, H | 1 |
| Asakura, H | 1 |
| Nakano, S | 2 |
| Mori, S | 3 |
| Ohe, M | 2 |
| Okuda, R | 1 |
| Hara, A | 2 |
| Takamura, T | 1 |
| Yamagishi, M | 3 |
| Nakamura, H | 2 |
| Colvin, J | 1 |
| Krishnamurthy, V | 2 |
| Jin, J | 2 |
| Shin, J | 2 |
| Siperstein, A | 2 |
| Berber, E | 2 |
| Yen, RF | 4 |
| Wang, TD | 1 |
| Wang, CY | 1 |
| Tu, ST | 1 |
| Jeff Chueh, SC | 1 |
| Tseng, FY | 1 |
| Yamashita, T | 1 |
| Koyama, M | 1 |
| Ohno, K | 1 |
| Mita, T | 1 |
| Tobisawa, T | 1 |
| Takada, A | 2 |
| Togashi, N | 1 |
| Ohnuma, Y | 1 |
| Tsuchida, A | 1 |
| Endo, T | 2 |
| Ando, T | 2 |
| Yoshida, H | 4 |
| Fukuma, S | 1 |
| Fukuhara, S | 1 |
| Moniwa, N | 1 |
| Miura, T | 1 |
| Donà, G | 1 |
| Holmes, DT | 4 |
| Huang, KC | 1 |
| Lee, JK | 6 |
| Chen, CW | 2 |
| Feng, X | 1 |
| Wei, G | 1 |
| Cao, X | 1 |
| Mourtzinis, G | 1 |
| Ebrahimi, A | 1 |
| Gustafsson, H | 1 |
| Manhem, K | 1 |
| Diego, M | 1 |
| Denimal, D | 2 |
| Lemaire, S | 1 |
| Duvillard, L | 2 |
| Prada, ETA | 1 |
| Zheng, FF | 1 |
| Zhu, LM | 2 |
| Zhou, WL | 1 |
| Li, MY | 1 |
| Zhu, DL | 5 |
| Suematsu, S | 3 |
| Robinson-Cohen, C | 1 |
| Luque-Fernandez, MA | 1 |
| Allison, MA | 2 |
| Ix, JH | 1 |
| Kestenbaum, B | 1 |
| de Boer, IH | 1 |
| Xie, C | 1 |
| Wu, P | 1 |
| Wei, Q | 1 |
| Tan, W | 1 |
| Xue, Y | 1 |
| Guan, M | 1 |
| Pemayun, TGD | 1 |
| Naibaho, R | 1 |
| Wiyati, MW | 1 |
| Santosa, A | 1 |
| Amarwati, S | 1 |
| Yin, Z | 1 |
| Kim, BJ | 1 |
| Kwak, MK | 1 |
| Ahn, SH | 1 |
| Kim, H | 1 |
| Cronin, PA | 1 |
| Farley, DR | 7 |
| Richards, ML | 3 |
| Thompson, GB | 9 |
| Ahmed, A | 2 |
| Ungerer, J | 1 |
| McWhinney, B | 1 |
| Gordon, R | 4 |
| Hughes, DT | 1 |
| Cohen, MS | 1 |
| Gauger, PG | 3 |
| Boix, J | 1 |
| Bigas, J | 1 |
| Sevilla, LM | 1 |
| Citton, M | 2 |
| Torresan, F | 3 |
| Pérez, P | 1 |
| Zhen, Q | 2 |
| Zhang, S | 3 |
| Qing, H | 1 |
| Bruemmer, D | 1 |
| Peng, B | 1 |
| Duh, QY | 4 |
| Suh, I | 2 |
| Catena, C | 15 |
| Sechi, LA | 15 |
| Strajina, V | 1 |
| Al-Hilli, Z | 1 |
| de Nooijer, AH | 2 |
| Burgers, VWG | 1 |
| Husson, O | 1 |
| Kuppusamy, M | 6 |
| Scortegagna, M | 1 |
| Berthon, A | 2 |
| Settas, N | 1 |
| Giannakou, A | 1 |
| Garcia, G | 1 |
| Li, JL | 1 |
| James, B | 1 |
| Liddington, RC | 1 |
| Vilches-Moure, JG | 1 |
| Ronai, ZA | 1 |
| van der Wilt, GJ | 4 |
| Swearingen, AJ | 1 |
| Kahramangil, B | 1 |
| Monteiro, R | 1 |
| DeCarlo, KE | 1 |
| Agrawal, N | 1 |
| Prisco, S | 2 |
| Gallina, M | 2 |
| Wang, X | 4 |
| Tuka, V | 1 |
| Matoulek, M | 1 |
| Rosa, J | 5 |
| Petrák, O | 5 |
| Mikeš, O | 1 |
| Štrauch, B | 7 |
| Holaj, R | 5 |
| Zelinka, T | 7 |
| Käyser, SC | 1 |
| de Grauw, WJ | 1 |
| Schalk, BW | 1 |
| Bor, HJ | 1 |
| Lenders, JW | 8 |
| Schermer, TR | 1 |
| Biermans, MC | 1 |
| Pasini, B | 1 |
| Ladd, MR | 1 |
| Zeiger, MA | 1 |
| Yamasaki, T | 2 |
| Ogawa, O | 2 |
| Tanaka, Y | 2 |
| Fukuoka, T | 7 |
| Kawamura, T | 3 |
| Tabara, Y | 1 |
| Matsuda, F | 1 |
| Wei, LH | 1 |
| Athyros, VG | 4 |
| Karagiannis, A | 4 |
| Lang, K | 6 |
| Chang, YC | 1 |
| Unger, T | 1 |
| Zoltowska, DM | 1 |
| Agrawal, Y | 1 |
| Kalavakunta, JK | 1 |
| Westerink, J | 1 |
| Valaiyapathi, B | 1 |
| Quack, I | 3 |
| Seufert, J | 2 |
| Aristizabal Prada, ET | 1 |
| Sušnik, E | 2 |
| Raber, I | 1 |
| Isom, RT | 1 |
| Louie, JD | 1 |
| Vasanawala, S | 1 |
| Faucon, AL | 2 |
| Blanchard, A | 2 |
| Baffalie, L | 1 |
| Faucard, C | 1 |
| Pagny, JY | 6 |
| Houillier, P | 3 |
| Katsiki, N | 1 |
| Petidis, K | 2 |
| Kamparoudis, A | 1 |
| Petras, P | 1 |
| Georgopoulou, V | 1 |
| Finitsis, S | 1 |
| Papadopoulos, C | 1 |
| Verheyen, N | 4 |
| Schwetz, V | 1 |
| Pandis, M | 1 |
| Aberer, F | 1 |
| Grübler, MR | 1 |
| Meinitzer, A | 4 |
| Bachmann, A | 1 |
| Voelkl, J | 2 |
| Alesutan, I | 1 |
| März, W | 7 |
| Obermayer-Pietsch, B | 2 |
| Tomaschitz, A | 10 |
| Gagnon, N | 1 |
| Cáceres-Gorriti, KY | 1 |
| El Ghoyareb, N | 1 |
| Ludwig, N | 1 |
| Dick, SM | 1 |
| Queiroz, M | 1 |
| Brondani, LA | 1 |
| Dall'Agnol, A | 1 |
| Bernardi, BL | 1 |
| Silveiro, SP | 1 |
| Kim, IY | 1 |
| Park, IS | 1 |
| Kim, MJ | 1 |
| Han, M | 1 |
| Rhee, H | 1 |
| Seong, EY | 1 |
| Lee, DW | 1 |
| Lee, SB | 1 |
| Kwak, IS | 1 |
| Song, SH | 1 |
| Chung, HC | 1 |
| Gwini, S | 1 |
| Venziano, F | 1 |
| Magnino, C | 1 |
| Terlouw, JM | 1 |
| Nijkamp, MD | 1 |
| Jacobs, N | 1 |
| Weng, J | 1 |
| Lie, M | 1 |
| Thorstensen, K | 1 |
| Matrozova, J | 1 |
| Bernardi, S | 1 |
| Giacchetti, G | 19 |
| Saint-Hilary, G | 1 |
| Douma, S | 2 |
| Hu, FQ | 1 |
| Soma, M | 5 |
| Simone, G | 1 |
| Anceschi, U | 1 |
| Tuderti, G | 1 |
| Misuraca, L | 1 |
| Celia, A | 1 |
| De Concilio, B | 1 |
| Costantini, M | 1 |
| Stigliano, A | 1 |
| Minisola, F | 1 |
| Ferriero, M | 1 |
| Guaglianone, S | 1 |
| Gallucci, M | 1 |
| Chang, HM | 1 |
| Yang, SY | 4 |
| Gilani, M | 3 |
| Asif, N | 2 |
| Akram, A | 2 |
| Ijaz, A | 1 |
| Malik, SS | 1 |
| Köhler, A | 1 |
| Franke, A | 2 |
| Löw, A | 1 |
| Treitl, M | 1 |
| Arlt, W | 1 |
| Li, WZ | 1 |
| Wan, X | 1 |
| Mathis, KW | 1 |
| Ryan, MJ | 1 |
| Rothenberg, ME | 1 |
| Schilbach, K | 1 |
| Junnila, RK | 1 |
| Matsumoto, T | 2 |
| Cowley, D | 3 |
| Ouyang, J | 4 |
| Chen, D | 1 |
| Nakamura, S | 3 |
| Ishimori, M | 1 |
| Yamakita, N | 7 |
| Lindeman, B | 1 |
| Porterfield, JR | 1 |
| Anand, SK | 1 |
| Taniguchi, M | 1 |
| Onishi, Y | 1 |
| Kumagai, N | 1 |
| Uraki, J | 1 |
| Fujimoto, N | 1 |
| Fujii, E | 1 |
| Ogura, T | 3 |
| Ito, M | 1 |
| Bhandari, S | 1 |
| Roses, RE | 3 |
| Aibara, Y | 2 |
| Noma, K | 2 |
| Liao, JK | 2 |
| Wang, D | 2 |
| Xu, JZ | 2 |
| Shao, S | 1 |
| Xu, TY | 2 |
| Morera, J | 1 |
| Reznik, Y | 4 |
| Shao, D | 1 |
| Zhou, S | 1 |
| Cai, Q | 1 |
| Zheng, Y | 1 |
| Sugiura, Y | 3 |
| Takeo, E | 1 |
| Shimma, S | 1 |
| Yokota, M | 1 |
| Higashi, T | 1 |
| Mizuno, Y | 2 |
| Ahmed, KS | 1 |
| Bogdanet, D | 1 |
| Abadi, S | 1 |
| Dineen, R | 1 |
| Boran, G | 1 |
| Woods, CP | 1 |
| Behan, LA | 1 |
| Sherlock, M | 1 |
| Gibney, J | 1 |
| Nishiyama, M | 1 |
| Terada, Y | 1 |
| Kita, T | 1 |
| Furukoji, E | 1 |
| Sakae, T | 1 |
| Kitamura, K | 2 |
| Nawaz, A | 1 |
| Hamberger, B | 7 |
| Zedenius, J | 3 |
| Juhlin, CC | 2 |
| Naito, T | 1 |
| Hagiya, H | 1 |
| Nakagami, F | 1 |
| Chikladze, NM | 1 |
| Favorova, OO | 1 |
| Chazova, IE | 2 |
| Darras, P | 2 |
| Okamura, K | 1 |
| Okuda, T | 1 |
| Fukuda, Y | 2 |
| Takamiya, Y | 1 |
| Shirai, K | 1 |
| Miyajima, S | 1 |
| Urata, H | 1 |
| Morkos, M | 1 |
| Vecchiola, A | 3 |
| Fuentes, CA | 3 |
| Barros, ER | 1 |
| Martínez-Aguayo, A | 4 |
| García, H | 4 |
| Allende, F | 2 |
| Solari, S | 2 |
| Olmos, R | 1 |
| Carvajal, C | 2 |
| Campino, C | 5 |
| Kalergis, AM | 2 |
| Adlin, EV | 5 |
| Xiao, L | 1 |
| Ning, G | 4 |
| Bothou, C | 1 |
| Engler, L | 1 |
| Pawlowski, M | 1 |
| Steiger, A | 1 |
| Lerco, S | 2 |
| Miotto, D | 11 |
| Vivien, M | 1 |
| Deberles, E | 1 |
| Morello, R | 1 |
| Haddouche, A | 1 |
| Guenet, D | 1 |
| Zhang, WJ | 2 |
| Li, HY | 4 |
| Zhang, XB | 1 |
| Shen, SM | 1 |
| Feng, WH | 2 |
| Acelajado, MC | 2 |
| Hughes, ZH | 1 |
| Oparil, S | 5 |
| Liang, K | 1 |
| Ou, X | 1 |
| Lan, Q | 1 |
| Zantour, B | 1 |
| Charrada, I | 1 |
| Elati, Z | 1 |
| Ammari, FL | 1 |
| Boubaker, F | 1 |
| Arfa, S | 1 |
| Berriche, O | 1 |
| Alaya, W | 1 |
| Sfar, MH | 1 |
| Campbell, RA | 1 |
| Young, DS | 1 |
| Shaver, CN | 1 |
| Snyder, SK | 1 |
| Milan, SA | 1 |
| Lairmore, TC | 1 |
| McDonald, DK | 1 |
| Wu, A | 1 |
| Shibata, S | 1 |
| Maharjan, R | 2 |
| Cupisti, K | 5 |
| Denieffe, S | 1 |
| Fitzgibbon, MC | 1 |
| Araos, P | 1 |
| Prado, C | 1 |
| Lozano, M | 1 |
| Figueroa, S | 1 |
| Espinoza, A | 1 |
| Berger, T | 1 |
| Mak, TW | 1 |
| Jaisser, F | 1 |
| Pacheco, R | 1 |
| Michea, L | 1 |
| Amador, CA | 1 |
| Nagasawa, M | 2 |
| Takeda, M | 2 |
| Akasaka, H | 2 |
| Yoshikawa, Y | 2 |
| Trinh, B | 1 |
| Hepprich, M | 1 |
| Burkard, T | 1 |
| Cavelti-Weder, C | 1 |
| Seelig, E | 1 |
| Meienberg, F | 1 |
| Kratschmar, DV | 1 |
| Hall, MN | 1 |
| Donath, MY | 1 |
| Swierczynska, MM | 1 |
| Shantsila, A | 1 |
| Lip, GYH | 1 |
| Beevers, DG | 9 |
| Ge, Q | 1 |
| Sheng, CS | 1 |
| Fukuda, H | 2 |
| Tsukiyama, H | 1 |
| Ito, H | 5 |
| Leung, A | 1 |
| Holmes, D | 3 |
| Izzo, JL | 3 |
| Hong, M | 2 |
| Hussain, T | 2 |
| Osmond, PJ | 2 |
| Groenewoud, H | 1 |
| Demirkiran, A | 1 |
| Everaars, H | 1 |
| Elitok, A | 1 |
| van de Ven, PM | 1 |
| Smulders, YM | 2 |
| Dreijerink, KM | 1 |
| Tanakol, R | 1 |
| Ozcan, M | 1 |
| Chueh, E | 1 |
| Mehta, K | 1 |
| Wu, CH | 3 |
| Wu, V | 1 |
| Yang, YW | 2 |
| Lin, PC | 1 |
| Neves, KB | 1 |
| Touyz, RM | 4 |
| Nakamaru, R | 1 |
| Zhu, KY | 1 |
| Frustaci, A | 1 |
| Verardo, R | 1 |
| Grande, C | 1 |
| Francone, M | 1 |
| Sansone, L | 1 |
| Russo, MA | 1 |
| Chimenti, C | 1 |
| Lorenzo Villalba, N | 1 |
| Rivera Martínez, E | 1 |
| Artiles Vizcaíno, J | 1 |
| Sablón González, N | 1 |
| Marrero Medina, I | 1 |
| Suárez Ortega, S | 1 |
| Amioka, M | 1 |
| Ikenaga, H | 1 |
| Ishida, M | 2 |
| Lechner, K | 1 |
| Kawashima, A | 1 |
| Onodera, Y | 1 |
| Ogata, H | 1 |
| Sung, SH | 1 |
| Liang, KW | 1 |
| Jahangiri, Y | 1 |
| Tsao, TF | 1 |
| Tyan, YS | 1 |
| Huang, HH | 1 |
| Sawai, K | 1 |
| Okuno, H | 3 |
| Shimatsu, A | 4 |
| Okumura, A | 1 |
| Kawa, G | 1 |
| Zhang, X | 5 |
| Xu, T | 1 |
| Pappa, T | 3 |
| Gouli, A | 4 |
| Mitsakis, K | 1 |
| Tsounas, P | 2 |
| Prevoli, A | 1 |
| Tsiavos, V | 2 |
| Zografos, G | 3 |
| Kakoki, M | 1 |
| Pochynyuk, OM | 1 |
| Hathaway, CM | 1 |
| Tomita, H | 1 |
| Hagaman, JR | 1 |
| Kim, HS | 2 |
| Zaika, OL | 1 |
| Mamenko, M | 1 |
| Kayashima, Y | 1 |
| Matsuki, K | 1 |
| Hiller, S | 1 |
| Grant, R | 1 |
| Bertorello, AM | 1 |
| Smithies, O | 2 |
| Dias, VC | 6 |
| Suzuki, K | 1 |
| Hyodo, R | 1 |
| Kawakami, K | 1 |
| Okochi, Y | 1 |
| Naganawa, S | 1 |
| Fischer, E | 10 |
| Pallauf, A | 5 |
| Then, C | 1 |
| Seissler, J | 2 |
| Ye, F | 1 |
| Tang, ZY | 1 |
| Wu, JC | 1 |
| Tian, XL | 1 |
| Huang, JJ | 1 |
| Zhang, SS | 1 |
| Chen, AH | 1 |
| Huang, TS | 1 |
| Wen, Z | 1 |
| Chuanwei, L | 1 |
| Chunyu, Z | 1 |
| Hui, H | 1 |
| Weimin, L | 1 |
| Rickard, AJ | 1 |
| Reuschl, S | 1 |
| Su, H | 1 |
| Gu, Y | 1 |
| Wang, Q | 1 |
| Huang, B | 1 |
| Jin, X | 1 |
| Ceccoli, L | 2 |
| Ronconi, V | 9 |
| Giovannini, L | 1 |
| Marcheggiani, M | 1 |
| Turchi, F | 7 |
| Tauber, P | 1 |
| Penton, D | 1 |
| Schweda, F | 2 |
| Sterner, C | 3 |
| Lalli, E | 5 |
| Lesage, F | 2 |
| Hartmann, M | 1 |
| Barhanin, J | 4 |
| Chao, CT | 1 |
| Kuo, CC | 7 |
| Pimenta, E | 15 |
| Murase, K | 1 |
| Nagaishi, R | 1 |
| Takenoshita, H | 1 |
| Nomiyama, T | 1 |
| Akehi, Y | 1 |
| Braitman, LE | 1 |
| Vasan, RS | 3 |
| Galati, SJ | 2 |
| Hopkins, SM | 2 |
| Cheesman, KC | 2 |
| Zhuk, RA | 2 |
| Levine, AC | 2 |
| Guichard, JL | 1 |
| Clark, D | 2 |
| Ahmed, MI | 3 |
| Kuo, KL | 1 |
| Hung, SC | 1 |
| Jin, S | 1 |
| Hui, SP | 1 |
| Sakurai, T | 1 |
| Fuda, H | 1 |
| Takeda, S | 1 |
| Fujikawa, M | 1 |
| Yanagisawa, K | 1 |
| Ikegawa, S | 1 |
| Kurosawa, T | 1 |
| Chiba, H | 1 |
| Manrique, C | 1 |
| DeMarco, VG | 1 |
| Aroor, AR | 1 |
| Mugerfeld, I | 1 |
| Garro, M | 1 |
| Habibi, J | 1 |
| Hayden, MR | 1 |
| Sowers, JR | 2 |
| Goh, G | 2 |
| de Oliveira, RC | 1 |
| Choi, M | 3 |
| Overton, JD | 1 |
| Fonseca, AL | 1 |
| Korah, R | 1 |
| Kunstman, JW | 1 |
| Prasad, ML | 2 |
| Hartung, EA | 1 |
| Mauras, N | 1 |
| Benson, MR | 1 |
| Brady, T | 1 |
| Shapiro, JR | 1 |
| Loring, E | 2 |
| Nelson-Williams, C | 3 |
| Mane, S | 2 |
| Westin, G | 3 |
| Åkerström, G | 2 |
| Carling, T | 3 |
| Hidalgo, P | 1 |
| Lagos, CF | 3 |
| Valdivia, C | 3 |
| Ogishima, T | 4 |
| Owen, G | 1 |
| Pizzolo, F | 10 |
| Zorzi, F | 3 |
| Chiecchi, L | 5 |
| Consoli, L | 1 |
| Aprili, I | 1 |
| Guarini, P | 6 |
| Castagna, A | 4 |
| Salvagno, GL | 1 |
| Pavan, C | 5 |
| Olivieri, O | 10 |
| Oßwald, A | 1 |
| Mussack, T | 1 |
| Hallfeldt, K | 2 |
| Weiner, ID | 2 |
| Viola, A | 4 |
| Tizzani, D | 4 |
| Crudo, V | 3 |
| Galmozzi, M | 2 |
| Versace, K | 2 |
| Loiacono, M | 1 |
| Januszewicz, W | 6 |
| Pęczkowska, M | 2 |
| Zgliczyński, W | 2 |
| van den Born, BJ | 1 |
| Frenkel, WJ | 1 |
| de Bruijne, EL | 1 |
| Kerstens, MN | 1 |
| Woittiez, AJ | 1 |
| Wijbenga, JA | 1 |
| Zietse, R | 2 |
| Danser, AH | 4 |
| van den Meiracker, AH | 5 |
| Lu, ZH | 1 |
| Zhu, XX | 1 |
| Tang, ZQ | 1 |
| Wang, XL | 2 |
| Yang, JZ | 1 |
| Gu, WJ | 2 |
| Jin, N | 2 |
| Yang, LJ | 2 |
| Dou, JT | 2 |
| Hattori, T | 1 |
| Murase, T | 1 |
| Nagasawa, K | 1 |
| Ohtake, M | 2 |
| Miyachi, M | 1 |
| Murohara, T | 1 |
| Nagata, K | 2 |
| Agha, A | 1 |
| Hornung, M | 1 |
| Iesalnieks, I | 1 |
| Schreyer, A | 1 |
| Jung, EM | 1 |
| Haneya, A | 1 |
| Schlitt, HJ | 1 |
| Flores-Robles, BJ | 1 |
| Sandoval, AR | 1 |
| Dardon, JD | 1 |
| Blas, CA | 1 |
| Miyake, Y | 1 |
| Tanaka, K | 9 |
| Takayanagi, R | 2 |
| Ueshiba, H | 1 |
| Iwasaki, Y | 2 |
| Tanaka, H | 1 |
| Tanahashi, Y | 1 |
| Katsumata, N | 1 |
| Tajima, T | 1 |
| Schultzekool, LJ | 1 |
| Blondin, D | 2 |
| Hermus, AR | 4 |
| Sweep, FC | 1 |
| Schack, VR | 1 |
| Annaratone, L | 1 |
| Lucatello, B | 4 |
| Bernini, G | 12 |
| Vilsen, B | 1 |
| Drelon, C | 1 |
| Ragazzon, B | 1 |
| Tissier, F | 1 |
| Samson-Couterie, B | 3 |
| Plouin, PF | 33 |
| Skah, S | 1 |
| Plateroti, M | 1 |
| Lefèbvre, H | 9 |
| Sahut-Barnola, I | 1 |
| Batisse-Lignier, M | 1 |
| Assié, G | 3 |
| Lefrançois-Martinez, AM | 1 |
| Bertherat, J | 1 |
| Martinez, A | 1 |
| Val, P | 1 |
| Ritz, E | 9 |
| Pieske, B | 4 |
| Rus-Machan, J | 2 |
| Kienreich, K | 4 |
| Gaksch, M | 4 |
| Grübler, M | 2 |
| Fahrleitner-Pammer, A | 5 |
| Mrak, P | 1 |
| Toplak, H | 2 |
| Kraigher-Krainer, E | 2 |
| Hyla-Klekot, L | 1 |
| Kokot, F | 10 |
| Daunt, N | 4 |
| Slater, GJ | 2 |
| Schumacher, CD | 1 |
| Steele, RE | 1 |
| Brunner, HR | 2 |
| Nugrahaningsih, DA | 1 |
| Emoto, N | 1 |
| Vignon-Zellweger, N | 1 |
| Purnomo, E | 1 |
| Yagi, K | 2 |
| Nakayama, K | 1 |
| Doi, M | 5 |
| Okamura, H | 3 |
| Hirata, K | 1 |
| Mihailidou, AS | 2 |
| Dutta, RK | 2 |
| Welander, J | 1 |
| Brauckhoff, M | 1 |
| Walz, M | 1 |
| Alesina, P | 1 |
| Arnesen, T | 1 |
| Söderkvist, P | 2 |
| Gimm, O | 2 |
| Feldman, RD | 1 |
| Williams, JS | 2 |
| Garg, R | 1 |
| Garza, AE | 1 |
| Pojoga, LH | 1 |
| Ruan, DT | 1 |
| Nguyen, G | 1 |
| Curis, E | 1 |
| Bergerot, D | 1 |
| Chambon, Y | 1 |
| Hirose, T | 2 |
| Caumont-Prim, A | 1 |
| Tabard, SB | 1 |
| Frank, M | 1 |
| Totsune, K | 2 |
| Soh, LM | 1 |
| Lau, JH | 2 |
| Reznek, R | 1 |
| Riddoch, F | 1 |
| Carpenter, R | 3 |
| Berney, D | 1 |
| Grossman, AB | 4 |
| Chew, SL | 3 |
| Monson, JP | 4 |
| Campos, AG | 1 |
| Belloni, AS | 2 |
| Ferraro, S | 1 |
| Skander, G | 1 |
| Bader, M | 2 |
| Derlet, F | 1 |
| Lepoutre, T | 1 |
| Gruson, D | 1 |
| Nicolini, G | 1 |
| Balzan, S | 1 |
| Morelli, L | 1 |
| Iacconi, P | 1 |
| Sabatino, L | 1 |
| Ripoli, A | 2 |
| Fommei, E | 2 |
| He, YB | 1 |
| Zhou, XR | 1 |
| Shu, BH | 1 |
| Liu, JH | 1 |
| Murthy, M | 2 |
| Massimo, G | 1 |
| O'Shaughnessy, KM | 3 |
| Howard, B | 1 |
| Xekouki, P | 2 |
| Jain, M | 1 |
| Meltzer, PG | 1 |
| Kebebew, E | 4 |
| Lonati, C | 1 |
| Bassani, N | 1 |
| Gritti, A | 1 |
| Biganzoli, E | 1 |
| Ho, YL | 12 |
| Chueh, SC | 11 |
| Changh, YS | 1 |
| Sui, MJ | 1 |
| Chen, MF | 4 |
| Pirvu, A | 1 |
| Naem, N | 1 |
| Baguet, JP | 4 |
| Thony, F | 1 |
| Chabre, O | 2 |
| Chaffanjon, P | 2 |
| Podluzhnyĭ, AA | 1 |
| Cecconi, D | 1 |
| Gunasekaran, M | 1 |
| Morandini, F | 2 |
| Brazzarola, P | 3 |
| Zolla, L | 1 |
| D'Alessandro, A | 1 |
| Bersuch, LA | 1 |
| Schmid, J | 1 |
| Drechsler, C | 3 |
| Moosbrugger, A | 1 |
| Stepan, V | 1 |
| Pieber, TR | 4 |
| Fazal, L | 3 |
| Azibani, F | 3 |
| Bihry, N | 1 |
| Coutance, G | 2 |
| Polidano, E | 3 |
| Merval, R | 3 |
| Vodovar, N | 1 |
| Launay, JM | 3 |
| Delcayre, C | 4 |
| Samuel, JL | 3 |
| Bozoglu, T | 1 |
| Rawal, R | 1 |
| De Leonardis, F | 1 |
| Benecke, AG | 2 |
| Monti, L | 1 |
| Petersen, AK | 1 |
| Döring, A | 2 |
| Rossi, A | 1 |
| Reiser, MF | 2 |
| di Tizio, V | 2 |
| Juutilainen, A | 1 |
| Savolainen, K | 1 |
| Romppanen, J | 1 |
| Turpeinen, U | 1 |
| Kemppainen, J | 1 |
| Moilanen, L | 1 |
| Pulkki, K | 1 |
| Griffin, AC | 1 |
| Kelz, R | 1 |
| LiVolsi, VA | 1 |
| Nakao, K | 6 |
| Hirokawa, Y | 1 |
| Shimbo, T | 1 |
| Haneveld, JK | 1 |
| ter Meer, M | 1 |
| Tops, B | 1 |
| Cicala, MV | 4 |
| Zinnamosca, L | 7 |
| Mareso, S | 2 |
| Sciomer, S | 3 |
| Mantero, F | 41 |
| Taylor, PJ | 5 |
| Piecha, G | 1 |
| Haas, J | 1 |
| Wiecek, A | 1 |
| Amrein, K | 1 |
| Lim, V | 1 |
| Guo, Q | 1 |
| Grant, CS | 6 |
| Malirova, E | 3 |
| Ballon, M | 3 |
| Chen, SF | 1 |
| Pu, YS | 1 |
| Osher, E | 1 |
| Marcus, Y | 1 |
| Stern, N | 1 |
| Allolio, B | 4 |
| Lee, HH | 2 |
| Liao, MT | 1 |
| Chen, YH | 5 |
| Fountoulakis, S | 2 |
| Kounadi, T | 2 |
| Tsiama, V | 1 |
| Dasou, A | 1 |
| Samara, C | 1 |
| Trejo, P | 3 |
| Delgado, JF | 1 |
| Aglony, M | 3 |
| Carrasco, C | 1 |
| Loureiro, C | 2 |
| Pignatelli, P | 2 |
| Carnevale, R | 2 |
| Marinelli, C | 5 |
| Settevendemmie, A | 1 |
| Tonnarini, G | 1 |
| De Toma, G | 4 |
| Violi, F | 2 |
| Qu, Q | 1 |
| Dai, B | 1 |
| Zhang, F | 1 |
| Kumar, B | 1 |
| Swee, M | 1 |
| Tamargo, J | 1 |
| Solini, A | 1 |
| Ruilope, LM | 3 |
| Balakrishnan, P | 1 |
| Hsein, YC | 1 |
| Wang, MJ | 1 |
| Gioco, F | 3 |
| Fishman, V | 1 |
| Zanotti, G | 1 |
| Oyama, K | 1 |
| Nozaki, A | 1 |
| Horie, I | 1 |
| Shigematsu, K | 3 |
| Takehara, K | 1 |
| Kawakami, A | 1 |
| Carrara, D | 2 |
| Paci, E | 2 |
| Iwakura, Y | 5 |
| Asmar, M | 2 |
| Hwang, I | 1 |
| Chong, A | 1 |
| Kim, JB | 1 |
| Kim, KH | 1 |
| Kwon, D | 1 |
| Glinicki, P | 1 |
| Jeske, W | 1 |
| Bednarek-Papierska, L | 1 |
| Kruszyńska, A | 1 |
| Gietka-Czernel, M | 1 |
| Rosłonowska, E | 1 |
| Słowińska-Srzednicka, J | 3 |
| Kasperlik-Załuska, A | 1 |
| Felizola, SJ | 2 |
| Maekawa, T | 1 |
| Kikuchi, K | 3 |
| Aritomi, S | 1 |
| Ikeda, K | 2 |
| Yoshimura, M | 2 |
| Tojo, K | 1 |
| Nakama, C | 1 |
| Kamide, K | 4 |
| Kawai, T | 2 |
| Hongyo, K | 1 |
| Ito, N | 1 |
| Onishi, M | 1 |
| Takeya, Y | 1 |
| Sugimoto, K | 1 |
| Tzeng, YL | 2 |
| Hsieh, FJ | 1 |
| Chang, KY | 1 |
| Ryu, S | 1 |
| Cho, JY | 1 |
| Kim, HW | 1 |
| Matsuzawa, Y | 2 |
| Konosu-Fukaya, S | 2 |
| Lorthioir, A | 2 |
| Berge, C | 1 |
| Courand, PY | 1 |
| Harbaoui, B | 1 |
| Paget, V | 1 |
| Khettab, F | 1 |
| Bricca, G | 1 |
| Fauvel, JP | 4 |
| Lantelme, P | 3 |
| Höög, A | 1 |
| Wahrenberg, H | 2 |
| Thorén, M | 4 |
| Freel, EM | 4 |
| van der Giet, M | 1 |
| Fernandes-Rosa, F | 3 |
| Aronova, A | 1 |
| Gordon, BL | 1 |
| Indra, T | 2 |
| Šomlóová, Z | 3 |
| Michalský, D | 1 |
| Novák, K | 1 |
| Wichterle, D | 3 |
| Venos, ES | 1 |
| Kogovsek, C | 3 |
| Lymperopoulos, A | 1 |
| Sturchler, E | 1 |
| Bathgate-Siryk, A | 1 |
| Dabul, S | 1 |
| Garcia, D | 1 |
| Walklett, K | 1 |
| Rengo, G | 1 |
| McDonald, P | 1 |
| Koch, WJ | 1 |
| Viel, G | 1 |
| Nitti, D | 1 |
| Duparc, C | 2 |
| Moreau, L | 1 |
| Dzib, JF | 2 |
| Boyer, HG | 1 |
| Tetsi Nomigni, M | 1 |
| Boutelet, I | 1 |
| Gobet, F | 1 |
| Rehan, M | 1 |
| Raizman, JE | 2 |
| Cavalier, E | 4 |
| Don-Wauchope, AC | 1 |
| Iwamoto, A | 1 |
| Oda, N | 1 |
| Hidaka, T | 1 |
| Kohno, N | 2 |
| Weigel, M | 1 |
| Hanslik, G | 2 |
| Endres, S | 2 |
| Wolley, MJ | 2 |
| Lethielleux, G | 1 |
| Raynaud, A | 2 |
| Recarti, C | 1 |
| Gonzales-Campos, A | 1 |
| Petrelli, L | 1 |
| Nussberger, J | 6 |
| Zhu, W | 1 |
| Martell-Claros, N | 2 |
| Abad-Cardiel, M | 2 |
| Alvarez-Alvarez, B | 2 |
| García-Donaire, JA | 1 |
| Pérez, CF | 1 |
| Wyskida, M | 1 |
| Wyskida, K | 1 |
| Olszanecka-Glinianowicz, M | 1 |
| Maruniak-Chudek, I | 1 |
| Sikora, J | 1 |
| Chudek, J | 1 |
| Tanase-Nakao, K | 1 |
| Murakami, N | 1 |
| Yoshida, N | 2 |
| Hamano, K | 1 |
| Miyakawa, M | 1 |
| Takeshita, A | 1 |
| Takeuchi, Y | 2 |
| Athyros, V | 1 |
| Papademetriou, V | 2 |
| Rye, P | 1 |
| Te Riet, L | 1 |
| van Esch, JH | 1 |
| Roks, AJ | 1 |
| Sasamoto, H | 1 |
| Honma, S | 2 |
| Okuyama, M | 2 |
| Arai, Y | 5 |
| Ducher, M | 2 |
| Mounier-Véhier, C | 4 |
| Li, NF | 1 |
| Yao, XG | 1 |
| Zhang, DL | 1 |
| Abulikemu, SF | 1 |
| Chang, GJ | 1 |
| Zhou, KM | 1 |
| Wang, GL | 1 |
| Wang, MH | 1 |
| Ouyang, WJ | 1 |
| Cheng, QY | 1 |
| Jia, Y | 1 |
| Matsuda, M | 1 |
| Behrend, EN | 1 |
| Kemppainen, R | 1 |
| Refsal, K | 1 |
| Johnson, A | 1 |
| Lee, H | 1 |
| Vichot, AA | 1 |
| Thiel, A | 1 |
| Lande, M | 1 |
| Frazier, BG | 1 |
| Rasoulpour, M | 1 |
| Bowlin, DL | 1 |
| Sethna, CB | 1 |
| Trachtman, H | 1 |
| Ardhanari, S | 1 |
| Kannuswamy, R | 1 |
| Chaudhary, K | 1 |
| Lockette, W | 1 |
| Whaley-Connell, A | 1 |
| Velasco, A | 1 |
| Chung, O | 1 |
| Raza, F | 1 |
| Pandey, A | 1 |
| Brinker, S | 1 |
| Arbique, D | 1 |
| Price, A | 1 |
| Lotan, Y | 1 |
| Das, SR | 1 |
| Nakabayashi, K | 1 |
| Tsuchiya, K | 4 |
| Minami, I | 3 |
| Bouchi, R | 2 |
| Izumiyama, H | 3 |
| Abe, K | 11 |
| Tayama, C | 1 |
| Hashimoto, K | 6 |
| Suganami, T | 1 |
| Hata, K | 1 |
| Kihara, K | 2 |
| Androulakis, II | 3 |
| Marakaki, C | 1 |
| Zacharoulis, A | 1 |
| Karavidas, A | 1 |
| Ragkou, D | 2 |
| Mailhot, JP | 2 |
| Traistaru, M | 1 |
| Ladouceur, M | 1 |
| Giroux, MF | 3 |
| Gilbert, P | 3 |
| Zhu, PS | 2 |
| Oliva, VL | 3 |
| Barigou, M | 3 |
| Ah-Kang, F | 1 |
| Orloff, E | 1 |
| Amar, J | 4 |
| Chamontin, B | 8 |
| Xie, LF | 1 |
| Ouyang, JZ | 1 |
| Wang, AP | 1 |
| Wang, WB | 1 |
| Li, XT | 1 |
| Wang, BJ | 2 |
| Lin, LY | 6 |
| Lin, SL | 4 |
| Chu, TS | 4 |
| Chang, YS | 1 |
| Su, MJ | 2 |
| Diamandis, EP | 1 |
| Satani, N | 2 |
| Nezu, M | 2 |
| Cohen, D | 1 |
| Kuo, LE | 1 |
| Kelz, RR | 1 |
| Kawasaki, Y | 1 |
| Ishidoya, S | 4 |
| McNamara, K | 1 |
| Leal Reyna, M | 1 |
| Gómez, RM | 1 |
| Lupi, SN | 1 |
| Belli, SH | 1 |
| Fenili, CA | 1 |
| Martínez, MS | 1 |
| Ruibal, GF | 1 |
| Rossi, MA | 1 |
| Chervin, RA | 1 |
| Cornaló, D | 1 |
| Contreras, LN | 1 |
| Costa, L | 1 |
| Nofal, MT | 1 |
| Damilano, SA | 1 |
| Pardes, EM | 1 |
| Kuick, R | 1 |
| Cani, AK | 1 |
| Hovelson, DH | 1 |
| Sanjanwala, AR | 1 |
| Edwards, MA | 1 |
| Teng, J | 1 |
| Hutchinson, ME | 1 |
| Doery, JC | 1 |
| Chen, WG | 1 |
| Zhou, TT | 1 |
| Zhou, P | 1 |
| Li, XW | 1 |
| Zhang, KY | 1 |
| Xing, JC | 1 |
| Lo, MT | 3 |
| Peng, CK | 1 |
| Ip, J | 1 |
| Moser, A | 1 |
| Robinson, B | 1 |
| Iwen, KA | 1 |
| Dralle, H | 1 |
| D Volpe, C | 1 |
| Bäckdahl, M | 2 |
| Botling, J | 2 |
| Stålberg, P | 1 |
| Walz, MK | 2 |
| Lehnert, H | 1 |
| Sidhu, S | 1 |
| Manolopoulou, J | 5 |
| Dietz, A | 3 |
| Diederich, S | 5 |
| Junnila, R | 1 |
| Grimminger, P | 1 |
| Fong, BM | 1 |
| Siu, TS | 1 |
| Tam, S | 1 |
| Shaikh, LH | 1 |
| Happerfield, L | 2 |
| Bienz, M | 1 |
| Tsai, CT | 3 |
| Wu, CK | 1 |
| van der Linde, AA | 1 |
| Claahsen van der Grinten, HL | 1 |
| Pasternak, JD | 1 |
| Epelboym, I | 1 |
| Seiser, N | 1 |
| Wingo, M | 1 |
| Herman, M | 1 |
| Cowan, V | 1 |
| Gosnell, JE | 1 |
| Shen, WT | 1 |
| Kerlan, RK | 2 |
| Lee, JA | 1 |
| Pedersen, M | 1 |
| Karlsen, MA | 1 |
| Ankjærgaard, KL | 1 |
| Jensen, LT | 1 |
| Akashi, T | 1 |
| Tabuchi, Y | 1 |
| Kasayama, S | 1 |
| Kosugi, K | 1 |
| Tsugawa, M | 1 |
| Mineo, I | 1 |
| Kurebayashi, S | 2 |
| Ohashi, M | 3 |
| Umayahara, Y | 1 |
| Kouhara, H | 2 |
| Taki, H | 1 |
| Matsuoka, TA | 1 |
| Imagawa, A | 2 |
| Funahashi, T | 1 |
| Zavatto, A | 1 |
| Zingaretti, V | 1 |
| Umbro, I | 1 |
| Fiacco, F | 1 |
| Tinti, F | 1 |
| Mitterhofer, AP | 1 |
| Leibrock, CB | 2 |
| Kohlhofer, U | 1 |
| Quintanilla-Martinez, L | 1 |
| Kuro-O, M | 2 |
| Lang, F | 3 |
| Okubo, Y | 1 |
| Nakasone, Y | 1 |
| Shirotori, K | 1 |
| Oguchi, K | 1 |
| Matsushita, T | 1 |
| Komatsu, M | 1 |
| Yamauchi, K | 1 |
| Aizawa, T | 1 |
| Aldea, ML | 1 |
| Barallat, J | 1 |
| Martín, MA | 1 |
| Rosas, I | 1 |
| Pastor, MC | 1 |
| Granada, ML | 1 |
| Colussi, G | 7 |
| Brosolo, G | 1 |
| Novello, M | 4 |
| Wängberg, B | 1 |
| Sakinis, A | 1 |
| Ye, L | 1 |
| Haketa, A | 3 |
| Ueno, T | 2 |
| Aoi, N | 1 |
| Ikeda, Y | 3 |
| Tahira, K | 1 |
| Colussi, GL | 3 |
| Uzzau, A | 1 |
| Azzolini, M | 1 |
| Calò, L | 2 |
| Kawate, H | 1 |
| Matsuzaki, C | 1 |
| Shibue, K | 1 |
| Ohnaka, K | 1 |
| Anzai, K | 1 |
| Nakajima, Y | 3 |
| Okamura, T | 2 |
| Horiguchi, K | 2 |
| Gohko, T | 1 |
| Miyamoto, T | 2 |
| Satoh, T | 3 |
| Ozawa, A | 3 |
| Ishii, S | 2 |
| Yamada, E | 2 |
| Okada, S | 4 |
| Takata, D | 1 |
| Horiguchi, J | 2 |
| Abe, T | 5 |
| Kobashi, N | 1 |
| Doi, Y | 4 |
| Izawa, A | 1 |
| Akama, K | 1 |
| Okumura, Y | 1 |
| Ikenaga, M | 1 |
| Kimura, H | 1 |
| Saji, H | 1 |
| Matsumoto, H | 2 |
| Chen, AX | 1 |
| Vinco, M | 1 |
| Hammer, GD | 3 |
| Zaheer, S | 1 |
| Shah, PK | 1 |
| Karakousis, GC | 1 |
| Long, J | 1 |
| Li, R | 1 |
| Ren, W | 1 |
| Weber, K | 1 |
| Dietz, AS | 1 |
| Friedrichs, N | 1 |
| OʼShea, PM | 1 |
| Lin, YT | 2 |
| Lee, MH | 1 |
| Moxey, JE | 1 |
| Derbyshire, MM | 1 |
| Ward, GM | 1 |
| Sachithanandan, N | 1 |
| Mazzuco, TL | 2 |
| Kawarazaki, W | 1 |
| Fujita, T | 2 |
| Murad, MH | 1 |
| Jensen, IS | 1 |
| Sorensen, MV | 1 |
| de Bruijn, PI | 1 |
| Bleich, M | 1 |
| Praetorius, HA | 1 |
| Leipziger, J | 1 |
| Iacobellis, G | 3 |
| Calvieri, C | 1 |
| Lisewski, U | 1 |
| Koehncke, C | 1 |
| Wilck, N | 1 |
| Buschmeyer, B | 1 |
| Roepke, TK | 1 |
| Moradi, S | 1 |
| Shafiepour, M | 1 |
| Amirbaigloo, A | 1 |
| Lucchiari, M | 1 |
| Bardet, S | 2 |
| Douillard, C | 4 |
| Hernigou, A | 2 |
| Joffre, F | 2 |
| Kitajima, N | 1 |
| Yasuda, A | 1 |
| Oki, M | 1 |
| Takagi, A | 1 |
| Hanai, K | 1 |
| Terachi, T | 1 |
| Fukagawa, M | 1 |
| Zachaki, A | 1 |
| Galassi, M | 1 |
| Lucia, P | 1 |
| Ciardi, A | 1 |
| Girerd, X | 6 |
| Hussein, T | 1 |
| Mezősi, E | 1 |
| Bódis, B | 1 |
| Nemes, O | 1 |
| Rucz, K | 1 |
| Bajnok, L | 1 |
| Noilhan, C | 1 |
| Bieler, L | 1 |
| Mok, Y | 1 |
| Debajyoti, R | 1 |
| How, CH | 1 |
| Ng, AK | 1 |
| Liu, SY | 2 |
| Chu, CC | 1 |
| Tsui, TK | 1 |
| Wong, SK | 2 |
| Kong, AP | 3 |
| Chiu, PW | 2 |
| Chow, FC | 2 |
| Ng, EK | 2 |
| Sarwar, A | 1 |
| Brook, OR | 1 |
| Sacks, AC | 2 |
| Sacks, BA | 2 |
| Goldberg, SN | 1 |
| Ahmed, M | 1 |
| Faintuch, S | 2 |
| Reimer, EN | 1 |
| Walenda, G | 1 |
| Elbers, LP | 1 |
| Sjouke, B | 1 |
| Zannad, F | 2 |
| Cicoira, M | 1 |
| Vizzardi, E | 1 |
| Václavík, J | 1 |
| Gerdes, VE | 1 |
| Squizzato, A | 1 |
| Perez-Rivas, LG | 2 |
| Bathon, K | 1 |
| Gebhard, C | 1 |
| Mauracher, B | 1 |
| Schwarzmayr, T | 1 |
| Calebiro, D | 1 |
| Vlachakis, D | 1 |
| Kossida, S | 1 |
| Campanac, E | 1 |
| Hoffman, DA | 1 |
| Sierra, ML | 1 |
| Manichaikul, A | 1 |
| Rich, SS | 1 |
| Sheng, C | 1 |
| Gao, P | 2 |
| Angeli, P | 1 |
| Rosi, S | 1 |
| Parker, MW | 1 |
| Aurigemma, GP | 1 |
| Durieux, P | 1 |
| Herpin, D | 2 |
| Kraimps, JL | 1 |
| Ménégaux, F | 3 |
| Pechère, A | 1 |
| Tabarin, A | 4 |
| Zinzindohoue, F | 3 |
| Geach, T | 1 |
| Kaplan, NM | 11 |
| Uchida, T | 1 |
| Fukumura, Y | 1 |
| Asahina, M | 1 |
| Goto, H | 1 |
| Kawano, Y | 6 |
| Shimizu, F | 1 |
| Tsujimura, A | 2 |
| Kabe, Y | 2 |
| Yao, T | 1 |
| Horie, S | 1 |
| Watada, H | 1 |
| Zhang, HL | 2 |
| Mei, YA | 1 |
| Goto, K | 6 |
| Kojima, R | 1 |
| Tentori, S | 1 |
| Messaggio, E | 1 |
| Brioni, E | 1 |
| Casamassima, N | 1 |
| Simonini, M | 1 |
| Zagato, L | 1 |
| Hamlyn, JM | 2 |
| Manunta, P | 2 |
| Lanzani, C | 1 |
| Bekkach, Y | 1 |
| Heijboer, AC | 1 |
| Endert, E | 2 |
| Ackermans, MT | 1 |
| Chu, CM | 1 |
| Dudenbostel, T | 1 |
| Ghazi, L | 1 |
| Liu, M | 1 |
| Goswami, R | 1 |
| Lichtenauer, UD | 2 |
| Gerum, S | 3 |
| Fourkiotis, V | 1 |
| Cornu, E | 1 |
| Nogueira-Silva, L | 1 |
| Küpers, E | 1 |
| Grataloup, C | 1 |
| Reil, JC | 2 |
| Tauchnitz, M | 1 |
| Tian, Q | 1 |
| Hohl, M | 2 |
| Linz, D | 1 |
| Oberhofer, M | 1 |
| Kaestner, L | 1 |
| Reil, GH | 2 |
| Thiele, H | 1 |
| Steendijk, P | 2 |
| Böhm, M | 2 |
| Neuberger, HR | 2 |
| Lipp, P | 2 |
| Miyaji, Y | 1 |
| Kawabata, Y | 1 |
| Joki, H | 1 |
| Seki, S | 1 |
| Kamide, T | 1 |
| Tamase, A | 1 |
| Shima, H | 1 |
| Kitamura, Y | 1 |
| Nakaguchi, H | 1 |
| Minami, T | 1 |
| Tsunoda, T | 1 |
| Sasaki, M | 3 |
| Tanaka, F | 1 |
| Vouillarmet, J | 1 |
| Graeppi-Dulac, J | 1 |
| Decaussin-Petrucci, M | 1 |
| Thivolet, C | 1 |
| Peix, JL | 1 |
| Clauser, E | 4 |
| Kramers, BJ | 1 |
| Kramers, C | 1 |
| Katano-Toki, A | 1 |
| Matsumoto, S | 1 |
| Yoshino, S | 1 |
| Tomaru, T | 1 |
| Saito, T | 6 |
| Shibusawa, N | 2 |
| Nagaoka, R | 1 |
| Takada, D | 1 |
| Oyama, T | 5 |
| Tao, B | 1 |
| Lu, X | 1 |
| Chu, S | 1 |
| Zhu, D | 1 |
| Schneller, J | 1 |
| Osswald, A | 2 |
| Koga, M | 1 |
| Sakaguchi, T | 1 |
| Lam, B | 1 |
| Neogi, SG | 1 |
| Yeo, GS | 1 |
| Khoo, JJ | 1 |
| Annamalai, AK | 1 |
| Prankerd-Smith, O | 1 |
| Freeman, N | 1 |
| Vengopal, K | 1 |
| Graggaber, J | 1 |
| Koulouri, O | 1 |
| Powlson, AS | 1 |
| Shaw, A | 1 |
| Halsall, DJ | 1 |
| Almarzooqi, MK | 1 |
| Perreault, P | 1 |
| Bouchard, L | 1 |
| Zaltron, C | 1 |
| Pattini, P | 1 |
| Chiariello, C | 1 |
| Salvagno, G | 1 |
| Husainy, MA | 1 |
| Nicolescu, A | 1 |
| Lewis, D | 1 |
| Kane, P | 1 |
| Vincent, RP | 1 |
| Durivage, C | 1 |
| Blanchette, R | 1 |
| Springer-Miller, R | 1 |
| Krakoff, L | 1 |
| Bagiella, E | 1 |
| Ying, TK | 1 |
| Amer, C | 1 |
| Boyajian, MK | 1 |
| Inabnet, WB | 1 |
| Takahiro, U | 1 |
| Sabrautzki, S | 1 |
| Hantel, C | 1 |
| Rathkolb, B | 1 |
| Hrabě de Angelis, M | 1 |
| Hsiao, YH | 1 |
| Leu, JG | 1 |
| Orton, DJ | 1 |
| Sadrzadeh, H | 1 |
| Obara, AW | 1 |
| Moriya, N | 1 |
| Ishida, A | 1 |
| Nagasaka, S | 1 |
| Pasquier, L | 1 |
| Kirouani, M | 1 |
| Fanget, F | 1 |
| Nomine, C | 1 |
| Caillard, C | 1 |
| Arnault, V | 1 |
| Finel, JB | 1 |
| Christou, N | 1 |
| Mathonnet, M | 1 |
| Trésallet, C | 2 |
| Hamy, A | 1 |
| de Calan, L | 1 |
| Lifante, JC | 1 |
| Hardouin, JB | 1 |
| Drui, D | 1 |
| Blanchard, C | 1 |
| Murata, M | 1 |
| Kitamura, T | 1 |
| Tamada, D | 1 |
| Hayashi, RD | 1 |
| Takeiri, S | 1 |
| Kajimoto, Y | 1 |
| Nakao, M | 2 |
| Hamasaki, T | 1 |
| Kishino, M | 1 |
| Nakadate, M | 1 |
| Katada, Y | 1 |
| Kanda, E | 1 |
| Nakaminato, S | 1 |
| Saida, Y | 1 |
| Tateishi, U | 1 |
| Hannon, MJ | 1 |
| Sharabi, Y | 1 |
| Vidal-Petiot, E | 1 |
| Dominiczak, AF | 1 |
| Dhaun, N | 1 |
| Chrissobolis, S | 1 |
| Matsubara, D | 1 |
| Fukushima, N | 1 |
| Tamba, M | 1 |
| Tabata, K | 1 |
| Ashizawa, K | 1 |
| Takei, A | 1 |
| Koizumi, M | 1 |
| Sakuma, Y | 1 |
| Sata, N | 1 |
| Oshiro, H | 1 |
| Sommerey, S | 1 |
| Buechner, S | 1 |
| Gallwas, J | 1 |
| Joy, TR | 1 |
| Hegele, RA | 1 |
| Yamane, K | 1 |
| Sakashita, Y | 1 |
| Kamei, N | 1 |
| Watanabe, H | 5 |
| Toyota, N | 1 |
| Shigeta, M | 1 |
| Myint, KS | 1 |
| Watts, M | 1 |
| Appleton, DS | 1 |
| Lomas, DJ | 1 |
| Jamieson, N | 1 |
| Taylor, KP | 1 |
| Coghill, S | 1 |
| Tziomalos, K | 2 |
| Kakafika, AI | 1 |
| Harsoulis, F | 1 |
| Mikhailidis, DP | 1 |
| Johnson, SP | 1 |
| Bagrosky, BM | 1 |
| Mitchell, EL | 1 |
| McIntyre, RC | 1 |
| Grant, NG | 1 |
| Muiesan, ML | 3 |
| Salvetti, M | 1 |
| Paini, A | 1 |
| Agabiti-Rosei, C | 1 |
| Monteduro, C | 1 |
| Galbassini, G | 1 |
| Belotti, E | 1 |
| Aggiusti, C | 1 |
| Rizzoni, D | 7 |
| Castellano, M | 2 |
| Agabiti-Rosei, E | 4 |
| Kasalický, M | 1 |
| Safarík, L | 1 |
| Letavernier, E | 1 |
| Peyrard, S | 2 |
| Fiquet, B | 1 |
| Maron, BA | 3 |
| Murashima, M | 2 |
| Han, D | 2 |
| Townsend, RR | 3 |
| Kalinin, AP | 3 |
| Kulikov, LK | 1 |
| Kozulin, MA | 1 |
| Privalov, IuA | 1 |
| Ghione, S | 1 |
| Maffei, S | 1 |
| Di Cecco, P | 1 |
| Iervasi, A | 1 |
| Turchi, S | 1 |
| Nogueira, AR | 1 |
| Bloch, KV | 1 |
| Foroni, M | 1 |
| Regolisti, G | 5 |
| Perazzoli, F | 4 |
| Santi, R | 2 |
| Grasselli, C | 2 |
| Galli, P | 1 |
| Gardini, G | 1 |
| Maheshwari, MB | 1 |
| Ryan, PG | 1 |
| Moss, MS | 1 |
| Harding, LK | 1 |
| Gandhi, MS | 2 |
| Deshmukh, PA | 3 |
| Kamalov, G | 7 |
| Zhao, T | 2 |
| Whaley, JT | 1 |
| Tichy, JR | 1 |
| Bhattacharya, SK | 13 |
| Ahokas, RA | 11 |
| Sun, Y | 13 |
| Gerling, IC | 11 |
| Weber, KT | 23 |
| Vehier, CM | 1 |
| Niizuma, S | 1 |
| Nakahama, H | 3 |
| Fukuchi, K | 2 |
| Iwanaga, Y | 1 |
| Nakata, H | 1 |
| Yoshihara, F | 3 |
| Horio, T | 3 |
| Mosso, LM | 4 |
| Westerdahl, C | 4 |
| Bergenfelz, A | 4 |
| Larsson, J | 1 |
| Nerbrand, C | 3 |
| Valdemarsson, S | 4 |
| Wihl, A | 2 |
| Isaksson, A | 4 |
| Stehr, CB | 3 |
| Lacourt, P | 1 |
| Alcaíno, H | 1 |
| Mellado, R | 2 |
| Cattani, A | 1 |
| Lavandera, S | 1 |
| White, ML | 1 |
| Doherty, GM | 1 |
| Cho, KJ | 1 |
| Thompson, NW | 2 |
| Kolentini, C | 1 |
| Krausch, M | 1 |
| Schott, M | 4 |
| Scherbaum, WA | 4 |
| Morello, F | 4 |
| Liew, CC | 1 |
| Bisbocci, D | 2 |
| Zwermann, O | 3 |
| Suttmann, Y | 1 |
| Rahimtoola, SH | 1 |
| Gaddam, KK | 3 |
| Husain, S | 1 |
| Zhang, YY | 1 |
| Handy, DE | 1 |
| Beuve, A | 1 |
| Tang, SS | 1 |
| Loscalzo, J | 2 |
| Escher, G | 1 |
| Desmarchelier, M | 1 |
| Lair, S | 1 |
| Dunn, M | 1 |
| Langlois, I | 1 |
| Nishida, N | 1 |
| Igawa, T | 1 |
| Kawai, K | 3 |
| Takahara, O | 1 |
| Ribeiro, MJ | 1 |
| Figueiredo Neto, JA | 1 |
| Memória, EV | 1 |
| Lopes, Mde C | 1 |
| Faria, Mdos S | 1 |
| Salgado Filho, N | 1 |
| Oliveira, TC | 1 |
| Kasifoglu, T | 2 |
| Akalin, A | 1 |
| Cansu, DU | 1 |
| Korkmaz, C | 2 |
| Connell, J | 1 |
| Wémeau, JL | 1 |
| Carnaille, B | 1 |
| Baburyan, NY | 1 |
| Johnson, PL | 2 |
| De Toni, R | 8 |
| Pitter, G | 3 |
| Hirata, Y | 3 |
| Cooper, DP | 1 |
| Chernyshev, VN | 1 |
| Skladchikova, TIu | 1 |
| Chernysheva, NI | 1 |
| Weickert, MO | 1 |
| Schöfl-Siegert, B | 1 |
| Arafat, AM | 1 |
| Pfeiffer, AF | 1 |
| Möhlig, M | 1 |
| Schöfl, C | 1 |
| Ku, YK | 1 |
| Jones, M | 1 |
| Hennings, J | 1 |
| Andreasson, S | 1 |
| Hägg, A | 1 |
| Sundin, A | 1 |
| Felner, EI | 1 |
| Taweevisit, M | 1 |
| Gow, K | 1 |
| Verhovez, A | 2 |
| Limerutti, G | 1 |
| Avenatti, E | 1 |
| Mete, O | 1 |
| Asa, SL | 1 |
| Maser-Gluth, C | 8 |
| Rossignol, P | 4 |
| Vakrilova, Y | 1 |
| Petersenn, S | 2 |
| Rilli, S | 2 |
| Di Mattia, D | 1 |
| Agostinelli, L | 2 |
| Bhandaru, M | 1 |
| Kempe, DS | 2 |
| Rotte, A | 1 |
| Rexhepaj, R | 2 |
| Kuhl, D | 1 |
| Martinerie, L | 1 |
| Pussard, E | 1 |
| Foix-L'Hélias, L | 1 |
| Petit, F | 1 |
| Cosson, C | 1 |
| Boileau, P | 1 |
| Lombès, M | 1 |
| Just, A | 1 |
| Herrada, AA | 1 |
| Castillo, CR | 2 |
| Contreras, FJ | 1 |
| Watson, T | 1 |
| Karthikeyan, VJ | 1 |
| Lip, GY | 1 |
| Mishima, E | 1 |
| Pagnin, E | 1 |
| Davis, PA | 1 |
| Mormino, P | 1 |
| Chang, HW | 5 |
| Hung, KY | 1 |
| Kao, TW | 2 |
| Hsieh, BS | 14 |
| Guthoff, M | 1 |
| Schnauder, G | 1 |
| Kirchhoff, K | 1 |
| Kurth, R | 1 |
| Horger, M | 1 |
| Müssig, K | 1 |
| Poulsen, PL | 2 |
| Ibsen, H | 2 |
| Motta, R | 4 |
| Vincenzi, M | 3 |
| Feltrin, G | 2 |
| Georgiades, C | 1 |
| Kharlip, J | 2 |
| Valdeig, S | 1 |
| Wacker, FK | 1 |
| Hong, K | 2 |
| Briscoe, K | 1 |
| Barrs, VR | 1 |
| Foster, DF | 1 |
| Beatty, JA | 1 |
| Kempers, MJ | 1 |
| van Outheusden, L | 1 |
| Schlüter, T | 1 |
| Riegel, T | 1 |
| Peters, BS | 1 |
| Beineke, A | 1 |
| Maschke, U | 1 |
| Hosten, N | 1 |
| Mullins, JJ | 1 |
| Wenzel, S | 1 |
| Tastan, I | 1 |
| Abdallah, Y | 1 |
| Schreckenberg, R | 1 |
| Schlüter, KD | 1 |
| Krajina, A | 1 |
| Brodak, M | 1 |
| Cap, J | 1 |
| Hiraiwa, T | 1 |
| Ibata, R | 1 |
| Yamamoto, N | 1 |
| Terasaki, J | 1 |
| Azuma, H | 1 |
| Hanafusa, T | 1 |
| Fiore, C | 2 |
| Vogt, B | 1 |
| Burnier, M | 1 |
| Dalla Pozza, A | 1 |
| Tecchio, M | 1 |
| Tona, F | 1 |
| Sonino, N | 13 |
| Ermani, M | 2 |
| Sabato, N | 1 |
| Fabris, B | 4 |
| Shahbaz, AU | 2 |
| Palumbo, G | 6 |
| Belfiore, A | 4 |
| Caridi, G | 1 |
| Desideri, G | 4 |
| Ferri, C | 6 |
| Mallamaci, F | 3 |
| Mannelli, M | 4 |
| Patalano, A | 2 |
| Raffaelli, R | 1 |
| Memmo, A | 1 |
| Guidi, GC | 1 |
| Franchi, M | 1 |
| Corrocher, R | 6 |
| Parthasarathy, HK | 1 |
| Alhashmi, K | 1 |
| McMahon, AD | 1 |
| Struthers, AD | 2 |
| McInnes, GT | 1 |
| Ford, I | 1 |
| Connell, JM | 14 |
| MacDonald, TM | 7 |
| Rosendorff, C | 1 |
| Fang, Y | 1 |
| Zang, M | 1 |
| Chen, S | 2 |
| Yan, F | 1 |
| Di, X | 1 |
| Duren, A | 1 |
| Salepçioglu, H | 1 |
| Godiris-Petit, G | 1 |
| Hoang, C | 1 |
| Robson, D | 2 |
| Koleganova, N | 1 |
| Lin, CY | 3 |
| Fang, CC | 1 |
| Iannaccone, A | 1 |
| Leggett, D | 1 |
| Ramakant, P | 1 |
| Verma, AK | 1 |
| Chitalia, N | 1 |
| Weeg, N | 1 |
| Antonios, TF | 1 |
| Späth, M | 2 |
| Engers, R | 1 |
| Anlauf, M | 2 |
| Dekomien, G | 2 |
| Schinner, S | 2 |
| Cotesta, D | 2 |
| Pergolini, M | 1 |
| Schulman, RL | 1 |
| Rigel, DF | 1 |
| Fu, F | 1 |
| Beil, M | 1 |
| Hu, CW | 1 |
| Liang, G | 1 |
| Jeng, AY | 1 |
| Dorrian, CA | 1 |
| Toole, BJ | 1 |
| Alvarez-Madrazo, S | 1 |
| Kelly, A | 1 |
| Wallace, AM | 1 |
| Lee, R | 1 |
| Storr, M | 1 |
| Hershfield, NB | 1 |
| Seely, EW | 3 |
| Munver, R | 1 |
| Yates, J | 1 |
| Maerz, W | 1 |
| Scharnagl, H | 1 |
| Renner, W | 1 |
| Boehm, BO | 1 |
| Weihrauch, G | 1 |
| Dobnig, H | 1 |
| Bravo, EL | 11 |
| Rafey, MA | 1 |
| Nguyen Quang, M | 1 |
| Krüger, B | 1 |
| Krüger, CD | 1 |
| Walberer, A | 1 |
| Schenck, B | 1 |
| Kisters, K | 1 |
| Wenning, M | 1 |
| Krämer, BK | 1 |
| Murakami, O | 3 |
| Ishibashi, T | 2 |
| Takahashi, S | 1 |
| Hopkins, TG | 1 |
| El-Gayar, H | 1 |
| Palazzo, FF | 1 |
| Tan, T | 1 |
| Urbanet, R | 4 |
| Calcagno, A | 1 |
| Peschechera, A | 1 |
| Hubert, EL | 1 |
| Toffanin, M | 1 |
| Giorgino, F | 2 |
| Vettor, R | 4 |
| Di Murro, A | 1 |
| Crescenzi, E | 1 |
| Saponara, M | 1 |
| Grasko, JM | 1 |
| Nguyen, HH | 1 |
| Glendenning, P | 2 |
| Grunenwald, S | 1 |
| Lampron, A | 1 |
| Balaş, M | 1 |
| Zosin, I | 1 |
| Hermsen, D | 1 |
| Knoefel, WT | 1 |
| Kahn, SL | 1 |
| Angle, JF | 1 |
| Wang, C | 2 |
| Wang, B | 3 |
| Shi, T | 3 |
| Gong, D | 1 |
| Ni, D | 1 |
| Vlková, J | 1 |
| Masek, M | 1 |
| Dvoráková, J | 2 |
| Kim, RM | 1 |
| Soh, EY | 1 |
| Xie, XY | 1 |
| Zhao, TY | 1 |
| Resch, M | 1 |
| Bergler, T | 1 |
| Fredersdorf, S | 1 |
| Griese, DP | 1 |
| Weil, J | 1 |
| Kreuzer, P | 1 |
| Brunner, S | 1 |
| Riegger, GA | 1 |
| Luchner, A | 1 |
| Endemann, DH | 1 |
| Barisa, M | 4 |
| Roman, E | 1 |
| Ocaranza, MP | 1 |
| Mosso, L | 10 |
| Becerra, E | 1 |
| Solis, M | 1 |
| García, L | 1 |
| Lavandero, S | 1 |
| Jalil, J | 1 |
| Di Fabio, A | 1 |
| Ju, Z | 1 |
| Fischer, SS | 1 |
| Siraskar, B | 1 |
| Boini, KM | 1 |
| Ackermann, TF | 1 |
| Föller, M | 1 |
| Hocher, B | 1 |
| Rosenblatt, KP | 1 |
| Palmowski, M | 1 |
| Mühlenbruch, G | 1 |
| Grouls, C | 1 |
| Günther, RW | 1 |
| Gonzaga, CC | 1 |
| Thomas, SJ | 1 |
| Harding, SM | 3 |
| Cofield, SS | 2 |
| Mathur, A | 2 |
| Kemp, CD | 1 |
| Dutta, U | 1 |
| Baid, S | 1 |
| Ayala, A | 2 |
| Chang, RE | 1 |
| Steinberg, SM | 1 |
| Lange, E | 1 |
| Pingpank, JF | 1 |
| Alexander, HR | 1 |
| Phan, GQ | 1 |
| Linehan, WM | 2 |
| Pinto, PA | 1 |
| Lee, IS | 1 |
| Kim, SY | 1 |
| Jang, HW | 1 |
| Kim, MK | 1 |
| Lee, YH | 1 |
| Jo, YS | 1 |
| Zia, AA | 1 |
| Newman, KP | 2 |
| McGee, JE | 1 |
| Menard, J | 11 |
| Watson, C | 1 |
| Koch, M | 1 |
| Aker, S | 1 |
| Haastert, B | 1 |
| Somekh, NN | 1 |
| Finkielstein, D | 1 |
| Fujiwara, M | 1 |
| Murao, K | 1 |
| Imachi, H | 1 |
| Yoshida, K | 3 |
| Muraoka, T | 1 |
| Ohyama, T | 1 |
| Kushida, Y | 1 |
| Haba, R | 1 |
| Kakehi, Y | 1 |
| Ishida, T | 2 |
| Thum, T | 1 |
| Schmitter, K | 1 |
| Fleissner, F | 1 |
| Wiebking, V | 1 |
| Dietrich, B | 1 |
| Widder, JD | 1 |
| Jazbutyte, V | 1 |
| Ertl, G | 1 |
| Bauersachs, J | 1 |
| Benecke, A | 2 |
| Sharman, JE | 1 |
| Hsu, HL | 1 |
| Huang, CY | 1 |
| Tsai, CW | 2 |
| Wang, WJ | 3 |
| Phakdeekitcharoen, B | 1 |
| Kittikanokrat, W | 1 |
| Kijkunasathian, C | 1 |
| Chatsudthipong, V | 1 |
| Kornelius, E | 1 |
| Chen, KS | 1 |
| Huang, CN | 1 |
| Hu, D | 1 |
| Toniato, A | 3 |
| Chien, KL | 1 |
| Korovkin, S | 1 |
| Antke, C | 1 |
| Yamaguchi, Y | 1 |
| Fustin, JM | 1 |
| Calvird, M | 1 |
| Young, R | 1 |
| Yue, P | 1 |
| Zhao, B | 1 |
| Ji, W | 1 |
| Cho, Y | 1 |
| Patel, A | 1 |
| Men, CJ | 1 |
| Lolis, E | 1 |
| Wisgerhof, MV | 1 |
| Geller, DS | 1 |
| Albiger, NM | 1 |
| Sartorato, P | 2 |
| Mariniello, B | 2 |
| Finco, I | 1 |
| Kaiho, Y | 1 |
| Samavat, S | 1 |
| Ahmadpoor, P | 1 |
| Samadian, F | 1 |
| Hlavacova, N | 1 |
| Wes, PD | 1 |
| Ondrejcakova, M | 1 |
| Flynn, ME | 1 |
| Poundstone, PK | 1 |
| Babic, S | 1 |
| Jezova, D | 1 |
| Yang, WS | 1 |
| Lai, CF | 1 |
| Lee, TY | 1 |
| Wu, MS | 1 |
| Lüthi, S | 1 |
| Zimmerli, L | 1 |
| Suter, PM | 1 |
| Battegay, E | 1 |
| Fu, B | 1 |
| Wang, GX | 1 |
| Lang, B | 1 |
| Li, HZ | 2 |
| Shi, TP | 1 |
| Ai, X | 1 |
| Zhou, HX | 1 |
| Zheng, T | 1 |
| Bacca, A | 1 |
| Carli, V | 1 |
| Materazzi, G | 1 |
| Berti, P | 2 |
| Miccoli, P | 2 |
| Pisano, R | 1 |
| Tantardini, V | 1 |
| Bernini, M | 2 |
| Taddei, S | 3 |
| Wedatilake, YN | 1 |
| Scanlon, MJ | 1 |
| Barnes, SC | 1 |
| Quillo, AR | 1 |
| Gallina, V | 2 |
| Bancalari, R | 2 |
| Bolte, L | 1 |
| Avalos, C | 1 |
| Brinkmann, K | 1 |
| Giadrosich, V | 1 |
| Mericq, V | 1 |
| Avila, A | 1 |
| Perez, V | 1 |
| Inostroza, A | 1 |
| Seyberth, HW | 2 |
| Schlingmann, KP | 1 |
| Tzonou, A | 1 |
| Vamvakidis, K | 1 |
| Kontogeorgos, G | 1 |
| Taguchi, R | 1 |
| Monden, T | 1 |
| Mori, M | 2 |
| Kamrath, C | 1 |
| Haag, C | 1 |
| Schulze, E | 1 |
| Sala, C | 1 |
| Rescaldani, M | 1 |
| Turolo, L | 1 |
| Sarlon, G | 1 |
| Brem, AS | 1 |
| Morris, DJ | 1 |
| Gong, R | 1 |
| Sonoyama, T | 2 |
| Miyashita, K | 2 |
| Yamahara, K | 2 |
| Park, K | 1 |
| Oyamada, N | 1 |
| Taura, D | 2 |
| Inuzuka, M | 2 |
| Kojima, K | 2 |
| Honda, K | 2 |
| Fukunaga, Y | 2 |
| Kanamoto, N | 2 |
| Miura, M | 2 |
| Arai, H | 2 |
| Bellary, SR | 1 |
| Schwender, FT | 1 |
| Magotra, M | 1 |
| de Jongh Curry, AL | 1 |
| Garcia, EA | 1 |
| Lopez, JR | 1 |
| Meier, JL | 1 |
| Swislocki, AL | 1 |
| Siegel, D | 1 |
| Krysiak, R | 2 |
| Okopien, B | 2 |
| Cheng, Y | 1 |
| Lo, SC | 1 |
| Huang, PH | 1 |
| Liang, CJ | 1 |
| Kuo, YS | 1 |
| Wu, EL | 1 |
| Sun, YY | 1 |
| Chen, JW | 1 |
| Lin, SJ | 1 |
| Selejan, S | 1 |
| Drautz, F | 1 |
| Kazakow, A | 1 |
| Münz, BM | 1 |
| Müller, P | 1 |
| Allessie, MA | 1 |
| Hattangady, NG | 1 |
| Olala, LO | 1 |
| Bollag, WB | 1 |
| Cavalieri, S | 1 |
| Belloni, L | 1 |
| Gemelli, G | 1 |
| Della Valle, E | 1 |
| Reznek, RH | 5 |
| López-Andrés, N | 1 |
| Martin-Fernandez, B | 1 |
| Lahera, V | 1 |
| Fortuno, MA | 1 |
| Cachofeiro, V | 1 |
| Díez, J | 1 |
| Sica, DA | 1 |
| Burton, TJ | 1 |
| Hood, S | 1 |
| Repaci, A | 1 |
| Rinaldi, E | 1 |
| Giampalma, E | 1 |
| Minni, F | 1 |
| Marrano, N | 1 |
| Pasquali, R | 1 |
| Tichauer, JE | 1 |
| Mellado, C | 1 |
| Saha, S | 1 |
| Graessler, J | 1 |
| Kopprasch, S | 1 |
| Fourkiotis, VG | 1 |
| Hanusch, F | 1 |
| Lepenies, J | 1 |
| Ríos, MC | 1 |
| Izquierdo, A | 1 |
| Sotelo, M | 1 |
| Honnorat, E | 1 |
| Rodríguez Cuimbra, S | 1 |
| Catay, E | 1 |
| Popescu, BM | 1 |
| Chen, A | 1 |
| Su, TC | 1 |
| Wang, PC | 1 |
| White, PC | 3 |
| Pascoe, L | 4 |
| Curnow, KM | 3 |
| Tannin, G | 1 |
| Rösler, A | 1 |
| Kowalski, B | 1 |
| Pelouch, R | 1 |
| Bomback, AS | 1 |
| Klemmer, PJ | 1 |
| Schirpenbach, C | 4 |
| Morak, M | 1 |
| Holinski-Feder, E | 1 |
| Hofbauer, L | 1 |
| Golib-Dzib, JF | 1 |
| Perrocheau, M | 1 |
| Yin, G | 2 |
| Wu, M | 2 |
| Xu, M | 3 |
| Cho, MJ | 1 |
| Sung, EY | 1 |
| Park, JA | 1 |
| Lee, HD | 1 |
| Rainey, W | 1 |
| Kukidome, D | 1 |
| Miyamura, N | 1 |
| Sakakida, K | 1 |
| Shimoda, S | 1 |
| Shigematu, Y | 1 |
| Nishi, K | 1 |
| Yamashita, Y | 2 |
| Eto, M | 1 |
| Horina, JH | 1 |
| Ofner, M | 1 |
| Takata, H | 1 |
| Künzel, HE | 2 |
| Northcott, CA | 1 |
| Fink, GD | 1 |
| Garver, H | 1 |
| Haywood, JR | 1 |
| Laimon-Thomson, EL | 1 |
| McClain, JL | 1 |
| Pires, PW | 1 |
| Rigsby, CS | 1 |
| Dorrance, AM | 1 |
| Rutledge, MR | 1 |
| Farah, V | 1 |
| Adeboye, AA | 1 |
| Seawell, MR | 1 |
| Ueda, Y | 2 |
| Kondo, E | 1 |
| Yamada, G | 1 |
| Fujii, T | 1 |
| Mikami, Y | 1 |
| Myśliwiec, J | 2 |
| Zukowski, Ł | 1 |
| Grodzka, A | 1 |
| Piłaszewicz, A | 1 |
| Dragowski, S | 1 |
| Górska, M | 2 |
| Van Der Gugten, JG | 1 |
| Dubland, J | 1 |
| Liu, HF | 1 |
| Wang, A | 1 |
| Joseph, C | 1 |
| Tamanaha, T | 1 |
| Kawashima, ST | 1 |
| Lam, BY | 1 |
| Newhouse, SJ | 1 |
| Kuc, RE | 1 |
| Clarke, J | 1 |
| Hoffman, GJ | 1 |
| Schertz, EM | 1 |
| Tyson, DA | 1 |
| Friedrich, N | 1 |
| Völzke, H | 1 |
| Felix, SB | 1 |
| Biffar, R | 1 |
| Meisinger, C | 1 |
| Wichmann, HE | 1 |
| Benard, L | 1 |
| Schlossarek, S | 2 |
| Tournoux, F | 1 |
| Carrier, L | 2 |
| Chatziantoniou, C | 2 |
| Terata, S | 1 |
| Kikuya, M | 1 |
| Satoh, M | 2 |
| Ohkubo, T | 1 |
| Hashimoto, T | 4 |
| Obara, T | 3 |
| Metoki, H | 1 |
| Inoue, R | 1 |
| Asayama, K | 1 |
| Kanno, A | 1 |
| Hoshi, H | 1 |
| Satoh, H | 1 |
| Sato, H | 1 |
| Imai, Y | 4 |
| Queisser, N | 1 |
| Schupp, N | 1 |
| Hu, WL | 1 |
| Zhang, LC | 1 |
| Xiao, YS | 1 |
| Bin, C | 1 |
| Devaux, Y | 1 |
| Solal, AC | 1 |
| Waeckel, L | 1 |
| Potier, L | 1 |
| Chollet, C | 1 |
| Taveau, C | 1 |
| Bruneval, P | 1 |
| Roussel, R | 1 |
| Alhenc-Gelas, F | 1 |
| Bouby, N | 1 |
| Saleh, A | 1 |
| Song, MS | 1 |
| Seo, SW | 1 |
| Bae, SB | 1 |
| Leoni, L | 1 |
| Pengo, M | 1 |
| Ragazzo, F | 2 |
| Caielli, P | 1 |
| Cipollone, F | 1 |
| Cottone, S | 1 |
| Grassi, G | 1 |
| Sechi, L | 1 |
| Volpe, M | 1 |
| Frigo, AC | 1 |
| Siregar, P | 1 |
| Song, AL | 1 |
| Tong, AL | 1 |
| Fu, CL | 1 |
| Wang, YH | 1 |
| Sun, ML | 4 |
| van der Lubbe, N | 1 |
| Salih, M | 1 |
| Fenton, RA | 1 |
| El Wakil, A | 2 |
| Guy, N | 2 |
| Bendahhou, S | 2 |
| Niehrs, C | 1 |
| Mari, B | 1 |
| Küpers, EM | 1 |
| Carter, Y | 1 |
| Roy, M | 1 |
| Sippel, RS | 1 |
| Baba, Y | 3 |
| Hayashi, S | 1 |
| Nakajo, M | 3 |
| Apostolopoulou, K | 1 |
| Merkle, K | 1 |
| Schulz, S | 1 |
| Brand, V | 1 |
| Cao, CX | 1 |
| Yang, XC | 1 |
| Gao, YX | 1 |
| Zhuang, M | 1 |
| Wang, KP | 1 |
| Sun, LJ | 1 |
| Wang, XS | 1 |
| Horváth, D | 1 |
| Lőcsei, Z | 1 |
| Csizmadia, Z | 1 |
| Toldy, E | 1 |
| Szabolcs, I | 1 |
| Rácz, K | 6 |
| Al-Salameh, A | 1 |
| Cohen, R | 1 |
| Chanson, P | 1 |
| Weisbrod, AB | 1 |
| Webb, RC | 1 |
| Barak, S | 1 |
| Abraham, SB | 1 |
| Quezado, M | 1 |
| Shapiro, I | 1 |
| Meurer, S | 1 |
| Kulle, A | 1 |
| Riepe, F | 1 |
| Opotowsky, AR | 1 |
| Landzberg, MJ | 1 |
| Waxman, AB | 1 |
| Luque-Fernandez, L | 1 |
| Fernández, C | 1 |
| Fernández-Cruz, A | 1 |
| Potthoff, SA | 1 |
| Khan, MU | 1 |
| Khalid, H | 1 |
| Salpietro, V | 1 |
| Nicoli, D | 1 |
| Casali, B | 1 |
| Walther, T | 1 |
| Hinchliffe, E | 1 |
| Carter, S | 1 |
| Owen, LJ | 1 |
| Keevil, BG | 1 |
| Bendersky, M | 1 |
| Batlouni, M | 1 |
| Kashiwagi, Y | 1 |
| Harada, E | 1 |
| Shono, M | 1 |
| Yano, M | 1 |
| Yasue, H | 1 |
| Benso, A | 1 |
| Tabaro, I | 1 |
| Capello, E | 1 |
| Caprino, MP | 1 |
| Marafetti, L | 2 |
| Oleandri, SE | 1 |
| Xanthakis, V | 1 |
| Vasikaran, SD | 1 |
| Tsai, GC | 1 |
| Tseng, YZ | 1 |
| Ding, W | 1 |
| Hu, R | 1 |
| Mardini, M | 1 |
| Raison, M | 1 |
| Montori, VM | 1 |
| Seifarth, C | 2 |
| Trenkel, S | 2 |
| Schobel, H | 2 |
| Hahn, EG | 2 |
| Hensen, J | 3 |
| Sani, C | 2 |
| Davoli, S | 1 |
| Jackson, RV | 2 |
| Lafferty, A | 1 |
| Stratakis, C | 1 |
| Lauwers, P | 1 |
| Schwartz, GL | 2 |
| Chapman, AB | 1 |
| Kisabeth, RM | 1 |
| Turner, ST | 2 |
| Sywak, M | 1 |
| Lacolley, P | 1 |
| Labat, C | 1 |
| Pujol, A | 1 |
| Benetos, A | 1 |
| Safar, M | 2 |
| Zarzur, J | 1 |
| Ameur, A | 1 |
| el Younassi, B | 1 |
| Lezrek, M | 1 |
| Beddouch, A | 1 |
| Arharbi, M | 1 |
| Nishizaka, MK | 6 |
| Zaman, MA | 4 |
| Thakkar, RB | 1 |
| Weissmann, P | 1 |
| Milan, A | 4 |
| Paglieri, C | 1 |
| Chiandussi, L | 4 |
| Ganzaroli, C | 4 |
| Maresca, A | 1 |
| Nussdorfer, GG | 4 |
| Schmidt, BM | 1 |
| Schmieder, RE | 1 |
| Fritsch Neves, M | 1 |
| Yang, KC | 1 |
| Mao, JP | 1 |
| Jeschke, K | 1 |
| Janetschek, G | 2 |
| Peschel, R | 1 |
| Schellander, L | 1 |
| Bartsch, G | 2 |
| Henning, K | 1 |
| Kozàkovà, M | 1 |
| Buralli, S | 1 |
| Palombo, C | 1 |
| Moretti, A | 4 |
| Favilla, S | 1 |
| Salvetti, A | 7 |
| Kim, YA | 1 |
| Lee, SS | 1 |
| Ibrahim, HN | 4 |
| Hostetter, TH | 4 |
| Corry, DB | 2 |
| Tuck, ML | 3 |
| Soyama, A | 2 |
| Fraser, R | 42 |
| MacKenzie, S | 1 |
| Davies, E | 7 |
| Hokotate, H | 2 |
| Inoue, H | 1 |
| Tsuchimochi, S | 1 |
| Bähr, V | 2 |
| Oelkers, W | 9 |
| Baas, SJ | 1 |
| Fliers, E | 1 |
| Prummel, MF | 1 |
| Wiersinga, WM | 1 |
| Caksen, H | 1 |
| Cesur, Y | 1 |
| Akgün, C | 1 |
| Odabaş, D | 1 |
| Takagi, S | 2 |
| Imaki, T | 2 |
| Takano, K | 3 |
| Tezuka, M | 1 |
| Kimura, Y | 3 |
| Wake, K | 1 |
| Takanishi, T | 1 |
| Hamaguchi, S | 1 |
| Okuda, Y | 1 |
| Kitajima, T | 1 |
| González, A | 1 |
| Barraza, A | 1 |
| Avila, F | 1 |
| Montero, J | 6 |
| Huete, A | 3 |
| Gederlini, A | 1 |
| Sasaki, S | 2 |
| Abdelhamid, S | 14 |
| Blomer, R | 1 |
| Hommel, G | 1 |
| Haack, D | 8 |
| Lewicka, S | 9 |
| Fiegel, P | 4 |
| Krumme, B | 1 |
| Ferrari, P | 2 |
| Bonny, O | 1 |
| Kiani, MF | 1 |
| Guntaka, RV | 1 |
| Postlethwaite, AE | 2 |
| Warrington, KJ | 2 |
| Semplicini, A | 5 |
| Espiner, EA | 13 |
| Ross, DG | 1 |
| Yandle, TG | 2 |
| Richards, AM | 1 |
| Hunt, PJ | 1 |
| Inenaga, T | 1 |
| Takiuchi, S | 2 |
| CHESTERMAN, FC | 4 |
| FRANKS, LM | 4 |
| KNUDSEN, ET | 2 |
| WILLIAMS, PC | 2 |
| MILNE, MD | 3 |
| MUEHRCKE, RC | 3 |
| HOLTEN, C | 2 |
| PETERSEN, VP | 3 |
| EALES, L | 2 |
| LINDER, GC | 2 |
| DOORENBOS, H | 5 |
| ELINGS, HS | 3 |
| VAN BUCHEM, FS | 4 |
| CORCORAN, AC | 2 |
| DUSTAN, HP | 7 |
| PAGE, IH | 2 |
| BEAULIEU, EE | 2 |
| FUNEL, P | 2 |
| LEMONNIER, F | 2 |
| VESIN, P | 3 |
| BERNING, H | 2 |
| DORKEN, H | 2 |
| COLSKY, J | 2 |
| FINE, D | 2 |
| MEISELAS, LE | 2 |
| OXENHORN, S | 2 |
| CONN, JW | 19 |
| FAJANS, SS | 1 |
| LOUIS, LH | 2 |
| STREETEN, DH | 7 |
| JOHNSON, RD | 1 |
| WOLFF, HP | 10 |
| KOCZOREK, KR | 2 |
| BUCHBORN, E | 2 |
| FERREIRA, AC | 1 |
| LLAURADO, JG | 3 |
| WOODRUFF, MF | 2 |
| AIRD, I | 1 |
| SKANSE, B | 1 |
| MOLLER, F | 1 |
| GYDELL, K | 1 |
| JOHANSSON, S | 1 |
| WULFF, HB | 1 |
| HUDSON, B | 1 |
| BARNETT, AJ | 1 |
| BORNSTEIN, J | 1 |
| MUCIO, G | 1 |
| ROMANELLI, R | 3 |
| GIOMINI, ML | 1 |
| RUSSELL, GF | 1 |
| TUCKER, JB | 1 |
| FRASER, JD | 1 |
| DE WARDENER, HE | 1 |
| CRANE, MG | 4 |
| SHORT, G | 1 |
| PETERSON, JE | 1 |
| GOLDSMITH, RS | 2 |
| BARTTER, FC | 17 |
| ROSCH, PJ | 1 |
| MERONEY, WH | 2 |
| HERNDON, EG | 1 |
| RICHTER, HS | 1 |
| BIGLIERI, EG | 32 |
| MELLINGER, R | 1 |
| THERIAN, B | 1 |
| KLINE, IT | 1 |
| DITZLER, J | 1 |
| SMITH, R | 1 |
| FINE, G | 1 |
| BERKER, F | 1 |
| SIPAHIOGLU, H | 1 |
| BARUH, S | 1 |
| SAYIL, T | 1 |
| DANOPULO, D | 1 |
| SALASSA, RM | 2 |
| MATTOX, VR | 1 |
| POWER, MH | 1 |
| SORCE, RC | 1 |
| WHITSTONE, WE | 1 |
| PARRISH, RA | 1 |
| BLEHA, O | 2 |
| POLAK, E | 1 |
| MOTLIK, K | 2 |
| KUCHEL, O | 9 |
| SHREIBER, V | 1 |
| KANDRAC, MS | 2 |
| PACOVSKY, V | 1 |
| KOMARKOVA, A | 1 |
| ZIKANOVA, Z | 1 |
| MACH, O | 1 |
| BRUHL, W | 1 |
| ALSTED, G | 2 |
| HALBERG, P | 2 |
| BARRETT, PK | 2 |
| BAYLISS, RI | 1 |
| REES, JR | 2 |
| WARTER, J | 2 |
| SCHWARTZ, J | 2 |
| METAIS, P | 1 |
| BOBEK, K | 1 |
| OPATRNY, K | 1 |
| PONEC, V | 1 |
| SHEIKMAN, MB | 1 |
| FABRE, J | 1 |
| MULLER, AF | 11 |
| GAUTIER, A | 1 |
| DEMANET, JC | 1 |
| PESTEL, M | 1 |
| ORTUZAR, R | 1 |
| THOMSEN, P | 1 |
| GONZALEZ, J | 1 |
| MACH, RS | 7 |
| FANCONI, A | 1 |
| BERNHEIM, P | 2 |
| NEHER, R | 2 |
| BUGARD, P | 2 |
| HENRY, M | 1 |
| DI PERRI, T | 1 |
| GUIDERI, R | 1 |
| RAVENNI, G | 2 |
| BIANCHI, V | 1 |
| MONCIATTI, C | 1 |
| RUBEGNI, M | 2 |
| BRACONI, M | 1 |
| KRETCHMER, N | 1 |
| DICKINSON, WA | 1 |
| McNAMARA, H | 1 |
| KARL, R | 1 |
| SLATER, RJ | 1 |
| GEIGER, DW | 1 |
| LEESON, J | 1 |
| GORNALL, AG | 5 |
| THERIEN, B | 1 |
| MELLINGER, RC | 2 |
| CALDWELL, JR | 1 |
| HOWARD, PJ | 1 |
| YANKOPOULOS, NA | 2 |
| DAVIS, JO | 11 |
| KLIMAN, B | 2 |
| PETERSON, RE | 6 |
| CASPER, A | 1 |
| VERECKEI, I | 1 |
| GLAZ, E | 6 |
| OO, M | 1 |
| SARY, B | 1 |
| ANDERSSON, R | 1 |
| CALLAY, R | 1 |
| MATHIS, P | 1 |
| COUDOUX, P | 1 |
| CAREY, LC | 1 |
| ELLISON, EH | 1 |
| CEJKA, V | 2 |
| MERKELBACH, JW | 1 |
| de VRIES, L | 2 |
| CONN, ES | 1 |
| GORDON, GB | 1 |
| EICHENHOLZ, A | 1 |
| HALPRIN, H | 1 |
| HIGGINS, HP | 1 |
| O'SULLIVAN, M | 1 |
| Hill, SR | 1 |
| Hood, WG | 1 |
| Farmer, TA | 1 |
| Burnum, JF | 1 |
| DAVIS, PL | 1 |
| SHUMWAY, M | 1 |
| COST, WS | 2 |
| VEGTER, JJ | 1 |
| DULAC, JF | 1 |
| OUGIER, J | 1 |
| DOURY, P | 1 |
| BEN-ZENOU, A | 1 |
| WEIL, B | 1 |
| NORTH, JD | 1 |
| SIMS, FH | 1 |
| SAYERS, EG | 1 |
| PLAYOUST, MR | 1 |
| BLACKET, RB | 1 |
| RAPOPORT, A | 1 |
| ROGERS, FA | 1 |
| SEGNI, G | 1 |
| LAMBIE, AT | 1 |
| ROBSON, JS | 1 |
| LANES, P | 1 |
| LARAGH, JH | 15 |
| LENNON, EJ | 1 |
| RUETZ, PP | 1 |
| ENGSTROM, WW | 1 |
| MALLEIN, R | 1 |
| BESSET, C | 1 |
| OLIVIER, L | 1 |
| VACHON, A | 1 |
| MINICONI, P | 1 |
| MOOREHEAD, MT | 1 |
| ANDREWS, RO | 1 |
| PHILLIPS, WA | 1 |
| TRONCHETTI, F | 2 |
| JAKOBSON, T | 2 |
| MARRACK, D | 1 |
| BAULIEU, EE | 3 |
| ROBEL, P | 5 |
| SIGUIER, F | 2 |
| JAYLE, MF | 3 |
| CAPERS, TH | 1 |
| RACE, GJ | 1 |
| BORST, JG | 1 |
| CHALMERS, TM | 1 |
| CHRISTIAENS, L | 1 |
| FONTAINE, G | 1 |
| LEFEBVRE, R | 1 |
| FOSSATI, P | 2 |
| CORTES, F | 1 |
| SHUMAN, CR | 1 |
| CHANNICK, BJ | 4 |
| LIEBERMAN, F | 1 |
| HOLMAN, J | 1 |
| BAHN, RC | 1 |
| DELORME, P | 3 |
| DEMERS, R | 1 |
| DAVIGNON, J | 2 |
| ARABIAN, J | 1 |
| VEILLEUX, J | 1 |
| GENEST, J | 16 |
| FERRI, F | 1 |
| PANESI, M | 1 |
| FLEISHMAN, SJ | 1 |
| SENIOR, B | 1 |
| SUZMAN, MM | 1 |
| GALE, I | 1 |
| JORY, HI | 1 |
| MULLIGAN, L | 1 |
| WOOLLEN, JW | 1 |
| KOIW, E | 3 |
| BEAUREGARD, P | 1 |
| NOWACZYNSKI, W | 6 |
| SANDOR, T | 1 |
| BROUILLET, J | 1 |
| BOLTE, E | 1 |
| VERDY, M | 1 |
| MARCAURELE, J | 1 |
| GUINET, P | 1 |
| TRUNIGER, B | 3 |
| BLOCH, R | 1 |
| WEAVER, WF | 1 |
| BURCHELL, HB | 1 |
| ZIMMERMANN, B | 2 |
| MORAN, WH | 1 |
| ROSENBERG, JC | 1 |
| KENNEDY, BJ | 2 |
| FREY, RJ | 1 |
| BONOMO, L | 1 |
| PERRINI, M | 1 |
| ROSS, EJ | 4 |
| ARGUELLES, AE | 1 |
| RICCA, A | 1 |
| CHEKHERDEMIAN, M | 1 |
| ARROYO, H | 1 |
| BERNARD, A | 1 |
| BAYER, JM | 4 |
| SLATON, PE | 7 |
| FORSHAM, PH | 2 |
| CARPENTER, CC | 1 |
| WALLACE, CR | 1 |
| HAMILTON, WF | 1 |
| CHEN, CM | 1 |
| YANG, HF | 1 |
| CHEN, PH | 1 |
| WU, CT | 1 |
| HSIEH, YF | 4 |
| HSU, TC | 1 |
| KUO, SI | 1 |
| TREMBLAY, G | 2 |
| FITZHUGH, FW | 1 |
| FLANAGAN, MJ | 1 |
| GANTT, CJ | 1 |
| McDONALD, JH | 1 |
| FORD, HC | 2 |
| BLUEMLE, LW | 1 |
| BLAKEMORE, WS | 1 |
| JEFFERS, WA | 1 |
| GADRAT, J | 1 |
| DELAUDE, A | 1 |
| JORDA, MF | 1 |
| MOREAU, G | 1 |
| GOWENLOCK, AH | 1 |
| WRONG, O | 2 |
| GUILLEMAN, P | 2 |
| BENOIT, B | 1 |
| HERPOL, J | 1 |
| Smithwick, RH | 1 |
| Kinsey, D | 1 |
| Whitelaw, GP | 1 |
| HORTON, R | 8 |
| RIGHI, V | 1 |
| ALBEAUX-FERNET, M | 1 |
| BELLOT, L | 1 |
| CHABOT, J | 1 |
| DERIBREUX, J | 1 |
| GELINET, M | 1 |
| ROMANI, JD | 2 |
| BURROWS, BA | 1 |
| DE MARTINIS, C | 1 |
| FONZO, D | 1 |
| ABBOUD, FM | 1 |
| MANNING, EL | 2 |
| HODLER, J | 2 |
| BOZADZHIEVA, E | 1 |
| SAMBHI, MP | 1 |
| BECK, JC | 1 |
| VENNING, EH | 1 |
| KOMOR, K | 1 |
| KUKES, VG | 1 |
| MACARTHUR, E | 1 |
| O'DONNELL, VJ | 1 |
| GOMEZ, RE | 1 |
| PRIETO, ME | 1 |
| DOMINGUEZ, JP | 1 |
| GENERINI, G | 1 |
| MANZO, S | 1 |
| FORCONI, S | 1 |
| GIBINSKI, K | 2 |
| NOWAK, S | 2 |
| GIEC, L | 2 |
| TORIKAI, T | 9 |
| FASCIOLO, JC | 1 |
| DEVITO, E | 1 |
| ROMERO, JC | 1 |
| CUCCHI, JN | 1 |
| URQUHART, J | 4 |
| HIGGINS, JT | 8 |
| CANNON, PJ | 3 |
| AMES, RP | 1 |
| LAIDLAW, JC | 6 |
| YENDT, ER | 2 |
| BIRD, CE | 1 |
| STEINBECK, AW | 1 |
| HANADA, M | 1 |
| FUKUCHI, S | 32 |
| SHIOJI, R | 3 |
| HANATA, M | 2 |
| DEMURA, H | 12 |
| ABE, S | 1 |
| TAKAHASHI, H | 1 |
| EGERT, H | 1 |
| LUETSCHER, JA | 12 |
| LAMBERG, BA | 1 |
| POLIANTSEVA, LR | 1 |
| ERMOLENKO, VM | 1 |
| HOFFMEISTER, W | 1 |
| SICINSKI, A | 1 |
| KUMAGAI, A | 3 |
| TAKEUCHI, N | 3 |
| UEDA, H | 1 |
| KOTANI, S | 1 |
| YAMAMURA, Y | 1 |
| KELLY, WG | 1 |
| RUBIN, EC | 1 |
| HARTROFT, PM | 2 |
| ORLOFF, MJ | 1 |
| ROSS, TH | 1 |
| BADDELEY, RM | 2 |
| NUTTING, RO | 1 |
| SPITZ, BR | 1 |
| SLOOP, RD | 1 |
| NEESBY, T | 1 |
| HALASZ, NA | 1 |
| GERASIMOVA, EN | 1 |
| PALEEVA, FM | 1 |
| RATNER, NA | 1 |
| BRYAN, GT | 2 |
| GILL, JR | 14 |
| BLEDSOE, T | 1 |
| ISLAND, DP | 2 |
| RIONDEL, AM | 2 |
| LIDDLE, GW | 8 |
| BUCHT, H | 1 |
| BERGSTROEM, J | 1 |
| LINDHOLMER, B | 1 |
| WIJNBLADH, H | 1 |
| HOEKFELT, B | 1 |
| LINQUETTE, M | 1 |
| MEEROVICH, R | 1 |
| PASQUALINI, JR | 2 |
| MEYER, P | 2 |
| SAMARCQ, P | 1 |
| DRITEL, D | 1 |
| MILLIEZ, P | 5 |
| SUGAR, K | 1 |
| SIEGENTHALER, W | 24 |
| MANN, M | 1 |
| GFELLER, J | 1 |
| GANZONI, A | 1 |
| ROVNER, DR | 6 |
| KNOPF, RF | 1 |
| COHEN, EL | 9 |
| HSUEH, MT | 1 |
| MIYAKE, T | 1 |
| FISHER, DA | 1 |
| MORRIS, MD | 1 |
| GWINUP, G | 1 |
| HAMWI, GJ | 1 |
| LABOS, I | 1 |
| LOMMER, D | 4 |
| TORBICA, M | 1 |
| SCOTT, D | 1 |
| DOBSON, A | 1 |
| WALKER, WG | 2 |
| JOST, LJ | 2 |
| JOHNSON, JR | 1 |
| KOWARSKI, A | 5 |
| HOET, JJ | 1 |
| MOLINEAUX, L | 1 |
| KLOTZ, HP | 1 |
| LAMOTTE-BARRILLON, S | 1 |
| CREMER, G | 1 |
| MANNING, RT | 1 |
| DELP, MH | 1 |
| KITTLE, CF | 1 |
| WEBER, RW | 1 |
| BROSIUS, FC | 1 |
| MORAN, W | 1 |
| GOETZ, FC | 1 |
| MELBY, J | 2 |
| ORNDAHL, G | 1 |
| HOKFELT, B | 4 |
| LJUNGGREN, E | 1 |
| HOOD, B | 1 |
| PORTUONDO Y DE CASTRO, JM | 1 |
| ROZZELL, A | 1 |
| HOESLI, P | 1 |
| BETOURNE, C | 1 |
| SCHOELLER, JP | 1 |
| CAQUET, R | 1 |
| SILTANEN, P | 1 |
| SIPILA, W | 1 |
| JACOBSON, L | 1 |
| BARNARD, PJ | 1 |
| OHTOMO, M | 1 |
| UETA, H | 1 |
| YANO, S | 2 |
| NISHINO, K | 1 |
| YAMAMOTO, M | 2 |
| ASANUMA, Y | 1 |
| TAKAHASHI, A | 1 |
| LIANG, DS | 1 |
| MOBLEY, JE | 1 |
| HEADSTREAM, JW | 1 |
| MOSTOW, JH | 1 |
| MUELLER, AF | 1 |
| MURISASCO, A | 1 |
| REYNAUD, M | 1 |
| BOUISSON, M | 1 |
| NOVAKOVA, L | 1 |
| OSBORNE, RW | 1 |
| KALLSEN, R | 1 |
| RICHTER, R | 1 |
| BARDOS, Z | 1 |
| Postuła, M | 1 |
| Cybulska, I | 1 |
| Dobrucki, T | 1 |
| Kabat, M | 1 |
| Janas, J | 1 |
| Janaszek-Sitkowska, H | 1 |
| Makowiecka-Cieśla, M | 1 |
| Januszkiewicz, A | 1 |
| Padfield, PL | 9 |
| Lim, PO | 6 |
| Cherif, L | 1 |
| Ben Abdallah, N | 1 |
| Khiari, K | 1 |
| Hadj, AI | 1 |
| Ben Maïz, H | 1 |
| Yahyaoui, R | 1 |
| Essaies, O | 1 |
| Ktari, S | 1 |
| Zidi, B | 1 |
| Wodi, LA | 1 |
| Herring, PA | 1 |
| Gunasekera, TG | 2 |
| Cowley, DC | 1 |
| Archibald, C | 1 |
| Smithers, BM | 1 |
| Leotta, G | 1 |
| Tartière, JM | 1 |
| Kesri, L | 1 |
| Mourad, JJ | 2 |
| Blacher, J | 1 |
| Coruzzi, P | 4 |
| Gualerzi, M | 1 |
| Parati, G | 1 |
| Brambilla, L | 1 |
| Brambilla, V | 1 |
| Di Rienzo, M | 1 |
| Novarini, A | 3 |
| Magni, P | 2 |
| Motta, M | 2 |
| Morra Di Cella, S | 1 |
| De Iasio, R | 1 |
| Montanari, P | 1 |
| Seiler, L | 5 |
| Greminger, P | 2 |
| Di Legge, S | 1 |
| Tamayo, A | 1 |
| Hachinski, V | 1 |
| Pecen, L | 1 |
| Loh, KC | 3 |
| Schulte-Mönting, J | 1 |
| Slawik, M | 1 |
| Borm, K | 1 |
| Pavenstädt, H | 1 |
| Failor, RA | 1 |
| Capell, PT | 1 |
| Kalady, MF | 1 |
| McKinlay, R | 1 |
| Olson, JA | 1 |
| Pinheiro, J | 1 |
| Lagoo, S | 1 |
| Park, A | 1 |
| Eubanks, WS | 1 |
| Chatellier, G | 3 |
| Paşaoğlu, O | 1 |
| Shaw, SG | 1 |
| Nicod, J | 1 |
| Saner, E | 1 |
| Unger, N | 1 |
| Lopez Schmidt, I | 1 |
| Pitt, C | 1 |
| Philipp, T | 4 |
| Mann, K | 1 |
| Honda, M | 4 |
| Tsukada, T | 1 |
| Horiuchi, T | 2 |
| Tanaka, R | 1 |
| Yamaguchi, K | 2 |
| Miyakawa, H | 1 |
| Ishibashi, M | 1 |
| Green, SA | 1 |
| Renfroe, KY | 1 |
| Abd-Allah, NM | 1 |
| Hassan, FH | 1 |
| Esmat, AY | 1 |
| Hammad, SA | 1 |
| Miyoshi, T | 2 |
| Otsuka, F | 2 |
| Suzuki, J | 1 |
| Inagaki, K | 1 |
| Kishida, M | 1 |
| Mimura, Y | 1 |
| Nagai, A | 1 |
| Makino, H | 3 |
| Kurtulmus, N | 1 |
| Yarman, S | 1 |
| Azizlerli, H | 1 |
| Kapran, Y | 1 |
| Dluhy, RG | 8 |
| Evans, JC | 1 |
| Larson, MG | 1 |
| Wilson, PW | 1 |
| Meigs, JB | 1 |
| Rifai, N | 1 |
| Benjamin, EJ | 1 |
| Levy, D | 1 |
| Lingam, RK | 1 |
| Sohaib, SA | 2 |
| Rockall, AG | 1 |
| Isidori, AM | 1 |
| Chew, S | 1 |
| Grossman, A | 2 |
| Besser, GM | 3 |
| Perschel, FH | 1 |
| Schemer, R | 1 |
| Mechelhoff, D | 1 |
| Tauber, R | 1 |
| Vetshev, SP | 1 |
| Polunin, GV | 2 |
| Sotnikova, VA | 1 |
| Krishnan, PH | 1 |
| MacDonald, T | 2 |
| Stiefel, P | 1 |
| Aparicio, R | 1 |
| Carneado, J | 1 |
| Pamies, E | 1 |
| Villar, J | 1 |
| TRUNINGER-RATHE, I | 1 |
| SPUHLER, O | 1 |
| Torchinsky, MY | 1 |
| Deputy, S | 1 |
| Rambeau, F | 1 |
| Chalew, SA | 1 |
| Tiu, SC | 1 |
| Choi, CH | 1 |
| Shek, CC | 1 |
| Ng, YW | 1 |
| Chan, FK | 1 |
| Ng, CM | 1 |
| Carr, CE | 1 |
| Cope, C | 1 |
| Zidek, W | 1 |
| Kleta, R | 1 |
| O'Brien, K | 1 |
| Syed, AA | 1 |
| Redfern, CP | 1 |
| Weaver, JU | 1 |
| Kong, C | 1 |
| Yang, C | 1 |
| Mitka, M | 1 |
| Nguyen, DN | 2 |
| Nguyen, LT | 2 |
| Luong, KV | 2 |
| Sato, S | 3 |
| Fukushima, K | 2 |
| Naito, H | 1 |
| Funayama, Y | 1 |
| Krozowski, Z | 1 |
| Shibata, C | 1 |
| Sasaki, I | 1 |
| Javadi, S | 1 |
| Djajadiningrat-Laanen, SC | 1 |
| Kooistra, HS | 3 |
| van Dongen, AM | 1 |
| Voorhout, G | 3 |
| van Sluijs, FJ | 3 |
| van den Ingh, TS | 2 |
| Boer, WH | 3 |
| Rijnberk, A | 3 |
| Meyer, A | 1 |
| Brabant, G | 1 |
| Behrend, M | 1 |
| Stanson, AW | 2 |
| van Heerden, JA | 4 |
| Sealey, JE | 3 |
| Blumenfeld, J | 1 |
| Lamarre-Cliche, M | 1 |
| de Champlain, J | 3 |
| Lacourcière, Y | 1 |
| Poirier, L | 1 |
| Karas, M | 1 |
| Larochelle, P | 1 |
| Grim, CE | 17 |
| Cowley, AW | 1 |
| Hamet, P | 2 |
| Gaudet, D | 1 |
| Kaldunski, ML | 1 |
| Kotchen, JM | 1 |
| Krishnaswami, S | 1 |
| Pausova, Z | 1 |
| Roman, R | 1 |
| Tremblay, J | 1 |
| Kotchen, TA | 3 |
| Chhokar, VS | 1 |
| Myers, LK | 1 |
| Xing, Z | 1 |
| Smith, RA | 1 |
| Kater, CE | 3 |
| Labuzek, K | 1 |
| Szkróbka, W | 1 |
| Herman, ZS | 1 |
| Stewart, PM | 2 |
| Saruta, T | 14 |
| Guiheneuf-Tobie, C | 1 |
| Lasserre, R | 1 |
| Minifie, C | 1 |
| Lemetayer, P | 1 |
| Clementy, J | 1 |
| Oberleithner, H | 1 |
| Sun, X | 1 |
| Castro, CY | 1 |
| Pratt-Ubunama, M | 1 |
| Cofield, S | 1 |
| Bovy, C | 1 |
| Delanaye, P | 2 |
| Radermecker, RP | 1 |
| Maweja, S | 1 |
| Krzesinski, JM | 2 |
| Sakai, K | 1 |
| Sato, F | 1 |
| Mattarello, MJ | 2 |
| Albiger, N | 1 |
| Médeau, V | 1 |
| Duffy, DL | 1 |
| Jeske, YW | 1 |
| Lin-Su, K | 1 |
| New, MI | 15 |
| Juutilainen, AM | 1 |
| Voutilainen, ET | 1 |
| Mykkänen, L | 1 |
| Niskanen, L | 1 |
| Izumi, Y | 4 |
| Kim-Mitsuyama, S | 1 |
| Wake, R | 1 |
| Izumiya, Y | 1 |
| Yukimura, T | 1 |
| Ueda, M | 1 |
| Yoshiyama, M | 1 |
| Iwao, H | 1 |
| Duffy, SJ | 1 |
| Biegelsen, ES | 1 |
| Eberhardt, RT | 1 |
| Kahn, DF | 1 |
| Kingwell, BA | 1 |
| Vita, JA | 1 |
| Sabaini, G | 1 |
| Righetti, PG | 1 |
| Auzan, C | 1 |
| Gasc, JM | 1 |
| Baviera, E | 1 |
| Balaton, A | 1 |
| Elalouf, JM | 1 |
| Corvol, P | 16 |
| Trabetti, E | 1 |
| Girelli, D | 1 |
| Fujii, H | 1 |
| Miyake, O | 1 |
| Nagai, M | 1 |
| Okuyama, A | 2 |
| Yutani, C | 1 |
| Raji, A | 1 |
| Conlin, PR | 1 |
| Prakash, ES | 1 |
| Bodary, PF | 1 |
| Sambaziotis, C | 1 |
| Wickenheiser, KJ | 1 |
| Rajagopalan, S | 1 |
| Eitzman, DT | 1 |
| Geerling, JC | 1 |
| Engeland, WC | 1 |
| Kawata, M | 1 |
| Loewy, AD | 1 |
| Roggenland, D | 1 |
| Schneider, S | 1 |
| Klein, HH | 1 |
| Kann, PH | 1 |
| Perraudin, V | 1 |
| Delarue, C | 4 |
| Do Rego, JL | 1 |
| Vaudry, H | 4 |
| Kuhn, JM | 4 |
| Tiwari, S | 1 |
| Packer, RK | 1 |
| Hu, X | 1 |
| Sugimura, Y | 1 |
| Verbalis, JG | 1 |
| Ecelbarger, CA | 1 |
| Matsumura, K | 1 |
| Fujii, K | 1 |
| Oniki, H | 1 |
| Oka, M | 3 |
| Iida, M | 1 |
| Vetshev, PS | 1 |
| Feltrin, GP | 3 |
| Szücs, N | 1 |
| Varga, I | 5 |
| Tóth, M | 2 |
| Kiss, R | 5 |
| Patócs, A | 1 |
| Jakab, C | 1 |
| Perner, F | 1 |
| Járay, J | 1 |
| Horányi, J | 2 |
| Dabasi, G | 2 |
| Molnár, F | 1 |
| Major, L | 1 |
| Füto, L | 3 |
| Tulassay, Z | 1 |
| Maciá-Bobes, C | 1 |
| Ronzón-Fernández, A | 1 |
| Castaño-Fernández, G | 1 |
| Botas-Cervero, P | 1 |
| Krakoff, LR | 3 |
| Lucarelli, G | 1 |
| Janmohamed, S | 1 |
| Bouloux, PM | 1 |
| Bernante, P | 2 |
| Pelizzo, MR | 2 |
| Sartori, M | 1 |
| Mascagna, V | 1 |
| Realdi, A | 1 |
| Macchini, L | 1 |
| Ciccariello, L | 1 |
| Cattelan, F | 1 |
| Jefic, D | 1 |
| Mohiuddin, N | 1 |
| Alsabbagh, R | 1 |
| Fadanelli, M | 1 |
| Steigerwalt, S | 1 |
| Doi, SA | 1 |
| Abalkhail, S | 1 |
| Al-Qudhaiby, MM | 1 |
| Al-Humood, K | 1 |
| Hafez, MF | 1 |
| Al-Shoumer, KA | 1 |
| Tsujihata, M | 1 |
| Nonomura, N | 1 |
| Nishimura, K | 1 |
| Fardella, C | 4 |
| Tan, YY | 1 |
| Ogilvie, JB | 1 |
| Triponez, F | 1 |
| Caron, NR | 1 |
| Kebebew, EK | 1 |
| Clark, OH | 2 |
| Nwariaku, FE | 1 |
| Holt, S | 1 |
| Watumull, L | 1 |
| Dolmatch, B | 1 |
| Nesbitt, S | 1 |
| Victor, R | 1 |
| Wians, F | 1 |
| Livingston, E | 1 |
| Snyder, WH | 1 |
| Rüdiger, F | 1 |
| Nickel, C | 1 |
| Yang, TY | 1 |
| Cheng, NJ | 1 |
| Ko, YS | 1 |
| Kuo, CT | 1 |
| Labinson, PT | 1 |
| White, WB | 3 |
| Tendler, BE | 1 |
| Mansoor, GA | 3 |
| Corgnati, A | 1 |
| Bassi, A | 1 |
| Lapenna, R | 5 |
| Baroselli, S | 4 |
| Nadalini, E | 5 |
| Favret, G | 1 |
| Melis, A | 1 |
| Cavarape, A | 1 |
| Goodwin, KD | 2 |
| Mattsson, C | 1 |
| Kakafika, A | 1 |
| Florentin, M | 1 |
| Barr, M | 1 |
| MacKenzie, SM | 2 |
| Wilkinson, DM | 1 |
| Holloway, CD | 1 |
| Friel, EC | 2 |
| Miller, S | 1 |
| Caliumi, C | 1 |
| Parenti, G | 1 |
| Porteri, E | 3 |
| Goh, BK | 1 |
| Tan, YH | 1 |
| Chang, KT | 1 |
| Eng, PH | 2 |
| Yip, SK | 1 |
| Cheng, CW | 1 |
| Aslanidis, S | 1 |
| Papaefthimiou, P | 1 |
| Kartali, N | 1 |
| Zamboulis, C | 1 |
| Chen, SX | 1 |
| Du, YL | 1 |
| Gong, YC | 1 |
| Hu, YR | 1 |
| He, QB | 1 |
| Song, YY | 1 |
| Liu, ZJ | 1 |
| Shao, JM | 1 |
| Yan, JT | 1 |
| Wang, DW | 1 |
| Lombardi, CP | 1 |
| Raffaelli, M | 1 |
| De Crea, C | 1 |
| Rufini, V | 1 |
| Treglia, G | 1 |
| Bellantone, R | 1 |
| Vieira, MT | 1 |
| Costa, AF | 1 |
| Resurreição, FM | 1 |
| dos Santos, VM | 1 |
| Altenhenne, C | 1 |
| Büchner, NJ | 1 |
| Weiner, SM | 1 |
| Sellin, L | 1 |
| Hofebauer, S | 1 |
| Epplen, JT | 1 |
| Yan, QZ | 1 |
| Pan, DL | 1 |
| Plamondon, I | 1 |
| Douville, P | 3 |
| Lebel, M | 5 |
| Ikoma, A | 1 |
| Tamemoto, H | 1 |
| Suminaga, Y | 1 |
| Yamada, S | 1 |
| Ishikawa, SE | 1 |
| Chapelle, JP | 1 |
| Fogari, R | 1 |
| Preti, P | 1 |
| Zoppi, A | 1 |
| Rinaldi, A | 1 |
| Fogari, E | 1 |
| Mugellini, A | 1 |
| Ramé, A | 1 |
| Gavras, I | 1 |
| Freriks, K | 1 |
| Timmers, HJ | 1 |
| Danilovic, DL | 1 |
| Freire, DS | 1 |
| Paraíba, DB | 1 |
| Brandão Neto, RA | 1 |
| Lucon, AM | 1 |
| Pereira, MA | 1 |
| Montemurro, D | 1 |
| Chiuch, A | 4 |
| Bazzocchi, M | 1 |
| Garrone, C | 3 |
| Tritos, NA | 1 |
| Thomas, M | 1 |
| Vidal, A | 1 |
| Carmona-Bayonas, A | 1 |
| Soler, IO | 1 |
| Gómez, FI | 1 |
| Billalabeitia, EG | 1 |
| Saura, HP | 1 |
| Tafalla, MS | 1 |
| Díaz, MP | 1 |
| Della Mea, P | 1 |
| Tamimi, NA | 1 |
| Georgiades, CS | 1 |
| Geschwind, JF | 1 |
| Liddell, R | 1 |
| Syed, L | 1 |
| Arepally, A | 1 |
| Maiz, A | 1 |
| Ortiz, EH | 1 |
| Artigas, RA | 1 |
| Pratt-Ubunama, MN | 1 |
| Gianfagna, P | 1 |
| Pagni, R | 1 |
| Ye, P | 1 |
| Chun, TY | 1 |
| Nyirenda, MJ | 1 |
| Neal, MT | 1 |
| Roberts, M | 1 |
| Hatcher, EA | 1 |
| Kokulinsky, P | 1 |
| Adams, S | 1 |
| Liermann, D | 1 |
| Hahn, K | 1 |
| Linhart, KB | 1 |
| Majzoub, JA | 1 |
| Heitzmann, D | 1 |
| Derand, R | 1 |
| Jungbauer, S | 1 |
| Mengual, R | 1 |
| Reichold, M | 1 |
| Aller, MI | 1 |
| Wisden, W | 1 |
| Weber, A | 2 |
| Makhanova, N | 1 |
| Hagaman, J | 1 |
| Tzanela, M | 1 |
| Effraimidis, G | 1 |
| Effremidis, G | 1 |
| Vassiliadi, D | 1 |
| Szabo, A | 1 |
| Gavalas, N | 1 |
| Valatsou, A | 1 |
| Botoula, E | 1 |
| Thalassinos, NC | 1 |
| McKenzie, CA | 1 |
| Wright-Pascoe, R | 1 |
| Boyne, MS | 1 |
| Dinleyici, EC | 1 |
| Dogruel, N | 1 |
| Acikalin, MF | 1 |
| Tokar, B | 1 |
| Oztelcan, B | 1 |
| Ilhan, H | 1 |
| Tamura, Y | 2 |
| Adachi, J | 1 |
| Takeda, K | 1 |
| Kasuya, Y | 1 |
| Murayama, T | 1 |
| Sawabe, M | 1 |
| Araki, A | 1 |
| Bloom, AI | 1 |
| Wilson, MW | 1 |
| Laberge, JM | 1 |
| Gordon, RL | 1 |
| Davies, LA | 1 |
| Sen, N | 1 |
| Talley, EM | 1 |
| Stas, S | 1 |
| Whaley-Connell, AT | 1 |
| Sontia, B | 1 |
| Montezano, AC | 1 |
| Paravicini, T | 1 |
| Tabet, F | 1 |
| Mazza, A | 1 |
| Zamboni, S | 1 |
| Armigliato, M | 1 |
| Zennaro, R | 1 |
| Cuppini, S | 1 |
| Rempelou, P | 1 |
| Rubello, D | 1 |
| Selektor, Y | 1 |
| Bolognesi, M | 1 |
| Piva, A | 1 |
| Tiberio, GA | 1 |
| Giulini, SM | 2 |
| Matsukawa, T | 1 |
| Fejes-Tóth, G | 1 |
| Frindt, G | 1 |
| Náray-Fejes-Tóth, A | 1 |
| Palmer, LG | 1 |
| Shahmarvand, N | 1 |
| Orlandini, C | 1 |
| Bardini, M | 1 |
| Taurino, C | 1 |
| Lopez-Sublet, M | 1 |
| Lejeune, S | 1 |
| Safar, ME | 1 |
| Yu, XY | 1 |
| Kong, CZ | 1 |
| Li, ZH | 1 |
| Sun, ZX | 1 |
| Li, ZL | 1 |
| Bi, JB | 1 |
| Gong, DX | 1 |
| Mohaupt, MG | 1 |
| Hirono, Y | 1 |
| Sprintsson, RG | 1 |
| Tucci, JR | 3 |
| Jagger, PI | 5 |
| Lauler, DP | 5 |
| Davis, WW | 1 |
| Newsome, HH | 1 |
| Wright, LD | 1 |
| Hammond, WG | 1 |
| Easton, J | 1 |
| Dawborn, JK | 1 |
| McBryde, AC | 1 |
| Glenn, JF | 2 |
| Gunnells, JC | 5 |
| Maroon, JC | 1 |
| Lukemeyer, GT | 1 |
| Salokangas, A | 1 |
| Adlercreutz, H | 1 |
| Möhring, J | 2 |
| Weidmann, P | 12 |
| Travis, RH | 1 |
| Royer, P | 2 |
| Melby, JC | 26 |
| Spark, RF | 6 |
| Dale, SL | 8 |
| Egdahl, RH | 2 |
| Kahn, PC | 4 |
| Drafta, D | 1 |
| Oprescu, M | 1 |
| Busneanu, M | 1 |
| Wisgerhof, M | 8 |
| Mulrow, PJ | 3 |
| Nomura, K | 6 |
| Naruse, K | 5 |
| Shizume, K | 5 |
| Horký, K | 6 |
| Schreiber, V | 1 |
| Jugrinov, OG | 1 |
| Slavnov, VN | 2 |
| Komissarenko, IV | 2 |
| Oleinik, VA | 2 |
| Benikova, EA | 1 |
| Jibiki, K | 2 |
| Demura, R | 4 |
| Hogan, MJ | 4 |
| Brown, RD | 11 |
| Hegstad, R | 3 |
| Cserháti, E | 1 |
| Körner, A | 1 |
| Vaughan, NJ | 1 |
| Jowett, TP | 2 |
| Slater, JD | 3 |
| Wiggins, RC | 1 |
| Lightman, SL | 1 |
| Ma, JT | 1 |
| Payne, NN | 1 |
| Guthrie, GP | 2 |
| Brown, JJ | 26 |
| Davies, D | 1 |
| Lever, AF | 28 |
| Morton, JJ | 11 |
| Robertson, JI | 30 |
| Watson, ML | 1 |
| Branch, RA | 2 |
| Oates, JA | 3 |
| Brash, AR | 1 |
| Kretinina, LN | 1 |
| Kozhevnikova, IuN | 1 |
| Molinatti, GM | 2 |
| Limone, P | 1 |
| Lieber, IH | 1 |
| Stoneburner, SD | 1 |
| Floyd, M | 1 |
| McGuffin, WL | 4 |
| Shigetomi, S | 2 |
| Haruyama, K | 12 |
| Yamazaki, M | 6 |
| Thibonnier, M | 3 |
| Sassano, P | 5 |
| Dufloux, MA | 2 |
| Ding, JF | 1 |
| Liu, DQ | 1 |
| Tian, MR | 1 |
| Xin, RP | 1 |
| Donald, RA | 1 |
| Brown, G | 2 |
| Douglas, J | 1 |
| Bravo, E | 1 |
| Ganguly, A | 21 |
| Zager, PG | 2 |
| Limal, JM | 2 |
| Rappaport, R | 2 |
| Chen, FW | 7 |
| Chen, WY | 9 |
| Yen, TS | 7 |
| Hsu, HC | 4 |
| Wambach, G | 6 |
| Helber, A | 5 |
| Bönner, G | 4 |
| Hummerich, W | 3 |
| Konrads, A | 2 |
| Kaufmann, W | 10 |
| Mason, PA | 3 |
| Young, J | 2 |
| Levine, LS | 6 |
| Weinberger, MH | 26 |
| Sakamoto, N | 1 |
| Uda, M | 1 |
| Kojima, S | 2 |
| Tsuchiya, M | 2 |
| Ito, K | 2 |
| Ogino, K | 1 |
| Ikeda, M | 2 |
| Watabe, R | 1 |
| Lee, SM | 2 |
| Lightner, E | 2 |
| Witte, M | 2 |
| Oberfield, S | 1 |
| Levine, L | 1 |
| Sebastian, A | 3 |
| Hulter, HN | 2 |
| Kurtz, I | 1 |
| Maher, T | 1 |
| Schambelan, M | 12 |
| Luderer, JR | 1 |
| Demers, LM | 1 |
| Harrison, TS | 1 |
| Hayes, AH | 1 |
| Roy, C | 1 |
| Cruveiller, J | 1 |
| Harpey, JP | 1 |
| Renault, F | 1 |
| Debray, P | 1 |
| Caille, B | 1 |
| Beretta-Piccoli, C | 5 |
| Boddy, K | 1 |
| Cumming, AM | 4 |
| Davies, DL | 6 |
| Williams, ED | 1 |
| Mizuno, K | 4 |
| Yaginuma, K | 3 |
| Toki, T | 3 |
| Kato, T | 6 |
| Kaneko, K | 2 |
| Takai, K | 1 |
| Oseko, F | 4 |
| Ikeda, F | 4 |
| Nakano, R | 2 |
| Taniguchi, A | 3 |
| Imura, H | 6 |
| Endo, J | 1 |
| Fineberg, NS | 2 |
| Griffing, GT | 6 |
| Zoccali, C | 1 |
| Usherwood, T | 1 |
| Jungmann, E | 2 |
| Schwedes, U | 3 |
| Usadel, KH | 2 |
| Obert, I | 1 |
| Schöffling, K | 2 |
| Hubl, W | 5 |
| Taubert, H | 1 |
| Freymann, E | 1 |
| Hofmann, F | 1 |
| Meissner, D | 1 |
| Garten, CD | 4 |
| Schmidt, PK | 2 |
| Thiele, HJ | 1 |
| Neef, B | 1 |
| Okabe, T | 2 |
| Hidaka, H | 3 |
| Ohsawa, N | 1 |
| Tsushima, T | 3 |
| Sen, S | 3 |
| Dolan, LM | 2 |
| Malchoff, CD | 3 |
| Bumpus, FM | 2 |
| Holbrook, MM | 1 |
| Jiang, NS | 2 |
| Kao, P | 2 |
| Weinshilboum, RM | 1 |
| Strong, C | 1 |
| Donohue, JP | 6 |
| Tarazi, RC | 5 |
| Fouad, FM | 1 |
| Textor, SC | 1 |
| Gifford, RW | 1 |
| Vidt, DG | 1 |
| Slee, PH | 1 |
| Schaberg, A | 1 |
| Van Brummelen, P | 1 |
| Ferriss, JB | 8 |
| Peacock, M | 1 |
| Telner, AH | 1 |
| Lyons, DF | 1 |
| Kem, DC | 12 |
| Hanson, CS | 2 |
| Carollo, ML | 1 |
| Davison, AG | 1 |
| Snodgrass, GJ | 1 |
| Trinkle, PL | 1 |
| Clearfield, M | 1 |
| Nakada, T | 8 |
| Gotoh, M | 1 |
| Matsui, J | 1 |
| Yum, MN | 1 |
| Yune, HY | 2 |
| Batlle, DC | 2 |
| Kurtzman, NA | 3 |
| Shimizu, A | 1 |
| Aoi, W | 2 |
| Akahoshi, M | 1 |
| Utsunomiya, T | 1 |
| Kuramochi, M | 4 |
| Hashiba, K | 3 |
| Winterborn, MH | 1 |
| Hewitt, GJ | 1 |
| Mitchell, MD | 2 |
| Fujimaki, M | 1 |
| Senba, S | 2 |
| Saito, I | 4 |
| Konishi, K | 2 |
| Battaia, L | 1 |
| Pedrazzoli, M | 1 |
| Pachor, ML | 1 |
| Bambara, LM | 1 |
| Bryer-Ash, M | 1 |
| Wilson, DM | 1 |
| Tune, BM | 1 |
| Rosenfeld, RG | 1 |
| Shochat, SJ | 1 |
| Nishimiya, T | 1 |
| Oimatsu, H | 1 |
| Ota, S | 1 |
| Shimamoto, K | 3 |
| Iimura, O | 5 |
| Lüscher, T | 1 |
| Tenschert, W | 5 |
| Pedrinelli, R | 2 |
| Maurer, R | 2 |
| Turini, F | 1 |
| Maltinti, G | 2 |
| Vetter, H | 18 |
| Vetter, W | 20 |
| Ozawa, Y | 1 |
| Kato, E | 1 |
| Amagasaki, Y | 1 |
| Nakata, I | 1 |
| Higuma, K | 1 |
| Fujishima, S | 2 |
| Shionoiri, H | 5 |
| Tochikubo, O | 1 |
| Uneda, S | 1 |
| Fujiki, Y | 1 |
| Kaneko, Y | 3 |
| Grekin, RJ | 8 |
| Nicholls, MG | 5 |
| Ikram, H | 2 |
| Maslowski, AH | 1 |
| Hamilton, EJ | 1 |
| Bones, PJ | 1 |
| Iakovlev, AA | 2 |
| Iugrinov, OG | 1 |
| Markov, VV | 1 |
| Colton, R | 1 |
| Perez, GO | 1 |
| Fishman, LM | 5 |
| Pokrovskiĭ, AV | 2 |
| Kazanchian, PO | 3 |
| Babloian, GV | 1 |
| Migalina, LA | 1 |
| Litvinov, AP | 1 |
| Takeda, R | 12 |
| Watanabe, F | 1 |
| Ryota, T | 1 |
| Mathias, CJ | 1 |
| Peart, WS | 5 |
| Carron, DB | 1 |
| Hemingway, AP | 1 |
| Allison, DJ | 1 |
| Terayama, Y | 4 |
| Furusawa, M | 2 |
| Kido, K | 3 |
| Eba, H | 2 |
| Nigawara, K | 3 |
| Hitomi, H | 2 |
| Yagihashi, Y | 2 |
| Kogawa, T | 3 |
| Kawamata, A | 2 |
| Tulachan, Y | 2 |
| Funyu, T | 3 |
| Burke, M | 1 |
| Papo, J | 1 |
| Stavorovsky, M | 1 |
| Almog, C | 1 |
| Kawasaki, T | 14 |
| Nakamuta, S | 2 |
| Muratani, H | 5 |
| Omae, T | 9 |
| Merrill, RH | 1 |
| Dombroski, RA | 1 |
| MacKenna, JM | 1 |
| Shimizu, Y | 2 |
| Hanew, K | 1 |
| Sasaki, A | 1 |
| Yoshinaga, K | 8 |
| Haruyama, T | 2 |
| Sato, M | 4 |
| Hiwatari, M | 1 |
| Sato, K | 3 |
| Kasai, Y | 1 |
| Goto, T | 1 |
| Tajima, J | 1 |
| Itoh, S | 1 |
| Geisinger, MA | 1 |
| Zelch, MG | 1 |
| Risius, BF | 1 |
| O'Donovan, PB | 1 |
| Borkowski, GP | 1 |
| Ojima, M | 3 |
| Trono, D | 1 |
| Cereda, JM | 1 |
| Favre, L | 2 |
| Legrand, S | 1 |
| Meisel, C | 1 |
| Legrand, JC | 7 |
| Granberg, PO | 1 |
| Adamsson, U | 1 |
| Lins, PE | 3 |
| Fukushi, S | 1 |
| Tanioka, T | 1 |
| Yamashita, M | 1 |
| Taniguchi, K | 2 |
| Kudo, T | 4 |
| Matsuki, A | 4 |
| Scattini, CM | 2 |
| Barsotti, JT | 1 |
| Talarico, V | 1 |
| Adam, A | 1 |
| Ghiglione, J | 1 |
| Lema, B | 1 |
| Hauger Klevene, J | 1 |
| Lantos, CP | 2 |
| Dahl, V | 2 |
| Xu, FJ | 1 |
| Ferriss, B | 1 |
| Lasaridis, A | 1 |
| Semple, PF | 3 |
| Carpenter, P | 1 |
| Hegstad, RL | 1 |
| Marone, C | 1 |
| Bianchetti, MG | 1 |
| Link, L | 1 |
| Anderson, GH | 3 |
| Kramer, NJ | 7 |
| Wenting, GJ | 5 |
| Man in 't Veld, AJ | 3 |
| Derkx, FH | 3 |
| Schalekamp, MA | 7 |
| Marks, AD | 3 |
| Ben-Yosef, S | 1 |
| Knobel, B | 1 |
| Krispin, M | 1 |
| Zaidel, L | 1 |
| Vierhapper, H | 2 |
| Waldhäusl, W | 4 |
| Kuntz, E | 3 |
| Quigley, C | 1 |
| Sullivan, PA | 1 |
| Gonggrijp, H | 1 |
| Crowley, MJ | 1 |
| O'Sullivan, DJ | 1 |
| Witzgall, H | 7 |
| Müller, OA | 1 |
| Weber, PC | 5 |
| Elterman, JJ | 1 |
| Hagen, GA | 1 |
| Chrétien, M | 1 |
| Seidah, NG | 1 |
| Lis, M | 1 |
| Gutkowska, J | 2 |
| Cantin, M | 1 |
| Wedler, B | 2 |
| Reding, R | 1 |
| Schultz, J | 1 |
| Gross, MD | 5 |
| Shapiro, B | 1 |
| Meyers, L | 1 |
| Swanson, DP | 1 |
| Beierwaltes, WH | 3 |
| Vecsei, P | 20 |
| Mittelstädt, GV | 1 |
| Lichtwald, K | 4 |
| Tsuchiyama, H | 4 |
| Hammond, TG | 1 |
| Buchanan, JD | 1 |
| Scoggins, BA | 8 |
| Thatcher, R | 1 |
| Whitworth, JA | 3 |
| DeCarvalho, JG | 1 |
| Emery, AC | 1 |
| Frohlich, ED | 1 |
| Lund, JO | 9 |
| Nielsen, MD | 5 |
| Baylen, BG | 1 |
| Johnson, G | 1 |
| Tsang, R | 1 |
| Srivastava, L | 1 |
| Kaplan, S | 1 |
| Nivet, H | 1 |
| Rolland, JC | 1 |
| Lebranchu, Y | 1 |
| Dray, F | 2 |
| Benatre, A | 1 |
| Drucker, J | 1 |
| Grenier, B | 1 |
| Bagros, P | 1 |
| Lan, NC | 1 |
| Matulich, DT | 1 |
| Stockigt, JR | 7 |
| Winter, JS | 2 |
| McKenzie, JK | 3 |
| Baxter, JD | 1 |
| Gregorová, I | 4 |
| Lien, WP | 2 |
| Iwaoka, T | 5 |
| Umeda, T | 5 |
| Katsuragi, S | 1 |
| Takeuchi, T | 3 |
| Shiratsuchi, T | 1 |
| Hatano, M | 1 |
| Coghlan, JP | 7 |
| Abshagen, U | 1 |
| Spörl, S | 1 |
| Shimoyama, R | 1 |
| Zgliczyński, S | 1 |
| Shiroto, H | 1 |
| Ando, H | 1 |
| Ebitani, I | 1 |
| Hara, M | 1 |
| Numazawa, K | 1 |
| Kawamura, S | 1 |
| Sasaki, H | 5 |
| Keiser, HR | 7 |
| Uezono, K | 4 |
| Ueno, M | 4 |
| Noda, Y | 1 |
| Kumamoto, K | 2 |
| Fukiyama, K | 1 |
| Menon, M | 1 |
| Mersey, JH | 2 |
| Klempa, I | 1 |
| Steinau, U | 1 |
| Schneider, M | 1 |
| Röttger, P | 1 |
| Okumura, M | 3 |
| Asano, T | 3 |
| Arakawa, K | 4 |
| Hulthén, L | 1 |
| Jonsson, K | 1 |
| Lecerol, H | 1 |
| Chiba, S | 2 |
| Yasujima, M | 2 |
| Ito, T | 4 |
| Sakurai, Y | 1 |
| Irokawa, N | 1 |
| Otsuka, Y | 1 |
| Etzioni, A | 1 |
| Chaimovitz, C | 1 |
| Levi, Y | 1 |
| Benderli, A | 1 |
| Better, OS | 1 |
| Dunn, MJ | 3 |
| Cuspidi, C | 1 |
| Gelosa, M | 1 |
| Moroni, E | 1 |
| Sampieri, L | 1 |
| Frisina, N | 1 |
| Buemi, M | 1 |
| Ciraolo, O | 1 |
| Naso, G | 1 |
| Lasco, A | 1 |
| Costa, G | 1 |
| Rapaport, R | 1 |
| Petrovic, M | 1 |
| Wilson, T | 1 |
| Draznin, M | 1 |
| Bejar, RL | 1 |
| Johanson, A | 1 |
| Hata, S | 2 |
| Kunita, H | 2 |
| Kadena, N | 1 |
| Ito, Y | 3 |
| Nakagawa, K | 1 |
| Nakagawa, S | 1 |
| Oberfield, SE | 1 |
| Stoner, E | 1 |
| Chow, D | 1 |
| Rauh, W | 1 |
| Greig, F | 1 |
| Gniadek, TC | 2 |
| Villareal, JZ | 2 |
| Ploier, R | 2 |
| Tulzer, W | 2 |
| Fink, M | 1 |
| Bohrn, E | 1 |
| Giese, J | 3 |
| Haschke, F | 2 |
| Wimmer, M | 2 |
| Parth, K | 3 |
| Shkhvatsabaia, IK | 4 |
| Nekrasova, AA | 2 |
| Ustinova, SE | 7 |
| Mackett, MC | 1 |
| Smith, LL | 1 |
| Chodakowska, J | 4 |
| Bergstein, J | 1 |
| Vancura, J | 2 |
| Silinková-Málková, E | 2 |
| Hradec, E | 1 |
| Gless, KH | 2 |
| Walb, D | 4 |
| Opocher, G | 14 |
| Büchner, M | 4 |
| Dörner, G | 1 |
| Valpione, E | 1 |
| Moroki, N | 1 |
| Imamura, Y | 1 |
| Chan, JC | 1 |
| Cooper, SM | 1 |
| Ohmori, Y | 1 |
| Muranaka, H | 1 |
| Khosla, MC | 2 |
| Rodriguez, JA | 2 |
| Iba, K | 1 |
| Morii, H | 1 |
| Wada, M | 1 |
| Yasumoto, R | 1 |
| Kishimoto, T | 1 |
| Mitsuhashi, T | 1 |
| Hojo, K | 1 |
| Okahara, T | 1 |
| Popow, C | 1 |
| Pollak, A | 1 |
| Herkner, K | 1 |
| Schober, E | 1 |
| Rom-Boguslavskaia, ES | 1 |
| Nishikawa, M | 2 |
| Inada, M | 3 |
| Kurata, S | 2 |
| Oishi, M | 2 |
| Naito, K | 1 |
| Ishii, H | 1 |
| Mashio, Y | 2 |
| Dunnick, NR | 3 |
| Doppman, JL | 4 |
| Strott, CA | 1 |
| Brennan, MF | 1 |
| Schöneshöfer, M | 3 |
| Weber, B | 1 |
| Dulce, HJ | 1 |
| Belkien, L | 1 |
| Benraad, TJ | 3 |
| Hofman, J | 1 |
| Meurer, KA | 7 |
| Tsunoda, S | 1 |
| Nishioka, T | 1 |
| Ohno, N | 1 |
| Fukunaga, T | 1 |
| Yumura, W | 1 |
| Savage, MO | 2 |
| Jefferson, IG | 1 |
| Dillon, MJ | 2 |
| Milla, PJ | 1 |
| Honour, JW | 1 |
| Grant, DB | 1 |
| Mazzocchi, G | 2 |
| Robba, C | 1 |
| Gottardo, G | 1 |
| Meneghelli, V | 1 |
| Shipton, EA | 1 |
| Hugo, JM | 1 |
| Jackson, CE | 1 |
| Cerny, JC | 2 |
| Block, MA | 1 |
| Fialkow, PJ | 1 |
| Levinson, PD | 1 |
| Zadik, Z | 3 |
| Hamilton, BP | 2 |
| White, RI | 1 |
| Kowarski, AA | 2 |
| Brust, N | 1 |
| Chang, B | 1 |
| Hirai, J | 1 |
| Ulick, S | 3 |
| Chu, MD | 1 |
| Taylor, HC | 1 |
| Douglas, JG | 1 |
| Berg, GJ | 1 |
| Buu, NT | 1 |
| Bourque, M | 1 |
| Aiba, M | 4 |
| Murai, M | 4 |
| Tazaki, H | 2 |
| Sutton, JM | 1 |
| Poler, SM | 1 |
| de Bruyn, JH | 1 |
| Elmgreen, J | 1 |
| Gammelgaard, PA | 2 |
| Hansner, E | 1 |
| Albert, JP | 2 |
| Hartmann, F | 2 |
| Markov, KhM | 3 |
| Bakova, VV | 1 |
| Kucherenko, AG | 2 |
| Golov, AG | 1 |
| Gerasimenko, PP | 7 |
| Zheleznyĭ, VI | 1 |
| Gerasimenko, MP | 1 |
| Boers, GH | 1 |
| Bogman, MJ | 1 |
| Debruyne, FM | 1 |
| Hoefnagels, WH | 2 |
| Kloppenborg, PW | 3 |
| Drayer, JI | 3 |
| Kaneshige, H | 1 |
| Endoh, M | 1 |
| Nomoto, Y | 1 |
| Arimori, S | 2 |
| Sugihara, M | 1 |
| Wada, S | 1 |
| Senoo, J | 1 |
| Yamamoto, Y | 3 |
| Hinuma, K | 1 |
| Aoki, T | 1 |
| Nakamura, M | 2 |
| Gordon, M | 1 |
| Pollard, A | 1 |
| Pandya, KJ | 1 |
| Whitehead, R | 1 |
| Crowley, J | 1 |
| Citrin, DL | 1 |
| Ametov, AS | 2 |
| Kramer, AA | 1 |
| Abashidze, RI | 1 |
| Hasner, E | 1 |
| Hesse, B | 3 |
| Tønnesen, KH | 1 |
| Korolenko, SS | 1 |
| Okuno, T | 2 |
| Eguchi, T | 2 |
| Yasui, T | 1 |
| Nakamura, R | 2 |
| Kondo, K | 2 |
| Matsuki, S | 2 |
| Hellman, DE | 1 |
| Kartchner, M | 1 |
| Komar, N | 1 |
| Mayes, D | 3 |
| Pitt, M | 1 |
| Smals, AG | 2 |
| Brecht, G | 2 |
| Fischer, M | 2 |
| Galanski, M | 2 |
| Glänzer, K | 4 |
| Cramer, BM | 1 |
| Pouliadis, G | 2 |
| Sialer, G | 1 |
| Studer, A | 2 |
| Wollnik, S | 1 |
| Zumkley, H | 1 |
| Carpenter, PC | 3 |
| Edis, AJ | 1 |
| Holland, OB | 4 |
| de Talancé, N | 1 |
| Boulangé, M | 2 |
| Salvador, M | 4 |
| Guittard, J | 1 |
| Begasse, F | 2 |
| Massien-Simon, C | 3 |
| Battaglia, C | 1 |
| Guyene, TT | 3 |
| Duclos, JM | 2 |
| Charru, A | 1 |
| Aupetit-Faisant, B | 3 |
| Shackleton, CH | 2 |
| Jamieson, A | 3 |
| Murdoch, D | 1 |
| Kennedy, JA | 1 |
| Munakata, M | 2 |
| Hashimoto, J | 1 |
| Klemm, SA | 20 |
| Ballantine, DM | 2 |
| Tunny, TJ | 23 |
| Rao, A | 2 |
| Wilson, TE | 1 |
| Fanning, S | 1 |
| Ishisaka, DY | 1 |
| Merritt, TA | 1 |
| Vaughan, Ed | 4 |
| Sasagawa, I | 3 |
| Yagisawa, T | 1 |
| Ishigooka, M | 3 |
| Yoshimi, T | 3 |
| Taminato, T | 1 |
| Campbell, SE | 1 |
| Slight, SH | 1 |
| Ganjam, VK | 1 |
| Swinfard, RW | 1 |
| Diaz-Arias, AA | 1 |
| Yasuda, G | 2 |
| Umemura, S | 2 |
| Takasaki, I | 2 |
| Ishii, M | 2 |
| Kumar, A | 1 |
| Lall, SB | 1 |
| Ammini, A | 1 |
| Peshin, SS | 1 |
| Karmarkar, MG | 1 |
| Talwar, KK | 1 |
| Seth, SD | 1 |
| Li, JT | 1 |
| Shu, SG | 1 |
| Chi, CS | 1 |
| Murakawa, T | 1 |
| Siragy, HM | 1 |
| Vieweg, WV | 1 |
| Pincus, S | 1 |
| Veldhuis, JD | 1 |
| Sato, A | 2 |
| Miyamori, I | 7 |
| Bige, K | 3 |
| Lorenz, H | 1 |
| Nensel, U | 1 |
| Röckel, A | 2 |
| Yagi, A | 2 |
| Ichikawa, S | 4 |
| Sakamaki, T | 3 |
| Ono, Z | 2 |
| Sakamoto, H | 2 |
| Murata, K | 4 |
| Rutherford, JC | 7 |
| Rocco, S | 10 |
| Rebuffat, P | 1 |
| Cimolato, M | 2 |
| Ganten, D | 1 |
| Feltynowski, T | 5 |
| Ignatowska-Switalska, H | 4 |
| Wocial, B | 4 |
| Lewandowski, J | 2 |
| Nemoto, T | 1 |
| Niimura, S | 1 |
| Hayashi, A | 1 |
| Gomibuchi, T | 1 |
| Sanada, H | 1 |
| Watanabe, Y | 2 |
| Tenedieva, VD | 1 |
| Kulikovsky, VP | 1 |
| Lyamin, PV | 1 |
| Nepomnyaschi, VP | 1 |
| Jonsson, JR | 2 |
| Lai, FC | 1 |
| Chen, HC | 1 |
| Peng, HC | 1 |
| Chang, WT | 1 |
| Wen, MC | 1 |
| Morita, H | 4 |
| Yasuda, K | 7 |
| Miura, K | 11 |
| Sridhar, CB | 1 |
| Falaschi, P | 1 |
| Gualdi, G | 1 |
| Coassin, S | 2 |
| Carlomagno, A | 1 |
| De Siati, L | 1 |
| Bonavita, MS | 1 |
| Balsano, F | 1 |
| Bachmann, AW | 5 |
| Storie, WJ | 2 |
| Kuhnle, U | 4 |
| Akiyama, M | 1 |
| Suyama, B | 1 |
| Bonvalet, JP | 1 |
| Weigel, RJ | 1 |
| Wells, SA | 1 |
| Leight, GS | 2 |
| Hambling, C | 2 |
| Jung, RT | 4 |
| Browning, MC | 2 |
| Gunn, A | 2 |
| Anderson, JM | 1 |
| Ou, YC | 1 |
| Yang, CR | 1 |
| Chang, CL | 1 |
| Hwang, TI | 1 |
| Wu, HC | 1 |
| Ho, YJ | 1 |
| Kao, CH | 1 |
| Leng-Peschlow, E | 1 |
| Odenthal, KP | 1 |
| Voderholzer, W | 1 |
| Müller-Lissner, S | 1 |
| Nami, R | 1 |
| Martinelli, M | 2 |
| Buracchi, P | 1 |
| Lucani, B | 1 |
| Panza, F | 1 |
| Pavese, G | 1 |
| Carletti, F | 1 |
| Saia, F | 1 |
| Gennari, C | 1 |
| Jakob, F | 1 |
| Schröder, K | 1 |
| Ludwig, J | 1 |
| Rendl, J | 1 |
| Ishibashi, K | 1 |
| Matsuura, H | 1 |
| Ozono, R | 1 |
| Mitsuda, H | 1 |
| Oshima, T | 1 |
| Kanbe, M | 1 |
| Mattingly, D | 1 |
| Martin, H | 1 |
| Tyler, CM | 1 |
| Agrawal, JK | 1 |
| Naomi, S | 4 |
| Inoue, J | 4 |
| Yamauchi, J | 1 |
| Klemm, S | 1 |
| Pinet, F | 1 |
| Rioual-Caroff, N | 1 |
| Tunny, T | 1 |
| Ziesak, MD | 1 |
| Martin, N | 1 |
| Epping, A | 1 |
| Conic, S | 1 |
| Pekarske, SL | 1 |
| Herold, DA | 1 |
| Sergev, O | 2 |
| Eiam-Ong, S | 1 |
| Sabatini, S | 1 |
| Wiener, H | 1 |
| Nielsen, JM | 1 |
| Klaerke, DA | 1 |
| Jørgensen, PL | 1 |
| Cook, MD | 1 |
| Phillips, MI | 1 |
| Cook, VI | 1 |
| Kimura, B | 1 |
| Wilcox, CS | 1 |
| Chiesura-Corona, M | 2 |
| Tregnaghi, A | 1 |
| Zanin, L | 1 |
| Perale, R | 1 |
| Soattin, S | 1 |
| Gleason, PE | 1 |
| Bihrle, R | 1 |
| Dugan, J | 1 |
| Eller, D | 1 |
| Brilla, CG | 1 |
| Matsubara, LS | 1 |
| Roubidoux, MA | 1 |
| Leder, RA | 1 |
| Paulson, E | 1 |
| Kurylo, L | 1 |
| Ruby, ST | 1 |
| Burch, A | 1 |
| Bogdan, A | 1 |
| Auzéby, A | 1 |
| Touitou, Y | 3 |
| Yamamoto, H | 1 |
| Kato, Y | 1 |
| Blumenfeld, JD | 1 |
| Atlas, SA | 1 |
| Wang, JZ | 1 |
| Ishimura, Y | 1 |
| Nakao, Y | 2 |
| Abe, I | 3 |
| Fujishima, M | 4 |
| Ichiya, Y | 1 |
| Onizuka, H | 1 |
| Takishita, S | 5 |
| Noshiro, T | 1 |
| Akama, H | 1 |
| Kusakari, T | 1 |
| Shibukawa, S | 1 |
| Miura, W | 1 |
| Miura, Y | 5 |
| Tanaka, M | 2 |
| Shibasaki, T | 1 |
| Baert, D | 1 |
| Nobels, F | 1 |
| Van Crombrugge, P | 1 |
| Casoli, MC | 1 |
| Dotti, C | 1 |
| Ura, N | 1 |
| Nomura, N | 1 |
| Iwata, M | 1 |
| Aoyama, T | 1 |
| Takagawa, Y | 1 |
| Toraya, S | 1 |
| Kono, A | 1 |
| Ogasawara, M | 1 |
| Kikuchi, C | 1 |
| Litchfield, WR | 3 |
| Yokoyama, T | 1 |
| Rossi, G | 2 |
| Pavan, E | 3 |
| Sheaves, R | 1 |
| Goldin, J | 1 |
| Dacie, JE | 1 |
| Lowe, DG | 1 |
| Ross, RJ | 2 |
| Wass, JA | 1 |
| Müller-Lobeck, H | 1 |
| Pahl, S | 1 |
| Remberger, K | 1 |
| Bönhof, JA | 1 |
| Sanna, AL | 1 |
| Ciampani, T | 1 |
| Mancini, G | 1 |
| Giannini, D | 1 |
| Bonifacio, V | 1 |
| Abasiyanik, A | 1 |
| Oran, B | 1 |
| Kaymakçi, A | 1 |
| Yaşar, C | 1 |
| Calişkan, U | 1 |
| Erkul, I | 1 |
| Solomon, CG | 1 |
| Thiet, M | 1 |
| Moore, F | 1 |
| Liu, D | 2 |
| Chen, Q | 2 |
| Zheng, C | 2 |
| Nishikimi, T | 1 |
| Yoshitomi, Y | 1 |
| Nakasone, I | 1 |
| Matsuoka, H | 2 |
| Vallotton, MB | 6 |
| Merino Arribas, JM | 1 |
| Rámila de la Torre, E | 1 |
| Sánchez Martín, J | 1 |
| Avellanosa Arnaiz, A | 1 |
| González de la Rosa, JB | 1 |
| Brown, MA | 1 |
| Cramp, HA | 1 |
| Zammit, VC | 1 |
| Watanabe, N | 1 |
| Tsunoda, K | 1 |
| Halimi, JM | 1 |
| Mimran, A | 1 |
| Huang, YY | 1 |
| Hsu, BR | 1 |
| Tsai, JS | 1 |
| Kolokythas, O | 1 |
| Krämer, SC | 1 |
| Aschoff, AJ | 1 |
| Hanson, JA | 1 |
| Cotterill, AM | 1 |
| Harris, RJ | 1 |
| Armstrong, P | 1 |
| Blanchouin-Emeric, N | 1 |
| Khatibi, F | 1 |
| Vernier, I | 1 |
| Bennet, A | 1 |
| Carroll, J | 1 |
| Dluhy, R | 1 |
| Pistorello, M | 3 |
| Bradwin, G | 1 |
| Mortensen, R | 1 |
| Pratesi, C | 2 |
| Scali, M | 3 |
| Zovato, S | 1 |
| Gottardo, C | 1 |
| Simoncini, M | 1 |
| Spigariol, A | 1 |
| Zampollo, V | 2 |
| Ingram, MC | 1 |
| Inglis, GC | 2 |
| Jamieson, AJ | 1 |
| Ingram, M | 1 |
| Soro, A | 2 |
| Kreze, A | 1 |
| Okálová, D | 1 |
| Hrnclar, J | 1 |
| Bonnardeaux, A | 1 |
| Matsuda, A | 1 |
| Beniko, M | 1 |
| Ikota, A | 1 |
| Koizumi, S | 1 |
| Mizumoto, H | 1 |
| Matsuya, K | 1 |
| Koren, W | 1 |
| Postnov, IY | 1 |
| Postnov, YV | 1 |
| Shigematsu, Y | 1 |
| Hamada, M | 1 |
| Okayama, H | 1 |
| Hara, Y | 1 |
| Hayashi, Y | 1 |
| Kodama, K | 1 |
| Kohara, K | 1 |
| Hiwada, K | 1 |
| Uehara, S | 1 |
| Mino, N | 1 |
| Tsuchida, M | 1 |
| Nishikibe, M | 1 |
| Fukamizu, A | 2 |
| Murakami, K | 2 |
| Ikemoto, F | 1 |
| Kubo, A | 1 |
| Kunimoto, M | 1 |
| Kanmatsuse, K | 1 |
| Lhotta, K | 1 |
| Gasser, R | 1 |
| Finkenstedt, G | 1 |
| Jaschke, W | 1 |
| Sacchetto, A | 5 |
| Palatini, P | 1 |
| Graniero, GR | 1 |
| Canali, C | 1 |
| Pozzan, GB | 1 |
| Cecchetto, G | 1 |
| Rigon, F | 1 |
| Zacchello, F | 1 |
| Coolidge, C | 2 |
| Silva, P | 1 |
| Chen, LG | 1 |
| Lee, TI | 1 |
| Lin, HD | 1 |
| Wang, HC | 1 |
| Liu, WY | 1 |
| Tang, KT | 1 |
| Goncalvesová, E | 1 |
| Hnilica, P | 1 |
| Motovská, Z | 1 |
| Goncalves, F | 1 |
| Kovác, A | 1 |
| Hase, M | 1 |
| Adamczyk, M | 1 |
| Smith, J | 1 |
| Gartside, MG | 2 |
| Taylor, WL | 3 |
| Oka, K | 1 |
| Hayashi, K | 1 |
| Nakazato, T | 1 |
| Suzawa, T | 1 |
| Fujiwara, K | 1 |
| Dhib, M | 1 |
| Godin, M | 2 |
| Contesse, V | 3 |
| Rieu, M | 1 |
| Wolf, LM | 1 |
| Chowdhury, TA | 1 |
| Lasker, SS | 1 |
| Barzon, L | 2 |
| Gregianin, M | 1 |
| Macrì, C | 1 |
| Bettoni, G | 1 |
| Tiberio, G | 1 |
| Tan, KE | 1 |
| Khoo, DH | 1 |
| Tan, CE | 1 |
| Lim, HS | 1 |
| Lim, SC | 1 |
| Koh, LK | 1 |
| Ho, SC | 1 |
| Tai, ES | 1 |
| Fok, AC | 1 |
| Sirén, J | 1 |
| Välimäki, M | 1 |
| Huikuri, K | 1 |
| Sivula, A | 1 |
| Voutilainen, P | 1 |
| Haapiainen, R | 1 |
| Héron, F | 1 |
| Glorioso, N | 1 |
| Jackson, SN | 1 |
| Williams, B | 1 |
| Houtman, P | 1 |
| Trembath, RC | 1 |
| Kano, H | 1 |
| Orita, S | 1 |
| Hirose, M | 1 |
| Kawano, M | 1 |
| Okamura, M | 1 |
| Tani, T | 1 |
| Minami, M | 1 |
| Yokokawa, A | 1 |
| Haraguchi, M | 1 |
| Yasunari, K | 1 |
| Yoshikawa, J | 1 |
| Lazurova, I | 2 |
| Sokol, L | 2 |
| Trejbal, D | 2 |
| Bober, J | 2 |
| Zachar, M | 2 |
| Pajtasova, D | 1 |
| Aihara, A | 1 |
| Gärtner, F | 1 |
| Grotz, W | 1 |
| Schollmeyer, P | 1 |
| Lin, JP | 1 |
| Huggard, PR | 4 |
| Taymans, SE | 1 |
| Bercovici, JP | 2 |
| Roudaut, N | 1 |
| Kerlan, V | 1 |
| Floch, HH | 1 |
| Otsuka-Misunaga, F | 1 |
| Koyama, S | 1 |
| Yamanari, H | 1 |
| Ohe, T | 1 |
| Scognamiglio, R | 2 |
| Pietra, M | 1 |
| Molino, P | 1 |
| Cat Genova, G | 1 |
| Melchio, R | 1 |
| Grosso, T | 1 |
| Martini, G | 1 |
| Rodgers, P | 1 |
| Cardale, K | 1 |
| Watson, AD | 1 |
| Fujiyama, S | 1 |
| Matsubara, H | 1 |
| Maruyama, K | 1 |
| Masaki, H | 1 |
| Yonemoto, T | 1 |
| Nagata, T | 1 |
| Umeda, Y | 1 |
| Matsuda, T | 1 |
| Iwasaka, T | 1 |
| Izumi, T | 1 |
| IIjima, Y | 1 |
| Abdo, A | 1 |
| Bebb, RA | 1 |
| Wilkins, GE | 2 |
| Murray, GD | 2 |
| Kubota, K | 2 |
| Noie, T | 1 |
| Kimura, W | 1 |
| Makuuchi, M | 1 |
| Taniguchi, R | 1 |
| Koshiyama, H | 1 |
| Inoue, D | 1 |
| Sugawa, A | 1 |
| Muramatsu, Y | 1 |
| Ghose, RP | 1 |
| Hall, PM | 1 |
| Román, O | 1 |
| Chan, NN | 1 |
| Isaacs, AJ | 1 |
| Wilson, P | 1 |
| Vantyghem, MC | 1 |
| Ronci, N | 1 |
| Provost, F | 1 |
| Ghulam, A | 1 |
| Lefebvre, J | 2 |
| Telles, EC | 1 |
| Machado, FS | 1 |
| da Silva, EP | 1 |
| Lutucuta, S | 1 |
| Almeida, G | 1 |
| Coucelo, J | 1 |
| Vagueiro, C | 1 |
| Harper, R | 1 |
| Ferrett, CG | 1 |
| McKnight, JA | 1 |
| McIlrath, EM | 1 |
| Russell, CF | 1 |
| Sheridan, B | 1 |
| Atkinson, AB | 1 |
| Arabidze, GG | 4 |
| Sergakova, LM | 1 |
| Iarovaia, EB | 1 |
| Rossetti, TR | 3 |
| Kagami, S | 1 |
| Seki, N | 1 |
| Iizuka, T | 1 |
| Sasano, K | 1 |
| Kim, KS | 2 |
| Chen, YQ | 1 |
| Blevins, LS | 1 |
| Nadeau, JH | 1 |
| Meranze, SG | 1 |
| Vaughan, DE | 1 |
| Delva, P | 1 |
| Pastori, C | 1 |
| Degan, M | 1 |
| Montesi, G | 1 |
| Lechi, A | 2 |
| Warnock, DG | 2 |
| Rojas, P | 1 |
| Sánchez, O | 1 |
| Rojas, V | 1 |
| Rojas, A | 1 |
| Soto, J | 3 |
| Foradori, A | 3 |
| Peppercorn, PD | 1 |
| Allan, C | 1 |
| Mrnka, L | 1 |
| Pácha, J | 1 |
| Sindelka, G | 3 |
| Haas, T | 1 |
| Prázný, M | 2 |
| Hilgertová, J | 1 |
| Skrha, J | 3 |
| Toriumi, M | 1 |
| Okazaki, R | 1 |
| Slifer, A | 1 |
| Aronoff, DM | 1 |
| Dow, E | 1 |
| Brennan, G | 1 |
| Cortés, P | 2 |
| Gómez, L | 1 |
| Pinto, M | 1 |
| Oestreicher, E | 2 |
| Alexander, GL | 1 |
| Schwartz, DA | 1 |
| Ogawa, R | 1 |
| Schwartz, P | 1 |
| Wagnerova, H | 1 |
| Trejbalova, L | 1 |
| Valansky, L | 1 |
| Koay, ES | 1 |
| Khaw, MC | 1 |
| Emmanuel, SC | 1 |
| Rayner, BL | 2 |
| Opie, LH | 2 |
| Davidson, JS | 2 |
| Denolle, T | 1 |
| Hanon, O | 1 |
| Marquand, A | 1 |
| Laurent, P | 1 |
| Tison, E | 1 |
| Equine, O | 1 |
| Ducloux, D | 1 |
| Mychka, VB | 1 |
| Dmitriev, VV | 1 |
| Masenko, VP | 2 |
| Phillips, JL | 1 |
| Walther, MM | 1 |
| Pezzullo, JC | 1 |
| Rayford, W | 1 |
| Choyke, PL | 1 |
| Berman, AA | 1 |
| Rosenberg, ME | 2 |
| Juknevicius, I | 2 |
| Cartier, D | 1 |
| Lihrmann, I | 1 |
| Fischmeister, R | 1 |
| van der Waarden, RJ | 1 |
| IJzer, J | 2 |
| Boer, P | 2 |
| Glodny, B | 1 |
| Kühle, C | 1 |
| Cromme, S | 1 |
| Brockmann, J | 1 |
| Winde, G | 1 |
| Raff, H | 1 |
| Shaker, JL | 1 |
| Brickner, RC | 1 |
| Knechtges, TE | 1 |
| Kehoe, ME | 1 |
| Tsubochi, H | 1 |
| Darnel, AD | 1 |
| Krozowski, ZS | 1 |
| Kondo, T | 2 |
| Gallay, BJ | 1 |
| Ahmad, S | 1 |
| Toivola, B | 1 |
| Davidson, RC | 1 |
| Doggrell, SA | 1 |
| Brown, L | 1 |
| Gac, H | 1 |
| Claverie, X | 1 |
| Ahuad, J | 1 |
| Kasalová, Z | 1 |
| Frey, FJ | 1 |
| Stokes, GS | 4 |
| Monaghan, JC | 2 |
| Ryan, M | 1 |
| Woodward, M | 1 |
| Grose, JH | 2 |
| van Vonderen, IK | 1 |
| Mol, JA | 1 |
| van Rossum, TG | 1 |
| de Jong, FH | 1 |
| Hop, WC | 1 |
| Boomsma, F | 1 |
| Schalm, SW | 1 |
| Ogihara, M | 1 |
| Nakagawa, A | 2 |
| Tamura, C | 1 |
| Maejima, K | 1 |
| Kigoshi, T | 1 |
| Uchida, K | 3 |
| Matsubara, J | 1 |
| Dosh, SA | 1 |
| Sawka, AM | 1 |
| Leibson, C | 1 |
| Zacharieva, S | 1 |
| Atanassova, I | 1 |
| Natchev, E | 1 |
| Orbetzova, M | 1 |
| Tzingilev, D | 1 |
| Gomi, Y | 1 |
| Taniyama, M | 1 |
| Ban, Y | 1 |
| Takahashi, R | 1 |
| Myers, JE | 1 |
| Trinder, YA | 1 |
| Foo, R | 1 |
| Enberg, U | 1 |
| Farnebo, LO | 1 |
| Wedell, A | 1 |
| Gröndal, S | 2 |
| Grimelius, L | 2 |
| Kjellman, M | 1 |
| Nishiyama, K | 1 |
| Hishida, A | 1 |
| Long, W | 1 |
| Li, G | 1 |
| Yang, H | 1 |
| Liao, TS | 1 |
| Lai, MK | 1 |
| Chen, SJ | 1 |
| Su, CT | 1 |
| Forneris, M | 1 |
| Gottardo, L | 1 |
| Albertin, G | 1 |
| Malendowicz, LK | 1 |
| Benchetrit, S | 1 |
| Bernheim, J | 1 |
| Podjarny, E | 1 |
| Shargorodsky, M | 1 |
| Zimlichman, R | 1 |
| Al Saad, KO | 1 |
| Chan, NH | 1 |
| Narikiyo, T | 1 |
| Adachi, M | 1 |
| Iwashita, K | 1 |
| Shiraishi, N | 1 |
| Nonoguchi, H | 1 |
| Chen, LM | 1 |
| Chai, KX | 1 |
| Chao, J | 1 |
| Tomita, K | 1 |
| Okawa, T | 1 |
| Asano, K | 1 |
| Fujimori, K | 1 |
| Yanagida, K | 1 |
| Nikwan, NZ | 1 |
| Fujiwara, T | 1 |
| Garagezova, AR | 1 |
| Fiquet-Kempf, B | 1 |
| Launay-Mignot, P | 1 |
| Bobrie, G | 1 |
| Braam, RL | 1 |
| Pieters, GF | 1 |
| Thien, T | 1 |
| Argenio, G | 1 |
| Kok, KY | 1 |
| Yapp, SK | 1 |
| Castro, OL | 1 |
| Racine, MC | 1 |
| Arici, MH | 1 |
| Karimeddini, MK | 1 |
| Whalen, GF | 1 |
| Yamamoto, A | 1 |
| Masatsugu, K | 1 |
| Sawada, N | 1 |
| Yurugi, T | 1 |
| Hirata, S | 1 |
| Honda, T | 1 |
| Fukasawa, H | 1 |
| Kimura, N | 1 |
| Hoshi, K | 1 |
| Di Bello, V | 1 |
| Bertini, A | 1 |
| Giorgi, D | 1 |
| Mariani, M | 1 |
| di Cella, SM | 1 |
| Haghfelt, T | 2 |
| Leroy, JP | 1 |
| Caroff, J | 1 |
| Charles, JF | 1 |
| Robson, WL | 1 |
| Arbus, GS | 1 |
| Balfe, JW | 1 |
| Norby, L | 2 |
| Flamenbaum, W | 1 |
| Lentz, R | 1 |
| Ramwell, P | 1 |
| Marek, J | 2 |
| Skrabal, F | 6 |
| Auböck, J | 1 |
| Edwards, CR | 2 |
| Braunsteiner, H | 1 |
| Marks, P | 1 |
| Anderson, J | 1 |
| Vincent, R | 1 |
| Herwig, KR | 4 |
| Shah, V | 1 |
| Floret, D | 2 |
| David, M | 2 |
| Roux, A | 1 |
| Hage, GN | 1 |
| Teyssier, G | 1 |
| Potts, JL | 1 |
| Dalakos, TG | 2 |
| Jones, D | 1 |
| Hiramatsu, M | 1 |
| Yamane, Y | 1 |
| Takahara, J | 1 |
| Ota, Z | 1 |
| Ofuji, T | 1 |
| Takehisa, Y | 1 |
| Melada, GA | 3 |
| Dowdy, AJ | 5 |
| Hughes, H | 1 |
| Ross, J | 1 |
| Stewart, DT | 1 |
| Rössler, R | 1 |
| Todesco, S | 1 |
| Terribile, V | 1 |
| Borsatti, A | 1 |
| Messerli, FH | 2 |
| Tolis, G | 1 |
| Seth, K | 1 |
| Parvin-Pande, R | 1 |
| Kubo, S | 1 |
| Grose, J | 1 |
| Ledoux, F | 1 |
| Higgins, JR | 3 |
| Saenger, P | 1 |
| Gion, M | 3 |
| Tomsová, Z | 1 |
| Ohbuchi, S | 1 |
| Murakami, T | 2 |
| Néel, JL | 1 |
| Loubrieu, G | 1 |
| Menagé, JJ | 1 |
| Claire, M | 1 |
| Rafestin-Oblin, ME | 1 |
| Michaud, A | 1 |
| Roth-Meyer, C | 1 |
| Tatibouet, L | 1 |
| Morin, PP | 1 |
| Griffe, J | 1 |
| Lopez, JM | 2 |
| Siebenschein, R | 1 |
| Witassek, F | 4 |
| Furrer, J | 2 |
| Hollifield, JW | 3 |
| Wellman, H | 1 |
| Man in't Veld, AJ | 2 |
| Brummelen, PV | 1 |
| Guelpa-Decorzant, C | 1 |
| Chabert, PR | 1 |
| Nakajima, K | 13 |
| Mills, SR | 1 |
| Vinci, JM | 1 |
| Zusman, RM | 1 |
| Bowden, RE | 4 |
| Horwitz, D | 2 |
| Pisano, JJ | 3 |
| Tree, M | 7 |
| Roberts, A | 1 |
| Ram, CV | 1 |
| Nielsen, I | 4 |
| Christensen, P | 2 |
| Liau, CS | 1 |
| Mitchell, JR | 1 |
| Taylor, AA | 4 |
| Pool, JL | 1 |
| Lake, CR | 1 |
| Rollins, DE | 1 |
| Antropova, NV | 1 |
| Ivanova, NA | 1 |
| Vinogradova, LA | 3 |
| Leckie, B | 1 |
| Sudre, Y | 1 |
| Demange, J | 1 |
| Ibayashi, H | 4 |
| Takasugi, M | 1 |
| Rosenthal, J | 1 |
| Abenhaim, L | 1 |
| Khristov, V | 1 |
| Nakai, T | 1 |
| Miyamoto, M | 1 |
| Hashiba, T | 1 |
| Yoshimitsu, K | 1 |
| Miwa, U | 1 |
| Mason, P | 1 |
| Morgan, T | 1 |
| Myers, J | 1 |
| Carney, S | 1 |
| Yoshitake, T | 2 |
| Saigusa, M | 1 |
| Radfar, N | 2 |
| Vaisrub, S | 2 |
| Jessurun, RF | 1 |
| Struyvenberg, A | 1 |
| Dorhout Mees, EJ | 1 |
| Drozdova, ES | 1 |
| Hoshima, M | 1 |
| Ritsu, K | 1 |
| Oshima, K | 2 |
| Maruta, S | 1 |
| Shimomura, Y | 1 |
| Ayers, CR | 2 |
| Peach, MJ | 1 |
| Herf, SM | 1 |
| Glasson, P | 1 |
| Flory, ED | 1 |
| Matustik, MC | 1 |
| Carpentieri, U | 1 |
| Corn, C | 1 |
| Meyer, WJ | 1 |
| Ceresa, F | 1 |
| Sudan, M | 1 |
| Stacy, WK | 1 |
| Falls, WF | 1 |
| Spech, HJ | 2 |
| Titterington, M | 1 |
| Melby, SC | 1 |
| García Puig, J | 1 |
| Gancedo González, P | 1 |
| Mateos Antón, F | 1 |
| Herrero Huerta, E | 1 |
| Muro González, J | 1 |
| Ortíz Vázquez, J | 1 |
| Knaack, JR | 1 |
| Casado, S | 1 |
| Jiménez, JL | 1 |
| Farese, RV | 1 |
| Karsh, SJ | 1 |
| Bidot-López, P | 1 |
| Tomycz, N | 1 |
| Düsing, R | 1 |
| Spät, A | 2 |
| Nagy, K | 1 |
| Tarján, E | 2 |
| Tóth, G | 1 |
| Wronski, R | 1 |
| Jentzen, F | 1 |
| Takagi, T | 1 |
| Mikami, K | 1 |
| Moriya, H | 1 |
| Lijnen, P | 1 |
| Amery, A | 1 |
| Fagard, R | 1 |
| Reybrouck, T | 1 |
| Charbonnel, B | 1 |
| Nick, C | 1 |
| Patrusheva, IF | 1 |
| Shimizu, N | 8 |
| Kamiko, J | 1 |
| Nagazaka, H | 1 |
| Arakawa, M | 1 |
| Kohl, KH | 2 |
| Ogawa, H | 1 |
| Sakurami, T | 1 |
| Murayama, M | 1 |
| Aoi, H | 1 |
| Mathis, JM | 1 |
| Gerlock, AJ | 1 |
| Onstad, GR | 1 |
| Carboni, A | 1 |
| Contini, SA | 1 |
| Salvadori, C | 1 |
| Higa, K | 1 |
| Hirahashi, T | 1 |
| Eto, T | 1 |
| Onoyama, K | 1 |
| Takebayashi, S | 1 |
| Schildberg, FW | 1 |
| Witte, J | 1 |
| Bachhuber, F | 1 |
| Schreiber, M | 1 |
| Tuck, M | 1 |
| Okabe, Y | 1 |
| Hidai, H | 1 |
| Kinoshita, Y | 1 |
| Asakura, K | 1 |
| Mimura, H | 1 |
| Marks, DB | 1 |
| Kim, YN | 1 |
| Moctezuma, J | 1 |
| Aida, M | 3 |
| Kambegawa, A | 1 |
| Cordone, G | 1 |
| Fasce, L | 1 |
| Gianfranceschi, P | 1 |
| Delucchi, M | 1 |
| Iester, A | 1 |
| Torcia, R | 1 |
| Labadie, P | 1 |
| Klinkmann, H | 1 |
| Holtz, M | 1 |
| Kröger, E | 1 |
| Osten, B | 1 |
| Schmicker, R | 1 |
| Dummler, W | 1 |
| Sugawara, T | 1 |
| Sasano, N | 2 |
| Nakamura, K | 1 |
| Pellnitz, W | 1 |
| Connolly, TM | 1 |
| Ammenti, A | 1 |
| Bock, KD | 1 |
| Cremer, W | 1 |
| Werner, U | 1 |
| Himathongkam, T | 1 |
| Kaojarern, S | 1 |
| Gavras, H | 1 |
| Oliver, JA | 1 |
| Fichman, MP | 1 |
| Telfer, N | 1 |
| Zia, P | 1 |
| Speckart, P | 1 |
| Golub, M | 1 |
| Rude, R | 1 |
| Christlieb, AR | 3 |
| Assal, JP | 1 |
| Katsilambros, N | 1 |
| Kozak, GP | 1 |
| Frölich, JC | 2 |
| Seyberth, H | 1 |
| Adamson, U | 2 |
| Efendic, S | 1 |
| Löw, H | 1 |
| Luft, FC | 1 |
| Willis, LR | 1 |
| Hiner, LB | 1 |
| Gruskin, AB | 1 |
| Schmidt, KH | 1 |
| Graupner, J | 1 |
| Haussig, K | 1 |
| Hildebrandt, E | 1 |
| Braley, LM | 1 |
| Rawer, C | 1 |
| Wiederholt, M | 1 |
| Palicki, H | 1 |
| Vertes, V | 3 |
| Bruschi, G | 1 |
| Banchini, E | 1 |
| Mutti, A | 1 |
| Biggi, A | 2 |
| Civardi, E | 1 |
| Appenheimer, M | 1 |
| Lucas, R | 1 |
| Weiand, H | 1 |
| Herschbach, ML | 1 |
| Krück, F | 4 |
| Sakaguchi, H | 1 |
| Shibagaki, M | 1 |
| Fukui, T | 1 |
| Halushka, PV | 1 |
| Wohltmann, H | 1 |
| Privitera, PJ | 1 |
| Hurwitz, G | 1 |
| Margolius, HS | 2 |
| Houde, M | 1 |
| Benguigui, L | 1 |
| Tonnelier, M | 1 |
| Saito, M | 1 |
| Iinuma, K | 1 |
| Donker, AJ | 1 |
| de Jong, PE | 1 |
| van Eps, LW | 1 |
| Brentjens, JR | 1 |
| Bakker, K | 1 |
| Gramann, W | 1 |
| Dequiedt, P | 1 |
| Raviart, B | 1 |
| Vanhille, P | 1 |
| Lepoutre, E | 1 |
| Lelièvre, G | 1 |
| Tacquet, A | 1 |
| Smiley, JW | 1 |
| Del Guercio, ET | 1 |
| March, NM | 1 |
| Hornych, A | 1 |
| Hinerman, DL | 1 |
| Schwarz, HA | 1 |
| Zia, PK | 1 |
| Flammer, J | 1 |
| Reubi, RC | 1 |
| Nishizato, K | 1 |
| Brust, NL | 1 |
| Chang, BC | 1 |
| Slater, KL | 1 |
| Ignatowski-Switalska, H | 1 |
| Wiggins, R | 1 |
| Jowett, T | 1 |
| Loose, H | 1 |
| Oomen, AP | 1 |
| Swaan, JW | 1 |
| van der Spek, A | 1 |
| Andreotti, L | 1 |
| Klaus, D | 1 |
| Zehner, J | 1 |
| Dürr, H | 1 |
| Lange, H | 1 |
| Shimbo, S | 1 |
| Nanno, M | 1 |
| Spark, R | 1 |
| Eisenberg, H | 1 |
| Maeder, HU | 1 |
| Ross, D | 1 |
| Weber, HP | 1 |
| Beckerhoff, R | 4 |
| Redlich, B | 1 |
| Cottier, P | 2 |
| Mauser, R | 2 |
| Wobst, E | 1 |
| Mark, AL | 1 |
| Kaloyanides, GJ | 1 |
| Sann, L | 2 |
| Richard, P | 1 |
| Sassard, J | 4 |
| Bizollon, CA | 1 |
| Francois, R | 2 |
| Stahl, F | 2 |
| Perini, A | 1 |
| Antunes, JR | 1 |
| Doi, K | 1 |
| Ogihara, T | 4 |
| Ichihara, K | 1 |
| Hata, T | 1 |
| Kumahara, Y | 3 |
| Brown, WC | 1 |
| Rosei, EA | 1 |
| Trust, PM | 1 |
| Müller, G | 1 |
| Wellhöfer, G | 1 |
| Wernze, H | 1 |
| Wilkinson, SP | 1 |
| Bernardi, M | 1 |
| Jameson, JB | 1 |
| Perry, EG | 1 |
| Miles, K | 1 |
| Dunn, PJ | 1 |
| Cheng, JT | 1 |
| Cuesta, V | 1 |
| Garbus, SB | 1 |
| Katz, FH | 3 |
| Romfh, P | 1 |
| Smith, JA | 1 |
| Lowder, SC | 1 |
| Perez-Stable, EC | 1 |
| Materson, BJ | 1 |
| ørjavik, OS | 1 |
| Fauchald, P | 1 |
| Hovig, T | 1 |
| øystese, B | 1 |
| Brodwall, EK | 1 |
| Hendler, N | 1 |
| Moreau, P | 1 |
| Longin, B | 1 |
| Solomon, RJ | 1 |
| Brown, RS | 1 |
| Kizaki, M | 1 |
| Koshimizu, T | 1 |
| Szalay, KS | 1 |
| Bácsy, E | 1 |
| Stark, E | 1 |
| Allison, ME | 1 |
| Luke, RG | 1 |
| Takenouchi, T | 4 |
| Sugita, A | 1 |
| Hunt, TK | 1 |
| Kafrouni, G | 1 |
| Oakes, MD | 1 |
| Lurvey, AN | 1 |
| DeQuattro, V | 1 |
| Breuer, H | 2 |
| Rohde, W | 1 |
| Sobbe, A | 2 |
| Krehl, WA | 1 |
| Cecchettin, M | 1 |
| Albertini, A | 1 |
| Ghielmi, S | 1 |
| Signorini, C | 1 |
| Orlandini, A | 1 |
| Maiorca, R | 1 |
| Acquaviva, G | 1 |
| Arzilli, F | 2 |
| Wallach, L | 1 |
| Nyarai, I | 1 |
| Dawson, KG | 1 |
| Hackl, JM | 1 |
| Scuro, LA | 1 |
| McRae, J | 1 |
| Götz, M | 1 |
| Singer, P | 1 |
| Weissenbacher, G | 1 |
| Deck, KA | 3 |
| Luedtke, A | 1 |
| Eberlein, L | 2 |
| Braun, KP | 1 |
| Swander, A | 1 |
| Noblins, M | 1 |
| Kleinknecht, D | 1 |
| Dommergues, JP | 1 |
| Nazaret, C | 1 |
| Garay, RP | 1 |
| Jullien, M | 1 |
| Guillot, M | 1 |
| Fries, D | 1 |
| Charpentier, B | 1 |
| Crabbé, J | 1 |
| Wang, GY | 1 |
| Yamazaki, T | 1 |
| Koshida, H | 3 |
| Morise, T | 3 |
| Cailleux, N | 1 |
| Moore, N | 1 |
| Levesque, H | 1 |
| Courtois, H | 1 |
| Muto, S | 1 |
| Asano, Y | 1 |
| Okazaki, H | 1 |
| Kano, S | 1 |
| Cerci, S | 1 |
| De Ciocchis, A | 1 |
| Tarsitani, P | 1 |
| D'Ambrosio, C | 1 |
| Scavo, D | 1 |
| Brzezińska, A | 1 |
| Wieteska-Klimczak, A | 1 |
| Wyszyńska, T | 1 |
| Januszewicz, P | 1 |
| Udvardy, M | 2 |
| Hársfalvi, J | 2 |
| Rak, K | 2 |
| Carpené, G | 6 |
| Vettoretti, A | 1 |
| Sokolova, RI | 4 |
| Volkov, VN | 1 |
| Bulkina, OS | 2 |
| Etker, S | 1 |
| Enger, EA | 1 |
| Ishida, J | 1 |
| Sonezaki, S | 1 |
| Yamaguchi, M | 1 |
| Roche, J | 1 |
| Grunstein, H | 1 |
| Kawabe, H | 1 |
| Furukawa, T | 1 |
| Kojuma, I | 1 |
| Namba, M | 1 |
| Komura, H | 1 |
| Satoh, N | 1 |
| Ohtomo, T | 1 |
| Takada, T | 1 |
| Marusaki, S | 1 |
| Guan, BJ | 2 |
| Zang, MF | 1 |
| Shi, YF | 1 |
| Takasaki, H | 3 |
| Itoh, Y | 1 |
| Iki, K | 2 |
| Cugini, P | 2 |
| Battisti, P | 2 |
| Di Palma, L | 2 |
| Cavallini, M | 1 |
| Pozzilli, P | 1 |
| Scibilia, G | 1 |
| Cassisi, A | 1 |
| Cioli, AR | 1 |
| Marino, B | 1 |
| Gumowski, J | 1 |
| Proch, M | 1 |
| Kessler, CA | 1 |
| Oh-hashi, S | 1 |
| Takata, M | 2 |
| Ueno, H | 1 |
| Tomoda, F | 1 |
| Yasumoto, K | 1 |
| Iida, H | 2 |
| Sasayama, S | 1 |
| Kageyama, Y | 1 |
| Stimpel, M | 6 |
| Bartlett, WA | 1 |
| Degenhardt, S | 1 |
| Grimm, U | 1 |
| Krone, W | 1 |
| Detollenaere, M | 1 |
| Duprez, D | 1 |
| Missault, L | 1 |
| Rubens, R | 1 |
| De Buyzere, M | 1 |
| Vermeulen, A | 1 |
| Clement, DL | 1 |
| Clerico, A | 1 |
| Panarace, G | 1 |
| Spessot, M | 1 |
| Graziadei, L | 1 |
| Del Chicca, MG | 1 |
| Budd, PS | 2 |
| Corrie, JE | 2 |
| Kenyon, CJ | 1 |
| Shigemasa, C | 1 |
| Kouchi, T | 1 |
| Yoshida, A | 1 |
| Mashiba, H | 1 |
| Bart, G | 1 |
| Neugebauer, H | 1 |
| Ueda, S | 2 |
| Himeno, H | 1 |
| Gotoh, E | 2 |
| Noguchi, K | 1 |
| Seo, MS | 1 |
| Radin, DR | 1 |
| Manoogian, C | 1 |
| Nadler, JL | 2 |
| Veenhoven, RH | 1 |
| Vande Walle, JG | 1 |
| Donckerwolcke, RA | 1 |
| Wit, JM | 1 |
| Griffiven, AW | 1 |
| Chouman, M | 2 |
| Voci, P | 1 |
| Bilotta, F | 1 |
| Viola, R | 1 |
| Gargallo Fernández, MA | 1 |
| Marcos del Río, N | 1 |
| Sola López, D | 1 |
| Larrañaga, J | 1 |
| Vázquez Martínez, C | 1 |
| Finn, WL | 3 |
| Krek, AL | 1 |
| Haji, M | 2 |
| Nawata, H | 4 |
| Leprat, F | 1 |
| Dubourg, H | 1 |
| Barat, JL | 1 |
| Ducassou, D | 1 |
| Roger, P | 1 |
| Dallocchio, M | 1 |
| Latapie, JL | 1 |
| Higaki, J | 1 |
| Miya, A | 1 |
| Miki, T | 2 |
| Morishita, R | 1 |
| Mikami, H | 1 |
| Takai, S | 1 |
| Short, F | 1 |
| James, VH | 2 |
| Musiari, L | 1 |
| Carra, N | 1 |
| Panzali, AF | 1 |
| Miyazaki, S | 1 |
| Kuo, YM | 2 |
| Hsieh, CH | 1 |
| Lee, PW | 1 |
| Tan, SA | 2 |
| Berk, LS | 1 |
| Tan, LG | 2 |
| Komarov, FI | 1 |
| Iakovlev, VA | 1 |
| Shustov, SB | 1 |
| Bornemann, M | 1 |
| Sun, M | 1 |
| Biason, A | 1 |
| Jardine, A | 1 |
| Trofimov, VM | 1 |
| Nechaĭ, AI | 1 |
| Matsubara, T | 3 |
| Soma, R | 2 |
| Okamoto, S | 2 |
| Merrell, RC | 1 |
| Takayama, Y | 1 |
| Irony, I | 1 |
| Di Simone, S | 1 |
| Proença, R | 1 |
| Machado, J | 1 |
| Maltez, F | 1 |
| Alberto, MJ | 1 |
| Martins, G | 1 |
| Gonçalves, P | 1 |
| Levitskaia, IuV | 1 |
| Obtrakht, NV | 1 |
| Gorbacheva, ON | 1 |
| Levi, M | 1 |
| Zdrojewicz, Z | 1 |
| Pinna, G | 1 |
| Piras, D | 1 |
| Mahdyoon, H | 1 |
| Mermiges, DN | 1 |
| Bergman, B | 1 |
| Kulkarni, JN | 1 |
| Mistry, RC | 1 |
| Kamat, MR | 1 |
| Chinoy, R | 1 |
| Lotlikar, RG | 1 |
| Miura, F | 2 |
| Hamasaki, S | 2 |
| Kosmacheva, ED | 1 |
| Minkin, SE | 1 |
| At'kov, OIu | 1 |
| Kusakabe, K | 1 |
| Maki, M | 1 |
| Torres, VE | 1 |
| Offord, KP | 1 |
| Hattery, RR | 1 |
| D'Agostino, D | 2 |
| David, D | 1 |
| Furuta, H | 1 |
| Katayama, T | 2 |
| Sumiya, H | 1 |
| Shimazaki, J | 1 |
| Hawkins, PG | 2 |
| Hamlet, SM | 5 |
| Kewal, NK | 1 |
| Purton, KJ | 1 |
| Leone, L | 2 |
| O'Mahony, S | 1 |
| Burns, A | 1 |
| Murnaghan, DJ | 1 |
| Noritake, N | 2 |
| Mercado-Asis, LB | 2 |
| Murase, H | 2 |
| Fujio, N | 1 |
| Kato, K | 3 |
| Matsuo, H | 1 |
| McLeod, MK | 1 |
| Bronshteĭn, ME | 2 |
| Kazeev, KN | 2 |
| Kersztejn, M | 1 |
| Kuczera, M | 1 |
| Ivens, K | 1 |
| Volkmann, HP | 1 |
| Takeuchi, K | 1 |
| Christensen, JA | 1 |
| Bohle, A | 1 |
| Mikeler, E | 1 |
| Taugner, R | 1 |
| Karbowiak, I | 1 |
| Wallace, C | 1 |
| Zaruba, AIu | 1 |
| Kutsenko, AI | 1 |
| Kukharchuk, VV | 1 |
| Osterziel, KJ | 1 |
| Zeier, M | 1 |
| Raue, F | 1 |
| Buhr, H | 1 |
| Andrassy, K | 1 |
| Ziegler, R | 1 |
| Tsuchihashi, T | 3 |
| Tomita, Y | 4 |
| Kon-i, I | 1 |
| Kobayashi, T | 2 |
| Backmann, AW | 1 |
| Todua, FI | 1 |
| Uchite'l, IA | 1 |
| Yasuhara, S | 1 |
| Pham-Huu-Trung, MT | 1 |
| Bogyo, A | 1 |
| Leneuve, P | 1 |
| Girard, F | 1 |
| Motoyama, T | 1 |
| Sano, H | 1 |
| Kawaguchi, K | 1 |
| Yokota, Y | 1 |
| Ishikawa, Y | 1 |
| Yokoyama, M | 1 |
| Fukuzaki, H | 1 |
| Ishizuka, T | 1 |
| Nagao, S | 1 |
| Sugimoto, T | 2 |
| Fukui, K | 1 |
| Yamakado, M | 2 |
| Tagawa, H | 2 |
| Miyata, A | 1 |
| Kangawa, K | 1 |
| Shigeta, H | 1 |
| Tasaki, N | 1 |
| Kitazumi, S | 1 |
| Kitagawa, Y | 1 |
| Nakano, K | 1 |
| Kanatsuna, T | 1 |
| Kondo, M | 1 |
| Simpson, FO | 1 |
| Crozier, IG | 1 |
| Cuneo, RC | 1 |
| McCormick, D | 1 |
| Kogure, M | 1 |
| Tajima, Y | 1 |
| Pertile, F | 2 |
| Menegus, A | 1 |
| Garcia-Robles, R | 1 |
| Kelly, TM | 1 |
| Nelson, DH | 1 |
| Nagata, S | 1 |
| Saitoh, F | 1 |
| Iwata, S | 1 |
| Ashizawa, A | 1 |
| Chen, JH | 1 |
| Tsai, JH | 1 |
| Lai, YH | 1 |
| Hwang, SJ | 1 |
| Pringle, SD | 1 |
| Macfarlane, PW | 1 |
| Isles, CG | 1 |
| Cameron, HL | 1 |
| Brown, IA | 1 |
| Lorimer, AR | 1 |
| Dunn, FG | 1 |
| McIntosh, T | 1 |
| Berelowitz, B | 2 |
| Hudson, M | 2 |
| Salzman, R | 2 |
| Manson, JA | 2 |
| Pershakova, LP | 1 |
| Uchitel', IA | 1 |
| Yoshioka, M | 1 |
| Luzzi, T | 1 |
| Pedini, F | 1 |
| Pasini, C | 1 |
| Tishenina, RS | 1 |
| Fedorovich, IuN | 1 |
| Molchanova, GS | 1 |
| Khzardzhian, VG | 1 |
| Strasser, T | 2 |
| Breitschwerdt, EB | 1 |
| Meuten, DJ | 1 |
| Greenfield, CL | 1 |
| Anson, LW | 1 |
| Cook, CS | 1 |
| Fulghum, RE | 1 |
| Shenker, Y | 1 |
| Jones, DB | 1 |
| Bar-Andziak, E | 2 |
| Kasperlik-Załauska, A | 1 |
| Sznajderman, M | 1 |
| Matsuo, K | 2 |
| Ueki, Y | 1 |
| Liu, TH | 1 |
| Uribarri, J | 1 |
| Carroll, HJ | 1 |
| Tietze, U | 1 |
| Saule, H | 1 |
| Schroeter, C | 1 |
| Butenandt, I | 1 |
| Bidlingmaier, F | 1 |
| Horiba, N | 1 |
| Wehling, M | 2 |
| Kawazoe, N | 2 |
| Bursztyn, M | 1 |
| Grossman, E | 1 |
| Rosenthal, T | 1 |
| Emili, M | 1 |
| Cuppone, R | 1 |
| Ricci, GL | 1 |
| Kirilov, G | 1 |
| Lu, YR | 1 |
| Rostaing, L | 1 |
| Salva, P | 1 |
| Kutyrina, IM | 2 |
| Nikishova, TA | 1 |
| Tareyeva, IE | 1 |
| Valenta de Almeida, L | 1 |
| Farge, D | 2 |
| Julien, J | 1 |
| Iri, H | 1 |
| Mili, F | 1 |
| Chamakhi, S | 1 |
| Ben Slama, C | 1 |
| Bel Hadj, H | 1 |
| Hadj Salah, H | 1 |
| Kammoun, M | 1 |
| Boukhris, R | 1 |
| Kato, S | 1 |
| Fisher, T | 1 |
| Winter, J | 4 |
| Heinrich, U | 3 |
| Bokkenheuser, VD | 2 |
| Umeki, S | 1 |
| Terao, A | 1 |
| Sawayama, T | 1 |
| Koike, H | 1 |
| Akiya, T | 1 |
| Mizumura, Y | 1 |
| Dickson, BA | 1 |
| Franks, RC | 1 |
| Kimura, G | 1 |
| Saito, F | 1 |
| Yoshimi, H | 1 |
| Ashida, T | 1 |
| Kawamura, M | 1 |
| Khamidov, RI | 1 |
| Khalmuratova, RA | 1 |
| Sattarova, FK | 1 |
| McKenzie, IM | 1 |
| Heiman, D | 1 |
| Pirich, K | 1 |
| Graninger, W | 1 |
| Nowotny, P | 1 |
| Webb, DJ | 1 |
| Clark, SA | 1 |
| Brown, WB | 1 |
| Müller, J | 1 |
| Miyajima, E | 1 |
| Uemura, J | 1 |
| Okada, K | 2 |
| Kumakura, S | 1 |
| Ishikawa, S | 2 |
| Kuzuya, T | 2 |
| Shimizu, H | 1 |
| Sakamoto, Y | 1 |
| Nagano, M | 1 |
| Umezu, M | 1 |
| Kiyose, H | 1 |
| Itoh, N | 1 |
| Kuhls, S | 1 |
| Theisen, K | 1 |
| Murgia, A | 1 |
| Lam, J | 1 |
| Arteaga, E | 1 |
| Michaud, P | 1 |
| Téllez, R | 1 |
| Fraser, AG | 1 |
| Croxson, MS | 1 |
| Synek, B | 1 |
| Bokkenheuser, V | 1 |
| Hsueh, WA | 1 |
| Levin, PA | 1 |
| Gläser, V | 1 |
| Hallebach, V | 1 |
| Hans, S | 1 |
| Jackson, B | 1 |
| Valentine, R | 1 |
| Wagner, G | 1 |
| Aralov, MD | 1 |
| Briazgunov, IP | 1 |
| Iatsyk, PK | 1 |
| Tsai, TJ | 1 |
| Hiramatsu, K | 1 |
| Kashgarian, M | 1 |
| Ardito, T | 1 |
| Hirsch, DJ | 1 |
| Hayslett, JP | 3 |
| Marks, ES | 1 |
| Herd, GW | 1 |
| Parker, D | 1 |
| Davidson, JK | 2 |
| Hilditch, TE | 1 |
| Althoff, PH | 1 |
| Rosak, C | 1 |
| Krŭsteva, R | 1 |
| Vasilev, T | 1 |
| Robeva, R | 1 |
| Milkov, V | 1 |
| Odavić, MR | 1 |
| Jayasinghe, LS | 1 |
| Martin, RS | 1 |
| Ozeki, S | 1 |
| Yokoyama, K | 1 |
| Sawada, T | 1 |
| Adam, WR | 1 |
| von zur Mühlen, A | 1 |
| Myts, BV | 1 |
| Khachatrian, AP | 1 |
| Vorob'ev, IV | 1 |
| Zakharova, NF | 1 |
| Lorenz, R | 1 |
| von Werder, K | 1 |
| Resnick, LM | 1 |
| Liu, LS | 1 |
| Marty, H | 1 |
| Salvadé, G | 1 |
| Crivelli, PL | 1 |
| Drury, PL | 1 |
| Rasmussen, S | 1 |
| Damkjaer Nielsen, M | 1 |
| Tareeva, IE | 1 |
| Szécsény, A | 1 |
| Alánt, O | 1 |
| Darvas, K | 1 |
| Berentei, E | 1 |
| Szende, B | 1 |
| Murphy, BF | 1 |
| Kincaid-Smith, P | 1 |
| Ulmann, A | 1 |
| Bertagna, C | 1 |
| Le Go, A | 1 |
| Husson, JM | 1 |
| Tache, A | 1 |
| Groth, H | 1 |
| Klaiber, E | 1 |
| Stieber, U | 1 |
| Baumgart, P | 1 |
| Winterberg, B | 1 |
| Levin, P | 1 |
| Tang, K | 1 |
| Painton, R | 1 |
| Hsueh, W | 1 |
| Hirsch, D | 1 |
| Pace, P | 1 |
| Binder, HJ | 1 |
| Fujita, H | 1 |
| Fujie, M | 1 |
| Kumakura, H | 1 |
| Aurrechia, S | 1 |
| Pedersen, RC | 1 |
| Brownie, AC | 1 |
| Yoshida, M | 1 |
| Tsuruta, K | 1 |
| Ikegami, K | 1 |
| Kahaly, G | 1 |
| Krause, U | 1 |
| Ritthaler, H | 1 |
| Cordes, U | 1 |
| Günther, R | 1 |
| Schrezenmeir, J | 1 |
| Beyer, J | 1 |
| Higuchi, K | 1 |
| Anshelevich, IuV | 1 |
| Merson, MA | 1 |
| Afanas'eva, GA | 1 |
| Linnanvuo-Laitinen, M | 1 |
| Pirttiaho, H | 1 |
| Huttunen, K | 1 |
| Viinikka, L | 1 |
| Han, DC | 1 |
| Rybakov, SI | 1 |
| Iurginov, OG | 1 |
| Kay, AW | 2 |
| Neville, AM | 2 |
| O'Muircheartaigh, IG | 1 |
| Symington, T | 2 |
| Love, DR | 1 |
| Bell, PR | 1 |
| Ruthven, IS | 1 |
| Anderson, JE | 1 |
| Richards, P | 1 |
| Burstyn, PG | 2 |
| Horrobin, DF | 2 |
| Abbott, EC | 1 |
| Sutherland, DJ | 1 |
| Stiefel, M | 3 |
| Erbler, H | 1 |
| Erbler, HC | 2 |
| Oda, T | 6 |
| Silen, WS | 1 |
| Galante, M | 1 |
| Bailey, RE | 1 |
| Greenberg, AJ | 1 |
| Arboit, JM | 1 |
| Worthen, HG | 1 |
| Fleischer, N | 3 |
| Kronfield, SJ | 1 |
| Deck, JB | 1 |
| Sasaki, C | 2 |
| Blaise, BH | 1 |
| Düsterdieck, G | 3 |
| Jahnecke, J | 3 |
| Schieffer, H | 1 |
| Lee, TC | 1 |
| de Wied, D | 1 |
| Gross, F | 4 |
| Veragut, U | 1 |
| Iino, M | 2 |
| Brackett, NC | 2 |
| Koppel, M | 1 |
| Randall, RE | 1 |
| Nixon, WP | 1 |
| Katsushima, I | 7 |
| Maebashi, M | 5 |
| Newton, MA | 3 |
| Henkin, RI | 1 |
| Boucher, R | 2 |
| Veyrat, R | 13 |
| Gordon, SJ | 1 |
| Vogt, JH | 2 |
| Haber, E | 1 |
| Steiner, B | 4 |
| Schürholz, J | 1 |
| Streicher, E | 3 |
| Nieth, H | 1 |
| Dürr, F | 4 |
| Held, H | 1 |
| Allner, R | 1 |
| Kuska, J | 1 |
| Czekala, Z | 1 |
| Kiecoń, I | 1 |
| Maxwell, M | 1 |
| Ducrot, H | 1 |
| Richet, G | 1 |
| Péquignot, H | 1 |
| Imai, M | 2 |
| Yabuta, K | 1 |
| Murata, H | 1 |
| Takita, S | 1 |
| Ohbe, Y | 1 |
| Sokabe, H | 1 |
| Bizollon, A | 1 |
| Froment, A | 1 |
| Vincent, M | 1 |
| Lambrinidis, S | 1 |
| Gharib, C | 1 |
| Hardin, JG | 1 |
| Coker, AS | 1 |
| Blanton, JH | 1 |
| Endres, P | 2 |
| Baumann, K | 3 |
| Gysling, E | 3 |
| Rubli, H | 1 |
| Schönbeck, M | 3 |
| Werning, C | 14 |
| Brown, H | 1 |
| Graham, DY | 1 |
| Deleña, S | 1 |
| Schletter, FE | 1 |
| Clift, GV | 1 |
| Stevenson, CT | 1 |
| Cekański, A | 1 |
| Trygstad, CW | 1 |
| Mangos, JA | 1 |
| Bloodworth, JM | 1 |
| Lobeck, CC | 1 |
| Miura, S | 1 |
| Zhukovskiĭ, MA | 1 |
| Kireeva, VS | 1 |
| Sudarev, PV | 1 |
| Lim, NY | 1 |
| Mimica, N | 1 |
| Dingman, JF | 1 |
| Goodman, AD | 1 |
| Vagnucci, AH | 4 |
| Torigai, T | 2 |
| Maxwell, MH | 1 |
| Fontenaille, C | 1 |
| Camelot, G | 1 |
| Béquart, P | 1 |
| Collins, RD | 2 |
| Nokes, GW | 2 |
| Gonzales, CM | 1 |
| Desmit, EM | 1 |
| Drews, J | 1 |
| Hellman, L | 1 |
| Bradlow, HL | 1 |
| Zumoff, B | 1 |
| Schütterle, G | 1 |
| Dieker, P | 1 |
| Stiel, D | 2 |
| Schweikert, HU | 1 |
| Fukase, M | 1 |
| Iwai, K | 1 |
| Arant, BS | 1 |
| Young, RB | 1 |
| Still, WJ | 1 |
| Sawasaki, C | 1 |
| Okada, H | 1 |
| Igarashi, Y | 1 |
| Egi, S | 1 |
| Kawato, H | 1 |
| Suwa, S | 1 |
| Kihara, I | 1 |
| Grandchamp, A | 2 |
| Scholer, D | 2 |
| Boyd, GW | 1 |
| Blair-West, JR | 3 |
| Denton, DA | 3 |
| Wright, RD | 3 |
| Simopoulos, AP | 1 |
| Delea, CS | 2 |
| White, MG | 1 |
| Geyer, G | 1 |
| Oddie, CJ | 2 |
| Baer, L | 2 |
| Buhler, FR | 1 |
| Haywood, E | 1 |
| Anghel, S | 1 |
| Strauch, G | 1 |
| Bricaire, H | 1 |
| Wilkinson, R | 1 |
| Cain, JP | 1 |
| Rosenoff, SH | 1 |
| Gastaut, JA | 1 |
| Mizukoshi, H | 3 |
| Miyazaki, T | 2 |
| Araki, Y | 4 |
| Giebink, GS | 1 |
| Gotlin, RW | 1 |
| Shioji, T | 1 |
| Furuyama, T | 1 |
| McDonald, WJ | 3 |
| Blough, WM | 1 |
| Lucas, CP | 3 |
| Mayor, GH | 1 |
| Eveland, WC | 1 |
| Bookstein, JJ | 3 |
| Lapides, J | 1 |
| Batsakis, JG | 1 |
| Strumia, E | 1 |
| Stein, JH | 1 |
| Ferris, TF | 1 |
| Siegal, EJ | 1 |
| Ramanathan, K | 1 |
| Gantt, C | 1 |
| Lerman, R | 1 |
| Furuyama, S | 2 |
| Nugent, CA | 4 |
| Modlinger, RS | 2 |
| Nicolis, GL | 2 |
| Gabrilove, JL | 3 |
| Berman, LB | 1 |
| Yoshitoshi, Y | 1 |
| Börner, H | 1 |
| Shapiro, AP | 2 |
| Freeman, RH | 1 |
| Johnson, JA | 1 |
| Spielman, WS | 1 |
| Nast, HP | 1 |
| Yoshitoski, Y | 1 |
| Mertz, DP | 1 |
| Berger, M | 2 |
| Armbruster, H | 1 |
| Momose, G | 1 |
| Yoshida, T | 1 |
| Tateno, Y | 1 |
| Shigematsu, H | 1 |
| Sundsfjord, JA | 2 |
| Marton, P | 1 |
| Jorgensen, H | 2 |
| Aakvaag, A | 1 |
| Speller, PJ | 1 |
| Gyódi, G | 1 |
| Juhász, EK | 1 |
| Wilhelm, O | 1 |
| Verniory, A | 1 |
| Staroukine, M | 1 |
| Delwiche, F | 1 |
| Postel-Vinay, MC | 1 |
| Alberti, GM | 1 |
| Ricour, C | 1 |
| Tannen, RL | 1 |
| Arbeiter, G | 1 |
| Meyer-Burg, J | 1 |
| Losse, H | 1 |
| Risse, E | 1 |
| Wessels, F | 1 |
| Kinouchi, T | 1 |
| Aupetit, B | 2 |
| Zogbi, F | 2 |
| Malméjac, A | 2 |
| Desgrez, P | 2 |
| Yuen, BH | 1 |
| Kelch, RP | 2 |
| Jaffe, RB | 1 |
| Fsicher, N | 1 |
| Schmitz, TE | 1 |
| Cellerino, R | 1 |
| Frezza, M | 1 |
| Andrews, BS | 1 |
| Hagon, E | 1 |
| Thornell, IR | 1 |
| Palmer, AA | 1 |
| Posen, S | 1 |
| Kurokawa, Y | 1 |
| Sakoda, K | 1 |
| Akita, H | 1 |
| Sander, S | 1 |
| Wooster, LD | 1 |
| Hook, EW | 1 |
| Rosskamp, E | 1 |
| Dickmans, HA | 1 |
| Shida, N | 1 |
| Matsuda, I | 1 |
| Aloia, JF | 1 |
| Beutow, G | 1 |
| Zech, P | 1 |
| Pozet, N | 1 |
| Leitienne, P | 1 |
| Blanc, N | 1 |
| Colon, S | 1 |
| Berthoux, F | 1 |
| Touraine, JL | 1 |
| Traeger, J | 1 |
| Van Haelst, AJ | 1 |
| Benraad, HB | 1 |
| Van't Laar, A | 1 |
| Okuda, K | 1 |
| Omori, S | 1 |
| Obuchi, S | 1 |
| Kikuiri, K | 1 |
| Sugawara, M | 1 |
| Ishida, R | 1 |
| Takiguchi, M | 1 |
| Kimura, K | 1 |
| Wong, AK | 1 |
| Liu, TS | 1 |
| Kosman, ME | 1 |
| Dress, D | 1 |
| Urbani, S | 1 |
| Jacobsen, JG | 1 |
| Olesen, KH | 1 |
| Guedon, J | 1 |
| Luscko, M | 1 |
| Lissac, J | 1 |
| Harrison, JH | 1 |
| Jenkins, D | 1 |
| Bennett, AH | 1 |
| First, MR | 1 |
| Ripa, R | 1 |
| Mills, IH | 2 |
| Bondarenko, BB | 1 |
| Il'enko, TI | 1 |
| Egorova, IA | 1 |
| Smirnova, GA | 1 |
| Berndt, A | 1 |
| Distler, A | 2 |
| Müller, B | 1 |
| Rubens, RD | 1 |
| Lambert, HP | 1 |
| Fournier, A | 3 |
| Nakache, JP | 2 |
| Salmon, D | 2 |
| Kazandjian, M | 2 |
| Baulon, A | 2 |
| Lagrue, G | 2 |
| Just, HJ | 1 |
| Bertagna, X | 1 |
| Priscu, R | 1 |
| Maiorescu, M | 1 |
| Sichitiu, S | 1 |
| Haydl, H | 1 |
| Frischauf, H | 1 |
| Munck, O | 1 |
| Burden, RP | 1 |
| Booth, LJ | 1 |
| Aber, GM | 1 |
| Wilson, RJ | 1 |
| Craig, GM | 1 |
| Champion, PK | 1 |
| Rosset, G | 1 |
| Dart, RA | 1 |
| Tremann, JA | 1 |
| Gibbons, RP | 1 |
| Correa, RJ | 1 |
| Euchenhofer, M | 2 |
| Würz, H | 2 |
| Knox, FG | 1 |
| Connors, MH | 1 |
| Kaplan, SL | 1 |
| Grumbach, MM | 1 |
| Tsuchida, S | 1 |
| Kuroda, M | 1 |
| Simonini, N | 1 |
| Harris, JJ | 2 |
| Daniliak, IG | 1 |
| Kovacs, K | 1 |
| Horvath, E | 1 |
| Frölich, M | 1 |
| Bruning, PF | 1 |
| Moolenaar, AJ | 1 |
| Green, MF | 1 |
| Baxter, RH | 1 |
| Wang, I | 1 |
| Scheler, F | 1 |
| Wildhirt, E | 1 |
| Bolte, HD | 1 |
| Lüderitz, B | 1 |
| Bol'shakova, TD | 1 |
| Vaccaro, E | 1 |
| Solitro, A | 1 |
| Leeming, JM | 1 |
| Sommers, SC | 2 |
| Winters, RW | 1 |
| Ehrlich, EN | 1 |
| Sai, Z | 3 |
| Bongiovanni, AM | 1 |
| Eberlein, WR | 1 |
| Goldman, AS | 1 |
| New, M | 1 |
| Peters, G | 1 |
| Vinogradov, AV | 1 |
| Sycheva, IM | 1 |
| Griffin, JA | 1 |
| Liebowitz, HR | 1 |
| Moller, I | 1 |
| Păun, R | 1 |
| Ionescu-Tîrgovişte, C | 1 |
| Mićić, R | 1 |
| Lebedev, VP | 2 |
| Vodolazhskaia-Levina, EE | 1 |
| Chemidze, NP | 1 |
| Khovanskaia, MP | 1 |
| Kalashnikova, OA | 1 |
| Esch, I | 1 |
| Aitchison, J | 1 |
| Oelert, H | 1 |
| Leumann, EP | 1 |
| Bauer, RP | 1 |
| Holliday, MA | 1 |
| Borwn, JJ | 1 |
| Johns, VJ | 1 |
| Koppes, G | 1 |
| Finck, E | 1 |
| Hare, WS | 1 |
| Mitty, HA | 1 |
| Penke, B | 1 |
| Joumaah, A | 1 |
| Wisenbaugh, PE | 1 |
| Garst, JB | 1 |
| Hull, C | 1 |
| Freedman, RJ | 1 |
| Matthews, DN | 1 |
| Hadady, M | 1 |
| Hilmer, W | 1 |
| Stoeckel, H | 1 |
| Korpassy, A | 1 |
| Imada, A | 2 |
| Castleman, B | 1 |
| Scully, RE | 1 |
| McNeely, BU | 1 |
| Amsterdam, EA | 2 |
| Dobrzinsky, SJ | 2 |
| Hickler, RB | 2 |
| Finnerty, FA | 1 |
| Cashion, WR | 1 |
| Fisher, CE | 1 |
| Turner, FA | 1 |
| Sirs, JA | 1 |
| Mayes, DM | 1 |
| Mulrow, RJ | 1 |
| Morrow, LB | 1 |
| Shutkin, PM | 1 |
| Marieb, N | 1 |
| Suemori, H | 1 |
| Kato, F | 1 |
| Yogo, H | 1 |
| Uede, T | 1 |
| Ishigami, K | 1 |
| Kawase, M | 1 |
| Emoto, K | 2 |
| Kelleher, MD | 1 |
| Egdahl, BH | 1 |
| Anseri, AN | 1 |
| Cangiano, JL | 1 |
| Gould, AB | 1 |
| Kusla, J | 1 |
| Luciak, M | 1 |
| Gasiński, J | 2 |
| Wilson, DR | 2 |
| Ruse, JL | 3 |
| Kopecká, J | 1 |
| Pavlová, A | 1 |
| Aschermann, M | 1 |
| Shani, M | 1 |
| Sheba, H | 1 |
| Endo, Y | 1 |
| Narikawa, J | 1 |
| Takahira, T | 1 |
| Kato, M | 1 |
| Goto, U | 1 |
| Wilson, E | 1 |
| Vel'tishchev, IuE | 1 |
| Vodopazhskaia, EE | 1 |
| Yoshinaga, H | 1 |
| Chinn, RH | 2 |
| Düsterdieck, GO | 1 |
| Gleadle, RH | 1 |
| Chinn, R | 1 |
| Kuzmanic, A | 1 |
| Maira, J | 1 |
| Faivovich, A | 1 |
| Pizarro, D | 1 |
| Melfi, M | 1 |
| Lennon, H | 1 |
| Reid, A | 1 |
| Arguedas, C | 1 |
| Alvo, M | 1 |
| Behn, C | 1 |
| Tsai, ZH | 1 |
| Purjesz, I | 1 |
| Dahm, K | 1 |
| Castiglioni, GC | 1 |
| Gennari, R | 1 |
| Dinç, I | 3 |
| Barlas, O | 3 |
| De Nicola, AF | 1 |
| Traikov, H | 1 |
| Birmingham, MK | 1 |
| Palmer, JD | 1 |
| Ruddick, DW | 1 |
| Conn, J | 1 |
| Simon, NM | 1 |
| Bergan, JJ | 1 |
| Edmonds, CJ | 1 |
| Godfrey, R | 1 |
| Biancani, J | 1 |
| Hedeland, H | 1 |
| Dymling, JF | 1 |
| Nikolaev, OV | 1 |
| Kertsman, VI | 1 |
| Goodwin, FJ | 1 |
| Torres, M | 1 |
| Garella, S | 1 |
| Chazan, JA | 1 |
| Cohen, JJ | 1 |
| George, JM | 2 |
| Wright, L | 1 |
| Bell, NH | 1 |
| Holmes, AM | 1 |
| Hesling, CM | 1 |
| Wilson, TM | 1 |
| Kassirer, JP | 1 |
| London, AM | 1 |
| Goldman, DM | 1 |
| Schwartz, WB | 1 |
| Bayard, F | 2 |
| Beitins, IZ | 2 |
| Migeon, CJ | 2 |
| Lloyd, IJ | 1 |
| Kahuho, SK | 1 |
| Mulimba, O | 1 |
| Webala, GS | 1 |
| Ravon, R | 1 |
| Imbert, D | 1 |
| Guibert, B | 1 |
| Fischer, G | 1 |
| Mansuy, L | 1 |
| McDonald, RH | 1 |
| Enger, E | 1 |
| Arnesen, E | 1 |
| Ludwig, RN | 1 |
| Nelson, J | 1 |
| Terzakis, JA | 1 |
| Robinson, RR | 1 |
| Wells, S | 1 |
| Silver, D | 1 |
| Jacobsen, J | 1 |
| Gall, G | 2 |
| Usher, P | 1 |
| Klein, R | 2 |
| Vaitukaitis, J | 1 |
| Haddow, JE | 1 |
| Lohmann, FW | 2 |
| Dissmann, T | 2 |
| Gotzen, R | 2 |
| Molzahn, M | 2 |
| Rücker, G | 1 |
| Baumgärtel, H | 1 |
| Bachmann, D | 2 |
| Barbi, G | 1 |
| Giocoli, G | 1 |
| Cavina, G | 1 |
| Sardini, D | 1 |
| Basiliere, J | 1 |
| Newcomer, AD | 1 |
| Shishito, S | 1 |
| Matsunage, M | 1 |
| Weinberger, M | 1 |
| Marsen, B | 1 |
| Alicandri, CL | 1 |
| Lubash, GD | 1 |
| Rikimaru, S | 1 |
| Cocchieri, G | 1 |
| Daniele, GM | 1 |
| McCoy, RM | 2 |
| Fishman, L | 1 |
| Rhamy, RK | 2 |
| Scott, HW | 2 |
| Michelakis, AM | 2 |
| Creditor, MC | 1 |
| Loschky, UK | 1 |
| Gentle, JL | 1 |
| Edwards, KD | 1 |
| Tourniaire, J | 1 |
| Pousset, G | 1 |
| Bizollon, C | 1 |
| Toulouse, P | 1 |
| Desirat, C | 1 |
| Zwahlen, P | 1 |
| Oertli, P | 1 |
| Gray, MJ | 1 |
| Strausfeld, KS | 1 |
| Sims, EA | 1 |
| Solomon, S | 1 |
| Gillespie, L | 1 |
| Chick, WT | 1 |
| Balikian, HM | 1 |
| Brodie, AH | 1 |
| Tait, JF | 1 |
| Robert, M | 1 |
| Kogut, Z | 1 |
| Stefan, H | 1 |
| Helge, H | 1 |
| Merker, HJ | 1 |
| Korochkin, IM | 1 |
| Matveeva, IV | 1 |
| Sidorenko, BA | 1 |
| Arshakuni, RO | 1 |
| Birchall, R | 1 |
| Batson, HM | 1 |
| Fanestil, DD | 1 |
| Scherrer, JR | 1 |
| Radó, JP | 1 |
| Takó, J | 1 |
| Szabó, T | 1 |
| Endes, P | 1 |
| Wabrosch, G | 1 |
| Szántó, Z | 1 |
| Hermann, LS | 1 |
| Hansen, NC | 1 |
| Gronboek, P | 1 |
| Iversen, M | 1 |
| Hilton, JG | 1 |
| Kiepenheuer, K | 1 |
| Rhomberg, F | 1 |
| Salti, IS | 2 |
| Delarue, NC | 1 |
| Reidbord, H | 1 |
| Fisher, ER | 1 |
| Greenlee, HB | 1 |
| Sparagana, M | 1 |
| Jose, A | 1 |
| Charron, RC | 1 |
| Leme, CE | 1 |
| Ing, TS | 1 |
| Wrong, OM | 1 |
| Raman, PB | 1 |
| Sharma, DC | 1 |
| Dorfman, RI | 1 |
| Gleichmann, U | 1 |
| Bostroem, B | 1 |
| Kreuzer, H | 1 |
| Löhr, B | 1 |
| Teodosiev, LS | 1 |
| Hartog, M | 1 |
| Descovich, P | 1 |
| Descovich, GC | 1 |
| Brillante, C | 1 |
| Goding, JR | 1 |
| Wintour, M | 1 |
| Hickie, JB | 1 |
| Lazarus, L | 1 |
| Felt, V | 1 |
| Hänze, S | 1 |
| Pierach, CA | 1 |
| Kahnt, FW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevalence of Primary Aldosteronism in Patients With Stroke[NCT03789357] | 300 participants (Actual) | Observational | 2018-05-01 | Completed | |||
| Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate[NCT03990701] | Early Phase 1 | 25 participants (Actual) | Interventional | 2018-05-21 | Completed | ||
| Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism: Evaluation of the Blood Pressure Control and of Its Safety.[NCT02756754] | 31 participants (Actual) | Interventional | 2016-11-07 | Completed | |||
| 68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study[NCT05131061] | 100 participants (Actual) | Observational | 2021-11-11 | Completed | |||
| Multicenter Study on Use and Interpretation of Adrenal Vein Sampling[NCT01234220] | 2,604 participants (Actual) | Observational | 2010-05-31 | Completed | |||
| Characteristics Predicting Clinically Relevant Reduction of Hypertension Following Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis[NCT04761354] | 514 participants (Actual) | Observational | 2016-03-26 | Completed | |||
| Electronic Alert-Based Computerized Decision Support to Improve Testing For Primary Aldosteronism in Patients With Hypertension: ALERT-PA[NCT05925569] | 1,600 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | |||
| Resident Doctor, Master Degree Candidate[NCT05991856] | 45 participants (Anticipated) | Observational | 2020-01-01 | Recruiting | |||
| Preoperative Supine Time for Adrenal Venous Sampling: A Prospective Randomized Controlled Trial[NCT05658705] | 120 participants (Anticipated) | Interventional | 2023-03-29 | Recruiting | |||
| Efficacy and Safety of Percutaneous Superselective Adrenal Arterial Embolization in the Treatment of Primary Aldosteronism With Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study[NCT05186675] | 50 participants (Anticipated) | Interventional | 2022-01-01 | Enrolling by invitation | |||
| The Long-term Effect of Superselective Adrenal Arterial Embolization and Medical Treatment for Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile.[NCT05262660] | 400 participants (Anticipated) | Observational [Patient Registry] | 2022-04-01 | Not yet recruiting | |||
| LC-MS/MS-specific Cutoffs for Screening and Confirmatory Testing of Primary Aldosteronism: A Multi-center Study[NCT05959863] | 300 participants (Anticipated) | Observational | 2023-08-30 | Recruiting | |||
| Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension: the DYNAMIC-study[NCT01742702] | 2,000 participants (Anticipated) | Observational | 2006-05-25 | Recruiting | |||
| HyperAldosteronism in Pregnancy Predicted Impacts[NCT05636995] | 200 participants (Anticipated) | Observational [Patient Registry] | 2023-01-10 | Recruiting | |||
| Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas[NCT02362308] | 10 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Effectiveness and Safety of Superselective Adrenal Arterial Embolization (SAAE) for Resistant Hypertension: A Randomized, Parallel, Controlled Clinical Trial[NCT05552300] | 144 participants (Anticipated) | Interventional | 2022-10-01 | Not yet recruiting | |||
| An Open-label, Prospective, Controlled Clinical Trial on Effects and Safety of Adrenal Artery Ablation (Triple A) for Primary Aldosteronism[NCT03398785] | Phase 3 | 66 participants (Actual) | Interventional | 2017-10-01 | Completed | ||
| Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension[NCT05593055] | Phase 4 | 75 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | ||
| Prospective Assessment of The Prevalence of Primary Aldosteronism in Hypertensive Patients Presenting With Atrial Flutter or Fibrillation[NCT01267747] | 411 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA): A Study Of Personalized Diagnosis of Primary Aldosteronism With Implications For Treatment[NCT03414918] | 342 participants (Anticipated) | Interventional | 2018-03-31 | Not yet recruiting | |||
| Usefulness of the Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in the Subtype Diagnosis of Primary Aldosteronism[NCT04378387] | 60 participants (Actual) | Observational | 2005-01-01 | Completed | |||
| Effects of Mineralocorticoid and AT-1 Receptor Antagonism on the Aldosterone-Renin Ratio (ARR) In Primary Aldosteronism Patients (EMIRA Study): Rationale and Design[NCT04185857] | 50 participants (Actual) | Observational | 2018-01-01 | Completed | |||
| Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism The ADOPA Randomized Clinical Trial[NCT04461535] | 228 participants (Actual) | Interventional | 2020-07-08 | Completed | |||
| A Phase II, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Effects of LCI699 on Cortisol in Patients With Hypertension[NCT00817414] | Phase 2 | 63 participants (Actual) | Interventional | 2009-01-14 | Completed | ||
| A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Dose Finding Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo After 8 Weeks Treatment in Patients With Essential Hypertension[NCT00758524] | Phase 2 | 628 participants (Actual) | Interventional | 2008-09-11 | Completed | ||
| A Phase II, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group, Multi-center, Dose Ranging Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo After 8 Weeks Treatment in Patients With Resistant Hypertension[NCT00817635] | Phase 2 | 155 participants (Actual) | Interventional | 2008-12-22 | Completed | ||
| A Pilot, Single-blind, Forced-titration Study to Assess the Hemodynamic and Hormonal Effects, Safety and Tolerability of the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism[NCT00732771] | Phase 2 | 12 participants (Anticipated) | Interventional | 2008-06-30 | Completed | ||
| Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications[NCT01406015] | 38 participants (Actual) | Interventional | 2009-02-28 | Completed | |||
| Aldosterone and Glucose Homeostasis[NCT00732160] | 34 participants (Actual) | Interventional | 2008-09-30 | Completed | |||
| Caveolin-1 and Vascular Dysfunction[NCT01426529] | Phase 1 | 120 participants (Anticipated) | Interventional | 2010-10-01 | Active, not recruiting | ||
| Salt Sensitive Hypertension and Striatin[NCT03683069] | Phase 4 | 400 participants (Actual) | Interventional | 2019-01-15 | Active, not recruiting | ||
| Case Detection and Confirmation, Subtype Classification of Patients With Primary Aldosteronism[NCT02755519] | 300 participants (Actual) | Observational | 2014-05-31 | Completed | |||
| Case Detection and Confirmation, Subtype Classification of Patients With Primary Aldosteronism[NCT03500120] | 200 participants (Actual) | Observational | 2017-09-01 | Completed | |||
| Identification of New Biomarkers for the Classification and Monitoring of Difficult-to-treat Arterial Hypertension: Prospective Observational Study[NCT03034265] | 24 participants (Actual) | Observational | 2016-05-31 | Completed | |||
| Comparison of Saline Infusion Test, Captopril Challenge Test, and Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism[NCT04193137] | 200 participants (Actual) | Observational | 2019-11-30 | Completed | |||
| Prospective Evaluation of Confirmatory Testing For Primary Aldosteronism[NCT04422756] | 200 participants (Anticipated) | Observational | 2017-01-15 | Recruiting | |||
| Primary Aldosteronism In Hypertensive Patients in China[NCT03155139] | 3,500 participants (Actual) | Observational | 2017-06-03 | Completed | |||
| Changes in Tissue Potassium Amount Before and After Treatment of Primary Hyperaldosteronism Assessed by 39K-MRI[NCT04251780] | 10 participants (Anticipated) | Interventional | 2018-01-01 | Recruiting | |||
| Prospective Cross-sectional Study on Prevalence of Primary Aldosteronism in Resistant Hypertension and Association With Cardiometabolic Complications[NCT04213963] | 100 participants (Anticipated) | Observational | 2011-09-01 | Recruiting | |||
| The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale andDesign of A Randomized Study (I-PADUA)[NCT03449797] | 200 participants (Anticipated) | Interventional | 2018-04-01 | Not yet recruiting | |||
| Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Screening for Primary Aldosteronism：a Prospective Study[NCT04991961] | 330 participants (Anticipated) | Observational | 2020-09-15 | Recruiting | |||
| Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment - A Randomized Controlled Trial[NCT05797558] | 80 participants (Anticipated) | Interventional | 2023-04-28 | Recruiting | |||
| Hypertension in High School Students: Genetic and Environmental Factors[NCT06049641] | 2,638 participants (Actual) | Observational | 2014-10-31 | Completed | |||
| Chongqing Primary Aldosteronism Study[NCT03224312] | 1,500 participants (Anticipated) | Observational | 2016-10-01 | Recruiting | |||
| Towards Cost-effective Management of Patients With Hypertension Due to Primary Aldosteronism: Adrenal Vein Sampling or Ct-scan?[NCT01096654] | Phase 3 | 200 participants (Actual) | Interventional | 2010-07-31 | Completed | ||
| [NCT00917345] | 150 participants (Anticipated) | Observational | 2008-01-31 | Recruiting | |||
| Effect of Spironolactone on the Progression of Coronary Calcification in Peritoneal Dialysis Patients[NCT03314493] | Phase 3 | 33 participants (Actual) | Interventional | 2014-11-07 | Completed | ||
| The Influence of High and Low Salt on Exosomes in the Urine[NCT02823613] | 10 participants (Actual) | Interventional | 2016-08-31 | Completed | |||
| Genetic Epidemiology of Responses to Antihypertensives[NCT00005520] | 1,200 participants (Actual) | Observational | 1997-02-28 | Completed | |||
| The Prevalence and the Prognosis of Resistant Hypertension Ascertained With Systemic Investigation and Optimal Treatment With Antihypertensive Drugs[NCT01703780] | 9,638 participants (Actual) | Observational | 2012-07-31 | Active, not recruiting | |||
| Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism[NCT00173082] | 100 participants (Anticipated) | Observational | 2005-06-30 | Recruiting | |||
| Aldosterone-Renin Ratio to Diagnose Primary Aldosteronism in a Population of Patients With Therapy-Resistant Hypertension: Test Characteristics, Diagnostic Value and Predictive Value for Antihypertensive Treatment. The Dutch ARRAT Study.[NCT00407784] | 500 participants | Observational | 2007-01-31 | Recruiting | |||
| A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients[NCT04515095] | 30 participants (Actual) | Interventional | 2020-08-16 | Completed | |||
| Genes of Hypertension in African Americans[NCT00063505] | 5,000 participants (Actual) | Observational | 2002-12-31 | Completed | |||
| The Role of Aldosterone on Sympathetic Nerve Activity and Insulin Sensitivity[NCT02102243] | Phase 4 | 0 participants (Actual) | Interventional | 2010-11-30 | Withdrawn (stopped due to No longer interested in study topic) | ||
| Postoperative Cardiovascular Index Change of Primary Aldosteronism[NCT00746070] | 300 participants (Actual) | Observational | 2007-01-31 | Enrolling by invitation | |||
| Effects of Nebivolol Versus Metoprolol on Blood Flow Responses to Exercise and Angiotensin II in Hypertensive Patients[NCT01502787] | Phase 4 | 46 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
| [NCT00005138] | 0 participants | Observational | 1976-06-30 | Completed | |||
| A Clinical Trial of Renin Profiling in Selection of Initial Antihypertensive Drug[NCT00834600] | 185 participants (Actual) | Interventional | 2005-12-31 | Completed | |||
| Anesthesia for Upper Endoscopy and Colonoscopy in Cardiac Patients With Acute Anemia: Pretreatment With Low-dose Ketamine Can Reduce the Dose of Etomidate. A Randomized Clinical Trial.[NCT04857450] | 60 participants (Anticipated) | Interventional | 2020-11-20 | Recruiting | |||
| [NCT00005394] | 0 participants | Observational | 1995-08-31 | Completed | |||
| Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue[NCT00005927] | 690 participants (Actual) | Observational | 2002-07-01 | Completed | |||
| [NCT00155064] | Phase 4 | 100 participants (Anticipated) | Interventional | 2002-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00817414)
Timeframe: Days 7, 28: Pre-dose and 3 hours post-dose; Day 30: Pre-dose; Day 42: Pre-dose and 0.5, 1, 2, 3, 4, and 8-hours post-dose
| Intervention | hr (Geometric Mean) |
|---|---|
| Cohort A: LCI699 0.5 mg QD | 4.67 |
| Cohort A: LCI699 1.0 mg QD | 3.79 |
| Cohort B1: LCI699 1.0 mg BID | 5.52 |
| Cohort B1: LCI699 2.0 mg QD | 4.90 |
(NCT00817414)
Timeframe: Day 42: Pre-dose and 0.5, 1, 2, 3, 4, and 8-hours post-dose
| Intervention | nanogram*hour per milliliter (ng*hr/mL) (Geometric Mean) |
|---|---|
| Cohort A: LCI699 0.5 mg QD | 6.60 |
| Cohort A: LCI699 1.0 mg QD | 14.1 |
| Cohort B1: LCI699 1.0 mg BID | 24.1 |
| Cohort B1: LCI699 2.0 mg QD | 46.4 |
(NCT00817414)
Timeframe: Days 7, 28: Pre-dose and 3 hours post-dose; Day 30: Pre-dose; Day 42: Pre-dose and 0.5, 1, 2, 3, 4, and 8-hours post-dose
| Intervention | ng*hr/mL (Geometric Mean) |
|---|---|
| Cohort A: LCI699 0.5 mg QD | 9.23 |
| Cohort A: LCI699 1.0 mg QD | 18.8 |
| Cohort B1: LCI699 1.0 mg BID | 30.6 |
| Cohort B1: LCI699 2.0 mg QD | 68.9 |
(NCT00817414)
Timeframe: Predose and 3 hours post-dose on Day 7
| Intervention | nanogram per milliliter (ng/mL) (Geometric Mean) |
|---|---|
| Cohort A: LCI699 0.5 mg QD | 1.51 |
| Cohort A: LCI699 1.0 mg QD | 2.88 |
| Cohort B1: LCI699 1.0 mg BID | 3.92 |
| Cohort B1: LCI699 2.0 mg QD | 6.73 |
(NCT00817414)
Timeframe: Days 7, 28: Pre-dose and 3 hours post-dose; Day 30: Pre-dose; Day 42: Pre-dose and 0.5, 1, 2, 3, 4, and 8-hours post-dose
| Intervention | ng/mL (Geometric Mean) |
|---|---|
| Cohort A: LCI699 0.5 mg QD | 1.42 |
| Cohort A: LCI699 1.0 mg QD | 2.94 |
| Cohort B1: LCI699 1.0 mg BID | 4.62 |
| Cohort B1: LCI699 2.0 mg QD | 8.86 |
As per the protocol, MTD is the dose at which 4 participants exhibited ACTH-stimulated cortisol results <400 nanomoles per liter (nmol/L). The change in the distribution across the treatments were analyzed using 1- way analysis of variance (ANOVA) for continuous variables. (NCT00817414)
Timeframe: Up to Week 6
| Intervention | milligrams (mg) (Number) |
|---|---|
| LCI699 | 1.30 |
An AE is an adverse medical event which occurs in a participant of the study and which is not necessarily in a causal relationship with the treatment the participant receives. (NCT00817414)
Timeframe: Up to 8 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Cohort A: LCI699 0.5 mg QD | 6 |
| Cohort A: LCI699 1 mg QD | 9 |
| Cohort B1: LCI699 1 mg BID | 10 |
| Cohort B1: LCI699 2 mg QD | 10 |
| Placebo | 10 |
(NCT00817414)
Timeframe: Days 7, 28: Pre-dose and 3 hours post-dose; Day 30: Pre-dose; Day 42: Pre-dose and 0.5, 1, 2, 3, 4, and 8-hours post-dose
| Intervention | hour (hr) (Median) |
|---|---|
| Cohort A: LCI699 0.5 mg QD | 2.21 |
| Cohort A: LCI699 1.0 mg QD | 1.00 |
| Cohort B1: LCI699 1.0 mg BID | 1.00 |
| Cohort B1: LCI699 2.0 mg QD | 1.00 |
Exposure-response relationship was assessed using ACTH stimulation test. Tests were done 2 hours after study drug administration (i.e., at peak LCI699 concentrations). An increase in cortisol greater than >500 nmol at 60 minutes after ACTH administration was expected. (NCT00817414)
Timeframe: Up to Week 6
| Intervention | nanomoles per liter (nmol/L) (Mean) | ||
|---|---|---|---|
| Day 7 | Day 28 | Day 42 | |
| Cohort A: LCI699 0.5 mg QD | 690.0 | 634.87 | 647.51 |
| Cohort A: LCI699 1.0 mg QD | 669.40 | 573.41 | 626.08 |
| Cohort B1: LCI699 1.0 mg BID | 625.06 | 554.79 | 539.68 |
| Cohort B1: LCI699 2.0 mg QD | 562.04 | 539.09 | 479.91 |
| Placebo | 799.06 | 804.86 | 812.91 |
Automated arterial BP determinations was made with an automated BP device (such as the Omron BP monitor) in accordance with the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV. Sitting and standing BP and HR measurements were performed. MSDBP response was defined as the percentage of participants with a MSDBP <90 mmHg or a >= 10 mmHg reduction from baseline. MSDBP control was defined as the percentage of participants with a MSDBP <90 mmHg for non-diabetic participants and <80mHg for diabetic participants. (NCT00817414)
Timeframe: Week 6
| Intervention | percentage of participants (Number) | |
|---|---|---|
| MSDBP Response | MSDBP Control | |
| Cohort A: LCI699 0.5 mg QD | 58.3 | 58.3 |
| Cohort A: LCI699 1 mg QD | 66.7 | 66.7 |
| Cohort B1: LCI699 1 mg BID | 100 | 76.9 |
| Cohort B1: LCI699 2 mg QD | 76.9 | 76.9 |
| Placebo | 61.5 | 46.2 |
Automated arterial BP determinations was made with an automated BP device (such as the Omron BP monitor) in accordance with the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV. Sitting and standing blood pressure (BP) and heart rate (HR) measurements were performed. MSSBP response was defined as the percentage of participants with a MSSBP <140 mmHg or a >=20 mmHg reduction from baseline. MSSBP control was defined as the percentage of participants with a MSSBP <140 mmHg for non-diabetic participants and <130mHg for diabetic participants. (NCT00817414)
Timeframe: Week 6
| Intervention | percentage of participants (Number) | |
|---|---|---|
| MSSBP Response | MSSBP Control | |
| Cohort A: LCI699 0.5 mg QD | 58.3 | 50.0 |
| Cohort A: LCI699 1 mg QD | 50.0 | 41.7 |
| Cohort B1: LCI699 1 mg BID | 69.2 | 61.5 |
| Cohort B1: LCI699 2 mg QD | 76.9 | 76.9 |
| Placebo | 61.5 | 53.8 |
An ABPM measured a participant's BP over a 24-hour period readings using an automated validated monitoring device from Baseline to Week 8. The 24-hour DBP was calculated by taking the mean of all ambulatory DBP readings for the 24-hour period. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | mm Hg (Least Squares Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | -4.03 |
| Core Period: LCI699 0.5 mg QD | -2.44 |
| Core Period: LCI699 1.0 mg QD | -4.96 |
| Core Period: LCI699 0.5 mg BID | -2.75 |
| Core Period: Eplerenone 50 mg BID | -6.03 |
| Core Period: Placebo | 1.03 |
An ABPM measured a participant's BP over a 24-hour period readings using an automated validated monitoring device from Baseline to Week 8. The 24-hour SBP was calculated by taking the mean of all ambulatory SBP readings for the 24-hour period. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | mm Hg (Least Squares Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | -7.15 |
| Core Period: LCI699 0.5 mg QD | -4.90 |
| Core Period: LCI699 1.0 mg QD | -7.73 |
| Core Period: LCI699 0.5 mg BID | -6.18 |
| Core Period: Eplerenone 50 mg BID | -10.52 |
| Core Period: Placebo | 1.11 |
Automated arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV, using an automated BP device (such as the Omron BP monitor). The change in the MSDBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from baseline in MSDBP was analyzed using an analysis of covariance model (ANCOVA) with treatment and region as factors and baseline MSDBP level as a covariate. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | mm Hg (Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | -4.47 |
| Core Period: LCI699 0.5 mg QD | -5.50 |
| Core Period: LCI699 1.0 mg QD | -7.11 |
| Core Period: LCI699 0.5 mg BID | -4.25 |
| Core Period: Eplerenone 50 mg BID | -7.49 |
| Core Period: Placebo | -3.22 |
Automated arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV, using an automated BP device (such as the Omron BP monitor). The change in the MSSBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from baseline in MSSBP was analyzed using an ANCOVA with treatment and region as factors and baseline MSSBP levels as a covariate. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | mm Hg (Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | -9.00 |
| Core Period: LCI699 0.5 mg QD | -10.69 |
| Core Period: LCI699 1.0 mg QD | -11.93 |
| Core Period: LCI699 0.5 mg BID | -9.10 |
| Core Period: Eplerenone 50 mg BID | -13.31 |
| Core Period: Placebo | -2.93 |
Change from baseline was analyzed using plasma aldosterone values measured at Baseline and Week 8. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | picomoles per liter (pmol/L) (Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | -21.5 |
| Core Period: LCI699 0.5 mg QD | -20.0 |
| Core Period: LCI699 1.0 mg QD | -9.9 |
| Core Period: LCI699 0.5 mg BID | -47.5 |
| Core Period: Eplerenone 50 mg BID | 277.1 |
| Core Period: Placebo | -28.8 |
The ACTH stimulation cortisol test was a standard procedure to measure the ability of adrenal cortex to respond to exogenous ACTH and directly assess the adrenal reserve. Serum cortisol concentrations at 1 hour after injection were measured to assess the maximum stimulated cortisol level achieved. Potential adrenal suppression was indicated if the serum cortisol concentration was <500 nanomoles per liter (nmol/L) at 1 hour after the injection. (NCT00758524)
Timeframe: Baseline, 1 hour post-dose at Week 8
| Intervention | nanomoles per liter (nmol/L) (Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | 729.20 |
| Core Period: LCI699 0.5 mg QD | 692.74 |
| Core Period: LCI699 1.0 mg QD | 604.46 |
| Core Period: LCI699 0.5 mg BID | 609.21 |
| Core Period: Eplerenone 50 mg BID | 802.32 |
| Core Period: Placebo | 822.65 |
Automated arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV, using an automated BP device (such as the Omron BP monitor). The change in the MSDBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from baseline in MSDBP was analyzed using an analysis of covariance model (ANCOVA) with treatment and region as factors and baseline MSDBP level as a covariate. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | mm Hg (Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | -4.47 |
| Core Period: LCI699 0.5 mg QD | -5.50 |
| Core Period: LCI699 1.0 mg QD | -7.11 |
| Core Period: LCI699 0.5 mg BID | -4.25 |
Automated arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV, using an automated BP device (such as the Omron BP monitor). The change in the MSSBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from baseline in MSSBP was analyzed using an ANCOVA with treatment and region as factors and baseline MSSBP levels as a covariate. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | mm Hg (Mean) |
|---|---|
| Core Period: LCI699 0.25 mg QD | -9.00 |
| Core Period: LCI699 0.5 mg QD | -10.69 |
| Core Period: LCI699 1.0 mg QD | -11.93 |
| Core Period: LCI699 0.5 mg BID | -9.10 |
Automated arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV, using an automated BP device (such as the Omron BP monitor). The change in the MSDBP was calculated comparing the Week 9 readings to the readings taken at Week 8 (Baseline). The change from Week 8 to week 9 in MSDBP was analyzed using an ANCOVA with treatment and region as factors and Week 8 MSDBP level as a covariate. (NCT00758524)
Timeframe: From Week 8 to Week 9
| Intervention | mm Hg (Least Squares Mean) |
|---|---|
| Withdrawal Period: LCI699 0.25 mg QD | 0.5 |
| Withdrawal Period: LCI699 0.25 mg QD Placebo | 0.5 |
| Withdrawal Period: LCI699 0.5 mg QD | 1.6 |
| Withdrawal Period: LCI699 0.5 mg QD Placebo | -0.2 |
| Withdrawal Period: LCI699 1.0 mg QD | -0.5 |
| Withdrawal Period: LCI699 1.0 mg QD Placebo | 2.5 |
| Withdrawal Period: LCI699 0.5 mg BID | 1.3 |
| Withdrawal Period: LCI699 0.5 mg BID Placebo | 1.3 |
| Withdrawal Period: Eplerenone 50 mg BID | -1.2 |
| Withdrawal Period: Eplerenone 50 mg BID Placebo | 0.4 |
| Withdrawal Period: Placebo | 1.6 |
Automated arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the Guidelines for management of hypertension: report of the 4th working party of the British Hypertension Society, 2004-BHS IV, using an automated BP device (such as the Omron BP monitor). The change in the MSSBP was calculated comparing the Week 9 readings to the readings taken at Week 8 (Baseline). The change from Week 8 to week 9 in MSSBP was analyzed using an ANCOVA with treatment and region as factors and Week 8 MSSBP level as a covariate. (NCT00758524)
Timeframe: From Week 8 to Week 9
| Intervention | mm Hg (Least Squares Mean) |
|---|---|
| Withdrawal Period: LCI699 0.25 mg QD | 0.3 |
| Withdrawal Period: LCI699 0.25 mg QD Placebo | 3.3 |
| Withdrawal Period: LCI699 0.5 mg QD | 0.5 |
| Withdrawal Period: LCI699 0.5 mg QD Placebo | 2.5 |
| Withdrawal Period: LCI699 1.0 mg QD | 0.4 |
| Withdrawal Period: LCI699 1.0 mg QD Placebo | 5.3 |
| Withdrawal Period: LCI699 0.5 mg BID | 1.6 |
| Withdrawal Period: LCI699 0.5 mg BID Placebo | 4.4 |
| Withdrawal Period: Eplerenone 50 mg BID | -1.5 |
| Withdrawal Period: Eplerenone 50 mg BID Placebo | 2.7 |
| Withdrawal Period: Placebo | 1.8 |
An AE was an adverse medical event which occurs in a participant of the study and which is not necessarily in a causal relationship with the treatment the participant receives. SAEs were AEs leading to death, are life-threatening, require hospitalizations or prolongation of hospitalizations, represent an innate malformation or a congenital abnormality. (NCT00758524)
Timeframe: AEs: From start of the study drug treatment up to 8 weeks; SAE: From signing of the informed consent up to 8 weeks
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| AEs | SAEs | Deaths | |
| Core Period: Eplerenone 50 mg BID | 26 | 0 | 0 |
| Core Period: LCI699 0.25 mg QD | 23 | 1 | 0 |
| Core Period: LCI699 0.5 mg BID | 27 | 0 | 0 |
| Core Period: LCI699 0.5 mg QD | 22 | 0 | 0 |
| Core Period: LCI699 1.0 mg QD | 24 | 0 | 0 |
| Core Period: Placebo | 23 | 1 | 0 |
MSDBP response was defined as the percentage of participants with a MSDBP <90 mmHg or a >=10 mmHg reduction from Baseline. MSDBP control was defined as the percentage of participants with a MSDBP <90 mmHg. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | percentage of participants (Number) | |
|---|---|---|
| MSDBP Response | MSDBP Control | |
| Core Period: Eplerenone 50 mg BID | 48.8 | 45.2 |
| Core Period: LCI699 0.25 mg QD | 39.1 | 32.6 |
| Core Period: LCI699 0.5 mg BID | 34.4 | 29.2 |
| Core Period: LCI699 0.5 mg QD | 34.1 | 29.4 |
| Core Period: LCI699 1.0 mg QD | 50.0 | 41.9 |
| Core Period: Placebo | 27.6 | 18.4 |
MSSBP response was defined as the percentage of participants with a MSSBP <140 mmHg or a >=20 mmHg reduction from baseline reduction from baseline. MSSBP control was defined as the percentage of participants with a MSSBP <140 mmHg. (NCT00758524)
Timeframe: Baseline, Week 8
| Intervention | percentage of participants (Number) | |
|---|---|---|
| MSSBP Response | MSSBP Control | |
| Core Period: Eplerenone 50 mg BID | 52.4 | 44.0 |
| Core Period: LCI699 0.25 mg QD | 39.1 | 31.5 |
| Core Period: LCI699 0.5 mg BID | 34.4 | 25.0 |
| Core Period: LCI699 0.5 mg QD | 37.6 | 27.1 |
| Core Period: LCI699 1.0 mg QD | 48.8 | 40.7 |
| Core Period: Placebo | 17.1 | 15.8 |
Trough to peak ratios were derived from an ANCOVA model containing treatment, region, hour, treatment by hour interaction as factors with Baseline as a covariate. (NCT00758524)
Timeframe: Baseline, every hour up to 24 hours post-dose at Week 8
| Intervention | ratio (Least Squares Mean) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 8, Hour 1 | Week 8, Hour 2 | Week 8, Hour 3 | Week 8, Hour 4 | Week 8, Hour 5 | Week 8, Hour 6 | Week 8, Hour 7 | Week 8, Hour 8 | Week 8, Hour 9 | Week 8, Hour 10 | Week 8, Hour 11 | Week 8, Hour 12 | Week 8, Hour 13 | Week 8, Hour 14 | Week 8, Hour 15 | Week 8, Hour 16 | Week 8, Hour 17 | Week 8, Hour 18 | Week 8, Hour 19 | Week 8, Hour 20 | Week 8, Hour 21 | Week 8, Hour 22 | Week 8, Hour 23 | Week 8, Hour 24 | |
| Core Period: Eplerenone 50 mg BID | 0.17 | -1.65 | -2.42 | -1.39 | -2.91 | -4.86 | -3.70 | -2.30 | -2.81 | -2.43 | -1.93 | -3.20 | -5.35 | -7.64 | -9.03 | -12.55 | -12.88 | -13.49 | -10.13 | -10.47 | -10.51 | -7.60 | -5.54 | -2.78 |
| Core Period: LCI699 0.25 mg QD | 3.91 | 1.44 | 1.16 | 0.51 | 1.11 | -1.18 | -1.85 | -3.01 | -1.24 | -0.59 | -1.02 | -1.60 | -4.32 | -6.47 | -8.34 | -8.92 | -10.26 | -10.68 | -10.13 | -10.73 | -9.31 | -7.90 | -4.94 | -0.21 |
| Core Period: LCI699 0.5 mg BID | 3.87 | 3.44 | 4.01 | 2.64 | 1.45 | 1.20 | 1.21 | 2.09 | 3.27 | 0.49 | 1.54 | -1.06 | -1.45 | -2.96 | -6.10 | -9.54 | -10.38 | -11.85 | -10.78 | -10.49 | -8.22 | -6.35 | -2.67 | 1.36 |
| Core Period: LCI699 0.5 mg QD | 2.95 | 1.85 | 1.13 | 2.91 | -0.02 | -2.36 | -0.95 | -1.38 | -0.07 | 2.60 | 1.72 | 2.53 | -1.20 | -3.29 | -5.82 | -8.37 | -10.99 | -11.73 | -10.12 | -8.06 | -7.68 | -4.93 | -1.93 | 1.45 |
| Core Period: LCI699 1.0 mg QD | 0.27 | 0.17 | -0.36 | 0.35 | -1.69 | -3.01 | -2.63 | -2.43 | -2.25 | -1.65 | -1.54 | -3.10 | -5.31 | -7.38 | -8.89 | -10.50 | -12.71 | -11.88 | -9.74 | -10.43 | -9.66 | -5.37 | -1.18 | 0.29 |
| Core Period: Placebo | 7.11 | 6.28 | 4.99 | 7.02 | 4.31 | 1.82 | 3.62 | 2.65 | 3.30 | 3.86 | 2.38 | 3.24 | 1.52 | -0.90 | -1.01 | -1.61 | -4.20 | -6.89 | -5.84 | -5.21 | -4.12 | -1.09 | 1.82 | 1.98 |
Trough to peak ratios were derived from an ANCOVA model containing treatment, region, hour, treatment by hour interaction as factors with Baseline as a covariate. (NCT00758524)
Timeframe: Baseline, every hour up to 24 hours post-dose at Week 8
| Intervention | ratio (Least Squares Mean) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 8, Hour 1 | Week 8, Hour 2 | Week 8, Hour 3 | Week 8, Hour 4 | Week 8, Hour 5 | Week 8, Hour 6 | Week 8, Hour 7 | Week 8, Hour 8 | Week 8, Hour 9 | Week 8, Hour 10 | Week 8, Hour 11 | Week 8, Hour 12 | Week 8, Hour 13 | Week 8, Hour 14 | Week 8, Hour 15 | Week 8, Hour 16 | Week 8, Hour 17 | Week 8, Hour 18 | Week 8, Hour 19 | Week 8, Hour 20 | Week 8, Hour 21 | Week 8, Hour 22 | Week 8, Hour 23 | Week 8, Hour 24 | |
| Core Period: Eplerenone 50 mg BID | -5.33 | -5.90 | -5.89 | -5.12 | -7.22 | -7.91 | -8.70 | -8.06 | -7.46 | -7.35 | -5.75 | -6.25 | -8.81 | -10.91 | -12.04 | -16.68 | -19.59 | -18.55 | -15.49 | -16.09 | -15.34 | -12.47 | -9.02 | -8.90 |
| Core Period: LCI699 0.25 mg QD | -0.54 | -1.59 | -2.11 | -2.06 | -4.29 | -4.21 | -4.95 | -5.28 | -3.98 | -3.69 | -2.47 | -5.19 | -6.45 | -7.37 | -10.61 | -11.71 | -13.71 | -14.49 | -13.78 | -13.92 | -14.33 | -13.46 | -7.88 | -3.16 |
| Core Period: LCI699 0.5 mg BID | -1.42 | -0.57 | 0.91 | 1.50 | -1.70 | -1.02 | -0.76 | -3.02 | -1.87 | -1.73 | -1.74 | -3.92 | -4.05 | -6.12 | -9.78 | -13.03 | -13.72 | -15.60 | -15.93 | -15.47 | -13.63 | -10.55 | -6.73 | -3.76 |
| Core Period: LCI699 0.5 mg QD | 0.09 | 0.15 | -1.53 | -1.18 | -3.09 | -3.12 | -2.10 | -4.69 | -1.59 | -0.30 | -0.43 | 0.73 | -2.30 | -5.68 | -8.28 | -10.01 | -11.96 | -14.37 | -13.08 | -13.22 | -10.06 | -8.35 | -6.23 | -0.64 |
| Core Period: LCI699 1.0 mg QD | -4.51 | -3.56 | -4.86 | -4.15 | -3.47 | -5.88 | -5.40 | -5.30 | -4.78 | -3.40 | -4.22 | -4.35 | -7.25 | -9.33 | -11.26 | -12.63 | -15.46 | -14.54 | -12.85 | -12.54 | -12.78 | -7.52 | -5.77 | -3.45 |
| Core Period: Placebo | 8.23 | 6.48 | 4.60 | 4.68 | 2.78 | 1.42 | 2.25 | 3.76 | 2.39 | 2.54 | 3.51 | 4.69 | 3.20 | 0.75 | 0.02 | -0.33 | -3.03 | -6.35 | -6.98 | -6.53 | -3.89 | -0.94 | 2.18 | 0.70 |
Arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the American Heart Association guidelines using a calibrated standard aneroid or mercury sphygmomanometer or a calibrated standard sphygmomanometer. The change in the MSDBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from Baseline in MSDBP was analyzed using an ANCOVA with treatment and country as factors and Baseline MSDBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | mmHg (Mean) |
|---|---|
| LCI699 0.25 mg BID | -4.5 |
| LCI699 1 mg QD | -6.0 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -6.1 |
| Eplerenone 50 mg BID | -7.7 |
| Placebo | -4.8 |
Arterial blood pressure (BP) determinations were made after the participant was in the sitting position for 5 minutes according to the American Heart Association guidelines using a calibrated standard aneroid or mercury sphygmomanometer or a calibrated standard sphygmomanometer. The change in the MSSBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from Baseline in MSSBP was analyzed using an analysis of covariance model (ANCOVA) with treatment and country as factors and Baseline MSSBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | mmHg (Mean) |
|---|---|
| LCI699 0.25 mg BID | -11.4 |
| LCI699 1 mg QD | -13.1 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -12.5 |
| Eplerenone 50 mg BID | -18.7 |
| Placebo | -8.8 |
Arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the American Heart Association guidelines using a calibrated standard aneroid or mercury sphygmomanometer or a calibrated standard sphygmomanometer. The change in the MSDBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from Baseline in MSDBP was analyzed using an ANCOVA with treatment and country as factors and Baseline MSDBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | mmHg (Mean) |
|---|---|
| LCI699 0.25 mg BID | -4.5 |
| LCI699 1 mg QD | -6.0 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -6.1 |
Arterial BP determinations were made after the participant was in the sitting position for 5 minutes according to the American Heart Association guidelines using a calibrated standard aneroid or mercury sphygmomanometer or a calibrated standard sphygmomanometer. The change in the MSSBP was calculated comparing the Week 8 readings to the readings taken at Baseline. The change from Baseline in MSSBP was analyzed using an ANCOVA with treatment and country as factors and Baseline MSSBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | mmHg (Mean) |
|---|---|
| LCI699 0.25 mg BID | -11.4 |
| LCI699 1 mg QD | -13.1 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -12.5 |
Serum cortisol concentrations at 1 hour after injection were measured to assess the maximum stimulated cortisol level achieved. Potential adrenal suppression was indicated if the serum cortisol concentration was <500 nanomoles per liter (nmol/L) at 1 hour after the injection. (NCT00817635)
Timeframe: 1-hour post-dose at Week 8
| Intervention | Participants (Count of Participants) |
|---|---|
| LCI699 0.25 mg BID | 0 |
| LCI699 1 mg QD | 1 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | 4 |
| Eplerenone 50 mg BID | 0 |
| Placebo | 0 |
Percent change from Baseline was analyzed by ANCOVA model using active renin values measured at Baseline and Week 8 LOCF, with treatment and country as factors and Baseline value as the covariate. Negative percent change from Baseline shows improvement. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | percent change in ARC (Geometric Least Squares Mean) |
|---|---|
| LCI699 0.25 mg BID | 73.1 |
| LCI699 1 mg QD | 72.8 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | 156.4 |
| Eplerenone 50 mg BID | 430.6 |
Percent change from Baseline was analyzed by ANCOVA model using plasma renin values measured at Baseline and Week 8 LOCF, with treatment and country as factors and Baseline value as the covariate. Negative percent change from Baseline shows improvement. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | percent change in PRA (Geometric Least Squares Mean) |
|---|---|
| LCI699 0.25 mg BID | 41.6 |
| LCI699 1 mg QD | 74.3 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | 107.7 |
| Eplerenone 50 mg BID | 414.1 |
Percent change from Baseline was analyzed by ANCOVA model using percent ratio of PA to PRA values measured at Baseline and Week 8 LOCF, with treatment and country as factors and Baseline value as the covariate. Negative percent change from Baseline shows improvement. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | percent change in ratio of PA to PRA (Geometric Least Squares Mean) |
|---|---|
| LCI699 0.25 mg BID | -46.7 |
| LCI699 1 mg QD | -50.0 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -78.3 |
| Eplerenone 50 mg BID | -57.1 |
Percent change from Baseline was analyzed by ANCOVA model using PA values measured at Baseline and Week 8 LOCF, with treatment and country as factors and Baseline value as the covariate. Negative percent change from Baseline shows improvement. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | percent change in aldosterone (Geometric Least Squares Mean) |
|---|---|
| LCI699 0.25 mg BID | -22.3 |
| LCI699 1 mg QD | -30.4 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -53.1 |
| Eplerenone 50 mg BID | 115.0 |
An ABPM measured a participant's blood pressure over a 24-hour period including daytime and nighttime readings using an automated validated monitoring device from Baseline to Week 4. The 24-hour DBP was calculated by taking the mean of all ambulatory diastolic blood pressure readings for the 24-hour period. The change from Baseline in DBP was analyzed using an ANCOVA with treatment and country as factors and Baseline MSDBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 4
| Intervention | mmHg (Mean) | ||
|---|---|---|---|
| 24-hour Mean DBP | Daytime Mean DBP | Nighttime Mean DBP | |
| LCI699 0.5 mg BID | -2.5 | -2.6 | -2.8 |
| LCI699 1 mg QD | -4.3 | -3.9 | -4.5 |
An ABPM measured a participant's blood pressure over a 24-hour period including daytime and nighttime readings, using an automated validated monitoring device from Baseline to Week 8. The 24-hour DBP was calculated by taking the mean of all ambulatory diastolic blood pressure readings for the 24-hour period. The change from Baseline in DBP was analyzed using an ANCOVA with treatment and country as factors and Baseline MSDBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | mmHg (Mean) | ||
|---|---|---|---|
| 24-hour Mean DBP | Daytime Mean DBP | Nighttime Mean DBP | |
| Eplerenone 50 mg BID | -9.6 | -9.5 | -9.6 |
| LCI699 0.25 mg BID | 1.0 | 0.6 | 1.9 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -3.7 | -3.4 | -4.6 |
| LCI699 1 mg QD | -3.4 | -3.6 | -2.5 |
| Placebo | -0.2 | -0.8 | 1.2 |
An ABPM measured a participant's blood pressure over a 24-hour period including daytime and nighttime readings using an automated validated monitoring device from Baseline to Week 4. The 24-hour SBP was calculated by taking the mean of all ambulatory systolic blood pressure readings for the 24-hour period. The change from Baseline in SBP was analyzed using an ANCOVA with treatment and country as factors and Baseline MSDBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 4
| Intervention | mmHg (Mean) | ||
|---|---|---|---|
| 24-hour Mean SBP | Daytime Mean SBP | Nighttime Mean SBP | |
| LCI699 0.5 mg BID | -4.7 | -5.3 | -4.5 |
| LCI699 1 mg QD | -7.8 | -8.1 | -6.8 |
An ABPM measured a participant's blood pressure over a 24-hour period including daytime and nighttime readings, using an automated validated monitoring device from Baseline to Week 8. The 24-hour SBP was calculated by taking the mean of all ambulatory systolic blood pressure readings for the 24-hour period. The change from Baseline in SBP was analyzed using ANCOVA with treatment and country as factors and Baseline MSSBP as a covariate. (NCT00817635)
Timeframe: Baseline, Week 8
| Intervention | mmHg (Mean) | ||
|---|---|---|---|
| 24-hour Mean SBP | Daytime Mean SBP | Nighttime Mean SBP | |
| Eplerenone 50 mg BID | -15.7 | -15.7 | -15.4 |
| LCI699 0.25 mg BID | -4.4 | -4.9 | -3.2 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | -6.3 | -6.3 | -7.0 |
| LCI699 1 mg QD | -5.7 | -6.0 | -4.8 |
| Placebo | -1.0 | -1.6 | 0.4 |
An AE was an adverse medical event which occurs in a participant of the study and which is not necessarily in a causal relationship with the treatment the participant receives. SAEs were AEs leading to death, are life-threatening, require hospitalizations or prolongation of hospitalizations, represent an innate malformation or a congenital abnormality. Hyperkalemia was defined as potassium level >5.5 millimoles per liter (mmol/L). It is the medical term that describes a potassium level that's higher than normal. Hyponatremia was defined as sodium level <135 mmol/L. It is the medical term that describes a sodium level that's lesser than normal. (NCT00817635)
Timeframe: AEs, Hyperkalemia, and Hyponatremia: From start of the study drug treatment up to 10 weeks; SAE: From signing of the informed consent up to 10 weeks
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| AE(s) | SAE(s) | Hyperkalemia [potassium level >5.5 mmol/L] | Hyperkalemia [potassium level ≥6.0 mmol/L] | Hyponatremia [sodium level <130 and ≥125 mmol/L] | Hyponatremia [sodium level <135 mmol/L and ≥130mmol/L] | |
| Eplerenone 50 mg BID | 13 | 1 | 0 | 0 | 1 | 3 |
| LCI699 0.25 mg BID | 15 | 0 | 2 | 2 | 0 | 3 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | 8 | 0 | 0 | 0 | 0 | 7 |
| LCI699 1 mg QD | 15 | 0 | 0 | 0 | 0 | 2 |
| Placebo | 16 | 0 | 1 | 0 | 0 | 2 |
MSDBP response was defined as the percentage of participants with a MSDBP <90 mmHg or a >=10 mmHg reduction from baseline. MSDBP control was defined as the percentage of participants with a MSDBP <90 mmHg for non-diabetic participants and <80mHg for diabetic participants. (NCT00817635)
Timeframe: Week 8
| Intervention | percentage of participants (Number) | |
|---|---|---|
| MSDBP Response | MSDBP Control | |
| Eplerenone 50 mg BID | 71.9 | 56.3 |
| LCI699 0.25 mg BID | 67.7 | 54.8 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | 71.0 | 58.1 |
| LCI699 1 mg QD | 73.1 | 65.4 |
| Placebo | 57.6 | 54.5 |
MSSBP response was defined as the percentage of participants with a MSSBP <140 mmHg or a >=20 mmHg reduction from baseline reduction from baseline. MSSBP control was defined as the percentage of participants with a MSSBP <140 mmHg for non-diabetic participants and <130mHg for diabetic participants. (NCT00817635)
Timeframe: Week 8
| Intervention | percentage of participants (Number) | |
|---|---|---|
| MSSBP Response | MSSBP Control | |
| Eplerenone 50 mg BID | 65.6 | 53.1 |
| LCI699 0.25 mg BID | 54.8 | 51.6 |
| LCI699 0.5 mg Followed by LCI699 1 mg BID | 41.9 | 32.3 |
| LCI699 1 mg QD | 57.7 | 50.0 |
| Placebo | 42.4 | 36.4 |
Insulin resistance was measured using the 75 G glucose tolerance test. Participants ingested 75 grams of glucose in 300-400 mL of water over 5 minutes. Blood samples were taken before ingesting glucose and then every 30 minutes for 120 minutes. HOMA-IR was calculated using the Insulin and glucose levels obtained. A negative change (decrease in insulin resistance) indicates improvement. (NCT01406015)
Timeframe: Baseline and Week 6 (Prior to ingesting glucose and every 30 minutes for 120 minutes)
| Intervention | IR index (Mean) | |
|---|---|---|
| Baseline | Change from Baseline at Week 6 | |
| Placebo | 3.4 | 0.1 |
| Spironolactone | 2.7 | 0.1 |
Insulin sensitivity was measured using the 75 gram (G) glucose tolerance test. Participants ingested 75 grams of glucose in 300-400 milliliters (mL) of water over 5 minutes. Blood samples were taken before ingesting glucose and then every 30 minutes for 120 minutes. Insulin sensitivity index was calculated by Matsuda and Defronzo's formula using the values obtained. A positive change from Baseline (increase in insulin sensitivity) indicates improvement. (NCT01406015)
Timeframe: Baseline and Week 6 (Prior to ingesting glucose and every 30 minutes for 120 minutes)
| Intervention | IS index (Mean) | |
|---|---|---|
| Baseline | Change from Baseline at Week 6 | |
| Placebo | 4.6 | -1.1 |
| Spironolactone | 3.7 | -0.1 |
Renal plasma blood flow was determined by clearance of para-aminohippurate (PAH). A loading dose of PAH (8 mg/kg) was given intravenously followed by a 1 hour constant infusion of PAH at a rate of 12 mg/minute (min). Plasma samples were obtained at Baseline and at 50 and 60 minutes. PAH clearance was calculated from the plasma levels and infusion rates and reported in millimeters (mL)/minute (min). A positive change from Baseline indicates improvement. (NCT01406015)
Timeframe: Baseline and Week 6 (Prior to PAH infusion and at 50 and 60 minutes post PAH infusion)
| Intervention | mL/min (Mean) | |
|---|---|---|
| Baseline | Change from Baseline at Week 6 | |
| Placebo | 521 | -5.2 |
| Spironolactone | 488 | -2.3 |
Ultrasonography of the brachial artery was performed to evaluate endothelial function by flow mediated dilatation (FMD) studies. A blood pressure cuff was placed on the participant's upper arm and was compressed for 5 minutes. After release of compression, brachial artery diameter and blood flow velocity were measured. FMD was expressed as the percentage change in brachial artery diameter. A positive change from Baseline indicates improvement. (NCT01406015)
Timeframe: Baseline and Week 6
| Intervention | percent dilalation (Mean) | |
|---|---|---|
| Baseline | Change from Baseline at Week 6 | |
| Placebo | 10.2 | -2.0 |
| Spironolactone | 9.6 | -1.2 |
Acute Insulin response during Hyperglycemic clamp (delta insulin uU/mL, t=0-10) (NCT00732160)
Timeframe: 3 hours
| Intervention | uU/mL (Mean) |
|---|---|
| Vehicle, HS | 48.9 |
| Vehicle, LS | 37.6 |
| Aldosterone, HS | 51.8 |
| Aldosterone, LS | 34.4 |
Insulin sensitivity index (ISI) was calculated by dividing the average glucose infusion rate (mg glucose infusion/kg body weight/min) by the average insulin concentration (uU/mL) from 90 to 120 minutes. This was multiplied by 100 (thus, x100 in units description), per reporting convention in literature. (NCT00732160)
Timeframe: 3 hours
| Intervention | mg/kg/min per uU/mL*100 (Mean) |
|---|---|
| Vehicle, HS | 25.2 |
| Vehicle, LS | 24.8 |
| Aldosterone, HS | 23.4 |
| Aldosterone, LS | 24.7 |
(NCT01502787)
Timeframe: 12 weeks after initiation of metoprolol
| Intervention | mmHg (Mean) |
|---|---|
| Metoprolol | 114 |
| Nebivolol | 113 |
(NCT01502787)
Timeframe: 12 weeks
| Intervention | mmHg (Mean) |
|---|---|
| Initial Treatment With Metoprolol | 101 |
| Initial Treatment With Nebivolol | 103 |
(NCT01502787)
Timeframe: 12 weeks after each specified medication
| Intervention | ml/min (Mean) |
|---|---|
| First Intervention Metoprolol: 12 Weeks | 96 |
| Second Intervention Nebivolol: 24 Weeks | 105 |
549 reviews available for aldosterone and Hyperaldosteronism
| Article | Year |
|---|---|
Autonomous Aldosterone Secretion as a Subclinical Form of Primary Aldosteronism: Pathogenesis and Clinical Significance.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2022 |
Adrenal venous sampling in the diagnostic workup of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Blood Specimen Collection; Humans; Hyperaldosteronism; Hypertension; Ma | 2022 |
Primary Hyperaldosteronism: Approach to Diagnosis and Management.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiot | 2021 |
Approach to the Patient with an Incidental Adrenal Mass.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Catecholamines; Diagnosis, Di | 2021 |
Pathophysiology and histopathology of primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2022 |
Diagnosis and treatment of primary aldosteronism.
Topics: Adenoma; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertensio | 2021 |
[Conn's syndrome-Frequent and still too rarely diagnosed to underdiagnosed].
Topics: Adrenalectomy; Aldosterone; Diabetes Mellitus, Type 2; Humans; Hyperaldosteronism; Hypertension; Ren | 2022 |
Primary Aldosteronism, Aldosterone, and Extracellular Vesicles.
Topics: Aldosterone; Biomarkers; Extracellular Vesicles; Gene Expression Regulation; Humans; Hyperaldosteron | 2022 |
[Diagnosis of primary hyperaldosteronism].
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2022 |
Prognosis of adrenalectomy guided by computed tomography versus adrenal vein sampling in patients with primary aldosteronism: A systematic review and meta-analysis.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Prognosis; Ret | 2022 |
Primary Aldosteronism: Where Are We Now? Where to From Here?
Topics: Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Sodium, Dietary | 2022 |
The Role of Aldosterone in OSA and OSA-Related Hypertension.
Topics: Aldosterone; Continuous Positive Airway Pressure; Humans; Hyperaldosteronism; Hypertension; Sleep Ap | 2021 |
High Prevalence of Autonomous Aldosterone Production in Hypertension: How to Identify and Treat It.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Prevalence; Renin | 2022 |
Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects.
Topics: Aldosterone; Animals; Aorta; Aortic Diseases; Atrial Fibrillation; Humans; Hyperaldosteronism | 2022 |
Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic Paradigm.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2020 |
[Persistent and serious hyperkalemia after surgery of primary aldosteronism: A case report].
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemia; Potassium | 2022 |
Diagnostic value of aldosterone to renin ratio calculated by plasma renin activity or plasma renin concentration in primary aldosteronism: a meta-analysis.
Topics: Aldosterone; Area Under Curve; Humans; Hyperaldosteronism; Hypertension; Renin | 2022 |
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight.
Topics: Aldosterone; Fibrosis; Humans; Hyperaldosteronism; Hypertension; Kidney | 2022 |
Pathophysiology of bilateral hyperaldosteronism.
Topics: Adrenal Glands; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism | 2022 |
Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Primary Health Care; Renin | 2022 |
Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review.
Topics: Adrenalectomy; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Pregnancy; Retrospecti | 2022 |
Aldosterone as a Mediator of Cardiovascular Damage.
Topics: Aldosterone; Atrial Fibrillation; Cardiovascular System; Heart Failure; Humans; Hyperaldosteronism; | 2022 |
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; G Protein-Coupled Inwardly-Rectifying | 2022 |
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; G P | 2022 |
Approach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism.
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Renin; Renin-Angiotensin System | 2022 |
Secondary diabetes mellitus due to primary aldosteronism.
Topics: Aldosterone; Diabetes Mellitus; Glucocorticoids; Glucose; Humans; Hyperaldosteronism; Hypokalemia; I | 2023 |
Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation.
Topics: Adrenocortical Adenoma; Aldosterone; Cell Death; Cell Proliferation; Humans; Hyperaldosteronism; Hyp | 2022 |
Clinical Translationality of
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; G Protein-Coupled Inwardly-R | 2022 |
Primary aldosteronism - a multidimensional syndrome.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Risk Factors; Syndrome | 2022 |
Identification of risk loci for primary aldosteronism in genome-wide association studies.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Animals; DNA-Binding P | 2022 |
Who should be screened for primary aldosteronism? A comprehensive review of current evidence.
Topics: Adrenal Gland Neoplasms; Aldosterone; Diuretics; Humans; Hyperaldosteronism; Hypertension; Renin | 2022 |
Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Sleep Apnea, Obstructive | 2022 |
Personalized Treatment of Patients With Primary Aldosteronism.
Topics: Aldosterone; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Patient-Cente | 2023 |
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study.
Topics: Aldosterone; Captopril; Furosemide; Humans; Hyperaldosteronism; Renin | 2023 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
Vascular and hormonal interactions in the adrenal gland.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2022 |
CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity.
Topics: Aldosterone; Chromatography, Liquid; DNA-Binding Proteins; Genome-Wide Association Study; Humans; Hy | 2023 |
CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity.
Topics: Aldosterone; Chromatography, Liquid; DNA-Binding Proteins; Genome-Wide Association Study; Humans; Hy | 2023 |
CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity.
Topics: Aldosterone; Chromatography, Liquid; DNA-Binding Proteins; Genome-Wide Association Study; Humans; Hy | 2023 |
CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity.
Topics: Aldosterone; Chromatography, Liquid; DNA-Binding Proteins; Genome-Wide Association Study; Humans; Hy | 2023 |
[The genetic background of primary aldosteronism].
Topics: Adrenocortical Adenoma; Aldosterone; Genetic Background; Humans; Hyperaldosteronism; Hypertension | 2023 |
HCG-responsive aldosteronoma with transient secretion during pregnancy confirmed through HCG-stimulated adrenal venous sampling.
Topics: Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hyperaldosteroni | 2023 |
Cardiovascular and metabolic characters of
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Female; G Protein-Coupled Inwardly-Rectifying Potassiu | 2023 |
Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection.
Topics: Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension; Renin | 2023 |
The Effect of Aldosterone on Cardiorenal and Metabolic Systems.
Topics: Aldosterone; Cardiovascular Diseases; Essential Hypertension; Humans; Hyperaldosteronism; Hypertensi | 2023 |
Primary Aldosteronism Prevalence - An Unfolding Story.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Prevalence; Renin | 2023 |
Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: A systematic review and meta-analysis.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Progno | 2023 |
Improving Detection Rates for Primary Aldosteronism.
Topics: Aldosterone; Blood Pressure; Heart Disease Risk Factors; Humans; Hyperaldosteronism; Hypertension; P | 2023 |
Recent progress in the diagnosis and treatment of primary aldosteronism.
Topics: Aldosterone; Glucose; Humans; Hyperaldosteronism; Hyperkalemia; Hypertension; Mineralocorticoid Rece | 2023 |
Ca
Topics: Aldosterone; Calcium Channels, T-Type; Calcium Signaling; Humans; Hyperaldosteronism; Hypertension; | 2023 |
Advances in the molecular imaging of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Molecular Imaging; Tomography | 2023 |
Mineralocorticoid receptor signalling in primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Quali | 2023 |
Role of NCC in the pathophysiology of hypertension in primary aldosteronism.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Kidney Tubules, Distal; Phosp | 2023 |
Role of Adrenal Vein Sampling in Guiding Surgical Decision in Primary Aldosteronism.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; R | 2023 |
Primary aldosteronism: molecular medicine meets public health.
Topics: Adenoma; Adult; Aldosterone; Humans; Hyperaldosteronism; Molecular Medicine; Public Health | 2023 |
Key to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertensi | 2023 |
Primary aldosteronism 2.0: an update for clinicians on diagnosis and treatment.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Therapeutic management of congenital forms of endocrine hypertension.
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocort | 2023 |
Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Hormones; Aldosterone; Chromatography, Liquid; Cytochrome P- | 2019 |
Endothelial Dysfunction in Primary Aldosteronism.
Topics: Aldosterone; Cardiovascular Diseases; Cerebrovascular Disorders; Disease Progression; Humans; Hypera | 2019 |
Low-Renin Hypertension.
Topics: Aldosterone; Citrus paradisi; Cushing Syndrome; Glycyrrhiza; Humans; Hyperaldosteronism; Hypertensio | 2019 |
Resistant Hypertension: A Clinical Perspective.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Liddle Syndrome; Renin | 2019 |
Adrenal Venous Sampling: Where Do We Stand?
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Blood Chemical Analysis; Humans; Hyperaldosteronism; Pro | 2019 |
[Primary aldosteronism : Genetics and pathology].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mutation; | 2019 |
[Secondary hypertension in women].
Topics: Adult; Age Factors; Aldosterone; Computed Tomography Angiography; Female; Fibromuscular Dysplasia; H | 2019 |
Arterial Hypertension, Aldosterone, and Atrial Fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Randomize | 2019 |
[Hormonal Assessment of Secondary Hypertension - How to do it and what to expect?]
Topics: Aldosterone; Antihypertensive Agents; Blood Chemical Analysis; Diagnosis, Differential; Diagnostic T | 2019 |
Primary Aldosteronism: JACC State-of-the-Art Review.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension | 2019 |
Primary aldosteronism: Treatment of the disease, and new therapeutic approaches.
Topics: Adrenalectomy; Aldosterone; Antihypertensive Agents; Endocrinology; Humans; Hyperaldosteronism; Hype | 2020 |
Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?
Topics: Aldosterone; Bone Density; Diabetes Mellitus; Disease Management; Humans; Hyperaldosteronism; Hypert | 2020 |
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnostic Techniques, Endocrine; Huma | 2020 |
Molecular Mechanisms of Primary Aldosteronism.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Inflammation Mediators; TOR Serine-Threonine Kinas | 2019 |
Old and new genes in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Genetic Association Studies; Genetic | 2020 |
Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Blood Specimen Collection; Diagnostic Techniques, Endocrine; Humans; Hy | 2020 |
The spectrum of low-renin hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Molecular Diagnostic Techniques; Renin | 2020 |
MicroRNAs and Adrenocortical Tumors: Where do we Stand on Primary Aldosteronism?
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertens | 2020 |
Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II Type 1 Receptor Blocke | 2020 |
The cardiovascular consequences of hyperaldosteronism.
Topics: Aldosterone; Blood Pressure; Cardiovascular Diseases; Humans; Hyperaldosteronism; Hypertension | 2021 |
The Potential Role of Aldosterone-Producing Cell Clusters in Adrenal Disease.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Cytoc | 2020 |
Salt Appetite and its Effects on Cardiovascular Risk in Primary Aldosteronism.
Topics: Aldosterone; Appetite; Cardiovascular Diseases; Feeding Behavior; Heart Disease Risk Factors; Humans | 2020 |
Hypokalemia and the Prevalence of Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Disease Progression; Humans; Hyperald | 2020 |
Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Cytoc | 2020 |
Primary Aldosteronism in the Elderly.
Topics: Adrenal Glands; Age Factors; Aged; Aging; Aldosterone; Humans; Hyperaldosteronism | 2020 |
Primary aldosteronism is a public health issue: challenges and opportunities.
Topics: Aldosterone; Blood Pressure; Essential Hypertension; Humans; Hyperaldosteronism; Hypertension; Publi | 2020 |
[Update and Research Progress in the Diagnosis of Primary Aldosteronism].
Topics: Aldosterone; Captopril; Humans; Hyperaldosteronism; Hypertension; Renin | 2020 |
Genetic and Genomic Mechanisms of Primary Aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Animals; Calcium Signaling; Genetics; Genomics; Humans; Hyperal | 2020 |
Treatment of primary hyperaldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Ant | 2020 |
Pathogenesis and treatment of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Animals; Humans; Hyperaldosteronism; Hypertension; Mutation | 2020 |
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
Topics: Aldosterone; Blood Pressure; Diagnostic Techniques, Endocrine; Humans; Hyperaldosteronism; Hypertens | 2020 |
Five Reasons for the Failure to Diagnose Aldosterone Excess in Hypertension.
Topics: Aldosterone; Diagnosis, Differential; Diagnostic Errors; Humans; Hyperaldosteronism; Hypertension | 2020 |
The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Calcium Channels, L-Type; Calcium Sig | 2020 |
Left ventricular remodeling and dysfunction in primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypertrophy, Left Ventricular; Ventricular Dy | 2021 |
MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Endocrine System Diseases; Heart Diseases; Humans; Hyperaldosteronism; K | 2020 |
Update: Selective adrenal venous sampling (AVS) - Indication, technique, and significance.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies; Veins | 2021 |
Confounders of the aldosterone-to-renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Renin-Angiotensin System | 2021 |
Ablation versus laparoscopic adrenalectomy for the treatment of aldosterone‑producing adenoma: a meta-analysis.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Laparoscop | 2021 |
The effect of medication on the aldosterone-to-renin ratio. A critical review of the literature.
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Hypertension; Renin | 2021 |
China nationwide screening and registry of primary aldosteronism in hypertensive patients.
Topics: Aldosterone; China; Humans; Hyperaldosteronism; Hypertension; Multicenter Studies as Topic; Prospect | 2021 |
The mineralocorticoid receptor-an emerging player in metabolic syndrome?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Metabolic Syndrome; Mineralocorticoid Recepto | 2021 |
[Hyperaldosteronism].
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Minera | 2021 |
How common is primary aldosteronism?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2021 |
Functional Characteristic and Significance of Aldosterone-Producing Cell Clusters in Primary Aldosteronism and Age-Related Hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Age Factors; Aging; Aldosterone; H | 2021 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Prevalence; Renin | 2022 |
Cortisol Co-Secretion and Clinical Usefulness of ACTH Stimulation Test in Primary Aldosteronism: A Systematic Review and Biases in Epidemiological Studies.
Topics: Adrenocorticotropic Hormone; Aldosterone; Epidemiologic Studies; Humans; Hydrocortisone; Hyperaldost | 2021 |
Unravelling the Genetic Basis of Primary Aldosteronism.
Topics: Aldosterone; Germ-Line Mutation; High-Throughput Nucleotide Sequencing; Humans; Hyperaldosteronism; | 2021 |
Adrenocorticotropic Hormone-Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyp | 2021 |
Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism.
Topics: Aldosterone; Clinical Decision-Making; Female; Humans; Hyperaldosteronism; Male; Renin; Sensitivity | 2021 |
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Ant | 2021 |
Adrenal venous sampling with adrenocorticotropic hormone stimulation: A meta-analysis.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; Prospective St | 2021 |
Primary Aldosteronism: a Continuum from Normotension to Hypertension.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Kidney; Renin | 2021 |
Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Cytochrome P-450 CYP11B2; DNA Mutational Analysis; Fixatives; | 2021 |
Primary Aldosteronism Presenting with Hypertension Five Days after Delivery: A Case Report and Literature Review.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; | 2022 |
Primary aldosteronism: a common cause of resistant hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2017 |
Adrenal venous sampling for primary aldosteronism: laboratory medicine best practice.
Topics: Adrenal Cortex Function Tests; Adrenal Glands; Aldosterone; Biomarkers; Blood Specimen Collection; H | 2017 |
Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Animals; Biomarkers; Humans; Hyperaldosteronism; Sig | 2017 |
Biological diagnosis of primary aldosteronism: summary of new French and international guidelines.
Topics: Aldosterone; Diagnostic Techniques, Endocrine; France; Humans; Hyperaldosteronism; Internationality; | 2017 |
Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism.
Topics: Aldosterone; Germ-Line Mutation; Humans; Hyperaldosteronism; Phenotype | 2017 |
Primary Aldosteronism: The Next Five Years.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Pituitary-Adrenal Function Tests; Practice G | 2017 |
Unanswered Questions in the Genetic Basis of Primary Aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; DNA Copy Num | 2017 |
Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?
Topics: Aldosterone; Diagnostic Techniques, Endocrine; Humans; Hyperaldosteronism; Mass Screening; Pituitary | 2017 |
Is Primary Aldosteronism Still Largely Unrecognized?
Topics: Aldosterone; Diagnostic Errors; Diagnostic Techniques, Endocrine; Diagnostic Tests, Routine; Humans; | 2017 |
The SPARTACUS Trial: Controversies and Unresolved Issues.
Topics: Adrenal Glands; Aldosterone; Blood Specimen Collection; Clinical Trials as Topic; Diagnosis, Differe | 2017 |
Subtyping of Patients with Primary Aldosteronism: An Update.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Renin | 2017 |
Health-Related Quality of Life and Mental Health in Primary Aldosteronism: A Systematic Review.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Aldosterone; Health Status; Humans; Hyperaldoster | 2017 |
Aldosterone-Producing Cell Clusters in Normal and Pathological States.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldoste | 2017 |
Disordered CYP11B2 Expression in Primary Aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Aldosterone; Cytochrome P-450 CYP11B2; Gene Expre | 2017 |
Primary Aldosteronism and Obstructive Sleep Apnea: Is This A Bidirectional Relationship?
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Prevalence; Risk Factors; Sle | 2017 |
Aging and Adrenal Aldosterone Production.
Topics: Adrenal Cortex; Aging; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mutation | 2018 |
Regulation of aldosterone production by ion channels: From basal secretion to primary aldosteronism.
Topics: Aldosterone; Animals; Basal Metabolism; Calcium Channels; Humans; Hyperaldosteronism; Ion Channels; | 2018 |
GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism.
Topics: Aldosterone; Calcium Channels, L-Type; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gen | 2018 |
Overview of aldosterone-related genetic syndromes and recent advances.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Age Factors; Aging; Aldosterone; C | 2018 |
Update in adrenal venous sampling for primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Blood Specimen Collection; Female; Humans; Hyperaldoster | 2018 |
Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.
Topics: Aldosterone; Humans; Hyperaldosteronism; Metabolic Syndrome; Mineralocorticoid Receptor Antagonists; | 2018 |
Primary aldosteronism in the primary care setting.
Topics: Adrenalectomy; Aldosterone; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Huma | 2018 |
Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
Topics: Aldosterone; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Profiling; Ge | 2018 |
The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aging; Aldosterone; Humans; Hyperaldosteronism; Zo | 2018 |
Primary Hyperaldosteronism Induced by Aldosterone-Producing Adenoma Co-Existing with A Left Suprarenal Accessory Spleen: Two Case Reports and A Review of The Literature.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Male | 2019 |
Aldosterone to Renin Ratio as Screening Tool in Primary Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Renin | 2019 |
Primary Aldosteronism: Practical Approach to Diagnosis and Management.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Antihypertensive Agents; Blood Pressure; Humans; Hyperal | 2018 |
MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Renin; Renin-Angiotensin System | 2019 |
Immunohistochemistry for aldosterone synthase CYP11B2 and matrix-assisted laser desorption ionization imaging mass spectrometry for in-situ aldosterone detection.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Cytochrome P-450 CYP11B | 2019 |
Links between aldosterone excess and metabolic complications: A comprehensive review.
Topics: Aldosterone; Blood Glucose; Diabetes Complications; Humans; Hyperaldosteronism; Insulin; Insulin Res | 2020 |
Treatment of Resistant and Refractory Hypertension.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Drug Resistance; Drug Therapy, Combin | 2019 |
Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels.
Topics: Aldosterone; Chloride Channels; Humans; Hyperaldosteronism | 2019 |
Evaluation of bone health in patients with adrenal tumors.
Topics: Absorptiometry, Photon; Adrenal Gland Neoplasms; Adrenalectomy; Aged; Aldosterone; Bone Density; Cus | 2019 |
Role of Pendrin in the Pathophysiology of Aldosterone-Induced Hypertension.
Topics: Acid-Base Equilibrium; Aldosterone; Animals; Blood Pressure; Humans; Hyperaldosteronism; Hypertensio | 2019 |
The aldosterone to renin ratio in the diagnosis of primary aldosteronism: Promises and challenges.
Topics: Aldosterone; Biomarkers; Humans; Hyperaldosteronism; Hypertension; Practice Guidelines as Topic; Ren | 2019 |
Adrenal venous sampling: cosyntropin stimulation or not?
Topics: Adrenal Glands; Aldosterone; Cosyntropin; Hormones; Humans; Hyperaldosteronism; Phlebotomy | 2019 |
THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Trea | 2019 |
Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; beta Catenin; Calcium Channels, L-Typ | 2019 |
Effectiveness of Thermal Ablation for Aldosterone-Producing Adrenal Adenoma: A Systematic Review and Meta-Analysis of Clinical and Biochemical Parameters.
Topics: Ablation Techniques; Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Antihypertensive Agents; | 2019 |
Regulation of aldosterone secretion: from physiology to disease.
Topics: Adenoma; Aldosterone; Animals; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Genome-Wide | 2013 |
Genetics of mineralocorticoid excess: an update for clinicians.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Disease Models, Animal; G Pr | 2013 |
Diagnosis and management of primary aldosteronism: an updated review.
Topics: Adenoma; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adrenalectomy; Aldosterone; Humans; Hypera | 2013 |
Aldosterone receptor antagonists: current perspectives and therapies.
Topics: Aldosterone; Animals; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Rec | 2013 |
Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Eplerenone; Humans; Hy | 2013 |
Diagnosis and treatment of unilateral forms of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Diagnosis, Differential; Humans; Hyper | 2013 |
Primary aldosteronism - recent progress and current concepts.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldoster | 2013 |
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Topics: Adrenalectomy; Aldosterone; Animals; Bone Density; Bone Diseases; Calcium; Cardiovascular Diseases; | 2014 |
Primary aldosteronism: a new insight into pathogenesis, diagnosis, and treatment in hypertensive patients.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Receptor Antag | 2013 |
Aldosterone and blood pressure regulation: recent milestones on the long and winding road from electrocortin to KCNJ5, GPER, and beyond.
Topics: Aldosterone; Blood Pressure; Cardiovascular System; G Protein-Coupled Inwardly-Rectifying Potassium | 2014 |
Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
Topics: Adrenal Glands; Aldosterone; Animals; Calcium; Cell Membrane; Channelopathies; G Protein-Coupled Inw | 2014 |
Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aged; Aldosterone; Female; Humans; Hyperaldoster | 2014 |
Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.
Topics: Aldosterone; Cardiovascular Diseases; Female; Humans; Hyperaldosteronism; Hyperparathyroidism, Prima | 2014 |
Novel genes in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Calcium Channels, L-Type; Female; G P | 2014 |
[Programs for continuing medical education: a session; 6. Differential diagnosis and treatment of adrenal incidentaloma].
Topics: Adrenal Gland Neoplasms; Aldosterone; Biomarkers; Catecholamines; Cushing Syndrome; Diagnosis, Diffe | 2014 |
Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Hypoaldosteronism; Mineralocorticoids; Renin-Angio | 2014 |
Comparison of agents that affect aldosterone action.
Topics: Aldosterone; Animals; Epithelial Sodium Channel Blockers; Humans; Hydrocortisone; Hyperaldosteronism | 2014 |
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.
Topics: Aldosterone; Animals; Gene Expression Profiling; Gene Expression Regulation; High-Throughput Nucleot | 2015 |
[Primary hyperaldosteronism: boundaries of diagnostics and therapy].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocortical Hyperfunction; Aldos | 2014 |
Dissecting the molecular pathways of primary aldosteronism.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Ion Channels; Mutation; Receptors, G-Protein-Coupl | 2014 |
Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
Topics: Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagoni | 2015 |
Update in primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Quality of Life | 2015 |
An update on novel mechanisms of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Calcium Channels, L-Type; G | 2015 |
Laboratory challenges in primary aldosteronism screening and diagnosis.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Practice Guidelines as Topic; | 2015 |
[Hypertension in the course of primary aldosteronism during pregnancy].
Topics: Acid Sensing Ion Channel Blockers; Aldosterone; Amiloride; Antihypertensive Agents; Eplerenone; Fema | 2015 |
Hypertension: renin-angiotensin-aldosterone system alterations.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anim | 2015 |
Issues in the Diagnosis and Treatment of Primary Aldosteronism.
Topics: Aldosterone; Biomarkers; Critical Pathways; Humans; Hyperaldosteronism; Hypertension; Practice Guide | 2016 |
Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; Aldosterone; Drug | 2015 |
[Genetic alterations in primary aldosteronism].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Calcium Channels, L-Type; G | 2015 |
Aldosterone biosynthesis in the human adrenal cortex and associated disorders.
Topics: Adrenal Cortex; Aldosterone; Biosynthetic Pathways; Gene Expression Regulation; Humans; Hyperaldoste | 2015 |
A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Female; G Protein-Coupled Inwardly-Rectifying | 2015 |
Pharmacological treatment of aldosterone excess.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Dihydropyridines; Drug Interactions; Epithelial Sodium Channe | 2015 |
Adrenal histopathology in primary aldosteronism: is it time for a change?
Topics: Adrenal Cortex; Aging; Aldosterone; Humans; Hyperaldosteronism | 2015 |
[Primary aldosteronism: new insights into familial forms].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; DNA Mutational Analysis; G Protein-Co | 2015 |
Aldosterone and Left Ventricular Remodeling.
Topics: Aldosterone; Essential Hypertension; Heart Ventricles; Humans; Hyperaldosteronism; Hypertension; Ven | 2015 |
Parathyroid Gland Function in Primary Aldosteronism.
Topics: Aldosterone; Calcium; Homeostasis; Humans; Hyperaldosteronism; Hyperparathyroidism, Primary; Parathy | 2015 |
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery?
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Qua | 2015 |
Local Control of Aldosterone Production and Primary Aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Gene Express | 2016 |
The Role of Aldosterone in Obesity-Related Hypertension.
Topics: Aldosterone; Animals; Blood Pressure; Caloric Restriction; Diet, Sodium-Restricted; Humans; Hyperald | 2016 |
Hyperaldosteronism: Screening and Diagnostic Tests.
Topics: Aldosterone; Biomarkers; Critical Pathways; Humans; Hyperaldosteronism; Hypertension; Mass Screening | 2016 |
Novel genetic determinants of adrenal aldosterone regulation.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2016 |
Genetic disorders in primary aldosteronism-familial and somatic.
Topics: Adenoma; Adenosine Triphosphatases; Adrenal Cortex Neoplasms; Adult; Aldosterone; Chimera; Female; G | 2017 |
Hyperaldosteronism: How to Discriminate Among Different Disease Forms?
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Aldosterone; Biomarkers; Diagnos | 2016 |
Syndromes that Mimic an Excess of Mineralocorticoids.
Topics: Aldosterone; Biomarkers; Cushing Syndrome; Dexamethasone; Diet; Genetic Predisposition to Disease; G | 2016 |
Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials.
Topics: Aldosterone; Cardiovascular Diseases; Hemorrhage; Hemostasis; Humans; Hyperaldosteronism; Mineraloco | 2016 |
Clock genes and salt-sensitive hypertension: a new type of aldosterone-synthesizing enzyme controlled by the circadian clock and angiotensin II.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldosterone; Angiotensin II; Animals; Circadian Clocks; Circadian R | 2016 |
Genetics of primary hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Animals; Genetic Pred | 2016 |
Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis.
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Mass Screening; Publication Bias; | 2016 |
Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.
Topics: Aldosterone; Animals; Blood Pressure; Humans; Hyperaldosteronism; Hypertension, Renal; Kidney | 2016 |
Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.
Topics: Aldosterone; Animals; Biocatalysis; Cytochrome P-450 CYP11B2; High-Throughput Nucleotide Sequencing; | 2017 |
Of channels and pumps: different ways to boost the aldosterone?
Topics: Aldosterone; beta Catenin; Calcium Channels, L-Type; Calcium Channels, T-Type; G Protein-Coupled Inw | 2017 |
Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
Topics: Aldosterone; Animals; Cardiovascular Diseases; Endothelium, Vascular; Epithelial Cells; Humans; Hype | 2017 |
Radiofrequency ablation treatment for aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Catheter Ablation; Hum | 2017 |
Medical treatment as an alternative to adrenalectomy in patients with aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldostero | 2008 |
Mineralocorticoid receptor antagonists and endothelial function.
Topics: Aldosterone; Animals; Endocrine System Diseases; Endothelium, Vascular; Eplerenone; Humans; Hyperald | 2008 |
[Hyper- and hypoaldosteronism].
Topics: Aldosterone; Global Health; Humans; Hyperaldosteronism; Hypoaldosteronism; Morbidity | 2008 |
Mineralocorticoid antagonism and cardiac hypertrophy.
Topics: Aldosterone; Antihypertensive Agents; Cardiomegaly; Fibrosis; Humans; Hyperaldosteronism; Hypertensi | 2008 |
[Primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Renin; Renin-Angiotensin Syst | 2008 |
Aldosterone and cardiovascular disease.
Topics: Adrenalectomy; Aldosterone; Animals; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular | 2009 |
Hyperaldosteronism in pregnancy.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Female; Humans; Hyperaldosteronism; Pregnancy; P | 2009 |
[Primary hyperaldosteronisms: from diagnosis to treatment].
Topics: Adrenal Cortex Function Tests; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Antihypertensive | 2009 |
Resistant hypertension: who and how to evaluate.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Humans; Hyperaldosteron | 2009 |
Differential diagnosis of primary aldosteronism subtypes.
Topics: Aldosterone; Animals; Blood Pressure; Diagnosis, Differential; Humans; Hyperaldosteronism | 2009 |
[Use of C-arm CT for improving the hit rate for selective blood sampling from adrenal veins].
Topics: Adrenal Glands; Aldosterone; Blood Chemical Analysis; Female; Humans; Hyperaldosteronism; Male; Midd | 2009 |
Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Magnetic R | 2009 |
Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Magnetic R | 2009 |
Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Magnetic R | 2009 |
Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Magnetic R | 2009 |
Aldosterone and cardiovascular risk.
Topics: Aldosterone; Antihypertensive Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; | 2009 |
Animal models of primary aldosteronism.
Topics: Aldosterone; Animals; Cell Line; Disease Models, Animal; Hyperaldosteronism; Mice; Mice, Knockout; M | 2010 |
Aldosterone and arterial hypertension.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Blood Vessels; Brain; Cytochrome P-45 | 2010 |
Progress in primary aldosteronism: present challenges and perspectives.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Endocrinolog | 2010 |
Aldosterone in uremia - beyond blood pressure.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Endothelial Cells; Endothelium, Vascular; | 2010 |
Confirmatory tests in the diagnosis of primary aldosteronism.
Topics: Aldosterone; Algorithms; Diagnostic Techniques, Endocrine; Fludrocortisone; Humans; Hyperaldosteroni | 2010 |
Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism?
Topics: Aldosterone; Algorithms; Diagnostic Techniques, Endocrine; Humans; Hyperaldosteronism; Mass Screenin | 2010 |
Aldosterone and cardiovascular disease.
Topics: Aldosterone; Animals; Cardiovascular Diseases; Circadian Rhythm; Disease Models, Animal; Humans; Hyp | 2010 |
Diagnosis and surgical management for primary hyperaldosteronism.
Topics: Adrenalectomy; Aldosterone; Biomarkers; Diagnosis, Differential; Humans; Hyperaldosteronism; Laparos | 2010 |
Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism | 2010 |
Aberrant hormone receptors in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Gene Expression; Humans; Hyperaldosteronism; Models, Biological; Mutant | 2010 |
Adrenal vein sampling.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocort | 2010 |
Prevalence and diagnosis of primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Blood Chemical Analysis; Blood Pressure Monitoring, Ambu | 2010 |
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.
Topics: Adrenalectomy; Aldosterone; Animals; Blood Pressure; Cardiovascular System; Humans; Hyperaldosteroni | 2010 |
From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.
Topics: Aldosterone; Animals; Calcium; Coronary Vessels; Disease Models, Animal; Hyperaldosteronism; Myocard | 2010 |
Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Animals; Humans; Hydrocortisone; Hyperaldosteronism | 2011 |
Hypertension due to loss of clock: novel insight from the molecular analysis of Cry1/Cry2-deleted mice.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldosterone; Animals; Biological Clocks; Circadian Rhythm; CLOCK Pr | 2011 |
Aldosterone, hypertension, and beyond.
Topics: Aldosterone; Epigenomics; Epithelial Sodium Channels; Humans; Hyperaldosteronism; Hypertension; Hypo | 2011 |
Envoi.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2011 |
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
Topics: Adult; Aldosterone; Bartter Syndrome; Female; Gitelman Syndrome; Humans; Hyperaldosteronism; Kidney | 2011 |
Mutations in KCNJ5 gene cause hyperaldosteronism.
Topics: Adenoma; Aldosterone; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Humans; Hype | 2011 |
This is not Dr. Conn's aldosterone anymore.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2011 |
Aldosterone-induced fibrosis in the kidney: questions and controversies.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Antihypertensive Agents; Blood Pressure; Child, | 2011 |
Acute and chronic regulation of aldosterone production.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Humans; Hyperaldosteronism; Metab | 2012 |
Aldosterone and the heart: from basic research to clinical evidence.
Topics: Aldosterone; Animals; Heart; Heart Diseases; Humans; Hyperaldosteronism | 2012 |
Primary aldosteronism and metabolic syndrome.
Topics: Aldosterone; Animals; Glucose; Humans; Hyperaldosteronism; Insulin; Metabolic Syndrome | 2012 |
Primary aldosteronism: who should be screened?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Practice Guidelines as Topic | 2012 |
Prevalence of primary aldosteronism in patient's cohorts and in population-based studies--a review of the current literature.
Topics: Aldosterone; Cohort Studies; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Population Gr | 2012 |
Factors affecting the aldosterone/renin ratio.
Topics: Aldosterone; Diagnostic Tests, Routine; Female; Humans; Hyperaldosteronism; Male; Pregnancy; Renin; | 2012 |
Aldosterone and the kidney.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Kidney; Kidney Diseases; Receptors, Mineralocortic | 2012 |
Molecular biology of 11β-hydroxylase and 11β-hydroxysteroid dehydrogenase enzymes.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenal Hyperplasia, Congenital; Aldosterone; | 1992 |
Mineralocorticoid receptor blockade in chronic kidney disease.
Topics: Aldosterone; Animals; Diabetes Complications; Humans; Hyperaldosteronism; Kidney; Kidney Failure, Ch | 2012 |
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
Topics: Aldosterone; Animals; Cardiovascular Diseases; Chronic Disease; Heart Failure; Hemodynamics; Humans; | 2012 |
Psychopathological symptoms in patients with primary hyperaldosteronism--possible pathways.
Topics: Aldosterone; Animals; Anxiety; Depression; Humans; Hyperaldosteronism; Mental Disorders; Psychopatho | 2012 |
Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Parathyroid Hormone; Ventricular Remodeling | 2013 |
Resistant hypertension and aldosterone: an update.
Topics: Aldosterone; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Hyperaldosteronis | 2012 |
Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases.
Topics: Aldosterone; Animals; Cardiovascular Diseases; Disease Models, Animal; Heart Failure; Humans; Hypera | 2012 |
Salt, aldosterone and hypertension.
Topics: Aldosterone; Animals; Appetite; Cardiovascular Diseases; Humans; Hyperaldosteronism; Hypertension; K | 2013 |
Integrating genetics and genomics in primary aldosteronism.
Topics: Aldosterone; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Genomics; Humans; Hyperaldost | 2012 |
Primary aldosteronism: a common and important problem. A practical guide to the diagnosis and treatment.
Topics: Academic Medical Centers; Aldosterone; Diagnostic Techniques, Endocrine; Diagnostic Tests, Routine; | 2012 |
Circadian clock-deficient mice as a tool for exploring disease etiology.
Topics: Aldosterone; Animals; Circadian Clocks; Circadian Rhythm; Cryptochromes; Diabetes Mellitus; Humans; | 2012 |
[Update on endocrine hypertension].
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Cardiovascular Diseases; Endocrine Sys | 2012 |
[Primay hyperaldosteronism--diagnostic and treatment].
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocortical Adenoma; A | 2012 |
Role of KCNJ5 in familial and sporadic primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Animals; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Huma | 2013 |
[Resistant hypertension].
Topics: Age Factors; Aldosterone; Coronary Vasospasm; Disease Management; Diuretics; Humans; Hyperaldosteron | 2012 |
Aldosterone and the risk of hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Renin | 2013 |
Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.
Topics: Aldosterone; Animals; Cardiomegaly; Cardiovascular System; Heart Failure; Humans; Hyperaldosteronism | 2002 |
Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mass Screening; Renin | 2002 |
New genetic insights in familial hyperaldosteronism.
Topics: Adrenal Cortex Diseases; Aldosterone; Chromosomes, Human, Pair 7; Cytochrome P-450 CYP11B2; Humans; | 2002 |
Primary aldosteronism: management issues.
Topics: Adrenal Cortex Diseases; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypok | 2002 |
Aldosterone-induced cardiac damage: focus on blood pressure independent effects.
Topics: Aldosterone; Animals; Blood Pressure; Cardiomyopathies; Heart Failure; Hyperaldosteronism; Hypertens | 2003 |
Aldosterone: a risk factor for vascular disease.
Topics: Aldosterone; Animals; Arteries; Fibrosis; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoi | 2003 |
Aldosterone in renal disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Clinical Trials as | 2003 |
The effect of aldosterone on glucose metabolism.
Topics: Aldosterone; Diabetes Mellitus; Glucose; Glucose Intolerance; Humans; Hyperaldosteronism; Insulin Re | 2003 |
[Occurrence and diagnosis of primary aldosteronism and its therapy].
Topics: Adrenocorticotropic Hormone; Aldosterone; Biomarkers; Diagnosis, Differential; Humans; Hyperaldoster | 2003 |
Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension?
Topics: Adrenal Glands; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Hypertension; Phe | 2003 |
[Monogenic hypertension].
Topics: Adolescent; Adult; Aldosterone; Child; Female; Genes, Dominant; Genotype; Humans; Hyperaldosteronism | 2003 |
[Role of ion channels of kidney in water-electrolyte metabolism].
Topics: Aldosterone; Alkalosis; Animals; Bartter Syndrome; Chloride Channels; Humans; Hyperaldosteronism; Hy | 2003 |
Forms of mineralocorticoid hypertension.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; | 2003 |
Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets.
Topics: Aldosterone; Animals; Biomarkers; Coronary Circulation; Fibrosis; Heart Failure; Humans; Hyperaldost | 2003 |
Pseudohyperaldosteronism: pathogenetic mechanisms.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Humans; Hyperaldosteronism; Mutation; Syndrome | 2003 |
Primary aldosteronism: from genesis to genetics.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Phenotype | 2003 |
[Primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Antihypertensive Agent | 2003 |
Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism | 2003 |
[REGULATION OF ALDOSTERONE SECRETION].
Topics: Aldosterone; Corticosterone; Hyperaldosteronism; Hypophysectomy; Physiology | 1963 |
[ENDOCRINOLOGY].
Topics: Addison Disease; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Carcinoma; Chlor | 1964 |
THE ADRENAL CORTEX AND REPRODUCTIVE FUNCTIONS.
Topics: Addison Disease; Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormon | 1963 |
[ALDOSTERONE AND HYPERALDOSTERONISM. (REVIEW)].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Renal Artery Obstru | 1964 |
ALDOSTERONISM.
Topics: Aldosterone; Diagnosis, Differential; Diuretics; Humans; Hyperaldosteronism; Hypertension; Kidney Di | 1964 |
ALDOSTERONE AND ANGIOTENSIN. INTERRELATIONSHIPS IN NORMAL AND DISEASED STATES.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensins; Desoxycorticosterone; Digoxin; Dogs; Heart F | 1964 |
[ALDOSTERONE AND ITS ROLE IN THE ORGANISM].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1964 |
ALDOSTERONE: ITS BIOCHEMISTRY AND PHYSIOLOGY.
Topics: Aldosterone; Angiotensins; Biochemical Phenomena; Biochemistry; Blood; Edema; Female; Homeostasis; H | 1964 |
ALDOSTERONE IN CLINICAL MEDICINE.
Topics: Aldosterone; Blood Volume; Body Weight; Desoxycorticosterone; Dexamethasone; Diuretics; Drug Therapy | 1964 |
[PHYSIOPATHOLOGY OF ARTERIAL HYPERTENSION. ROLE OF ANGIOTENSIN AND ALDOSTERONE SECRETION].
Topics: Adrenal Glands; Aldosterone; Angiotensins; Biochemical Phenomena; Biochemistry; Hyperaldosteronism; | 1964 |
[ALDOSTERONE AND ALDOSTERONISM. NEW RESULTS AND EXPERIENCES].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1964 |
Recent advances in diagnosis and treatment of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Biomarkers; Glucocorticoids; Humans; | 2003 |
Aldosterone and aldosteronism.
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism | 2003 |
Aldosterone receptor antagonists: biology and novel therapeutical applications.
Topics: Aldosterone; Heart Failure; Hirsutism; Humans; Hyperaldosteronism; Hypertension; Liver Cirrhosis; Mi | 2003 |
Primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Diagnosis, Differential; Humans; Hyperaldoster | 2003 |
[The aldosterone to Renin ratio in secondary hypertension].
Topics: Adrenalectomy; Adult; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension | 2003 |
A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism.
Topics: Aldosterone; Antioxidants; Cytokines; Endomyocardial Fibrosis; Heart Failure; Humans; Hyperaldostero | 2003 |
[Rational diagnostic approach in hypertension].
Topics: Adrenal Gland Neoplasms; Aldosterone; Angiography; Cushing Syndrome; Diabetic Nephropathies; Diagnos | 2003 |
Hyperaldosteronism and pheochromocytoma: new tricks and tests.
Topics: Adrenal Gland Neoplasms; Aldosterone; Catecholamines; Epinephrine; Female; Humans; Hyperaldosteronis | 2003 |
Laparoscopic adrenalectomy for pheochromocytoma. A comparison to aldosteronoma and incidentaloma.
Topics: Academic Medical Centers; Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenalectomy; A | 2004 |
Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Remission Induction | 2004 |
The challenge of more robust and reproducible methodology in screening for primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Immunologic Techniques; Mass Screening; Renin | 2004 |
Genetics of primary aldosteronism.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Gene Expression Regulation; Genetic Variation; Genetics; Huma | 2004 |
[Hypertension secondary to primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Antihypertensive Agents; Diagnosis, Di | 2004 |
[Diagnosis and treatment of primary hyperaldosteronism].
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Diagnosis, Differential; Hum | 2004 |
Hypokalemia and alkalosis in adipsic hypernatremia are not associated with hyperaldosteronism.
Topics: Adolescent; Aldosterone; Alkalosis; Humans; Hyperaldosteronism; Hypernatremia; Hypokalemia; Male; Po | 2004 |
[Aldosterone].
Topics: Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Humans; Hyperaldos | 2004 |
[Primary aldosteronism--new insight into an old disease].
Topics: Adrenal Cortex Hormones; Aldosterone; Clinical Chemistry Tests; Diagnosis, Differential; Humans; Hyp | 2004 |
Diagnosis of primary aldosteronism: from screening to subtype differentiation.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Huma | 2005 |
[Discovery and significance of aldosterone].
Topics: Aldosterone; Humans; Hyperaldosteronism | 2005 |
Aldosterone receptor antagonists: biology and novel therapeutic applications.
Topics: Aldosterone; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Ant | 2005 |
[Hypertension due to primary aldosteronism].
Topics: Aldosterone; Decision Trees; Humans; Hyperaldosteronism; Hypertension | 2005 |
[Familial aspect of primary hyperaldosteronism: analysis of families compatible with primary hyperaldosteronism type 2].
Topics: Aldosterone; Chromosome Mapping; Chromosomes, Human, Pair 7; Family; Female; Humans; Hyperaldosteron | 2005 |
Efficacy of aldosterone receptor antagonism in heart failure: potential mechanisms.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Vessels; Calcium; Diuretics; Heart Fail | 2004 |
[18-hydroxycorticosterone (18-OH -B)].
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Aldoste | 2005 |
[Aldosterone].
Topics: Adrenocorticotropic Hormone; Aldosterone; Biomarkers; Furosemide; Humans; Hyperaldosteronism; Hypoal | 2005 |
Adrenal vein sampling: how to make it quick, easy, and successful.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Phlebotomy; Radiography | 2005 |
Primary aldosteronism: diagnostic and therapeutic considerations.
Topics: Adrenalectomy; Aldosterone; Biomarkers; Blood Pressure; Diagnosis, Differential; Humans; Hyperaldost | 2005 |
Miscellaneous endocrine causes of hypertension.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Biomarkers; Humans; Hyperaldoster | 2005 |
The pharmacological treatment of primary aldosteronism.
Topics: Aldosterone; Amiloride; Calcium Channel Blockers; Clinical Trials as Topic; Drug Therapy, Combinatio | 2006 |
Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
Topics: Aldosterone; Antihypertensive Agents; Captopril; Humans; Hyperaldosteronism; Hypertension; Renin; Se | 2006 |
[Clinical characteristics of primary and secondary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Drug Therapy, Combination; E | 2006 |
[Idiopathic hyperaldosteronism (IHA)].
Topics: Adrenal Cortex; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hyperplasia; Miner | 2006 |
[Glucocorticoid remediable aldosteronism].
Topics: Adrenal Glands; Aldosterone; Cytochrome P-450 CYP11B2; Dexamethasone; Diagnosis, Differential; Gluco | 2006 |
Primary aldosteronism: diagnostic and treatment strategies.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Algorithms; Animals; A | 2006 |
Screening for primary aldosteronism.
Topics: Aldosterone; Algorithms; Humans; Hyperaldosteronism; Hypertension; Potassium; Prevalence; Renin | 2006 |
Surgically correctable hypertension caused by primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Algorit | 2006 |
[Normokalemic primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Diagnosis, Differential; Humans; Hype | 2006 |
Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Hypertension, Renal; Mass Screenin | 2007 |
Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases.
Topics: Adrenal Glands; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Male; Mi | 2007 |
[Diagnosis of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia | 2007 |
[Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
Topics: Adrenal Cortex Function Tests; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Antihyperten | 2006 |
New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Blood Pressure; Diagnosis, Differential; Humans; Hyperaldosteronism; Hy | 2007 |
[Treatment for symptoms of pseudoaldosteronism].
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Diet, Sodium-Restricted; Glycyrrhiza; Glyc | 2007 |
The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.
Topics: Aldosterone; Animals; Atherosclerosis; Cardiovascular Diseases; Heart Failure; Humans; Hyperaldoster | 2007 |
Aldosteronism and hypertension.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Mass | 2006 |
Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Models, Biological; Pheochrom | 2007 |
Hyperaldosteronism: a commonly occurring underlying feature of essential hypertension and the metabolic syndrome?
Topics: Aldosterone; Black or African American; Humans; Hyperaldosteronism; Hypertension; Insulin Resistance | 2007 |
Aldosterone and refractory hypertension.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Drug Resistance; Humans; Hyperaldosteronism; H | 2007 |
The importance of lost minerals in heart failure.
Topics: Aldosterone; Calcium; Heart Failure; Humans; Hyperaldosteronism; Magnesium; Parathyroid Hormone; Ren | 2007 |
[Diagnostic criteria for primary aldosteronism].
Topics: Adrenocorticotropic Hormone; Aldosterone; Biomarkers; Diagnosis, Differential; Humans; Hyperaldoster | 2007 |
Resistant hypertension and aldosteronism.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Bloc | 2007 |
Endocrine arterial hypertension: diagnostic approach in clinical practice.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Algorithms; Catecholamines; Cushing Syndrome; Diagnos | 2008 |
A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function.
Topics: Aldosterone; Animals; Cardiovascular Physiological Phenomena; Humans; Hyperaldosteronism; Hypertensi | 2008 |
Selection of patients for surgery for primary aldosteronism.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Patient Selection; Renin | 2008 |
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.
Topics: Aldosterone; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Re | 2008 |
The role of adrenal steroidogenesis in arterial hypertension.
Topics: Adrenal Glands; Aldosterone; Animals; Blood Pressure; Female; Humans; Hyperaldosteronism; Hypertensi | 2008 |
[Diagnostic tests for endocrine hypertension].
Topics: Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone; A | 1984 |
Disorders of the adrenal cortex: their effects on electrolyte metabolism.
Topics: Addison Disease; Adrenal Cortex Diseases; Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; | 1984 |
Renin-angiotensin-aldosterone and hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensinogen; Angiotensins; Animals; Blood Press | 1980 |
Measurement of the hormones of the renin system in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin I; Angiotensin II; Angiotensins; Blood Volume; | 1981 |
[The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey].
Topics: Acromegaly; Aldosterone; Angiotensin I; Angiotensin II; Captopril; Cushing Syndrome; Glycoproteins; | 1981 |
[Aldosterone tests in children (author's transl)].
Topics: Adolescent; Adrenal Cortex Function Tests; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; A | 1980 |
Hypertension of childhood with suppressed renin.
Topics: 18-Hydroxydesoxycorticosterone; 20-alpha-Dihydroprogesterone; Adolescent; Adrenal Cortex; Adrenal Hy | 1980 |
Disorders of distal nephron function.
Topics: Acidosis, Renal Tubular; Aldosterone; Bartter Syndrome; Bicarbonates; Biological Transport; Chloride | 1982 |
Enzymatic disorders and hypertension.
Topics: Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; A | 1981 |
The kinins and prostaglandins in hypertension.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Water; Dinoprost; Female; Furos | 1981 |
[Major endocrine diseases].
Topics: Adrenocorticotropic Hormone; Aldosterone; Bartter Syndrome; Humans; Hyperaldosteronism; Neoplasms; R | 1982 |
[Renin-angiotensin-aldosterone function tests].
Topics: Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Desoxycorti | 1982 |
Primary aldosteronism: pathophysiology, diagnosis and treatment.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplas | 1983 |
Clinical disorders of aldosterone metabolism.
Topics: Acidosis; Adrenal Hyperplasia, Congenital; Aldosterone; Bartter Syndrome; Cushing Syndrome; Diagnosi | 1984 |
The Franz Gross Memorial Lecture. The renin-aldosterone connection: past, present and future.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Animals; Diet, Sodium-Restricted; Dogs; Humans; Hyper | 1984 |
[Disturbances of water and electrolyte equilibrium in liver disease: Part 2: Clinical picture (author's transl)].
Topics: Aldosterone; Ascites; Hepatitis; Humans; Hyperaldosteronism; Liver Cirrhosis; Liver Diseases; Water- | 1982 |
Primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Amiloride; Diagnosis, Differential; F | 1980 |
Primary aldosteronism--a review.
Topics: 18-Hydroxycorticosterone; Adenoma; Adolescent; Adrenal Glands; Adult; Aldosterone; Child; Humans; Hy | 1980 |
Prostaglandins and Bartter's syndrome.
Topics: Acidosis; Aldosterone; Bartter Syndrome; Chemical Phenomena; Chemistry; Diet; Female; Humans; Hypera | 1981 |
The renin-angiotensin system and aldosterone in hypertension: a brief review of some aspects.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Renin | 1981 |
Surgical management of aldosterone-producing adrenal adenomas: a review of 16 patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adult; Aged; Aldosterone; Female; Hu | 1981 |
[Primary hyperaldosteronism-current theories].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia | 1981 |
Primary aldosteronism. The etiologic spectrum of disorders and their clinical differentiation.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Diagnosis, Differential; Glucocortico | 1982 |
Pathogenesis of mineralocorticoid hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Aldosterone; Animals; Bloo | 1981 |
[Hyperaldosteronism].
Topics: Adrenal Cortex; Aldosterone; Humans; Hyperaldosteronism; Renin; Renin-Angiotensin System | 1982 |
[New data on mineralocorticoid hormones. Physiopathological implications].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Receptors, Glucocorticoid; Receptors, Mineral | 1995 |
[Aldosterone producing tumor].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldostero | 1993 |
[Aldosterone producing adenoma].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism | 1993 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Incidence | 1995 |
Genetic recombination as a cause of inherited disorders of aldosterone and cortisol biosynthesis and a contributor to genetic variation in blood pressure.
Topics: Aldosterone; Blood Pressure; Crossing Over, Genetic; Genetic Diseases, Inborn; Humans; Hydrocortison | 1995 |
Primary aldosteronism--some genetic, morphological, and biochemical aspects of subtypes.
Topics: Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Incidence; Pedigree | 1995 |
Aldosterone-secreting adrenal cortical adenoma in an 11-year-old child and collective review of the literature.
Topics: Adrenocortical Adenoma; Aldosterone; Alkalosis; Child; Female; Humans; Hyperaldosteronism; Hypertens | 1994 |
19-Noraldosterone, a new mineralocorticoid.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism | 1994 |
Disorders of steroid 11 beta-hydroxylase isozymes.
Topics: Adrenal Cortex; Adrenal Hyperplasia, Congenital; Aldosterone; Cytochrome P-450 CYP11B2; Cytochrome P | 1994 |
Disorders of aldosterone biosynthesis and action.
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Cytochrome P-450 CYP11B2; Cytochrome P-450 Enzyme Syst | 1994 |
Glucocorticoid-remediable aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mutation | 1994 |
Glucocorticoid-suppressible hyperaldosteronism: from confusion to conclusion?
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Animals; Cytochrome P-450 CYP11B2; Cytochr | 1993 |
Secondary aldosteronism.
Topics: Aldosterone; Blood Pressure; Edema; Female; Humans; Hyperaldosteronism; Hypertension, Renovascular; | 1995 |
Conn syndrome in a child, caused by adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Child; Fatigue; Female; Humans; Hyperaldosteronism; H | 1996 |
Primary aldosteronism. Part I. Diagnosis of primary hyperaldosteronism.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Furosemide; Humans; Hyp | 1996 |
[11-beta-hydroxylase deficiency and glucocorticoid-sensitive hyperaldosteronism].
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aldosterone; Child, Preschool; Dexamet | 1996 |
[Mineralocorticoid-induced hypertension].
Topics: 17-Hydroxysteroid Dehydrogenases; Adenoma; Aldosterone; Chromosomes, Human, Pair 8; Crossing Over, G | 1997 |
Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension.
Topics: Adrenalectomy; Aldosterone; Animals; Heart; Heart Ventricles; Humans; Hyperaldosteronism; Hypertensi | 1997 |
Primary aldosteronism and its variants.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Aldostero | 1998 |
[Mineralocorticoids and hypertension].
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Animals; Child; Child, Pres | 1998 |
[Differential diagnosis and therapy of primary hyperaldosteronism].
Topics: Adrenalectomy; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Mineralocorticoid R | 1998 |
Primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Humans; Hype | 1998 |
Hyper- and hypoaldosteronism.
Topics: Adolescent; Adult; Aldosterone; Animals; Child; Humans; Hyperaldosteronism; Hypoaldosteronism; Infan | 1999 |
A rare combination consisting of primary hyperaldosteronism and glucagonoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Carcinoma, Renal Cell; Glucagonoma; H | 1999 |
19-Noraldosterone.
Topics: Age Factors; Aging; Aldosterone; Angiotensin II; Animals; Corticosterone; Hyperaldosteronism; Mass S | 1999 |
[Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
Topics: Aldosterone; Electrolytes; Humans; Hyperaldosteronism; Hypertension; Hypoaldosteronism; Mineralocort | 1999 |
Low renin hypertension in the next millennium.
Topics: Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension, Renal; Mutation; Receptors, M | 2000 |
[Aldosterone].
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Infant, Newborn; Male | 1999 |
Heart-hitting tales of salt and destruction.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Cardiovascular Diseases; Humans; Hyperaldosteronism; | 2000 |
Aldosterone-related genetic effects in hypertension.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Epithelium; Humans; Hyperaldosteronism; Hypertension; Ion Tra | 2000 |
Aldosterone in renal disease.
Topics: Aldosterone; Animals; Hyperaldosteronism; Kidney Diseases; Renal Insufficiency | 2001 |
A review of the medical treatment of primary aldosteronism.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Humans; Hyperaldost | 2001 |
Primary aldosteronism: revival of a syndrome.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mutation; Renin; Syndrome | 2001 |
The spironolactone renaissance.
Topics: Aldosterone; Androgen Antagonists; Angiogenesis Inhibitors; Animals; Clinical Trials as Topic; Colla | 2001 |
The hypertensive patient with hypokalaemia: the search for hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Magnetic Resonance Angiography; | 2001 |
The diagnosis of essential and secondary hypertension in adults.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Algorithms; Angiography; Blood Pressure Determination; | 2001 |
New perspectives on the role of aldosterone excess in cardiovascular disease.
Topics: Aldosterone; Animals; Heart Diseases; Humans; Hyperaldosteronism | 2001 |
Hyperaldosteronism: recent concepts, diagnosis, and management.
Topics: Aged; Aldosterone; Diuretics; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; M | 2001 |
Primary aldosteronism: are we diagnosing and operating on too few patients?
Topics: Aldosterone; Diagnostic Techniques, Endocrine; Endocrine Surgical Procedures; Humans; Hyperaldostero | 2001 |
Familial hyperaldosteronism.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Female; Genetic Linkage; Glucocorticoids; Humans; Hyperaldost | 2001 |
Aldosterone in progressive renal disease.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hyperaldoste | 2001 |
[Primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Algorithms; Amiloride; Di | 1998 |
The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism?
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Disease Progression; Humans; Hyperaldosteronism; Hypertension | 2002 |
Diagnosis and management of primary aldosteronism.
Topics: Aldosterone; False Negative Reactions; False Positive Reactions; Humans; Hyperaldosteronism; Mass Sc | 2001 |
Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
Topics: Aldosterone; Antihypertensive Agents; Biomarkers; Humans; Hyperaldosteronism; Hypertension; Prevalen | 2002 |
Primary aldosteronism, a common entity? the myth persists.
Topics: Aldosterone; Biomarkers; Humans; Hyperaldosteronism; Hypertension; Potassium; Renin | 2002 |
[Cardiovascular complications in mineralocorticism syndrome].
Topics: Aldosterone; Cardiovascular Diseases; Humans; Hyperaldosteronism; Mineralocorticoids; Syndrome; Term | 2002 |
Familial varieties of primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Chromosome Mapping; Chromosomes, Human, Pair 7; Genetic Variati | 2001 |
Primary aldosteronism.
Topics: Aldosterone; Clinical Chemistry Tests; Diagnosis, Differential; Humans; Hyperaldosteronism; Prevalen | 2002 |
Functional tests for primary aldosteronism: value of captopril suppression.
Topics: Aldosterone; Captopril; Humans; Hyperaldosteronism; Immunoradiometric Assay; Reference Values; Renin | 2002 |
The renin system in essential, renovascular and adrenocortical hypertension: an overview.
Topics: Aldosterone; Blood Volume; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant | 1977 |
Abnormal regulation of aldosterone in hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Circadian Rhythm; Diures | 1975 |
Mineralocorticoid hormones.
Topics: Acid-Base Imbalance; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Anima | 1976 |
Spirolactones: clinical and pharmacologic studies.
Topics: Aldosterone; Animals; Binding, Competitive; Canrenoic Acid; Canrenone; Diuresis; Humans; Hyperaldost | 1977 |
Control of aldosterone secretion.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Dogs; Humans; Hyperaldosteronism; | 1979 |
Renin-angiotensin system.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Amino Acid Sequence; Angiotens | 1975 |
Primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; | 1977 |
[Pathophysiological aspects of the renin-angiotensin-aldosterone system].
Topics: Adrenal Insufficiency; Aldosterone; Angiotensin II; Bartter Syndrome; Contraceptives, Oral; Half-Lif | 1977 |
Significance of renin and angiotensin in hypertension.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Angiotensin I; Angiotensin II; Female; Humans; Hyper | 1978 |
[Pathogenesis of arterial hypertension with a low renin activity in the blood plasma].
Topics: Adolescent; Adult; Age Factors; Aged; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteroni | 1978 |
[Primary hyperaldosteronism due to bilateral adrenal hyperplasia of the adrenals. Study based upon one case and a review of the literature (author's transl)].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Humans; Hyperaldosteronism; Hy | 1978 |
[Primary aldosteronism--aldosterone-induced sodium storing hypertension--symptoms and differential diagnosis].
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Alkalosis; Animals; Diagnosis, Differential; Dogs; F | 1979 |
An apraisal of the role of aldosterone and the sympathetic nervous system in essential hypertension.
Topics: Aldosterone; Animals; Disease Models, Animal; Humans; Hyperaldosteronism; Hypertension; Sympathetic | 1979 |
[Prostaglandins, kallikrein-kinin and dopamine. Practical implications of this vasodilator-natriuretic system].
Topics: Aldosterone; Angiotensin II; Anti-Inflammatory Agents; Arachidonic Acids; Bartter Syndrome; Bradykin | 1979 |
[Renin-angiotensin-aldosterone system: the present status and problems].
Topics: Aldosterone; Angiotensin II; Animals; Enzyme Activation; Enzyme Precursors; Feedback; Humans; Hypera | 1979 |
Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure.
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rat | 1976 |
[Determination of aldosterone and other mineralocorticoids].
Topics: Adolescent; Adult; Age Factors; Aldosterone; Child; Child, Preschool; Circadian Rhythm; Diet; Humans | 1976 |
Role of prostaglandins in the pathogenesis of Bartter's syndrome.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Body Composition; Body Weight; Chi | 1976 |
Inter-relationships between plasma angiotensin II, arterial pressure, aldosterone and exchangeable sodium in normotensive and hypertensive man.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Diet, Sodium-Restricted; Humans; Hyperaldosteronism; Hy | 1975 |
Aldosterone action, and the cost of flame photometry.
Topics: Aldosterone; Animals; Chlorides; Extracellular Space; Humans; Hydrocortisone; Hyperaldosteronism; Ki | 1992 |
Endocrinopathies of hyperfunction: Cushing's syndrome and aldosteronism.
Topics: Adrenocortical Hyperfunction; Adult; Aldosterone; Androgens; Cushing Syndrome; Humans; Hydrocortison | 1992 |
[The diagnosis of primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism | 1992 |
Cellular origin of aldosteronomas.
Topics: Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism | 1992 |
[The therapy of primary aldosteronism].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Carcinoma; Dexamethasone; Humans; Hy | 1992 |
Diagnosis of hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperplasia; Male | 1991 |
[Diagnosis of adrenal diseases focusing on morphological and endocrinological viewpoints].
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Magnetic R | 1991 |
Aldosterone-producing tumors (Conn's syndrome).
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Mid | 1990 |
Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenal | 1990 |
Primary hyperaldosteronism.
Topics: Aldosterone; Desoxycorticosterone; Electrolytes; Humans; Hyperaldosteronism; Hypertension; Kidney Tu | 1990 |
[The renin-angiotensin-aldosterone (RAA) system in endocrine diseases].
Topics: Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Cushing Syndrome; Endocrine System Diseases; H | 1990 |
Sodium intake, body sodium, and sodium excretion.
Topics: Adaptation, Physiological; Aldosterone; Humans; Hyperaldosteronism; Kidney; Male; Models, Biological | 1988 |
Pharmacological influences on aldosterone secretion.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Dopamine; Histamine; Humans; Hypera | 1987 |
Diagnosis and treatment of primary aldosteronism and isolated hypoaldosteronism.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Amiloride; Animals; Blood Pressure; Female; Human | 1985 |
Potassium metabolism and hypertension.
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aldosterone; Animals; Catecholamines; | 1985 |
Recent progress in the control of aldosterone secretion.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Blood Pressure; Blood Proteins; D | 1986 |
Hypertension: relating drug therapy to pathogenetic mechanisms.
Topics: Aldosterone; Angiotensinogen; Catecholamines; Creatinine; Humans; Hydrocortisone; Hyperaldosteronism | 1988 |
[New data on the regulation of aldosterone secretion (aldosterone-stimulating factor and the dopaminergic system)].
Topics: Adrenal Cortex; Aldosterone; Animals; Glycoproteins; Humans; Hyperaldosteronism; Proteins; Receptors | 1988 |
Regulation of aldosterone biosynthesis. Physiological and clinical aspects.
Topics: Adrenal Cortex; Age Factors; Aldosterone; Biogenic Amines; Cations; Enzyme Inhibitors; Feedback; Fem | 1987 |
[Clinical studies on a disorder of mineralocorticoid metabolism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Kanamycin; Ketoconazole; Metyrapone; Mineralocorticoids; Mi | 1986 |
[Current status and prospects of the laboratory diagnosis of arterial hypertension].
Topics: Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Catecholamines; Diagnosis, Differential; Human | 1986 |
Disorders of mineralocorticoid activity.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Glands; Adult; Aldosterone; Angiotensin II; Blood Specime | 1985 |
[Hypertensive syndrome in kidney diseases].
Topics: Aldosterone; Blood Pressure; Blood Volume; Diagnosis, Differential; Diuresis; Humans; Hyperaldostero | 1985 |
Assessment of adrenocortical function.
Topics: 17-Ketosteroids; Addison Disease; Adolescent; Adrenal Glands; Adrenal Insufficiency; Adult; Aldoster | 1971 |
Aldosteronism and hypertension.
Topics: Aldosterone; Angiotensin II; Hyperaldosteronism; Hypertension; Renin | 1965 |
Aldosterone in childhood.
Topics: Adolescent; Adrenal Glands; Adrenal Insufficiency; Adrenocortical Hyperfunction; Adrenocorticotropic | 1968 |
Aldosterone in clinical medicine.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Heart Failure; Humans; Hyperaldosteronism; | 1968 |
The regulation of aldosterone secretion by the renin-angiotensin system under various conditions.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Carcinoma, Bronch | 1968 |
[Adrenal cortex hormone secretion disorders and their clinical aspects].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Cushing Syndrome; Desoxycorticost | 1967 |
[Recent concept of primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Insufficiency; Aldosterone; Angiotensin II; Carbohydrate M | 1967 |
[Hypokalemic hypertension].
Topics: Acid-Base Equilibrium; Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Angiotensin II; Diureti | 1968 |
Recent developments in pathophysiologic studies of the renin-angiotensin system.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Amino Acid Sequence; Angiotensin II; Biological Assay | 1969 |
[Recent data on the physiopathologic metabolism of aldosterone].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Aorta; Edema; Female; Heart Disea | 1967 |
Control of aldosterone secretion by the renin-angiotensin system and by corticotropin.
Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Female; Humans; | 1968 |
[Experimental bases of the pathophysiology of the renin-angiotensin system].
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Female; Humans; Hyperaldosteronism; Hypertensi | 1968 |
[Renin-angiotensin-aldosterone system in blood pressure regulation disorders].
Topics: Adult; Aldosterone; Angiotensin II; Child; Electrolytes; Female; Humans; Hydrogen-Ion Concentration; | 1968 |
[Significance of renin in physiopathology and diagnosis].
Topics: Acute Kidney Injury; Aldosterone; Angiography; Angiotensin II; Humans; Hyperaldosteronism; Hypertens | 1969 |
[The role of renin in the pathophysiology and diagnosis, excluding pregnancy and its complications].
Topics: Aldosterone; Angiotensin II; Extracellular Space; Humans; Hyperaldosteronism; Hypertension; Kidney; | 1969 |
[New endocrine disorders attracting current interest--adrenal system].
Topics: Addison Disease; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Ho | 1969 |
[Primary aldosteronism (Conn's syndrome)].
Topics: Adolescent; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aldosterone; Female; Humans; Hyperald | 1969 |
[Hyperaldosteronism and the renin-angiotensin system].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Animals; Catecholamines | 1969 |
[The renin--angiotensin--aldosterone system].
Topics: Adrenal Cortex Hormones; Aldosterone; Angiotensin II; Animals; Arteries; Blood Pressure; Blood Volum | 1969 |
[Renin-angiotensin-aldosterone system from the clinical viewpoint].
Topics: Addison Disease; Aldosterone; Angiotensin II; Cushing Syndrome; Female; Humans; Hyperaldosteronism; | 1970 |
[Endocrine function tests for etiological diagnosis of hypertensive patients].
Topics: Adult; Aldosterone; Angiotensin II; Catecholamines; Cushing Syndrome; Endocrine Glands; Glucocortico | 1970 |
[Adrenal gland hyperfunctions].
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfuncti | 1970 |
Recent advances in human steroid metabolism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Carbon Isotopes; Dexamethasone; Estriol; Etiocholanolone; | 1970 |
[Role of the adrenal cortex in the pathogenesis of hypertension].
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Hydrocortisone; Hyperaldosteronism; Hypertension; Renin | 1970 |
[Renal hypertension].
Topics: Aldosterone; Angiotensin II; Animals; Calcium; Catecholamines; Dogs; Erythrocytes; Glomerulonephriti | 1970 |
[Recent progress in endocrinology].
Topics: Adrenocorticotropic Hormone; Aldosterone; Catecholamines; Endocrine System Diseases; Estrogens; Huma | 1971 |
[Aldosteronism--past, present and future].
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Potassium; Radioimmunoassay | 1971 |
[Menstrual cycle, pregnancy, and aldosterone].
Topics: Aldosterone; Angiotensin II; Female; Fetus; Humans; Hyperaldosteronism; Menstruation; Placenta; Preg | 1971 |
[Glucocorticoid responsive aldosteronism: our pediatric cases and presentation of concepts].
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Child; Dexamethas | 1971 |
[Juxtaglomerular cell tumor and aldosterone-secreting renal tumor].
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Female; Hemangiope | 1971 |
The relationship between angiotensin and aldosterone.
Topics: Adrenal Gland Neoplasms; Aldosterone; Alkalosis; Angiotensin II; Animals; Humans; Hyperaldosteronism | 1971 |
Perspectives in aldosterone and renin control.
Topics: Aldosterone; Angiotensin II; Animals; Bionics; Glomerular Filtration Rate; Humans; Hyperaldosteronis | 1971 |
[The renin-angiotensin-aldosterone system in arterial hypertension].
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Diagnosis, Differential; Feedback; Glomeru | 1971 |
[Primary aldosteronism].
Topics: Aldosterone; Angiotensin II; Aortography; Blood Glucose; Cushing Syndrome; Diagnosis, Differential; | 1971 |
Physiologic characteristics of hypertension.
Topics: Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Autonomic Nervous System; Blood Volume; Cardia | 1972 |
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Angiotensin II; Contraceptives, Oral; | 1972 |
[Hyperaldosteronism].
Topics: Acid-Base Equilibrium; Aldosterone; Angiotensin II; Blood Pressure; Feedback; Glomerular Filtration | 1972 |
[Abnormalities of sodium and water metabolism with special reference to hypertensive diseases].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hype | 1972 |
Endocrine causes of hypertension.
Topics: Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Catecholamines; | 1973 |
The physiology of renin.
Topics: Aldosterone; Angiotensin II; Edema; Extracellular Space; Female; Glomerular Filtration Rate; Humans; | 1973 |
[Clinical physiopathology of certain forms of secondary arterial hypertension].
Topics: Adenoma; Adult; Aged; Aldosterone; Angiotensin II; Female; Humans; Hyperaldosteronism; Hypertension, | 1973 |
Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; | 1973 |
The pathophysiology of renin.
Topics: Aldosterone; Angiotensin II; Animals; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; | 1973 |
[Renin-angiotensin-(aldosterone)-system-clinical aspects].
Topics: Acute Kidney Injury; Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Angioten | 1973 |
Perspectives on the renin-angiotensin-aldosterone system in hypertension.
Topics: Aldosterone; Angiotensin II; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; | 1974 |
Agents which block the action of the renin-angiotensin system.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; | 1974 |
[Primary hypo- and hyperreninism].
Topics: Addison Disease; Adolescent; Adult; Aldosterone; Angiotensin II; Blood Volume; Diagnosis, Differenti | 1974 |
[Hepatogenous (secondary) aldosteronism (author's transl)].
Topics: Aldosterone; Angiotensin II; Chronic Disease; Esophageal and Gastric Varices; Hepatitis; Hepatitis A | 1974 |
[Primary aldosteronism].
Topics: Aldosterone; Angiotensin II; Desoxycorticosterone; Glucocorticoids; Humans; Hyperaldosteronism; Hype | 1973 |
Low-renin hypertension.
Topics: Adrenal Glands; Age Factors; Aldosterone; Angiotensin II; Blood Volume; Extracellular Space; Female; | 1974 |
[Oral contraceptives and arterial hypertension].
Topics: Aldosterone; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Body Weight; Contraceptives | 1974 |
[Biosynthesis of mineral corticoid and secretory regulation factor: recent findings and criticisms].
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Dogs; Glucocortic | 1974 |
Adrenal mineralocorticoids causing hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Corticosterone; Desoxyc | 1972 |
Hyperplasia and tumors of the adrenal cortex.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; A | 1972 |
[Diagnosis and therapy of primary hyperaldosteronism].
Topics: Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; H | 1972 |
Sodium handling by the kidney in health and disease. A review.
Topics: Absorption; Aldosterone; Animals; Biological Transport, Active; Blood Pressure; Capillaries; Diabete | 1973 |
Aldosteronism updated.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Dexamethasone; Diagnosis, Differentia | 1973 |
The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Antihypertensive Agents; Carc | 1973 |
[Present trends in the diagnosis of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Desoxycorticosterone; Humans; Hyperaldosteronism; Pot | 1974 |
[Low renin essential hypertension].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium; Renin; Spironolactone; Trichlormet | 1973 |
Primary hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Corticosterone; Desoxycorticosterone; Electrocardiography; Hum | 1974 |
[Clinical course, diagnosis and treatment of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cushing Syndrome; Diagnosis, Differential; Fe | 1974 |
Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): a re-evaluation of the pathophysiology.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aldosterone; Child; Child, Preschool; Female; Humans; Hype | 1968 |
Aldosterone, the adrenal cortex, and hypertension.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Animals; Bloo | 1968 |
[Abnormal secretion of aldosterone].
Topics: Adrenal Insufficiency; Adrenocortical Hyperfunction; Aldosterone; Animals; Dysautonomia, Familial; E | 1967 |
[Recent pathological findings on tumors producing adrenal cortex hormones].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Glucocorticoids; Gonadal Steroid Hormo | 1967 |
Disorders of adrenal steroid biogenesis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; | 1967 |
[Aldosterone in the pathogenesis of metabolic alkalosis].
Topics: Acid-Base Equilibrium; Aldosterone; Alkalosis; Desoxycorticosterone; Gastric Juice; Humans; Hyperald | 1968 |
Commentary on incidence of primary aldosteronism: current estimations based on objective data.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Blood Pressure; Desoxycorticosterone; | 1969 |
[Role of aldosterone in the pathogenesis of cardiac insufficiency (review of the literature)].
Topics: Aldosterone; Animals; Cats; Chlorine; Depression, Chemical; Dogs; Edema; Heart Failure; Humans; Hype | 1967 |
Pathogenesis of ascites in cirrhosis of liver. II.
Topics: Aldosterone; Animals; Ascites; Ascitic Fluid; Ethanol; Heart Failure; Hemodynamics; Humans; Hyperald | 1969 |
[Aspect of hormones and hypertension].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Aldosterone; Blood Pressure; Catechol | 1969 |
[Approach to the etiological study of essential hypertension].
Topics: Aldosterone; Animals; Catecholamines; Diagnosis, Differential; Hemodynamics; Humans; Hyperaldosteron | 1969 |
[Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
Topics: Aldosterone; Ascites; Blood Proteins; Capillary Permeability; Diuretics; Edema; Electrolytes; Humans | 1969 |
[Hypertension and aldosterone].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1970 |
[Relations between aldosterone secretion and hypertension].
Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Hypertension | 1970 |
[Recent knowledge of diseases with abnormal aldosterone secretion].
Topics: Addison Disease; Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Aldosterone; A | 1971 |
[Aldosterone (including in the urinary content)--how to read its figures].
Topics: Adrenal Glands; Age Factors; Aldosterone; Blood Chemical Analysis; Circadian Rhythm; Diet; Extracell | 1971 |
[Primary aldosteronism--current concepts and diagnosis].
Topics: 17-Hydroxycorticosteroids; Aldosterone; Humans; Hyperaldosteronism; Radioimmunoassay; Renin | 1971 |
[Malignant hypertension with special reference to the role of aldosterone].
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Hypertension, Malignant; Prognosis | 1971 |
[Aldosterone and sodium balance].
Topics: Adrenal Insufficiency; Aldosterone; Cholesterol; Humans; Hyperaldosteronism; Sodium | 1970 |
[Hypermineralocorticoidism and hypertension].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Cushing Syndrome; Dexam | 1971 |
[Mineralocorticoid function of the adrenal cortex under normal conditions and in pathology (review of the literature)].
Topics: Adrenal Gland Diseases; Adrenal Glands; Adrenal Insufficiency; Adrenalectomy; Adult; Aging; Aldoster | 1971 |
[The third factor].
Topics: Aldosterone; Animals; Biological Assay; Dogs; Extracorporeal Circulation; Female; Glomerular Filtrat | 1971 |
[Aldosterone and aldosterone antagonists in surgery].
Topics: Adult; Aldosterone; Blood Volume; Brain Edema; Cardiac Surgical Procedures; Child; Digitalis Glycosi | 1971 |
[Aldosterone analysis (including urinary aldosterone test): interpretation of the test results].
Topics: Adrenal Glands; Adult; Age Factors; Aldosterone; Child; Circadian Rhythm; Diet; Humans; Hyperaldoste | 1969 |
Aldosterone and electrolyte balance in human hypertension.
Topics: Adrenocortical Hyperfunction; Aldosterone; Animals; Corticosterone; Furosemide; Humans; Hyperaldoste | 1970 |
Disorders of aldosterone secretion in childhood.
Topics: Adolescent; Adrenal Insufficiency; Adult; Aldosterone; Child; Child, Preschool; Female; Humans; Hype | 1966 |
82 trials available for aldosterone and Hyperaldosteronism
| Article | Year |
|---|---|
11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial.
Topics: Adrenal Glands; Aldosterone; Carbon Radioisotopes; Etomidate; Humans; Hyperaldosteronism; Pilot Proj | 2022 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
Topics: Aldosterone; Captopril; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Studies; | 2023 |
Surgical versus medical treatment for unilateral primary aldosteronism: an alternative to a randomized controlled trial.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: The salt CONNtrol trial.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Sodi | 2023 |
Enhanced CT-guided adrenal venous sampling versus traditional X-ray-guided adrenal venous sampling in patients with primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Retrospective Studies; Tomo | 2023 |
Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Biomarkers; Blood Specimen Collection; Female; Follow-Up Studies; Humans; | 2020 |
A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism.
Topics: Adrenal Cortex Function Tests; Adult; Aldosterone; Captopril; Diagnosis, Differential; Drug Administ | 2020 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial.
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Treatment Outcome | 2021 |
ACTH Stimulation Maximizes the Accuracy of Peripheral Steroid Profiling in Primary Aldosteronism Subtyping.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Cosyntropin; Diagnostic Techniques, Endocrine | 2021 |
Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Con Side of the Argument.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Blood | 2018 |
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
Topics: Aged; Aldosterone; Double-Blind Method; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathy | 2018 |
Treatment of Primary Aldosteronism With mTORC1 Inhibitors.
Topics: Adult; Aldosterone; Angiotensin II; Animals; Blood Pressure; Everolimus; Female; Hemodynamics; Human | 2019 |
Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Case-Control Studies; Cohort Studies; Dexamethasone; Diagn | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Blood Pre | 2013 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Captopril; Diuretics; Dose-Response Rel | 2014 |
Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism.
Topics: Aged; Aldosterone; Body Size; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertrop | 2013 |
Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Topics: Adrenal Cortex Function Tests; Adult; Aged; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldos | 2014 |
Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Topics: Adrenal Cortex Function Tests; Adult; Aged; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldos | 2014 |
Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Topics: Adrenal Cortex Function Tests; Adult; Aged; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldos | 2014 |
Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Topics: Adrenal Cortex Function Tests; Adult; Aged; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldos | 2014 |
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
Topics: Aldosterone; Blood Pressure; Bufanolides; Carotid Intima-Media Thickness; Essential Hypertension; Fe | 2015 |
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Diagnostic Techniques, Endocrine; Female; Humans; Hyperaldo | 2015 |
Serum aldosterone and cortisol concentrations before and after suppression with fludrocortisone in cats: a pilot study.
Topics: Administration, Oral; Aldosterone; Animals; Anti-Inflammatory Agents; Cat Diseases; Cats; Cross-Over | 2015 |
Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.
Topics: Adenoma; Adult; Age Factors; Aged; Aldosterone; Female; G Protein-Coupled Inwardly-Rectifying Potass | 2015 |
The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women.
Topics: Adult; Aldosterone; Cohort Studies; False Positive Reactions; Female; Gonadal Steroid Hormones; Huma | 2009 |
Physiologic variance of corticotropin affects diagnosis in adrenal vein sampling.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Cosyntropin; Diagnostic Techn | 2009 |
A reverse postural test as a screening tool for aldosterone-producing adenoma: a pilot study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Diagnosis, Differential; Exercise; Female; Hum | 2009 |
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.
Topics: Aldosterone; Bendroflumethiazide; Blood Pressure; Cross-Over Studies; Diuretics; Drug Therapy, Combi | 2010 |
Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Topics: Adult; Aged; Aldosterone; Area Under Curve; Captopril; Diagnosis, Differential; Female; Humans; Hype | 2010 |
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Aldosterone; Cath | 2010 |
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Aldosterone; Cath | 2010 |
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Aldosterone; Cath | 2010 |
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Aldosterone; Cath | 2010 |
Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Blood Pressure; Cytochrome P-450 CYP11B2; Fem | 2010 |
Aldosterone increases Na+ -K+ -ATPase activity in skeletal muscle of patients with Conn's syndrome.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Muscle, Skeletal; Potassi | 2011 |
Captopril suppression: limitations for confirmation of primary aldosteronism.
Topics: Adult; Aldosterone; Antihypertensive Agents; Captopril; Female; Health; Humans; Hyperaldosteronism; | 2011 |
Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients.
Topics: Adult; Aldosterone; Antidepressive Agents; Blood Pressure; Citalopram; Depression; Humans; Hydrocort | 2011 |
Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteron | 2011 |
Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients.
Topics: Adult; Aged; Aldosterone; Algorithms; Antihypertensive Agents; Diagnostic Techniques, Endocrine; Diu | 2012 |
Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Cardiomyopathies; Echocardiography; Fe | 2012 |
Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.
Topics: Aldosterone; Diagnostic Techniques and Procedures; Female; Fludrocortisone; Humans; Hyperaldosteroni | 2012 |
Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Female; Functional La | 2012 |
Hyperaldosteronism among black and white subjects with resistant hypertension.
Topics: Adult; Aged; Aged, 80 and over; Alabama; Aldosterone; Black People; Blood Pressure; Diuretics; Drug | 2002 |
Hyperaldosteronism among black and white subjects with resistant hypertension.
Topics: Adult; Aged; Aged, 80 and over; Alabama; Aldosterone; Black People; Blood Pressure; Diuretics; Drug | 2002 |
Hyperaldosteronism among black and white subjects with resistant hypertension.
Topics: Adult; Aged; Aged, 80 and over; Alabama; Aldosterone; Black People; Blood Pressure; Diuretics; Drug | 2002 |
Hyperaldosteronism among black and white subjects with resistant hypertension.
Topics: Adult; Aged; Aged, 80 and over; Alabama; Aldosterone; Black People; Blood Pressure; Diuretics; Drug | 2002 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, | 2002 |
Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; | 2003 |
Potassium supplementation improves the natriuretic response to central volume expansion in primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Diet; Dietary Sup | 2003 |
Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Differential Threshold; Female; Humans; | 2004 |
Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Calibration; Female; Humans; Hyperaldost | 2004 |
Comparison of sequential versus simultaneous methods of adrenal venous sampling.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Catheterizatio | 2004 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
Topics: Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2005 |
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Convertin | 2005 |
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate.
Topics: Adult; Aldosterone; Blood Pressure; Canrenoic Acid; Electrolytes; Female; Follow-Up Studies; Humans; | 2005 |
Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Cross-Over Studies; Double-Blind Method; Female; | 2006 |
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hydrocortisone; Hype | 2007 |
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hydrocortisone; Hype | 2007 |
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hydrocortisone; Hype | 2007 |
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hydrocortisone; Hype | 2007 |
Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism?
Topics: Adrenalectomy; Adult; Aldosterone; Angiotensin II; Baroreflex; Blood Pressure; Dose-Response Relatio | 2008 |
Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldost | 2008 |
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Amiloride; Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Diuretics | 1983 |
Spironolactone and triamterene in volume-dependent essential hypertension.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Hum | 1980 |
[Hyperaldosteronism after metoclopramide administration].
Topics: Adult; Aldosterone; Clinical Trials as Topic; Female; Humans; Hyperaldosteronism; Male; Metocloprami | 1980 |
[Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertensi | 1980 |
Normal sympathetic vasomotor and cardiac parasympathetic activities in patients with primary aldosteronism: assessment by spectral analysis.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Electroca | 1995 |
The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Captopril; Female; Humans; Hyperaldosteronism; Hypertensio | 1993 |
Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Dexamethasone; Female; H | 1993 |
Effect of dexamethasone on plasma free dopamine: dopaminergic modulation in hypertensive patients.
Topics: Adult; Aldosterone; alpha-Methyltyrosine; Dexamethasone; Dopamine; Dopamine Agents; Epinephrine; Hum | 1995 |
Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Dopamine; Dopamine Antagonists; Female; | 1995 |
Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension.
Topics: Adult; Aldosterone; Echocardiography; Female; Heart Ventricles; Humans; Hyperaldosteronism; Hyperten | 1996 |
Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Cisapride; Female; Humans; Hyperald | 1997 |
Effect of the serotonin4 receptor agonist cisapride on plasma aldosterone levels in cirrhotic patients with secondary hyperaldosteronism.
Topics: Aldosterone; Cisapride; Female; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Piperidines; Sero | 1998 |
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Blotting, Northern; C | 2000 |
Suppression of surgical hyperaldosteronism by potassium canrenoate during gynecologic surgery under sevoflurane anesthesia.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Anesthesia, Inhalation; Anesthetics, Inhalation; Bl | 2000 |
Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperal | 2000 |
Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocorticotropi | 2000 |
Efficacy of an angiotensin II receptor antagonist in managing hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compou | 2001 |
Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension.
Topics: Administration, Oral; Age Factors; Aldosterone; Angiotensin Receptor Antagonists; Antihypertensive A | 2001 |
Renin-aldosterone profiling in hypertension.
Topics: Aldosterone; Angiotensin II; Benzothiadiazines; Clinical Trials as Topic; Diagnosis, Differential; D | 1977 |
[Search for ways to correct volemic disorders in thyrotoxicosis before surgery].
Topics: Aldosterone; Blood Volume; Circadian Rhythm; Clinical Trials as Topic; Drug Evaluation; Humans; Hype | 1977 |
Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Female; Hemodynamics; Humans; Hydroco | 1990 |
Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism.
Topics: Administration, Oral; Adult; Aldosterone; Blood Pressure; Delayed-Action Preparations; Female; Human | 1990 |
Effect of ketanserin in primary aldosteronism.
Topics: Aldosterone; Blood Pressure; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension; Ketanserin; P | 1985 |
[Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism].
Topics: Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypera | 1989 |
Therapeutic value of calcium antagonists in autonomous hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Fema | 1989 |
Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesis.
Topics: Aldosterone; Blood Pressure; Dihydrotestosterone; Diuretics; Double-Blind Method; Female; Humans; Hy | 1989 |
Acute and chronic effect of nifedipine in primary aldosteronism.
Topics: Adenoma; Aldosterone; Antihypertensive Agents; Blood Pressure; Humans; Hyperaldosteronism; Nifedipin | 1989 |
Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dexamethasone; Female; Humans; Hydrocortisone; Hype | 1987 |
Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
Topics: Aldosterone; Canrenoic Acid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperald | 1988 |
Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism.
Topics: Adult; Aldosterone; Clinical Trials as Topic; Double-Blind Method; Fludrocortisone; Furosemide; Huma | 1985 |
The effect of metyrapone on aldosterone secretion in man.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Aldosterone; Body We | 1967 |
The postural plasma renin activity response in essential hypertension and primary hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Clinical Trials as Topic; Female; Humans; Hyperaldosteronism; Hypertension | 1969 |
2747 other studies available for aldosterone and Hyperaldosteronism
| Article | Year |
|---|---|
A Chinese pedigree with glucocorticoid remediable aldosteronism.
Topics: Adult; Aldosterone; China; Cytochrome P-450 CYP11B2; Glucocorticoids; Humans; Hyperaldosteronism; Hy | 2021 |
Retrospective study of aldosterone and progesterone secreting adrenal tumors in 10 cats.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Animals; Cat Diseases; Cats; Hy | 2021 |
Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors.
Topics: Adrenal Cortex Neoplasms; Aldosterone; Calcium; Humans; Hyperaldosteronism; Parathyroid Hormone; Ret | 2022 |
[Controversy and strategy of partial versus total adrenalectomy in the treatment of primary aldosteronism].
Topics: Adenoma; Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Neoplasm Recurrence | 2021 |
[The potential application of a three-dimensional visualization technique in adrenal vein sampling].
Topics: Adrenal Glands; Aldosterone; Blood Specimen Collection; Female; Humans; Hyperaldosteronism; Imaging, | 2021 |
The role of surgery in Conn's syndrome - a case of refractory hypertension secondary to an aldosterone secreting adenoma.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Male | 2021 |
The Effects of Verapamil, Hydralazine, and Doxazosin on Renin, Aldosterone, and the Ratio Thereof.
Topics: Aldosterone; Antihypertensive Agents; Doxazosin; Humans; Hydralazine; Hyperaldosteronism; Hypertensi | 2023 |
Hyperparathyroidism in patients with overt and mild primary aldosteronism.
Topics: Aldosterone; Calcium; Humans; Hyperaldosteronism; Hyperparathyroidism, Secondary; Parathyroid Hormon | 2021 |
Anatomical Variations of the Left Adrenal Vein Encountered During Venous Sampling.
Topics: Adrenal Glands; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Phlebography; Re | 2022 |
Colocalization of Wnt/β-Catenin and ACTH Signaling Pathways and Paracrine Regulation in Aldosterone-producing Adenoma.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Aldos | 2022 |
Prevalence of primary aldosteronism in type 2 diabetes mellitus and hypertension: A prospective study from Western India.
Topics: Adult; Aldosterone; Diabetes Mellitus, Type 2; Female; Humans; Hyperaldosteronism; Hypertension; Ind | 2022 |
Utility of Epinephrine Levels in Determining Adrenal Vein Cannulation During Adrenal Venous Sampling for Primary Aldosteronism.
Topics: Adrenal Glands; Aldosterone; Catheterization; Epinephrine; Humans; Hydrocortisone; Hyperaldosteronis | 2022 |
Developing an ultra-performance liquid chromatography-tandem mass spectrometry for detecting aldosterone in human plasma.
Topics: Adult; Aldosterone; Chromatography, High Pressure Liquid; Female; Humans; Hyperaldosteronism; Limit | 2021 |
Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism".
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Reni | 2022 |
Letter to the Editor From Paolo Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism".
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Reni | 2022 |
Recurrence of Primary Aldosteronism 10 Years After Left Adrenalectomy for Aldosterone-Producing Adenoma: A Case Report.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Prognosis | 2021 |
Indices of ACTH-stimulated adrenal venous sampling as predictors of postsurgical outcomes in primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; | 2022 |
Hypertension with unilateral adrenal aldosterone and cortisol cosecreting adenoma: A case report.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Humans; Hydrocortisone; Hyperal | 2021 |
Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Hypertension; | 2022 |
Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Humans; Hy | 2021 |
In Silico Analysis of the Gene Expression Patterns between Aldosterone-Producing Adenoma and Nonfunctional Adrenocortical Adenoma.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Gene Expression; Humans; Hyperaldosteronism; Membrane | 2021 |
Letter to the Editor From Singhania et al: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades-Yet an Underdiagnosed Disorder".
Topics: Aldosterone; Humans; Hyperaldosteronism; Incidence; Sweden | 2022 |
Response to Letter to the Editor From Singhania et al.: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet an Underdiagnosed Disorder".
Topics: Aldosterone; Humans; Hyperaldosteronism; Incidence; Sweden | 2022 |
Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism.
Topics: Adenoma; Aldosterone; Case-Control Studies; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Re | 2022 |
Prediction of long-term biochemical cure in patients with unilateral primary hyperaldosteronism treated surgically based on the early post-operative plasma aldosterone value.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Postoperative Period; Renin; R | 2022 |
γENaC/CD9 in urinary extracellular vesicles as a potential biomarker of MR activity.
Topics: Adult; Aged; Aldosterone; Biomarkers; Cohort Studies; Epithelial Sodium Channels; Extracellular Vesi | 2021 |
Evaluation of Intra-Renal Stiffness in Patients with Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Essential Hypertension; Female; Humans; Hyperaldosteronism; Hypertension; | 2022 |
Plasma aldosterone concentration is associated with white matter lesions in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Renin; Retrospectiv | 2022 |
Radiological characteristics and diagnostic impact of duplicated right adrenal veins on adrenal venous sampling in primary aldosteronism.
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studi | 2021 |
Aldosterone-producing nodules and CYP11B1 signaling correlate in primary aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Steroid 11-beta-Hydr | 2022 |
Screening Rate for Primary Aldosteronism Among Patients With Apparent Treatment-Resistant Hypertension: Retrospective Analysis of Current Practice.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Mass Scree | 2022 |
Suspected primary hyperreninism in a cat with malignant renal sarcoma and global renin-angiotensin-aldosterone system upregulation.
Topics: Aldosterone; Animals; Cat Diseases; Cats; Hyperaldosteronism; Hypertension; Kidney Neoplasms; Male; | 2022 |
Positive Association Between Plasma Aldosterone Concentration and White Matter Lesions in Patients With Hypertension.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Magnetic Resonance Imaging; Ma | 2021 |
Enhanced performance of a modified diagnostic test of primary aldosteronism in patients with adrenal adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Dexamethasone; Female; Humans | 2022 |
Morphologically Normal-Appearing Adrenal Glands as a Prevalent Source of Aldosterone Production in Primary Aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies; Tomog | 2022 |
Th17/Treg imbalance in patients with primary hyperaldosteronism and resistant hypertension.
Topics: Aldosterone; Angiotensin II; Blood Pressure Monitoring, Ambulatory; Forkhead Transcription Factors; | 2022 |
External Validation of Clinical Prediction Models in Unilateral Primary Aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged; Models, Statistical; Pro | 2022 |
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy.
Topics: Aldosterone; Humans; Hyperaldosteronism; Immunoassay; Mass Spectrometry; Renin; Saline Solution | 2022 |
Letter to editor on "Thirty-six-month results of laparoscopic-based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone-producing Adenoma".
Topics: Adenoma; Adrenalectomy; Aldosterone; Denervation; Humans; Hyperaldosteronism; Hypertension; Laparosc | 2022 |
Mass spectrometry-based cortisol profiling during adrenal venous sampling reveals misdiagnosis for subtyping primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Chromatography, Liquid; Diagnostic Errors; Humans; Hydrocortisone; Hype | 2022 |
Screening for primary aldosteronism in the diabetic population: a cohort study.
Topics: Aldosterone; Cohort Studies; Diabetes Mellitus, Type 2; Humans; Hyperaldosteronism; Hypertension; Ma | 2023 |
Higher Plasma Aldosterone Concentrations Are Associated With Elevated Risk of Aortic Dissection and Aneurysm: a Case-Control Study.
Topics: Aldosterone; Aortic Dissection; Case-Control Studies; Female; Humans; Hyperaldosteronism; Hypertensi | 2022 |
Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA).
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Amlodipine; Calcium Channel Blockers; | 2022 |
Prognostic value of contralateral suppression for remission after surgery in patients with primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteron | 2022 |
[Diagnosis and therapy of primary aldosteronism: new aspects].
Topics: Adrenalectomy; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hyperplasia; Hypert | 2022 |
Primary Aldosteronism: Imaging vs. Lateralization.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism | 2022 |
Establishing Reference Ranges for Aldosterone, Renin and Aldosterone-to-Renin Ratio for Women in the Third-Trimester of Pregnancy.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Pregnancy; Pregnancy Trimester | 2022 |
Syndromes of Pseudo-Hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Renin; Syndrome | 2022 |
Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling.
Topics: Adrenal Glands; Aldosterone; Androgens; Androstenedione; Cosyntropin; Dehydroepiandrosterone; Humans | 2022 |
Screening for primary aldosteronism is underutilised in patients with chronic kidney disease.
Topics: Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium; Renal Insufficiency, Chroni | 2022 |
Detecting primary aldosteronism in Australian primary care: a prospective study.
Topics: Adult; Aldosterone; Australia; Humans; Hyperaldosteronism; Hypertension; Primary Health Care; Prospe | 2022 |
The Accuracy of Simple and Adjusted Aldosterone Indices for Assessing Selectivity and Lateralization of Adrenal Vein Sampling in the Diagnosis of Primary Aldosteronism Subtypes.
Topics: Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hyperplasia; Hypokalemia; Reproducibility o | 2022 |
Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; DNA Methylation; Humans; Hyperaldosteronism; Mutation; | 2022 |
Application of Metanephrine and Normetanephrine in Evaluating the Selectivity of Adrenal Vein Sampling.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Metanephrine; Normetanephri | 2022 |
Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling.
Topics: Adrenal Glands; Adult; Aldosterone; Catheters; Humans; Hydrocortisone; Hyperaldosteronism; Metanephr | 2022 |
KCNJ5 Somatic Mutation Is Associated With Higher Aortic Wall Thickness and Less Calcification in Patients With Aldosterone-Producing Adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Aorta; Calcinosis; G Protein | 2022 |
Discordant imaging: adrenal vein sampling in almost half of patients with primary aldosteronism and a unilateral adrenal adenoma.
Topics: Adenoma; Adrenal Glands; Adult; Aged; Aldosterone; Humans; Hyperaldosteronism; Middle Aged; Retrospe | 2023 |
Plasma aldosterone to renin ratio for the detection of primary aldosteronism in patients with drug-resistant hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2022 |
Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk.
Topics: Aldosterone; Cross-Sectional Studies; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Prot | 2022 |
True unilateral primary aldosteronism exists, and unilateral adrenalectomy saves lives.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism | 2022 |
Primary aldosteronism in pregnancy: diagnostic and therapeutic challenges.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Female; Humans; Hyperaldosteronism; Pr | 2022 |
Machine learning-based models for predicting clinical outcomes after surgery in unilateral primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Antihypertensive Agents; Cross-Sectional Studies; Humans; Hyperaldostero | 2022 |
Re-Assessment of the Oral Salt Loading Test Using a New Chemiluminescent Enzyme Immunoassay Based on a Two-Step Sandwich Method to Measure 24-Hour Urine Aldosterone Excretion.
Topics: Aldosterone; Chromatography, Liquid; Humans; Hyperaldosteronism; Immunoenzyme Techniques; Sodium Chl | 2022 |
Case Report: Primary Aldosteronism Due to Bilateral Aldosterone-Producing Micronodules With HISTALDO Classical and Contralateral Non-Classical Pathology.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Female; G Protein-Coupled In | 2022 |
Early Renin Recovery After Adrenalectomy in Aldosterone-Producing Adenomas: A Prospective Study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone | 2022 |
Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism.
Topics: Adrenalectomy; Aldosterone; Algorithms; Female; Humans; Hyperaldosteronism; Retrospective Studies | 2022 |
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Japan; Mineralocorticoid Recep | 2022 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2022 |
The Role of Urinary Extracellular Vesicles Sodium Chloride Cotransporter in Subtyping Primary Aldosteronism.
Topics: Aldosterone; Biomarkers; Extracellular Vesicles; G Protein-Coupled Inwardly-Rectifying Potassium Cha | 2022 |
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppression.
Topics: Adenoma; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Humans; Hydrocortisone; H | 2022 |
[Immunogenetics of primary hyperaldosteronism: fundamental studies and their clinical prospects].
Topics: Adrenal Glands; Aldosterone; Autoantibodies; Humans; Hyperaldosteronism; Immunogenetics | 2022 |
Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Embolic Stroke; Humans; Hyperaldosteronism; Hypertension; Renin; S | 2022 |
Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-R | 2022 |
Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data.
Topics: Aldosterone; Ankle Brachial Index; Cross-Sectional Studies; Fibrosis; Follow-Up Studies; Humans; Hyd | 2022 |
Machine learning approach to predict subtypes of primary aldosteronism is helpful to estimate indication of adrenal vein sampling.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Machine Learning; Renin; Retrospective Stud | 2022 |
Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study.
Topics: Aldosterone; Atherosclerosis; Atrial Fibrillation; Heart Atria; Heart Failure; Humans; Hyperaldoster | 2022 |
Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in primary aldosteronism.
Topics: Adrenalectomy; Aged; Aldosterone; Cost-Benefit Analysis; Humans; Hyperaldosteronism; Medicare; Tomog | 2022 |
Radiomics utilization to differentiate nonfunctional adenoma in essential hypertension and functional adenoma in primary aldosteronism.
Topics: Adenoma; Adrenalectomy; Aldosterone; Essential Hypertension; Humans; Hyperaldosteronism; Retrospecti | 2022 |
Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.
Topics: Aldosterone; Cortisone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Lipocalin | 2022 |
Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea.
Topics: Adult; Aldosterone; Blood Pressure Monitoring, Ambulatory; Female; Humans; Hyperaldosteronism; Hyper | 2022 |
'I can't understand why others don't screen more': a qualitative study exploring why Australian general practitioners screen for primary aldosteronism.
Topics: Aldosterone; Antihypertensive Agents; Australia; Female; General Practitioners; Humans; Hyperaldoste | 2022 |
Usefulness and accuracy of segmental adrenal venous sampling on localisation and functional diagnosis of various adrenal lesions in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Retrospective Studies | 2022 |
Liddle syndrome misdiagnosed as primary aldosteronism is caused by inaccurate aldosterone-rennin detection while a novel
Topics: Adult; Aldosterone; Chymosin; Diagnostic Errors; Epithelial Sodium Channels; Female; Humans; Hyperal | 2022 |
Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register).
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Magnetic Resonance Imaging; | 2022 |
A Novel Somatic Mutation of
Topics: Adrenalectomy; Aldosterone; Calcium Channels, T-Type; Cytochrome P-450 CYP11B2; Humans; Hyperaldoste | 2022 |
Ambulatory fludrocortisone suppression test in the diagnosis of primary aldosteronism: Safety, accuracy and cost-effectiveness.
Topics: Aldosterone; Cost-Benefit Analysis; Fludrocortisone; Humans; Hyperaldosteronism; Hypertension; Renin | 2022 |
Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism.
Topics: Aldosterone; Cardiovascular Diseases; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Re | 2022 |
Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients With Primary Aldosteronism.
Topics: Aldosterone; Echocardiography; Humans; Hyperaldosteronism; Hypertension; Hypertrophy, Left Ventricul | 2022 |
Histopathology and Genetic Causes of Primary Aldosteronism in Young Adults.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channels, L-T | 2022 |
Subtyping primary aldosteronism by inconclusive adrenal vein sampling: A derivation and validation study in a tertiary centre.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Retrospectiv | 2022 |
Reliability Analysis of a Functional Diagnostic Test for Primary Hyperaldosteronism Based on Data Analysis.
Topics: Aldosterone; Data Analysis; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Hypertension; Ren | 2022 |
Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aldosterone; Cytochrome P-450 CYP11B2; Hum | 2022 |
Assessment of cardiovascular disease risk by plasma renin activity changes in patients with primary aldosteronism on mineralocorticoid receptor antagonist treatment.
Topics: Aldosterone; Cardiovascular Diseases; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagon | 2022 |
Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Male; Mass Screen | 2022 |
Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Australia; Humans; Hyperaldosteronism; Potassium; Retros | 2022 |
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects.
Topics: Adenoma; Aldosterone; Diabetes Mellitus, Type 2; Female; Humans; Hydrocortisone; Hyperaldosteronism; | 2022 |
Newly diagnosed diabetes mellitus is a risk factor for cardiocerebrovascular events in primary aldosteronism.
Topics: Aldosterone; Diabetes Mellitus; Humans; Hyperaldosteronism; Prevalence; Retrospective Studies; Risk | 2022 |
[Unilateral primary aldosteronism with "negative" adrenal CT imaging: a case report].
Topics: Aldosterone; Humans; Hyperaldosteronism; Tomography, X-Ray Computed | 2022 |
Clinical and biochemical predictors and predictive model of primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Middle Aged; | 2022 |
Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Reproducibility of Results | 2022 |
Two cases of aldosterone and cortisol producing adenoma with different histopathological features: A case report.
Topics: Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hydrocortisone; Hyperaldosteronism; Hyperten | 2022 |
Changes of the CYP11B2 Expressing Zona Glomerulosa in Human Adrenals From Birth to 40 Years of Age.
Topics: Adenoma; Adolescent; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Child; Child, Presc | 2022 |
Genetic screening of hypertensive patients with aldosterone hypersecretion under conditions of stress.
Topics: Aldosterone; Genetic Testing; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor A | 2022 |
Primary aldosteronism caused by a pI157S somatic
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Child; Female; G | 2022 |
Influence of cortisol cosecretion on non-ACTH-stimulated adrenal venous sampling in primary aldosteronism: a retrospective cohort study.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Dexamethasone; Hu | 2022 |
Prevalence of Primary Aldosteronism in Newly Diagnosed Hypertensive Patients in Primary Care.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Prevalence; Primary Health Care; | 2022 |
Aldosterone-Producing Adenomas of Increased Size Are Associated With Higher Steroidogenic Activity.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-Rectifying Potassium Channe | 2022 |
Clinical Characteristics of Target Organ Damage in Primary Aldosteronism with or without Metabolic Syndrome.
Topics: Albuminuria; Aldosterone; Cardiomegaly; Carotid Intima-Media Thickness; Glucose; Humans; Hyperaldost | 2022 |
Impact of dedicated multidisciplinary service on patient selection and outcomes for surgical treatment of primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Patient Selection; Retrospecti | 2022 |
Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes.
Topics: Adrenalectomy; Aldosterone; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; Essential Hype | 2022 |
Intrinsic Adrenal TWIK-Related Acid-Sensitive TASK Channel Dysfunction Produces Spontaneous Calcium Oscillations Sufficient to Drive AngII (Angiotensin II)-Unresponsive Hyperaldosteronism.
Topics: Aldosterone; Angiotensin II; Animals; Calcium; Calcium Signaling; Hyperaldosteronism; Mice; Zona Glo | 2022 |
Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies | 2022 |
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Fibrillation; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; M | 2023 |
Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Renin; Retrospecti | 2022 |
Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical C | 2022 |
Primary aldosteronism presenting as embolic myocardial infarction.
Topics: Adrenal Glands; Aldosterone; Arrhythmias, Cardiac; Embolism; Female; Humans; Hyperaldosteronism; Hyp | 2022 |
Intraprocedural cortisol testing improves adrenal vein cannulation success and diagnostic accuracy in assessment of primary aldosteronism, in a medium throughput centre.
Topics: Adrenal Glands; Aldosterone; Catheterization; Humans; Hydrocortisone; Hyperaldosteronism; Retrospect | 2023 |
Screening for primary aldosteronism: The "PA" Shiny app.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Mobile Applications; Renin | 2022 |
Unilateral Adrenalectomy for Primary Aldosteronism Due to Bilateral Adrenal Disease Can Result in Resolution of Hypokalemia and Amelioration of Hypertension.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperald | 2023 |
[History, current situation and disputes over adrenal vein sampling in the diagnosis and treatment of primary aldosteronism].
Topics: Aldosterone; Dissent and Disputes; Humans; Hyperaldosteronism; Retrospective Studies | 2022 |
Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenalectomy; Aldosterone; Catheters; Humans; Hyperaldosteronism; Hypertension; Retrospect | 2023 |
Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: The potential importance of post-treatment plasma renin levels.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor An | 2023 |
Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemia; Kidney; Progno | 2023 |
Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with bilateral adrenal masses.
Topics: Adrenal Gland Diseases; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Hum | 2023 |
Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Cardiovascular Diseases; Humans; Hyperaldos | 2022 |
[Primary hyperaldosteronism: indications for screening].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Renin | 2022 |
The performance of left/right adrenal volume ratio and volume difference in predicting unilateral primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Case-Control Studies; Humans; Hyperaldosteronism; Retros | 2023 |
Screening for unilateral aldosteronism should be combined with the maximum systolic blood pressure, history of stroke and typical nodules.
Topics: Adrenal Glands; Aldosterone; Blood Pressure; China; Humans; Hyperaldosteronism; Hyperplasia; Middle | 2022 |
[Research progress of ACTH stimulation test with 1 mg dexamethasone suppression test in determining the subtypes of primary aldosteronism].
Topics: Adrenocorticotropic Hormone; Aldosterone; Dexamethasone; Humans; Hydrocortisone; Hyperaldosteronism | 2022 |
Implication of MR Activity in Posttreatment Arterial Stiffness Reversal in Patients With Primary Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Pulse Wave Analysis; Renin; Vascular Stiffnes | 2023 |
Left adrenal aldosteronism coexisting with left paraaortic paraganglioma presenting as bilateral adrenal and left paraaortic tumors- comprehensive adrenal evaluation aiding perfect management: a case report.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Humans; | 2022 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Cost Analysis of Radiofrequency Ablation for Adrenal Adenoma in Patients with Primary Aldosteronism and Hypertension: Results from the ADERADHTA Pilot Study and Comparison with Surgical Adrenalectomy.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Costs and Cost Analysis; Humans; Hype | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Evaluation of standardized uptake value on
Topics: Adenoma; Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Radionucli | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
Intra-individual Variability of Serum Aldosterone and Implications for Primary Aldosteronism Screening.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Renin | 2023 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
TSPAN12 (Tetraspanin 12) Is a Novel Negative Regulator of Aldosterone Production in Adrenal Physiology and Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II; Animals; Hum | 2023 |
An elderly patient with 17α-hydroxylase deficiency misdiagnosed as primary aldosteronism: a case report.
Topics: Adult; Aged; Aldosterone; Diagnostic Errors; Female; Humans; Hydrocortisone; Hyperaldosteronism; Met | 2022 |
An elderly patient with 17α-hydroxylase deficiency misdiagnosed as primary aldosteronism: a case report.
Topics: Adult; Aged; Aldosterone; Diagnostic Errors; Female; Humans; Hydrocortisone; Hyperaldosteronism; Met | 2022 |
An elderly patient with 17α-hydroxylase deficiency misdiagnosed as primary aldosteronism: a case report.
Topics: Adult; Aged; Aldosterone; Diagnostic Errors; Female; Humans; Hydrocortisone; Hyperaldosteronism; Met | 2022 |
An elderly patient with 17α-hydroxylase deficiency misdiagnosed as primary aldosteronism: a case report.
Topics: Adult; Aged; Aldosterone; Diagnostic Errors; Female; Humans; Hydrocortisone; Hyperaldosteronism; Met | 2022 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Node-by-node diagnosis for multiple ipsilateral nodules by segmental adrenal venous sampling in primary aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Retrospec | 2023 |
Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism.
Topics: Aldosterone; Chromatography, Liquid; Humans; Hyperaldosteronism; Immunoassay; Saline Solution; Sitti | 2022 |
Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism.
Topics: Aldosterone; Chromatography, Liquid; Humans; Hyperaldosteronism; Immunoassay; Saline Solution; Sitti | 2022 |
Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism.
Topics: Aldosterone; Chromatography, Liquid; Humans; Hyperaldosteronism; Immunoassay; Saline Solution; Sitti | 2022 |
Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism.
Topics: Aldosterone; Chromatography, Liquid; Humans; Hyperaldosteronism; Immunoassay; Saline Solution; Sitti | 2022 |
Primary aldosteronism is a clinical issue that should not be underestimated anymore.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Primary aldosteronism is a clinical issue that should not be underestimated anymore.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Primary aldosteronism is a clinical issue that should not be underestimated anymore.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Primary aldosteronism is a clinical issue that should not be underestimated anymore.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism.
Topics: Adolescent; Aldosterone; Diagnostic Errors; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; L | 2023 |
A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism.
Topics: Adolescent; Aldosterone; Diagnostic Errors; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; L | 2023 |
A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism.
Topics: Adolescent; Aldosterone; Diagnostic Errors; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; L | 2023 |
A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism.
Topics: Adolescent; Aldosterone; Diagnostic Errors; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; L | 2023 |
Adrenal Vein Sampling Results and Surgical Outcomes in Patients with a Normal Plasma Aldosterone Concentration.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Retrospective S | 2023 |
Adrenal Vein Sampling Results and Surgical Outcomes in Patients with a Normal Plasma Aldosterone Concentration.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Retrospective S | 2023 |
Adrenal Vein Sampling Results and Surgical Outcomes in Patients with a Normal Plasma Aldosterone Concentration.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Retrospective S | 2023 |
Adrenal Vein Sampling Results and Surgical Outcomes in Patients with a Normal Plasma Aldosterone Concentration.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Retrospective S | 2023 |
A new machine learning-based prediction model for subtype diagnosis in primary aldosteronism.
Topics: Aldosterone; Artificial Intelligence; Captopril; Humans; Hyperaldosteronism; Machine Learning | 2022 |
A new machine learning-based prediction model for subtype diagnosis in primary aldosteronism.
Topics: Aldosterone; Artificial Intelligence; Captopril; Humans; Hyperaldosteronism; Machine Learning | 2022 |
A new machine learning-based prediction model for subtype diagnosis in primary aldosteronism.
Topics: Aldosterone; Artificial Intelligence; Captopril; Humans; Hyperaldosteronism; Machine Learning | 2022 |
A new machine learning-based prediction model for subtype diagnosis in primary aldosteronism.
Topics: Aldosterone; Artificial Intelligence; Captopril; Humans; Hyperaldosteronism; Machine Learning | 2022 |
Adrenal ablation therapy for unilateral primary aldosteronism: pros and cons.
Topics: Adenoma; Adrenal Glands; Aldosterone; Catheters; Humans; Hyperaldosteronism | 2023 |
Fatty acids as a direct regulator of aldosterone hypersecretion.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Fatty Acids; Humans; Hyperaldosteronism; Hypertension; Palmit | 2023 |
Pre-interventional assessment of right renal to right adrenal vein distance: Impact on procedure time and radiation dose in adrenal vein sampling.
Topics: Adrenal Glands; Aldosterone; Contrast Media; Humans; Hyperaldosteronism; Radiation Dosage; Retrospec | 2022 |
Autonomous cortisol secretion in patients with primary aldosteronism: A possible risk factor for new-onset diabetes mellitus.
Topics: Aldosterone; Diabetes Mellitus; Humans; Hydrocortisone; Hyperaldosteronism; Risk Factors | 2023 |
Role of Renin-Angiotensin-Aldosterone System and Cortisol in Endometriosis: A Preliminary Report.
Topics: Aldosterone; Endometriosis; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hypothalamo-Hypophys | 2022 |
Subtyping primary aldosteronism by inconclusive adrenal vein sampling.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies | 2023 |
Effect of Oral Contraception on Screening Tests for Primary Aldosteronism: A 10-Year Longitudinal Study.
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Longitudinal Studi | 2023 |
Advances in Medical Treatment of Primary Aldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Ant | 2023 |
Diabetes mellitus is associated with more adverse non-hemodynamic left ventricular remodeling and less recovery in patients with primary aldosteronism.
Topics: Aldosterone; Diabetes Mellitus; Echocardiography; Humans; Hyperaldosteronism; Hypertension; Hypertro | 2023 |
Saline suppression to distinguish the primary aldosteronism subtype: a diagnostic study.
Topics: Adrenal Glands; Aldosterone; Australia; Cohort Studies; Humans; Hyperaldosteronism; Retrospective St | 2023 |
New CT Scan Distinguishes Primary Aldosteronism Subtypes.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Tomography, X-Ray Computed | 2023 |
Acute psychotic episode inaugurating a primary hyperaldosteronism: a case report.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypok | 2022 |
The effect of age, sex and BMI on the aldosterone-to-renin ratio in essential hypertensive individuals.
Topics: Aldosterone; Body Mass Index; Female; Humans; Hyperaldosteronism; Hypertension; Male; Renin | 2023 |
Decreasing the Effects of Aldosterone in Resistant Hypertension - A Success Story.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension | 2023 |
Aldosterone and Treatment-Resistant Hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Monit | 2023 |
Malignant Hypertension and Bilateral Primary Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Mineralocorticoid Re | 2023 |
Coexistence of Pheochromocytoma and Primary Aldosteronism due to Multiple Aldosterone-producing Micronodules in the Ipsilateral Adrenal Gland.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Female; Humans; Hyperaldosteron | 2023 |
International multicenter survey on screening and confirmatory testing in primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Surveys and Questionnaires | 2023 |
Significance of computed tomography combined with postural stimulation test in predicting laterality of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Predictive Value of Tests; Retrospective St | 2023 |
Aldosterone Synthase Inhibitors and the Treatment of Essential Hypertension.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Essential Hypertension; Humans; Hyperaldosteronism; Hypertens | 2023 |
Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism.
Topics: Aldosterone; Cardiovascular Diseases; Humans; Hyperaldosteronism; Hypertension; Intra-Abdominal Fat; | 2023 |
Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
Topics: Aldosterone; Captopril; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Immunoassay; Renin; R | 2023 |
Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Female; Humans; Hyperaldosteron | 2023 |
RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Renin | 2023 |
A hyperaldosteronism subtypes predictive model using ensemble learning.
Topics: Adenoma; Aldosterone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Potassium; | 2023 |
Unilateral adrenalectomy in bilateral adrenal hyperplasia with primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Hyperplasia | 2023 |
[Noninvasive stratification of primary aldosteronism: a glimpse of latest updates].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Phosphoproteomics Reveals the Wolframin-Calcium Axis as an Important Pathogenic Signaling Node in Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Calcium; Calcium Signaling; | 2023 |
Screening for Primary Aldosteronism Among Hypertensive Adults with Obstructive Sleep Apnea: A Retrospective Population-Based Study.
Topics: Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Ontario; Renin; Retrospec | 2023 |
Visceral fat: a bad companion for mineralocorticoid receptor overactivation.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Intra-Abdominal Fat; Receptors, Mineralocorti | 2023 |
Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hyperkalemia; Hypertension; | 2023 |
Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study.
Topics: Adrenal Glands; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Renin; Retrospective Studie | 2023 |
An Abbreviated History of Aldosterone Metabolism, Current and Future Challenges.
Topics: Aldosterone; Animals; Glucuronides; Glucuronosyltransferase; Hyperaldosteronism; Hypertension | 2023 |
18-Oxocortisol: A journey.
Topics: Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; G Protein-Coupled Inwardly-Rectifying Potassium Chan | 2023 |
[Clinical Characteristics of Obstructive Sleep Apnea and Comorbid Primary Aldosteronism].
Topics: Aldosterone; Comorbidity; Humans; Hyperaldosteronism; Retrospective Studies; Sleep Apnea, Obstructiv | 2023 |
Different cell compositions and a novel somatic
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cushing Syndrome; Cyt | 2023 |
Prevalence of Cortisol Cosecretion in Patients With Primary Aldosteronism: Role of Metanephrine in Adrenal Vein Sampling.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Metanephrine; Prevalence; R | 2023 |
Reference intervals for LC-MS /MS measurements of plasma renin activity, aldosterone, angiotensin II, and 24-hour urinary aldosterone in Northern Chinese Han population.
Topics: Aldosterone; Angiotensin II; Chromatography, Liquid; East Asian People; Healthy Volunteers; Humans; | 2023 |
Renal Artery Stenosis Complicated with Primary Aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Renal Artery Obstruction; Reni | 2023 |
Decoding Hypertension Through Primary Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Using Renin Activity to Guide Mineralocorticoid Receptor Antagonist Therapy in Patients with Low Renin and Hypertension.
Topics: Adult; Aldosterone; Cohort Studies; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Rece | 2023 |
Diagnostic accuracy of using multiple cytokines to predict aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Biomarkers; Chemokine C | 2023 |
Hypertension in Primary Aldosteronism Is Initiated by Salt-Induced Increases in Vascular Resistance With Reductions in Cardiac Output.
Topics: Aldosterone; Animals; Blood Pressure; Cardiac Output; Hemodynamics; Hyperaldosteronism; Hypertension | 2023 |
Primary Aldosteronism and Drug Resistant Hypertension: A "Chicken-Egg" Story.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Risk Factors | 2023 |
Evidence and Uncertainties Surrounding Renin-Guided Medical Therapy for Primary Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Miner | 2023 |
[Adrenalectomy for primary hyperaldosteronism : retrospective review of 57 patients in CHU of Liege].
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Retros | 2023 |
Screening for primary aldosteronism in primary care.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Primary Health Care; Renin | 2023 |
Unique Case of Cardiomyopathy Secondary to Adrenal Adenoma (Primary-Aldosteronism).
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Cardiomyopathies; Female; Humans; Hyperaldosteronism; | 2023 |
Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Antioxidants; Cytochrome P-4 | 2023 |
The Prevalence of Primary Aldosteronism in Screening Populations: Is Hypokalaemia Important?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Mass Screening; Prevalence | 2023 |
Duplicated adrenal veins in primary aldosteronism misdiagnosed with ectopic aldosteronoma due to apparent bilateral aldosterone suppression.
Topics: Adrenal Glands; Aldosterone; Diagnostic Errors; Humans; Hyperaldosteronism; Hypertension; Hypokalemi | 2023 |
Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Feasibility St | 2023 |
Adrenocorticotropic hormone application lowered aldosterone/cortisol value on dominant side without superior surgical outcomes during adrenal venous sampling.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism | 2023 |
Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Renin; Reproducibility of Result | 2023 |
Adrenal Vein Sampling in the Young - Necessary or Not?
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Retrospect | 2023 |
Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses.
Topics: Aldosterone; Diabetes Mellitus; Genome-Wide Association Study; Humans; Hyperaldosteronism; Mendelian | 2023 |
High plasma aldosterone concentration is associated with worse 24-h ambulatory blood pressure profile in patients with primary aldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Car | 2023 |
[Diagnosis and treatment of aldosterone-producing adenoma presenting as bilateral adrenal lesions: a case report].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism | 2023 |
Biochemical Evaluation by Confirmatory Tests after Unilateral Adrenalectomy for Primary Aldosteronism.
Topics: Adrenalectomy; Aldosterone; Captopril; Furosemide; Humans; Hyperaldosteronism; Hypertension; Renin; | 2023 |
A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism.
Topics: Aldosterone; Chromatography, Liquid; Glucuronidase; Glucuronides; Humans; Hydrolysis; Hyperaldostero | 2023 |
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cell Adhesion Molecule-1; Cytochrome | 2023 |
Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC-MS/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol.
Topics: Adrenocorticotropic Hormone; Aldosterone; Chromatography, Liquid; Humans; Hydrocortisone; Hyperaldos | 2023 |
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies | 2023 |
Case series: Primary aldosteronism diagnosed despite normal screening investigations: A report of three cases.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Positron Emi | 2023 |
Role of adrenal venous sampling in the differential diagnosis and treatment protocol of ACTH-independent Cushing's syndrome with bilateral adrenal lesions.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Clinical Protocols; Cushing Syndrome; Diag | 2023 |
Association of urinary liver-type fatty acid-binding protein with outcomes after adrenalectomy for unilateral primary aldosteronism.
Topics: Adrenalectomy; Adult; Aldosterone; Creatinine; Female; Humans; Hyperaldosteronism; Hypertension; Liv | 2023 |
Importance of plasma aldosterone concentrations as a clinical indicator of nocturnal hypertension in primary aldosteronism.
Topics: Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hyperaldosteronism; Hype | 2023 |
Prolonged postoperative hypoaldosteronism related to hyperkalemia in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemi | 2023 |
Non-suppression of renin by renal cysts in a subset of patients with primary aldosteronism-a prospective observational single center study.
Topics: Adult; Aged; Aldosterone; Cysts; Female; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases, | 2023 |
Using plasma aldosterone concentrations at 1 h of saline infusion test for the diagnosis of primary aldosteronism.
Topics: Aldosterone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Infusions, Intraveno | 2023 |
The Impact of Obesity on the Resolution of Hypertension Following Adrenalectomy for Primary Hyperaldosteronism.
Topics: Adrenalectomy; Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Hypertension; Hypok | 2023 |
Utility of right adrenal signature veins in venous sampling for primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Catheterization; Humans; Hyperaldosteronism; Phlebography; Retrospectiv | 2023 |
To Use or Not to Use? Quantifying the Benefit of Microcatheter Use in Adrenal Vein Sampling.
Topics: Adrenal Glands; Aldosterone; Hemorrhage; Humans; Hyperaldosteronism; Retrospective Studies | 2023 |
KCNJ5 mutation is a predictor for recovery of endothelial function after adrenalectomy in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenalectomy; Aldosterone; Ankle Brachial Index; Essential Hypertension; G Protein-Coupled | 2023 |
Utility of Carbon Dioxide Venography and Intraprocedural CT for Adrenal Venous Sampling in Patients with an Allergy to Iodinated Contrast Media.
Topics: Adrenal Glands; Aldosterone; Carbon Dioxide; Contrast Media; Humans; Hyperaldosteronism; Hypersensit | 2023 |
Could we be missing something when calculating the aldosterone-to-renin ratio?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2023 |
Reply to 'Could we be missing something when calculating the aldosterone-to-renin ratio?'
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2023 |
Progress in Primary Aldosteronism 7: No better time to meet!
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Aldosterone and renin concentrations and blood pressure in young Indigenous and non-Indigenous adults in the Northern Territory: a cross-sectional study.
Topics: Adult; Aldosterone; Blood Pressure; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hyp | 2023 |
Utility of 18-hydroxycortisol and 18-oxocortisol: potential markers of aldosterone-producing adenomas.
Topics: Adenoma; Aldosterone; Chromatography, Liquid; Humans; Hydrocortisone; Hyperaldosteronism; Tandem Mas | 2023 |
Simple standing test without furosemide is useful in the diagnosis of primary aldosteronism.
Topics: Aldosterone; Captopril; Furosemide; Humans; Hyperaldosteronism; Hypertension; Retrospective Studies | 2023 |
Differences between left adrenal vein sampling sites revealed with segmental sampling in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Retrospective Studies; Vein | 2023 |
Emerging association between KCNJ5 mutations and vascular failure in primary aldosteronism.
Topics: Adenoma; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-Rectifying P | 2023 |
Diagnostic performance of the adrenal vein to inferior vena cava aldosterone ratio in classifying the subtype of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies; Vena Cava, Inferior | 2023 |
Associations Between Aldosterone-Renin-Ratio and Bone Parameters Derived from Peripheral Quantitative Computed Tomography and Impact Microindentation in Men.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Male; Renin; Renin-Angiotensin System; Tomogr | 2023 |
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.
Topics: Adult; Aldosterone; Blood Pressure; Cytochrome P-450 CYP11B2; Humans; Hyperaldosteronism; Hypertensi | 2023 |
Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Machine Learning; Prospective Studies; Tomography, X-Ray Co | 2023 |
Isradipine therapy in Cacna1dIle772Met/+ mice ameliorates primary aldosteronism and neurologic abnormalities.
Topics: Adenoma; Aldosterone; Animals; Autism Spectrum Disorder; Calcium; Female; Humans; Hyperaldosteronism | 2023 |
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cation Transport Proteins; G | 2023 |
Primary Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Spironolactone | 2023 |
Surgery based on computed tomography images might be feasible for primary aldosteronism patients with visible unilateral adenoma.
Topics: Adenoma; Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Middl | 2023 |
Skin NA+, K+ and water before and after surgical cure of human primary aldosteronism: Erratum.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Water | 2023 |
Who and How Should We Screen for Primary Aldosteronism?
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Reni | 2023 |
Fluorinated aldosterone synthase (CYP11B2)-inhibitors for differential diagnosis between bilateral and unilateral conditions of primary aldosteronism.
Topics: Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; Diagnosis, Differential; Humans; Hyperaldosteronism; | 2023 |
Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Antihypertensive Agents; Bisoprolol; Eplerenone; Heart F | 2023 |
Increasing rates of referrals for investigation of primary aldosteronism at a tertiary centre.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Ant | 2023 |
[Is there an alternative treatment option for patients with primary aldosteronism?]
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2023 |
Transvenous Radiofrequency Catheter Ablation for an Aldosterone-Producing Tumor of the Left Adrenal Gland: A First in Human Case Report.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Catheter Ablation; Catheters; Humans; Hyperald | 2023 |
Liddle syndrome presenting with normal aldosterone levels: A case report.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Liddle Syndrome; Renin | 2023 |
Bilateral co-secretory lesions presenting with coexisting Cushing syndrome and primary aldosteronism: a case report.
Topics: Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Cushing Syndrome; Female; Humans; | 2023 |
The relevance of cortisol co-secretion from aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Dexamethasone; Diagnostic Tech | 2019 |
Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia.
Topics: Adenoma; Adult; Aged; Aldosterone; Cytochrome P-450 CYP11B2; DNA Methylation; Epigenesis, Genetic; F | 2019 |
Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin During Adrenal Vein Sampling.
Topics: Adrenal Cortex Function Tests; Adrenal Glands; Aldosterone; Catheterization; Cosyntropin; Female; Hu | 2019 |
Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism.
Topics: Adult; Aged; Albuminuria; Aldosterone; Ankle Brachial Index; Biomarkers; Blood Pressure; C-Reactive | 2019 |
Decreased plasma aldosterone levels in patients with type 2diabetes mellitus: A possible pitfall in diagnosis of primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Artifacts; Blood Chemical Analysis; Blood Pressure; Case-Control Studies; | 2019 |
Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.
Topics: Adrenal Glands; Aldosterone; Blood Specimen Collection; Endocrinology; Female; Hematologic Tests; Hu | 2020 |
Diagnosis of unilateral aldosterone hypersecretion in adrenal venous sampling.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism | 2019 |
Using microwave thermal ablation to develop a subtotal, cortical-sparing approach to the management of primary aldosteronism.
Topics: Ablation Techniques; Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Animals; Hydrocortiso | 2019 |
Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Specimen Collection; Female; Humans; Hypera | 2019 |
Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Specimen Collection; Female; Humans; Hypera | 2019 |
Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Specimen Collection; Female; Humans; Hypera | 2019 |
Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Specimen Collection; Female; Humans; Hypera | 2019 |
Enigma of the Origin of Primary Aldosteronism.
Topics: Aldosterone; Autoantibodies; Humans; Hyperaldosteronism; Receptor, Angiotensin, Type 1 | 2019 |
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism?
Topics: Adrenalectomy; Adult; Aldosterone; Autoantibodies; Humans; Hyperaldosteronism; Male; Middle Aged; Re | 2019 |
In situ metabolomics of aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channels, L-T | 2019 |
Long-term blood pressure outcomes of patients with adrenal venous sampling-proven unilateral primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Retrospectiv | 2020 |
Reply to: Assessing outcomes after adrenalectomy for unliateral primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Cohort Studies; Consensus; Humans; Hyperaldosteronism | 2019 |
A clinical prediction score using age at diagnosis and saline infusion test parameters can predict aldosterone-producing adenoma from idiopathic adrenal hyperplasia.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Age Factors; Aldosterone; Female; Humans; H | 2020 |
ANO4 (Anoctamin 4) Is a Novel Marker of Zona Glomerulosa That Regulates Stimulated Aldosterone Secretion.
Topics: Adrenal Cortex; Aldosterone; Analysis of Variance; Anoctamins; Cell Communication; Cell Proliferatio | 2019 |
Adherence to consensus guidelines for screening of primary aldosteronism in an urban healthcare system.
Topics: Aged; Aldosterone; Animals; Consensus; Female; Guideline Adherence; Humans; Hyperaldosteronism; Hype | 2020 |
Left-versus-right-adrenal-volume ratio as a screening index before adrenal venous sampling to identify unilateral primary aldosteronism patients.
Topics: Adrenal Glands; Adult; Aldosterone; China; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Re | 2020 |
CLCN2 clicks with aldosterone-producing adenomas, too!
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mutation | 2019 |
Seated saline infusion test in predicting subtype diagnosis of primary aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aldosterone; Cosyntropin; Female; Humans; Hyperaldosteronism; Hyperte | 2019 |
Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Biomarkers; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Hy | 2020 |
Response to Letter to the Editor: "Impaired Glucose Metabolism in Primary Aldosteronism Is Associated with Cortisol Cosecretion".
Topics: Aldosterone; Glucose; Humans; Hydrocortisone; Hyperaldosteronism | 2020 |
Letter to the Editor: "Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion".
Topics: Aldosterone; Glucose; Humans; Hydrocortisone; Hyperaldosteronism | 2020 |
Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Blood Glucose; Female; G | 2020 |
Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/MS.
Topics: Aldosterone; Chromatography, High Pressure Liquid; Cohort Studies; Female; Humans; Hyperaldosteronis | 2020 |
Splice-variant-specific effects of primary aldosteronism point mutations on human Ca
Topics: Aldosterone; Alternative Splicing; Calcium; Calcium Channels, T-Type; Cells, Cultured; Electrophysio | 2019 |
Can incomplete adrenal venous sampling data be used in predicting the subtype of primary aldosteronism?
Topics: Adrenal Glands; Adult; Aldosterone; Blood Specimen Collection; China; Clinical Decision-Making; Fema | 2019 |
Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation.
Topics: Adrenal Glands; Aldosterone; Amino Acid Sequence; Animals; Base Sequence; Blood Pressure; Chloride C | 2019 |
Renin-Angiotensin-Aldosterone System Triple-A Analysis for the Screening of Primary Aldosteronism.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Essential Hypertension; Female; Humans; Hyperaldo | 2020 |
Simplifying the Diagnosis of Primary Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium | 2020 |
Comprehensive Analysis of Steroid Biomarkers for Guiding Primary Aldosteronism Subtyping.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Biomarkers; Female; Humans; Hydrocortisone; Hyperaldostero | 2020 |
Mild primary aldosteronism (PA) followed by overt PA are possibly the most common forms of low renin hypertension: a single-center retrospective study.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Retrospective Studies | 2020 |
Left-right differences in adrenal vein sampling for primary aldosteronism.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Blood Specimen Collection; Female; | 2020 |
Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
Topics: Adolescent; Adult; Aged; Aldosterone; Cross-Sectional Studies; Diagnostic Techniques, Endocrine; Fem | 2020 |
Aldosterone-potassium ratio predicts primary aldosteronism subtype.
Topics: Adrenal Glands; Adult; Aldosterone; Europe; Female; Humans; Hyperaldosteronism; Male; Middle Aged; M | 2020 |
Unilateral primary aldosteronism as an independent risk factor for vertebral fracture.
Topics: Adult; Aged; Aldosterone; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Hyperaldost | 2020 |
[Stress the standardized diagnosis and management of primary aldosteronism].
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hyperkalemia; Hypertension; Renin | 2020 |
Letter to the Editor: Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism | 2020 |
Mass Spectrometry Imaging Establishes 2 Distinct Metabolic Phenotypes of Aldosterone-Producing Cell Clusters in Primary Aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Cell Division; Cytochrome P-450 CYP11B2; Fourier Ana | 2020 |
Molecular mechanisms of posaconazole- and itraconazole-induced pseudohyperaldosteronism and assessment of other systemically used azole antifungals.
Topics: Aldosterone; Animals; Antifungal Agents; Azoles; Cricetinae; Disease Models, Animal; Drug Monitoring | 2020 |
Guideline Adherence for Primary Aldosteronism: Breaking the Vicious Cycle.
Topics: Adrenalectomy; Aldosterone; Guideline Adherence; Humans; Hyperaldosteronism | 2020 |
Adrenalectomy for Primary Aldosteronism: Significant Variability in Work-Up Strategies and Low Guideline Adherence in Worldwide Daily Clinical Practice.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Female; Guideline Adherence; Humans; Hyperaldosteronism; Ma | 2020 |
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Canrenone; Drug Therapy, Combination; Female; | 2020 |
Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Chromatography, High Pressure Liquid; Female; | 2020 |
Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma.
Topics: Adenoma; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Retrospective Studies | 2020 |
The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Parathyroid Hormone; Renin; V | 2020 |
Author's Reply: Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism | 2020 |
Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Cytochro | 2020 |
Lipoprotein insulin resistance score and branched-chain amino acids increase after adrenalectomy for unilateral aldosterone-producing adenoma: a preliminary study.
Topics: Adenoma; Adrenalectomy; Aldosterone; Amino Acids, Branched-Chain; Diabetes Mellitus, Type 2; Humans; | 2020 |
Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
Topics: Adult; Aldosterone; Cohort Studies; Diagnosis, Differential; Diagnostic Techniques, Endocrine; Diagn | 2020 |
Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
Topics: Aldosterone; Biomarkers; China; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hypera | 2020 |
Not All Hypertension Is a Lifelong Disease: A Teachable Moment.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Antihypertensive Agent | 2020 |
The risk factors for hepatic steatosis in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Fatty Liver; Female; Humans; Hyperaldosteronism; Hypertension; I | 2020 |
Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Middle Aged; Prevalence; Stroke; | 2020 |
Age- and sex-specific reference ranges are needed for the aldosterone/renin ratio.
Topics: Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Infant, Newb | 2020 |
Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interference.
Topics: Adrenalectomy; Adult; Aldosterone; Artifacts; Diagnostic Errors; Humans; Hyperaldosteronism; Immunoa | 2020 |
Performance of the unilateral AV/IVC index in primary hyperaldosteronism subtype prediction: A validation study in a single tertiary centre.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Retrospective Studies | 2020 |
Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics.
Topics: Adrenal Cortex Function Tests; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle | 2020 |
Autonomous Aldosterone Production and Left Ventricular Hypertrophy.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypertrophy, Left Ventricular | 2020 |
The Impact of Glucocorticoid Co-Secretion in Primary Aldosteronism on Thyroid Autoantibody Titers During the Course of Disease.
Topics: Adult; Aged; Aldosterone; Autoantibodies; Cohort Studies; Disease Progression; Female; Germany; Gluc | 2020 |
Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralization.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Cross-Sectional Studies; Humans; Hyperaldo | 2020 |
Unilateral Disease Is Common in Patients With Primary Aldosteronism Without Adrenal Nodules.
Topics: Adrenal Glands; Age Factors; Aldosterone; Blood Specimen Collection; Canada; Cross-Sectional Studies | 2021 |
Primary Aldosteronism: At the Tipping Point.
Topics: Aldosterone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Prevalence | 2020 |
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2020 |
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2020 |
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2020 |
The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2020 |
Prospective evaluation of aldosterone LC-MS/MS-specific cutoffs for the saline infusion test.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chrom | 2020 |
Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism.
Topics: Adenoma; Aldosterone; Biomarkers; Female; Follow-Up Studies; Glucose Intolerance; Humans; Hyperaldos | 2020 |
Can unilateral forms of primary aldosteronism be excluded with confidence preoperatively by methods other than adrenal venous sampling? The search continues.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Potassium | 2020 |
Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Cohor | 2020 |
Vasculometabolic and Inflammatory Effects of Aldosterone in Obesity.
Topics: Aged; Aged, 80 and over; Aldosterone; Atherosclerosis; Biomarkers; Carotid Arteries; Cross-Sectional | 2020 |
Precise Mapping of Intra-Adrenal Aldosterone Activities Provides a Novel Surgical Strategy for Primary Aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Angiography; Female; H | 2020 |
[Diagnostic Efficiency of Different Screening Indexes for Primary Aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Retrospective Studies | 2020 |
[The Value of Serum Potassium and Ratio of Sodium to Potassium after Saline Infusion Test in Differential Diagnosis of Primary Hyperaldosteronism].
Topics: Aldosterone; China; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension; Potassium; Re | 2020 |
[Diagnosis and Treatment of Primary Aldosteronism in West China Hospital of Sichuan University from 2009 to 2018].
Topics: Adrenal Gland Neoplasms; Aldosterone; China; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2020 |
Development and Validation of Prediction Models for Subtype Diagnosis of Patients With Primary Aldosteronism.
Topics: Adrenal Cortex Function Tests; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Clinical Decision- | 2020 |
[Primary hyperaldosteronism: difficulties in diagnosis].
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Tomography, X-Ray Computed | 2019 |
Primary Aldosteronism: The Next Decade.
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Ramipril; Renin | 2020 |
Seizure and coma secondary to Conn's syndrome: a case report.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Antihypertensive Agents; Coma; Humans; | 2020 |
Adrenal vein sampling: External validation of multinomial regression modelling and left adrenal vein-to-peripheral vein ratio to predict lateralization index without right adrenal vein sampling.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies; Vena Cava, Inferior | 2020 |
Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2020 |
Normotensive hypokalemic primary hyperaldosteronism mimicking clinical features of anorexia nervosa in a young patient: A case report.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Alkalosis; Anorexia Nervosa; Blood Pressure; Diagnosis, | 2020 |
Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.
Topics: Adenoma; Adiposity; Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged; Taiwan | 2020 |
The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation.
Topics: Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adu | 2020 |
Clinical outcomes of primary aldosteronism based on lateralization index and contralateral suppression index after adrenal venous sampling in real-world practice: a retrospective cohort study.
Topics: Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Blood Specimen Collection; Catheterizat | 2020 |
Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels.
Topics: Adult; Aldosterone; Aortic Diseases; China; Cross-Sectional Studies; Female; Humans; Hyperaldosteron | 2020 |
Segmental Adrenal Vein Sampling in Patients With Primary Aldosteronism: Superlative or Superfluous?
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism | 2020 |
Low-grade Cortisol Cosecretion Has Limited Impact on ACTH-stimulated AVS Parameters in Primary Aldosteronism.
Topics: Adrenal Cortex Function Tests; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone | 2020 |
Cellular Pathophysiology of Mutant Voltage-Dependent Ca2+ Channel CACNA1H in Primary Aldosteronism.
Topics: Adrenal Glands; Aldosterone; Animals; Calcium; Calcium Channels, T-Type; CHO Cells; Cricetinae; Cric | 2020 |
The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression - Lessons from primary aldosteronism.
Topics: Aldosterone; Anxiety; Depression; Female; Humans; Hyperaldosteronism; Hypertension; Male; Receptors, | 2020 |
Primary aldosteronism: Involvement of sympathetic system in the persistence of hypertension after surgery.
Topics: Adenoma; Adrenalectomy; Aldosterone; Denervation; Humans; Hyperaldosteronism; Hypertension; Laparosc | 2020 |
Higher prevalence of metabolic disorders in patients with bilateral primary aldosteronism than unilateral primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Metabolic Syndrome; Prevalence; Retrospecti | 2021 |
A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2020 |
Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism.
Topics: Adrenal Cortex Function Tests; Adrenal Glands; Adrenalectomy; Adult; Aged; Aged, 80 and over; Aldost | 2020 |
Prediction of unilateral hyperaldosteronism on adrenal vein sampling using captopril challenge test in patients with primary aldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Blood Specimen Collection; Captopril; Diagnosis, Differential; D | 2021 |
Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Arteries; Humans; Hyperaldosteronism; Hypertension; Pros | 2020 |
Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Arteries; Humans; Hyperaldosteronism; Hypertension; Pros | 2020 |
Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Arteries; Humans; Hyperaldosteronism; Hypertension; Pros | 2020 |
Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: An efficacy and safety, proof-of-principle trial.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Arteries; Humans; Hyperaldosteronism; Hypertension; Pros | 2020 |
Significance of aldosterone gradient within left adrenal vein in diagnosing unilateral subtype of primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospective Stud | 2021 |
Taiwan mini-frontier of primary aldosteronism: Updating detection and diagnosis.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Taiwan | 2021 |
The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies; Tomog | 2021 |
Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Contrast Media; Cross-Sectional Studies; Female; Humans; H | 2020 |
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.
Topics: Aldosterone; Consensus; Humans; Hyperaldosteronism; Hypertension; Prevalence | 2020 |
Primary Aldosteronism: New Insights Into its Detection and Cardiac Involvement.
Topics: Aldosterone; Extracellular Matrix; Humans; Hyperaldosteronism; Hypertension; Magnetic Resonance Spec | 2020 |
131I-6β-iodomethyl-19-norcholesterol adrenal scintigraphy as an alternative to adrenal venous sampling in differentiating aldosterone-producing adenoma from bilateral idiopathic hyperaldosteronism.
Topics: 19-Iodocholesterol; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Diagnosis, | 2020 |
Case 30-2020: A 54-Year-Old Man with Sudden Cardiac Arrest.
Topics: Aldosterone; Blood Chemical Analysis; Cardiac Catheterization; Cardiopulmonary Resuscitation; Death, | 2020 |
Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Diagnost | 2021 |
Clinical characteristics of primary aldosteronism in newly diagnosed diabetes mellitus with hypertensive patients.
Topics: Aldosterone; Diabetes Mellitus; Humans; Hyperaldosteronism; Hypertension; Renin | 2020 |
Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.
Topics: Adult; Aldosterone; Asian People; Case-Control Studies; China; Essential Hypertension; Female; Human | 2020 |
Prediction of hyperaldosteronism subtypes when adrenal vein sampling is unilaterally successful.
Topics: Adrenal Glands; Adult; Aldosterone; Blood Specimen Collection; Diagnosis, Differential; Female; Huma | 2020 |
Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS.
Topics: Adult; Aged; Aldosterone; Blood Chemical Analysis; Chromatography, Liquid; Cohort Studies; Diagnosis | 2021 |
[Prevalence and clinical characteristics of obstructive sleep apnea in patients with primary hyperaldosteronism].
Topics: Aldosterone; Body Mass Index; China; Creatinine; Glycated Hemoglobin; Humans; Hyperaldosteronism; Pr | 2020 |
Response to Letter to the Editor from Zhu and Rossi: "Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism".
Topics: Aldosterone; Humans; Hyperaldosteronism | 2021 |
Letter to the Editor from Zhu and Rossi: "Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism".
Topics: Aldosterone; Humans; Hyperaldosteronism | 2021 |
CACNA1H Calcium Channel Mutations in Primary Aldosteronism - Is Sodium the Culprit?
Topics: Aldosterone; Calcium; Calcium Channels; Calcium Channels, T-Type; Humans; Hyperaldosteronism; Mutati | 2020 |
Association of Adrenal Venous Sampling With Outcomes in Primary Aldosteronism for Unilateral Adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Female; Humans; Hypera | 2021 |
Significance of Discordant Results Between Confirmatory Tests in Diagnosis of Primary Aldosteronism.
Topics: Adrenal Glands; Aged; Aldosterone; Blood Specimen Collection; Cross-Sectional Studies; Diagnosis, Di | 2021 |
Variability of Aldosterone Measurements During Adrenal Venous Sampling for Primary Aldosteronism.
Topics: Adrenal Glands; Aldosterone; Blood; Blood Pressure; Female; Humans; Hyperaldosteronism; Hypertension | 2021 |
The diagnostic accuracy of adjusted unconventional indices for adrenal vein sampling in the diagnosis of primary aldosteronism subtypes.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Reproducibility of Results; | 2021 |
Aldosterone-to-renin ratio is related to arterial stiffness when the screening criteria of primary aldosteronism are not met.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Cross-Sectional Studies; Female; Heart Rate; Hemodynamics; | 2020 |
The establishment of a novel high-throughput screening system using RNA-guided genome editing to identify chemicals that suppress aldosterone synthase expression.
Topics: Adrenal Cortex; Aldosterone; Base Sequence; Calcium Signaling; Cell Line; Cytochrome P-450 CYP11B2; | 2021 |
Effect of sodium-glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study.
Topics: Aged; Aldosterone; Diabetes Mellitus, Type 2; Female; Humans; Hyperaldosteronism; Hypertension; Male | 2020 |
Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Blood Glucose; Fasting; Female; Humans; Hyperaldosteronism; | 2020 |
Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection.
Topics: Adult; Aldosterone; Biological Variation, Individual; Chromatography, Liquid; Female; Humans; Hypera | 2021 |
Repeat Adrenal Vein Sampling in Aldosteronism: Reproducibility and Interpretation of Persistently Discordant Results.
Topics: Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Blood Specimen Collection; Catheterizat | 2021 |
VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism.
Topics: Aldosterone; Animals; Apoptosis; Calcium Signaling; Cytochromes c; Disease Models, Animal; Fibrosis; | 2020 |
[Primary aldosteronism: The Mayo Clinic approach].
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocortic | 2020 |
Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.
Topics: Adrenal Glands; Aged; Aldosterone; Blood Specimen Collection; Female; Humans; Hyperaldosteronism; Ma | 2021 |
High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension; Middle Aged; | 2021 |
Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
Topics: Aldosterone; Antihypertensive Agents; Canrenone; Diagnostic Techniques, Endocrine; Duration of Thera | 2021 |
Exploration Of The Seated Saline Suppression Test For The Diagnosis Of Primary Aldosteronism In The Chinese Population.
Topics: Adrenocortical Adenoma; Aldosterone; Asian People; Humans; Hyperaldosteronism; Hypertension; Renin | 2020 |
Adrenal Vein Sampling Without Discontinuation of Mineralocorticoid Receptor Antagonist Therapy.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Min | 2020 |
Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Humans; Hyp | 2020 |
Primary Aldosteronism: Strike Two.
Topics: Aldosterone; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Hypertension | 2021 |
Growth differentiation factor 15 levels are similar in primary aldosteronism and essential hypertension and do not predict arterial inflammation.
Topics: Aldosterone; Arteritis; Essential Hypertension; Growth Differentiation Factor 15; Humans; Hyperaldos | 2021 |
Association between plasma aldosterone and markers of tubular and glomerular damage in primary aldosteronism.
Topics: Albuminuria; Aldosterone; Biomarkers; Cross-Sectional Studies; Humans; Hyperaldosteronism; Retrospec | 2021 |
Outcomes of Adrenalectomy and the Aldosteronoma Resolution Score in the Black and Hispanic Population.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Black or African American; Female; Hispanic or L | 2021 |
Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Luminescent Measurements; Renin | 2021 |
Novel chemiluminescent immunoassay to measure plasma aldosterone and plasma active renin concentrations for the diagnosis of primary aldosteronism.
Topics: Aldosterone; Essential Hypertension; Humans; Hyperaldosteronism; Hypertension; Radioimmunoassay; Ren | 2022 |
Primary Aldosteronism: Three Strikes and Out.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2021 |
Primary aldosteronism investigation in the elderly: challenges and opportunities.
Topics: Aged; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2021 |
Treatment of Primary Aldosteronism Increases Plasma Epoxyeicosatrienoic Acids.
Topics: Adrenalectomy; Adult; Aldosterone; Animals; Arachidonic Acids; Blood Pressure; Epoxide Hydrolases; F | 2021 |
Letter to the Editor: Very high cortisol concentration in adrenal venous sampling in primary aldosteronism-physiological or pathological.
Topics: Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Vascular Surgical Procedures | 2022 |
Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism: A Prospective Cohort Study.
Topics: Adrenalectomy; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Min | 2021 |
Volumetric evaluation of CT images of adrenal glands in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Antihypertensive Agents; Cone-Beam Computed Tomography; Correlation of | 2021 |
KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; G Protein-Cou | 2021 |
Endocrine Workup for Primary Aldosteronism Should Include Adrenal Venous Sampling in Young Patients.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2021 |
Primary aldosteronism and obstructive sleep apnea: A single-center cross-sectional study of the Japanese population.
Topics: Adult; Aldosterone; Asian People; Body Mass Index; Cross-Sectional Studies; Female; Humans; Hyperald | 2021 |
Evaluation of Hypokalemia.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Algorithms; Female; Humans; Hyperaldosteronism; Hyper | 2021 |
Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety.
Topics: Adrenalectomy; Aldosterone; Anxiety; Depression; Female; Humans; Hyperaldosteronism; Male; Mineraloc | 2021 |
Steroidogenic Activity in Unresected Adrenals Associated With Surgical Outcomes in Primary Aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronis | 2021 |
Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study.
Topics: Aldosterone; Captopril; Humans; Hyperaldosteronism; Hypertension; Prospective Studies; Renin | 2021 |
"Double-Down" Adrenal Vein Sampling Results in Patients with Apparent Bilateral Aldosterone Suppression: Utility of Repeat Sampling including Super-Selective Sampling.
Topics: Adrenal Cortex Function Tests; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Biomarkers; | 2021 |
[Primary aldosteronism: from diagnosis to therapy in clinical practice].
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Ant | 2021 |
Aldosterone-producing adenoma associated with non-suppressed renin: a case series.
Topics: Adenoma; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male | 2022 |
Partial Adrenalectomy Carries a Considerable Risk of Incomplete Cure in Primary Aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Endosonography; Female; Genotype; Humans; Hypera | 2021 |
Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age.
Topics: Adult; Aldosterone; Humans; Hyperaldosteronism; Middle Aged; Retrospective Studies; Tomography, X-Ra | 2021 |
Primary Aldosteronism with Parathyroid Hormone Elevation: A Single-center Retrospective Study.
Topics: Aldosterone; Calcium; Humans; Hyperaldosteronism; Hypertension; Parathyroid Hormone; Retrospective S | 2021 |
Validation of the Fujirebio Lumipulse G1200 aldosterone assay for measurements during adrenal venous sampling for primary hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies | 2021 |
Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism.
Topics: Aldosterone; Blood Pressure; Cardiovascular Diseases; Female; Humans; Hyperaldosteronism; Hypertensi | 2021 |
Hypokalemia-Induced Rhabdomyolysis Caused by Adrenal Tumor-Related Primary Aldosteronism: A Report of 2 Cases.
Topics: Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Male; M | 2021 |
Prevalence, Subtype Classification, and Outcomes of Treatment of Primary Aldosteronism: A Prospective Study in China.
Topics: Aldosterone; China; Humans; Hyperaldosteronism; Hypertension; Prevalence; Prospective Studies; Renin | 2021 |
Prospective Screening for Primary Aldosteronism in Patients With Suspected Obstructive Sleep Apnea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperaldosteronism; Male; M | 2021 |
[HYPERTENSION IN A YOUNG WOMAN WITH ANXIETY DISORDER: THE CHICKEN OR THE EGG?]
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Anxiety Disorder | 2021 |
Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aged; Aldosterone; Blood Specimen Collection | 2021 |
Contralateral Suppression Index Does Not Predict Clinical Cure in Patients Undergoing Surgery for Primary Aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Humans; Hyperaldosteronism; Retrospective Studies | 2021 |
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Topics: Adolescent; Adrenalectomy; Adult; Aged; Aldosterone; Canrenone; Cohort Studies; False Negative React | 2021 |
Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
Topics: Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; Echocardiography; Essenti | 2021 |
Urinary sodium/potassium ratio as a screening tool for hyperaldosteronism in men with hypertension.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Potas | 2021 |
Limited diagnostic utility of partially successful adrenal vein sampling for primary aldosteronism subtyping.
Topics: Adrenal Glands; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Male; Retr | 2021 |
Pathology of Aldosterone Biosynthesis and its Action.
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Mutation | 2021 |
Computed tomography image fusion, Coaxial guidewire technique, Fast intraprocedural cortisol testing technique improves success rate and decreases radiation exposure, procedure time, and contrast use for adrenal vein sampling.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Radiation Exposure; Retrosp | 2021 |
Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas.
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Female; Follow-Up Stud | 2021 |
Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement.
Topics: Aldosterone; Humans; Hyperaldosteronism; Luminescence; Radioimmunoassay; Renin | 2021 |
Apparent failed and discordant adrenal vein sampling: A potential confounding role of cortisol cosecretion?
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Retrospective Studies | 2022 |
Screening for primary aldosteronism in pregnancy.
Topics: Adult; Aldosterone; Biomarkers; Electronic Health Records; Female; Humans; Hyperaldosteronism; Mass | 2021 |
Letter to the Editor from Rui Zhu et al: "Performance of the Aldosterone-to-Renin Ratio as a Screening Test for Primary Aldosteronism: A Systematic Review and Meta-Analysis".
Topics: Aldosterone; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Hypertension; Renin | 2021 |
Response Letter to the Editor from Zhu et al: "Performance of the Aldosterone-to-Renin Ratio as a Screening Test for Primary Aldosteronism: A Systematic Review and Meta-Analysis".
Topics: Aldosterone; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Hypertension; Renin | 2021 |
Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International Study.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Asia; Australia; Cohort Studies; Europe; Female; | 2021 |
The Value of Different Single or Combined Indexes of the Captopril Challenge Test in the Diagnosis of Primary Aldosteronism.
Topics: Aldosterone; Captopril; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Renin; ROC Curve | 2021 |
Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Retro | 2021 |
Commentary on Weakness and Low Potassium in a 47-Year-Old Male.
Topics: Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium | 2021 |
Commentary on Weakness and Low Potassium in a 47-Year-Old Male.
Topics: Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium | 2021 |
Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Japan; Lumine | 2021 |
Prevalence of Primary Aldosteronism Across the Stages of Hypertension Based on a New Combined Overnight Test.
Topics: Adult; Aged; Aldosterone; Biomarkers; Case-Control Studies; Diagnostic Tests, Routine; Female; Follo | 2021 |
A case of primary aldosteronism with a negative aldosterone-to-renin ratio.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Antihypertensive Agents; Biomarkers; B | 2021 |
Beta-2-Microglobulin is an Independent Risk Factor for Asymptomatic Carotid Atherosclerosis in Patients with Primary Aldosteronism.
Topics: Aldosterone; Carotid Artery Diseases; Carotid Intima-Media Thickness; Carotid Stenosis; Cross-Sectio | 2022 |
Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; G Protein-Coupled Inwardly-Rectifying | 2021 |
Multiple corticosteroid abnormalities in cats with hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Cat Diseases; Cats; Corticosterone; Hydrocortison | 2021 |
Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
Topics: Abdominal Fat; Adult; Aged; Aldosterone; Databases, Factual; Essential Hypertension; Female; Humans; | 2021 |
Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Intra-Abdominal Fat | 2021 |
Lipid Profiles in Primary Aldosteronism Compared with Essential Hypertension: Propensity-Score Matching Study.
Topics: Aldosterone; Essential Hypertension; Humans; Hyperaldosteronism; Hypertension; Lipids; Retrospective | 2021 |
Contralateral Suppression at Adrenal Venous Sampling Is Associated with Renal Impairment Following Adrenalectomy for Unilateral Primary Aldosteronism.
Topics: Adenoma; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Middle Aged; Retrospective Studies | 2021 |
Aldosterone and Primary Aldosteronism: Star Performers in Hypertension Research.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2021 |
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; beta Catenin; Fema | 2021 |
Aldosterone suppresses cardiac mitochondria.
Topics: Adenoma; Adenosine Triphosphate; Adrenal Gland Neoplasms; Aldosterone; Animals; Caspase 3; Cytochrom | 2022 |
Monogenic forms of low-renin hypertension: clinical and molecular insights.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium; Renin | 2022 |
Reassessment of Postural Stimulation Testing as a Simple Tool to Identify a Subgroup of Patients With Unilateral Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Specimen Collection; Cohort Studies; Diagnosis, Differential; Female | 2022 |
Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity.
Topics: Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; Hypertension; Linear Models; | 2017 |
Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.
Topics: Aldosterone; Animals; Gene Expression Regulation; Heart; Heart Diseases; Hyperaldosteronism; Hyperte | 2017 |
Prenatal diagnosis of Bartter syndrome: amniotic fluid aldosterone.
Topics: Aldosterone; Amniotic Fluid; Bartter Syndrome; Case-Control Studies; Female; Gestational Age; Humans | 2017 |
Adrenal Vein Sampling for Primary Aldosteronism: A 2-Week Protocol for Withdrawal of Renin-Stimulating Antihypertensives.
Topics: Adrenal Glands; Aged; Aldosterone; Antihypertensive Agents; Female; Humans; Hyperaldosteronism; Male | 2017 |
Effect of Combined Hormonal Replacement Therapy on the Aldosterone/Renin Ratio in Postmenopausal Women.
Topics: Aldosterone; Blood Specimen Collection; Drug Combinations; Estrogen Replacement Therapy; Estrogens, | 2017 |
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives.
Topics: Aldosterone; Humans; Hyperaldosteronism; Prevalence; Primary Health Care | 2017 |
Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.
Topics: Adrenal Cortex; Adult; Aged; Aldosterone; Calcium Channels, L-Type; Female; G Protein-Coupled Inward | 2017 |
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Cytoch | 2017 |
Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin).
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Cytochrome P-450 CYP11B2; Extracellular Matri | 2017 |
Clinical Utility of the Adrenocorticotropin Stimulation Test with/without Dexamethasone Suppression for Definitive and Subtype Diagnosis of Primary Aldosteronism.
Topics: Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Adult; Aldosterone; Dexamethasone; Femal | 2017 |
Aldosterone and Mineralocorticoid Receptors-Physiology and Pathophysiology.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenocorticotropic Hormone; Aldosterone; Animals; Arteries; | 2017 |
Prevalence of primary aldosteronism among patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Blood Pressure; Cross-Sectional Studies; Diabetes Melli | 2017 |
A case of confirmed primary hyperaldosteronism diagnosed despite normal screening investigations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertens | 2017 |
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.
Topics: Adrenocortical Adenoma; Aldosterone; Biomarkers, Tumor; Blood Pressure; Disease Progression; Female; | 2017 |
Rating the blood pressure outcome after adrenalectomy for unilateral primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Retrospective | 2017 |
NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Cell Line, Tumor; Cell Proliferation; Dopamine Agonis | 2017 |
Aldosterone-Producing Adenomas: Genotypes and Phenotypes.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Genotype; Humans; Hyperaldosteronism; Phenotype | 2017 |
Functional TASK-3-Like Channels in Mitochondria of Aldosterone-Producing Zona Glomerulosa Cells.
Topics: Aldosterone; Cells, Cultured; Humans; Hyperaldosteronism; Membrane Potential, Mitochondrial; Mitocho | 2017 |
Considering Postoperative Functional Hypoaldosteronism after Unilateral Adrenalectomy.
Topics: Adrenalectomy; Adult; Aldosterone; Biomarkers; Female; Follow-Up Studies; Humans; Hyperaldosteronism | 2017 |
Associations of aldosterone and renin concentrations with inflammation-the Study of Health in Pomerania and the German Conn's Registry.
Topics: Adult; Aldosterone; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Fibrinogen; Germany; Hum | 2017 |
Rapid Diagnosis of Primary Aldosteronism: Oxymoron or One Small Step?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2017 |
Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.
Topics: Adult; Aldosterone; Antihypertensive Agents; Chromatography, Liquid; Comparative Effectiveness Resea | 2017 |
Consider Beta-blocker withdrawal when using the Aldosterone Renin Ratio for case detection of Primary Aldosteronism.
Topics: Adrenergic beta-Antagonists; Aldosterone; Humans; Hyperaldosteronism; Renin; Withholding Treatment | 2017 |
Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldostero | 2017 |
Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Obesity; Thinness | 2017 |
Prevalence of primary aldosteronism without hypertension in the general population: Results in Shika study.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Disease Progression; Female; Humans; Hyperaldosteronism; H | 2018 |
A Comparison of Robotic Versus Laparoscopic Adrenalectomy in Patients With Primary Hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Blood Loss, Surgical; Female; Humans; Hyperaldo | 2017 |
Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
Topics: Adosterol; Adrenalectomy; Aldosterone; Consensus; Humans; Hyperaldosteronism; Radionuclide Imaging; | 2017 |
Aldosterone in Advancing Age: Don't Shoot the Messenger.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2017 |
Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K.
Topics: Adult; Aldosterone; Area Under Curve; Biomarkers; Female; Humans; Hydrogen-Ion Concentration; Hypera | 2018 |
Hypothesis on a relationship between hyperaldosteronism, inflammation, somatic mutations, and autoimmunity.
Topics: Aldosterone; Autoimmunity; Desoxycorticosterone; Genetic Predisposition to Disease; Humans; Hyperald | 2017 |
Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
Topics: Adult; Aged; Aldosterone; Echocardiography; Essential Hypertension; Female; Heart; Humans; Hyperaldo | 2018 |
Favorable surgical outcomes of aldosterone-producing adenoma based on lateralization by CT imaging and hypokalemia: a non-AVS-based strategy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertensi | 2017 |
Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation.
Topics: Aldosterone; Atrial Fibrillation; Female; Humans; Hyperaldosteronism; Hypertension; Male; Mass Scree | 2017 |
The subtyping of primary aldosteronism by adrenal vein sampling: sequential blood sampling causes factitious lateralization.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2018 |
A novel somatic mutation 145-147delETEinsK in KCNJ5 increases aldosterone production.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Biomarkers, Tumor; Calcium; Female; G | 2017 |
KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; G Prote | 2018 |
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.
Topics: Aged; Aged, 80 and over; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; H | 2017 |
Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma.
Topics: 3T3-L1 Cells; Adenoma; Adipocytes, Brown; Adipogenesis; Adipokines; Adrenalectomy; Aldosterone; Anim | 2018 |
Primary Hyperaldosteronism Due to Adrenocortical Adenoma: a Case Report.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; | 2017 |
A Multi-institutional Comparison of Adrenal Venous Sampling in Patients with Primary Aldosteronism: Caution Advised if Successful Bilateral Adrenal Vein Sampling is Not Achieved.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; | 2018 |
Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess.
Topics: Absorptiometry, Photon; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Bone Density; Cancellous | 2018 |
Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism.
Topics: Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperkalemia; Incidence; Male | 2018 |
Primary aldosteronism and cardiovascular risk, before and after treatment.
Topics: Aldosterone; Cardiovascular Diseases; Humans; Hyperaldosteronism; Hypertension; Risk Factors | 2018 |
Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Biomarkers; Female; Humans; Hyperaldosteronism; Hypertensio | 2018 |
Primary aldosteronism patients show skin alterations and abnormal activation of glucocorticoid receptor in keratinocytes.
Topics: Aged; Aged, 80 and over; Aldosterone; Animals; Cells, Cultured; Cytokines; Female; Humans; Hyperaldo | 2017 |
Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.
Topics: Adrenal Cortex; Adrenal Cortex Function Tests; Adult; Aldosterone; Captopril; Clinical Chemistry Tes | 2018 |
It's Complicated: How Often are Patients with Primary Aldosteronism Cured After Adrenalectomy?
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2018 |
Primary aldosteronism: making sense of partial data sets from failed adrenal venous sampling-suppression of adrenal aldosterone production can be used in clinical decision making.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Clinical Dec | 2018 |
The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion.
Topics: Adrenal Glands; Adrenal Medulla; Adult; Aldosterone; Animals; Cholesterol; Female; Gene Expression R | 2017 |
Adrenal Vein Sampling Is the Preferred Method to Select Patients With Primary Aldosteronism for Adrenalectomy: Pro Side of the Argument.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Austra | 2018 |
Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Biomarkers; Female; Follow-Up Studies; Humans; Hyperaldoste | 2018 |
Double hit! A unique case of resistant hypertension.
Topics: Adrenal Glands; Aldosterone; Diuretics; Female; Humans; Hyperaldosteronism; Hyperparathyroidism, Pri | 2017 |
Mutations of the Twik-Related Acid-Sensitive K+ Channel 2 Promoter in Human Primary Aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aldosterone; Binding Sites; Female; Germ-Line Mutation; Humans; Hyper | 2018 |
Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism.
Topics: Adrenal Cortex Function Tests; Adult; Aldosterone; Asian People; Captopril; Essential Hypertension; | 2018 |
The effect of adrenalectomy on exercise response of the renin-angiotensin-aldosterone system and exercise tolerance in primary aldosteronism.
Topics: Adrenalectomy; Adult; Aldosterone; Anaerobic Threshold; Blood Pressure Monitoring, Ambulatory; Exerc | 2018 |
Prevalence of primary aldosteronism in primary care: a cross-sectional study.
Topics: Adult; Aged; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; | 2018 |
Who was Dr. William C. Baum?
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; History, 20th Century; Humans; Hyperal | 2018 |
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
Topics: Adult; Age Distribution; Aged; Aldosterone; Cardiovascular Diseases; Cohort Studies; Comorbidity; Fe | 2018 |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis.
Topics: Adult; Aldosterone; Animals; Cardiomegaly; Case-Control Studies; Cells, Cultured; Collagen; Cytokine | 2018 |
Subclinical target organ damage in primary aldosteronism: resistant to spironolactone therapy?
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Spironolactone | 2018 |
[Conn's syndrome - more than just aldosterone excess?]
Topics: Aldosterone; Humans; Hyperaldosteronism | 2018 |
The influence of the peripheral cortisol fluctuation on the success rate of adrenal venous sampling.
Topics: Adrenal Glands; Adult; Aldosterone; Biological Assay; Female; Humans; Hydrocortisone; Hyperaldostero | 2018 |
The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiotensin II Type 1 Receptor Blocke | 2018 |
Can aldosterone break your heart? Takotsubo cardiomyopathy in a patient with newly diagnosed primary aldosteronism.
Topics: Aldosterone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agen | 2018 |
Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypokalemia; Male; Retrospective Studies; To | 2018 |
Case detection in primary aldosteronism: high-diagnostic value of the aldosterone-to-renin ratio when performed under standardized conditions.
Topics: Adult; Aged; Aldosterone; False Negative Reactions; False Positive Reactions; Female; Humans; Hypera | 2018 |
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms.
Topics: Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Female; Germany; Humans; Hyperaldostero | 2018 |
A Novel High-Resolution Magnetic Resonance Imaging Protocol Detects Aldosterone-Producing Adenomas in Patients With Negative Computed Tomography.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Diffu | 2018 |
Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
Topics: Adolescent; Adult; Aged; Aldosterone; Case-Control Studies; Chromatography, Liquid; Essential Hypert | 2018 |
Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?
Topics: Adrenal Gland Neoplasms; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypoka | 2018 |
Genetic Characterization of GnRH/LH-Responsive Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Case-Control Studies; DN | 2018 |
Update in diagnosis and management of primary aldosteronism: reply to a Letter to the Editor.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2018 |
Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
Topics: Adrenalectomy; Adult; Aldosterone; Female; Glomerular Filtration Rate; Humans; Hyperaldosteronism; M | 2018 |
Saline suppression test parameters may predict bilateral subtypes of primary aldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Blood Specimen Collection; Female; Humans; Hyperaldosteronism; M | 2018 |
Role of Cryptochrome-1 and Cryptochrome-2 in Aldosterone-Producing Adenomas and Adrenocortical Cells.
Topics: Adenoma; Aldosterone; Angiotensin II; Animals; Cell Line, Tumor; Cryptochromes; Gene Expression Regu | 2018 |
Psychological Symptoms and Well-Being After Treatment for Primary Aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; | 2018 |
Comment on "Body mass index and contralateral ratio predict outcome following unilateral adrenalectomy in primary aldosteronism".
Topics: Adrenalectomy; Aldosterone; Body Mass Index; Humans; Hyperaldosteronism | 2018 |
A precise, sensitive and stable LC-MSMS method for detection of picomolar levels of serum aldosterone.
Topics: Aldosterone; Biomarkers; Chromatography, Liquid; Humans; Hyperaldosteronism; Liquid-Liquid Extractio | 2018 |
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Biomarkers; Blood Specimen Collection; Female; Hu | 2018 |
Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Cytochrome P-450 CYP11B2; Female; Humans; Hyperal | 2018 |
[Efficacy of Screening and Confirmatory Tests of Primary Aldosteronism in Diagnosing Aldosterone Producing Adenoma].
Topics: Adenoma; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin; Retrospective Studies | 2018 |
Development and validation of subtype prediction scores for the workup of primary aldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium | 2018 |
Robot-assisted Partial Adrenalectomy for the Treatment of Conn's Syndrome: Surgical Technique, and Perioperative and Functional Outcomes.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2019 |
miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Apoptosis; Biomarkers, Tumor | 2018 |
Spectrum of renin angiotensin aldosterone system disorders in young hypertensives.
Topics: Adolescent; Adult; Aldosterone; Blood Gas Analysis; Cross-Sectional Studies; Electrolytes; Humans; H | 2018 |
Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2018 |
Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Chromatography, High Pressure Liquid; Diagnostic Techniques, Endocrine; Fe | 2018 |
MicroRNA-21 ablation exacerbates aldosterone-mediated cardiac injury, remodeling, and dysfunction.
Topics: Aldosterone; Animals; Blood Pressure; Cardiomegaly; Hyperaldosteronism; Male; Mice; Mice, Knockout; | 2018 |
Aldosterone overload: An overlooked cause of high blood pressure?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2018 |
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Diabetes Mellitus; Dyslipidemias; Essential Hypertensio | 2018 |
[Recent Progress in Primary Aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Ion Channels; Mineralocorticoid Receptor Antagonists; Mutat | 2017 |
Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Endothelium, Vascular; Essential Hypertension; Female; Humans; H | 2018 |
Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Blood Specimen Collection; False Negative Reactions; Femal | 2019 |
Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Diagnostic Techniques, Endocrine; Female; Fludrocortiso | 2018 |
High efficiency of the aldosterone-to-renin ratio in precisely detecting primary aldosteronism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Child; Female; Follow-Up Studie | 2019 |
Association of Papillary Thyroid Carcinoma with Primary Aldosteronism.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Female; Humans; Hy | 2019 |
Sustaining the momentum: Negative cross-sectional imaging for primary hyperaldosteronism should not preclude endocrine surgical referral.
Topics: Aldosterone; Endocrine Surgical Procedures; Humans; Hyperaldosteronism; Referral and Consultation | 2019 |
Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Topics: Aldosterone; Calcium Channels, L-Type; Cytochrome P-450 CYP11B2; Female; G Protein-Coupled Inwardly- | 2018 |
Idiopathic Hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2018 |
Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hype | 2019 |
Primary aldosteronism with nonlocalizing imaging.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Female; Humans; Hydroc | 2019 |
Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.
Topics: Adult; Aldosterone; Ankle Brachial Index; Antihypertensive Agents; Blood Pressure; Brachial Artery; | 2019 |
Speckle-Tracking Echocardiographic Layer-Specific Strain Analysis on Subclinical Left Ventricular Dysfunction in Patients With Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Asymptomatic Diseases; Biomarkers; Blood Pressure; Case-Control Studies; C | 2019 |
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.
Topics: Adult; Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hyperaldosteronis | 2019 |
Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: A case report.
Topics: Aged; Aldosterone; Arrhythmias, Cardiac; China; Electrocardiography; Humans; Hyperaldosteronism; Hyp | 2018 |
Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; | 2018 |
Visualizing Adrenal Steroids in Primary Aldosteronism.
Topics: Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Steroids | 2018 |
Rates of abnormal aldosterone/renin ratio in African-origin compared to European-origin patients: A retrospective study.
Topics: Adult; Africa; Aldosterone; Echocardiography; Female; Humans; Hyperaldosteronism; Hypertension; Hypo | 2019 |
Discordance Between Imaging and Adrenal Vein Sampling in Primary Aldosteronism Irrespective of Interpretation Criteria.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Clinical Decision-Making; Female; Humans; Hydrocortisone | 2019 |
Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism.
Topics: Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldosterone; Blood Pressure; Co | 2019 |
Introduction to the 2018 Keith L. Parker Award Lecture, William E. Rainey, PhD.
Topics: Adrenal Glands; Aldosterone; Androgens; Awards and Prizes; Biomedical Research; Endocrinology; Histo | 2019 |
Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Captopril; | 2019 |
Frequency of Primary Hyperaldosteronism in Young Hypertensives in a Tertiary Care Setting of Rawalpindi.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Cross-Sectional Studies; Female; Humans; Hyperaldost | 2019 |
Impact of immunohistochemistry on the diagnosis and management of primary aldosteronism: An important tool for improved patient follow-up.
Topics: Adenoma; Adrenalectomy; Adult; Aftercare; Aged; Aldosterone; Biomarkers; Cytochrome P-450 CYP11B2; F | 2020 |
An uncommon cause of leg oedema.
Topics: Aged; Aldosterone; Edema; Female; Humans; Hyperaldosteronism; Hypokalemia; Leg; Magnetic Resonance I | 2019 |
Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Genetic Predisposition to Disease; Hu | 2019 |
Family hyperaldosteronism type I: a clinical case and review of literature.
Topics: Adrenalectomy; Aldosterone; Antihypertensive Agents; Blood Pressure; Corticosterone; Cytochrome P-45 | 2018 |
Surprisingly low aldosterone levels in peripheral veins following intravenous sedation during adrenal vein sampling: implications for the concept of nonsuppressibility in primary aldosteronism.
Topics: Administration, Intravenous; Adrenal Glands; Aldosterone; Blood Specimen Collection; Humans; Hyperal | 2019 |
[Two case reports on resistant hypertension].
Topics: Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension | 2019 |
A Case of Primary Aldosteronism Due to A Primary Adrenal Adenoma Diagnosed by Segmental Adrenal Venous Sampling (S-AVS) Using a Modified Catheter System and Lateral Cine Angiography.
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Angiography; Blood Specimen Col | 2019 |
Response to Letter to the Editor: "Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism".
Topics: Aldosterone; Humans; Hyperaldosteronism; Saline Solution | 2019 |
Letter to the Editor: "Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism".
Topics: Aldosterone; Humans; Hyperaldosteronism; Saline Solution | 2019 |
The Aldosterone/Renin Ratio Predicts Cardiometabolic Disorders in Subjects Without Classic Primary Aldosteronism.
Topics: Adult; Aldosterone; Biomarkers; Blood Pressure; Cross-Sectional Studies; Disease Progression; Female | 2019 |
Subclinical Primary Aldosteronism and Cardiometabolic Disorders.
Topics: Adult; Aged; Aldosterone; Cardiovascular Diseases; Female; Global Health; Humans; Hyperaldosteronism | 2019 |
A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism.
Topics: Adult; Aldosterone; Algorithms; Calibration; China; Endocrinology; Female; Humans; Hyperaldosteronis | 2019 |
Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression.
Topics: Adolescent; Adult; Aged; Aldosterone; Anxiety; Blood Pressure; Depression; Depressive Disorder; Elec | 2019 |
The Key Role of CT for Success of Adrenal Venous Sampling Illustrated by a Unique Clinical Case.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Biomar | 2019 |
Evaluation of Biochemical Conditions Allowing Bypass of Confirmatory Testing in The Workup of Primary Aldosteronism: A Retrospective Study in a French Hypertensive Population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperte | 2019 |
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
Topics: Adenoma; Adrenal Hyperplasia, Congenital; Adrenalectomy; Aldosterone; Angiotensin II; Antihypertensi | 2019 |
[Adrenal androgen measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism].
Topics: Adrenal Glands; Adult; Aldosterone; Cosyntropin; Female; Humans; Hydrocortisone; Hyperaldosteronism; | 2019 |
Adrenocortical hypofunction with simultaneous primary aldosteronism: A case report.
Topics: Adrenal Insufficiency; Aged; Aldosterone; Cushing Syndrome; Female; Humans; Hydrocortisone; Hyperald | 2019 |
[Corticosurrenaloma: an exceptional cause of primary hyperaldosteronism].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Glucocorticoids; Hepatectomy; Humans; Hyperaldosteronis | 2018 |
Influence of Adrenal Venous Sampling on Management in Patients with Primary Aldosteronism Independent of Lateralization on Cross-Sectional Imaging.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Catheterization; Diagnosis, Different | 2019 |
RNA Sequencing Provides Novel Insights into the Transcriptome of Aldosterone Producing Adenomas.
Topics: Adenoma; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; beta Catenin; Calcium Cha | 2019 |
Dendritic cells are crucial for cardiovascular remodeling and modulate neutrophil gelatinase-associated lipocalin expression upon mineralocorticoid receptor activation.
Topics: Aldosterone; Animals; Cardiomegaly; Cardiovascular System; CD11 Antigens; Coculture Techniques; Dend | 2019 |
Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; An | 2019 |
Clinical outcomes after surgery for primary aldosteronism: Evaluation of the PASO-investigators' consensus criteria within a worldwide cohort of patients.
Topics: Adrenalectomy; Adult; Aldosterone; Australia; Blood Pressure Determination; Canada; Cohort Studies; | 2019 |
Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Cohort Studies; Female; Humans; H | 2019 |
CaseReport: Aldosterone-secreting adrenal carcinoma complicating longstanding hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Carcinoma; Humans; H | 2020 |
Clinical characteristics of snoring patients with primary aldosteronism and obstructive sleep apnea-hypopnea syndrome.
Topics: Adult; Aldosterone; Biomarkers; Blood Pressure; Body Mass Index; Female; Glomerular Filtration Rate; | 2019 |
Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Female; Follow-Up Studies; | 2019 |
Possible causes of plasma aldosterone reduction in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Renin | 2019 |
Reply.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism | 2019 |
Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography.
Topics: Adult; Aged; Aldosterone; Atrial Fibrillation; Echocardiography; Female; Heart Atria; Heart Ventricl | 2019 |
Long-term BP control and vascular health in patients with hyperaldosteronism treated with low-dose, amiloride-based therapy.
Topics: Aftercare; Aldosterone; Amiloride; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitorin | 2019 |
Hypertension with primary aldosteronism is associated with increased carotid intima-media thickness and endothelial dysfunction.
Topics: Aldosterone; Antihypertensive Agents; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickn | 2019 |
Aldosterone level after saline infusion test could predict clinical outcome in primary aldosteronism after adrenalectomy.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Biomarkers; Female; Humans; Hyperaldosteronism; Male; Middl | 2019 |
Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Female; Humans; | 2019 |
Plasma Aldosterone After Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes After Adrenalectomy for Primary Aldosteronism.
Topics: Adrenal Cortex Function Tests; Adrenalectomy; Adult; Aldosterone; Biomarkers; Captopril; Female; Hum | 2019 |
Extracellular Vesicles as Biomarkers and Biovectors in Primary Aldosteronism.
Topics: Aldosterone; Biomarkers; Extracellular Vesicles; Humans; Hyperaldosteronism | 2019 |
Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism.
Topics: Adrenalectomy; Adult; Age Distribution; Age of Onset; Aged; Aldosterone; Databases, Factual; Female; | 2019 |
The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population.
Topics: Adult; Aldosterone; Captopril; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; | 2019 |
Primary aldosteronism-associated cardiomyopathy: Clinical-pathologic impact of aldosterone normalization.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Cardiomyopathies; Humans; Hyperaldosteronism; Male; Middle | 2019 |
[Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review)].
Topics: Adrenal Gland Neoplasms; Aldosterone; Cushing Syndrome; Humans; Hydrocortisone; Hyperaldosteronism | 2019 |
[Primary hyperaldosteronism in a population of hypertensive patients].
Topics: Aged; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2019 |
Elevated Plasma Renin Activity Caused by Accelerated-malignant Hypertension in a Patient with Aldosterone-producing Adenoma Complicated with Renal Insufficiency.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension, Mal | 2019 |
Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Biomarkers; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; K | 2019 |
Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Albuminuria; Aldosterone; Amiloride; Ankle Brachial Index; | 2019 |
The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Calcium; | 2019 |
Excess Arterial Damage in Hyperaldosteronism.
Topics: Aldosterone; Arteries; Humans; Hyperaldosteronism; Hypertension | 2019 |
Aldosterone Induces Vascular Damage.
Topics: Adult; Aldosterone; Antihypertensive Agents; Area Under Curve; Arterial Pressure; Cohort Studies; Cr | 2019 |
Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Aged; Aldoste | 2013 |
Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: outcomes in a large series.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Antihypertensive Agents; Blood | 2013 |
Primary aldosteronism and impaired natriuresis in mice underexpressing TGFβ1.
Topics: Aldosterone; Amiloride; Angiotensin II; Animals; Blood Pressure; DNA Primers; Gene Expression Regula | 2013 |
Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Antihypertensiv | 2013 |
Comparison of the central adrenal vein and the common trunk of the left adrenal vein for adrenal venous sampling.
Topics: Adrenal Glands; Adult; Aldosterone; Biomarkers; Blood Specimen Collection; Female; Humans; Hydrocort | 2013 |
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
Topics: Adult; Aldosterone; Blood Glucose; Female; Humans; Hyperaldosteronism; Hypertension; Insulin; Insuli | 2013 |
Hormones other than aldosterone may contribute to hypertension in 3 different subtypes of primary aldosteronism.
Topics: Adrenal Medulla; Adult; Aldosterone; Blood Pressure Determination; Female; Glucocorticoids; Humans; | 2013 |
Serum dehydroepiandrosterone sulfate concentration is lower in women with primary aldosteronism.
Topics: Adenoma; Adult; Aged; Aldosterone; Cholesterol, HDL; Creatinine; Dehydroepiandrosterone Sulfate; Ess | 2015 |
Rhabdomyolysis presenting with severe hypokalemia in hypertensive patients: a case series.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperald | 2013 |
Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry.
Topics: Adult; Aged; Aldosterone; Female; Germany; Humans; Hyperaldosteronism; Male; Mass Screening; Middle | 2013 |
The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Cell Line; Cell Proliferation; Female; Humans; Hyperaldosteronis | 2013 |
Bone health and aldosterone excess.
Topics: Absorptiometry, Photon; Adult; Aged; Aldosterone; Bone Density; Calcium; Essential Hypertension; Fem | 2013 |
Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system.
Topics: Adrenal Glands; Aldosterone; Animals; Animals, Newborn; Corticosterone; Cytochrome P-450 CYP11B2; Fe | 2013 |
Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension.
Topics: Aged; Aldosterone; Angiotensin Receptor Antagonists; Antihypertensive Agents; Asian People; Diabetes | 2013 |
Bimodal aldosterone distribution in low-renin hypertension.
Topics: Aged; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2013 |
Primary aldosteronism: emerging trends.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Renin | 2013 |
Catheterization during adrenal vein sampling for primary aldosteronism: failure to use (1-24) ACTH may increase apparent failure rate.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Catheterization, Peripheral; Cosyntropin; Female; Humans | 2013 |
Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Creatinine; Essential Hypertension; Female; Hu | 2013 |
Quantification of urinary 18-hydroxycortisol using LC-MS/MS.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Biomarkers, Tumor; Chromatography, Liquid; Essential | 2013 |
Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.
Topics: Age Factors; Aldosterone; Animals; Biomarkers; Calcium Signaling; Compliance; Diet, High-Fat; Female | 2013 |
Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Amino Acid Sequence; Calcium Channels | 2013 |
Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Estradiol; HEK293 Cells; Humans; Hyperaldo | 2013 |
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Natriuretic | 2014 |
Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Topics: Adenosine Triphosphatases; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Age Fac | 2013 |
Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Renin; Reproducibility of | 2014 |
Female sex hormones are associated with the reduction of serum sodium and hypertension complications in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Biomarkers; Cerebrovascular Disorders; | 2013 |
Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Echocardiography; Endoth | 2014 |
Predictors of malignancy in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Aged; Aldosterone; Cell Transformation, Neoplastic; Female; | 2014 |
Lethal liquorice lollies (liquorice abuse causing pseudohyperaldosteronism).
Topics: Aldosterone; Diagnosis, Differential; Electrocardiography; Female; Follow-Up Studies; Glycyrrhiza; H | 2013 |
Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study.
Topics: Adenoma; Aldosterone; Epidemiologic Studies; Female; Health Surveys; Humans; Hyperaldosteronism; Hyp | 2014 |
Plasma metanephrine for assessing the selectivity of adrenal venous sampling.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Blood Specimen Collection; Cosyntropin; Female; Humans; Hy | 2013 |
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cytochrome P-450 CYP11B2; Fema | 2014 |
Ins and outs of aldosterone-producing adenomas of the adrenal: from channelopathy to common curable cause of hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Female; G Protein-Coupled Inwardly-Re | 2014 |
WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Animals; Cell Line, Tumor; Cyt | 2014 |
Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Female; Hematologic Tests; | 2013 |
Chronic hyperaldosteronism in cryptochrome-null mice induces high-salt- and blood pressure-independent kidney damage in mice.
Topics: Aldosterone; Animals; Blood Pressure; Cryptochromes; Gene Expression; Gene Expression Regulation; Hy | 2014 |
Introduction: Aldosterone and salt: heart and kidney.
Topics: Aldosterone; Cardiovascular Diseases; Congresses as Topic; Heart; Humans; Hyperaldosteronism; Kidney | 2013 |
Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Base Sequence; Female; G | 2014 |
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.
Topics: Adolescent; Adult; Aged; Aldosterone; Black People; Diabetes Mellitus, Type 1; Diabetes Mellitus, Ty | 2014 |
Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Rad | 2014 |
A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2014 |
Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Cells, Cultured; Down-Regulation; Gene Expression Pr | 2014 |
Aldosterone testing: evaluation of a novel automated immunoassay.
Topics: Aldosterone; Case-Control Studies; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Limit of D | 2014 |
LH, progesterone, and TSH can stimulate aldosterone in vitro: a study on normal adrenal cortex and aldosterone producing adenoma.
Topics: Adenoma; Adrenal Cortex; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; In Vitro Techniques; | 2014 |
[Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Case-Control Studies; Essential Hypertension; Female; H | 2013 |
Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Amino Acid Sequence; Animals | 2014 |
Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; CpG Islands; Cytochrome | 2014 |
Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Antihypertensive Agents; Blood Chemical Ana | 2014 |
Is adrenal venous sampling mandatory before surgical decision in case of primary hyperaldosteronism?
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Pressure; | 2014 |
[Diagnosis and treatment of patients with benign formations of the adrenal cortex].
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Humans; | 2013 |
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma.
Topics: Adenoma; Adrenal Glands; Adult; Aged; Aldosterone; Antigens, Neoplasm; Biomarkers; Case-Control Stud | 2014 |
Aldosterone to active Renin ratio as screening test for primary aldosteronism: reproducibility and influence of orthostasis and salt loading.
Topics: Aldosterone; Cohort Studies; Dizziness; Essential Hypertension; Female; Humans; Hyperaldosteronism; | 2014 |
Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice.
Topics: Aldosterone; Animals; Blood Glucose; Cytochrome P-450 CYP11B2; Diabetes Mellitus, Type 2; Diet, High | 2014 |
Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion.
Topics: Adrenal Cortex; Adult; Aged; Aldosterone; Angiotensin II; Animals; Anion Transport Proteins; Cell Li | 2014 |
Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Blood Specimen Collection; Female; Germany; Humans; Hyperaldoste | 2014 |
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
Topics: Adult; Aged; Aldosterone; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Essential Hyperten | 2014 |
Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Automation; Blood Chemical Analysis; Child; | 2014 |
A subtype prediction score for primary aldosteronism.
Topics: Adult; Aldosterone; Female; Forecasting; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium; R | 2014 |
[Suppression test to diagnose hyperaldosteronism in cats].
Topics: Aldosterone; Animals; Cat Diseases; Cats; Hyperaldosteronism; Hypertension | 2014 |
Channels and pumps in aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Potassium Channels, Tand | 2014 |
Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aged; Aldosterone; DNA Muta | 2014 |
KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Female; Follow-Up Studies; G Protein- | 2014 |
Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism.
Topics: Adolescent; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Blood Chemical Analysis; Blood | 2014 |
The role of urinary aldosterone for the diagnosis of primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Diagnostic Tests, Routine; Female; Humans; Hyperaldosteronism; Male; Middl | 2014 |
Clinical outcomes in patients undergoing laparoscopic adrenalectomy for unilateral aldosterone producing adenoma: partial versus total adrenalectomy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Female; H | 2014 |
A single-step approach to the diagnosis of primary hyperaldosteronism: filling a true void or burdening the bottleneck of adrenal vein sampling?
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male; Renin | 2014 |
High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses.
Topics: Adrenal Glands; Adult; Aldosterone; False Positive Reactions; Female; Humans; Hydrocortisone; Hypera | 2014 |
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Age Factors; Aldosterone; Calcium Channels, | 2014 |
Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension.
Topics: Adult; Aldosterone; Echocardiography; Essential Hypertension; Female; Humans; Hyperaldosteronism; Hy | 2014 |
Primary aldosteronism in hypertensive patients: clinical implications and target therapy.
Topics: Adrenocorticotropic Hormone; Aldosterone; Antihypertensive Agents; Case-Control Studies; Female; Hum | 2014 |
Pregnancy normalized familial hyperaldosteronism type I: a novel role for progesterone?
Topics: Adolescent; Aldosterone; Female; Humans; Hyperaldosteronism; Pregnancy; Pregnancy Complications; Pro | 2015 |
Oxidative stress in patients affected by primary aldosteronism.
Topics: Adenoma; Adrenalectomy; Adult; Aged; Aldosterone; Essential Hypertension; Female; Humans; Hyperaldos | 2014 |
Despite limited specificity, computed tomography predicts lateralization and clinical outcome in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Age Factors; Aldosterone; Blood Pressure; F | 2014 |
4-Hydroxychalcone attenuates hyperaldosteronism, inflammation, and renal injury in cryptochrome-null mice.
Topics: Aldosterone; Animals; Blood Pressure; Chalcones; Cryptochromes; Hyperaldosteronism; Inflammation; In | 2014 |
Aldosterone-renin ratio in the assessment of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; | 2014 |
The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.
Topics: Aldosterone; Captopril; Demography; Female; Humans; Hyperaldosteronism; Hypertension; Losartan; Male | 2015 |
A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Topics: Adenoma; Adrenal Cortex; Adrenocortical Adenoma; Aged; Aldosterone; Antihypertensive Agents; Cell Li | 2014 |
Deoxycorticosterone-producing adenoma concomitant with aldosterone-producing microadenoma: a challenging combination.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Male; Mid | 2014 |
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; Male | 2014 |
Failure mode analysis in adrenal vein sampling: a single-center experience.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Biomarkers; Blood Specimen Collection; Cath | 2014 |
Adrenal cortical scintigraphy for lateralization of bilateral adrenal nodules in primary aldosteronism.
Topics: Adosterol; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aged; Al | 2014 |
The ratios of aldosterone / plasma renin activity (ARR) versus aldosterone / direct renin concentration (ADRR).
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Renin; Sensitivity | 2015 |
Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Aldosterone; Calcium Channels; Cytochrome P-450 CY | 2014 |
The influence of aging on the diagnosis of primary aldosteronism.
Topics: Adult; Aged; Aged, 80 and over; Aging; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captop | 2014 |
Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.
Topics: Adrenalectomy; Aldosterone; Animals; Cell Line; Dose-Response Relationship, Drug; Fibroblasts; Fibro | 2014 |
Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Cushing Syndrom | 2014 |
Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
Topics: Adenoma; Aldosterone; Cardiovascular Diseases; Female; Follow-Up Studies; G Protein-Coupled Inwardly | 2015 |
Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
Topics: Adenoma; Adult; Aldosterone; Cohort Studies; Essential Hypertension; Female; Humans; Hyperaldosteron | 2015 |
Primary aldosteronism: functional histopathology and long-term follow-up after unilateral adrenalectomy.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Cytochrome P- | 2015 |
Adrenal vein sampling: is there now a consensus?
Topics: Adrenal Glands; Aldosterone; Consensus; Humans; Hyperaldosteronism; Practice Guidelines as Topic; Ve | 2015 |
Defining contralateral adrenal suppression in primary aldosteronism: implications for diagnosis and outcome.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Cohort Studies | 2015 |
[How to unravel hyperaldosteronism in clinical practice].
Topics: Aldosterone; Algorithms; Antihypertensive Agents; Diagnosis, Differential; Drug Resistance; Humans; | 2014 |
Aldosteronoma resolution score predicts long-term resolution of hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Blood Pressure Determination; C | 2014 |
Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Carotid I | 2015 |
A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable.
Topics: Adrenal Glands; Adult; Aldosterone; Cosyntropin; Female; Glomerular Filtration Rate; Humans; Hydroco | 2014 |
Should aldosterone suppression tests be conducted during a particular phase of the menstrual cycle, and, if so, which phase? Results of a preliminary study.
Topics: Adult; Aldosterone; Chromatography, High Pressure Liquid; Diagnostic Techniques, Endocrine; Estradio | 2015 |
Different potencies of angiotensin receptor blockers at suppressing adrenal β-Arrestin1-dependent post-myocardial infarction hyperaldosteronism.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; H | 2014 |
Outcome of surgical treatment of primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Biomarkers; Blood Pressure; Diagnostic Imaging; Female; Humans; Hyperald | 2015 |
Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Cell Count; Cell Proliferation; Cells, Cultured; Gen | 2015 |
Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
Topics: Adenoma; Adult; Aldosterone; Blood Pressure; Endothelium, Vascular; Female; Follow-Up Studies; Human | 2015 |
Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study.
Topics: Adolescent; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Blood Specimen Collection; Fema | 2015 |
Influence of diagnostic criteria on the interpretation of adrenal vein sampling.
Topics: Adrenal Glands; Adult; Aldosterone; Blood Pressure; Catheterization, Peripheral; Diagnosis, Differen | 2015 |
Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aldosterone; Animals; Case-Control Studies | 2015 |
Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotro | 2015 |
Primary aldosteronism and its various clinical scenarios.
Topics: Adult; Aged; Aldosterone; Cardiovascular Diseases; Female; Humans; Hyperaldosteronism; Hypertension; | 2015 |
Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Retrospective Stud | 2015 |
Primary aldosteronism presenting with an atypical aldosterone-renin ratio in the acute phase of cerebral hemorrhage.
Topics: Adult; Aldosterone; Cerebral Hemorrhage; Early Diagnosis; Humans; Hyperaldosteronism; Male; Renin; S | 2015 |
Screening for Primary Aldosteronism: Whom and How?
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male; Renin | 2015 |
Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.
Topics: Adult; Aldosterone; Antihypertensive Agents; Body Mass Index; Female; Humans; Hyperaldosteronism; Hy | 2015 |
Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Biomarkers; Diagnosis, Differential; Enzyme-Linked Im | 2015 |
Reliability of a Bayesian network to predict an elevated aldosterone-to-renin ratio.
Topics: Adult; Aldosterone; Bayes Theorem; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Ag | 2015 |
Potential effects of age on screening for primary aldosteronism.
Topics: Adult; Age Factors; Aged; Aldosterone; Biomarkers; Female; Humans; Hyperaldosteronism; Male; Middle | 2016 |
Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.
Topics: Adolescent; Adult; Age of Onset; Aldosterone; Amino Acid Sequence; Calcium; Calcium Channels, T-Type | 2015 |
Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure Monitoring, Ambulatory; Cost-Benefit Analysis; | 2015 |
Integration of transcriptome and methylome analysis of aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; DNA Methylation; Female; | 2015 |
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Cortex; Adrenocortical Adenoma; Adult; Aldosterone; Calcium Channels, L-Type; Cytoc | 2015 |
Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Case-Control Studies; Cy | 2015 |
Adrenal Vein Sampling in Primary Aldosteronism: Sensitivity and Specificity of Basal Adrenal Vein to Peripheral Vein Cortisol and Aldosterone Ratios to Confirm Catheterization of the Adrenal Vein.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Catheterization, Peripheral; Female; Human | 2015 |
Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Posture; Prospecti | 2015 |
Gene Expression Profile of Persistent Postoperative Hypertension Patients with Aldosterone-producing Adenomas.
Topics: Adenoma; Adrenalectomy; Aldosterone; Blood Pressure; Gene Expression Profiling; Humans; Hyperaldoste | 2015 |
Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Diastole; Echoc | 2015 |
A renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management.
Topics: Aldosterone; Calcium Channels, L-Type; Fludrocortisone; G Protein-Coupled Inwardly-Rectifying Potass | 2015 |
Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Angiography; Female; Humans; Hyperaldosteronism; Male; Mid | 2016 |
Reversing the established order: Should adrenal venous sampling precede cross-sectional imaging in the evaluation of primary aldosteronism?
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Algorithms; Biomar | 2015 |
Incidental and Intentional Medicine Achieve Similar Results in Primary Hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Female; Follow-Up Studies; Humans; Hyp | 2015 |
Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Blood | 2015 |
Screening for primary aldosteronism in an argentinian population: a multicenter prospective study.
Topics: Adolescent; Adult; Aged; Aldosterone; Argentina; Female; Humans; Hyperaldosteronism; Hypertension; M | 2015 |
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.
Topics: Adrenal Cortex; Adrenal Glands; Aldosterone; Cytochrome P-450 CYP11B2; DNA; Gene Expression Regulati | 2015 |
Primary Aldosteronism: Seismic Shifts.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Stress, Psychological | 2015 |
Role of adrenal vein sampling in primary aldosteronism: the Monash Health experience.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Australia; Delivery of Health | 2015 |
Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Area Under Curve; Biomarkers; Child; China; | 2015 |
Reversible heart rhythm complexity impairment in patients with primary aldosteronism.
Topics: Aldosterone; Arrhythmias, Cardiac; Biological Clocks; Computer Simulation; Electrocardiography, Ambu | 2015 |
Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aged, 80 and over; Aldosterone; Bioma | 2015 |
[Primary aldosteronism].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Algorithms; Antihypert | 2015 |
Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone | 2015 |
Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Blood Pressure; Essential Hypertension; Female; Humans; | 2015 |
Measurement of serum aldosterone in picomolar level by LC-MS/MS using charge-tagged technique.
Topics: Adult; Aged; Aldosterone; Calibration; Chromatography, Liquid; Female; Humans; Hyperaldosteronism; L | 2015 |
Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; beta Catenin; Female; Humans; Hyperaldosteroni | 2015 |
Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research.
Topics: Adrenalectomy; Adult; Aldosterone; Blood Pressure; Cells, Cultured; Female; Humans; Hyperaldosteroni | 2015 |
Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Catheterization; Female; Humans; Hydrocortisone; Hyperaldo | 2016 |
Discussion.
Topics: Adrenal Glands; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male | 2016 |
Primary hyperaldosteronism diagnosed with adrenal vein sampling. Characteristics and follow-up after adrenalectomy in a Danish study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Female; F | 2016 |
A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11 | 2015 |
Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan.
Topics: Adrenal Gland Neoplasms; Aged; Aldosterone; Cushing Syndrome; Female; Humans; Hyperaldosteronism; Ja | 2016 |
Hypokalemic rhabdomyolysis: a rare manifestation of primary aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypokalemia; Rhabdomyolysis | 2015 |
Normoaldosteronemic aldosterone-producing adenoma: immunochemical characterization and diagnostic implications.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Blood Pressure; Cytochrome P-45 | 2015 |
Bicarbonate-sensitive calcification and lifespan of klotho-deficient mice.
Topics: Acidosis; Aldosterone; Animals; Calcinosis; Calcitriol; Calcium; Genotype; Glucuronidase; Hyperaldos | 2016 |
Extraordinarily high aldosterone, 901.0 ng/dL, in a patient with primary aldosteronism: an insight into the underlying mechanism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Humans; Hyperaldosteronism; Ma | 2016 |
Sodium interference in the determination of urinary aldosterone.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Immunoassay; Reproducibility of Results; Sodi | 2016 |
Sodium Infusion Test for Diagnosis of Primary Aldosteronism in Chinese Population.
Topics: Adult; Aged; Aldosterone; Area Under Curve; Asian People; Blood Pressure; Female; Humans; Hyperaldos | 2016 |
[The importance of adrenal vein sampling in primary aldosteronism. Necessary examination for many patients as computed tomography can lead to errors].
Topics: Adrenal Glands; Adrenalectomy; Aged; Aldosterone; Blood Specimen Collection; Catheterization; Humans | 2015 |
Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Cytochrome P-450 CYP11B2; DNA; | 2016 |
Factors affecting parathyroid hormone levels in different types of primary aldosteronism.
Topics: Adenoma; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adult; Aldosterone; Calcium; Essential Hype | 2016 |
Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.
Topics: Adenoma; Adenosine Triphosphatases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Ald | 2016 |
Subtype prediction in primary aldosteronism: measurement of circadian variation of adrenocortical hormones and 24-h urinary aldosterone.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Area Under Curve; Blood Specimen Collection; Circad | 2016 |
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study.
Topics: Adenoma; Aldosterone; Biomarkers; Databases, Factual; Humans; Hyperaldosteronism; Hypertension; Pred | 2016 |
Regarding "Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein".
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Catheterization; Humans; Hyperaldosteronism; R | 2016 |
Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness | 2016 |
GNAS mutations in adrenal aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Chromogranins; Cohort St | 2016 |
A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Animals; Autoradiography; Benzimidazo | 2016 |
Molecular Heterogeneity in Aldosterone-Producing Adenomas.
Topics: Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11B2; DNA; G | 2016 |
Role of adrenal vein sampling in primary aldosteronism: Impact of imaging, localization, and age.
Topics: Adrenal Glands; Adrenalectomy; Adult; Age Factors; Aged; Aldosterone; Blood Specimen Collection; Fem | 2016 |
[Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
Topics: Aldosterone; Area Under Curve; Case-Control Studies; Chymosin; Essential Hypertension; Humans; Hyper | 2016 |
Prevalence of Malignancies in Patients With Primary Aldosteronism.
Topics: Adult; Aged; Aldosterone; Biomarkers, Tumor; Blood Pressure; Case-Control Studies; Female; Germany; | 2016 |
A cross-sectional study of the effects of β-blocker therapy on the interpretation of the aldosterone/renin ratio: can dosing regimen predict effect?
Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Antihypertensive Agents; Cross-Sectional Studies; Di | 2016 |
A useful tool to improve the case detection rate of primary aldosteronism: the aldosterone-renin ratio (ARR)-App.
Topics: Aldosterone; Diagnostic Techniques, Endocrine; Europe; Humans; Hyperaldosteronism; Renin; Software | 2016 |
The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism.
Topics: Aldosterone; Biomarkers; Diagnosis, Computer-Assisted; Discriminant Analysis; Humans; Hyperaldostero | 2016 |
Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Ankle Brachial Index; Female; Hemodynamics; Humans; Hype | 2016 |
Decrease in serum potassium levels post saline suppression test in primary aldosteronism: an under-recognised phenomenon?
Topics: Aldosterone; Diagnostic Tests, Routine; Female; Humans; Hyperaldosteronism; Hypertension; Potassium; | 2016 |
Basal and Post-ACTH Aldosterone and Its Ratios Are Useful During Adrenal Vein Sampling in Primary Aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; B | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Consensus; Evidence-Based Medicine; Humans; Hyperaldoste | 2016 |
Hyperaldosteronism after decreased renal K+ excretion in KCNMB2 knockout mice.
Topics: Aldosterone; Animals; Blood Pressure; Epithelial Sodium Channels; Eplerenone; Female; Hyperaldostero | 2016 |
Adrenal Venous Sampling in Patients With Positive Screening but Negative Confirmatory Testing for Primary Aldosteronism.
Topics: Adrenal Glands; Age Factors; Aged; Aldosterone; Cohort Studies; Cosyntropin; Female; Humans; Hyperal | 2016 |
Epicardial Fat Thickness and Primary Aldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Fats; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Per | 2016 |
Increased aldosterone-dependent Kv1.5 recycling predisposes to pacing-induced atrial fibrillation in Kcne3-/- mice.
Topics: Adrenal Glands; Aldosterone; Animals; Atrial Fibrillation; Electrophysiological Phenomena; Gene Expr | 2016 |
A Woman with Normotensive Primary Hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; | 2016 |
An App for the Diagnosis of Primary Aldosteronism.
Topics: Aldosterone; Arterial Pressure; Biomarkers; Computers, Handheld; Humans; Hyperaldosteronism; Hyperte | 2016 |
Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Luminescent Measurements; Male; Middle Aged; Prospe | 2016 |
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Age Factors; Aldosterone; France; Humans; Hydrocorti | 2016 |
A Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushing's Syndrome without Cardiovascular Complications.
Topics: Adrenal Gland Neoplasms; Aldosterone; Cardiovascular Diseases; Cushing Syndrome; Female; Glucocortic | 2016 |
A new highly sensitive and specific overnight combined screening and diagnostic test for primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Captopril; Dexamethasone; Diagnostic Tests, Routine; Female; Humans; Hyper | 2016 |
Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism.
Topics: Adrenocortical Adenoma; Aldosterone; Anthropometry; CD40 Ligand; Female; Humans; Hyperaldosteronism; | 2016 |
Aldosterone Induces Tissue Inhibitor of Metalloproteinases-1 Expression and Further Contributes to Collagen Accumulation: From Clinical to Bench Studies.
Topics: Aldosterone; Analysis of Variance; Animals; Biopsy, Needle; Blotting, Western; Collagen; Disease Mod | 2016 |
Bilateral aldosterone suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: analysis of data from the WAVES-J study.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Bloo | 2016 |
2016 Endocrine Society guidelines update for the diagnosis of primary aldosteronism: are the proposed aldosterone-to-renin ratio cut-off values relevant in the era of fully automated immunoassays?
Topics: Aldosterone; Automation, Laboratory; Endocrinology; Humans; Hyperaldosteronism; Hypertension; Immuno | 2016 |
Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cushing Syndrome; Cyclic AMP-Dependen | 2016 |
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
Topics: Age Factors; Aldosterone; Antihypertensive Agents; Blood Specimen Collection; Female; Humans; Hypera | 2016 |
[Renin and aldosterone determinations in hypertensive patients].
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Biomarkers; Female; Humans; Hyperaldosteronism; Hyperte | 2016 |
Causes of secondary hypertension in the young population: A monocentric study.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Aortic Coarctation; Biomarkers; Blood Pressure Monitori | 2016 |
Secondary hypertension in adults.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Aortic Coarctation; Blood Pressure; Glomerulo | 2016 |
Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Blood Specimen Collection; Catheterization | 2016 |
Aldosterone-producing Adenoma in Primary Aldosteronism: CT-guided Radiofrequency Ablation-Long-term Results and Recurrence Rate.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Biomarkers, Tumor; Catheter Ablation; | 2016 |
Clinical Outcomes following Percutaneous Radiofrequency Ablation of Unilateral Aldosterone-Producing Adenoma: Comparison with Adrenalectomy.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Antihypertensive Agents; Bioma | 2016 |
[An evaluation of plasma aldosterone-to-active-renin ratio in different postures in combination with aldosterone concentration in the diagnosis of aldosteronoma].
Topics: Aldosterone; Asian People; China; Essential Hypertension; Humans; Hyperaldosteronism; Hypertension; | 2016 |
CACNA1H(M1549V) Mutant Calcium Channel Causes Autonomous Aldosterone Production in HAC15 Cells and Is Inhibited by Mibefradil.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Amino Acid Substitution; Calcium Ch | 2016 |
PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Amino Acid Substitution; Cells | 2016 |
Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Topics: Adrenocorticotropic Hormone; Aldosterone; Cytochrome P-450 CYP11B2; Electrophysiological Phenomena; | 2016 |
KCNK3 Variants Are Associated With Hyperaldosteronism and Hypertension.
Topics: Aldosterone; Blood Pressure; Blood Pressure Determination; California; Ethnicity; Female; Genetic Pr | 2016 |
A feasibility study on percutaneous forearm vein access for adrenal venous sampling.
Topics: Adrenal Glands; Aldosterone; Biomarkers; Catheterization, Peripheral; Feasibility Studies; Forearm; | 2017 |
Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.
Topics: Adult; Aged; Aldosterone; Biomarkers; Biomechanical Phenomena; Blood Pressure; Case-Control Studies; | 2016 |
Cardiac Structure and Function in Hyperaldosteronism.
Topics: Aldosterone; Heart; Humans; Hyperaldosteronism; Hypertension | 2016 |
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Calcium Channel Blockers; France; Humans | 2016 |
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
Topics: Aldosterone; Captopril; Diagnosis, Differential; France; Humans; Hyperaldosteronism; Renin; Sensitiv | 2016 |
Adrenal vein sampling for subtyping in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism | 2016 |
Adrenal function: No difference between CT and AVS for determining treatment options in primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Tomography, X-Ray Computed; | 2016 |
ARAs to the RESCUE.
Topics: Aldosterone; Eplerenone; Gynecomastia; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Meta-A | 2016 |
Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Cushing Syndrome; Cytochrome | 2017 |
Small-Conductance Ca2+-Activated Potassium Channels Negatively Regulate Aldosterone Secretion in Human Adrenocortical Cells.
Topics: Adrenal Cortex; Adult; Aged; Aldosterone; Analysis of Variance; Angiotensin II; Apamin; Calcium Chan | 2016 |
Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Essential Hypertension; Female; Humans; Hyperaldosteronism; Hype | 2016 |
Determination of urinary aldosterone using a plasma aldosterone 2D ID LC-MS/MS method.
Topics: Aldosterone; Calibration; Chromatography, Liquid; Humans; Hyperaldosteronism; Limit of Detection; Ta | 2016 |
Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aftercare; Aged; Aged, 80 and ov | 2016 |
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male; Metoclopramide; Middle Aged; Prospective Stud | 2016 |
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.
Topics: Adult; Age Factors; Aged; Aldosterone; Blood Pressure Determination; Body Mass Index; Comorbidity; C | 2016 |
The Clinical Value of Salivary Aldosterone in Diagnosis and Follow-Up of Primary Aldosteronism.
Topics: Adrenalectomy; Aged; Aldosterone; Case-Control Studies; Circadian Rhythm; Eplerenone; Female; Follow | 2016 |
Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism.
Topics: Adrenalectomy; Adult; Aldosterone; Cohort Studies; Diagnostic Techniques, Endocrine; Female; France; | 2016 |
Hyperaldosteronism induces left atrial systolic and diastolic dysfunction.
Topics: Aldosterone; Animals; Atrial Function, Left; Calcium; Diastole; Heart Atria; Hemodynamics; Hyperaldo | 2016 |
Primary aldosteronism in patients with acute stroke: prevalence and diagnosis during initial hospitalization.
Topics: Aged; Aldosterone; Comorbidity; Female; Hospitalization; Humans; Hyperaldosteronism; Hypertension; J | 2016 |
Aldosterone-Producing Adenoma With a Somatic KCNJ5 Mutation Revealing APC-Dependent Familial Adenomatous Polyposis.
Topics: Adenoma; Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Adrenal Gland Neoplasms; Ad | 2016 |
Effects of Treating Primary Aldosteronism on Renal Function.
Topics: Adrenalectomy; Adult; Aldosterone; Female; Glomerular Filtration Rate; Humans; Hyperaldosteronism; M | 2017 |
Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; G Protein-Couple | 2017 |
PRIMARY ALDOSTERONISM IN THE PRIMARY CARE CLINIC: RIFE OR RARE?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Primary Health Care; Renin | 2016 |
Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Diagnosis, Differential; Female; Follow-Up Studie | 2016 |
Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Glands; Adult; Aged; Aldosterone; Case-Control Studies; Diagnosis, Differential; Fe | 2017 |
Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.
Topics: Adrenocortical Adenoma; Aldosterone; DNA Methylation; Female; G Protein-Coupled Inwardly-Rectifying | 2016 |
Some Considerations About Primary Aldosteronism and Its Follow-Up.
Topics: Aldosterone; Follow-Up Studies; Humans; Hyperaldosteronism; Hypertension; Renin | 2016 |
Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.
Topics: Adenoma; Adrenal Cortex; Aldosterone; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene | 2016 |
Adrenal vein sampling versus CT scanning in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Tomography, X-Ray Computed | 2016 |
Adrenal vein sampling versus CT scanning in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Tomography, X-Ray Computed | 2016 |
Adrenal vein sampling versus CT scanning in primary aldosteronism - Authors' reply.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Tomography, X-Ray Computed | 2016 |
Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Ad | 2017 |
Adrenal vein sampling in primary aldosteronism: concordance of simultaneous vs sequential sampling.
Topics: Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hydrocortisone; Hyperal | 2017 |
Many Channels Lead to Aldosterone.
Topics: Aldosterone; Animals; Calcium Channels, L-Type; Calcium Channels, T-Type; G Protein-Coupled Inwardly | 2016 |
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Biomarkers; Blood Pressure; Epithelial Sodium Channels; Essential Hypertension; | 2017 |
Success in adrenal venous sampling between two protocols: experience at a tertiary centre.
Topics: Adrenal Glands; Aldosterone; Blood Specimen Collection; Humans; Hyperaldosteronism; Veins | 2017 |
Adrenal venous sampling in primary aldosteronism: multinomial regression modeling to detect aldosterone secretion lateralization when right adrenal sampling is missing.
Topics: Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Area Under Curve; Cosyntropin; Female; | 2017 |
Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling.
Topics: Adrenal Glands; Adult; Aldosterone; Blood Specimen Collection; Diagnosis, Differential; Female; Huma | 2017 |
Primary aldosteronism as a public health issue.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Public Health | 2016 |
PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.
Topics: Adult; Aged; Aldosterone; Comorbidity; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middl | 2016 |
High-sensitive C-reactive protein in primary aldosteronism.
Topics: Aldosterone; C-Reactive Protein; Humans; Hyperaldosteronism; Hypertension | 2017 |
Role of adrenocorticotropic hormone in essential hypertension and primary aldosteronism.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Blood Pressure; Essential Hypertension; Humans; H | 2017 |
Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Blood Pressure; Essential Hypertensi | 2017 |
Genetic characterization of a mouse line with primary aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Disease Models, Animal; Exome; Female; Genetic Association Studies | 2017 |
Hypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Hyperaldosternoism: A Case Report.
Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Antithyroid Agents; Biomarkers; Diagnosis, Differen | 2017 |
Novel Approach to Establishing an Aldosterone: Renin Ratio Cutoff for Primary Aldosteronism.
Topics: Alberta; Aldosterone; Biomarkers; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Age | 2017 |
Adrenal hormones before and after venography during adrenal venous sampling: a self-controlled study.
Topics: Adrenal Glands; Aldosterone; Blood Specimen Collection; Catheterization, Peripheral; Contrast Media; | 2017 |
Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Blood Glucose; | 2017 |
Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aged, 80 and over; Aldoste | 2017 |
Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Essentia | 2017 |
Optimization of left adrenal vein sampling in primary aldosteronism: Coping with asymmetrical cortisol secretion.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Asymptomatic Diseases | 2017 |
Adrenal Venous Sampling Versus Computed Tomographic Scan to Determine Treatment in Primary Aldosteronism (The SPARTACUS Trial): A Critique.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Tomography, X-Ray Computed | 2017 |
Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aged, 80 and over; Aldosterone; Antihypertensive Agents; Blood Pressure; | 2017 |
Case of Primary Aldosteronism With Discordant Hormonal and Computed Tomographic Findings.
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium | 2017 |
A case of primary aldosteronism caused by unilateral multiple adrenocortical micronodules presenting as muscle cramps at rest: The importance of functional histopathology for identifying a culprit lesion.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Im | 2017 |
Primary Aldosteronism or Not Primary Aldosteronism: Is This Now the Question in Normotension?
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension | 2017 |
A Late Diagnosis of Primary Aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Antihypertensiv | 2017 |
Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged | 2017 |
The failure of torcetrapib: what have we learned?
Topics: Aldosterone; Anticholesteremic Agents; Blood Pressure; Cardiovascular Diseases; Cholesterol Ester Tr | 2008 |
Primary aldosteronism and hypercortisolism due to bilateral functioning adrenocortical adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cushing Syndrome; Diagnosis, Differen | 2008 |
Aldosterone, hypertension, and cardiovascular disease: an endless story.
Topics: Aldosterone; Cardiovascular Diseases; Chronic Disease; Comorbidity; Disease Progression; Female; Hum | 2008 |
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Antihypertensive Agents; Blood Pressu | 2008 |
CT-guided radiofrequency ablation of an aldosterone-secreting primary adrenal tumor in a surgically unfit patient.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Catheter Ablation; Female; Huma | 2008 |
Inappropriate left ventricular mass in patients with primary aldosteronism.
Topics: Adaptation, Physiological; Adult; Aged; Aldosterone; Echocardiography; Female; Humans; Hyperaldoster | 2008 |
Adrenalectomy improves arterial stiffness in primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Blood Pressure; Carotid Arteries; Female; Femoral Artery; Follow-Up Stud | 2008 |
Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Blood Pressure; Female; Follow- | 2008 |
Change in the pattern of adrenal venous sampling over time in patients with primary aldosteronism.
Topics: Aldosterone; Blood Specimen Collection; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Mi | 2009 |
Screening for primary aldosteronism in a cohort of Brazilian patients with resistant hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aged; Aldosterone; Brazil; Cross-Sectional Studies | 2008 |
Combined Conn's syndrome and subclinical hypercortisolism from an adrenal adenoma associated with homolateral renal carcinoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Carcinoma, Renal Cell; C | 2008 |
Hypertension due to a renin-secreting juxtaglomerular cell tumor.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Biomarkers; Humans; Hyperaldosteronism; Hyp | 2008 |
Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism.
Topics: Acetazolamide; Aldosterone; Animals; Calcium; Chronic Disease; Disease Models, Animal; Homeostasis; | 2008 |
[Primary hyperaldosteronism in hypertension].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2008 |
Primary aldosteronism in newly diagnosed hypertensive patients.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Predictive Value of Tests; Reference Values; | 2008 |
The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Aged; Aldosterone; Antihypertensi | 2008 |
The case for high-dose dexamethasone suppression testing preoperatively in aldosterone-producing adenoma to exclude cosecretion of cortisol.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Cushing Syndrome; Dexame | 2008 |
Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone.
Topics: Adult; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldosteronism; Male; Middle Aged; Potassiu | 2009 |
[Subclinical endothelial inflammation markers in a family with type I familial hyperaldosteronism caused by a de novo mutation].
Topics: Adolescent; Aldosterone; Biomarkers; C-Reactive Protein; Cytochrome P-450 CYP11B2; Endothelium, Vasc | 2008 |
The role of radiologic studies in the evaluation and management of primary hyperaldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Catheterization; Female; Humans; Hyperaldos | 2008 |
The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male; Mineralocorticoids; Potassium; Renin; Sodium; | 2009 |
Adrenal endothelin-1 levels are not associated with aldosterone secretion in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aged; Aldosterone; Aspartic Acid Endopeptidases; E | 2009 |
Screening for membrane hormone receptor expression in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Genetic Testing; Humans; Hyperaldosteron | 2009 |
Aldosterone and Cardiovascular Disease. Foreword.
Topics: Adrenalectomy; Aldosterone; Animals; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular | 2009 |
Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.
Topics: Aldosterone; Animals; Cattle; Chlorocebus aethiops; COS Cells; Disulfides; Dose-Response Relationshi | 2009 |
Primary hyperaldosteronism in a domestic ferret with an adrenocortical adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Animals; Fatal Outcome; Female; Ferre | 2008 |
Primary aldosteronism with aldosterone-producing adenoma consisting of pure zona glomerulosa-type cells in a pregnant woman.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Estrogen Recept | 2009 |
Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league.
Topics: Adrenal Glands; Aldosterone; Antihypertensive Agents; Fasting; Female; Humans; Hyperaldosteronism; H | 2009 |
Aldosterone and metabolic dysfunction: an unresolved issue.
Topics: Aldosterone; Animals; Dyslipidemias; Humans; Hyperaldosteronism; Hypertension; Hypokalemia | 2009 |
Hypokalemic paralysis due to primary hyperaldosteronism simulating Gitelman's syndrome.
Topics: Aldosterone; Biopsy; Diagnosis, Differential; Electromyography; Female; Gitelman Syndrome; Humans; H | 2009 |
Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Pressure; | 2009 |
Medical management of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2009 |
Animal models of primary aldosteronism.
Topics: Aldosterone; Animals; Animals, Genetically Modified; Disease Models, Animal; Hyperaldosteronism; Mic | 2009 |
Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism.
Topics: Aldehydes; Aldosterone; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Dis | 2009 |
Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Dose-Response | 2009 |
Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Dose-Response | 2009 |
Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Dose-Response | 2009 |
Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Dose-Response | 2009 |
Endothelial dysfunction is related to aldosterone excess and raised blood pressure.
Topics: Aged; Aldosterone; Endothelium, Vascular; Female; Humans; Hyperaldosteronism; Hypertension; Male; Mi | 2009 |
Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry.
Topics: Adolescent; Adult; Aged; Aldosterone; Automation; Chromatography, High Pressure Liquid; Cohort Studi | 2009 |
[Anesthetic management and surgical technique in treatment of primary hyperaldosteronism].
Topics: Adrenalectomy; Aldosterone; Anesthesia, General; Antihypertensive Agents; Humans; Hyperaldosteronism | 2009 |
Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Cohort Studies; Female; Follow-Up Studies; | 2009 |
Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Analysis of Variance; | 2010 |
Hyperaldosteronism in an adolescent with Gardner's syndrome.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Female; Fibromatosis, Aggr | 2009 |
Aldosterone-producing adrenal cortical adenoma with oncocytic change and cytoplasmic eosinophilic globular inclusions.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aged; Aldosterone; Antihypertensive Agents; Female | 2009 |
Saliva as a medium for aldosterone measurement in repeated sampling studies.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Artifacts; Case-Control Studies; Circadian Rhythm; | 2009 |
Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
Topics: Adiponectin; Aldosterone; Biomarkers; Blood Glucose; Chi-Square Distribution; Cross-Sectional Studie | 2010 |
Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC.
Topics: Adenomatous Polyposis Coli Protein; Aldosterone; Animals; Blood Pressure; Blood Volume; Body Weight; | 2009 |
Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience.
Topics: Adrenalectomy; Adult; Aldosterone; Blood Pressure; Creatinine; Female; Humans; Hyperaldosteronism; H | 2009 |
Physiological partial aldosterone resistance in human newborns.
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Infant, Newborn; Middle Aged; Mi | 2009 |
Going with the Wnt? Focus on "Hyperaldosteronism, hypervolemia, and increased blood pressure in mice expressing defective APC".
Topics: Adenomatous Polyposis Coli Protein; Aldosterone; Animals; Blood Pressure; Blood Volume; Glomerular F | 2009 |
Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.
Topics: Adult; Aldosterone; Cross-Sectional Studies; Female; Humans; Hyperaldosteronism; Hypertension; Inter | 2009 |
Atrial fibrillation in primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Fibrillation; Female; Humans; Hyperaldosteronism; Hypertension; Hypertrop | 2009 |
Adrenocorticotropic hormone stimulation during adrenal vein sampling.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Dose-Response Relationship, Drug; Humans; | 2009 |
Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Female; Gene E | 2010 |
Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Blood Pressure; Creatinine; Fe | 2009 |
[Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Diagnosis, Diff | 2009 |
[Endocrine hypertension].
Topics: Adrenal Gland Neoplasms; Aldosterone; Cushing Syndrome; Humans; Hyperaldosteronism; Hypertension; Hy | 2009 |
Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Biomarkers; Catheterization, Peripheral; Female; Hepatic | 2009 |
Hyperaldosteronism and hyperprogesteronism in a cat.
Topics: Adrenal Cortex Function Tests; Adrenocortical Hyperfunction; Aldosterone; Animals; Cat Diseases; Cat | 2009 |
Primary aldosteronism--one picture is not worth a thousand words.
Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Magnetic Resonance | 2009 |
Update in primary aldosteronism.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Amiloride; Antihypertensive Agents; Chromos | 2009 |
Lack of cardiac fibrosis in a new model of high prorenin hyperaldosteronism.
Topics: Administration, Oral; Aldosterone; Animals; Cardiomegaly; Collagen Type I; Cytochrome P-450 CYP1A1; | 2009 |
Aldosterone improves contractile function of adult rat ventricular cardiomyocytes in a non-acute way: potential relationship to the calcium paradox of aldosteronism.
Topics: Aldosterone; Angiotensin II; Animals; Calcium; Cell Size; Heart Failure; Hyperaldosteronism; In Vitr | 2010 |
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hyperten | 2009 |
Adrenal venous sampling: where is the aldosterone disappearing to?
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Diagnosis, Differential; Female; Hepatic Veins; Humans; Hy | 2010 |
Acute cerebral hemorrhage normalized plasma renin activity in a patient with primary aldosteronism.
Topics: Acute Disease; Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Humans; Hyperaldosteronism; Int | 2009 |
Some considerations about evolution of idiopathic primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Refer | 2009 |
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study.
Topics: Adult; Aldosterone; Fatty Liver; Female; Homeostasis; Humans; Hyperaldosteronism; Hypertension; Hypo | 2010 |
Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism.
Topics: Aldosterone; Animals; Calcium; Dinoprost; Disease Models, Animal; Glutathione Peroxidase; Homeostasi | 2010 |
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldoste | 2010 |
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.
Topics: Aldosterone; Comorbidity; Contraceptives, Oral; Estradiol; Female; Humans; Hyperaldosteronism; Hyper | 2010 |
Spironolactone for all hypertensive patients?
Topics: Aldosterone; Diuretics; Drug Therapy, Combination; Humans; Hyperaldosteronism; Hypertension; Practic | 2010 |
A dispensable role for P450(scc) in the overproduction of aldosterone in aldosterone-producing adenoma and idiopathic hyperaldosteronism in patients with primary aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aldosterone; Blotting, Northern; Cholesterol Side-Chain Cleavage Enzy | 2010 |
The role of radiologic studies in the evaluation and management of primary hyperaldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Radiography | 2010 |
Clinical outcome after laparoscopic adrenalectomy for primary hyperaldosteronism: the role of pathology.
Topics: Adrenalectomy; Adult; Aldosterone; Blood Pressure; Female; Follow-Up Studies; Humans; Hyperaldostero | 2010 |
Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Female; Health Status; Humans; Hyperaldoste | 2010 |
Adrenal venous sampling: is it to be done routinely or selectively in evaluation of primary hyperaldosteronism? How far have we come in conclusion...
Topics: Aldosterone; Humans; Hyperaldosteronism | 2010 |
Aldosterone-producing adrenal adenoma and idiopathic intracranial hypertension--a pathogenetic link for aldosterone?
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldostero | 2010 |
Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Blotting, Western; Cytochrome P-450 C | 2010 |
Adipokines and cardiometabolic profile in primary hyperaldosteronism.
Topics: Adenoma; Adiponectin; Adult; Aged; Aldosterone; Biomarkers; Blood Glucose; Blood Pressure; C-Reactiv | 2010 |
Salivary aldosterone as a diagnostic aid in primary aldosteronism.
Topics: Adenoma; Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aged; Aged, 80 and over; Aldos | 2010 |
Feline primary hyperaldosteronism.
Topics: Aging; Aldosterone; Animals; Cat Diseases; Cats; Hyperaldosteronism | 2010 |
Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone.
Topics: Adrenal Glands; Aldosterone; Animals; Blood Pressure; Blood Proteins; Chromatography, Liquid; Cortic | 2010 |
Aldosterone-producing adenomas: mining for genes.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Female; Genetic Predisposition to Disease; Genetic T | 2010 |
A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.
Topics: Adolescent; Adult; Aged; Aldosterone; Humans; Hyperaldosteronism; Immunoassay; Luminescent Measureme | 2010 |
A case of Conn's syndrome revealed after oral sodium phosphate (Fleet) preparation for colonoscopy.
Topics: Adenoma; Administration, Oral; Adrenal Gland Neoplasms; Aldosterone; Colonoscopy; Female; Humans; Hy | 2010 |
Current Opinion in Endocrinology, Diabetes & Obesity. Editorial overview.
Topics: Adrenal Cortex; Adrenal Insufficiency; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hype | 2010 |
Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
Topics: Aldosterone; Biomarkers; Cohort Studies; Coronary Angiography; Cross-Sectional Studies; Female; Huma | 2010 |
New insight into the role of aldosterone/renin ratio in elevated peripheral and central blood pressure.
Topics: Aldosterone; Biomarkers; Humans; Hyperaldosteronism; Hypertension; Renin; Renin-Angiotensin System | 2010 |
[A 58-year-old hypertensive patient with primary hyperaldosteronism and renal artery stenosis].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Angiography; Angioplasty, Balloon; Di | 2010 |
Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cushin | 2011 |
Familial adenomatous polyposis and hypertension.
Topics: Adenomatous Polyposis Coli; Adrenal Glands; Adult; Aldosterone; Humans; Hyperaldosteronism; Hyperpla | 2010 |
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
Topics: Adiponectin; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldoster | 2010 |
Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Italy; Male; Middle Aged; Obesity; Prevalenc | 2010 |
Delayed diagnosis of primary hyperaldosteronism.
Topics: Adult; Aldosterone; Calcium Channel Blockers; Delayed Diagnosis; Dihydropyridines; Drug Resistance; | 2010 |
Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Biomarkers; Blood Pressure; Female; Humans; Hyperaldosteronism; Hypertensi | 2010 |
Aortic cell apoptosis in rat primary aldosteronism model.
Topics: Aldosterone; Animals; Aorta; Apoptosis; Endothelial Cells; Hyperaldosteronism; Male; Random Allocati | 2010 |
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Biomarkers; Blood Pressure; Body Mass Index; C | 2010 |
Congestive heart failure: where homeostasis begets dyshomeostasis.
Topics: Aldosterone; Calcium; Dietary Supplements; Heart Failure; Homeostasis; Humans; Hyperaldosteronism; M | 2010 |
Predictors of resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenoma.
Topics: Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyper | 2010 |
[The accuracy of combining aldosterone to renin ratio and low renin level in diagnosing primary aldosteronism].
Topics: Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Renin; ROC C | 2010 |
Metabolic syndrome and primary aldosteronism: time for reappraisal?
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Biomarkers; Blood Pressure; Body Mass Index; Humans; | 2010 |
Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure.
Topics: Aldosterone; Animals; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Epithelial | 2010 |
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.
Topics: Adenoma; Adult; Aged; Aldosterone; Blood Chemical Analysis; Captopril; Female; Humans; Hyperaldoster | 2010 |
Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients.
Topics: Adult; Aldosterone; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiomyopathies; Case-Control S | 2010 |
Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; China; Cytochro | 2010 |
Hyperaldosteronism in Klotho-deficient mice.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Blood Chemical Analysis; Blood Pressure; Body Wei | 2010 |
Aldosterone and parathyroid hormone: a complex and clinically relevant relationship.
Topics: Aldosterone; Animals; Cardiovascular Diseases; Disease Models, Animal; Female; Humans; Hyperaldoster | 2010 |
[Bilateral adrenal vein sampling in single catheter technique using a 4F cobra catheter in regular and inverse configuration].
Topics: Adrenal Glands; Adult; Aldosterone; Catheterization, Peripheral; Equipment Design; Female; Humans; H | 2011 |
Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.
Topics: Adult; Aged; Aldosterone; Comorbidity; Cross-Sectional Studies; Drug Resistance; Female; Humans; Hyp | 2010 |
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocorticotropic | 2010 |
Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Topics: Adolescent; Aldosterone; Asian People; Cytochrome P-450 CYP11B2; Dexamethasone; Family; Female; Gluc | 2010 |
Clinical relevance of dietary salt intake on aldosterone and the aldosterone-to-renin ratio as screening parameters for primary aldosteronism.
Topics: Age Factors; Aldosterone; Antihypertensive Agents; Cross-Sectional Studies; Female; Humans; Hyperald | 2010 |
A mother/daughter case of familial hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Antihypertensive Agents; Biomarkers; Blo | 2010 |
Misdiagnosis of two cases of primary aldosteronism owing to failure of computed tomography to detect adrenal microadenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Diagnostic Errors; Fem | 2010 |
Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.
Topics: Aldosterone; Animals; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Endothelial Cells; Endo | 2011 |
Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cytochrome P-450 CYP11B2; Fem | 2010 |
A question of central importance.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Renin; Renin-Angiotensin System | 2010 |
A patient with concurrent primary aldosteronism and Page kidney.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Hematoma; Humans; Hyperaldosteronism; H | 2010 |
Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?
Topics: Adult; Aldosterone; Chromatography, High Pressure Liquid; False Positive Reactions; Female; Follicle | 2011 |
Mitochondria-targeted cardioprotection in aldosteronism.
Topics: Aldosterone; Animals; Antioxidants; Calcium; Cardiotonic Agents; Cyclosporine; Dinoprost; Hydrogen P | 2011 |
Progesterone increase counteracts aldosterone action in a pregnant woman with primary aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Pregnancy; Progesterone | 2011 |
Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenalectomy; Adult; Aldosterone; Blood Pressure; Female; Fludrocortisone; Humans; Hyperal | 2011 |
Current diagnosis and treatment of primary aldosteronism.
Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocortic | 2010 |
Torsade de pointes--a rare presentation of primary hyperaldosteronism.
Topics: Aged; Aldosterone; Electrocardiography; Emergency Service, Hospital; Heart; Humans; Hyperaldosteroni | 2012 |
Differential effects of down-regulated steroidogenic factor-1 on basal and angiotensin II-induced aldosterone secretion.
Topics: Aldosterone; Angiotensin II; Cell Line; Cytochrome P-450 CYP11B2; Down-Regulation; Humans; Hyperaldo | 2011 |
Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism.
Topics: Adenoma; Adrenal Glands; Adrenalectomy; Aldosterone; Diagnosis, Differential; Humans; Hyperaldostero | 2011 |
The association of serum potassium level with left ventricular mass in patients with primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Case-Control Studies; Diastole; Female; Heart Ventricles; | 2011 |
Medicine. The genetics of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Animals; Disease Mode | 2011 |
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Cell Line; Cell Proli | 2011 |
Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Blood Specimen Collection; Female; Fludrocortisone; Humans | 2011 |
Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Biomarkers, Tumor; Blood Specimen Collection; Chromogranin A; Data Inte | 2011 |
A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion?
Topics: Adult; Aldosterone; Case-Control Studies; Female; Gene Expression Regulation; Humans; Hydrocortisone | 2011 |
Single-center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling.
Topics: Adrenalectomy; Aldosterone; Cohort Studies; Female; Hematologic Tests; Humans; Hyperaldosteronism; L | 2011 |
Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder.
Topics: Aldosterone; Animals; Depression; Depressive Disorder, Major; Gene Expression Regulation; Hyperaldos | 2012 |
Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).
Topics: Adenoma; Aldosterone; Cohort Studies; Demography; Female; Humans; Hyperaldosteronism; Hypertension; | 2011 |
[Primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Aged; Aldosterone; Carcinoma; Di | 2011 |
Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Aged; Aldosterone; Blood | 2012 |
The clinical utility of two renin mass methods to detect primary hyperaldosteronism compared with renin activity.
Topics: Adult; Aged; Aldosterone; Blood Chemical Analysis; Cryopreservation; Female; Humans; Hyperaldosteron | 2011 |
Primary aldosteronism: results of adrenalectomy for nonsingle adenoma.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aged, 80 and over; Aldoste | 2011 |
Subtyping of primary aldosteronism by adrenal vein sampling: effect of acute D(2) receptor dopaminergic blockade on adrenal vein cortisol and chromogranin A levels.
Topics: Adrenal Glands; Adult; Aldosterone; Chromogranin A; Dopamine D2 Receptor Antagonists; Female; Humans | 2011 |
Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Child; Child, Preschool; Chile; Comorbidity; Cross-S | 2011 |
Is familial hyperaldosteronism underdiagnosed in hypertensive children?
Topics: Aldosterone; Blood Pressure; Child; Chile; Comorbidity; Cytochrome P-450 CYP11B2; Family Health; Gen | 2011 |
Insulin signaling in adipose tissue of patients with primary aldosteronism.
Topics: Adipocytes; Adipose Tissue; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; | 2011 |
High prevalence of autonomous aldosterone secretion among patients with essential hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aged; Aldosterone; Blood Pressure; Case-Control St | 2011 |
18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Biomarker | 2011 |
Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Circadian Rhythm; Cross-Sectional Studies; Female; Hear | 2011 |
Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.
Topics: Adolescent; Adult; Aldosterone; Child; Chimera; Cytochrome P-450 CYP11B2; Dexamethasone; Female; Glu | 2011 |
Methodological remarks about plasma renin assays.
Topics: Adenoma; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Renin | 2011 |
Coexisting renal artery aneurysm and adrenal adenoma in resistant hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Aneurysm; Female; Humans; Hyperaldosteronism; Hyperte | 2011 |
Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Dexamethasone; Female; | 2011 |
Spironolactone prevents the inducibility of ventricular tachyarrhythmia in rats with aldosteronism.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Collagen; Electric Stimulation; Electrocardiograp | 2011 |
Resistant hypertension and undiagnosed primary hyperaldosteronism detected by use of a computerized database.
Topics: Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Clinical Pharmacy Information Systems; D | 2011 |
Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Amiloride; Australia; Diuretics; Drug Therapy, Combination; | 2011 |
Coexistence of primary aldosteronism and Hashimoto's thyroiditis.
Topics: Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Autoimmun | 2012 |
Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Blood Pressure; Cytochrome P-450 CYP1 | 2011 |
Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
Topics: Adenoma; Adult; Aged; Aldosterone; Apoptosis; Arteries; Biomarkers; C-Reactive Protein; Cell Count; | 2011 |
Aldosterone promotes atrial fibrillation.
Topics: Aldosterone; Animals; Atrial Fibrillation; Connexin 43; Electrocardiography; Electrophysiologic Tech | 2012 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
Topics: Aldosterone; Humans; Hyperaldosteronism | 2011 |
Intraprocedural cortisol measurement increases adrenal vein sampling success rate in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Angiotensin I; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male | 2011 |
Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; Hypertension; Insulin Resist | 2011 |
A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Catheterization; Diagnosis, Differential; Female; Humans; | 2012 |
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
Topics: Aldosterone; Animals; Blood Pressure; Blotting, Western; Collagen; Cytokines; Disease Models, Animal | 2011 |
What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated?
Topics: Aldosterone; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperkalemia; Hypertension; Male; Miner | 2011 |
A diagnostic algorithm--the holy grail of primary aldosteronism.
Topics: Aldosterone; Algorithms; Humans; Hyperaldosteronism; Japan; Renin | 2011 |
Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Cross-Sectional Studies; Data In | 2012 |
Conn's syndrome unmasked by thiazide-induced hypokalaemia.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Pressure Monitoring, Ambulatory; Diagnosis, | 2011 |
Combined aldosterone and cortisol secretion by adrenal incidentaloma.
Topics: Adrenal Gland Neoplasms; Aged; Aldosterone; Cushing Syndrome; Diabetes Mellitus, Type 2; Female; Hum | 2012 |
A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
Topics: Adolescent; Adult; Aldosterone; Chile; Chromosome Breakpoints; Chromosome Segregation; Cytochrome P- | 2012 |
Diabetic lipoproteins and adrenal aldosterone synthesis--a possible pathophysiological link?
Topics: Adrenal Cortex; Aldosterone; Cell Line, Tumor; Cytochrome P-450 CYP11B2; Diabetes Complications; Hum | 2012 |
[Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
Topics: Adult; Aldosterone; Argentina; Blood Pressure; Cross-Sectional Studies; Female; Humans; Hyperaldoste | 2011 |
Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Analysis of Vari | 2012 |
Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; DNA, Neoplasm; Female; G Protein-Coup | 2012 |
Role of K(+) channels in the pathophysiology of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; DNA, Neoplasm; Female; G Protein-Coupled Inwardly-Rec | 2012 |
The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Child; Cohort Studies; Female; Germany; Hum | 2012 |
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
Topics: Adult; Aldosterone; Female; Follow-Up Studies; G Protein-Coupled Inwardly-Rectifying Potassium Chann | 2012 |
The genetics of primary aldosteronism: chapter two.
Topics: Aldosterone; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Humans; Hyperaldoster | 2012 |
Primary aldosteronism: are we missing the wood for the trees?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Pract | 2012 |
Lessons from Africa: the importance of measuring plasma renin and aldosterone in resistant hypertension.
Topics: Africa; Aldosterone; Antihypertensive Agents; Black or African American; Drug Resistance; Female; Hu | 2012 |
Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.
Topics: Adult; Age Factors; Aged; Aging; Aldosterone; Case-Control Studies; Female; Humans; Hyperaldosteroni | 2012 |
Congestive heart failure as an initial manifestation of reninoma.
Topics: Adolescent; Aldosterone; Cardiomyopathy, Dilated; Female; Heart Failure; Humans; Hyperaldosteronism; | 2011 |
A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Blood Specimen Collection; Female; Humans; Hyperaldosteronism; M | 2012 |
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Catheterization; Female; Humans; Hy | 2012 |
A case of cortisol producing adrenal adenoma associated with a latent aldosteronoma: usefulness of the ACTH loading test for the detection of covert aldosteronism in overt Cushing syndrome.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Adult; | 2012 |
Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Antihypertensive Agents; Cardiomegaly; Enalapril; Human | 2012 |
Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
Topics: Adrenalectomy; Adult; Aldosterone; Blood Pressure; Female; Heart Ventricles; Humans; Hyperaldosteron | 2012 |
The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity.
Topics: Adrenal Glands; Aldosterone; Animals; Blood Pressure; Body Weight; Cytochrome P-450 CYP11B2; Dietary | 2012 |
Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients.
Topics: Adipocytes; Adiponectin; Adult; Aged; Aldosterone; Carrier Proteins; Cells, Cultured; Down-Regulatio | 2012 |
A case of myelolipoma with bilateral adrenal hyperaldosteronism cured after unilateral adrenalectomy.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Comorbidity; Humans; Hyperaldosteronism; Hypert | 2012 |
Progress in primary aldosteronism 2.
Topics: Aldosterone; History, 20th Century; History, 21st Century; Humans; Hyperaldosteronism | 2012 |
Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
Topics: Aldosterone; Diagnostic Tests, Routine; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Renin | 2012 |
Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system.
Topics: Aldosterone; Calibration; Chromatography, High Pressure Liquid; Humans; Hyperaldosteronism; Liquid-L | 2012 |
Confirmatory testing in primary aldosteronism.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Component | 2012 |
Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Female; G Protein-Coupled Inwardly-Recti | 2012 |
TASK-3 channel deletion in mice recapitulates low-renin essential hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Gene Expression Regulation; Humans; Hy | 2012 |
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies.
Topics: Adult; Aged; Aldosterone; Comorbidity; Female; Germany; Health Surveys; Humans; Hyperaldosteronism; | 2012 |
Editorial overview: the adrenal cortex.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Ald | 2012 |
Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
Topics: Aldosterone; Animals; Animals, Newborn; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blo | 2012 |
Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.
Topics: Aldosterone; Biomarkers; Comorbidity; Creatinine; Female; Follow-Up Studies; Glomerular Filtration R | 2012 |
Polymorphic variation of CYP11B2 predicts postoperative resolution of hypertension in patients undergoing adrenalectomy for aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Cytochrome P-450 CYP11 | 2012 |
Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice.
Topics: Aldosterone; Animals; Cardiomegaly; Cyclic AMP Response Element-Binding Protein; Female; Fetus; Gene | 2012 |
Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse.
Topics: Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Hyperaldosteronism; Male; Mice; Renin | 2012 |
Have main types of primary aldosteronism different phenotype?
Topics: Adenoma; Adult; Albuminuria; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Phe | 2012 |
One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
Topics: Adult; Aldosterone; China; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension | 2012 |
Aldosterone-producing adrenocortical carcinoma without hypertension.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aldosterone; Biopsy; Femal | 2012 |
Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design.
Topics: Aldosterone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Biomarkers; Chi-Square Dis | 2013 |
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Calcium; Comor | 2012 |
Sixteen years experience in six cases of Conn syndrome in Jakarta.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Alkalosis; Female; Humans; Hyperaldosteronism; | 2012 |
[Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Female; Humans; Hyperaldosteronism; Hypertensi | 2012 |
The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Diet, Sodium-Restricted; Disease Models, Animal; Dose-Response Rel | 2012 |
The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Diet, Sodium-Restricted; Disease Models, Animal; Dose-Response Rel | 2012 |
The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Diet, Sodium-Restricted; Disease Models, Animal; Dose-Response Rel | 2012 |
The phosphorylated sodium chloride cotransporter in urinary exosomes is superior to prostasin as a marker for aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Diet, Sodium-Restricted; Disease Models, Animal; Dose-Response Rel | 2012 |
Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex.
Topics: Adaptor Proteins, Signal Transducing; Adrenal Cortex; Aldosterone; Animals; Calcium; Cluster Analysi | 2012 |
A clinical prediction score to diagnose unilateral primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; | 2012 |
Persistent hypertension after adrenalectomy for an aldosterone-producing adenoma: weight as a critical prognostic factor for aldosterone's lasting effect on the cardiac and vascular systems.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Blood Pressure; Body Mass Index | 2012 |
Modification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenalectomy; Al | 2012 |
Are catecholamine-derived indexes in adrenal venous sampling useful for judging selectivity and laterality in patients with primary aldosteronism?
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Dopamine; Epinephrine; Female; Humans | 2013 |
Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.
Topics: Adrenalectomy; Aged; Aldosterone; Female; Germany; Humans; Hyperaldosteronism; Male; Middle Aged; Mi | 2012 |
Expression of aldosterone synthase and adrenocorticotropic hormone receptor in adrenal incidentalomas from normotensive and hypertensive patients: Distinguishing subclinical or atypical primary aldosteronism from adrenal incidental
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Asymptomatic Diseases; Biomark | 2012 |
Primary aldosteronism: clinical lateralization and costs.
Topics: Adrenal Cortex; Aldosterone; Diagnostic Techniques, Endocrine; Female; Humans; Hyperaldosteronism; M | 2012 |
[Clinical evaluation of the renin-aldosterone system: comparison of two methods in different clinical conditions].
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Biomarkers; Blood Donors; Female; Humans; Hungary | 2012 |
Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Antihypertensive Agent | 2013 |
Characterization of NCI-H295R cells as an in vitro model of hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Aldosterone; Cell Adhesion; Cell Line, Tumor; Cy | 2013 |
Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Cardiac Catheterization; Cardiac Output, Low; Case-Cont | 2013 |
Screening for primary aldosteronism in a primary care unit.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Cohort Studies; Female; Humans; H | 2013 |
Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk.
Topics: Aged; Aldosterone; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Female; Heart Diseases; | 2013 |
Idiopathic intracranial hypertension associated with either primary or secondary aldosteronism.
Topics: Adolescent; Adult; Aldosterone; Child; Electrolytes; Female; Humans; Hyperaldosteronism; Male; Middl | 2013 |
Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Aldosterone; Autoantibodies; Autoimmunity; Diagnosis | 2013 |
Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry.
Topics: Aldosterone; Chromatography, High Pressure Liquid; Humans; Hyperaldosteronism; Linear Models; Reprod | 2013 |
Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism.
Topics: Aldosterone; Blood Pressure; Comorbidity; Cross-Sectional Studies; Female; Humans; Hyperaldosteronis | 2013 |
Suppression of primary aldosteronism and resistant hypertension by the peroxisome proliferator-activated receptor gamma agonist pioglitazone.
Topics: Aldosterone; Blood Pressure; Comorbidity; Humans; Hyperaldosteronism; Hypertension; Male; Middle Age | 2013 |
Long-term re-evaluation of primary aldosteronism after medical treatment reveals high proportion of normal mineralocorticoid secretion.
Topics: Adult; Aged; Aldosterone; Cross-Sectional Studies; Female; Fludrocortisone; Follow-Up Studies; Human | 2013 |
Surgically correctable hypertension.
Topics: Adrenal Glands; Aldosterone; Epinephrine; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension, | 2002 |
Dopaminergic modulation of aldosterone secretions on changes of sodium intake in aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Blood Pressure; Diet, Sodium-R | 2002 |
Clinical and gene mutation studies on a Chinese pedigree with glucocorticoid-remediable aldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Female; Glucocorticoids; Humans; Hyperaldosteronism | 2002 |
Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Eplerenone; Heart Ventricles | 2002 |
Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Diagnosi | 2002 |
High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hyperaldost | 2002 |
Primary hyperaldosteronism as a cause of hypertension.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Renin | 1967 |
Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.
Topics: Adult; Aldosterone; Black People; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Age | 2002 |
Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism.
Topics: Adrenalectomy; Aldosterone; Antihypertensive Agents; Blood Pressure; Cost-Benefit Analysis; Female; | 2002 |
Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone.
Topics: Aldosterone; Animals; Blood Pressure; Blotting, Northern; Carotid Arteries; Collagen; Collagen Type | 2002 |
[Bilateral Conn's adenoma. Diagnostic discussions].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Male; Midd | 2002 |
Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.
Topics: Adrenocorticotropic Hormone; Aldosterone; Endothelin Receptor Antagonists; Female; Humans; Hydrocort | 2003 |
[Diagnosis of subtypes and lateralization for primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; | 2001 |
Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Female; Hu | 2003 |
Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin.
Topics: Adult; Aldosterone; Analysis of Variance; Blood Pressure; Echocardiography; Endothelins; Female; Hum | 2003 |
Conn's syndrome associated with Behcet's disease.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Behcet Syndrome; Female; Human | 2003 |
[Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic beta-Antagonists; Aldosterone; Angiotens | 2003 |
Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Chemoembolization, Therapeutic; Ethanol; | 2003 |
Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Chemoembolization, Therapeutic; Ethanol; | 2003 |
Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Chemoembolization, Therapeutic; Ethanol; | 2003 |
Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Chemoembolization, Therapeutic; Ethanol; | 2003 |
Establishment of reference values for endocrine tests. III: Primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Diagnostic Techniques, Endocrine; Diagnostic Tests, Routine; Female; Human | 2003 |
Very high serum aldesterone level in an infant who expired.
Topics: Aldosterone; Diarrhea; Emergency Treatment; Fatal Outcome; Gastroenteritis; Humans; Hyperaldosteroni | 2003 |
Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Humans; Hyperaldosteronism; Inpatients; | 2003 |
[Anesthetic management for electroconvulsive therapy (ECT) in a patient with primary aldosteronism].
Topics: Aged; Aldosterone; Anesthesia, General; Depressive Disorder; Electroconvulsive Therapy; Humans; Hype | 2003 |
Primary aldosteronism and hypertensive disease.
Topics: Aldosterone; Cross-Sectional Studies; Female; Fludrocortisone; Humans; Hyperaldosteronism; Hypertens | 2003 |
Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study.
Topics: Adolescent; Adult; Aldosterone; Female; Glucuronides; Humans; Hyperaldosteronism; Male; Mass Screeni | 2003 |
Efficacy of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Biomarkers; Female; Humans; Hyperaldosteronism; J | 2003 |
ALDOSTERONE and aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Aldosterone; Body Fluids; Hyperaldosteronism; Succinates; U | 1955 |
Possible aldosteronism in stilboestrol-treated guinea pigs.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Guinea Pigs; Hyperaldoster | 1956 |
Possible aldosteronism in stilboestrol-treated guinea pigs.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Guinea Pigs; Hyperaldoster | 1956 |
Possible aldosteronism in stilboestrol-treated guinea pigs.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Guinea Pigs; Hyperaldoster | 1956 |
Possible aldosteronism in stilboestrol-treated guinea pigs.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Guinea Pigs; Hyperaldoster | 1956 |
Experimental production of morphological changes resembling Conn's syndrome.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Hyperaldosteronism | 1956 |
Experimental production of morphological changes resembling Conn's syndrome.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Hyperaldosteronism | 1956 |
Experimental production of morphological changes resembling Conn's syndrome.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Hyperaldosteronism | 1956 |
Experimental production of morphological changes resembling Conn's syndrome.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diethylstilbestrol; Hyperaldosteronism | 1956 |
Primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1956 |
Primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1956 |
Primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1956 |
Primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1956 |
Malignant hypertension and hyperaldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hype | 1956 |
Malignant hypertension and hyperaldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hype | 1956 |
Malignant hypertension and hyperaldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hype | 1956 |
Malignant hypertension and hyperaldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hype | 1956 |
Primary aldosteronism; some observations on a case in a Cape Coloured woman.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Clothing; Female; Humans; Hyperaldosteronism | 1956 |
Primary aldosteronism; some observations on a case in a Cape Coloured woman.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Clothing; Female; Humans; Hyperaldosteronism | 1956 |
Primary aldosteronism; some observations on a case in a Cape Coloured woman.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Clothing; Female; Humans; Hyperaldosteronism | 1956 |
Primary aldosteronism; some observations on a case in a Cape Coloured woman.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Clothing; Female; Humans; Hyperaldosteronism | 1956 |
Conn's syndrome, caused by adrenocortical hyperplasia; pathogenesis of the signs and symptoms.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Aldosterone; Humans; Hyperald | 1956 |
Conn's syndrome, caused by adrenocortical hyperplasia; pathogenesis of the signs and symptoms.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Aldosterone; Humans; Hyperald | 1956 |
Conn's syndrome, caused by adrenocortical hyperplasia; pathogenesis of the signs and symptoms.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Aldosterone; Humans; Hyperald | 1956 |
Conn's syndrome, caused by adrenocortical hyperplasia; pathogenesis of the signs and symptoms.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Aldosterone; Humans; Hyperald | 1956 |
Renal function in primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Kidney | 1956 |
Renal function in primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Kidney | 1956 |
Renal function in primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Kidney | 1956 |
Renal function in primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism; Kidney | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Hypokalemia as a cause of constipation; differential diagnosis of the so-called potassium deficiency nephritis and Conn's primary aldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Constipation; Diagnosis, Differential; Humans; | 1957 |
[Hypokalemia as a cause of constipation; differential diagnosis of the so-called potassium deficiency nephritis and Conn's primary aldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Constipation; Diagnosis, Differential; Humans; | 1957 |
[Hypokalemia as a cause of constipation; differential diagnosis of the so-called potassium deficiency nephritis and Conn's primary aldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Constipation; Diagnosis, Differential; Humans; | 1957 |
[Hypokalemia as a cause of constipation; differential diagnosis of the so-called potassium deficiency nephritis and Conn's primary aldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Constipation; Diagnosis, Differential; Humans; | 1957 |
Primary aldosteronism; report of a case and discussion of the pathogenesis.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1957 |
Primary aldosteronism; report of a case and discussion of the pathogenesis.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1957 |
Primary aldosteronism; report of a case and discussion of the pathogenesis.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1957 |
Primary aldosteronism; report of a case and discussion of the pathogenesis.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1957 |
Intermittent aldosteronism in periodic paralysis; dependence of attacks on retention of sodium, and failure to induce attacks by restriction of dietary sodium.
Topics: Aldosterone; Humans; Hyperaldosteronism; Paralysis; Social Behavior; Sodium; Sodium Chloride, Dietar | 1957 |
[Aldosterone and aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
[Physiopathological and clinical studies of secondary hyperaldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Biomedical Research; Humans; Hyperaldosteronis | 1957 |
[Aldosterone and aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
Hyperaldosteronism in heart disease.
Topics: Aldosterone; Heart Diseases; Heart Failure; Humans; Hyperaldosteronism | 1957 |
[Conns Syndrome].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism | 1957 |
Postoperative transient aldosteronism.
Topics: Adrenal Cortex; Aldosterone; Humans; Hyperaldosteronism; Postoperative Period | 1957 |
The electrocardiogram and potassium metabolism; electrocardiographic abnormalities in primary aldosteronism and familial periodic paralysis.
Topics: Aldosterone; Electrocardiography; Humans; Hyperaldosteronism; Paralyses, Familial Periodic; Paralysi | 1957 |
Primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism | 1957 |
[Hyperaldosteronism & other clinical conditions with chronic potassium deficiency].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Kidney Diseases; Potassium; Potassium Deficien | 1957 |
Observations on primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
[Conn syndrome: clinical findings & physiopathological data].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
Potassium-losing nephritis and primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Nephritis; Potassium; Potassium Deficiency | 1957 |
Primary aldosteronism: a brief account.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
Observations on a case of primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1958 |
Primary aldosteronism associated with significant edema.
Topics: Aldosterone; Edema; Humans; Hyperaldosteronism | 1958 |
Action of antidiuretic hormone in potassium-depleted rats; relation to aldosteronism.
Topics: Aldosterone; Animals; Hyperaldosteronism; Hypokalemia; Potassium; Potassium Deficiency; Rats; Vasopr | 1958 |
Primary aldosteronism: clinical staff conference at the National Institutes of Health.
Topics: Aldosterone; Humans; Hyperaldosteronism; National Institutes of Health (U.S.); United States | 1958 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1958 |
[Cushing syndrome with diffuse edema at its beginning and hyperaldosteronism].
Topics: Aldosterone; Cushing Syndrome; Edema; Hyperaldosteronism; Medical Records | 1957 |
Some observations on the mechanism of postoperative transient aldosteronism with special reference to early changes in serum electrolyte levels.
Topics: Aldosterone; Electrolytes; Humans; Hyperaldosteronism; Postoperative Period; Potassium; Surgical Pro | 1958 |
Clinical implications of postoperative transient aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1958 |
Effect of an aldosterone antagonist on sodium and potassium excretion in primary hyperaldosteronism.
Topics: Aldosterone; Antihypertensive Agents; Diuretics; Humans; Hyperaldosteronism; Mineralocorticoid Recep | 1958 |
Primary aldosteronism with diabetes mellitus.
Topics: Aldosterone; Diabetes Mellitus; Humans; Hyperaldosteronism; Medical Records | 1958 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1958 |
[Primary aldosteronism. I].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
[Primary aldosteronism. II].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1957 |
[Review of the biological methods for the determination of mineralo-corticoid activity in the urine & analysis of our results in a patient suffering from primary aldosteronism].
Topics: Adrenal Cortex Hormones; Aldosterone; Body Fluids; Humans; Hyperaldosteronism; Urinalysis | 1957 |
[Contribution to the problem of kaliopenic nephropathy in primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Kidney Diseases; Medical Records; Potassium; P | 1957 |
[Aldosterone & corticosteroids in a patient suffering from primary aldosteronism & carcinoma of the adrenal cortex].
Topics: 17-Ketosteroids; Adrenal Cortex; Adrenal Cortex Hormones; Aldosterone; Glucocorticoids; Humans; Hype | 1957 |
[Case of primary aldosteronism (Conn's syndrome) with recovery after unilateral adrenalectomy].
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism | 1958 |
[Potassium-losing nephritis; primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Nephritis; Potassium | 1958 |
Potassium-losing nephritis: primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Nephritis; Potassium | 1958 |
Conn's syndrome.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism | 1958 |
[Mineral corticoid form of hypercorticism: primary hyperaldosteronism].
Topics: Adrenal Cortex Hormones; Adrenocortical Hyperfunction; Aldosterone; Humans; Hyperaldosteronism; Mine | 1958 |
[Cushing syndrome, Conn's syndrome & intestinal hyperabsorption].
Topics: Aldosterone; Cushing Syndrome; Humans; Hyperaldosteronism; Intestines | 1958 |
[Primary aldosteronism (Conn's syndrome)].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1958 |
[Clinical picture and therapy of primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1958 |
[Hyperaldosteronism in nephrotic syndrome].
Topics: Aldosterone; Humans; Hyperaldosteronism; Nephrotic Syndrome | 1958 |
[Clinical aspects of regulation disorders of aldosterone excretion; aldosteronism & aldosterone deficiency].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypoaldosteronism | 1958 |
[Primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1958 |
[Hyperaldosteronism with adenomatous hyperplasia of the adrenals in a case of hypertension with refractory edema].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Aldosterone; Edema; Humans; Hyperaldostero | 1959 |
[Hyperaldosteronism caused by muscular exercise in athletes].
Topics: Aldosterone; Athletes; Exercise; Humans; Hyperaldosteronism; Muscles; Sports | 1959 |
[Hyperaldosteronism of congestive heart failure; clinical contribution].
Topics: Aldosterone; Heart Failure; Humans; Hyperaldosteronism | 1958 |
Primary aldosteronism in a 9-year-old child.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
Aldosteronism and hypertension: the influence of complete adrenalectomy upon essential hypertension in a child.
Topics: Adrenalectomy; Aldosterone; Child; Essential Hypertension; Humans; Hyperaldosteronism; Hypertension; | 1959 |
Primary aldosteronism due to adrenal hyperplasia; occurrence in a boy aged 10 years.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfuncti | 1959 |
Evidence that a humoral agent stimulates the adrenal cortex to secrete aldosterone in experimental secondary hyperaldosteronism.
Topics: Adrenal Cortex; Aldosterone; Central Nervous System Agents; Humans; Hyperaldosteronism | 1959 |
[Conn's syndrome].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
[Trial treatment of secondary hyperaldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
[Conn's syndrome treated with spirolactone].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Diuretics; Hyperaldosteronism; Mineralocortico | 1961 |
Primary hyperaldosteronism and related hypertension. Surgical management.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1961 |
[The effect of spirolactone SC-9420 in a case of secondary aldosteronism].
Topics: Aldosterone; Diuretics; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Spironolactone | 1961 |
Primary aldosteronism versus hypertensive disease with secondary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1961 |
Aldosteronism and hypertension. Primary aldosteronism versus hypertensive disease with secondary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1961 |
Unusual renal function associated with saluresis accompanying water loading in a case of primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Kidney; Salts; Water | 1961 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
Use of an aldosterone antagonist in the diagnosis of primary hyperaldosteronism.
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagon | 1960 |
Idiopathic edema. Report of a case with orthostatic edema and hyperaldosteronism.
Topics: Aldosterone; Edema; Heart Failure; Humans; Hyperaldosteronism; Medical Records | 1960 |
Mechanisms regulating the secretion and metabolism of aldosterone in experimental secondary hyperaldosteronism.
Topics: Aldosterone; Hyperaldosteronism; Lipid Metabolism | 1961 |
Secondary hyperaldosteronism associated with hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1961 |
[Primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
[Initial results in the spirolactone treatment of 2 cases of the edematous syndrome with secondary aldosteronism].
Topics: Aldosterone; Diuretics; Edema; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Spironola | 1960 |
Primary aldosteronism. The value of spironolactone in diagnosis.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Lactones; Spirono | 1961 |
Primary aldosteronism with severe hypertension relieved by adrenalectomy.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hy | 1961 |
Secondary hyperaldosteronism in constrictive pericarditis.
Topics: Aldosterone; Humans; Hyperaldosteronism; Medical Records; Pericarditis; Pericarditis, Constrictive | 1961 |
Primary aldosteronism. Diagnosis, surgical management, and report of two cases operated upon.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
[A case of congenital hyperaldosteronism in an infant].
Topics: Aldosterone; Humans; Hyperaldosteronism; Infant; Infant, Newborn; Infant, Newborn, Diseases | 1961 |
Aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
Primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1961 |
Aldosteronism and arterial hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1961 |
Reversal of diurnal rhythm in excretion of water and salt in primary hyperaldosteronism.
Topics: Aldosterone; Circadian Rhythm; Hyperaldosteronism; Sodium Chloride; Sodium Chloride, Dietary; Water; | 1961 |
Primary aldosteronism: content of adrenocortical steroids in adrenal tissue.
Topics: Adrenal Cortex Hormones; Aldosterone; Humans; Hyperaldosteronism; Steroids | 1961 |
[Changes in urinary aldosterone and the role of hyperaldosteronism in the hydropigenous syndrome of cirrhotics].
Topics: Aldosterone; Humans; Hyperaldosteronism; Liver Cirrhosis; Syndrome | 1961 |
[Secondary hyperaldosteronisms].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
Primary aldosteronism--a new and curable hypertensive syndrome.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Syndrome | 1961 |
[Conn's syndrome and essential arterial hypertension].
Topics: Aldosterone; Essential Hypertension; Humans; Hyperaldosteronism; Hypertension | 1960 |
[Conn's syndrome].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
Case of Conn's syndrome.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
Metabolic observations in a case of pure primary hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Lipid Metabolism | 1959 |
[The adrenals in hyperaldosteronism. Primary bilateral hyperplasia of the adrenal cortex in a case of hyperaldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hy | 1960 |
[Is there a hyperaldosteronism in the premenstrual syndrome?].
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Premenstrual Syndrome | 1960 |
Primary aldosteronism without adrenal adenomata: report of a case.
Topics: Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism | 1960 |
The diuretic effect of spirolactone SC-9420 in a case of secondary aldosteronism.
Topics: Aldosterone; Diuretics; Hyperaldosteronism; Spironolactone | 1960 |
Conn's syndrome.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
[Recurring paralysis with hyperaldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Paralysis; Recurrence | 1960 |
Evolution of primary aldosteronism as a highly specific clinical entity.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
Primary aldosteronism, observations on 2 cases.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
The role of the anterior pituitary in the control of aldosterone secretion in experimental secondary hyperaldosteronism.
Topics: Aldosterone; Biological Transport; Humans; Hyperaldosteronism; Pituitary Gland; Pituitary Gland, Ant | 1960 |
[Primary hyperaldosteronism. A review of the medical literature from 1995 to June 1958].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
Primary aldosteronism. A review of medical literature from 1955 to June 1958.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
[Primary hyperaldosteronism. A review of the medical literature from 1995 to June 1958].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
[Primary aldosteronism and the lesser circulation].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
Renal tubular acidosis. The role of defective renal tubular sodium reabsorption and secondary hyperaldosteronism in its pathogenesis.
Topics: Acidosis; Acidosis, Renal Tubular; Aldosterone; Humans; Hyperaldosteronism; Kidney Diseases; Medical | 1959 |
Primary aldosteronism: a case with severe hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1960 |
Electrolyte and corticosteroid studies in a 15-year-old girl with primary aldosteronism and malignant hypertension.
Topics: Adolescent; Adrenal Cortex Hormones; Aldosterone; Electrolytes; Female; Humans; Hyperaldosteronism; | 1960 |
[Syndromes of hyperaldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Syndrome | 1960 |
[Studies on the problem of secondary aldosteronism in edemas of different origin].
Topics: Aldosterone; Edema; Humans; Hyperaldosteronism | 1960 |
[Secondary hyperaldosteronism in the course of arterial hypertension].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Vascular Diseases | 1960 |
An evaluation of the electrocardiogram and the acidity of the urine as a screening test for primary aldosteronism.
Topics: Aldosterone; Electrocardiography; Humans; Hyperaldosteronism; Hypertension | 1959 |
Physiologic and surgical problems in the management of primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Disease Management; Humans; Hyperaldosteronism | 1959 |
[Primary hyperaldosteronism due to unilateral adrenal hyperplasia, with diabetes].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Al | 1960 |
Prominent peripheral edema associated with primary aldosteronism due to an adrenocortical adenoma.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Edema; Human | 1960 |
Modification of the effects of aldosterone on electrolyte excretion in man by simultaneous administration of corticosterone and hydrocortisone. Relevance to Conn's syndrome.
Topics: Adrenal Cortex Hormones; Aldosterone; Corticosterone; Electrolytes; Humans; Hydrocortisone; Hyperald | 1960 |
[ALDOSTERONISM and aldosterone deficiency in pediatrics].
Topics: Aldosterone; Child; Humans; Hyperaldosteronism; Hypoaldosteronism; Pediatrics | 1959 |
[PRIMARY and secondary hyperaldosteronism: Conn's syndrome].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1959 |
[Study of urinary aldosterone in secondary hyperaldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1961 |
[False Conn's syndrome of renal origin].
Topics: Aldosterone; Humans; Hyperaldosteronism; Kidney; Kidney Diseases | 1962 |
[On the operative treatment of primary aldosteronism (Conn's syndrome)].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
Useful parameters in the diagnosis of primary aldosteronism.
Topics: Aldosterone; Blood Volume; Humans; Hyperaldosteronism; Potassium; Sodium | 1961 |
Acute effects of cardiac glycosides on aldosterone secretion in dogs with hyperaldosteronism secondary to chronic right heart failure.
Topics: Aldosterone; Animals; Cardiac Glycosides; Dogs; Glycosides; Heart Failure; Hyperaldosteronism | 1962 |
[The first case of Conn's disease in Taiwan. (Primary aldosteronism)].
Topics: Adrenocortical Adenoma; Aldosterone; Humans; Hyperaldosteronism; Taiwan | 1961 |
The evolution of primary aldosteronism from 1954 to 1960.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
Parallel biochemical and histochemical studies of an adrenocortical adenoma from a patient with primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Humans; Hype | 1961 |
Primary hyperaldosteronism, a curable form of hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1962 |
Primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism | 1962 |
Primary aldosteronism. Case observed in a patient subjected previously to thoracolumbar sympathectomy.
Topics: Aldosterone; Chlorothiazide; Humans; Hyperaldosteronism; Hypertension; Sympathectomy | 1962 |
[Conn's syndrome with adrenocortical adenoma. Action of spirolactone, SC-9420].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diuretics; Humans; Hy | 1962 |
Hyperaldosteronism secondary to renal ischaemia.
Topics: Aldosterone; Humans; Hyperaldosteronism; Ischemia; Kidney; Kidney Diseases | 1962 |
[The syndromes of hyperaldosteronism and their treatment].
Topics: Aldosterone; Humans; Hyperaldosteronism; Syndrome | 1962 |
[Obesity, paralysis and hyperaldosteronism].
Topics: Aldosterone; Child; Humans; Hyperaldosteronism; Infant; Obesity; Paralysis | 1961 |
Surgical treatment of hypertension -- primary aldosteronism. A review of 13 cases.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Essential Hypertension; Humans; Hyperaldoster | 1962 |
Effect of aldosterone on the metabolism of magnesium.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Magnesium; Potassium; Spironolactone | 1962 |
[Effect of roentgen therapy on urinary aldosterone excretion].
Topics: Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; Radiotherapy; Stress, Physiolo | 1962 |
[Intervention of aldosterone and electrolytes in the pathogenesis of essential hypertension].
Topics: Aldosterone; Electrolytes; Essential Hypertension; Humans; Hyperaldosteronism; Hypertension; Sodium; | 1962 |
[The clinical importance of spironolactones, peripheral antagonists of aldosterone].
Topics: Aldosterone; Edema; Humans; Hyperaldosteronism; Spironolactone; Water-Electrolyte Balance | 1961 |
Current therapeutics. 82. Aldosterone.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists | 1963 |
[Studies on the urinary excretion of aldosterone. II. On the role of aldosterone in the pathogenesis of some clinical syndromes].
Topics: Aldosterone; Diabetes Insipidus; Edema; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Liv | 1962 |
RENIN, ANGIOTENSIN, AND ALDOSTERONE.
Topics: Aldosterone; Angiotensins; Hyperaldosteronism; Metabolism; Physiology; Renin | 1963 |
[HYPOKALEMIA, ALDOSTERONE EXCRETION AND PRIMARY HYPERALDOSTERONISM].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Hypokalemia; Kidney; Uri | 1963 |
[I. ALDOSTERONE: SYNDROMES OF HYPERALDOSTERONISM].
Topics: Aldosterone; Humans; Hyperaldosteronism; Syndrome | 1963 |
MALIGNANT HYPERTENSION AND ALDOSTERONE SECRETION. INFLUENCE OF REVERSAL AND PROGRESSION OF THE SYNDROME IN TWO CASES.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Spironolactone; Urem | 1963 |
[ON THE TREATMENT OF ADRENAL CORTEX DISEASES].
Topics: Addison Disease; Adrenal Cortex Diseases; Adrenal Insufficiency; Adrenocortical Hyperfunction; Adren | 1963 |
[ON USE OF THE BLOCKING AGENT ALDOSTERONE].
Topics: Aldosterone; Aortic Valve; Diuretics; Heart Failure; Humans; Hyperaldosteronism; Mitral Valve Insuff | 1963 |
FORMATION OF STEROID HORMONES IN THE ADRENAL ADENOMA AND ADJACENT ADRENAL TISSUE OF A PATIENT WITH PRIMARY ALDOSTERONISM.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Aldosterone; Andr | 1963 |
[PHYSIOPATHOLOGY OF NEPHROTIC EDEMA; ROLE OF ALDOSTERONE].
Topics: Aldosterone; Angiotensins; Edema; Humans; Hyperaldosteronism; Nephrotic Syndrome; Proteinuria; Renin | 1963 |
[A FUNCTION TEST FOR INDIRECT APPRAISAL OF MINERALOCORTICOID RESERVE OF HUMAN ADRENAL CORTEX].
Topics: Addison Disease; Adrenal Cortex; Adrenal Insufficiency; Aldosterone; Angiotensins; Heart Failure; Hu | 1963 |
[ON THE MECHANISM OF ACTION OF THE DIURETIC ACTIVITY OF 2,4,7-TRIAMINO-6-PHENYL-PTERIDINE (TRIAMTERENE)].
Topics: Aldosterone; Ascites; Blood Chemical Analysis; Body Weight; Diuretics; Heart Failure; Humans; Hypera | 1963 |
ALDOSTERONE AND SWEAT GLAND FUNCTION.
Topics: Acclimatization; Aldosterone; Dehydration; Hot Temperature; Humans; Hyperaldosteronism; Physiology; | 1963 |
ALDOSTERONE IN THE MAINTENANCE OF THE WATER-ELECTROLYTE BALANCE.
Topics: Aldosterone; Body Fluids; Chlorides; Dehydration; Hot Temperature; Hyperaldosteronism; Physiology; P | 1963 |
THE RENIN CONTENT OF THE BLOOD OF HUMANS AND DOGS UNDER SEVERAL CONDITIONS.
Topics: Aldosterone; Blood Chemical Analysis; Diet, Sodium-Restricted; Dogs; Edema; Hyperaldosteronism; Hype | 1964 |
RENIN, ANGIOTENSIN AND ALDOSTERONE IN EXPERIMENTAL SECONDARY HYPERALDOSTERONISM.
Topics: Adrenal Glands; Aldosterone; Angiotensins; Arteriovenous Fistula; Blood Chemical Analysis; Desoxycor | 1964 |
INTERACTION BETWEEN ALDOSTERONE SECRETION, SODIUM AND POTASSIUM BALANCE, AND ANGIOTENSIN ACTIVITY IN MAN: STUDIES IN HYPERTENSION AND CIRRHOSIS.
Topics: Adrenal Glands; Aldosterone; Angiotensins; Blood Pressure; Edema; Humans; Hyperaldosteronism; Hypert | 1964 |
HYPERTENSION DUE TO RENAL ARTERY OCCLUSION SIMULATING PRIMARY ALDOSTERONISM.
Topics: Aldosterone; Angiotensins; Blood Chemical Analysis; Blood Pressure; Hyperaldosteronism; Hypertension | 1964 |
[ALDOSTERONE SECRETION RATE IN VARIOUS DISEASES].
Topics: Aldosterone; Cushing Syndrome; Diabetic Nephropathies; Heart Diseases; Humans; Hyperaldosteronism; H | 1963 |
INTERNATIONAL SYMPOSIUM ON ALDOSTERONE, PRAGUE, CZECHOSLOVAKIA, AUGUST 23-25, 1963.
Topics: Aldosterone; Angiotensins; Blood Chemical Analysis; Czechoslovakia; Edema; Hyperaldosteronism; Metab | 1964 |
[THE ROLE OF ALDOSTERONE IN THE DEVELOPMENT OF NEPHROTIC EDEMAS].
Topics: Aldosterone; Child; Edema; Humans; Hyperaldosteronism; Infant; Nephrosis; Nephrosis, Lipoid; Nephrot | 1964 |
DEMONSTRATION BY PRESSOR AND STEROIDOGENIC ASSAYS OF INCREASED RENIN IN LYMPH OF DOGS WITH SECONDARY HYPERALDOSTERONISM.
Topics: Adrenal Glands; Aldosterone; Angiotensins; Corticosterone; Dogs; Hyperaldosteronism; Hypertension; H | 1964 |
THE DIAGNOSTIC IMPLICATION OF RESTRICTION OF SALT INTAKE AND ADMINISTRATION OF VARIOUS DRUGS IN PRIMARY ALDOSTERONISM.
Topics: Aldosterone; Biomedical Research; Cushing Syndrome; Desoxycorticosterone; Diagnosis, Differential; D | 1964 |
THE JUXTAGLOMERULAR APPARATUS AND ALDOSTERONE IN HYPERALDOSTERONISM.
Topics: Aldosterone; Angiotensins; Biomedical Research; Carcinoma, Hepatocellular; Cushing Syndrome; Hepatit | 1964 |
[PLACE OF ALDACTONE IN THE THERAPY OF EDEMA].
Topics: Aldosterone; Edema; Heart Failure; Humans; Hyperaldosteronism; Liver Cirrhosis; Spironolactone | 1964 |
[ADRENAL CORTEX AND HYPERTENSION].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenalectomy; Aldosterone; Angiotensins; Chlorothiazide; D | 1964 |
ALDOSTERONE AND ALDOSTERONE ANTAGONISTS.
Topics: Acidosis; Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Mineralocorticoid Receptor Antagonis | 1964 |
[ALDOSTERONE AND SPIROLACTONES IN THE CLINICAL TREATMENT OF INTERNAL DISEASES (REVIEW OF THE LITERATURE AND ANALYSIS OF PERSONAL CASES)].
Topics: Albuminuria; Aldosterone; Blood; Cardiovascular Diseases; Drug Therapy; Humans; Hyperaldosteronism; | 1963 |
[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
Topics: Adrenocorticotropic Hormone; Aldosterone; Ascites; Body Fluids; Classification; Dexamethasone; Extra | 1964 |
THE PRODUCTION OF CORTICOIDS IN NORMAL AND PATHOLOGIC HUMAN ADRENAL SLICES AND INFLUENCES OF ACTH AND ANGIOTENSIN II ON CORTICOID-PRODUCTION.
Topics: Adenoma; Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortico | 1964 |
HYPERSECRETION OF ALDOSTERONE IN DOGS WITH A CHRONIC AORTIC-CAVAL FISTULA AND HIGH OUTPUT HEART FAILURE.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Aorta; Arteriovenous Fistula; Blood Pressure; Cor | 1964 |
EXPERIMENTAL ASCITES. VI. THE EFFECTS OF HEPATIC VENOUS OUTFLOW OBSTRUCTION AND ASCITES ON ALDOSTERONE SECRETION.
Topics: Adrenal Glands; Aldosterone; Ascites; Blood; Blood Pressure; Budd-Chiari Syndrome; Dogs; Hepatic Vei | 1964 |
PRIMARY ALDOSTERONISM: OBSERVATIONS IN SIX CASES AND REVIEW OF DIAGNOSTIC PROCEDURES.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Diabetes Mellitus; Diagnosis, Differen | 1964 |
[SIGNIFICANCE OF ALDOSTERONE IN THE PATHOGENESIS OF THE EDEMATOUS AND HYPERTENSIVE SYNDROME IN KIDNEY DISEASES].
Topics: Aldosterone; Blood; Edema; Glomerulonephritis; Humans; Hyperaldosteronism; Hypertension; Hypertensio | 1964 |
SIMULATION OF SPONTANEOUS SECONDARY HYPERALDOSTERONISM BY INTRAVENOUS INFUSION OF ANGIOTENSIN II IN DOGS WITH AN ARTERIOVENOUS FISTULA.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Angiotensins; Arteriovenous Fistula; Corticosterone; Des | 1964 |
EFFECT OF HUMAN RENIN ON ALDOSTERONE SECRETION RATE IN NORMAL MAN AND IN PATIENTS WITH THE SYNDROME OF HYPERALDOSTERONISM, JUXTAGLOMERULAR HYPERPLASIA AND NORMAL BLOOD PRESSURE.
Topics: Adrenalectomy; Aldosterone; Blood Pressure; Child; Humans; Hydrocortisone; Hyperaldosteronism; Hyper | 1964 |
MODIFICATION OF ALDOSTERONE SECRETION AND ELECTROLYTE EXCRETION IN MAN BY A CHEMICAL INHIBITOR OF 18-OXIDATION.
Topics: 17-Ketosteroids; Adrenalectomy; Aldosterone; Biomedical Research; Body Fluids; Corticosterone; Dexam | 1964 |
CATHETERIZATION OF THE LEFT ADRENAL VEIN FOR CONTRAST INJECTION AND STEROID ANALYSIS IN A CASE OF CONN'S SYNDROME.
Topics: 17-Ketosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Angiography; Blood; | 1964 |
[URINARY AND ADRENAL CORTICOSTEROIDS IN A CASE OF CONN'S SYNDROME].
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Clinical Laboratory Techniques; Corticosterone | 1964 |
NEW VIEWPOINTS IN THE USE OF PROGESTERONE IN THE TREATMENT OF CARDIAC OEDEMAS ASSOCIATED WITH SECONDARY HYPERALDOSTERONISM.
Topics: Aldosterone; Dexamethasone; Diuresis; Drug Therapy; Edema; Edema, Cardiac; Heart Failure; Humans; Hy | 1964 |
[ALDOSTERONE INVESTIGATION AND CLINICAL MEDICINE].
Topics: Adrenal Gland Diseases; Aldosterone; Angiotensins; Hyperaldosteronism; Metabolism; Mineralocorticoid | 1964 |
[A SYMPOSIUM ON ALDOSTERONE].
Topics: Aldosterone; Angiotensins; Hyperaldosteronism; Phenylephrine; Physiology; Potassium | 1964 |
NATURE OF RENAL ESCAPE FROM THE SODIUM-RETAINING EFFECT OF ALDOSTERONE IN PRIMARY ALDOSTERONISM AND IN NORMAL SUBJECTS.
Topics: Aldosterone; Creatine; Creatinine; Fluids and Secretions; Glomerular Filtration Rate; Humans; Hypera | 1965 |
[CLINICAL APPLICATION OF RADIOACTIVE STEROIDS].
Topics: Addison Disease; Adrenal Insufficiency; Aldosterone; Blood Proteins; Carbon Isotopes; Chemical Pheno | 1964 |
IDIOPATHIC EDEMA ND HYPERALDOSTERONURIA: POSTURAL VENOUS PLASMA POOLING.
Topics: Adolescent; Aldosterone; Angiotensins; Blood Pressure; Body Weight; Drug Therapy; Edema; Ephedrine; | 1965 |
"SECONDARY" ALDOSTERONISM.
Topics: Aldosterone; Diagnosis; Humans; Hyperaldosteronism; Kidney Tubules; Physiology; Water-Electrolyte Ba | 1965 |
[ALDOSTERONE IN EDEMA SYNDROME. HYPERALDOSTERONISM IN CONGESTIVE CARDIAC INSUFFICIENCY].
Topics: Aldosterone; Edema; Heart Failure; Humans; Hyperaldosteronism; Syndrome | 1964 |
[INVESTIGATION OF PLASMA ALDOSTERONE AND ALDOSTERONE METABOLISM IN HEALTHY SUBJECTS AND PATIENTS WITH HEART, LIVER AND KIDNEY DISEASE].
Topics: Aldosterone; Blood; Healthy Volunteers; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hyp | 1965 |
ALDOSTERONE AND THE METABOLISM OF MAGNESIUM AND OTHER MINERALS IN THE SHEEP.
Topics: Aldosterone; Animals; Blood Chemical Analysis; Calcium; Feces; Fluids and Secretions; Humans; Hypera | 1965 |
NORMAL AND ALTERED FUNCTION OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN MAN: APPLICATIONS IN CLINICAL AND RESEARCH MEDICINE.
Topics: Adrenal Glands; Aldosterone; Angiotensins; Edema; Hyperaldosteronism; Hypertension; Kidney; Physiolo | 1965 |
METABOLIC OBSERVATIONS ON SALT WASTING IN A PATIENT WITH RENAL DISEASE.
Topics: Aldosterone; Bicarbonates; Blood Urea Nitrogen; Calcium; Chlorides; Drug Therapy; Humans; Hyperaldos | 1965 |
Conn's syndrome: the effect of amphenone.
Topics: Aldosterone; Humans; Hyperaldosteronism; Propiophenones | 1960 |
[On the existence of spontaneously resolvent "functional Conn syndromes"].
Topics: Adrenal Cortex; Adrenal Cortex Diseases; Aldosterone; Humans; Hyperaldosteronism | 1959 |
Hypertension caused by renal artery occlusion simulating primary aldosteronism.
Topics: Aldosterone; Disease; Humans; Hyperaldosteronism; Hypertension; Renal Artery | 1960 |
[Concept of hyperaldosteronism: clinical criticism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Lipid Metabolism | 1959 |
Primary aldosteronism: report of two cases and review of the literature.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
Primary hyperaldosteronism without adrenal tumor.
Topics: Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism | 1960 |
Two cases of primary aldosteronism. Comments on differential diagnosis and difficulties in screening.
Topics: Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism | 1959 |
[Primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
[The secondary hyperaldosteronism of cardiac insufficiency. Pathogenic study and physiopathological implications].
Topics: Aldosterone; Heart Failure; Humans; Hyperaldosteronism | 1960 |
Hypertension and hypokalaemia associated with hypo-aldosteronism.
Topics: Aldosterone; Child; Humans; Hyperaldosteronism; Hypertension; Hypoaldosteronism; Hypokalemia; Infant | 1959 |
Primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1960 |
[Aldosterone in clinical medicine with special reference to hyperaldosteronism in edematous diseases].
Topics: Aldosterone; Edema; Humans; Hyperaldosteronism | 1959 |
[False Conn syndromes].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Medical Records; Potassium; Tetany | 1960 |
Hypertension associated with hypokalemia and alkalosis simulating primary hyperaldosteronism: report of a case.
Topics: Aldosterone; Alkalosis; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Potassium; Vascular D | 1959 |
A case of Conn's syndrome.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1962 |
Primary hyperaldosteronism and renal disease. Report of a case and comments on differential diagnosis.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hyperaldoste | 1961 |
[Experimental and clinical studies on secondary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
Primary aldosteronism. Report of a case.
Topics: Aldosterone; Humans; Hyperaldosteronism; Kidney Neoplasms | 1962 |
Primary aldosteronism. Preoperative preparation with spironolactone.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid | 1962 |
Aldosteronism and hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1962 |
[Primary and secondary hyperaldosteronism].
Topics: Aldosterone; Hyperaldosteronism | 1962 |
[Tissular aldactone saliuretic inhibitor of aldosterone. Its significance in the treatment of edemas associated with secondary hyperaldosteronism].
Topics: Aldosterone; Diuretics; Edema; Edetic Acid; Hyperaldosteronism; Spironolactone | 1961 |
[Primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
Primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Medical R | 1961 |
Hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1962 |
[Diuretic effect of Resteron in secondary hyperaldosteronism].
Topics: Aldosterone; Diuretics; Hyperaldosteronism; Progesterone | 1962 |
[Do there exist primary hyperaldosteronisms of central origin?].
Topics: Aldosterone; Central Nervous System Diseases; Humans; Hyperaldosteronism | 1961 |
[The secondary hyperaldosteronisms].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1961 |
The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
Topics: Adult; Age Factors; Aged; Aldosterone; Biomarkers; Blood Pressure; Blood Pressure Determination; Dia | 2003 |
Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Diagnosis, Differential; Diagnostic Tests, Routine; Hum | 2003 |
Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension.
Topics: Aldosterone; Antihypertensive Agents; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Hyperte | 2003 |
[Primary hyperaldosteronism. A study of 18 cases].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldostero | 2003 |
Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface.
Topics: Aldosterone; Animals; Calcium; Cell Separation; Coronary Vessels; Disease Models, Animal; Disease Pr | 2003 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone; Female; F | 2003 |
[Primary aldosteronism. A risk factor for aortic dissection?].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Aortic Aneurysm; Aortic Dissec | 2003 |
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Topics: Adult; Aged; Aldosterone; Cortodoxone; Cytochrome P-450 CYP11B2; Dexamethasone; Female; Genotype; Gl | 2004 |
Serum potassium level and dietary potassium intake as risk factors for stroke.
Topics: Aged; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium; Potassium, Dietary; Renin; R | 2003 |
Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Renin; Sleep Apnea | 2004 |
Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Blood Pressure; Blood Pressure Determination; Cas | 2004 |
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.
Topics: Aldosterone; Chile; Follow-Up Studies; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Italy; | 2004 |
Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Female; Humans; Hyperaldosteronism; Hypertensi | 2004 |
Conn's syndrome (primary hyperaldosteronism) simulating polymyositis.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Diagnosis, Diff | 2005 |
Primary aldosteronism--careful investigation is essential and rewarding.
Topics: Adrenal Gland Diseases; Aldosterone; Diagnosis, Differential; Female; Hospital Units; Humans; Hypera | 2004 |
Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Breast Neoplasms; DNA | 2004 |
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
Topics: Adult; Aldosterone; Brachial Artery; Endothelium, Vascular; Female; Hemorheology; Humans; Hyperaldos | 2004 |
Age dependence of the levels of plasma norepinephrine, aldosterone, renin activity and urinary vanillylmandelic acid in normal and essential hypertensives.
Topics: Adolescent; Adult; Age Factors; Aldosterone; Child; Child, Preschool; Epinephrine; Female; Humans; H | 2004 |
Aldosterone regulation for 18 years in a case of primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Biomarkers; Calcium Channel Blockers; Humans; Hypera | 2004 |
Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aldosterone; Diuretics; Female; Histocyto | 2004 |
Aldosterone--villain or bystander?
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium; Renin-Angiotensin System; Risk Fac | 2004 |
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
Topics: Aldosterone; Blood Pressure; Female; Heart Ventricles; Humans; Hyperaldosteronism; Hypertension; Hyp | 2004 |
Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome).
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldostero | 2004 |
Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays.
Topics: Adolescent; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Immunoassay; Luminescent M | 2004 |
The current epidemic of primary aldosteronism: causes and consequences.
Topics: Aldosterone; Disease Outbreaks; Humans; Hyperaldosteronism; Hypertension | 2004 |
The current epidemic of primary aldosteronism: causes and consequences.
Topics: Aldosterone; Disease Outbreaks; Humans; Hyperaldosteronism; Hypertension; Renin | 2004 |
The current epidemic of primary aldosteronism: causes and consequences.
Topics: Aldosterone; Disease Outbreaks; Humans; Hyperaldosteronism; Hypertension; Renin | 2004 |
[Secondary hyperaldosteronism with cyclic edema as a sequel to the chronic use of laxatives in a case of anorexia nervosa].
Topics: Aldosterone; Anorexia Nervosa; Catecholamines; Edema; Heart Failure; Humans; Hyperaldosteronism; Lax | 1960 |
The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Blood Specimen Collection; Female; Humans; Hyperaldoste | 2005 |
[One hypertensive in ten affected? Renaissance of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Cross-Sectional Studies; Diagnosis, Differential; Hum | 2004 |
The neuroendocrine-immune interface gone awry in aldosteronism.
Topics: Aldosterone; Animals; Central Nervous System; Heart Failure; Humans; Hyperaldosteronism; Kidney; Min | 2004 |
Aldosterone revisited.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists | 2004 |
Aldosterone revisited.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Sodium; Sodium, Dietary | 2004 |
[A brief history of diagnosis and treatment of primary aldosteronism.].
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Renin | 2004 |
Scientists probe aldosterone's role in hypertension and heart disease.
Topics: Aldosterone; Cardiovascular Agents; Cardiovascular Physiological Phenomena; Heart Diseases; Humans; | 2004 |
Primary aldosteronism in type 1 diabetes mellitus.
Topics: Aldosterone; Diabetes Mellitus, Type 1; Humans; Hyperaldosteronism; Hypokalemia; Male; Middle Aged | 2004 |
Induction of 11beta-hydroxysteroid dehydrogenase type 2 and hyperaldosteronism are essential for enhanced sodium absorption after total colectomy in rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Amiloride; Animals; Colectomy; Colonic Pou | 2005 |
Primary hyperaldosteronism, a mediator of progressive renal disease in cats.
Topics: Adrenal Glands; Aging; Aldosterone; Animals; Cat Diseases; Cats; Female; Hyperaldosteronism; Hyperpl | 2005 |
Long-term follow-up after adrenalectomy for primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Algorithms; Antihypertensive Ag | 2005 |
Role for adrenal venous sampling in primary aldosteronism.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperaldost | 2004 |
Role for adrenal venous sampling in primary aldosteronism.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperaldost | 2004 |
Role for adrenal venous sampling in primary aldosteronism.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperaldost | 2004 |
Role for adrenal venous sampling in primary aldosteronism.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperaldost | 2004 |
Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary aldosteronism.
Topics: Adenoma; Aldosterone; Chymosin; Enzyme Precursors; Humans; Hyperaldosteronism; Hypertension; Immunor | 2005 |
Hyperaldosteronism and hypertension: ethnic differences.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Black People; Blood Pressure; Blood Pressure Monitori | 2005 |
Hyperparathyroidism and the calcium paradox of aldosteronism.
Topics: Aldosterone; Animals; Bone Density; Bone Resorption; Calcium; Hyperaldosteronism; Hyperparathyroidis | 2005 |
Calcium, magnesium, and oxidative stress in hyperaldosteronism.
Topics: Aldosterone; Animals; Calcium; Heart Failure; Humans; Hyperaldosteronism; Magnesium; Oxidative Stres | 2005 |
The syndromes of low-renin hypertension: "separating the wheat from the chaff".
Topics: Adenoma; Adolescent; Adult; Aged; Aldosterone; Child; Diagnosis, Differential; Female; Humans; Hyper | 2004 |
[Biochemical detection of Conn's adenoma: definition of criteria and reference values].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged | 2005 |
Aldosterone makes human endothelium stiff and vulnerable.
Topics: Aldosterone; Biophysical Phenomena; Biophysics; Cells, Cultured; Endothelium, Vascular; Humans; Hype | 2005 |
Adrenocortical carcinoma with concomitant myelolipoma in a patient with hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aldosterone; Biomarkers, T | 2005 |
Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.
Topics: Alabama; Aldosterone; Biomarkers; Black or African American; Blood Pressure; Female; Humans; Hyperal | 2005 |
Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Female; Humans; Hyperaldo | 2005 |
Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.
Topics: Aldosterone; Chromosome Mapping; Chromosomes, Human, Pair 7; Female; Genetic Heterogeneity; Genetic | 2005 |
Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
Topics: Aldosterone; Diagnosis, Differential; Diagnostic Techniques, Endocrine; Female; Fludrocortisone; Hum | 2005 |
Editorial: aldosterone, normotension, and diastolic dysfunction.
Topics: Aldosterone; Animals; Blood Pressure; Cardiovascular Diseases; Diastole; Humans; Hyperaldosteronism | 2005 |
Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.
Topics: Acetylcysteine; Aldosterone; Animals; Blood Pressure; Cardiomegaly; Chemokine CCL2; Echocardiography | 2005 |
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation.
Topics: Adult; Aged; Aldosterone; Case-Control Studies; Female; Forearm; Humans; Hyperaldosteronism; Hyperte | 2005 |
Urinary prostasin: a candidate marker of epithelial sodium channel activation in humans.
Topics: Adult; Aged; Aldosterone; Biomarkers; Blotting, Western; Case-Control Studies; Diuretics; Dose-Respo | 2005 |
Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Calcium; Cholesterol; Electrons; Female; Gene | 2005 |
Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease.
Topics: Aged; Aldosterone; Angioplasty, Balloon; Blood Pressure; Blood Vessel Prosthesis Implantation; Femal | 2005 |
Primary aldosteronism combined with preclinical Cushing's syndrome in an elderly patient.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Aged, 80 and over; Aldosterone; Cushing Syn | 2005 |
The proinflammatory heart failure phenotype: a case of integrative physiology.
Topics: Aldosterone; Animals; Calcium; Coronary Circulation; Cytokines; Disease Models, Animal; Heart Failur | 2005 |
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia.
Topics: Aldosterone; Black People; Cross-Over Studies; Female; Humans; Hyperaldosteronism; Hypertension; Hyp | 2006 |
"Aldosterone escape" or refractory hyperaldosteronism?
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Humans; Hyperaldosteronism; Mineralocorticoid | 2005 |
Comparison of adrenal vein sampling value between aldosterone producing adrenal adenoma and non-functioning adrenal adenoma: evaluation using receiver operating characteristic analysis.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; False Positive Reactions; Female; Fun | 2005 |
Aldosterone promotes thrombosis formation after arterial injury in mice.
Topics: Aldosterone; Animals; Atherosclerosis; Carotid Artery Injuries; Hyperaldosteronism; Male; Mice; Mice | 2006 |
Aldosterone target neurons in the nucleus tractus solitarius drive sodium appetite.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adrenalectomy; Aldosterone; Animals; Appetite; Corticos | 2006 |
[Endosonography -- an additional diagnostic possibility in the differentiation between the two common types of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenalectomy; Aged; Aldosterone; | 2006 |
Increased renal alpha-ENaC and NCC abundance and elevated blood pressure are independent of hyperaldosteronism in vasopressin escape.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adrenalectomy; Aldosterone; Animals; Blood Pressure; Co | 2006 |
Cardiac consequences of aldosterone excess in human hypertension.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Blood Pressure; Calcium Channel Blockers; | 2006 |
Role of aldosterone in left ventricular hypertrophy in hypertension.
Topics: Adrenergic beta-Antagonists; Adrenocortical Adenoma; Adult; Aldosterone; Angiotensin II; Blood Press | 2006 |
[Moot and unsolved problems in diagnosis and surgical treatment of primary hyperaldosteronism (50 years since Conn's syndrome description)].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Algorithms; Diagnosis, Differential; H | 2006 |
To stimulate or not to stimulate: the differential diagnosis of aldosteronism revisited.
Topics: Adrenocorticotropic Hormone; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism | 2006 |
Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldoster | 2006 |
[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Cytochrome P-450 CYP11B2 | 2006 |
[Primary hyperaldosteronism: should we pose its systematic detection at health centres?].
Topics: Aldosterone; Blood Chemical Analysis; Clinical Trials as Topic; Humans; Hyperaldosteronism; Hyperten | 2006 |
Screening for primary aldosteronism: progress and frustration.
Topics: Aldosterone; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Mass Screening; Sensitivity and | 2006 |
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
Topics: Aldosterone; Diagnostic Tests, Routine; Female; Humans; Hyperaldosteronism; Male; Mass Screening; Mi | 2006 |
Vitamin D deficiency in primary aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; | 2006 |
The role of adrenal venous sampling in the surgical management of primary aldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Adenoma; Adrenocortical Hype | 2006 |
Aldosterone and refractory hypertension: a prospective cohort study.
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Cohort Studies; Drug Resistance; Female; Follo | 2006 |
The prevalence of primary aldosteronism in diabetic patients.
Topics: Aldosterone; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Hyperaldosteronism; H | 2006 |
Laparoscopic adrenalectomy for primary hyperaldosteronism: clinical experience with 60 cases.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aged, 80 and over; Aldosterone; Blood | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Fludrocortisone; Humans; Hyper | 2006 |
Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Female; Humans; Hyperaldo | 2006 |
Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Catheterization, Peripheral; Female; Follow-Up Studies; | 2006 |
Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
Topics: Adult; Aldosterone; False Negative Reactions; Female; Humans; Hyperaldosteronism; Hypertension; Hypo | 2006 |
QT interval is prolonged but QT dispersion is maintained in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Electrocardiography; Female; Humans; Hyperaldosteronism; Long QT Syndrome; Male; | 2007 |
Primary hyperaldosteronism associated with hypertensive emergencies.
Topics: Acute Disease; Adult; Aged; Aldosterone; Diagnosis, Differential; Emergency Medical Services; Female | 2006 |
Plasma aldosterone assays: comparison between chemiluminescence-based and RIA methods.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Luminescent Measurements; Plasma; Radioimmuno | 2006 |
Aldosterone, dietary salt, and renal disease.
Topics: Albuminuria; Aldosterone; Animals; Cross-Sectional Studies; Humans; Hyperaldosteronism; Hypertension | 2006 |
Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
Topics: Aldosterone; Antihypertensive Agents; Blood Glucose; Blood Pressure; C-Reactive Protein; Female; Glu | 2006 |
Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps.
Topics: Adult; Aldosterone; Autoanalysis; Female; Humans; Hyperaldosteronism; Immunoassay; Luminescent Measu | 2006 |
Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements.
Topics: Aldosterone; Animals; Calcitriol; Calcium; Cytoplasm; Dietary Supplements; Heart Failure; Humans; Hy | 2006 |
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism.
Topics: Aldosterone; Chemistry, Clinical; Diagnostic Tests, Routine; Humans; Hyperaldosteronism; Mass Screen | 2006 |
High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden.
Topics: Aged; Aldosterone; Fludrocortisone; Humans; Hyperaldosteronism; Hypertension; Middle Aged; Renin; Sw | 2006 |
Diagnosis of adenomatous primary aldosteronism in a patient with severe hypertension.
Topics: Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Algorithms; Humans; Hyperaldosteronism; | 2005 |
Aldosterone assays: an urgent need for improvement.
Topics: Aldosterone; Humans; Hyperaldosteronism; Immunoassay; Renin | 2006 |
Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.
Topics: Administration, Oral; Aldosterone; Clinical Trials as Topic; Eplerenone; Gynecomastia; Humans; Hyper | 2007 |
Functional effects of genetic variants in the 11beta-hydroxylase (CYP11B1) gene.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Animals; Biological Assay; Case-Control Stu | 2006 |
Primary hyperaldosteronism in a patient with end-stage renal disease.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Follow-Up Studies; Fosinopril | 2007 |
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Antihypertensive Agents; Blood Glucose | 2007 |
Aldosterone and cardiovascular disease: smoke and fire.
Topics: Aldosterone; Cardiovascular Diseases; Electrocardiography; Humans; Hyperaldosteronism; Hypertension; | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adult; Aldosterone; Blood Specimen | 2006 |
To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not?
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism | 2007 |
Hypertension associated with rhabdomyolysis.
Topics: Adult; Aldosterone; Blood Pressure; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hyp | 2007 |
[New concepts in searching for primary aldosteronism in hypertension: advances in screening, confirming and subtyping tests].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Renin; Renin-Angiotensin Syst | 2006 |
[Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Topics: Adult; Aged; Aldosterone; China; Clinical Chemistry Tests; Female; Humans; Hyperaldosteronism; Hyper | 2006 |
[Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism].
Topics: Aldosterone; Clinical Chemistry Tests; Follow-Up Studies; Humans; Hyperaldosteronism; Hypertension; | 2006 |
Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery?
Topics: Adenoma; Adosterol; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosterone | 2007 |
Clinics in diagnostic imaging (113).
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Diagnosis, Differential; Femal | 2007 |
A German family with glucocorticoid-remediable aldosteronism.
Topics: Adolescent; Aldosterone; Algorithms; Blood Pressure; Dexamethasone; Eplerenone; Female; Germany; Glu | 2007 |
[Causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and strategy therefore].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers, Tumor; Chymo | 2006 |
Morning plasma aldosterone predicts the subtype of primary aldosteronism independent of sodium intake.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Biomarkers; Circadian Rh | 2007 |
Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Cushing Syndrome; Enzymes; Female; Humans; Hydrocorti | 2007 |
Aldosteronism: too much of a good thing. The hormone aldosterone helps the body manage water and sodium. Too much of it is an overlooked cause of high blood pressure.
Topics: Adrenal Gland Diseases; Adrenal Glands; Aldosterone; Body Water; Humans; Hyperaldosteronism; Hyperte | 2007 |
Analytical variation in plasma renin activity: implications for the screening of primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Renin | 2007 |
Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Mass Screening; Mi | 2007 |
[Conn syndrome].
Topics: Aldosterone; Causality; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypernatremia; Hyperten | 2007 |
The incidentally discovered adrenal mass.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Black People; Humans; Hyperaldosteron | 2007 |
[Determining aldosterone in the adrenal veins in order to establish uni- or bilateral aldosterone production in patients with primary hyperaldosteronism].
Topics: Adrenalectomy; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension; Male; | 2007 |
Primary hyperaldosteronism: returning to the limelight?
Topics: Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2007 |
Unilateral adrenal hyperplasia.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; R | 2007 |
[Primary aldosteronism caused by aldosteronoma: problems in the etiologic diagnosis].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Fem | 2007 |
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
Topics: Adrenalectomy; Aldosterone; Follow-Up Studies; Humans; Hyperaldosteronism; Hypertension; Hypokalemia | 2007 |
Captopril test can give misleading results in patients with suspect primary aldosteronism.
Topics: Aldosterone; Captopril; Clinical Laboratory Techniques; Cohort Studies; Female; Humans; Hyperaldoste | 2007 |
Diagnosis of primary aldosteronism in a patient with an incidentally found adrenal mass.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Diagnosis, Differentia | 2007 |
Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone.
Topics: Aldosterone; Animals; Coronary Vessels; Disease Models, Animal; Feces; Fibrosis; Homeostasis; Hypera | 2007 |
Tailored hormonal therapy in secretory adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Ang | 2007 |
Adiponectin and insulin sensitivity in primary aldosteronism.
Topics: Adiponectin; Aldosterone; Biomarkers; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Insulin | 2007 |
Is there an unrecognized epidemic of primary aldosteronism? Con.
Topics: Adrenal Gland Neoplasms; Aldosterone; Disease Outbreaks; Humans; Hyperaldosteronism; Hypertension; I | 2007 |
Resistant hypertension: a methodological approach to diagnosis and treatment.
Topics: Aldosterone; Diagnosis, Differential; Drug Resistance; Humans; Hyperaldosteronism; Hypertension; Pat | 2007 |
Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Kidney; Kidney Diseases; Male; Middle Aged; Prospec | 2007 |
Adjunctive use of C-arm CT may eliminate technical failure in adrenal vein sampling.
Topics: Adrenal Glands; Aldosterone; Blood Chemical Analysis; Catheterization, Peripheral; Diagnostic Errors | 2007 |
A possible association between primary aldosteronism and a lower beta-cell function.
Topics: Aged; Aldosterone; Blood Glucose; C-Peptide; Case-Control Studies; Cholesterol; Female; Humans; Hype | 2007 |
Aldosterone excess and resistance to 24-h blood pressure control.
Topics: Adult; Age Factors; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Blood Pressure Monit | 2007 |
Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Antihypertensive Agents; Female; Follo | 2007 |
Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hydrocortisone | 2007 |
G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Base Sequence; Case-Control Studies; | 2007 |
[Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism].
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Female; Humans; Hydro | 2007 |
Pomc knockout mice have secondary hyperaldosteronism despite an absence of adrenocorticotropin.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Female; Hy | 2008 |
Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis.
Topics: Adrenal Glands; Aldosterone; Animals; Female; Homeostasis; Hyperaldosteronism; Male; Mice; Mice, Inb | 2008 |
More fuel to the debate on the "epidemics of primary aldosteronism".
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Captopril; Humans; Hyperaldosteronism; Hyperte | 2008 |
A not-so-modest proposal that a "modest" increase in aldosterone causes hypertension and more.
Topics: Aldosterone; Animals; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Mice; Renin; Sodium | 2008 |
Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP11B2; Female; Hyperaldoste | 2008 |
The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.
Topics: Adrenal Gland Diseases; Aldosterone; Biomarkers; Case-Control Studies; Diagnosis, Differential; Fema | 2007 |
Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy.
Topics: Adult; Aldosterone; Androstenes; Contraceptives, Oral, Hormonal; Contraindications; Ethinyl Estradio | 2007 |
Prospective evaluation and characteristics of patients with suspected primary hyperaldosteronism.
Topics: Adult; Aldosterone; Body Mass Index; Female; Glucose Intolerance; Humans; Hyperaldosteronism; Hypert | 2007 |
An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperaldosteronism; Hyper | 2007 |
Primary aldosteronism due to unilateral adrenal microadenoma in an elderly patient: efficacy of selective adrenal venous sampling.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Aged; Aldosterone; Humans; Hyperal | 2008 |
Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Antihypertensiv | 2008 |
Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Topics: Adrenalectomy; Adult; Aged; Aldosterone; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; | 2008 |
Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Case-Control Studies; F | 2008 |
TASK channel deletion in mice causes primary hyperaldosteronism.
Topics: Aldosterone; Animals; Base Sequence; DNA Primers; Hyperaldosteronism; In Situ Hybridization; Mice; M | 2008 |
Adrenal venous sampling is absolutely requisite for definitively diagnosing primary aldosteronism as well as for detecting laterality of the adrenal lesion.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Blood S | 2007 |
Aldosterone and hypertension in the cardiometabolic syndrome.
Topics: Aldosterone; Body Mass Index; Humans; Hyperaldosteronism; Hypertension; Metabolic Syndrome; Risk Fac | 2008 |
Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Down-Regulation; Fibrosis; Gene Expression; Hyper | 2008 |
Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism.
Topics: Aldosterone; alpha 1-Antitrypsin; Animals; Calcium; Cinacalcet; Hydrogen Peroxide; Hyperaldosteronis | 2008 |
A possible association between primary aldosteronism and a lower beta-cell function.
Topics: Aldosterone; Female; Glucose; Humans; Hyperaldosteronism; Insulin-Secreting Cells; Male | 2008 |
Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Antihypertensive Agents; Arteries; Blo | 2008 |
Low renin hypertension (LRH): shades of John Laragh.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 2008 |
Epithelial Na+ channel activation and processing in mice lacking SGK1.
Topics: Aldosterone; Animals; Epithelial Sodium Channels; Female; Heterozygote; Homozygote; Hyperaldosteroni | 2008 |
[Is there an unrecognized epidemic of primary aldosteronism? The Danish Society of Hypertension].
Topics: Aldosterone; Denmark; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Prevalence; Renin | 2008 |
Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Predictive Value o | 2008 |
Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Age Factors; Aged; Aldosterone; Antihyperten | 2008 |
[Study on multiple aldosterone-producing adenomas].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Follow-Up Studies; Huma | 2007 |
Diagnostic accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Age Factors; Aldosterone; Female; Humans; Hydroc | 2008 |
[Secondary aldosteronism in patients with liver cirrhosis and excretion of aldosterone in them following vascular anastomosis].
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension, Portal; Liver Cirr | 1966 |
Independence of blood pressure and aldosterone secretion.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Guanethidine; Humans; Hyperaldosteronism | 1967 |
Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
Topics: 17-Hydroxycorticosteroids; Adrenal Gland Diseases; Adrenal Glands; Aldosterone; Blood Urea Nitrogen; | 1967 |
The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Corticosterone; Female; Humans; Hydrocor | 1967 |
Effect of saline infusions on aldosterone secretion and electrolyte excretion in normal subjects and patients with primary aldosteronism.
Topics: Aldosterone; Blood Pressure Determination; Creatine; Female; Humans; Hyperaldosteronism; Infusions, | 1967 |
Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism.
Topics: Aldosterone; Benzothiadiazines; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Potassium; Re | 1967 |
The effect of prolonged administration of aldosterone on sodium and potassium turnover in the rabbit.
Topics: Aldosterone; Animals; Body Weight; Feces; Hyperaldosteronism; Hypokalemia; Infusions, Parenteral; In | 1967 |
Childhood primary aldosteronism with bilateral adrenocortical hyperplasia: plasma renin activity as an aid to diagnosis.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Child; Child, Preschool; Humans; Hyperaldosteronism; Hyp | 1967 |
Primary aldosteronism: case report with plasma renin suppression.
Topics: Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension; Hypok | 1967 |
A simplified procedure for the estimation of urinary aldosterone.
Topics: Aldosterone; Chromatography, Gas; Chromatography, Paper; Humans; Hyperaldosteronism; Spectrum Analys | 1967 |
[On the diagnosis of Conn's syndrome].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Renin | 1967 |
A quantitative gas-liquid chromatographic method for aldosterone in human urine.
Topics: Aldosterone; Carbon Isotopes; Chromatography, Gas; Chromatography, Paper; Humans; Hyperaldosteronism | 1967 |
[Congenital hypoaldosteronism].
Topics: Aldosterone; Body Weight; Corticosterone; Dehydration; Desoxycorticosterone; Diet, Sodium-Restricted | 1967 |
Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiography; Aortography; Chromatography, Thin | 1967 |
Pregnancy and primary aldosteronism.
Topics: Adult; Aldosterone; Carbon Dioxide; Chlorides; Female; Humans; Hyperaldosteronism; Hypertension; Pot | 1967 |
[Use of the method of determination of tetrahydroaldosterone in the study of clinical cases].
Topics: Adolescent; Adult; Aldosterone; Child, Preschool; Female; Humans; Hyperaldosteronism; Hypertension; | 1967 |
In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Angiotens | 1984 |
A possible role for intermediate lobe peptides in the pathogenesis of idiopathic aldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; beta-Lipotropin; Hyperaldosteronism; Melanocyte-S | 1984 |
In vivo evidence of cortisol secretion by aldosterone-producing adenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Metyr | 1984 |
The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
Topics: Adult; Aldosterone; Bartter Syndrome; Erythrocytes; Humans; Hyperaldosteronism; Ion Channels; Potass | 1984 |
[Complex study of the adrenal glands using angiography and radioimmunoassay of the hormone level in adrenal gland venous blood].
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Cushing | 1984 |
Endocrine characterization of the adrenal adenomas in a case of primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Cyclic | 1984 |
Idiopathic aldosteronism: diagnostic artifact?
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Methods | 1980 |
Bromocriptine in primary aldosteronism.
Topics: Aldosterone; Bromocriptine; Humans; Hyperaldosteronism; Male; Middle Aged; Secretory Rate | 1980 |
[A case of hyperaldosteronism in childhood].
Topics: Adrenergic beta-Antagonists; Aldosterone; Antihypertensive Agents; Child, Preschool; Humans; Hyperal | 1980 |
The diagnosis of primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adult; Aged; Aldosterone; Diagnos | 1981 |
The myth of idiopathic hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; | 1981 |
Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aldosterone; Bartter Syndrome; Child; Chlorides; Ep | 1983 |
[Malignant hypertension syndrome caused by aldosteroma-pheochromocytoma].
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperald | 1984 |
Potassium-wasting nephropathy secondary to chemotherapy simulating Bartter's syndrome.
Topics: Aldosterone; Antineoplastic Combined Chemotherapy Protocols; Bartter Syndrome; Bleomycin; Cyclophosp | 1984 |
[The effect of trilostane, a new inhibitor of adrenal steroid biosynthesis, on blood pressure, plasma aldosterone and other steroid hormones, serum potassium and plasma renin activity in primary aldosteronism (author's transl)].
Topics: Adult; Aldosterone; Blood Pressure; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Hyp | 1982 |
[A simple diagnostic test for primary hyperaldosteronism].
Topics: Adrenal Glands; Adult; Aldosterone; Captopril; Humans; Hyperaldosteronism; Hyperplasia; Hypertension | 1983 |
[Radioimmunoassay of plasma aldosterone].
Topics: Aldosterone; Animals; Female; Humans; Hyperaldosteronism; Male; Rabbits; Radioimmunoassay | 1983 |
Aldosterone regulation in primary aldosteronism: influence of salt balance, posture and ACTH.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; D | 1980 |
Angiotensin II receptors and in vitro aldosterone responses of aldosterone-producing adenomas, adjacent nontumorous tissue, and normal human adrenal glomerulosa.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angioten | 1980 |
Primary aldosteronism due to unilateral adrenal hyperplasia.
Topics: Adrenalectomy; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldosterone; Blood Pressur | 1980 |
Primary aldosteronism. IV. Observations on the postural variation of plasma aldosterone concentration.
Topics: Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; Posture; Renin | 1980 |
Sodium-potassium-dependent ATPase activity in erythrocyte ghosts of patients with primary and secondary hypertension.
Topics: Adult; Aldosterone; Cushing Syndrome; Erythrocyte Membrane; Erythrocytes; Female; Humans; Hydrocorti | 1980 |
The acute effect of angiotensin II on adrenal and anterior pituitary function in normal subjects and subjects with primary hyperaldosteronism.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Fem | 1980 |
Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aldosterone; Aminoglutethimide; Child, Preschool | 1981 |
Multiple plasma steroid responses to graded ACTH infusions in patients with primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortic | 1981 |
Glucocorticoid-suppressible hyperaldosteronism: a clue to the missing hormone?
Topics: Adrenocorticotropic Hormone; Aldosterone; Glucocorticoids; Humans; Hyperaldosteronism; Lipoproteins, | 1981 |
Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Depression, Chemical; Dexamethasone; Glucocorticoids; Huma | 1981 |
Hypertension, hypokalemia and hypoaldosteronism with suppressed renin: a clinical study of a patient with Liddle's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Biological Transport; Diagnosis, Differential; Fema | 1981 |
Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
Topics: Adrenocorticotropic Hormone; Aldosterone; Child; Dexamethasone; Glomerulonephritis; Humans; Hyperald | 1982 |
Converting enzyme inhibition with captopril in patients with primary hyperaldosteronism.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Drug Therapy, Comb | 1982 |
[Pseudohypoaldosteronism: familial forms. Eight case-reports, with a review of the literature (author's transl)].
Topics: Adult; Aldosterone; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Hyperaldostero | 1982 |
New insights and questions about glucocorticoid-suppressible hyperaldosteronism.
Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aldosterone; Animals; | 1982 |
Exchangeable and total body sodium and potassium in various hypertensive syndromes.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Humans; Hydrocortisone; Hyperaldosteronism | 1982 |
Effects of angiotensin III and ACTH on aldosterone secretion.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angiotensin III; Dexamethasone; Electrolyt | 1982 |
Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldoste | 1982 |
[The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dexamethasone; Dopamine; Female; Humans; Hydrocorti | 1982 |
[A study on the mechanism of abnormal steroid secretions in a case of dexamethasone suppressible hyperaldosteronism].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Aldosterone; Dexamethasone; | 1982 |
[Abnormal steroid hormone production (in adults)--with special reference to Cushing's syndrome and Bartter's disease].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Aldosterone; Bartter Syndrome; Bone and | 1982 |
Effects of a new angiotensin-converting enzyme inhibitor, MK 421, in normal men and patients.
Topics: Adult; Aldosterone; Angiotensin I; Antihypertensive Agents; Bartter Syndrome; Blood Pressure; Dipept | 1982 |
Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Dexamethasone; Glucocorticoids; Humans; Hydrocortisone; Hy | 1983 |
10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Corticosterone; Desoxycorticosterone; Dexa | 1983 |
Missing endogenous dopaminergic inhibition of aldosterone secretion in human CONN's adenoma tissue after heterotransplantation to thymusaplastic mice.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Animals; Bromocriptine; | 1983 |
A simple solid phase enzyme immunoassay for aldosterone in plasma and saliva.
Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; Immunoenzyme | 1983 |
Circulating pituitary hormones in primary aldosteronism.
Topics: Aldosterone; beta-Endorphin; Endorphins; Growth Hormone; Humans; Hydrocortisone; Hyperaldosteronism; | 1983 |
Long-term survival and aldosterone secretion pattern of aldosteronoma in culture.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin I; Angiotens | 1983 |
Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dexamethasone; Female; Humans; Hydrocortisone; Hype | 1983 |
ACTH sensitivity of isolated human pathological adrenocortical cells: variability of responses in aldosterone, corticosterone, deoxycorticosterone and cortisol production.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Corticos | 1984 |
Idiopathic hyperaldosteronism. A possible role for aldosterone-stimulating factor.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Dexamethasone; Female; Glycoprote | 1984 |
19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Desoxycorticosterone; Fe | 1983 |
Aging and aldosterone.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adult; Aged; Aging; Aldosterone; Blood Pressure; Diet | 1983 |
The changing clinical spectrum of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Diagnosis, Differential; | 1983 |
Carcinoma of the adrenal cortex causing primary hyperaldosteronism. A case report and review of the literature.
Topics: Adrenal Cortex Neoplasms; Adult; Aldosterone; Angiography; Carcinoma; Humans; Hydrocortisone; Hypera | 1983 |
Primary hyperparathyroidism associated with primary hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Alkaline Phosphatase; Angiotensin II; Calcium; Female; Humans; Hyperaldost | 1983 |
Adrenal cortical carcinoma: an unusual cause of hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adult; Aldosterone; Carcinoma; Humans; Hyperaldosteronism; Hypertension; H | 1983 |
Single dose captopril as a diagnostic test for primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Captopril; Diagnosis, Differential; Fema | 1983 |
[A new diagnostic test for primary tumoral hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Captopril; Humans; Hyperaldost | 1983 |
[Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Captopril; Humans; Hyperaldost | 1983 |
Cystic fibrosis mimicking Bartter's syndrome.
Topics: Aldosterone; Bartter Syndrome; Cystic Fibrosis; Diagnosis, Differential; Electrolytes; Female; Human | 1983 |
Primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged; Renin; | 1983 |
[Urinary kallikrein and other vasoactive substances in patients with primary aldosteronism and essential hypertension].
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Kallikreins; Male; Middle Aged | 1983 |
[Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
Topics: Adult; Aldosterone; Blood Pressure; Bradykinin; Captopril; Female; Humans; Hyperaldosteronism; Hyper | 1983 |
Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Glands; Adrenalectomy; Aldosterone; Female; Furosemide; Humans; Hyperaldoste | 1983 |
Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Aortic Dissection; Aortic Rupture; Female; Hu | 1983 |
The role of prostaglandins in Bartter's syndrome.
Topics: Aldosterone; Bartter Syndrome; Calcium; Child; Child, Preschool; Growth; Humans; Hyperaldosteronism; | 1984 |
Aldosterone and other mineralocorticoids in Bartter's syndrome.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Corticosterone; Deso | 1984 |
[Pseudohypoparathyroidism associated with hyperaldosteronism and polyglobulia].
Topics: Aldosterone; Anemia, Macrocytic; Bloodletting; Calcium; Exostoses, Multiple Hereditary; Hand; Hemato | 1984 |
Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Diagnosis, Differential; Diet, | 1984 |
Hypertension caused by an aldosterone-secreting adenoma. Occurrence in a 7-year-old child.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Child; Female; Humans; Hyperaldosteronism; Renin; To | 1984 |
A case of normotensive primary aldosteronism--comparison with 13 previously experienced cases with hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Female; Humans; Hyperaldosteronism; H | 1984 |
Primary aldosteronism due to adrenal carcinomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Combined Modality Therapy; Female; Foll | 1984 |
Hypokalemia and prostaglandin overproduction in Bartter's syndrome.
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Dinoprost; Dinoprostone; Female; Huma | 1984 |
[Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Aldosterone; Angiotensin II; Blood Pressure; Heart R | 1984 |
Clinical syndromes associated with disorders of renal tubular chloride transport: excess and deficiency of a circulating factor?
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Body Weight; Chlorides; Female; Furosemide; Humans; H | 1984 |
Hormone and blood pressure relationships in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Blood Pressure; Circadian Rhythm; Epinep | 1984 |
[Radioimmunoassay in the diagnosis of arterial hypertension].
Topics: Adrenal Gland Neoplasms; Aldosterone; Catecholamines; Diagnosis, Differential; Humans; Hyperaldoster | 1984 |
Primary aldosteronism in pregnancy.
Topics: Adolescent; Aldosterone; Female; Humans; Hyperaldosteronism; Pregnancy; Pregnancy Complications; Ren | 1984 |
[Clinical aspects, diagnosis and treatment of idiopathic hyperaldosteronism].
Topics: Adrenalectomy; Adult; Aldosterone; Electrolytes; Female; Hemodynamics; Humans; Hydrocortisone; Hyper | 1984 |
[Recent findings on mineralocorticoids].
Topics: Aldosterone; Animals; Circadian Rhythm; Humans; Hyperaldosteronism; Hypertension; Kidney; Mineraloco | 1984 |
Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application.
Topics: 18-Hydroxycorticosterone; ACTH Syndrome, Ectopic; Addison Disease; Adenoma; Adrenal Hyperplasia, Con | 1984 |
Aldosterone-stimulating factor is increased in idiopathic hyperaldosteronism.
Topics: Adult; Aldosterone; Blood Proteins; Female; Glycoproteins; Humans; Hyperaldosteronism; Male; Protein | 1984 |
Therapeutic venous infarction of an aldosterone producing adenoma (Conn's tumour).
Topics: Adenoma; Aldosterone; Embolization, Therapeutic; Female; Humans; Hyperaldosteronism; Middle Aged | 1984 |
[Corticoids secretion in primary aldosteronism. I. Diurnal variation and the effect of dexamethasone (author's transl)].
Topics: Adrenal Cortex Hormones; Adrenalectomy; Adult; Aldosterone; Circadian Rhythm; Corticosterone; Cortis | 1980 |
'Essential' hypertension with hypokalemia. Caused by aldosterone-secreting adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aged; Aldosterone; Chronic Disease; Humans; Hyperaldosteronism; Hy | 1984 |
[A simple radioimmunoassay determination of urinary aldosterone using 125I-labeled ligand [ALDOCTK-125KIT] and its clinical application].
Topics: Adolescent; Adult; Aldosterone; Circadian Rhythm; Cushing Syndrome; Female; Glomerulonephritis; Huma | 1984 |
Primary hyperaldosteronism during pregnancy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertensi | 1984 |
Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adult; Aldosterone; Desoxycorticosterone; | 1984 |
Primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adrenalectomy; Aldosterone; Amiloride; Humans; Hyperaldosteronism; Male; M | 1984 |
The pituitary and idiopathic hyperaldosteronism.
Topics: Aldosterone; Glycoproteins; Humans; Hyperaldosteronism; Pituitary Gland; Proteins | 1984 |
The role of renal kallikrein-kinin system in the renal escape from the sodium retaining effect of aldosterone in primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldostero | 1983 |
The adrenal cortex and hypertension.
Topics: Adrenal Cortex; Aldosterone; Cushing Syndrome; Diagnosis, Differential; Glucocorticoids; Humans; Hyp | 1983 |
The diagnosis of primary hyperaldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, Differential; Fludrocortisone; Glucocorti | 1984 |
Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplas | 1983 |
[Diagnosis of aldosterone-secreting tumors].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldoste | 1983 |
[Pseudo-Conn's syndrome due to intoxication with nonalcoholic pastis].
Topics: Aldosterone; Antiviral Agents; Beverages; Blood Pressure; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hu | 1983 |
[Aldosterone in primary hyperaldosteronism].
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Female; Humans; Hyperaldoste | 1983 |
Surgical treatment of primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Aldosterone; Female; Humans; Hydrocortis | 1983 |
[Anesthesia for primary aldosteronism evaluation of plasma aldosterone responses].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Anesthesia, Epidural; Anesthesia, General; Fem | 1983 |
Corticosteroidogenic tumour of the kidney causing primary aldosteronism with the histologic appearance of a hypernephroma.
Topics: Adenocarcinoma; Adrenal Cortex; Aldosterone; Corticosterone; Female; Humans; Hyperaldosteronism; Kid | 1983 |
[Primary aldosteronism: a comparison between adenoma and hyperplasia].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Diagnosis, Differential; Femal | 1983 |
Relation of blood pressure with body and plasma electrolytes in Conn's syndrome.
Topics: Adult; Aldosterone; Blood Pressure; Electrolytes; Female; Humans; Hyperaldosteronism; Hypertension; | 1983 |
Primary aldosteronism. Clinical management.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Diagnosis, Di | 1984 |
[The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adolescent; Adult; Aldosterone; Desoxycort | 1984 |
Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Diagnosis, Differential; Femal | 1984 |
Effect of standard oral glucose loading on aldosterone secretion in primary hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Glucose; Female; Glucose Tolerance Test; Humans; Hyperaldosteronism; | 1982 |
Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronism.
Topics: Administration, Oral; Aldosterone; Blood Glucose; Blood Pressure; Glucose; Humans; Hyperaldosteronis | 1982 |
Simplified screening procedures for primary aldosteronism. Studies on the mechanism of the hyper-responsiveness to furosemide and standing.
Topics: Aldosterone; Blood Pressure; Furosemide; Humans; Hyperaldosteronism; Hypertension; Mass Screening; P | 1982 |
Restoration of renin-aldosterone dynamics to normal following surgery in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Posture; R | 1982 |
Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes.
Topics: Aldosterone; Blood Pressure; Cardiac Output; Humans; Hyperaldosteronism; Hypertension; Potassium; Re | 1982 |
The salivary sodium/potassium ratio in hypertension: relation to race and plasma renin activity.
Topics: Adult; Aldosterone; Black People; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Middle A | 1982 |
The role of chloride transport in the thick ascending limb in the pathogenesis of Bartter's syndrome.
Topics: Absorption; Aldosterone; Bartter Syndrome; Bradykinin; Chlorides; Epoprostenol; Humans; Hyperaldoste | 1982 |
[Hyporeninemic hyperaldosteronism due to aldosteronoma].
Topics: Adrenal Gland Neoplasms; Aldosterone; Cyproheptadine; Diagnosis, Differential; Female; Humans; Hyper | 1982 |
Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Humans; Hyperaldosteronism; In | 1980 |
[Radioimmunoassay for plasma aldosterone and its clinical application (author's transl)].
Topics: Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; | 1982 |
Hyperaldosteronism in ketoacidosis and in poorly controlled non-ketotic diabetes.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Diabetes Complications; Diabetic Ketoacidosis; | 1982 |
Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.
Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adenoma; Adrenal Cortex Neoplasms; Adult; | 1983 |
Aldosteronism in pregnancy: association with virilization of female offspring.
Topics: Adrenalectomy; Adult; Aldosterone; Clitoris; Female; Heart Failure; Humans; Hyperaldosteronism; Infa | 1983 |
Response of human aldosteronoma cells in culture to the N-terminal glycopeptide of pro-opiomelanocortin and gamma 3-MSH.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Animals; Cells, Cultured; Female; Glycopeptides; Hum | 1983 |
[Modern diagnosis of primary hyperaldosteronism with special reference to surgical therapy].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplas | 1983 |
The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism.
Topics: Adenoma; Adosterol; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Dexamethasone; Humans; Hyp | 1983 |
Syndromes of aldosterone deficiency and excess.
Topics: Aldosterone; Bartter Syndrome; Diagnosis, Differential; Glucocorticoids; Humans; Hyperaldosteronism; | 1983 |
Aldosterone metabolites and possible aldosterone precursors in hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Antigen-Antibody Comple | 1983 |
Functional pathology of aldosterone-producing adenoma.
Topics: 3-Hydroxysteroid Dehydrogenases; Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; A | 1980 |
Renal prostaglandin E in primary aldosteronism.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Kidney; Male; Potassium; Prostaglandins E | 1982 |
Primary hyperaldosteronism in pregnancy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteron | 1982 |
Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosteron | 1980 |
The occurrence of hyperaldosteronism in infants with congestive heart failure.
Topics: Aldosterone; Body Weight; Epidemiologic Methods; Furosemide; Heart Failure; Humans; Hyperaldosteroni | 1980 |
[Corticoid secretion in primary aldosteronism. II. The renin releasing test and the angiotensin II analog infusion test (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Aldosterone; Angiotensin II; Corticosterone; Female; Humans; Hydroco | 1980 |
Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.
Topics: Adult; Aldosterone; Child; Circadian Rhythm; Dexamethasone; Humans; Hydroxycorticosteroids; Hyperald | 1980 |
[Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)].
Topics: Adolescent; Aldosterone; Angiotensin II; Bartter Syndrome; Child; Female; Growth Disorders; Humans; | 1980 |
Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
Topics: Adolescent; Aldosterone; Binding, Competitive; Child, Preschool; Desoxycorticosterone; Humans; Hydro | 1980 |
Renin-angiotensin-aldosterone system in arterial hypertension.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Fa | 1980 |
The renin-aldosterone system in secondary hypertension: relationship to blood pressure and plasma electrolytes.
Topics: Aldosterone; Blood Pressure; Electrolytes; Humans; Hyperaldosteronism; Hypertension; Kidney Failure, | 1980 |
High plasma renin activities in primary aldosteronism with malignant hypertension. A case report.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension, Mal | 1980 |
A simplified screening test for differentiating primary aldosteronism from essential hypertension with low plasma renin activity.
Topics: Aldosterone; Dexamethasone; Diagnosis, Differential; Furosemide; Humans; Hyperaldosteronism; Hyperte | 1980 |
Influence of spironolactone on aldosterone metabolism in hyperaldosteronism.
Topics: Aldosterone; Corticosterone; Humans; Hyperaldosteronism; Kinetics; Progesterone; Renin; Spironolacto | 1980 |
Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Aldosterone; Angiotensin Amide; Bartter Syndrome; Bl | 1980 |
Normotensive primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans | 1980 |
The kallikrein-kinin system in essential hypertension.
Topics: Adult; Aldosterone; Animals; Bartter Syndrome; Blood Pressure; Bradykinin; Guinea Pigs; Humans; Hype | 1980 |
Influence of unilateral adrenalectomy on renin-angiotensin-aldosterone system in primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Angiotensins; Female; Humans; Hyperaldos | 1980 |
[Adrenal cortex transplantation. Animal experimental models for the human Cushing and Conn syndromes--clinical aspects of adrenal cortex transplantation].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Animals; Corticosterone; Cushing Syndrome; Di | 1980 |
Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Aldosterone; Aminoglutethimide; Angiotensin II; Aspi | 1980 |
Kinins in relation to renin activity in renal and inferior caval veins in normal individuals and patients with primary aldosteronism.
Topics: Adult; Aldosterone; Catheterization; Female; Humans; Hyperaldosteronism; Kinins; Male; Middle Aged; | 1981 |
[Urinary prostaglandin E in patients with hypertension--relationship to renin-angiotensin-aldosterone system (author's transl)].
Topics: Adult; Aldosterone; Angiotensin II; Female; Humans; Hyperaldosteronism; Hypertension; Male; Prostagl | 1980 |
Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
Topics: Adolescent; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Body Weight; Humans; Hype | 1980 |
Low-renin hypertension with hyperaldosteronism in childhood.
Topics: Aldosterone; Child; Dexamethasone; Glucocorticoids; Humans; Hyperaldosteronism; Hypertension; Remiss | 1980 |
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases].
Topics: Adult; Aldosterone; Female; Glycyrrhiza; Humans; Hyperaldosteronism; Hypertension; Middle Aged; Plan | 1981 |
[The dopaminergic system and aldosterone secretion. I. Suppressive effects of L-dopa on secondary hyperaldosteronism].
Topics: Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension; Levodopa; Male | 1980 |
The renin-aldosterone system in cystic fibrosis.
Topics: Aldosterone; Chlorides; Cystic Fibrosis; Diagnosis, Differential; Electrolytes; Humans; Hyperaldoste | 1981 |
[Clinical observation of 12 cases of primary aldosteronism, special reference to the diagnostic problem (author's transl)].
Topics: Adrenal Cortex; Adult; Age Factors; Aged; Aldosterone; Circadian Rhythm; Female; Humans; Hyperaldost | 1980 |
Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adolescent; Adrenal Glands; Adult; Aldoste | 1981 |
Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Cyproheptadine; Depression, Chemical; Diet, So | 1981 |
[Therapy of Bartter syndrome with indomethacin].
Topics: Adolescent; Aldosterone; Angiotensin Amide; Bartter Syndrome; Child; Female; Humans; Hyperaldosteron | 1981 |
Prevalence of primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Denmark; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Ag | 1981 |
Hyperaldosteronism after heart surgery in children. Part II: Regulation of aldosterone secretion.
Topics: Adolescent; Aldosterone; Child; Child, Preschool; Heart Defects, Congenital; Humans; Hydrocortisone; | 1981 |
[Examination of the functional status of the hormonal system in the differential diagnosis of various forms of hyperaldosteronism].
Topics: Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Male; Middle Aged; | 1980 |
[Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)].
Topics: Aldosterone; Bartter Syndrome; Child; Diagnosis, Differential; Electrolytes; Female; Humans; Hyperal | 1981 |
Mineralocorticoid and metabolic response to metyrapone on normotensive children and children with dexamethasone-suppressible and primary hyperaldosteronism.
Topics: Aldosterone; Child; Desoxycorticosterone; Electrolytes; Female; Humans; Hyperaldosteronism; Hyperten | 1981 |
Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations.
Topics: Adult; Aldosterone; Child; Dexamethasone; Female; Genotype; Glycoproteins; HLA Antigens; Humans; Hyp | 1981 |
Primary aldosteronism -- screening, diagnosis and therapy.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteron | 1981 |
Elevated 'free' 18-hydroxy-corticosterone excretion as a possible indicator for early diagnosis of primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Corticosterone; Female; Humans; Hyperaldosteronism; Hy | 1981 |
Screening for surgically correctable hypertension caused by primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 1981 |
Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Captopril; Humans; Hyperaldosteronism; Hypertension; Pr | 1981 |
Enzyme immunoassay for plasma renin activity: II. Clinical application.
Topics: Addison Disease; Adrenal Hyperplasia, Congenital; Aldosterone; Anovulation; Child; Contraceptives, O | 1981 |
Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
Topics: Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hypopituitarism; Metoclopramide; Prolactin; | 1981 |
[A case of glucocorticoid responsive aldosteronism (author's transl)].
Topics: Aldosterone; Dexamethasone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertensio | 1981 |
Bartter's syndrome.
Topics: Aldosterone; Bartter Syndrome; Brain Diseases, Metabolic; Child, Preschool; Electrolytes; Humans; Hy | 1981 |
Simple screening procedure for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hype | 1981 |
Biological activity of des-asp1-des-arg2-angiotensin II in man.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin III; Bartter Syndrome; Blood Pressure; Captopril; Do | 1982 |
Hyper-responsiveness of aldosterone to metoclopramide in aldosteronism.
Topics: Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Metoclopramide; Potassium; Pr | 1982 |
Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones.
Topics: Aldosterone; Child; Humans; Hyperaldosteronism; Kidney Tubules; Male; Mineralocorticoids; Potassium; | 1981 |
A case report of pseudohypoparathyroidism (Drezner's type I) associated with probable Bartter's syndrome.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Humans; Hydroxycholecalciferol | 1981 |
[Diagnosis, treatment and follow-up of a patient with pseudohypoaldosteronism (author's transl)].
Topics: Acid-Base Equilibrium; Aldosterone; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Infant; P | 1982 |
Primary aldosteronism associated with a primary double cancer of the thyroid and rectum: report of a case.
Topics: Adenocarcinoma; Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hyperten | 1981 |
Localization of functional adrenal tumors by computed tomography and venous sampling.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Cushing Synd | 1982 |
Estimation of free urinary aldosterone and 18-hydroxycorticosterone by a combination of automatic high-performance liquid chromatography and radioimmunoassay.
Topics: 18-Hydroxycorticosterone; Aldosterone; Chromatography, High Pressure Liquid; Corticosterone; Humans; | 1982 |
Direct radioimmunoassays for "aldosterone" and "18-hydroxycorticosterone" in unprocessed urine, and their use in screening to distinguish primary aldosteronism from hypertension.
Topics: 18-Hydroxycorticosterone; Aldosterone; Corticosterone; Diagnosis, Differential; Female; Humans; Hype | 1982 |
[Primary hyperaldosteronism: differentiation between aldosterone-producing adenoma and idiopathic adrenocortical hyperplasia (author's transl)].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aldosterone; Diet, Sodium-Restricted; Fema | 1982 |
Familial Bartter's syndrome and the effect of indomethacin in one family member.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Child; Child, Preschool; Female; Humans; Hyper | 1982 |
Pseudohypoaldosteronism: severe salt wasting in infancy caused by generalized mineralocorticoid unresponsiveness.
Topics: Aldosterone; Consanguinity; Humans; Hyperaldosteronism; Infant, Newborn; Infant, Newborn, Diseases; | 1982 |
Ultrastructure of aldosterone secreting adrenal adenomata.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Cell Membrane; Cytoplasmic Granules; Endoplasm | 1982 |
An aldosterone-producing adrenal cortical adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Anesthesia, General; Female; H | 1982 |
Probable clonal origin of aldosteronomas versus multicellular origin of parathyroid "adenomas".
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Female; Genetic Linkage; Glucosephosphate Deh | 1982 |
Adrenal vein epinephrine levels: a useful aid in venous sampling for primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Epinephrine; Humans; Hydrocort | 1982 |
The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
Topics: 18-Hydroxydesoxycorticosterone; Adenoma; Aldosterone; Corticosterone; Desoxycorticosterone; Hydrocor | 1982 |
Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension.
Topics: Adenoma; Adrenal Cortex; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension | 1982 |
Primary aldosteronism caused by adrenal cortical carcinoma.
Topics: Adenoma; Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Aldosterone; Glucocorticoids; Huma | 1982 |
Are plasma aldosterone surges in primary aldosteronism due to a loss of an inhibitory dopaminergic control?
Topics: Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adult; Aldosterone; Circ | 1980 |
A radioimmunoassay for the measurement of tetrahydroaldosterone 3-glucosiduronic acid in human plasma.
Topics: Aldosterone; Animals; Antibody Formation; Female; Glucuronates; Humans; Hyperaldosteronism; Male; Ra | 1981 |
Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Animals; Female; Histocytochemistry; Humans; | 1981 |
Effect of mineralocorticoid replacement therapy on renal acid-base homeostasis in adrenalectomized patients.
Topics: Acid-Base Equilibrium; Adrenal Glands; Adrenalectomy; Aldosterone; Breast Neoplasms; Cushing Syndrom | 1980 |
Age-related differences in the long-term responses of systemic flow and resistance to mineralocorticoid excess in man.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Insufficiency; Adult; Age Factors; Aldoste | 1980 |
Adrenal scintigraphy in primary aldosteronism caused by an aldosterone producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Midd | 1980 |
[What role does secondary hyperaldosteronism play in decompensated liver cirrhosis?].
Topics: Aldosterone; Ascites; Diet, Sodium-Restricted; Diuretics; Humans; Hyperaldosteronism; Liver Cirrhosi | 1981 |
Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
Topics: Adolescent; Aldosterone; Canrenoic Acid; Child; Child, Preschool; Heart Defects, Congenital; Hematoc | 1981 |
[14C-aldosterone binding by plasma proteins in adolescents with primary arterial hypertension].
Topics: Adolescent; Aldosterone; Blood Proteins; Carbon Radioisotopes; Humans; Hyperaldosteronism; Hypertens | 1981 |
Cyproheptadine in idiopathic aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Cyproheptadine; Dexamethasone; Drug Synergism; Humans | 1981 |
[Clinical characteristics of bilateral and multiple adrenal aldosteromas].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldostero | 1981 |
Hyperaldosteronism due to adrenocortical carcinoma 12 years after surgical removal of an aldosterone-producing adrenocortical adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Carcinoma; Female; Humans; Hyperaldosteronism; Middl | 1981 |
Aldosterone-producing microadenoma in a patient with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged | 1981 |
[A case of primary aldosteronism with unusual secretory pattern (author's transl)].
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Middle Aged | 1981 |
[Anesthetic management of primary aldosteronism with extremely high plasma aldosterone level (author's transl)].
Topics: Adrenal Cortex Neoplasms; Aldosterone; Anesthesia; Female; Humans; Hyperaldosteronism; Middle Aged | 1981 |
Bartter's syndrome in a 74-year-old woman: response to anti-inflammatory agents.
Topics: Aged; Aldosterone; Anti-Inflammatory Agents; Bartter Syndrome; Female; Humans; Hyperaldosteronism; H | 1980 |
Primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Posture | 1980 |
Hyperaldosteronism associated with liver metastases.
Topics: Aldosterone; Alkaline Phosphatase; Ascites; Bilirubin; Edema; Female; Humans; Hyperaldosteronism; Li | 1980 |
[Suppression of adrenal function by dexamethasone in radionuclide differential diagnosis of hyperaldosteronism].
Topics: Adrenal Cortex; Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Adult; Aldosterone; Depress | 1980 |
Localization of aldosterone-producing tumours in primary aldosteronism by adrenal and renal vein catheterization.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood Pressure; | 1980 |
[Multiple, bilateral aldosteroma].
Topics: Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Neoplas | 1980 |
[Mineralocorticoid function of the adrenal cortex in chronic circulatory insufficiency].
Topics: Adolescent; Adrenal Cortex; Adult; Aged; Aldosterone; Chronic Disease; Female; Heart Failure; Humans | 1980 |
[Studies on the mechanism of secretion of adrenal steroid hormones from adenomas of primary aldosteronism and Cushing's syndrome (author's transl)].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cushing Syndrome; Female; Humans; Hydrocortis | 1980 |
Hyperaldosteronism, hyperparathyroidism, medullary sponge kidneys, and hypertension.
Topics: Adenoma; Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; Hyperparathyroidism | 1980 |
[A simple method for measuring aldosterone secretion rate using 125I-aldosterone (authors' transl)].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hyperthyroidism; Iodine Radioisotopes; Radioi | 1980 |
Nocturnal, daytime, and postural changes of plasma aldosterone before and during dexamethasone in adenomatous and idiopathic aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Circadian Rhythm; Dexamethasone; Female; Human | 1980 |
Lateralization procedures in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplas | 1980 |
The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Dose-Response Relationship, Dr | 1981 |
Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients.
Topics: Adult; Aldosterone; Black People; Diet; Female; Glucuronates; Humans; Hyperaldosteronism; Hypertensi | 1981 |
[Acid labile aldosteronuria. Comparison of radio-immunoassay and colorimetry (author's transl)].
Topics: Addison Disease; Adult; Aldosterone; Chromatography, Thin Layer; Circadian Rhythm; Humans; Hyperaldo | 1980 |
[Conceptual basis and diagnosis of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Diagnosis, Differential; Humans; Hyper | 1995 |
[Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio].
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Potassium; | 1995 |
[Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study].
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Dexamethasone; Fem | 1995 |
Left ventricular mass in hereditary human hypertension: glucocorticoid-suppressible hyperaldosteronism.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Child; Female; Genotype; Glucocorticoids; Humans; Hy | 1995 |
21-Deoxyaldosteronism is not a new syndrome.
Topics: Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Syndrome | 1995 |
The renin gene and aldosterone-producing adenomas.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aldosterone; Alleles; Female; Gene Expression; Gene Frequen | 1994 |
Prohormones in adrenal venous effluent in patients with primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Desoxycorticosterone; Female; | 1995 |
Possible metoclopramide-induced increase in serum aldosterone in a premature infant.
Topics: Aldosterone; Gastroesophageal Reflux; Humans; Hyperaldosteronism; Infant; Infant, Newborn; Infant, P | 1995 |
Renal and adrenal sparing surgery for patients with primary aldosteronism and primary reninoma.
Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Aldosterone; Humans | 1995 |
Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Angiotensin II; | 1995 |
Aldosterone and Hypertension. Proceedings of a satellite symposium to the 15th International Society of Hypertension Congress. Lorne, Victoria, Australia, March 17-19, 1994.
Topics: Aldosterone; Animals; Blood Pressure; History, 20th Century; Humans; Hyperaldosteronism; Hypertensio | 1995 |
Chronic mineralocorticoid excess and cardiovascular remodeling.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyp | 1995 |
Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Cu | 1994 |
Screening of a population of young hypertensives for primary hyperaldosteronism.
Topics: Adult; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Middle Aged; Renin | 1994 |
[Hormonal changes during removal of aldosterone-producing adrenal tumor under sevoflurane anesthesia].
Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; Anesthesia, Inhalation; Ca | 1994 |
Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Middle Aged; Osmolar C | 1995 |
Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
Topics: Adrenal Glands; Adult; Aldosterone; Angiotensin II; Base Sequence; Blood Platelets; Blotting, Northe | 1994 |
Role of 21-deoxyaldosterone in human hypertension.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Female; Humans; Hyperaldos | 1994 |
Aldosterone regulation in primary aldosteronism.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Spiro | 1994 |
Aldosterone response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Female; Furosemide; Humans; Hyperaldosteronism; Mal | 1994 |
High incidence of primary aldosteronism in 199 patients referred with hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperte | 1994 |
Zona glomerulosa of the adrenal gland in a transgenic strain of rat: a morphologic and functional study.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Ce | 1994 |
Postural stimulation test in patients with aldosterone producing adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Aldosterone; Female; Humans; Hydrocortisone; Hyperal | 1994 |
[A case of idiopathic hyperaldosteronism with normal plasma aldosterone concentrations for 5 years after onset: a 12-year follow-up study].
Topics: Aldosterone; Diagnosis, Differential; Follow-Up Studies; Furosemide; Humans; Hyperaldosteronism; Hyp | 1994 |
The CSF aldosterone in brain tumors with brain edema.
Topics: Adolescent; Adult; Aged; Aldosterone; Astrocytoma; Blood-Brain Barrier; Brain Edema; Brain Neoplasms | 1994 |
Association of restriction fragment length polymorphism at the atrial natriuretic peptide gene locus with aldosterone responsiveness to angiotensin in aldosterone-producing adenoma.
Topics: Adenoma; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Deoxyribonucleases, Type II Site-Sp | 1994 |
Adrenal adenoma with primary aldosteronism in a child: a case report.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Child; Female; Humans; Hyperaldosteronism; Hypertensi | 1994 |
Plasma 18-oxocortisol levels in the patients with adrenocortical disorders.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cushing Syndrome; Female; Humans; Hydrocortis | 1994 |
Primary hyperaldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Cushing Syndrome; Diagnosis, Differential; Female; H | 1993 |
Unilateral adrenal hypersecretion of both aldosterone and cortisol in two first cousins with a syndrome of mineralocorticoid excess but without signs of hypercortisolism.
Topics: Adrenal Glands; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hyperplasia; | 1994 |
An association of primary aldosteronism and adrenaline-secreting phaeochromocytoma.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Epinephrine; Fe | 1994 |
Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Cortodoxone; Cosyntropin; Desoxycorticosterone; Fem | 1994 |
[A case of normotensive primary aldosteronism in association with non-functioning adenoma and aldosterone producing adenoma in ipsilateral adrenal gland].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldostero | 1994 |
Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
Topics: Adenoma; Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Dopamine; Female | 1994 |
[Aldosterone and 11 beta-hydroxysteroid dehydrogenase: role in arterial hypertension].
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Humans; Hydroxysteroid Dehydrogenases; Hyperaldo | 1993 |
How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Australia; Female; Humans; Hyperaldosteronism; Hyperten | 1993 |
Surgical treatment of primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Female; Humans; Hyperaldo | 1994 |
Primary hyperaldosteronism--evaluation of procedures for diagnosis and localization.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Female; Humans; Hyperald | 1993 |
Comparison of five modalities in localization of primary aldosteronism.
Topics: Adrenal Glands; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Magnetic Resonance Ima | 1994 |
Chronic sennoside treatment does not cause habituation and secondary hyperaldosteronism in rats.
Topics: Aldosterone; Animals; Anthraquinones; Cathartics; Diarrhea; Female; Hyperaldosteronism; Intestinal M | 1993 |
[Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency].
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Blood Pressure; Cations; Creatinine; Female; Humans; | 1993 |
[Unilateral autonomous aldosterone production in hyperaldosteronism suppressible by dexamethasone].
Topics: Adrenal Cortex Hormones; Adult; Aldosterone; Dexamethasone; Female; Humans; Hydrocortisone; Hyperald | 1993 |
[The prediction of blood pressure after adrenalectomy in primary aldosteronism].
Topics: Adrenalectomy; Adult; Aldosterone; Blood Pressure; Female; Furosemide; Humans; Hyperaldosteronism; M | 1993 |
Estimation of urinary aldosterone using thin-layer chromatography and fluorimetry.
Topics: Adolescent; Adult; Aged; Aldosterone; Chromatography, Thin Layer; Female; Fluorometry; Humans; Hyper | 1993 |
Primary hyperaldosteronism.
Topics: Aldosterone; Captopril; Humans; Hyperaldosteronism; Potassium; Renin | 1993 |
Detection of renin mRNA in aldosterone-producing adenomas by polymerase chain reaction.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Angiotensin II; Base Sequence; Elect | 1993 |
Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldosteronism; Hy | 1993 |
Angiotensin-responsive aldosterone-producing adenomas: postoperative disappearance of aldosterone response to angiotensin.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Angiotensin II; Femal | 1993 |
Karyotypic abnormalities in benign adrenocortical tumors producing aldosterone.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Chromosome Aberrations; Chromosome Deletion; Chromosome | 1993 |
Primary aldosteronism: a new understanding.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertensi | 1993 |
Primary aldosteronism in a patient with an aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Humans; Hyperaldosteronism; Ma | 1993 |
The diagnosis of primary aldosteronism and separation of two major subtypes.
Topics: Adult; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Middle Aged; Renin; Sensiti | 1993 |
Direct inhibitory effect of etomidate on corticosteroid secretion in human pathologic adrenocortical cells.
Topics: 18-Hydroxycorticosterone; Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adul | 1993 |
Regulation of collecting tubule adenosine triphosphatases by aldosterone and potassium.
Topics: Adenosine Triphosphatases; Adrenalectomy; Aldosterone; Alkalosis; Animals; Diet; H(+)-K(+)-Exchangin | 1993 |
Cortisol production by aldosterone-producing adenomas in vitro.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiote | 1993 |
Aldosterone and thyroid hormone modulation of alpha 1-, beta 1-mRNA, and Na,K-pump sites in rabbit distal colon epithelium. Evidence for a novel mechanism of escape from the effect of hyperaldosteronemia.
Topics: Aldosterone; Animals; Blotting, Northern; Cell Membrane; Chromatography, Affinity; Colon; Diet, Sodi | 1993 |
Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
Topics: Adolescent; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Dexamethasone; Humans; Hyperal | 1993 |
Angiotensin II receptor subtypes on adrenal adenoma in primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angioten | 1993 |
Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Chromatography | 1993 |
Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aged; Aldosteron | 1993 |
Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.
Topics: Aldosterone; Angiotensin II; Animals; Cardiomyopathies; Fibrosis; Hyperaldosteronism; Hypertension; | 1993 |
CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Female; Humans; Hyperald | 1993 |
Unilateral renal artery stenosis seen initially as severe and symptomatic hypokalemia. Pathophysiologic assessment and effects of surgical revascularization.
Topics: Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension, Renovascular; Hypoka | 1993 |
In vitro glucocorticosteroid and mineralocorticosteroid biosynthesis in Conn's adenoma tissues.
Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Aldoster | 1993 |
[A rare case of primary aldosteronism due to bilateral functioning adrenocortical adenomas].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Diabetes Mellitus; Humans; Hyperaldosteronism | 1993 |
The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Corticosterone; Diagnosis, Differential; Female; Hum | 1993 |
Significance of steroidogenic enzymes in the pathogenesis of adrenal tumour.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aldosterone; Cush | 1993 |
[Evaluation of the localizing procedures of primary aldosteronism].
Topics: Abdomen; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyper | 1993 |
Unilateral diffuse adrenal hyperplasia masquerading as aldosterone-producing adenoma in primary hyperaldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; | 1993 |
Combined Conn's and Cushing's syndrome: an unusual presentation of adrenal adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aldosterone; Cushing Syndrome; Female; Humans; Hyd | 1995 |
Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Analysis | 1995 |
Significance of renal kininases in patients with primary aldosteronism.
Topics: Adrenalectomy; Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; Lysine Carbox | 1995 |
Characteristics of aldosterone-producing adenoma responsive to upright posture.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Diuretics; Female; Furosemide; | 1995 |
Primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldost | 1995 |
[Mechanism of inhibition of aldosterone secretion by a Ca2+ channel blocker in patients with essential hypertension and patients with primary aldosteronism].
Topics: Adult; Aged; Aldosterone; Calcium Channel Blockers; Depression, Chemical; Female; Humans; Hyperaldos | 1995 |
Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
Topics: Aldosterone; Blood Pressure; Dihydroergotoxine; Dopamine Agonists; Dopamine Antagonists; Female; Hum | 1995 |
Hyperaldosteronism: sampling the adrenal veins.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Aldos | 1996 |
Relative value of computed tomography scanning and venous sampling in establishing the cause of primary hyperaldosteronism.
Topics: Adenoma; Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Diagnosis, Differential; Evaluation S | 1996 |
Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients.
Topics: Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; | 1996 |
[Adrenal adenoma or hyperplasia? Problems of differential diagnosis in an unusual case of primary hyperaldosteronism].
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Diagnosis, | 1996 |
Primary hyperaldosteronism in pregnancy. A case report.
Topics: Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Antihypertensive Agents; Blood Pressure; Combined | 1996 |
[Evaluation of surgical treatment for patients with multiple aldosteronoma: analysis of 11 cases].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Diagnosis, Differential; Femal | 1995 |
Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
Topics: Adult; Aldosterone; Biomarkers; Case-Control Studies; Diagnosis, Differential; Female; Humans; Hyper | 1996 |
Bilateral aldosterone-producing adenomas in two patients diagnosed by immunohistochemical analysis of steroidogenic enzymes.
Topics: 3-Hydroxysteroid Dehydrogenases; Adenoma; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; | 1996 |
Aldosterone changes during angiotensin III and potassium infusions in patients with primary aldosteronism.
Topics: Aldosterone; Angiotensin III; Cross-Over Studies; Humans; Hyperaldosteronism; Potassium; Random Allo | 1996 |
Clinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I.
Topics: Adolescent; Adult; Aged; Aldosterone; Base Sequence; Blood Pressure; Blotting, Southern; Child; DNA; | 1995 |
Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
Topics: Albuminuria; Aldosterone; beta 2-Microglobulin; Female; Humans; Hyperaldosteronism; Hypertension; Ma | 1995 |
Paralytic myopathy--a leading clinical presentation for primary aldosteronism in Taiwan.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypokalemia; Male; Middle Aged; Muscle Weakn | 1996 |
[Adrenal cortex adenoma in Conn syndrome].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Diagnostic Ima | 1996 |
Magnetic resonance imaging of adrenocortical adenomas in childhood: correlation with computed tomography and ultrasound.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hor | 1996 |
[Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Diagnosis, Differential; Female; Humans; | 1996 |
Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Topics: Adenoma; Adult; Aldosterone; Chimera; Cytochrome P-450 CYP11B2; Female; Humans; Hyperaldosteronism; | 1996 |
Primary aldosteronism: adrenal venous sampling.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Female; Humans; Hydrocor | 1996 |
Further studies on the mechanism of the mineralocorticoid action of licorice in humans.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adult; Aldosterone; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrr | 1996 |
Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Aldosterone; Corticosterone; Cortodoxone; Desoxycorticosterone; Glucocorti | 1996 |
11 beta-Hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension?
Topics: Adrenocorticotropic Hormone; Aldosterone; Chimera; Corticosterone; Cortodoxone; Cytochrome P-450 CYP | 1996 |
[Is the aldosterone-renin ratio useful in screening for primary aldosteronism?].
Topics: Aldosterone; Humans; Hyperaldosteronism; Renin | 1996 |
Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Base Sequence; Female; H | 1997 |
Primary aldosteronism with bilateral multiple aldosterone-producing adrenal adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; Circadian Rhythm; | 1996 |
Increased Na(+)-H+ exchange in red blood cells of patients with primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adult; Age Factors; Aldosterone; Blood Pressure; Calmodulin; Erythrocytes; | 1997 |
Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Electrocardiography; Female; Humans; Hyperaldosteronism; Hypertension; Hyp | 1997 |
Development of polyuria in Tsukuba hypertensive mice carrying human renin and angiotensinogen genes.
Topics: Aldosterone; Angiotensinogen; Animals; Electrolytes; Humans; Hyperaldosteronism; Hypertension; Kidne | 1995 |
Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Bucladesine; Female; Humans; Hyperaldosteronism; Kinetics; | 1997 |
Idiopathic hyperplasia of the adrenal gland behaving like an aldosterone producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Diagnosis, Differential; Female; Huma | 1997 |
Adrenal-sparing laparoscopic surgery for aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Humans; Hyperaldosteronism; Lap | 1997 |
Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Blood Flow Velocity; Coronary Circulatio | 1997 |
Hypertensive cardiomegaly caused by an aldosterone-secreting adenoma in a newborn.
Topics: Adenoma; Adrenalectomy; Aldosterone; Cardiomegaly; Humans; Hyperaldosteronism; Hypertension; Infant; | 1997 |
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism.
Topics: Adult; Aldosterone; Female; Fludrocortisone; Glucocorticoids; Humans; Hydrocortisone; Hyperaldostero | 1997 |
Primary aldosteronism due to unilateral adrenal hyperplasia: a case report.
Topics: Adrenal Glands; Adult; Aldosterone; Follow-Up Studies; Humans; Hyperaldosteronism; Hyperplasia; Male | 1997 |
Adrenal incidentalomas--analysis of 23 cases discovered by ultrasound.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aged, 80 and over; Aldosterone; Carci | 1997 |
Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Cushing Syndrome; Echocardiography; Female; Humans; Hyp | 1997 |
Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium; Renin; R | 1997 |
An ominously low potassium level.
Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypokalemia; Male | 1997 |
Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Cytochrome P-450 CYP11B2; Dexamethasone; Glucocorti | 1997 |
In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Child; Circadian | 1997 |
Malignant hypertension in a patient with primary aldosteronism with elevated active renin concentration.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Antihypertensiv | 1997 |
Potassium and aldosterone secretion in glucocorticoid-remediable aldosteronism.
Topics: Aldosterone; Animals; Glucocorticoids; Humans; Hyperaldosteronism; Potassium | 1997 |
Coexisting renal artery stenosis and primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertensi | 1997 |
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
Topics: 17-alpha-Hydroxyprogesterone; 3-Iodobenzylguanidine; Adenoma; Adolescent; Adrenal Cortex Neoplasms; | 1998 |
Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure.
Topics: Acetylcholine; Adipose Tissue; Adrenal Gland Neoplasms; Aldosterone; Arterioles; Blood Pressure; Cho | 1998 |
Evidence for persistent dysfunction of wild-type aldosterone synthase gene in glucocorticoid-treated familial hyperaldosteronism type I.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blotting, Southern; Cytochrome P-450 CYP11B2; | 1997 |
Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; F | 1998 |
Aldosterone to renin ratios in the evaluation of primary aldosteronism.
Topics: Adrenocortical Adenoma; Adult; Aged; Aldosterone; Humans; Hyperaldosteronism; Middle Aged; Renin; Re | 1997 |
Adrenalectomy for primary aldosteronism: long-term follow-up study in 29 patients.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Diagnosis | 1998 |
The diagnosis of Liddle syndrome by identification of a mutation in the beta subunit of the epithelial sodium channel.
Topics: Aldosterone; Alleles; Amino Acid Sequence; Base Sequence; Blood Pressure; Chromosome Mapping; Chromo | 1998 |
[Case of primary aldosteronism associated with heart and kidney failure].
Topics: Aldosterone; Biomarkers; Female; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Kidney Dis | 1998 |
Aldosterone-producing adenoma associated with foci of myelolipoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Diagnosis, Differential; Female; Huma | 1998 |
Decreased blood pressure variability at rest in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Baroreflex; Blood Pressure; Diastole; Exercise; Female; Heart Rate; Humans; Hype | 1998 |
Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.
Topics: Aldosterone; Blotting, Southern; Chromosome Mapping; Chromosomes, Human, Pair 8; Cytochrome P-450 CY | 1998 |
[Primary hyperaldosteronism and adenoma of the adrenal cortex. Suppression of aldosterone with dexamethasone].
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Cortisone; Dexamethasone; Hormones; Humans; Hyperald | 1998 |
Hormonal characteristics of primary aldosteronism due to unilateral adrenal hyperplasia.
Topics: Adrenal Cortex; Adrenalectomy; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldosteron | 1998 |
Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production.
Topics: Adult; Aged; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldosteronism; Male; Middle Aged; Po | 1998 |
Left ventricular systolic function in primary aldosteronism and hypertension.
Topics: Adult; Aldosterone; Echocardiography, Doppler; Female; Humans; Hyperaldosteronism; Hypertension; Hyp | 1998 |
Impaired baroreflex function and arterial compliance in primary aldosteronism.
Topics: Adult; Aldosterone; Arteries; Baroreflex; Blood Pressure; Compliance; Female; Heart Rate; Hemodynami | 1999 |
Potentially high prevalence of primary aldosteronism in a primary-care population.
Topics: Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Predictive Value of Tests | 1999 |
Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Cesarean Sectio | 1999 |
Primary aldosteronism due to aldosterone producing adenoma without hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism | 1999 |
Ventricular fibrillation: an extreme presentation of primary hyperaldosteronism.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Aldosterone; Death, Sudden, | 1999 |
Conn's syndrome: no longer a needle in a haystack?
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Humans; Hyperaldosteronism; Logist | 1998 |
A case of aldosterone-producing adenoma with severe postoperative hyperkalemia.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Female; Fludrocortisone; Humans; Hyper | 1998 |
Medical management of aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; | 1999 |
[Mineralocorticoid hypertension. A new form of secondary hypertension?].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoids; Renin; Renin-Angiotensin | 1999 |
Primary aldosteronism in general practice.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; False Positive React | 1999 |
Primary aldosteronism in general practice.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium; Renin | 1999 |
Aldosterone-producing adenoma without hypertension: a report of two cases.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure Moni | 1999 |
Approach to a patient with suspected primary aldosteronism.
Topics: Aldosterone; Diagnosis, Differential; Female; Hematologic Tests; Humans; Hyperaldosteronism; Hyperte | 1999 |
[Primary hyperaldosteronism--12 clinical cases].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Midd | 1999 |
Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Biomarkers, Tumor; Female; Humans; Hydrocortis | 1999 |
[Left ventricular myocardial structure and function in patients with primary aldosteronism].
Topics: Adrenalectomy; Adult; Aldosterone; Blood Flow Velocity; Blood Pressure; Echocardiography, Doppler; F | 1999 |
Biochemical evidence of aldosterone overproduction and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I.
Topics: Adolescent; Adult; Aldosterone; Blood Pressure; Child; Dexamethasone; Female; Glucocorticoids; Homeo | 1999 |
Mutations in CYP11B1 gene converting 11beta-hydroxylase into an aldosterone-producing enzyme are not present in aldosterone-producing adenomas.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Base Sequence; Blotting, Southern; Cytochrome | 1999 |
[Case of primary aldosteronism caused by adrenal microadenoma that permitted clinical observation from onset].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aged; Aldosterone; Female; Hormones, Ectopic; Huma | 1999 |
Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis.
Topics: Adult; Aldosterone; Antiporters; Calcium; Canrenoic Acid; Case-Control Studies; Female; Homeostasis; | 2000 |
[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
Topics: Aldosterone; Comorbidity; Female; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Male; Middl | 1999 |
Primary hyperaldosteronism (Conn syndrome): MR imaging findings.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Female; Huma | 2000 |
[Factors for postoperative persistent hypertension in patients with aldosterone-producing adenoma].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Age Factors; Aldosterone; Female; Follow-Up Studies; Humans | 1997 |
Permissive effect of thyroid hormones on induction of rat colonic Na+ transport by aldosterone is not localised at the level of Na+ channel transcription.
Topics: Aldosterone; Animals; Colon; Hyperaldosteronism; Hypothyroidism; In Vitro Techniques; Ion Transport; | 2000 |
Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model.
Topics: Aldosterone; Animals; Blood Pressure; Circadian Rhythm; Glomerular Filtration Rate; Hyperaldosteroni | 2000 |
Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Glucose; Glucose Clamp Technique; Glucos | 2000 |
Bilateral adrenal cortical hyperplasia.
Topics: Adult; Aldosterone; Diagnosis, Differential; Diuretics; Female; Humans; Hydrocortisone; Hyperaldoste | 2000 |
High prevalence of primary aldosteronism in the Tayside hypertension clinic population.
Topics: Adult; Aged; Aldosterone; Female; Fludrocortisone; Humans; Hyperaldosteronism; Hypertension; Male; M | 2000 |
Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Topics: Aldosterone; Blood Pressure; Crossing Over, Genetic; Cytochrome P-450 CYP11B2; Dexamethasone; Female | 2000 |
Primary aldosteronism in a patient with familial adenomatous polyposis.
Topics: Adenomatous Polyposis Coli; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldos | 2000 |
Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Circadian Rhythm; Cytochrome P-45 | 2000 |
[Incidence of primary hyperaldosteronism in hospitalized patients with hypertension].
Topics: Adult; Aldosterone; Female; Hospitalization; Humans; Hyperaldosteronism; Hypertension; Male; Middle | 1999 |
Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; China; Female; Humans; Hyperaldos | 2000 |
The aldosterone/renin ratio as a screening test for primary aldosteronism.
Topics: Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 2000 |
[What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?].
Topics: Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Cohort Studies; Drug Combinations; Follo | 2000 |
Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
Topics: Aldosterone; Arteriosclerosis; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension, Ren | 2000 |
[Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
Topics: Adult; Aldosterone; Bromocriptine; Data Interpretation, Statistical; Dopamine; Dopamine Agonists; Fe | 2000 |
Dexamethasone-suppressible hypertension.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adult; Aldosterone; Dexamethasone; Female; Genotype; Glucocor | 2000 |
Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism.
Topics: Aldosterone; Cisapride; Female; Humans; Hyperaldosteronism; Male; Receptors, Serotonin; Receptors, S | 2000 |
Hyperaldosteronism in a cat with metastasised adrenocortical tumour.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aldosterone; Animals; Carcinoma; Cat Diseases; Cats; Const | 2001 |
An assessment of diagnostic procedures preparatory to retroperitoneoscopic removal of adenoma in cases of primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; False Negative Reactions; Fals | 2000 |
Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Diagnosis, Differentia | 2001 |
Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hydrocortisone | 2001 |
Modulation of transalveolar fluid absorption by endogenous aldosterone in adult rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Absorption; Aldosterone; Animals; Diet, Sodium-Restrict | 2001 |
Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Antihypertensive Agents; Female; Humans; Hyper | 2001 |
Cautions over the current epidemic of primary aldosteronism.
Topics: Aldosterone; Diagnostic Errors; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Renin | 2001 |
Twenty-Four hour blood pressure profile in subjects with different subtypes of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Blood Pressure Determination; | 2001 |
[Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Potas | 2000 |
Paraneoplastic hyperaldosteronism associated with non-Hodgkin's lymphoma.
Topics: Aldosterone; Cytochrome P-450 CYP11B2; Fatal Outcome; Humans; Hyperaldosteronism; Hypertension; Lymp | 2001 |
[Effect of insulin in hypertension with high and low levels of renin].
Topics: Adult; Aged; Aldosterone; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperaldosteronis | 2001 |
Captopril suppression versus salt loading in confirming primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hyper | 2001 |
Captopril suppression versus salt loading in confirming primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hyper | 2001 |
Captopril suppression versus salt loading in confirming primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hyper | 2001 |
Captopril suppression versus salt loading in confirming primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Humans; Hyper | 2001 |
Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome).
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Aldosterone; Case-Control Studies; Chi-Square Distri | 2001 |
Aldosteronoma in a dog with polyuria as the leading symptom.
Topics: Adrenalectomy; Aldosterone; Animals; Dog Diseases; Dogs; Hyperaldosteronism; Male; Osmolar Concentra | 2001 |
'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Aged; Aldosterone; Blood Pressure; Dehydro | 2001 |
[Renovascular hypertension coexisting with an aldosteronoma].
Topics: Adenocarcinoma; Adrenal Cortex Neoplasms; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hyp | 2001 |
Cautions over idiopathic aldosteronism.
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension | 2001 |
Cautions over idiopathic aldosteronism.
Topics: Aldosterone; Fludrocortisone; Humans; Hyperaldosteronism; Renin | 2001 |
Prevalence of primary aldosteronism in unselected hypertensive populations: screening and definitive diagnosis.
Topics: Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension; Mass Screening; Pota | 2001 |
Primary aldosteronism: factors associated with normalization of blood pressure after surgery.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aged, 80 and over; Aldosterone; Analys | 2001 |
Aldosterone-producing adenoma with prolonged amelioration by dexamethasone.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; B | 2001 |
Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups.
Topics: Aldosterone; Ethnicity; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Prevale | 2001 |
In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Cushing Syndrome; Cytoch | 2001 |
[Aldosterone-producing adenoma which was difficult to discriminate from idiopathic hyperaldosteronisim].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldoste | 2001 |
Primary aldosteronism in pregnancy: review of cases.
Topics: Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Pre-Eclampsia; Preg | 1999 |
Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldoster | 2001 |
Expression and function of adrenomedullin and its receptors in Conn's adenoma cells.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenomedullin; Aldosterone; Angiotensin II; Gene Expression Regu | 2001 |
Normokalemic hyperaldosteronism in patients with resistant hypertension.
Topics: Adult; Aged; Aldosterone; Analysis of Variance; Antihypertensive Agents; Creatinine; Female; Humans; | 2002 |
Primary aldosteronism: the most frequent form of secondary hypertension?
Topics: Aldosterone; Antihypertensive Agents; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Mineral | 2002 |
Test and teach. Surgically correctable hypertension. Conn's syndrome and spironolactone bodies.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Hypertens | 2001 |
Regulation of prostasin by aldosterone in the kidney.
Topics: Adrenalectomy; Aldosterone; Animals; Cell Line; Epithelial Sodium Channels; Female; Gene Expression | 2002 |
Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?
Topics: Adenoma; Adult; Aldosterone; Blood Glucose; Diabetes Mellitus; Humans; Hyperaldosteronism; Insulin; | 2001 |
The aldosterone-renin ratio and primary aldosteronism.
Topics: Aldosterone; Anti-Inflammatory Agents; Bias; Diagnosis, Differential; Fludrocortisone; Humans; Hyper | 2002 |
Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Cesarean Section; Female; Human | 2002 |
Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling.
Topics: Adenoma; Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Aldostero | 2002 |
Is primary aldosteronism underdiagnosed in clinical practice?
Topics: Adrenal Glands; Adrenocortical Adenoma; Aldosterone; Diagnosis, Differential; Humans; Hyperaldostero | 2001 |
[Hypertension: once primary, always primary?].
Topics: Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldosteron | 2002 |
Primary aldosteronism in normokalemic patients with adrenal incidentalomas.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Aldosterone; Blood Pressure; Fe | 2002 |
Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Prosp | 2002 |
Laparoscopic adrenal-sparing surgery for primary hyperaldosteronism due to aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Humans; Hyperal | 2002 |
Diagnostic value of the post-captopril test in primary aldosteronism.
Topics: Adult; Aldosterone; Captopril; Humans; Hyperaldosteronism; Male; Middle Aged; Renin; Retrospective S | 2002 |
Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning.
Topics: Adosterol; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Iodin | 2002 |
New diagnostic procedure for primary aldosteronism: adrenal venous sampling under adrenocorticotropic hormone and angiotensin II receptor blocker--application to a case of bilateral multiple adrenal microadenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; A | 2002 |
Aldosterone excess and essential hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension | 2002 |
Renin-producing serous cystoadenocarcinoma of the ovary: a case report.
Topics: Aldosterone; Cystadenocarcinoma, Serous; Diagnosis, Differential; Female; Humans; Hyperaldosteronism | 2002 |
Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Echocardiography, Doppler; Female; Heart; Heart Ventricles; Humans; Hypera | 2002 |
Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree.
Topics: Adult; Aldosterone; Blood Pressure; Crossing Over, Genetic; Cytochrome P-450 CYP11B2; Female; Glucoc | 2002 |
[Renal tubular acidosis, Renin-aldosterone system illustrated by a case with pronounced hypokalemia].
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Female; Humans; Hydrogen-Ion Concentration; Hyperaldost | 1977 |
Renal tubular acidosis.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Ammonia; Bicarbonates; Electrolytes; Extracellular Spac | 1977 |
[Recurrent aldosteronism and arterial hypertension following adrenalectomy. One clinical case (author's transl)].
Topics: Adrenal Glands; Adrenalectomy; Adrenergic beta-Antagonists; Adult; Aldosterone; Humans; Hyperaldoste | 1978 |
Bartter's syndrome. Differentiation into two clinical groups.
Topics: Aldosterone; Bartter Syndrome; Calcium; Child; Child, Preschool; Chlorides; Diet; Extracellular Spac | 1979 |
Prostaglandins and aspirin therapy in Bartter's syndrome.
Topics: Aldosterone; Aspirin; Bartter Syndrome; Body Weight; Female; Humans; Hyperaldosteronism; Infant; Pot | 1976 |
Bromocriptine and plasma-aldosterone.
Topics: Adult; Aldosterone; Bromocriptine; Ergolines; Female; Humans; Hyperaldosteronism; Male; Prolactin | 1976 |
Rectal potential difference in essential hypertension.
Topics: Action Potentials; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Rectum; Renin | 1976 |
Subtraction potential difference: In-vivo assay for mineralocorticoid activity.
Topics: Action Potentials; Adrenal Insufficiency; Aldosterone; Circadian Rhythm; Cosyntropin; Desoxycorticos | 1978 |
Aldosterone in myxoedema.
Topics: Aldosterone; Dose-Response Relationship, Drug; Heart Failure; Humans; Hyperaldosteronism; Myxedema; | 1978 |
Preoperative distinction of adenoma from hyperplasia in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Diagnosis, Differential; Humans; Hype | 1979 |
Disorders of chloriuretic hormone secretion.
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Biological Products; Bradykinin; Chlorides; Humans; H | 1979 |
Idiopathic aldosteronism: a diagnostic artifact?
Topics: Aldosterone; Angiotensin II; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension; Reni | 1979 |
Primary aldosteronism: a noninvasive procedure for tumor localization as well as for distinction from bilateral hyperplasia.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Dexamethasone; Dia | 1977 |
Bartter's syndrome: 10 cases in childhood. Results of long-term indomethacin therapy.
Topics: Adolescent; Aldosterone; Alkaline Phosphatase; Bartter Syndrome; Body Height; Body Weight; Calcium; | 1979 |
[Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)].
Topics: Adolescent; Aldosterone; Bartter Syndrome; Body Height; Body Weight; Bone Development; Child; Cycloo | 1979 |
Cardiomyopathy in an adult with Bartter's syndrome and hypokalemia. Hemodynamic, angiographic and metabolic studies.
Topics: Adult; Aldosterone; Bartter Syndrome; Cardiomegaly; Cardiomyopathies; Child; Female; Hemodynamics; H | 1977 |
Hypertension, hypokalemia, hyporeninemia and severe target organ damage.
Topics: Aldosterone; Blood Pressure; Cardiomegaly; Female; Humans; Hyperaldosteronism; Hypertension; Hypokal | 1976 |
Bartter's syndrome--case report.
Topics: Adult; Aldosterone; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Hyperplasia; Juxtaglomerul | 1979 |
Primary aldosteronism. A study in contrasts.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenalectomy; | 1975 |
[Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Bartter Syndrome; Dexamethasone; Glucocort | 1975 |
Primary aldosteronism due to a malignant ovarian tumor.
Topics: Adrenal Glands; Adult; Aldosterone; Child; Female; Humans; Hyperaldosteronism; Neoplasm Metastasis; | 1975 |
Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension.
Topics: 18-Hydroxydesoxycorticosterone; Adrenocorticotropic Hormone; Aldosterone; Carrier Proteins; Circadia | 1975 |
The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Depressi | 1976 |
Comparative biosynthetic studies in a case of primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Horm | 1976 |
Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
Topics: 18-Hydroxydesoxycorticosterone; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aldoste | 1976 |
Aldosterone regulation in primary aldosteronism: differences between adenoma and bilateral hyperplasia.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldoste | 1976 |
Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
Topics: 18-Hydroxydesoxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropi | 1977 |
[Secretory regulation and episodic secretion of aldosterone in patients with primary aldosteronism (author's transl)].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Circadian Rhythm; Dexamethasone; Fe | 1976 |
[In vivo and in vitro studies on steroid production by aldosteronoma (author's transl)].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenoco | 1978 |
[Pheochromocytoma with hyperaldosteronism and abnormalities of humoral immunity. Study of plasma renin activity].
Topics: Adrenal Gland Neoplasms; Adult; Agammaglobulinemia; Aldosterone; Female; Humans; Hyperaldosteronism; | 1977 |
[Primary hyperaldosteronism with paroxysmal arterial hypertension. Apropos of 2 operated cases].
Topics: Adrenal Glands; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Male; Mi | 1978 |
Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Female; | 1975 |
Adrenocorticotropin and plasma aldosterone concentration and deoxycorticosterone in man.
Topics: Adenoma; Adrenal Gland Diseases; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; A | 1977 |
Primary aldosteronism: inability to differentiate unilateral from bilateral adrenal lesions by various routine clinical and laboratory data and by peripheral plasma aldosterone.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; | 1978 |
Primary aldosteronism: diagnosis, localization, and treatment.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Hyperfun | 1979 |
ACTH-dependent aldosterone excess due to adrenocortical adenoma: a variant of primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensi | 1978 |
Effect of posture on the plasma concentrations of aldosterone in hypertension and primary hyperaldosteronism.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Circadian Rhythm; Desoxycorticost | 1979 |
Comparison of the urinary excretion of free aldosterone and its acid-labile conjugate in rats during experimental hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Hyperaldosteronism; Male; Potassium; Radioimmunoa | 1979 |
[Primary hyperaldosteronism syndrome].
Topics: Adenoma; Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone | 1979 |
Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldost | 1978 |
[ACTH administration for the study of aldosterone secretion].
Topics: Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism | 1979 |
Preoperative diagnosis and localization of aldosteronomas by measurement of corticosteroids in adrenal venous blood.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Female; Hum | 1979 |
[A study on the mechanism of aldosterone secretion in low-renin essential hypertension (author's transl)].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Electrolytes; Female; Furosemide; H | 1979 |
Relationship of human urinary and plasma kinins to sodium-retaining steroids and plasma renin activity.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Bartter Syndrome; Bradykinin; Child; Fe | 1979 |
Responses of aldosterone-producing adenomas to ACTH and angiotensins.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; A | 1979 |
Aldosterone and in vivo mineralocorticoid activity in normotensive and hypertensive man.
Topics: Action Potentials; Adrenal Cortex Diseases; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperte | 1979 |
Rectal potential difference in the diagnosis of aldosterone excess.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Desoxycorticosterone; Diet; Electrodes; Female; | 1975 |
Systems of life. No. 58. The adrenal glands--3.
Topics: Adrenal Gland Diseases; Adrenal Glands; Aldosterone; Female; Glucocorticoids; Humans; Hyperaldostero | 1979 |
Primary aldosteronism-recognition and management.
Topics: Aldosterone; Humans; Hyperaldosteronism; Male; Middle Aged | 1977 |
[A precise bioassay for in vivo mineralocorticoid activity in man: relation to plasma aldosterone in normal subjects, essential hypertension, hyperaldosteronism and adrenocortical insufficiency (author transl)].
Topics: Adrenal Cortex Diseases; Aldosterone; Circadian Rhythm; Humans; Hyperaldosteronism; Hypertension; In | 1977 |
On the pathogenetic role of prostaglandins in Bartter's syndrome.
Topics: Adolescent; Aldosterone; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Hypokalemia; Indometh | 1979 |
Hyperaldosteronism with coexistence of adrenal cortical adenoma and pheochromocytoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aldosterone; Humans; Hydrocortisone; Hyp | 1979 |
Primary aldosteronism. II. Biochemical features.
Topics: Aldosterone; Creatinine; Humans; Hyperaldosteronism; Potassium; Renin; Sodium | 1979 |
Primary aldosteronism. III. Localization of aldosteronoma by chemical methods.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldostero | 1979 |
Prolonged pseudoaldosteronism induced by glycyrrhizin.
Topics: Aged; Aldosterone; Blood Pressure; Diet, Sodium-Restricted; Female; Glycyrrhetinic Acid; Glycyrrhiza | 1979 |
[Biochemical diagnosis of hypertension in adrenal gland diseases].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Catecholamines; Corticosterone; Desoxycorticosterone; H | 1979 |
Are idiopathic hyperaldosteronism and low-renin hypertension variants of essential hypertension?
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Angiotensin II; Blood Pressure; | 1979 |
The evidence that salt is an important aetiological agent, if not the cause, of hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoids; Renin; Risk; Sodium; Sodi | 1979 |
Relationship between renin activity and aldosterone release in the patients with low cardiac output syndrome after open cardiac surgery.
Topics: Adolescent; Adult; Aldosterone; Cardiac Output, Low; Cardiac Surgical Procedures; Catecholamines; Do | 1979 |
Evaluation of patients for secondary hypertension.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Cushing Syndrome; Female; Humans; Hyp | 1979 |
Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
Topics: Adrenal Glands; Adult; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; Hyperaldosteroni | 1978 |
Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
Topics: Adolescent; Adult; Aldosterone; Aspirin; Bartter Syndrome; Blood Pressure; Child; Cyclooxygenase Inh | 1978 |
Bartter's syndrome--limelight on prostaglandins.
Topics: Aldosterone; Bartter Syndrome; Blood Pressure; Cyclooxygenase Inhibitors; Humans; Hyperaldosteronism | 1978 |
Value of the spironolactone test in the diagnosis of primary hyperaldosteronism.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Potassium; | 1979 |
[Disorder of the mineralocorticoid function of the adrenals in the acute period of myocardial infarct and the ways for its correction].
Topics: Acute Disease; Adrenal Gland Diseases; Adult; Aged; Aldosterone; Chronic Disease; Coronary Disease; | 1979 |
[Bartter's syndrome--a case study with special reference to the role of renal prostaglandins and the renin-angiotensin-aldosterone system].
Topics: Adult; Aldosterone; Bartter Syndrome; Humans; Hyperaldosteronism; Kidney; Male; Prostaglandins E; Re | 1979 |
[Clinical observation of primary aldosteronism].
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Potassium | 1979 |
Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin III; Blood Pressure; Humans; Hyperaldostero | 1979 |
[Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
Topics: Adult; Aldosterone; Bartter Syndrome; Depression, Chemical; Female; Humans; Hyperaldosteronism; Indo | 1979 |
The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Aldosteron | 1979 |
Hyperreninemia and hyperaldosteronism in sickle cell anemia.
Topics: Adolescent; Adult; Age Factors; Aldosterone; Anemia, Sickle Cell; Child; Diet; Diet, Sodium-Restrict | 1979 |
[Therapy of primary hyperaldosteronism].
Topics: Adrenalectomy; Aldosterone; Androgen Antagonists; Angiotensin II; Estrogen Antagonists; Female; Huma | 1979 |
Analysis of factors influencing the renin-aldosterone system in a patient with Bartter's syndrome.
Topics: Aldosterone; Bartter Syndrome; Body Weight; Humans; Hyperaldosteronism; Indomethacin; Male; Middle A | 1979 |
[Conn's disease with an edematous form of chronic glomerulonephritis].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Chronic Disease; Edema; Female; Glomerulonephritis; Hum | 1979 |
[Secondary hyperaldosteronism in patients with liver cirrhosis, frequently caused by therapy].
Topics: Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Diuretics; Glucuronates; Humans; Hyperaldoster | 1979 |
Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
Topics: Adenoma; Adult; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; Hyperaldosteronism; Hyp | 1979 |
Adrenocorticosteroids in experimental and human hypertension.
Topics: 18-Hydroxydesoxycorticosterone; Adrenal Cortex; Adrenal Cortex Hormones; Aldosterone; Animals; Biolo | 1979 |
[Role of secondary hyperaldosteronism in the pathomecanism of hydropic decompensation in the cirrhotic patient (author's transl)].
Topics: Adult; Aged; Aldosterone; Creatinine; Diuresis; Humans; Hyperaldosteronism; Liver Cirrhosis; Middle | 1979 |
[A simplified radioimmunoassay of serum aldosterone (author's transl)].
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male; Radioimmunoassay | 1979 |
Acute intermittent porphyria associated with inappropriate antidiuretic hormone secretion, hypokalemic alkalosis, and secondary hyperaldosteronism.
Topics: Acute Disease; Adult; Aldosterone; Alkalosis; Blood Urea Nitrogen; Female; Humans; Hyperaldosteronis | 1979 |
Reliability of screening methods for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Desoxycorticosterone; Female; | 1979 |
Prolactin in primary aldosteronism.
Topics: Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Prolactin | 1979 |
Hyperaldosteronism in the sodium-depleted rat: mechanism of aldosterone stimulation by peritoneal dialysis with glucose solution.
Topics: Aldosterone; Animals; Ascitic Fluid; Dexamethasone; Extracellular Space; Glucose; Hyperaldosteronism | 1979 |
Hyperaldosteronism in the sodium-depleted rat: mode of aldosterone-stimulating action of frusemide.
Topics: Adrenal Glands; Aldosterone; Animals; Dexamethasone; Furosemide; Hyperaldosteronism; Indomethacin; M | 1979 |
[Angiotensin (A) II and A III loading tests].
Topics: Aldosterone; Angiotensin II; Angiotensin III; Humans; Hyperaldosteronism | 1979 |
[DOCA loading test].
Topics: Aldosterone; Desoxycorticosterone; Humans; Hyperaldosteronism; Hypertension | 1979 |
[Dexamethasone suppression test].
Topics: Aldosterone; Dexamethasone; Humans; Hyperaldosteronism | 1979 |
[Determination of the aldosterone content of the adrenal vein blood].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Veins | 1979 |
Adrenal sensitivity to angiotensin II and undiscovered aldosterone stimulating factors in hypertension.
Topics: Adrenal Glands; Adult; Aldosterone; Dexamethasone; Female; Humans; Hyperaldosteronism; Hypertension; | 1979 |
[Plasma aldosterone and electrolytes in primary and secondard aldosteronism (author's transl)].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Ascites; Electrolytes; Female; Humans; Hypera | 1979 |
Some aspects of urinary kallikrein in a patient with Bartter's syndrome.
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Indomethacin; Iso | 1979 |
Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension.
Topics: 18-Hydroxycorticosterone; Aldosterone; Glucuronates; Humans; Hyperaldosteronism; Hypertension; Renal | 1979 |
The renin-angiotensin-aldosterone system in hypertension: its biochemistry and applications.
Topics: Adult; Age Factors; Aldosterone; Amino Acid Sequence; Angiotensin II; Angiotensins; Female; Humans; | 1979 |
[Blood aldosterone level under the effect of posture change in patients with primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hype | 1979 |
[Hints for the practitioner].
Topics: Adrenal Cortex; Adrenal Cortex Function Tests; Aldosterone; Androgens; Cushing Syndrome; Humans; Hyd | 1979 |
[Aldosterone in the blood of the adrenal vein in primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Aldosterone; Huma | 1979 |
[Effect of hypotensive therapy depending on the blood level of steroid hormones and their reaction to diuretics].
Topics: Adolescent; Adult; Aldosterone; Furosemide; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension | 1979 |
[Clinical and experimental studies of plasma and urinary aldosterone determination].
Topics: Adult; Aged; Aldosterone; Evaluation Studies as Topic; Female; Humans; Hyperaldosteronism; Hypertens | 1977 |
Diagnosis of secondary forms of hypertension. A comprehensive protocol.
Topics: Adolescent; Adult; Aged; Aldosterone; Blood Pressure; Catecholamines; Female; Furosemide; Humans; Hy | 1977 |
Radioimmunoassays of tetrahydroaldosterone (TH-aldo) in human urine.
Topics: Aldosterone; Antigens; Cross Reactions; Glucuronates; Humans; Hyperaldosteronism; Hypertension; Immu | 1978 |
Bartter's syndrome associated with Graves' disease and myasthenia gravis: report of a case.
Topics: Adult; Aldosterone; Angiotensin II; Azathioprine; Bartter Syndrome; Blood Pressure; Graves Disease; | 1978 |
[Radioimmunoassay of plasma aldosterone determination with 125I-aldosterone kit and its clinical application].
Topics: Adult; Aldosterone; Circadian Rhythm; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Radioim | 1977 |
Radiography of adrenal gland neoplasms.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Catecholamines; Diagnosis, Differential; Humans; Hydr | 1977 |
The problem was renal, the cause elusive.
Topics: Adult; Aldosterone; Bartter Syndrome; Humans; Hyperaldosteronism; Male; Potassium; Renin | 1977 |
[Aldosterone-Na-K interactions after operations with extracorporeal circulation].
Topics: Adult; Aldosterone; Cardiac Surgical Procedures; Extracorporeal Circulation; Humans; Hyperaldosteron | 1977 |
[A case of Bartter's syndrome with special referrence to the pathogenesis (author's transl)].
Topics: Adult; Aldosterone; Bartter Syndrome; Chronic Kidney Disease-Mineral and Bone Disorder; Electrolytes | 1977 |
[The significance of sodium intake in postoperative aldosteronism].
Topics: Aldosterone; Creatinine; Humans; Hydrocortisone; Hyperaldosteronism; Postoperative Complications; Po | 1977 |
The role of adrenal mineralocorticoids in hypertension.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplas | 1978 |
[A case report of primary adolsteronism caused by bilateral adrenal aldosteronomas (author's transl)].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hype | 1978 |
The pressor response to angiotensin II in patients with low renin essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Blood Urea Nitrogen; Humans; Hyperaldosteronism; | 1978 |
Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man.
Topics: 18-Hydroxydesoxycorticosterone; Adult; Aldosterone; Chromatography, Gel; Cushing Syndrome; Desoxycor | 1978 |
An approach to mineralocorticoid hormone hypertension.
Topics: Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Aldosterone; Cushing Syndrome; Desoxy | 1978 |
[Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
Topics: Aldosterone; Bartter Syndrome; Child; Electrolytes; Female; Humans; Hyperaldosteronism; Indomethacin | 1978 |
[The renin-angiotensin-aldosterone system and hypertensive syndromes].
Topics: Aldosterone; Angiotensins; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Renin | 1978 |
[Difficulties of clinical diagnosis of Conn's disease and topical diagnosis of aldosteromas].
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Aldosterone; Diagnosis, Differ | 1978 |
[Hemodialysis and metabolic disorders].
Topics: Aldosterone; Humans; Hyperaldosteronism; Lipid Metabolism; Metabolic Diseases; Potassium; Renal Dial | 1978 |
[The effect of cortisol infusion on plasma renin activity, aldosterone levels and 11-deoxycorticosterone levels in humans (author's transl)].
Topics: Adolescent; Adult; Aldosterone; Desoxycorticosterone; Female; Humans; Hydrocortisone; Hyperaldostero | 1978 |
[Microdetermination of corticosteroids in adrenocortical zones in various adrenal diseases (author's transl)].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Gland Neoplasms; A | 1978 |
Differentiation between subtypes of primary hyperaldosteronism by multiple steroid measurement after dexamethasone administration.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Aldosterone; Corticosterone; Desox | 1978 |
Aldosterone diagnosis in hypertension: comparative evaluation of radioimmunoassays for urinary aldosterone and 18-OH-corticosterone.
Topics: 18-Hydroxycorticosterone; 18-Hydroxydesoxycorticosterone; Aldosterone; Chromatography; Corticosteron | 1978 |
Chronic hypokalemic nephropathy: a clinical study.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Cathartics; Chlorides; Chronic Disease; Female; Humans; Hy | 1978 |
Primary aldosteronism, a review.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Male | 1979 |
Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, a state of secondary aldosteronism.
Topics: Adult; Aldosterone; Angiotensin II; Blood Glucose; Blood Volume; Diabetic Ketoacidosis; Female; Huma | 1975 |
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis.
Topics: Adolescent; Adult; Aldosterone; Bartter Syndrome; Blood Pressure; Female; Humans; Hyperaldosteronism | 1976 |
Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome.
Topics: Adolescent; Adult; Aged; Aldosterone; Bartter Syndrome; Cyclooxygenase Inhibitors; Female; Humans; H | 1976 |
[Renal tubular acidosis. Renin-aldosterone system in a case with pronounced hypokalemia].
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypokalemia; Renin | 1977 |
[Study of primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Patient Care Planning; Potassium; Renin | 1977 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1977.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aged; Aldosterone; Femal | 1977 |
Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis.
Topics: Adolescent; Adult; Aged; Aldosterone; Female; Furosemide; Humans; Hyperaldosteronism; Hypertension; | 1977 |
Diagnosis, localization, and treatment of primary aldosteronism.
Topics: Aldosterone; Antihypertensive Agents; Catheterization; Diagnosis, Differential; Humans; Hyperaldoste | 1977 |
Evaluation of patients for secondary hypertension.
Topics: Adolescent; Adult; Aged; Aldosterone; Female; Hospitalization; Humans; Hyperaldosteronism; Hypertens | 1977 |
The physiology of blood pressure regulation--normal and abnormal.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Cardiac Output; Child; Glomerular Filtration Rate; Hemo | 1977 |
[Radioimmunological determination of aldosterone in the serum. New method for the localization of aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Posture; Radioimmunoassay; Renin | 1977 |
Effects of dietary sodium and potassium intake and acute stimulation on aldosterone output by isolated human adrenal cells.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Corticosterone; Cosyntropin; Diet; Female; Humans; Hydr | 1977 |
[Catamnestic and endocrinological investigations in women with idiopathic edema (author's transl)].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aldosterone; Blood Proteins; Body Weight; Child; Contrac | 1977 |
Aids in the diagnosis of hypertension.
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Diuretics; Humans; Hyperaldosteronism; Hyperte | 1977 |
[Physiopathological and functional semeiologic considerations in a case of primary normoaldosteronemic hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Humans; Hyperaldosteronism; Male; Midd | 1977 |
Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Canrenone; Female; Glucuronates; Humans; Hyperaldoste | 1977 |
The pathogenesis of Bartter's syndrome. Functional and histologic studies.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Diuresis; Humans; Hyperaldosteronism; Hypotoni | 1977 |
Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Child; Female; Humans; Hyperaldosteronism; Indomethac | 1977 |
[The renin-angiotensin-aldosterone system in hypertensive patients. II. Diagnosis of primary hyperaldosteronism].
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Adult; Aldosterone; Blo | 1977 |
[A simple method measuring plasma aldosterone by radioimmunoassay without extraction (author's transl)].
Topics: Addison Disease; Aldosterone; Cushing Syndrome; Humans; Hyperaldosteronism; Radioimmunoassay | 1977 |
[The renin-aldosterone system in essential hypertension--aging, low renin hypertension and the relation between renin secretion and aldosterone secretion--].
Topics: Adult; Aged; Aging; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Middle Aged; Renin | 1977 |
Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
Topics: Adult; Aldosterone; Bartter Syndrome; Humans; Hyperaldosteronism; Indomethacin; Male; Potassium; Pro | 1977 |
Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Female; Humans; Hyperaldostero | 1977 |
[The renin-angiotensin-aldosterone system].
Topics: Aldosterone; Angiotensin II; Diuretics; Humans; Hyperaldosteronism; Hypokalemia; Polyuria; Renin | 1977 |
Evidence against prolactin stimulation of aldosterone in normal human subjects and patients with primary aldosteronism, including a patient with primary aldosteronism and a prolactin-producing pituitary microadenoma.
Topics: Adenoma; Adrenal Cortex Diseases; Adult; Aldosterone; Circadian Rhythm; Female; Humans; Hydrocortiso | 1977 |
[Value and limitations of indomethacin in the treatment of Bartter's syndrome].
Topics: Adult; Aldosterone; Angiotensins; Bartter Syndrome; Body Weight; Capillary Permeability; Female; Hum | 1977 |
[Bartter's syndrome. Primary renal hyperprostaglandinism].
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Kidney; Pr | 1977 |
Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; | 1977 |
[Increased renal prostaglandin E2 secretion in Bartter's syndrome].
Topics: Aldosterone; Bartter Syndrome; Humans; Hyperaldosteronism; Indomethacin; Kidney; Male; Middle Aged; | 1977 |
[Simple determination of urinary aldosterone without chromatography].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Radioimmunoassay | 1976 |
Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
Topics: Adult; Aldosterone; Circadian Rhythm; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Midd | 1976 |
[Radioimmune method for determination of aldosterone in urine].
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Radioimmunoassay | 1976 |
Proceedings: Adrenal venous aldosterone and cortisol concentrations in primary hyperaldosteronism.
Topics: Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism | 1976 |
[Unrecognized Conn's disease].
Topics: Adenoma; Adrenal Glands; Aldosterone; Diagnostic Errors; Female; Humans; Hyperaldosteronism; Hypokal | 1976 |
[Recent progress concerning the pathogenesis of arterial hypertension].
Topics: Affective Symptoms; Aldosterone; Blood Pressure; Elasticity; Heart Rate; Humans; Hyperaldosteronism; | 1976 |
[The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Diuresis; Female; Heart Rate; | 1976 |
Blood pressure fall by angiotensin II antagonist in patients with Bartter's syndrome.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Child; Humans; Hydrocortisone; | 1976 |
Medical aspects of adrenal surgery.
Topics: Adenoma; Adrenal Cortex Diseases; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Angiotensin I | 1976 |
[Diagnosis of primary hyperaldosteronism. Diagnostic means for hospital and private practice].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aldosterone; Family Practice; Female; Hosp | 1976 |
Bartter's syndrome: a metabolic study.
Topics: Adult; Aldosterone; Bartter Syndrome; Chlorine; Female; Humans; Hyperaldosteronism; Potassium; Renin | 1976 |
A perspective on aldosterone abnormalities.
Topics: Addison Disease; Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Hy | 1976 |
The dexamethasone-modified adrenal scintiscan in hyporeninemic aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal venous aldosterone.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; D | 1976 |
The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Cushing Syndrome; Female; Humans; Hyperaldosteronism; H | 1976 |
A system for the determination of mineralocorticoid activity by electrical potential difference measurements.
Topics: Aldosterone; Anal Canal; Electrophysiology; Hyperaldosteronism; Membrane Potentials; Mineralocortico | 1976 |
On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Flow Velocity; Blood Pressure; Blood Ure | 1976 |
Effect of sodium restriction and angiotensin II infusion in Bartter's syndrome.
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Child; Diet, Sodium-Restricted; Humans; Hyperaldoster | 1976 |
A direct radioimmunoassay for free aldosterone in urine without extraction and chromatography.
Topics: Addison Disease; Adult; Aldosterone; Humans; Hyperaldosteronism; Radioimmunoassay; Reference Values | 1976 |
[Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
Topics: Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Diazoxide; Humans; Hyperaldosteronism; Hyperte | 1976 |
[Physiopathology of arterial hypertension. Role of the nervous system and of the hormones].
Topics: Aldosterone; Animals; Bradykinin; Brain; Catecholamines; Hormones; Humans; Hyperaldosteronism; Hyper | 1976 |
Simplified radioimmunoassay for aldosterone using antisera to aldosterone-gamma-lactone.
Topics: Aldosterone; Antibodies; Cross Reactions; Humans; Hyperaldosteronism; Immune Sera; Lactones; Posture | 1976 |
[Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
Topics: Action Potentials; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; | 1976 |
Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Topics: Acidosis, Renal Tubular; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Pressure; Cushing Synd | 1976 |
The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Diet; Humans; Hyperaldosteronism; Hypertension; Kidney | 1976 |
[Hyperaldosteronism in acute viral hepatitis, liver cirrhosis and fulminating liver failure].
Topics: Aldosterone; Angiotensin II; Angiotensinogen; Corticosterone; Hepatic Encephalopathy; Hepatitis; Hum | 1976 |
[Neoplasms of the zona glomerulosa of the adrenal cortex].
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adult; Aldosterone; | 1976 |
[Enflurance anesthesia in primary aldosteronism, with special reference to its effects on serum aldosterone levels].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Anesthesia, Endotracheal; Enflurane; Female; | 1976 |
[Comparative study of diagnosis for location of adrenal adenoma in patients with primary aldosteronism (author's transl)].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Child; Female; Humans; Hyperal | 1976 |
Adrenal venography and sampling in the diagnosis and treatment of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hydrocortisone; Hyperaldoster | 1976 |
Outpatient screening tests for primary aldosteronism.
Topics: Adolescent; Adult; Aged; Aldosterone; Fludrocortisone; Humans; Hyperaldosteronism; Hypertension; Mid | 1976 |
Aldosterone excretion rate in normal subjects and hypertensive patients.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Sodium | 1976 |
Renin and hypertension.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Diuretics; Hyperaldosteronism; Hypertension; Juxtaglome | 1975 |
Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man.
Topics: Adult; Aldosterone; Circadian Rhythm; Contraceptives, Oral; Dexamethasone; Diet, Sodium-Restricted; | 1975 |
Hypertension corrected by discontinuing chronic sodium bicarbonate ingestion. Subsequent transient hypoaldosteronism.
Topics: 17-Hydroxycorticosteroids; Aldosterone; Angiotensin II; Antihypertensive Agents; Bicarbonates; Calci | 1975 |
Workup of the newly discovered hypertensive patient.
Topics: Adult; Aldosterone; Angiotensin II; Cardiac Output; Cerebrovascular Disorders; Contraceptives, Oral; | 1975 |
[Edematous hepatitis: a special form of acute virus hepatitis with secondary aldosteronism (author's transl)].
Topics: Adult; Aldosterone; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Edema; Female; | 1975 |
Renin-secreting renal tumour with severe hypertension. case report with tumour renin analysis, histopathological and ultrastructural studies.
Topics: Adult; Aldosterone; Cytoplasmic Granules; Endoplasmic Reticulum; Humans; Hyperaldosteronism; Hyperte | 1975 |
Editorial: Low renin "essential'' hypertension; a variant of classic primary aldosteronism?
Topics: Adrenal Cortex; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 1975 |
Lithium-responsive hyperaldosteronism in manic patients.
Topics: Aldosterone; Behavior; Bipolar Disorder; Female; Humans; Hyperaldosteronism; Lithium; Liver Function | 1975 |
Effect of acute volume depletion on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive subjects.
Topics: Acute Disease; Adolescent; Adult; Aldosterone; Blood Pressure; Body Fluids; Electrolytes; Female; Fu | 1975 |
Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; Hyperaldosteronism; | 1975 |
[Bartter's disease associated with hypercorticism, phosphate and magnesium deficiencies and familial renal tubular disease].
Topics: Adrenocortical Hyperfunction; Albuminuria; Aldosterone; Bartter Syndrome; Child; Humans; Hyperaldost | 1975 |
Bartter's syndrome. New insights into pathogenesis and treatment.
Topics: Adult; Aldosterone; Angiotensin II; Bartter Syndrome; Blood Volume; Female; Humans; Hyperaldosteroni | 1975 |
[Reliability and advantages of serum aldosterone RIA by sephadex LH-20 reversed-phase partition chromatography].
Topics: Adult; Aldosterone; Child; Child, Preschool; Chromatography, Gel; Female; Humans; Hyperaldosteronism | 1975 |
Extensive hypertensive work-up: pro.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Antihypertensive Agents; Attitude to Health; Epidemiolo | 1975 |
Adrenal potassium and sodium in experimental hyper- and hypoaldosteronism in the rat. Determination by electron probe x-ray microanalysis.
Topics: Adrenal Glands; Aldosterone; Animals; Corticosterone; Electron Probe Microanalysis; Hyperaldosteroni | 1975 |
Response of plasma aldosterone to fludrocortisone in primary hyperaldosteronism and other forms of hypertension.
Topics: Adenocarcinoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adult; Aldosterone; Desoxycorticost | 1975 |
Location of aldosterone-producing adenomas by the determination of plasma aldosterone in adrenal vein or renal vein blood.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Catheterization | 1975 |
Selection of patients and operative approach in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; | 1975 |
Regulation of aldosterone secretion in primary aldosteronism.
Topics: Adenoma; Aldosterone; Circadian Rhythm; Dexamethasone; Humans; Hydrocortisone; Hyperaldosteronism; P | 1975 |
[Na+/K+--quotient in the urine].
Topics: Aldosterone; Diuretics; Humans; Hyperaldosteronism; Potassium; Sodium | 1975 |
Aldosteronoma in a child with localization by adrenal vein aldosterone: collective review of the literature.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Catheterization; Child; Humans; Hyperaldosteronism; Male | 1975 |
[Proceedings: Normal values and samples of findings in diseases of the hypophysis and the adrenal cortex].
Topics: Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Hyperplasia, Cong | 1975 |
Radioimmunoassay for aldosterone in plasma without chromatography.
Topics: Addison Disease; Adsorption; Adult; Aldosterone; Cross Reactions; Humans; Hyperaldosteronism; Immune | 1975 |
[Primary aldosteronism: diagnosis, laterality and regulation of hormone secretion].
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, Differential; Female; Functional Laterali | 1975 |
Water, sodium, potassium, and electrolyte balance.
Topics: Aged; Aldosterone; Child, Preschool; Diet; Diet, Sodium-Restricted; Humans; Hyperaldosteronism; Hype | 1975 |
[Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function].
Topics: Adolescent; Adult; Aldosterone; Diazoxide; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases | 1975 |
[Aldosterone secretion in primary aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1975 |
[Renin and aldosterone].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Juxtaglomerular Apparatus; Li | 1975 |
[Aldosterone].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Potassium; Renin | 1975 |
Stimulated renin: a screening test for hypertension.
Topics: Adult; Aged; Aldosterone; Diagnosis, Differential; Evaluation Studies as Topic; Female; Furosemide; | 1975 |
[Plasma renin activity, plasma aldosterone and electrolyte balance in the postoperative period (author's transl)].
Topics: Adrenal Glands; Adult; Aldosterone; Anesthetics; Humans; Hyperaldosteronism; Kidney; Middle Aged; Po | 1975 |
[Physiopathology and clinical aspects of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Proteinuri | 1975 |
Location of aldosterone-producing adenomas with 131I-19-iodocholesterol.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Cholesterol; Humans; Hyperaldosteronism; Hypertension | 1976 |
Editorial: Solving the adrenal lesion(s) of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Cholesterol; Humans; Hyperaldosteronism; Hypertension | 1976 |
[Metabolic alkalosis and secondary hyperaldosteronism in cystic fibrosis (author's transl)].
Topics: Aldosterone; Alkalosis; Cystic Fibrosis; Diarrhea; Diet, Sodium-Restricted; Electrolytes; Humans; Hy | 1976 |
[Diurnal variation in the urinary excretion of vanilmandelic acid and aldosterone in normal and hypertensive persons (author's transl)].
Topics: Adult; Aldosterone; Circadian Rhythm; Creatinine; Female; Humans; Hyperaldosteronism; Hypertension; | 1976 |
[Primary aldosteronism].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Aldosterone; Antihyp | 1976 |
Enflurane anaesthesia for removal of aldosterone producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Anesthesia, Inhalation; Blood Pressure; Enflur | 1976 |
Urine aldosterone radioimmunoassay: validation of a method without chromatography.
Topics: Adrenal Gland Diseases; Aldosterone; Chromatography, Paper; Cushing Syndrome; Humans; Hyperaldostero | 1976 |
[Liddle syndrome (or pseudo-hyperaldosteronism). Long-term development and erythrocyte potassium flow study in 4 cases].
Topics: Aldosterone; Alkalosis; Cell Membrane Permeability; Child; Child, Preschool; Erythrocyte Membrane; F | 1992 |
[Diagnosis and treatment of primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperkalem | 1992 |
Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aged; Aldosterone; Fe | 1992 |
[Diagnosis and therapy of hypercorticism].
Topics: 17-Hydroxycorticosteroids; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aldosterone | 1992 |
[Idiopathic hyperaldosteronism and the related dexamethasone suppressive hyperaldosteronism].
Topics: Adrenocorticotropic Hormone; Aldosterone; Dexamethasone; Humans; Hyperaldosteronism; Renin-Angiotens | 1992 |
A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism.
Topics: Aged; Aldosterone; Female; Heparin, Low-Molecular-Weight; Humans; Hyperaldosteronism; Male; Middle A | 1992 |
Renal potassium wasting in distal renal tubular acidosis: role of aldosterone.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Ammonium Chloride; Bicarbonates; Blood Gas Analysis; Fe | 1992 |
[The behavior of serum angiotensin-converting enzyme in normotensive subjects, in subjects with essential hypertension and in subjects with primary hyperaldosteronism on the orthostatic test].
Topics: Adult; Aldosterone; Bed Rest; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; P | 1992 |
[Primary hyperaldosteronism suppressed after glucocorticoid administration].
Topics: Adolescent; Aldosterone; Delayed-Action Preparations; Dexamethasone; Female; Humans; Hyperaldosteron | 1992 |
Primary aldosteronism: hypertension with a genetic basis.
Topics: Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; Hypertension | 1992 |
Altered primary haemostasis in Conn's syndrome.
Topics: Adult; Aldosterone; beta-Thromboglobulin; Blood Coagulation Disorders; Blood Pressure; Female; Hemos | 1992 |
Usefulness of atrial natriuretic peptide assay in primary aldosteronism.
Topics: Adenoma; Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Diagnosis, Differential; Female; Human | 1992 |
[Functional state of the adrenals in various forms of arterial hypertension].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Aldosterone; Cushing Syndrome; Huma | 1992 |
[Primary hemostasis studies in Conn syndrome].
Topics: Adult; Aldosterone; Blood Coagulation; Blood Pressure; Female; Hemostasis; Humans; Hyperaldosteronis | 1992 |
Aldosterone-producing adrenal adenoma in children.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Child; Female; Humans; Hyperaldosteronism | 1992 |
High-performance liquid chromatographic determination of 3 alpha,5 beta-tetrahydroaldosterone in human urine with chemiluminescence detection.
Topics: Aldosterone; Chromatography, High Pressure Liquid; Glyoxal; Humans; Hydrogen Peroxide; Hyperaldoster | 1992 |
Ultrasonography in the diagnosis of aldosterone-producing adenoma: is it useful?
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Evaluation Studies as Topic; Female; Humans; Hyperald | 1992 |
Concurrence of primary aldosteronism and renal artery stenosis.
Topics: Adrenal Cortex; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Renal Arte | 1992 |
Importance of atrial natriuretic hormone in an exaggerated natriuresis during acute sodium load in primary aldosteronism.
Topics: Aldosterone; Atrial Natriuretic Factor; Dopamine; Glomerular Filtration Rate; Humans; Hyperaldostero | 1992 |
[Aldosterone receptor and action mechanism of the protector, 11beta-HSD, and glycyrrhizin].
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Cortisone; Glycyrrhetinic Acid; Glycyrrhizic Aci | 1992 |
[Study on uric acid metabolism in patients with primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteron | 1992 |
Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adult; Aldosterone; Endothelins; Female; Humans; H | 1992 |
Determination of urinary 18-hydroxycortisol in the diagnosis of primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Diagnosis, | 1992 |
Secondary aldosteronism documented by plasma renin and aldosterone circadian rhythm in subjects with kidney or heart transplantation.
Topics: Adult; Aldosterone; Circadian Rhythm; Cyclosporine; Female; Heart Transplantation; Humans; Hydrocort | 1992 |
Cytosolic free calcium concentration in platelets in patients with renovascular hypertension and primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Aminoquinolines; Blood Platelets; Calcium; Cytosol; Female; Fluorescence; | 1992 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1992. A 52-year-old man with hypertension, hypokalemia, and an adrenal mass.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemi | 1992 |
A case of pseudoaldosteronism induced by glycyrrhizin.
Topics: Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Glycyrrhetinic Acid; Glycyrrh | 1992 |
Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Captopril; Evaluation Studies as Topic; Female; Humans; Hyperaldosteronism | 1992 |
Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Female; Humans | 1992 |
[Does the captopril test improve the diagnosis of primary hyperaldosteronism?].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure; Captopril; Diagnosis, Differen | 1992 |
Diagnostic approach to patients with primary hyperaldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertens | 1991 |
Does a digoxin-like substance participate in vascular and pressure control during dietary sodium changes in patients with primary aldosteronism?
Topics: Aldosterone; Blood Pressure; Blood Proteins; Cardenolides; Digoxin; Electrolytes; Forearm; Hematocri | 1991 |
The origin and significance of 18-hydroxycortisol: studies in hyperaldosteronism and in bovine adrenocortical cells in vitro.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; A | 1991 |
An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; Furosemide; Human | 1991 |
[Panarteritis nodosa with secondary hyperaldosteronism involving renal arterioles].
Topics: Aldosterone; Arterioles; Biopsy, Needle; Child; Female; Fluorescent Antibody Technique; Humans; Hype | 1991 |
Basal and ACTH-stimulated cortisol and aldosterone release from adrenocortical adenomas in vitro.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Aged; Aldoste | 1991 |
Renin gene expression in the adrenal and kidney of patients with primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Carcinoma, Renal Cell; Gene Ex | 1992 |
Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Aldosteron | 1992 |
A neonate with idiopathic hyperaldosteronism.
Topics: Aldosterone; Calcium; Gastrointestinal Diseases; Humans; Hyperaldosteronism; Hypokalemia; Infant, Ne | 1991 |
Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Angiotensin II; Captopri | 1991 |
Aldosterone-secreting adenoma and dysautonomic failure: the challenging association of 2 extreme conditions.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Autonomic Nervous System Diseases; Chronic Disease; H | 1991 |
[Primary normotensive hyperaldosteronism: a silent form of Conn's syndrome].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperaldosteronism; Middle Aged; Synd | 1991 |
[Aldosteroma (Conn's syndrome)].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aldosterone; Diagnosis, Differential; Fema | 1991 |
Primary aldosteronism: implications of a new familial variety.
Topics: Adult; Aldosterone; Dexamethasone; Female; Fludrocortisone; Humans; Hyperaldosteronism; Male; Middle | 1991 |
Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism.
Topics: Aldosterone; Captopril; Humans; Hyperaldosteronism; Infusions, Parenteral; Potassium | 1991 |
Expression of cytochrome P-450 mRNAs in steroidogenesis of adrenocortical adenomas from patients with primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Aldosterone; Blotting, Northern; Cytochrome P-450 En | 1991 |
[Macronodule associated with bilateral adrenal hyperplasia. A rare misleading cause of primary aldosteronism (two cases)].
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Al | 1991 |
[Establishment of human adrenal gland and aldosterone-producing adenoma culture and the effect of alpha-human atrial natriuretic factor on aldosterone secretion in vitro].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aldosterone; Atrial Natriuretic Factor; Cu | 1991 |
Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Furosemide; Humans; Hyperaldosteronism; Hypertension; | 1991 |
Glucocorticoid-suppressible hyperaldosteronism: a paradigm of arrested adrenal zonation?
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Animals; Glucocorticoids; Humans; Hyperald | 1991 |
Contribution of the activation of the ras oncogene to the evolution of aldosterone- and renin-secreting tumors.
Topics: Adenoma; Adult; Aldosterone; Carcinoma, Hepatocellular; DNA, Neoplasm; Female; Gene Expression Regul | 1991 |
Primary hyperaldosteronism in England and Wales: a review of the use of a Supraregional Assay Service laboratory for the measurement of aldosterone and plasma renin activity.
Topics: Adenoma; Adrenal Hyperplasia, Congenital; Aldosterone; Clinical Laboratory Techniques; Electrolytes; | 1991 |
[Abnormal production of adrenal gland hormones--special reference to mineralocorticoids].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Calcium Channel Blockers; Dexameth | 1991 |
A new diagnostic test for primary aldosteronism.
Topics: Adenoma; Adult; Aldosterone; Blood Pressure; Diagnosis, Differential; Female; Humans; Hydrocortisone | 1991 |
A simulation study on renin and aldosterone secretions in primary aldosteronism.
Topics: Aldosterone; Computer Simulation; Humans; Hyperaldosteronism; Potassium; Renin; Sodium | 1990 |
Modulation of the renin-aldosterone system by iodotyrosines as tyrosine hydroxylase inhibitors.
Topics: Adult; Aldosterone; Diiodotyrosine; Dopamine; Humans; Hyperaldosteronism; Hypokalemia; Male; Monoiod | 1990 |
[Circadian rhythm of the renin-angiotensin-aldosterone system in the normal state and in pathology].
Topics: Aldosterone; Angiotensin III; Circadian Rhythm; Humans; Hyperaldosteronism; Hypertension; Reference | 1990 |
Pseudohyperaldosteronism from liquorice-containing laxatives.
Topics: Adult; Aged; Aldosterone; Cathartics; Drug Combinations; Female; Glycyrrhiza; Humans; Hyperaldostero | 1990 |
Long-term medical management of aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Benzothiadiazines; Combined Modality Therapy; Diureti | 1990 |
Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism.
Topics: Adult; Aldosterone; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Female; | 1990 |
[Effects of alpha-human ANF and angiotensin II on aldosterone secretion in vitro from cultured human adrenal tissues and APA tissues].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Culture Te | 1990 |
New aspects of mineralocorticoid hypertension.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Glands; Aldosterone; Atrial Natri | 1990 |
Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.
Topics: Adolescent; Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aldosterone; Child; Depression, Chem | 1990 |
Some aldosterone-producing adrenal tumours also secrete cortisol, but present clinically as primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Carcinoma; Dexamethasone | 1990 |
[Diagnosis of adrenal gland tumors].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Androsterone; Cushing Syndrome; Diagnosis, Differenti | 1990 |
Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; beta-Endorphin; C | 1990 |
Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
Topics: Adenoma; Administration, Oral; Adrenal Gland Neoplasms; Adult; Aldosterone; Corticosterone; Desoxyco | 1990 |
Bartter's syndrome associated with indirect hyperbilirubinemia: a possible clinical variety.
Topics: Adult; Aldosterone; Bartter Syndrome; Chlorides; Female; Humans; Hydrocortisone; Hyperaldosteronism; | 1990 |
[Significance of the captopril test in the diagnosis of primary hyperaldosteronism --apropos of 4 clinical cases].
Topics: Adult; Aged; Aldosterone; Captopril; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Renin | 1990 |
[Plasma mineralocorticoids--aldosterone and desoxycorticosterone-- in patients with"low-renin"arterial hypertension].
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Atrophy; Desoxycorticosterone; Humans; Hypera | 1990 |
Conn's syndrome with rhabdomyolysis mimicking deep vein thrombophlebitis.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hype | 1990 |
Primary aldosteronism. Study of twenty-six operated cases.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Female; Foll | 1990 |
Autonomous aldosterone-secreting ovarian tumor.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension, Malignant; Ovarian Neoplasms; | 1990 |
Localization of aldosterone-producing adenoma: venous sampling in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hydrocortisone | 1990 |
[Effects of surgical treatment on circadian variations of arterial pressure in patients with primary aldosteronism and renovascular hypertension].
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Blood Pressure; Blood Pressure Determin | 1990 |
Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity.
Topics: Adenoma; Adosterol; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Cholesterol; Dexame | 1990 |
Association of hypokalemia, aldosteronism, and renal cysts.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Chronic Disease; Female; Humans; Hyperaldoster | 1990 |
The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Atrial Natriuretic Facto | 1989 |
Levels of atrial natriuretic peptide are not always consistent with atrial pressure: is there alternative regulation as evidenced in Gordon's and Bartter's syndromes?
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Atrial Natriuretic | 1989 |
Lack of aldosterone inhibition by atrial natriuretic factor in primary aldosteronism: in vitro studies.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Atrial N | 1989 |
Dexamethasone-suppressible hyperaldosteronism: a large new kindred.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Blood Pressure; Child; Dexamethasone; F | 1989 |
Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aldosterone; Blood Pressure; Dexamethasone; Humans; Hyp | 1989 |
Cardiovascular, renal and endocrine effects of alpha-human atrial natriuretic peptide in patients with Cushing's syndrome and primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cushing Syndrome; Cyclic GMP; Female; | 1989 |
Possible hyperaldosteronism and discrepancy in enzyme activity deficiency in adrenal and gonadal glands in Japanese patients with 17 alpha-hydroxylase deficiency.
Topics: Adolescent; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Ald | 1989 |
Idiopathic aldosteronism masquerading as discrete aldosterone-secreting adrenal cortical neoplasms among patients with primary aldosteronism.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aldosterone; Blood Pressure; Diagnos | 1989 |
[Crisis of arterial hypertension in patients with primary aldosteronism].
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adult; Aldosterone; | 1989 |
[Clinical significance of aldosterone analysis in endocrine tests of the adrenal cortex].
Topics: Addison Disease; Adolescent; Adrenal Cortex Function Tests; Adult; Age Factors; Aged; Aldosterone; C | 1989 |
[Changes in aldosterone and cortisol secretion and serum thyroxine levels in patients with active urolithiasis].
Topics: Adrenal Cortex; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Hyperthyroxi | 1989 |
Plasma aldosterone level in a female case of pseudohyperaldosteronism (Liddle's syndrome).
Topics: Adult; Aldosterone; Blood Pressure; Dexamethasone; Diagnosis, Differential; Female; Humans; Hyperald | 1989 |
Renin-positive granulated Goormaghtigh cells. Immunohistochemical and electron-microscopic studies on biopsies from patients with pseudo-Bartter syndrome.
Topics: Adult; Aldosterone; Bartter Syndrome; Biopsy; Electrolytes; Female; Glomerular Mesangium; Humans; Hy | 1989 |
The pathogenesis of pseudohyperaldosteronism from carbenoxolone.
Topics: Adult; Aldosterone; Body Weight; Carbenoxolone; Cytosol; Electrolytes; Glycyrrhetinic Acid; Humans; | 1989 |
[Effect of isolated ultrafiltration on plasma hormone levels in patients with heart failure resistant to drug therapy].
Topics: Adult; Aged; Aldosterone; Drug Resistance; Female; Heart Failure; Hemofiltration; Humans; Hyperaldos | 1989 |
[Primary hyperaldosteronism without arterial hypertension].
Topics: 18-Hydroxycorticosterone; Acidosis, Renal Tubular; Adenoma; Adrenal Gland Neoplasms; Adult; Aldoster | 1989 |
Effect of single-administration captopril on plasma and urinary vasopressin in normotensive subjects and patients with essential hypertension and primary aldosteronism.
Topics: Adult; Aldosterone; Arginine Vasopressin; Captopril; Depression, Chemical; Female; Humans; Hyperaldo | 1989 |
Possible association of aldosterone producing adenoma and non-functioning adrenal tumor.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hydr | 1989 |
Unexpected incidence of low blood pressure 2 years after unilateral adrenalectomy for primary aldosteronism.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressur | 1989 |
Immunohistochemical demonstration of cholesterol side-chain cleavage cytochrome P-450 in bovine and human adrenals.
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Aldosterone; Animals; Cattle; Cus | 1989 |
[Clinico-morphologic characteristics of 2 tumor forms of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hyperpla | 1989 |
Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Dexamet | 1987 |
Effects of corticotropin-releasing factor (CRF) on aldosterone and 18-hydroxycorticosterone in essential hypertension and primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Corticosterone; Cor | 1987 |
In vitro studies in primary aldosteronism: baseline steroid production and aldosterone responses to ACTH and angiotensin II.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angioten | 1988 |
Effect of naloxone on the adrenal cortex in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Dexameth | 1988 |
[Primary aldosteronism with the typical circadian rhythm of blood pressure].
Topics: Adrenocorticotropic Hormone; Aldosterone; Blood Pressure; Cardiac Output; Circadian Rhythm; Humans; | 1988 |
Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
Topics: Adolescent; Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Animals; Child; D | 1988 |
Differential redistribution of protein kinase C in human aldosteronoma cells and adjacent adrenal cells stimulated with ACTH and angiotensin II.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Enzyme Activation; Humans; | 1988 |
Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension.
Topics: Adrenal Gland Neoplasms; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Hormone | 1988 |
Adrenal transitional zone steroids, 18-oxo and 18-hydroxycortisol, useful in the diagnosis of primary aldosteronism, are ACTH-dependent.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Chromatogra | 1988 |
Somatostatin suppresses plasma aldosterone concentration in a case of Bartter's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Bartter Syndrome; Female; Humans; Hyperaldosteronis | 1987 |
Studies on the secretion, metabolism and action of atrial natriuretic peptide in man.
Topics: Aldosterone; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cardiac Pacing, Artificial; Chromatogr | 1986 |
Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Desoxycorticosterone; Humans; Hydroco | 1987 |
Effect of alpha-human atrial natriuretic peptide in low renin essential hypertension and primary aldosteronism.
Topics: Adolescent; Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Diuresis; Humans; H | 1987 |
Alpha-h-ANP injection in normals, low renin hypertension and primary aldosteronism.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Diuresis; Heart Rate; Humans; Hydroco | 1987 |
Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adult; Aldosterone; Angiotensin II; Atrial Natriureti | 1987 |
Sodium excretion and atrial natriuretic peptide levels during mineralocorticoid administration. A mechanism for the escape from hyperaldosteronism.
Topics: Adult; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Glomerular Filtration Rate; Hum | 1987 |
Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Blood Volume; Cardiomegaly; Echocardiography; Female; Humans; Hy | 1988 |
Plasma atrial natriuretic peptide (ANP) in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Atrial Natriuretic Factor; Fem | 1988 |
Regression of electrocardiographic left ventricular hypertrophy following treatment of primary hyperaldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Cardiomegaly; Electrocardiography; Humans; Hyperaldosteronism; M | 1988 |
Plasma beta-endorphin levels in primary aldosteronism.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Age | 1985 |
[Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Hyperte | 1985 |
Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pres | 1985 |
Responses of patients with Bartter's syndrome to angiotensin III and angiotensin II-(3-8)-hexapeptide.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Angiotensin III; Arteries; Arterioles; Bartter Syndr | 1985 |
A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Dexamethasone | 1985 |
[Hormone levels of the blood of the adrenal veins and inferior vena cava in patients with adrenal and kidney diseases].
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Cushing Syndrome; | 1985 |
Mineralocorticoid and glucocorticoid receptors in circulating mononuclear leukocytes of patients with primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Dexamethasone; Humans; Hyperaldostero | 1985 |
Idiopathic hyperaldosteronism in a dog.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Dog Diseases; Dogs; Humans; Hydro | 1985 |
Central serotonergic stimulation of aldosterone secretion.
Topics: 5-Hydroxytryptophan; Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; | 1985 |
Factors affecting the secretion of 18-hydroxycortisol, a novel steroid of relevance to Conn's syndrome.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Circadian Rhythm; Dexameth | 1985 |
[Round-table conference "Biochemical diagnosis of arterial hypertension"].
Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Catechol | 1985 |
Glucocorticoid-suppressible hyperaldosteronism. Ultrastructural observation of a case.
Topics: Adrenal Cortex; Aldosterone; Dexamethasone; Endoplasmic Reticulum; Female; Humans; Hyperaldosteronis | 1985 |
[Morphological characteristics of aldosteronoma].
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Inclusion | 1985 |
The determination of mineralocorticoid receptors in human mononuclear leukocytes from patients with mineralocorticoid excess: physiological and pathological implications.
Topics: Adult; Aldosterone; Binding Sites; Humans; Hyperaldosteronism; Infant; Kidney; Leukocytes; Middle Ag | 1986 |
Long-term treatment of idiopathic hyperaldosteronism using trilostane.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Dihydrotestosterone; Female; Humans; Hydrocortisone | 1986 |
Adrenocortical adenoma with primary aldosteronism in culture.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; Cells, Cultured; | 1986 |
[Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Diuretics; Dopamine; Female; Humans; Hyperaldostero | 1987 |
Aldosterone receptors in different types of primary hyperaldosteronism.
Topics: Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Leukocytes; Male; Middle Aged; Recepto | 1987 |
Single oral administration of captopril may not bring an improvement in screening of primary aldosteronism.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diet; Humans; Hyperaldosteronism; | 1987 |
[Diurnal variation and responses of corticoids to dexamethasone and ACTH before and after adrenal surgery in primary aldosteronism].
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aldoster | 1987 |
The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Calcium Channel Blockers; Dihydropyridines; Hu | 1988 |
[Radioimmunoassay of aldosterone in saliva and its preliminary clinical use].
Topics: Adrenal Cortex Neoplasms; Adult; Aldosterone; Circadian Rhythm; Female; Humans; Hyperaldosteronism; | 1986 |
[Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism].
Topics: Aldosterone; Angiotensin II; Captopril; Female; Humans; Hyperaldosteronism; Male; Posture; Renin | 1987 |
Effects of heparin-induced aldosterone deficiency on renal function in patients with chronic glomerulonephritis.
Topics: Aldosterone; Blood Pressure; Glomerular Filtration Rate; Glomerulonephritis; Heparin; Humans; Hypera | 1987 |
[Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?].
Topics: Adult; Aldosterone; Blood Pressure; Heart Rate; Humans; Hyperaldosteronism; Hypertension; Hypertensi | 1988 |
[Malignant adrenal cortex carcinoma revealed by an isolated picture of primary hyperaldosteronism].
Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Neoplasms; Adult; Aldosterone; Calcinosis; Female; Human | 1988 |
Numerous mast cells in an 11-deoxycorticosterone-producing adrenocortical tumor. Histologic evaluation of benignancy and comparison with mast cell distribution in adrenal glands and neoplastic counterparts of 67 surgical specimens.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aldosterone; Carcinoma, Renal Cell; Dehydroepiandro | 1985 |
[Value of diagnostic localization in primary aldosteronism with venous catheterization].
Topics: Adrenal Glands; Adult; Aldosterone; Catheterization, Peripheral; Diagnosis, Differential; Female; Hu | 1988 |
[Idiopathic primary hyperaldosteronism: a study apropos of a case].
Topics: Adrenal Glands; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hyp | 1988 |
A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Dexamethasone; Female; Glucoco | 1988 |
Urinary excretion of aldosterone metabolite Kelly-M1 in patients with adrenal dysfunction.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Aldosterone; Cysti | 1988 |
A new syndrome: angiotensin-converting enzyme dysfunction syndrome: differential diagnosis and pathogenesis--case reports.
Topics: Adolescent; Adult; Aldosterone; Angiotensin I; Angiotensin II; Bartter Syndrome; Humans; Hyperaldost | 1988 |
Therapeutic results of primary aldosteronism with special reference to renal or renovascular lesions.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Diet, Sodium-Restricted; Female; Furosemide; H | 1988 |
Aldosterone-producing adenoma presenting with hypokalemic myopathy. Case report and review.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Child; Creatine Kinase; Humans; Hypera | 1988 |
Renal function curve in patients with secondary forms of hypertension.
Topics: Adult; Aldosterone; Blood Pressure; Creatinine; Female; Humans; Hyperaldosteronism; Hypertension, Re | 1987 |
Primary aldosteronism by carcinoma of the adrenal cortex.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Neoplasms; Aldosterone; Combined Modality | 1987 |
[Radioimmunologic determination of aldosterone and renin in the blood in the diagnosis of different forms of arterial hypertension].
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Rena | 1987 |
Effects of sodium intake on the captopril test for primary aldosteronism.
Topics: Adult; Aldosterone; Blood Pressure; Captopril; Diet; Female; Humans; Hyperaldosteronism; Hypertensio | 1987 |
Inactive renin and aldosterone in Bartter's syndrome.
Topics: Adolescent; Aldosterone; Amiloride; Angiotensin I; Angiotensinogen; Animals; Bartter Syndrome; Capto | 1987 |
[Detection of primary aldosteronism using the captopril test].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Captopril; Female; Humans; Hyp | 1987 |
[Clinical and morphologic characteristics of low-renin hyperaldosteronism].
Topics: Adrenal Cortex; Adult; Aldosterone; Enzyme Repression; Humans; Hyperaldosteronism; Hyperplasia; Midd | 1987 |
[Evaluation of the hypotensive effect of unilateral adrenalectomy in patients with low-renin hyperaldosteronism].
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Blood Pressure; Evaluation Studies as Topic; Follow-Up S | 1987 |
Dietary sodium deprivation raises blood pressure in the rat but does not produce irreversible hyperaldosteronism.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Corticosterone; Heart Rate; Hyperaldosteronism; M | 1987 |
Preoperative lateralisation of aldosteronomas by aldosterone/cortisol ratios in adrenal venous plasma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldoster | 1987 |
[A case of pachydermoperiostosis with Bartter's syndrome].
Topics: Adult; Aldosterone; Bartter Syndrome; Humans; Hyperaldosteronism; Male; Osteoarthropathy, Primary Hy | 1988 |
Extrarenal role of aldosterone in the regulation of blood pressure.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Canrenoic Acid; Humans; Hydrocortisone; Hyperaldosteronism | 1988 |
[Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III].
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adult; Aldosterone; Angiotensin II; Angiotensin III; Circad | 1988 |
Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism.
Topics: Adult; Aldosterone; Cell Separation; Cells, Cultured; Extracellular Space; Female; Humans; Hyperaldo | 1987 |
Effect of verapamil on aldosterone secretion in primary aldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Verapamil | 1987 |
Primary aldosteronism at Henry Ford Hospital in the 1980s.
Topics: Adrenalectomy; Adult; Aldosterone; Combined Modality Therapy; Female; Humans; Hyperaldosteronism; Hy | 1987 |
[Primary hyperaldosteronism: diagnosis, treatment and histopathological findings in 15 cases].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldostero | 1987 |
Adrenocortical carcinoma presenting as primary aldosteronism in a young man.
Topics: Adrenal Cortex Neoplasms; Adult; Aldosterone; Carcinoma; Diagnosis, Differential; Humans; Hyperaldos | 1987 |
Radioimmunoassay of urinary 21-deoxytetrahydroaldosterone in primary aldosteronism and 21-hydroxylase deficiency.
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Child; Female; Humans; Hyperaldosteronism; Male; Radio | 1986 |
21-Deoxyaldosterone excretion in patients with primary aldosteronism and 21-hydroxylase deficiency.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Aldosterone; Chromatography, High Pressure Liqui | 1987 |
Clinical aspects of hyper- and hypo-mineralocorticoidism.
Topics: Adrenal Hyperplasia, Congenital; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Japan; Kana | 1987 |
New insights into the medical management of primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Angiotensin II; Calcium Channel Blockers; Fem | 1986 |
Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Blood Pressure; Female; Humans; Hyperald | 1986 |
[Bartter syndrome and pseudo-Bartter syndrome--a case report].
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Bartter Syndrome; Blood Pressure; Cathartics; Diagnos | 1986 |
Primary aldosteronism due to a malignant ovarian tumour.
Topics: Aldosterone; Female; Hormones, Ectopic; Humans; Hyperaldosteronism; Middle Aged; Ovarian Neoplasms; | 1986 |
[The renin-angiotensin-aldosterone system in children and adolescents with nephrogenic hypertension].
Topics: Adolescent; Aldosterone; Blood Pressure; Child; Chronic Disease; Fibromuscular Dysplasia; Humans; Hy | 1986 |
Is single oral administration of captopril beneficial in screening for primary aldosteronism?
Topics: Adult; Aldosterone; Angiotensin II; Captopril; Diagnosis, Differential; Diet, Sodium-Restricted; Hum | 1986 |
Diagnostic value of captopril test in primary aldosteronism.
Topics: Adult; Aldosterone; Captopril; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; | 1986 |
Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Topics: Adolescent; Aldosterone; Dexamethasone; Humans; Hyperaldosteronism; Hypertension; Male; Posture; Ren | 1987 |
Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension; | 1986 |
A case report of aldosterone producing adenoma with masked hyperaldosteronemia.
Topics: Adenoma; Adrenal Cortex Neoplasms; Aldosterone; Female; Furosemide; Humans; Hyperaldosteronism; Midd | 1986 |
Response of collecting tubule cells to aldosterone and potassium loading.
Topics: Aldosterone; Animals; Hyperaldosteronism; Kidney Tubules; Kidney Tubules, Collecting; Male; Potassiu | 1987 |
The renal kallikrein-kinin system: a look at the controversies.
Topics: Aldosterone; Animals; Body Water; Humans; Hyperaldosteronism; Kallikreins; Kidney; Kinins; Renal Cir | 1986 |
False localization of an aldosteronoma by dexamethasone-suppressed adrenal scintigraphy.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cholesterol; Dexamethasone; Diagnostic Errors | 1987 |
Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
Topics: Adult; Aldosterone; Dopamine; Female; Humans; Hyperaldosteronism; Male; Metoclopramide; Middle Aged; | 1986 |
[Potentials for studying aldosterone by using the Adrenoprobe (a preliminary report)].
Topics: Adult; Aged; Aldosterone; Electrodes; Evaluation Studies as Topic; Female; Humans; Hyperaldosteronis | 1986 |
[Clinical significance and characteristics of the radioimmunologic determination of aldosterone levels in serum (plasma)].
Topics: Adolescent; Adult; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension | 1986 |
Distinguishing aldosterone-producing adenoma from other forms of hyperaldosteronism and lateralizing the tumour pre-operatively.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Hum | 1986 |
Role of aldosterone in the mechanism of renal potassium adaptation.
Topics: Adaptation, Physiological; Adrenalectomy; Aldosterone; Animals; Epithelium; Hyperaldosteronism; Kidn | 1986 |
[Fundamental evaluation of aldosterone by aldosterone radioimmunoassay kit II].
Topics: Aldosterone; Evaluation Studies as Topic; Humans; Hyperaldosteronism; Hypertension; Radioimmunoassay | 1986 |
A simple method for definition of incomplete suppression of aldosterone and its association with hypertension and hypokalaemia in man.
Topics: Aged; Aldosterone; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Hypertension; Hypoka | 1986 |
[Diagnosis of primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Diagnosis, Differential | 1986 |
[Diagnosis and surgical treatment of aldosteroma].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Midd | 1986 |
Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Topics: 18-Hydroxycorticosterone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Corticosterone; Depres | 1985 |
Calcium metabolism and parathyroid function in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenalectomy; Adult; Aged; Aldosterone; Blood Pressure; Calcium; | 1985 |
[Plasma renin activity, plasma aldosterone concentration in the differential diagnosis of curable forms of secondary hypertension].
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Angiotensin II; Diagnosis, Differential; Humans; Hyper | 1985 |
[Pseudo-Bartter syndrome in diuretics abuse].
Topics: Aldosterone; Bartter Syndrome; Female; Furosemide; Humans; Hyperaldosteronism; Hypokalemia; Middle A | 1985 |
Body-sodium and blood volume in a patient with licorice-induced hypertension.
Topics: Aged; Aldosterone; Blood Volume; Diagnosis, Differential; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrh | 1985 |
Urinary excretion of kallikrein before and after operation for aldosterone-producing adenoma.
Topics: Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Kallikreins; Male; Mi | 1985 |
[Results of the surgical management of primary aldosteronism based on a retrospective analysis of preoperative diagnosis and morphology of the adrenal gland].
Topics: Adrenal Glands; Adrenalectomy; Adult; Age Factors; Aged; Aldosterone; Angiotensin II; Corticosterone | 1985 |
Malignant hypertension due to an aldosterone producing adrenal adenoma.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension, | 1985 |
Adrenalectomy in primary aldosteronism: a long-term follow-up study.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blo | 1985 |
Primary aldosteronism: diagnosis and noninvasive lateralization procedures.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Blood Pressu | 1985 |
Clinical evaluation of the captopril screening test for primary aldosteronism.
Topics: Adult; Aldosterone; Captopril; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal | 1985 |
The diagnostic value of the 24 hour integrated concentration of plasma aldosterone.
Topics: Adolescent; Adult; Aged; Aldosterone; Analysis of Variance; Child; Diagnosis, Differential; Evaluati | 1985 |
Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizine-induced pseudoaldosteronism.
Topics: Adult; Aged; Aldosterone; Aspartate Aminotransferases; Blood Gas Analysis; Creatine Kinase; Female; | 1985 |
The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels.
Topics: 18-Hydroxycorticosterone; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Corticoster | 1985 |
Therapeutic effect of calcium channel blockade in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Aged; Aldosterone; Blood Pressure; Female; Humans; Hyperal | 1985 |
Evidence that aldosterone influences transport in target tissues by dissimilar mechanisms.
Topics: Aldosterone; Amiloride; Animals; Biological Transport; Biomechanical Phenomena; Chlorides; Colon; Hy | 1985 |
[Localization of aldosterone-producing tumor: comparative study of computed tomography, adrenal scintigraphy, and venous sampling].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldostero | 1985 |
Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension.
Topics: Adenoma; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Melanocyte-Stim | 1985 |
The second Sir George Pickering memorial lecture. What regulates whole body autoregulation? Clinical observations.
Topics: Adult; Aldosterone; Autonomic Nervous System Diseases; Blood Pressure; Body Fluids; Cardiac Output; | 1985 |
Aldosterone-producing gigantic adrenocortical adenoma with calcifications and cysts.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adult; Aldosterone; Calcinosis; Cysts; Hu | 1985 |
21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Hyperplas | 1985 |
Selective blood sampling in adrenal hypertension.
Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adult; Aldosterone; Cushing Syndrome; Epinephrine; | 1985 |
[The effects of metoclopramide and dopamine on aldosterone secretion in cultured adrenocortical adenoma cells and adjacent non-adenoma cells from patients with primary aldosteronism].
Topics: Adenoma; Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Aldosterone; Cells, Cultured; Chromatograp | 1985 |
[Serum aldosterone level in patients with hypertension during treatment by acupuncture].
Topics: Acupuncture Therapy; Adult; Aldosterone; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Hype | 1985 |
[Bartter's syndrome].
Topics: Adult; Aldosterone; Bartter Syndrome; Chlorides; Female; Humans; Hyperaldosteronism; Male; Naproxen; | 1985 |
Primary aldosteronism with normal aldosterone levels in blood and urine.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Female; Humans; Hyperaldosteronism; Mi | 1985 |
[Plasma aldosterone concentration in patients with primary aldosteronism in the last decade].
Topics: Adult; Aldosterone; Blood Pressure; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Mal | 1985 |
[Clinical picture, diagnosis and surgical treatment of aldosteromas].
Topics: Adrenal Cortex Neoplasms; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldoster | 1985 |
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
Topics: Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Age Fac | 1970 |
Raised plasma angiotensin II and aldosterone during dietary sodium restriction in man.
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Mal | 1972 |
Mineralocorticoids and rectal potential difference.
Topics: Aldosterone; Biological Transport, Active; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Me | 1973 |
Editorial: Sodium and the pressor role of angiotensin.
Topics: Aldosterone; Angiotensin II; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Hypertension, | 1973 |
Hypertension and secondary hyperaldosteronism associated with a renin-secreting renal juxtaglomerular-cell tumour.
Topics: Aldosterone; Angiotensin II; Child; Female; Humans; Hyperaldosteronism; Hypertension, Renal; Juxtagl | 1973 |
Inhibition by heparinoid of aldosterone biosynthesis in man.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Angiotensin II; Blood; Corticosterone; Female; | 1966 |
Clinical investigation of the effects of adrenal corticosteroid excess on the colon.
Topics: Addison Disease; Adrenal Cortex Hormones; Adrenocortical Hyperfunction; Adult; Aldosterone; Colon; C | 1969 |
Possible mechanism of action for aldosterone-induced hypertension.
Topics: Aldosterone; Animals; Blood Pressure; Carotid Sinus; Humans; Hyperaldosteronism; Hypertension; Hyper | 1970 |
The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aldosterone; Blood Pressure; Female; Glycosaminoglycans; | 1966 |
Proceedings: On the role of diuretic-and spironolactone-induced hyperaldosteronism on electrolyte excretion in man.
Topics: Aldosterone; Diuretics; Furosemide; Humans; Hyperaldosteronism; Potassium; Sodium; Spironolactone; T | 1974 |
Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.
Topics: Aldosterone; Butanes; Depression, Chemical; Diuresis; Hematocrit; Humans; Hydrochlorothiazide; Hyper | 1974 |
The effect of saluretics and spironolactone on aldosterone production and electrolyte excretion in man.
Topics: Adult; Aldosterone; Butanes; Diuresis; Female; Furosemide; Humans; Hydrochlorothiazide; Hyperaldoste | 1974 |
On the role of renin-angiotensin system with special relation to aldosterone for the etiology of hypertension.
Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Blood; Hyperaldosteronism; Hypertension; In Vit | 1966 |
Postoperative studies of adrenal function in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angioten | 1966 |
[Aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Animals; Edema; Female; Humans | 1965 |
The effect of heparin on aldosterone secretion and metabolism in primary aldosteronism.
Topics: Aldosterone; Angiotensin II; Carbon Isotopes; Chromatography, Paper; Heparin; Humans; Hyperaldostero | 1966 |
Normotensive secondary hyperaldosteronism.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Child, Preschool; Diet Therapy; Dwarfism; Female | 1966 |
Effects of amino-glutethimide on adrenal function in man.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hor | 1967 |
Primary aldosteronism with unusual secretory pattern.
Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Desoxycorticosterone; Dexamethaso | 1967 |
[Study on corticosterone secretion rate with reference to normal and hypertensive subjects].
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Aldosterone; Body Constitut | 1966 |
Role of aldosterone in edema formation.
Topics: Aldosterone; Angiotensin II; Edema; Heart Failure; Humans; Hyperaldosteronism; Kidney; Liver; Liver | 1966 |
In vitro aldosterone production by adrenals of normal recipient rats cross-circulated with rats with secondary hyperaldosteronism of dietary sodium restriction.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Animals; Diet, Sodium-Restricted; Hyperald | 1967 |
[Activity of renin/angiotensin system and secretion of aldosterone during pregnancy].
Topics: Aldosterone; Amniotic Fluid; Angiotensin II; Animals; Blood Volume; Female; Humans; Hyperaldosteroni | 1966 |
[Electrolyte-and acid-base equilibrium in functional anomalies of the adrenal cortex].
Topics: Acid-Base Equilibrium; Acidosis; Acids; Addison Disease; Adrenal Gland Diseases; Adrenocorticotropic | 1966 |
The aldosterone-renin constellation in Conn's syndrome.
Topics: Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Chromatography; Female; Humans; Hyperaldostero | 1967 |
Double isotope assay of aldosterone, corticosterone and cortisol in human peripheral plasma.
Topics: Adrenocorticotropic Hormone; Aldosterone; Carbon Isotopes; Chromatography, Paper; Corticosterone; Fu | 1968 |
Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).
Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Aldosterone; Ammonium Chloride; Angiotensin II; Bicarb | 1968 |
Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angioten | 1968 |
Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Dexameth | 1968 |
Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; A | 1968 |
[The physiological relationship between the renin-angiotensin system and aldosterone].
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Heart Failure; Humans; Hyperald | 1965 |
[Renin and aldosterone in human arterial hypertension (excluding Conn's syndrome)].
Topics: Adult; Aldosterone; Angiotensin II; Diagnosis, Differential; Diet, Sodium-Restricted; Female; Humans | 1965 |
[Secondary hyperaldosteronism].
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin | 1968 |
[Secondary aldosteronism].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Volume; Child; Female; Humans | 1968 |
Aldosterone production after suppression of corticotropic secretory activity.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Depression, Chemical; Dexamethasone; Diet, | 1968 |
[The renin-angiotensin-aldosterone axis. Pathophysiological mechanisms and differential diagnostic patterns].
Topics: Aldosterone; Angiotensin II; Diagnosis, Differential; Hyperaldosteronism; Hypertension, Renal; Juxta | 1968 |
A case of glucocorticoid-responsive hyperaldosteronism.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Blo | 1968 |
Suppressed plasma renin activity in hypertension.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aldostero | 1969 |
Manipulation by corticotropin and cortisol of aldosterone secretion in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfunction; Adrenocorticotropic | 1969 |
Activation of aldosterone secretion in primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Glucocorticoids; | 1969 |
[Differential diagnosis of the Bartter syndrome].
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Biopsy; Chymosin; Diagnosis, Differential; Female; Hu | 1968 |
Studies of plasma renin activity in patients with hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Diagnosis, Differential; Diet, Sodium-Restricted; Female; Humans | 1968 |
[Does the recent knowledge on the renin-angiotensin system have clinical applications?].
Topics: Aldosterone; Angiotensin II; Blood Pressure; Feedback; Humans; Hyperaldosteronism; Hypertension; Jux | 1968 |
A case of Bartter's syndrome with abnormal renin response to salt load.
Topics: Adrenal Gland Diseases; Aldosterone; Alkalosis; Angiotensin II; Blood Pressure; Child; Diet; Dwarfis | 1969 |
[Determination of renin activity and aldosteronuria in 24 hypertensives].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hype | 1968 |
Medical grand rounds from the University of Alabama Medical Center.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertens | 1969 |
[Plasma renin activity in peripheral venous blood under various stimulation conditions].
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Arteriosclerosis; Blood Pressure; Creat | 1969 |
Chronic laxative-induced hyperaldosteronism and hypokalemia simulating Bartter's syndrome.
Topics: Aldosterone; Angiotensin II; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Blood Volume Determ | 1969 |
[Secondary hyperaldosteronisms].
Topics: Aldosterone; Angiotensin II; Heart Failure; Hyperaldosteronism; Hyperkalemia; Hypertension, Malignan | 1969 |
[Physiopathology of renovascular hypertension].
Topics: Aldosterone; Angiotensin II; Creatinine; Humans; Hyperaldosteronism; Hypertension, Malignant; Hypert | 1968 |
[Study on the renin-angiotensin-aldosterone system. Effects of sodium restriction and postural changes on plasma renin activity and fluctuation in urinary aldosterone].
Topics: Aldosterone; Angiotensin II; Blood Pressure; Chromatography, Thin Layer; Diet, Sodium-Restricted; Hu | 1969 |
Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Carbon Iso | 1969 |
Studies of the renin-angiotensin-aldosterone system in patients with hypertension and in normal subjects.
Topics: Aldosterone; Angiotensin II; Blood Urea Nitrogen; Body Weight; Creatinine; Diet; Diet, Sodium-Restri | 1969 |
Renin-angiotensin-aldosterone system in hypertension. The clinical usefulness of measuring components of thisystem.
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Renin | 1969 |
A sibship with Bartter's syndrome: failure of total adrenalectomy to correct the potassium wasting.
Topics: Adrenal Gland Diseases; Adrenalectomy; Aldosterone; Alkalosis; Angiotensin II; Child, Preschool; Ery | 1969 |
Renal and adrenal factors in hypertension: diagnostic approaches.
Topics: Aldosterone; Angiotensin II; Contraceptives, Oral; Female; Humans; Hyperaldosteronism; Hypertension, | 1969 |
Hypermineralocorticoid-induced hypertension.
Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldosterone; Desoxycorticosterone; Humans | 1969 |
Hyperaldosteronism in hypertensive congenital adrenal hyperplasia.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenal Rest Tumor; Adr | 1969 |
Pathogenesis of Bartter's syndrome.
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Albumins; Aldosterone; Alkalosis; Angiotensin I | 1969 |
Primary aldosteronism in a hypertensive acromegalic patient.
Topics: 17-Hydroxycorticosteroids; Acromegaly; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone | 1969 |
[Diagnosis of secondary hyperaldosteronism].
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Diagnosis, Differential; Humans; Hyperaldo | 1969 |
[Hypertension and endocrinology].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Angiotensin II; Catecholamines; Cushi | 1969 |
Aldosteronism in hypertensive disease.
Topics: Adrenal Gland Diseases; Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Potas | 1970 |
[Renin, angiotensin, aldosterone and arterial hypertension. II].
Topics: Aldosterone; Angiotensin II; Animals; Dogs; Humans; Hyperaldosteronism; Hypertension, Renal; Juxtagl | 1969 |
[A case of arterial hypertension imputable to an estroprogestational contraceptive. Implication of the renin-angiotensin-aldosterone system].
Topics: Adult; Aldosterone; Angiotensin II; Contraceptives, Oral; Estrogens; Female; Humans; Hyperaldosteron | 1969 |
[Secondary hyperaldosteronism].
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Potassium | 1969 |
Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
Topics: Adolescent; Adrenocortical Hyperfunction; Adult; Aldosterone; Angiotensin II; Contraceptives, Oral; | 1970 |
An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone.
Topics: Adolescent; Adrenal Cortex Hormones; Albumins; Aldosterone; Alkalosis; Angiotensin II; Creatinine; D | 1970 |
Laboratory determinations of aldosterone and their clinical significance.
Topics: Aldosterone; Angiotensin II; Carbon Isotopes; Chemistry, Clinical; Chromatography; Desoxycorticoster | 1970 |
Clinical manifestations of primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Diagnosis, Differential; Female; Humans; Hyper | 1970 |
Secondary aldosteronism: with observations on the definition of hypokalemia.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Blood Volume; Edema; Estrogens; Female; Gl | 1970 |
Renin and angiotensin in relation to aldosterone.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Dogs; Furosemide; Heparin; Humans; Hydrocortis | 1970 |
[Endocrine hypertension].
Topics: Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Aldosterone; | 1970 |
[Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension].
Topics: Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Animals; Contraceptives, Oral; Female; Humans; | 1970 |
The etiopathology of hypertension.
Topics: Adrenal Hyperplasia, Congenital; Aldosterone; Angiotensin II; Blood Pressure; Blood Volume; Cardiac | 1970 |
Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease?
Topics: Aldosterone; Alkalosis; Angiotensin II; Bone Diseases; Child; Child, Preschool; Humans; Hyperaldoste | 1970 |
[Clarification of a hypertension].
Topics: Aldosterone; Angiotensin II; Aortic Coarctation; Blood Pressure Determination; Creatinine; Cushing S | 1970 |
[Primary aldosteronism].
Topics: Adrenocorticotropic Hormone; Aldosterone; Humans; Hyperaldosteronism; Hypertension, Renal; Kidney Di | 1969 |
On the role of aldosterone to hypertension, especially an extent of its participation.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Angiotensin II; Animals; Blood Pressure; Femal | 1971 |
The role of aldosterone in pathogenesis of arterial hypertension.
Topics: Addison Disease; Aldosterone; Angiotensin II; Animals; Arteries; Cushing Syndrome; Fundus Oculi; Hum | 1971 |
Determination of plasma renin concentration by angiotensin I immunoassay. Diagnotic import of precise measurement of subnormal renin in hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Hyperfunction; Aldos | 1971 |
Neurodegenerative disorders and hyperaldosteronism.
Topics: Adolescent; Aldosterone; Angiotensin II; Birth Weight; Blood Pressure; Body Weight; Bundle-Branch Bl | 1971 |
Bartter's syndrome. A manifestation of renal tubular defects.
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Bicarbonates; Chlorides; Diet Therapy; Diet, Sodium-R | 1972 |
Deoxycorticosterone production and regulation in man.
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Carbon Isotopes; Desoxycorticostero | 1972 |
[The renin-angiotensin-aldosterone system. Disorders and methods of clinical research].
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aldosterone; Angiotensin II; Dexamethasone; Electrol | 1970 |
Plasma desoxycorticosterone levels in man with simultaneous measurement of aldosterone, corticosterone, cortisol and 11-deoxycortisol.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Carbon Isotopes; Chromatography, Paper; Co | 1972 |
[The significance of renin-angiotensin-aldosterone system (RAA) in pathophysiology and diagnosis].
Topics: Acute Kidney Injury; Aldosterone; Angiotensin II; Animals; Blood Pressure; Diagnosis, Differential; | 1972 |
Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Angiotensin II; Blood Pr | 1972 |
Low renin hypertension and the adrenal cortex.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Blood Pressure; Cor | 1972 |
[Renin-angiotensin-aldosterone system in water-electrolyte homeostasis].
Topics: Aldosterone; Angiotensin II; Autonomic Nervous System; Electrolytes; Humans; Hyperaldosteronism; Hyp | 1972 |
The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly.
Topics: Acromegaly; Adolescent; Adult; Aldosterone; Angiotensin II; Blood Volume; Female; Growth Hormone; Hu | 1972 |
[Suppression and stimulation of plasma renin concentration in primary hyper-aldosteronism].
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Diet, Sodium-Restricted; Female; Humans; Hyperal | 1972 |
The regulation of aldosterone secretion in primary aldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Electrolytes; Humans; Hyperaldosteronism; | 1972 |
A kindred with familial glucocorticoid suppressible aldosteronism.
Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Aldosterone; Binding, Competitive; Child; Dexam | 1973 |
[Etiology of hyperaldosteronemia in adrenogenital syndrome].
Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Child; Fe | 1972 |
The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism).
Topics: Adolescent; Aldosterone; Angiography; Angiotensin II; Circadian Rhythm; Fluorescent Antibody Techniq | 1972 |
[Arterial hypertension and mineralocorticoids].
Topics: Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Cortisone; Cushing Syndrome; Female | 1973 |
Stand up and be diagnosed.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Angiotensin II; Diagnosis, Differential; Humans; Hype | 1973 |
Dexamethasone-suppressible hyperaldosteronism.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Aldosterone; Co | 1973 |
[Plasma aldosterone levels in primary aldosteronism. 1. Renin-angiotensin system and aldosterone].
Topics: Aldosterone; Angiotensin II; Enzyme Activation; Furosemide; Humans; Hydrochlorothiazide; Hyperaldost | 1973 |
Six year follow-up of a child with Bartter syndrome.
Topics: Aldosterone; Alkalosis; Angiotensin II; Biopsy; Blood Pressure; Child, Preschool; Diet Therapy; Fema | 1973 |
[Plasma aldosterone levels in primary aldosteronism. II. Aldosterone and ACTH].
Topics: Adrenocorticotropic Hormone; Aldosterone; Desoxycorticosterone; Dexamethasone; Humans; Hyperaldoster | 1973 |
Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aldoste | 1973 |
Some observations on the pathogenesis of Bartter's syndrome.
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Blood Volume; Drug Therapy, Combination; Humans; Hype | 1973 |
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
Topics: Aldosterone; Angiotensin II; Arteries; Blood Pressure; Diuretics; Humans; Hyperaldosteronism; Hypert | 1973 |
Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia.
Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Circadian Rhythm; Dexamethasone; Diet; Female; Hu | 1973 |
Proceedings: Blueprints for the solution of three endocrinological enigmas. The Sir Henry Dale Lecture for 1973.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Blood Glucose; Ca | 1973 |
[Concentration of aldosterone in the blood and its reactions to various stimulations in primary aldosteronism and various other diseases].
Topics: Aldosterone; Angiotensin II; Diet; Diuretics; Humans; Hyperaldosteronism; Posture; Sodium | 1973 |
Hormonal profiling in the diagnosis and treatment of essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Contraceptives, Oral; Female; Humans; Hyperaldosteronism; Hypert | 1974 |
[Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy].
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Antihypertensive Agents; Diagnosis, Differential; Human | 1974 |
Response of plasma aldosterone to postural change, diuretica, angiotensin II, sodium restriction or loading and prostaglandin.
Topics: Adrenocortical Hyperfunction; Aldosterone; Angiotensin II; Ascites; Cushing Syndrome; Diet; Diet, So | 1973 |
[Primary and secondary aldosteronism in hypertension].
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hype | 1974 |
Episodic secretion of aldosterone in primary aldosteronism: relationship to cortisol.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Circadian Rhythm; Depression, Chemical; De | 1974 |
Renin-angiotensin-aldosterone system of a woman with Bartter's syndrome: Juxtaglomerular cell hyperplasia without hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Hyp | 1974 |
Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Blood Pressure; Choleste | 1974 |
The role of mineralocorticoids in the pathogenesis of hypokalemic periodic paralysis.
Topics: Adult; Aldosterone; Angiotensin II; Desoxycorticosterone; Humans; Hydrocortisone; Hyperaldosteronism | 1974 |
[Bertter' syndrome in an 8-year-old child].
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Child; Humans; Hyperaldosteronism; Hypokalemia; Male; | 1974 |
Renin and hypertension.
Topics: Aldosterone; Angiotensin II; Antihypertensive Agents; Humans; Hyperaldosteronism; Hypertension; Hype | 1973 |
Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone.
Topics: Aldosterone; Angiotensin II; Child; Colon; Creatinine; Feces; Humans; Hydrocortisone; Hyperaldostero | 1974 |
The adrenal cortex and the kidney.
Topics: Adrenal Cortex; Adrenal Glands; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; Al | 1974 |
[Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
Topics: Aldosterone; Angiotensin II; Ascites; Capillary Permeability; Hemodynamics; Humans; Hyperaldosteroni | 1974 |
[Synthesis in vitro of 18-hydroxycorticosterone and aldosterone by 3 adenomas of the adrenal glomerula zone (Conn's syndrome) I. Conversion output].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Carbon Isotopes; Chromatography, Paper; Citric Acid C | 1969 |
[Synthesis in vitro of 18 hydroxycorticosterone and aldosterone by 3 adenomas of the adrenal glomerula zone (conn's syndrome) II. Metabolic routes].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Carbon Isotopes; Corticosterone; Desoxycorticosterone | 1969 |
Adrenal contribution to plasma oestrogens in adrenal disorders.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adult; Aldosterone; Cushing Syndrome; Es | 1974 |
[Aldosterone, cortisol and plasma renin activity in pheochromocytoma (author's transl)].
Topics: Adrenal Gland Neoplasms; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Pheochromocytoma; | 1974 |
[Mental anorexia associated with hypopotassemia and hyperaldosteronism].
Topics: Adult; Aldosterone; Anorexia Nervosa; Cathartics; Chlorides; Female; Humans; Hyperaldosteronism; Hyp | 1974 |
Bartter's syndrome presenting during pregnancy: results of amiloride therapy.
Topics: Adult; Aldosterone; Amiloride; Bartter Syndrome; Creatine Kinase; Diuretics; Female; Humans; Hyperal | 1974 |
The measurement of aldosterone as a parameter to evaluate portopulmonary shunt.
Topics: Aldosterone; Animals; Blood Proteins; Carbon Radioisotopes; Chlorides; Constriction; Dogs; Hyperaldo | 1974 |
Adrenal scintigraphy in primary aldosteronism.
Topics: Adrenal Glands; Aldosterone; Cholesterol; Female; Humans; Hyperaldosteronism; Iodine Radioisotopes; | 1974 |
Idiopathic edema.
Topics: Adult; Age Factors; Aldosterone; Edema; Female; Heart Failure; Humans; Hydrochlorothiazide; Hydrosta | 1974 |
Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.
Topics: Adult; Aldosterone; Blood Pressure; Diet; Diet, Sodium-Restricted; Fludrocortisone; Humans; Hyperald | 1974 |
[A simple routine method for the radioimmunological determination of urinary aldosterone (author's transl)].
Topics: Aldosterone; Analysis of Variance; Antibody Specificity; Cross Reactions; Glucuronates; Humans; Hydr | 1974 |
[Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
Topics: Adolescent; Adult; Aldosterone; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Hyperte | 1974 |
Glutaminase activity in the kidney of experimental nephrosis.
Topics: Acidosis, Renal Tubular; Aldosterone; Ammonia; Animals; Carbon Dioxide; Glutaminase; Hydrogen-Ion Co | 1974 |
Malignant hypertension with aldosteronoma producing adenoma.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hype | 1974 |
[Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
Topics: Adult; Aldosterone; Bartter Syndrome; Biological Transport, Active; Biopsy; Humans; Hyperaldosteroni | 1974 |
Primary aldosteronism, idiopathic aldosteronism and "low-renin" benign essential hypertension. A retrospective study.
Topics: Adult; Age Factors; Aged; Aldosterone; Blood Pressure; Cerebrovascular Disorders; Female; Humans; Hy | 1974 |
[Bartter's syndrome, a case report and some consideration on pathogenetic mechanism (author's transl)].
Topics: Aldosterone; Bartter Syndrome; Female; Humans; Hyperaldosteronism; Middle Aged; Renin | 1974 |
[Proceedings: Aldosterone secretion in primary aldosteronism: circadian rhythm and fluctuation of plasma aldosterone values following various stimulations and suppression tests].
Topics: Aldosterone; Circadian Rhythm; Humans; Hydrocortisone; Hyperaldosteronism; Radioimmunoassay | 1974 |
[Proceedings: Fluctuation of blood aldosterone concentration in anesthesia and surgery of 5 cases with primary aldosteronism].
Topics: Aldosterone; Anesthesia, Inhalation; Humans; Hyperaldosteronism; Surgical Procedures, Operative | 1974 |
Time series analysis of hormonal patterns in human plasma.
Topics: Adolescent; Adult; Aldosterone; Biological Clocks; Biometry; Circadian Rhythm; Female; Growth Hormon | 1974 |
Management of potassium problems during long-term diuretic therapy.
Topics: Aldosterone; Diet; Diuretics; Extracellular Space; Homeostasis; Humans; Hydrogen-Ion Concentration; | 1974 |
[Aldosterone].
Topics: Adrenal Glands; Aldosterone; Humans; Hyperaldosteronism; Kidney | 1974 |
Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Di | 1973 |
On the pathogenesis of the secondary hyperaldosteronism of the Bartter syndrome.
Topics: Adolescent; Adult; Aldosterone; Alkalosis; Biopsy; Diet Therapy; Female; Humans; Hyperaldosteronism; | 1973 |
[Physiopathology of water-electrolyte disorders in cardiac insufficiency].
Topics: Aldosterone; Catecholamines; Heart Failure; Hemodynamics; Humans; Hyperaldosteronism; Hypokalemia; H | 1973 |
Primary aldosteronism. Photoscanning of tumors after administration of 131 I-19-iodocholesterol.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Cholesterol; Dexamethasone; Diagnosis, Computer-Assiste | 1972 |
[Diagnostic difficulties in the diagnosis of primary hyperaldosteronism].
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Diagnosis, Differential; Humans; H | 1972 |
[Secretion, distribution, and metabolism of aldosterone in various types of hypertension].
Topics: Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Rena | 1972 |
The homeostatic function of the colon in acute gastroenteritis.
Topics: Acute Disease; Aldosterone; Bicarbonates; Child, Preschool; Colon; Diarrhea; Feces; Gastroenteritis; | 1972 |
Bartter's syndrome with possible hypothalamic dysfunction.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Adult; Aldosterone; Amenorrhea; Female; Follicle Stimulatin | 1972 |
[Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Age Factors; Aldosterone; Diet Therapy; Humans; Hyperald | 1972 |
[Pathogenesis of hypertension in primary aldosteronism].
Topics: Aldosterone; Capillary Resistance; Humans; Hyperaldosteronism; Hypertension; Potassium | 1972 |
[New methods of clinical exploration of aldosterone metabolism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Methods | 1972 |
[Iatrogenic heart failure in a case of congenital hypoaldosteronism treated by subcutaneous DOCA implant].
Topics: Acid-Base Equilibrium; Adrenal Insufficiency; Aldosterone; Anemia, Hypochromic; Child, Preschool; De | 1972 |
[Radioimmunoassay of steroid hormones].
Topics: Addison Disease; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Radioimmunoass | 1972 |
Determination of aldosterone by sephadex LH-20 chromatography and radioimmunoassay.
Topics: Aldosterone; Animals; Carbon Isotopes; Chromatography, Gel; Female; Humans; Hyperaldosteronism; Male | 1972 |
Urinary excretion of tetrahydroaldosterone in normal subjects and in patients with adrenal insufficiency and Conn's syndrome.
Topics: Acetylesterase; Adolescent; Adrenal Insufficiency; Adult; Aldosterone; Child; Child, Preschool; Chro | 1972 |
Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
Topics: Adult; Aldosterone; Blood Pressure; Diet, Sodium-Restricted; Female; Furosemide; Humans; Hyperaldost | 1972 |
The diagnostic and therapeutic value of spironolactone in patients with systemic hypertension.
Topics: Acid-Base Equilibrium; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Press | 1973 |
Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; | 1973 |
Metabolic studies in a patient with a phaeochromocytoma associated with hypokalaemia and hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Blood Urea Nitrogen; Blood Volume; Creatinine; | 1973 |
Urinary free aldosterone in healthy people and in patients with primary aldosteronism.
Topics: Aldosterone; Glucuronates; Humans; Hyperaldosteronism; Radioimmunoassay; Tritium | 1973 |
Evaluation of a simplified technic for the measurement of aldosterone in human urine.
Topics: Aldosterone; Carbon Isotopes; Chromatography, Gas; Chromatography, Thin Layer; Female; Humans; Hydro | 1973 |
[Diagnosis and lateral localization of primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Glucuronates; Humans; Hyperaldosteron | 1973 |
Primary excess and deficiency or renin.
Topics: Adolescent; Adult; Aged; Aldosterone; Child; Endocrine System Diseases; Hemangiopericytoma; Humans; | 1973 |
[Relationship between sweat, sodium and potassium excretion and the renin-angiotensin-aldosterone system in hypertension].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adult; Aged; Aldosterone; Child | 1973 |
Volume-dependent essential and steroid hypertension.
Topics: Adult; Aged; Aldosterone; Diet, Sodium-Restricted; Female; Follow-Up Studies; Humans; Hydrochlorothi | 1973 |
Plasma and extracellular fluid volumes in hypertension.
Topics: Aldosterone; Blood Pressure; Diuretics; Extracellular Space; Humans; Hyperaldosteronism; Hypertensio | 1973 |
Experience with primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Follow-Up Studies; Huma | 1973 |
[Studies on the autonomy of aldosterone secretion in primary hyperaldosteronism. Diagnosis and differential diagnosis of "Conn's syndrome"].
Topics: Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; M | 1973 |
Role of the proximal tubule in the regulation of urinary sodium excretion.
Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Animals; Dogs; Edema; Hyperaldosteronism; Kidney Tubules | 1973 |
The role of 18-hydroxy-11-deoxycorticosterone as a precursor in human adrenal tissue in vitro.
Topics: Adrenal Glands; Adult; Aldosterone; Breast Neoplasms; Carbon Isotopes; Humans; Hydroxycorticosteroid | 1973 |
[Significance of hyperaldosteronism in the pathogenesis of arterial hypertension in pheochromocytoma].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Biopsy; Catecholamines; Chromatography, Thi | 1973 |
Diagnostic considerations in secondary hypertension.
Topics: Aldosterone; Aortic Coarctation; Contraceptives, Oral; Cushing Syndrome; Diagnosis, Differential; Hu | 1973 |
A calcified aldosterone-producing tumor in a hypertensive, normokalemic, prepubertal girl.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Calcinosis; Child; Child Behavior Disorders; Desoxyco | 1973 |
Spironolactone as a nonspecific treatment for primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Urea Nitrogen; Body Weight; Carbon Dioxide; Creatini | 1973 |
[Treatment of essential arterial hypertension with spironolactone: its value for the screening of primary hyperaldosteronism and prediction of its efficacy].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Probability; Spironolactone | 1973 |
[The role of anti-aldosterones in the treatment of arterial hypertension].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor Antagonists; Potas | 1973 |
[Radioimmunoassay of plasma aldosterone and its clinical application].
Topics: Aldosterone; Chromatography, Paper; Cross Reactions; Humans; Hyperaldosteronism; Posture; Radioimmun | 1973 |
[Diagnosis of adrenal gland neoplasms causing primary aldosteronism by determination of plasma aldosterone in adrenal- or renal-vein blood].
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Child; Female; Humans; Hype | 1973 |
Renal tubular acidosis, presenting as a syndrome resembling Bartter's syndrome, in a patient with arachnodactyly.
Topics: Acidosis, Renal Tubular; Adult; Aldosterone; Alkalosis; Biopsy; Humans; Hyperaldosteronism; Hyperpla | 1973 |
The histopathology of Conn's adenoma and of attached adrenal cortex.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Chromatography, Gas; Eosinophi | 1973 |
Primary aldosteronism: observations on water and electrolyte changes during partial immersion.
Topics: Adult; Aldosterone; Blood Pressure; Carbon Radioisotopes; Creatinine; Drinking; Hematocrit; Humans; | 1973 |
[Plasma aldosterone in a patient with primary aldosteronism during and after adenoma excision].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hydrocortisone; Hyperaldostero | 1973 |
[Excretion of aldosterone in the urine in patients with chronic respiratory insufficiency].
Topics: Adrenal Glands; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Respirato | 1973 |
Ultrastructural features of corticomedullary cells in a human adrenocortical adenoma and in rat adrenal cortex.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Animals; Catecholamines; | 1973 |
Isolation of aldosterone urinary metabolites, glucuronides and sulfate.
Topics: Adrenalectomy; Adult; Aldosterone; Carbon Radioisotopes; Chromatography, DEAE-Cellulose; Chromatogra | 1973 |
Radioimmunoassay of aldosterone in adrenal venous effluent in a case of Conn's syndrome.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Animals; Female; Humans; Hyperaldoste | 1973 |
Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone.
Topics: Aldosterone; Animals; Depression, Chemical; Female; Humans; Hyperaldosteronism; Immune Sera; Male; M | 1973 |
Actual incidence of secondary hypertension.
Topics: Adult; Aldosterone; Biopsy; Blood Pressure; Catecholamines; Cushing Syndrome; Diagnosis, Differentia | 1973 |
Endocrine disorders in the elderly.
Topics: Acidosis; Aged; Aldosterone; Blood Glucose; Calcitonin; Diabetes Mellitus; Diet Therapy; Endocrine S | 1974 |
Malignant hypertension in a patient with Conn's syndrome.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Arteriosclerosis; Autopsy; Bronchial Neoplasms | 1974 |
[Aldosterone-Aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Male; Potassium; Sodium | 1974 |
[Aldosteronism in liver diseases].
Topics: Acute Disease; Aldosterone; Chronic Disease; Humans; Hyperaldosteronism; Liver Diseases; Spironolact | 1974 |
[Aldosteronism in cardiopulmonary diseases].
Topics: Aldosterone; Edema; Humans; Hyperaldosteronism; Metabolic Clearance Rate; Pulmonary Heart Disease; S | 1974 |
[Hormonal studies in clinical aspects of internal diseases].
Topics: Adrenal Glands; Aldosterone; Epinephrine; Humans; Hyperaldosteronism; Hypertension; Norepinephrine; | 1974 |
[Endocrine hypertension syndromes of adrenal pathogenesis. II. Syndromes due to hyperaldosteronism and hypercortisolism].
Topics: Adrenocortical Hyperfunction; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hydrocort | 1974 |
Influence of hyperaldosteronism upon gastric secretion.
Topics: Aldosterone; Animals; Dogs; Female; Gastric Juice; Gastric Mucosa; Hyperaldosteronism; Injections, I | 1969 |
[Aldosteronism. Evolution of the problem from 1955 to 1969].
Topics: Adult; Aldosterone; Diagnosis, Differential; Female; History, 20th Century; Humans; Hyperaldosteroni | 1969 |
[Antikaliuretic agents].
Topics: Adult; Aged; Aldosterone; Chemistry; Diuretics; Female; History, 20th Century; Humans; Hyperaldoster | 1971 |
Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adult; Aldosterone; Bicarbonates; Blood Pr | 1971 |
Renovascular hypertension in children.
Topics: Adolescent; Aldosterone; Angiography; Blood Chemical Analysis; Child; Humans; Hyperaldosteronism; Hy | 1970 |
Aldosterone excess and adrenal carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Aldosterone; Carcinoma; Humans; Hyperaldosteronism; Spironolactone | 1972 |
Hyporeninemic hypertension.
Topics: Adolescent; Adrenal Glands; Adult; Aged; Aldosterone; Blood Urea Nitrogen; Catecholamines; Diet, Sod | 1972 |
[Renin and aldosterone regulation in idiopathic edemas].
Topics: Adult; Aldosterone; Edema; Female; Humans; Hyperaldosteronism; Middle Aged; Renin; Spironolactone; S | 1972 |
Primary aldosteronism. Review of diagnostic tests and 15 cases.
Topics: Academic Dissertations as Topic; Adult; Aged; Aldosterone; Diagnosis, Differential; Electrolytes; Ev | 1972 |
Identifying the adrenal lesion in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Angiography; Catheterization; Hemorrh | 1972 |
Diagnosis and localization in primary aldosteronism.
Topics: Adenoma; Administration, Oral; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Catheterization | 1972 |
Preoperative lateralisation of aldosterone-producing tumours in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Catheterization; Cortico | 1972 |
Percutaneous adrenal venography. A clinical study of 50 patients.
Topics: Adolescent; Adrenal Gland Diseases; Adrenal Glands; Adult; Aldosterone; Catheterization; Cushing Syn | 1972 |
Hypertension.
Topics: Adult; Aldosterone; Antihypertensive Agents; Black or African American; Diet; Humans; Hyperaldostero | 1972 |
Radioimmunoassay of free aldosterone and of its 18-oxo-glucuronide in human urine.
Topics: Aldosterone; Animals; Antibody Formation; Cross Reactions; Glucuronates; Humans; Hyperaldosteronism; | 1972 |
Hypertension with primary and secondary hyperaldosteronism.
Topics: Adenoma; Aldosterone; Blood Pressure; Contraceptives, Oral; Diuretics; Humans; Hyperaldosteronism; H | 1972 |
Renin, aldosterone, sodium and hypertension.
Topics: Adrenal Glands; Adult; Age Factors; Aged; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Kid | 1972 |
[Electrocardiographic observations in secondary aldosteronism].
Topics: Aged; Aldosterone; Body Weight; Digitalis Glycosides; Diuresis; Electrocardiography; Female; Heart F | 1972 |
[Aldosterone and hydrocortisone secretion during prolonged stress and long-term artificial respiration].
Topics: Adult; Aged; Aldosterone; Humans; Hydrocortisone; Hyperaldosteronism; Intensive Care Units; Middle A | 1972 |
Studies on the renin-angiotensin-aldosterone system: studies on histological changes in adrenal and renal tissue; a follow-up study of postoperative blood pressure in primary and idiopathic aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Biopsy; Blood P | 1972 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-1972.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Diagnosis, Di | 1972 |
[When is it useful to measure aldosterone?].
Topics: Aldosterone; Biological Assay; Humans; Hyperaldosteronism | 1972 |
The pattern of plasma renin activity and aldosterone secretion in normal and hypertensive subjects before and after saline infusions.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Blood Pressure; Di | 1971 |
The pattern of electrolyte excretion in normal and hypertensive subjects before and after saline infusions. A simple electrolyte formula for the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Body Weight; Diet; Female; Hum | 1971 |
The diagnostic value of salt depletion and salt loading in screening for secondary hypertension.
Topics: Adrenal Glands; Aldosterone; Hyperaldosteronism; Hypertension; Hypertonic Solutions; Kidney; Natriur | 1971 |
Remission of primary hyperaldosteronism after adrenal venography.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Catheterization; Humans; Hyperaldosteronism; M | 1971 |
Erythrocyte function and aldosterone.
Topics: Adrenalectomy; Aldosterone; Animals; Elasticity; Erythrocytes; Hematocrit; Heparin; Humans; Hyperald | 1971 |
Saline suppression of plasma aldosterone in hypertension.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Infusions, Paren | 1971 |
Renin and aldosterone in essential hypertension.
Topics: Aldosterone; Catecholamines; Diet, Sodium-Restricted; Feces; Humans; Hyperaldosteronism; Hypertensio | 1971 |
[Idiopathic aldosteronism caused by bilateral adrenocortical hyperplasia].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocortical Hyperfunction; Adult; Aldosterone; | 1971 |
[Symposium. II. Hormones and electrolytes].
Topics: Addison Disease; Aldosterone; Calcium; Diabetes Complications; Diabetes Mellitus; Electrolytes; Gluc | 1971 |
[Studies on transcortin and aldosterone-binding proteins in human plasma. II. Studies on the plasma protein binding of various radioactive steroid hormones in patients with various disorders, pregnant women and estrogen-treated patients].
Topics: Addison Disease; Adolescent; Adult; Aged; Aldosterone; Blood Proteins; Carbon Isotopes; Cushing Synd | 1971 |
Hyperaldosteronism due to adrenocortical adenoma and adenomatous hyperplasia.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Hyperfunction; Adult | 1971 |
Adrenal arteriography and venography in primary aldosteronism.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Angiog | 1971 |
A decreased metabolic clearance rate of aldosterone in benign essential hypertension.
Topics: Adaptation, Physiological; Adolescent; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hyper | 1971 |
Visualization of aldosterone-producing tumors (APT) by scintillation scanning (SS) employing tracer amounts of 131 -iodocholesterol.
Topics: Adrenal Gland Neoplasms; Aldosterone; Cholesterol; Humans; Hyperaldosteronism; Iodine Radioisotopes; | 1971 |
Evaluation of renal vascular hypertension and primary hyperaldosteronism.
Topics: Aldosterone; Angiography; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension; Hyperte | 1971 |
Evaluation of select criteria for the diagnosis of primary aldosteronism in normokalemic hypertension.
Topics: Adult; Aldosterone; Desoxycorticosterone; Female; Humans; Hyperaldosteronism; Hypertension; Male; Mi | 1971 |
[Primary aldosteronism from the viewpoint of own observations].
Topics: 17-Ketosteroids; Adrenal Glands; Aldosterone; Germany, East; Humans; Hyperaldosteronism; Hypertensio | 1971 |
Fecal and salivary electrolytes in the diagnosis of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Feces; Female; Humans; Hyperaldosteronism; Hyp | 1971 |
[Primary hyperaldosteronism: differentiation between adenoma and primary hyperplasia of the adrenal glands and operative indications].
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Aldosterone; Dexamethasone; Diagnosis, Dif | 1971 |
[Role of upright posture in the pathogenesis of idiopathic edema].
Topics: Adult; Aldosterone; Edema; Female; Humans; Hyperaldosteronism; Metabolic Clearance Rate; Middle Aged | 1971 |
[Idiopathic edema due to excessive aldosterone secretion on standing].
Topics: Aldosterone; Edema; Female; Humans; Hyperaldosteronism; Middle Aged; Posture | 1971 |
[Clinical studies on the relation between aldosterone and various hypertensive and renal diseases. 1. Studies on the secretion and metabolism of aldosterone in various hypertensive and renal diseases].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Time Factors; Tritium | 1971 |
[Primary aldosteronism with normal secretion of aldosterone].
Topics: Adult; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Kidney Function Tests; Male; Phlebog | 1971 |
A rapid and practical determination of aldosterone in urine by double isotope method.
Topics: Aldosterone; Carbon Isotopes; Chromatography, Thin Layer; Humans; Hyperaldosteronism; Methods; Triti | 1971 |
Aldosterone antagonists and triamterene.
Topics: Aldosterone; Humans; Hyperaldosteronism; Natriuresis; Potassium; Spironolactone; Triamterene | 1966 |
Adrenalectomy for lesions of the adrenal gland.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Adult; Aldosterone; Ca | 1967 |
Plasma renin activity and aldosterone secretion in a pregnant woman with primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Biological Assay; Female; Humans; Hyper | 1967 |
[Clinical significance of the examination of renal excretion of aldosterone in children].
Topics: Adolescent; Aldosterone; Child; Child, Preschool; Chromatography, Thin Layer; Edema; Female; Glomeru | 1969 |
[Treatment of secondary hyperaldosteronism].
Topics: Adrenalectomy; Aldosterone; Aminoglutethimide; Aniline Compounds; Anticonvulsants; Diuretics; Humans | 1969 |
[Primary aldosteronism without association of hypokalemia].
Topics: 17-Hydroxycorticosteroids; Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hyperkalemia; Hy | 1969 |
[Current problems in primary aldosteronism--4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st degree, caused by hyperplasia (2 hypokalemic cases, a normokalemic case)].
Topics: 17-Hydroxycorticosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocortical Hyperfunctio | 1969 |
Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
Topics: Adrenal Glands; Aldosterone; Body Weight; Humans; Hyperaldosteronism; Hypertension; Plasma Volume; P | 1969 |
The control of aldosterone secretion and its relationship to the diagnosis of hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism; Potassium; Renin | 1969 |
[Potassium metabolism in man. 1. Normal physiologic data].
Topics: Adult; Aldosterone; Diuretics; Female; Glomerular Filtration Rate; Humans; Hyperaldosteronism; Kidne | 1969 |
Suppressed plasma renin activity in in hypertensive patients--its evaluation for the diagnosis of primary aldosteronism.
Topics: Aldosterone; Cushing Syndrome; Diet, Sodium-Restricted; Glomerulonephritis; Humans; Hydrochlorothiaz | 1969 |
[Primary aldosteronism].
Topics: Adolescent; Adult; Aldosterone; Carbon Dioxide; Diagnosis, Differential; Female; Humans; Hyperaldost | 1969 |
[8th International Symposium on the Progress in Internal Medicine, 10-22-1969. Diuresis. I. Physiopathology].
Topics: Adrenalectomy; Aldosterone; Biological Transport; Diuresis; Diuretics; Edema; Humans; Hyperaldostero | 1969 |
[Induced aldosteronism in hydropic heart insufficiency].
Topics: Acid-Base Equilibrium; Adult; Aged; Aldosterone; Body Weight; Carbon Isotopes; Cardiac Glycosides; E | 1969 |
[Measurement of aldosterone in peripheral blood and urine--analysis of the method and evaluation of estimated values in normal subjects and aldosteronism].
Topics: Adult; Aldosterone; Carbon Isotopes; Child; Chromatography, Paper; Female; Humans; Hyperaldosteronis | 1969 |
Studies on the biosynthesis of aldosterone in solitary adenoma and in nodular hyperplasia of the adrenal cortex in patients exhibiting Conn's syndrome.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Aldosterone; Chromatography; Cortico | 1969 |
[Biosynthesis of aldosterone and 11-desoxycorticosterone in the adrenal gland and in adenoma in a patient with primary hyperaldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldosterone; Desoxycorticosterone; Humans; | 1969 |
Studies on curable hypertension: special reference to renovascular hypertension and primary aldosteronism.
Topics: Adolescent; Adrenal Glands; Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; | 1969 |
[Aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Renin | 1969 |
[Aldosterone secretion in arterial hypertension].
Topics: Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Middle Aged | 1969 |
[Aldosterone in liver cirrhosis].
Topics: Adult; Aged; Aldosterone; Humans; Hyperaldosteronism; Liver Cirrhosis; Male; Middle Aged | 1969 |
[Urinary aldosterone in pyloric stenosis].
Topics: Adult; Aldosterone; Alkalosis; Humans; Hyperaldosteronism; Middle Aged; Pyloric Stenosis | 1969 |
18-hydroxylation by human adrenal tissue in vitro.
Topics: Adrenal Glands; Aldosterone; Breast Neoplasms; Carbon Isotopes; Corticosterone; Crystallization; Des | 1970 |
A physiologic approach to curable hypertension.
Topics: Adrenal Gland Neoplasms; Aldosterone; Cardiovascular Diseases; Catecholamines; Diagnosis, Differenti | 1970 |
A simple method of measuring transmucosal P.D. in man and its clinical application.
Topics: Aldosterone; Colon; Fludrocortisone; Humans; Hyperaldosteronism; Intestinal Mucosa; Membrane Potenti | 1970 |
[Secretion rate of 18-hydroxycorticosterone. Application of modified Ulick's method to different clinical cases].
Topics: Acetates; Adrenal Glands; Aldosterone; Chromatography; Corticosterone; Humans; Hyperaldosteronism; M | 1970 |
Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients.
Topics: Adolescent; Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Catecholamines; Depre | 1970 |
The intercurrent hypertension of primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Body Weight; Chronic Disease; Desoxyc | 1970 |
[Primary aldosteronism and its surgical treatment].
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Child; Female; Huma | 1970 |
The role of renin in the exaggerated natriuresis of hypertension.
Topics: Adult; Aldosterone; Ethacrynic Acid; Female; Furosemide; Glomerular Filtration Rate; Humans; Hyperal | 1970 |
Saline-resistant metabolic alkalosis or "chloride-wasting nephropathy". Report of four patients with severe potassium depletion.
Topics: Aged; Aldosterone; Alkalosis; Chlorides; Diuretics; Electrolytes; Female; Humans; Hydrocortisone; Hy | 1970 |
The syndrome of primary aldosteronism.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aldosterone; Blood U | 1970 |
A radioimmunoassay for plasma aldosterone.
Topics: 17-Hydroxycorticosteroids; Aldosterone; Animals; Antibodies; Chromatography, Paper; Chromatography, | 1970 |
Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis.
Topics: Adult; Aldosterone; Female; Gentamicins; Humans; Hyperaldosteronism; Hypokalemia; Magnesium; Male; M | 1970 |
On the pathogenesis of metabolic alkalosis in hyperaldosteronism.
Topics: Acid-Base Equilibrium; Adult; Aldosterone; Alkalosis; Bicarbonates; Diet Therapy; Humans; Hyperaldos | 1970 |
[Primary aldosteronism].
Topics: Adult; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; Potassium; Renin | 1970 |
[Renin-angiotensin-aldosterone system: effect of the hypertensive agents on plasma renin activity and clinical application, especially in screening of primary aldosteronism and other simialr diseases].
Topics: Adolescent; Adult; Aldosterone; Animals; Blood Pressure; Denervation; Diazoxide; Dogs; Female; Glome | 1970 |
Measurement of aldosterone secretion rate by radio-immunoassay.
Topics: Adolescent; Adult; Aldosterone; Child; Chromatography, Paper; Female; Humans; Hyperaldosteronism; In | 1970 |
The effects of progesterone on the responses of the cardiovascular system to intravenous infusions of aldosterone.
Topics: Aldosterone; Animals; Blood Pressure; Contraceptives, Oral; Drug Synergism; Female; Femoral Artery; | 1970 |
[1st results of the use of Soludactone in the treatment of certain forms of cerebral edema].
Topics: Adolescent; Adult; Aged; Aldosterone; Brain Edema; Female; Humans; Hyperaldosteronism; Male; Middle | 1970 |
Renal electrolyte cycles and mechanism of nocturia in primary aldosteronism.
Topics: Adult; Aldosterone; Chlorides; Circadian Rhythm; Epinephrine; Female; Glomerular Filtration Rate; Hu | 1970 |
[Functional hyperaldosteronism].
Topics: Aldosterone; Dexamethasone; Hyperaldosteronism; Hypertension; Hypokalemia; Renin | 1970 |
A preliminary evaluation for primary aldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Desoxycorticosterone; Fludrocortisone | 1970 |
Hypertension and adrenal cortex disease. A review of 100 autopsied cases.
Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Autopsy; Fem | 1970 |
Sodium homeostasis, salt appetite, and hypertension.
Topics: Aldosterone; Animals; Anxiety; Appetite; Bicarbonates; Diet; Diet, Sodium-Restricted; Female; Food A | 1970 |
Ultrastructural study of aldosterone-secreting cells of the adrenal cortex.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Cytoplasm; Endoplasmic Reticulum; Fem | 1970 |
Panel discussion: the incidence of aldosteronism and early detection in the population.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Humans; Hyperaldosteronism; Hypertension; Immunoassay | 1970 |
[Idiopathic edemas with secondary hyperaldosteronism. Definition, history, pathogenesis].
Topics: Adult; Age Factors; Aldosterone; Body Weight; Capillary Permeability; Edema; Female; Humans; Hyperal | 1970 |
Hypertension, adrenal abnormalities, and alterations in plasma renin activity.
Topics: Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aldoste | 1970 |
Plasma renin activity and aldosterone secretion rate in hypertension. The distinction between primary and secondary hyperaldosteronism.
Topics: Adolescent; Adrenalectomy; Adult; Aged; Aldosterone; Carbon Isotopes; Creatinine; Female; Humans; Hy | 1970 |
Effects of aldosterone and cortisol on human erythrocyte Na efflux.
Topics: Aldosterone; Biological Transport, Active; Cushing Syndrome; Erythrocytes; Humans; Hydrocortisone; H | 1971 |
Erythrocyte Na flux in a patient with Bartter's syndrome.
Topics: Aldosterone; Alkalosis; Ammonium Chloride; Biological Transport; Biological Transport, Active; Cell | 1971 |
[Functional diagnosis and late results in surgically treated hypertensive patients with renal artery stenosis].
Topics: Adolescent; Adult; Age Factors; Aged; Aldosterone; Angiography; Female; Follow-Up Studies; Functiona | 1971 |
[Clinical evaluation of a new method for the determination of urinary aldosterone].
Topics: Aldosterone; Chromatography, Thin Layer; Edema; Female; Heart Diseases; Humans; Hyperaldosteronism; | 1971 |
Primary aldosteronism associated with acute intermittent porphyria. Report of a case.
Topics: Acyltransferases; Adult; Aldosterone; Catheterization; Enzyme Induction; Feces; Female; Humans; Hype | 1971 |
Postoperative course and treatment in adrenal surgery. I. Electrolyte balance and supplement in primary aldosteronism.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Blood Pressure Determination; Female; Humans; Hyperaldo | 1971 |
Remission or recurrent hyperaldosteronism resulting from subtotal adrenalectomy of adenomatous hyperplastic adrenal glands.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; | 1971 |
Saline suppression of plasma aldosterone and plasma renin activity in hypertension.
Topics: Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension; Male; Postur | 1971 |
[Endocrinologic and circulatory findings in a case of primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Female; Hemodynamics; Humans; Hyperaldosteronism; Hyp | 1971 |
A dynamic study of plasma renin activity and aldosterone concentration in normal and hypertensive subjects.
Topics: Adolescent; Adult; Aldosterone; Body Weight; Diuresis; Female; Furosemide; Humans; Hyperaldosteronis | 1971 |
Urinary citrate excretion in primary aldosteronism.
Topics: Addison Disease; Adult; Aldosterone; Carbon Dioxide; Citrates; Desoxycorticosterone; Dexamethasone; | 1967 |
[Present hypertension problems].
Topics: Aldosterone; Diagnosis, Differential; Humans; Hyperaldosteronism; Hypertension; Renin | 1967 |
[Aldosterone and aldosteronism].
Topics: Aldosterone; Humans; Hyperaldosteronism | 1967 |
[Primary aldosteronism].
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertensi | 1967 |
Aldosterone and electrolyte movements in the colon.
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Intestinal Absorption; Middle Aged; Potassium; Sodi | 1968 |
Aldosterone secretion and sodium balance in salt-losing nephropathy.
Topics: Acidosis; Acute Kidney Injury; Adolescent; Aldosterone; Anemia; Calcium; Chlorides; Dehydration; Die | 1968 |
Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic.
Topics: Adult; Aldosterone; Blood Pressure; Child; Chlorothiazide; Cushing Syndrome; Diet; Female; Humans; H | 1968 |
Primary aldosteronism: review of 12 cases and present diagnostic criteria.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Female; Humans; Hyperaldosteronism; Hypertensi | 1968 |
Primary aldosteronism: experience with current diagnostic criteria and surgical treatment in fourteen patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Female; Humans; Hyperaldosteron | 1968 |
Incidence of suppressed renin activity and of normokalemic primary aldosteronism in hypertensive Negro patients.
Topics: Adult; Aldosterone; Black People; Chlorothiazide; Diet, Sodium-Restricted; Female; Humans; Hyperaldo | 1968 |
Unilateral adrenalectomy for aldosteronomas localized preoperatively by differential adrenal vein catheterization.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Angiography; Ao | 1968 |
Primary aldosteronism.
Topics: Aldosterone; Blood Pressure; Humans; Hyperaldosteronism; Hypertension; Mineralocorticoid Receptor An | 1968 |
Metabolic and hormonal studies in a patient with primary aldosteronism, presenting with acute hypokalaemic paresis induced by chlorothiazide.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Chlorothiazide; Diagnosis, Diff | 1968 |
[Licorice poisoning with hyperaldosteronuria].
Topics: Adult; Aldosterone; Glycyrrhiza; Humans; Hyperaldosteronism; Male; Plants, Medicinal; Substance-Rela | 1968 |
[On the surgical therapy of Conn's disease].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Female; Humans; Hyperaldosteronism; Middle Aged | 1968 |
Aldosterone secretory rates in the normal menstrual cycle.
Topics: Adrenal Glands; Adult; Aldosterone; Body Fluids; Body Weight; Chemistry, Clinical; Contraceptives, O | 1968 |
Aldosteronism in hypertension. The spironolactone response test.
Topics: Adrenalectomy; Aldosterone; Blood Pressure; Body Weight; Diagnosis, Differential; Electrolytes; Huma | 1968 |
Aldosterone secretion in hypertension.
Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aldosterone; Antihyp | 1968 |
Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria.
Topics: Adolescent; Adult; Aldosterone; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hyperte | 1968 |
Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man.
Topics: Adult; Aldosterone; Body Surface Area; Chromatography, Paper; Humans; Hyperaldosteronism; Kidney; Ma | 1968 |
[Secretion, plasma concentration, distribution, metabolism and excretion of aldosterone in healthy and sick subjects].
Topics: Aldosterone; Edema; Glomerulonephritis; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Liv | 1968 |
[Renin studies in idiopathic edemas with secondary hyperaldosteronism].
Topics: Adolescent; Adult; Aldosterone; Dextrans; Edema; Female; Humans; Hyperaldosteronism; Infusions, Pare | 1968 |
Surgical treatment of primary aldosteronism.
Topics: Adenoma; Adolescent; Adrenalectomy; Adult; Aldosterone; Child; Child, Preschool; Female; Humans; Hyp | 1968 |
[Conn's syndrome and similar diseases].
Topics: Aldosterone; Female; Humans; Hydrocortisone; Hyperaldosteronism; Male; Potassium; Renin; Sodium | 1968 |
[Kidney artery stenosis, renal hypertension and secondary hyperaldosteronism in an 8-year-old boy. (Stunted growth through potassium deficiency)].
Topics: Adrenal Glands; Aldosterone; Child; Dwarfism; Humans; Hyperaldosteronism; Hypertension, Renal; Hypok | 1968 |
[Hyperaldosteronism and the use of aldactone in cardiac insufficiency].
Topics: Adult; Aldosterone; Blood Flow Velocity; Blood Volume; Cardiac Output; Diuresis; Female; Heart Failu | 1968 |
[Aldosterone and arterial hypertension].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal | 1968 |
[The syndrome of hyperaldosteronism caused by hyperplasia of the juxtaglomerular apparatus].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hyperplasia; Juxtaglomerular Apparatus; Renin | 1968 |
[Diagnosis and countermeasures in primary aldosteronism].
Topics: Aldosterone; Electrolytes; Humans; Hyperaldosteronism; Renin | 1968 |
Test for pathologic secretion of aldosterone.
Topics: Adenoma; Adrenal Gland Neoplasms; Aldosterone; Diet; Humans; Hyperaldosteronism; Hyperplasia; Hypert | 1968 |
Aldosterone and hypertension.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Hypokalemia | 1969 |
Preoperative diagnosis of primary aldosteronism, including a comparison of operative findings and preoperative tumor localization by adrenal phlebography.
Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Aldosterone; Catheterization; Cushing S | 1969 |
Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenal Gland Neoplasms; Aldosterone; Blood Pre | 1969 |
A concluding response.
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension; Potassium; Renin | 1969 |
I. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in normal subjects.
Topics: Adult; Aldosterone; Corticosterone; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Ion | 1969 |
Correlation of plasma renin activity and aldosterone secretion rate in hypertensive patients.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Female; Humans; Hyperaldosteronism; Hypertension; Hyperten | 1969 |
Salt loading in renal aldosteronism before and after nephrectomy.
Topics: 17-Ketosteroids; Aged; Aldosterone; Blood Gas Analysis; Blood Pressure; Carbon Dioxide; Cortisone; H | 1969 |
[Hyperaldosteronism after weight reduction by complete fasting].
Topics: Aldosterone; Edema; Fasting; Female; Humans; Hyperaldosteronism; Injections, Intravenous; Male; Midd | 1969 |
Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
Topics: Aldosterone; Humans; Hyperaldosteronism; Potassium; Renin; Serologic Tests; Spironolactone | 1969 |
Aldosteronism and spironolactone.
Topics: Aldosterone; Humans; Hyperaldosteronism; Renin; Spironolactone | 1969 |
Aldosterone and spironolactone.
Topics: Aldosterone; Humans; Hyperaldosteronism; Renin; Spironolactone | 1969 |
[The importance of primary aldosteronism as cause of "essential" hypertension].
Topics: Aldosterone; Female; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Middle Aged; Potassium; | 1969 |
[Hypokalemic metabolic alkalosis].
Topics: Acid-Base Equilibrium; Adrenal Gland Diseases; Adrenocortical Hyperfunction; Adult; Aldosterone; Alk | 1969 |
Non-tumorous "primary" aldosteronism: II. Type not relieved by glucocorticoid.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Adult; Aldosterone; Blood | 1969 |
Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenalectomy; Adult; Aldosterone; Androgens | 1969 |
Aldosteronoma and nonfunctioning adrenal cortical adenoma. Comparative ultrastructural study.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Cytoplasm; Female; Humans; Hyperaldosteronism; | 1969 |
Primary aldosteronism: diagnosis and treatment.
Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adult; Aldosterone; Glucose Tolerance Test; Humans; Hyper | 1969 |
Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Animals; Biological Assay; Blood Urea Nitrogen; Chlorot | 1969 |
[Therapeutically induced aldosteronism in hydropic cardiac insufficiency].
Topics: Aldosterone; Carbon Isotopes; Cardiac Glycosides; Diuretics; Heart Failure; Humans; Hyperaldosteroni | 1969 |
The effect of adrenal steroids on stool composition, as revealed by in vivo dialysis of faeces.
Topics: Adult; Aldosterone; Depression, Chemical; Dialysis; Feces; Female; Fludrocortisone; Humans; Hydrocor | 1969 |
Biosynthesis of C-18-oxygenated steroids by an aldosterone-secreting human adrenal tumor. Metabolism of [4-14C] progesterone, [1,2-3H]11-deoxycorticosterone, and [4-14C] pregnenolone.
Topics: Adrenal Gland Neoplasms; Adult; Aldosterone; Chromatography, Paper; Chromatography, Thin Layer; Deso | 1965 |
[Secondary aldosteronism following surgery using the heart-lung machine and its regulation with Aldactone].
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aldosterone; Alkalosis; Cardiac Surgical Procedures; Child | 1965 |
[Aldostenuria in patients suffering from pneumonia associated with acute renal insufficiency; (Preliminary report)].
Topics: Acute Kidney Injury; Aged; Aldosterone; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Pneum | 1965 |
Growing points. Hormones and the endocrine system.
Topics: Aldosterone; Calcitonin; Endocrine Glands; Growth Hormone; Hormones; Humans; Hyperaldosteronism; Hyp | 1966 |
Treatment of primary and secondary hyperaldosteronism.
Topics: Aldosterone; Humans; Hyperaldosteronism | 1966 |
[Variations of urinary aldosterone before and after intervention in a case of right renal artery stenosis with the hypertensive syndrome].
Topics: Aldosterone; Humans; Hyperaldosteronism; Hypertension, Renal; In Vitro Techniques; Male; Middle Aged | 1966 |
The direct effect of increased sodium concentration in adrenal arterial blood on corticosteroid secretion in sodium deficient sheep.
Topics: Adrenal Glands; Aldosterone; Animals; Arteries; Hyperaldosteronism; Hypernatremia; Secretory Rate; S | 1966 |
Aldosterone metabolism in cardiac failure.
Topics: Aldosterone; Chlorothiazide; Diet, Sodium-Restricted; Digitalis Glycosides; Heart Failure; Humans; H | 1966 |
[Heparin and the biosynthesis of aldosterone in hyperaldosteronism].
Topics: Adult; Aldosterone; Female; Heparin; Humans; Hyperaldosteronism | 1966 |
[Contribution to the clinical aspects and biochemistry of hyperaldosteronism].
Topics: Acid-Base Equilibrium; Adrenal Cortex Hormones; Adult; Aldosterone; Alkalosis; Bicarbonates; Calcium | 1966 |